ligand;target;endogenous;ligand_species;target_species;pubmed_id;action
ML355;12S-LOX;f;;Human;24393039;Inhibition
PKUMDL_MH_1001;15-LOX-1;f;;Human;26290290;Positive
compound 34 [PMID: 20866075];15-LOX-1;f;;Human;20866075;Inhibition
ML351;15-LOX-1;f;;Human;24672829;Inhibition
compound 21n [PMID: 17656086];15-LOX-2;f;;Human;17656086;Inhibition
MLS000536924;15-LOX-2;f;;Human;25111178;Inhibition
I3MT-3;3-Mercaptopyruvate sulfurtransferase;f;;Human;28079151;Inhibition
7-hydroxystaurosporine;3-phosphoinositide dependent protein kinase 1;f;;Human;11896604;Inhibition
BX-795;3-phosphoinositide dependent protein kinase 1;f;;Human;15772071;Inhibition
BX-912;3-phosphoinositide dependent protein kinase 1;f;;Human;15772071;Inhibition
compound 1 [PMID: 20005102];3-phosphoinositide dependent protein kinase 1;f;;Human;20005102;Inhibition
GSK2334470;3-phosphoinositide dependent protein kinase 1;f;;Human;21341675;Inhibition
OSU-03012;3-phosphoinositide dependent protein kinase 1;f;;Human;15205346;Inhibition
PHT-427;3-phosphoinositide dependent protein kinase 1;f;;Human;20197390;Inhibition
urelumab;4-1BB;f;;Human;;Agonist
utomilumab;4-1BB;f;;Human;22406983;Agonist
4-1BB ligand;4-1BB;t;Human;Human;;None
4-acryloylphenol;4-aminobutyrate aminotransferase;f;;Human;16290145;Inhibition
CPP-115;4-aminobutyrate aminotransferase;f;;Human;22168767;Inhibition
vigabatrin;4-aminobutyrate aminotransferase;f;;Human;856582|22168767;Irreversible inhibition
IGN523;4F2hc;f;;Human;;Binding
nitisinone;4-hydroxyphenylpyruvate dioxygenase;f;;Pig;10853644;Inhibition
avitriptan;5-HT1A receptor;f;;Rat;9050026;Agonist
flibanserin;5-HT1A receptor;f;;Human;12177684;Agonist
frovatriptan;5-HT1A receptor;f;;Human;9986723;Agonist
LP-12;5-HT1A receptor;f;;Human;17649988;Agonist
LP-211;5-HT1A receptor;f;;Human;18800769;Agonist
LP-44;5-HT1A receptor;f;;Human;17649988;Agonist
SEP-363856;5-HT1A receptor;f;;Human;31371483;Agonist
1-naphthylpiperazine;5-HT1A receptor;f;;Human;9397179;Full agonist
5-CT;5-HT1A receptor;f;;Human;1386736|9760039|9550290|9205951;Full agonist
5-hydroxytryptamine;5-HT1A receptor;t;;Human;1386736|9760039|10431754|9550290|9205951|15628665;Full agonist
7-methoxy-1-naphthylpiperazine;5-HT1A receptor;f;;Human;9397179;Full agonist
8-OH-DPAT;5-HT1A receptor;f;;Human;1386736|9760039|9550290|15628665|9495870|10611634|12527336|9067310;Full agonist
asenapine;5-HT1A receptor;f;;Human;9760039|8935801;Full agonist
BMY-14802;5-HT1A receptor;f;;Human;9760039;Full agonist
cabergoline;5-HT1A receptor;f;;Human;12388666;Full agonist
clozapine;5-HT1A receptor;f;;Human;9760039|8935801|9732398;Full agonist
CP 93129;5-HT1A receptor;f;;Human;9205951;Full agonist
donitriptan;5-HT1A receptor;f;;Human;10381763;Full agonist
eletriptan;5-HT1A receptor;f;;Human;10193663;Full agonist
EMDT;5-HT1A receptor;f;;Human;10715164;Full agonist
FG-5893;5-HT1A receptor;f;;Human;9760039;Full agonist
flesinoxan;5-HT1A receptor;f;;Human;9760039;Full agonist
L-694,247;5-HT1A receptor;f;;Human;9205951;Full agonist
L-772,405;5-HT1A receptor;f;;Human;10585208;Full agonist
lisuride;5-HT1A receptor;f;;Human;9550290|9205951|12388666;Full agonist
LY 165,163;5-HT1A receptor;f;;Human;9760039;Full agonist
LY293284;5-HT1A receptor;f;;Human;11101361;Full agonist
LY334370;5-HT1A receptor;f;;Human;15900510;Full agonist
LY344864;5-HT1A receptor;f;;Human;9395253;Full agonist
Lysergide;5-HT1A receptor;f;;Human;12213075;Full agonist
nafadotride;5-HT1A receptor;f;;Human;9760039;Full agonist
naratriptan;5-HT1A receptor;f;;Human;9205951|10193663;Full agonist
NLX-101;5-HT1A receptor;f;;Human;19154445;Full agonist
ocaperidone;5-HT1A receptor;f;;Human;9065439;Full agonist
olanzapine;5-HT1A receptor;f;;Human;9760039|8935801;Full agonist
quetiapine;5-HT1A receptor;f;;Human;9760039|8935801;Full agonist
quinpirole;5-HT1A receptor;f;;Human;10431754;Full agonist
rizatriptan;5-HT1A receptor;f;;Human;10193663;Full agonist
RU 24969;5-HT1A receptor;f;;Human;9760039;Full agonist
S-14506;5-HT1A receptor;f;;Human;9760039|9550290;Full agonist
S-14671;5-HT1A receptor;f;;Human;9760039|9550290;Full agonist
spiroxatrine;5-HT1A receptor;f;;Human;9760039;Full agonist
sumatriptan;5-HT1A receptor;f;;Human;10193663;Full agonist
[3H]8-OH-DPAT;5-HT1A receptor;f;;Human;10431754|9550290|15628665|11101361;Full agonist
[3H]NLX-112;5-HT1A receptor;f;;Human;20799027;Full agonist
tandospirone;5-HT1A receptor;f;;Human;9760039;Full agonist
U92016A;5-HT1A receptor;f;;Human;7965808;Full agonist
xanomeline;5-HT1A receptor;f;;Human;9884068;Full agonist
zalospirone;5-HT1A receptor;f;;Human;9760039;Full agonist
zolmitriptan;5-HT1A receptor;f;;Human;10193663;Full agonist
apomorphine;5-HT1A receptor;f;;Human;12388666;Partial agonist
aripiprazole;5-HT1A receptor;f;;Human;12784105;Partial agonist
BMY-7378;5-HT1A receptor;f;;Human;9048968;Partial agonist
BRL-15572;5-HT1A receptor;f;;Human;9303567;Partial agonist
bromocriptine;5-HT1A receptor;f;;Human;12388666;Partial agonist
buspirone;5-HT1A receptor;f;;Human;1386736|9760039|9550290;Partial agonist
capeserod;5-HT1A receptor;f;;Human;12130738;Partial agonist
fluparoxan;5-HT1A receptor;f;;Human;10611634;Partial agonist
GR 127935;5-HT1A receptor;f;;Human;9397179|9303567;Partial agonist
ipsapirone;5-HT1A receptor;f;;Human;9760039|9550290;Partial agonist
lurasidone;5-HT1A receptor;f;;Rat;20404009;Partial agonist
pergolide;5-HT1A receptor;f;;Human;12388666;Partial agonist
piribedil;5-HT1A receptor;f;;Human;12388666;Partial agonist
roxindole;5-HT1A receptor;f;;Human;10431754|12388666;Partial agonist
(R)-UH 301;5-HT1A receptor;f;;Human;9760039;Partial agonist
S-15535;5-HT1A receptor;f;;Human;9550290;Partial agonist
S 16924;5-HT1A receptor;f;;Human;9732398;Partial agonist
SB 216641;5-HT1A receptor;f;;Human;9303567;Partial agonist
[3H]S-15535;5-HT1A receptor;f;;Human;9550290;Partial agonist
terguride;5-HT1A receptor;f;;Human;12388666;Partial agonist
vilazodone;5-HT1A receptor;f;;Human;19499624;Partial agonist
vilazodone;5-HT1A receptor;f;;Human;15341484;Partial agonist
vortioxetine;5-HT1A receptor;f;;Human;21486038;Partial agonist
ziprasidone;5-HT1A receptor;f;;Human;9760039|8935801;Partial agonist
RS-30199;5-HT1A receptor;f;;Human;9707291;Positive
9-OH-risperidone;5-HT1A receptor;f;;Human;8935801;Antagonist
(+)-butaclamol;5-HT1A receptor;f;;Human;9760039;Antagonist
chlorpromazine;5-HT1A receptor;f;;Human;9760039;Antagonist
cyamemazine;5-HT1A receptor;f;;Human;12527336;Antagonist
fluspirilene;5-HT1A receptor;f;;Human;8935801;Antagonist
GR 125,743;5-HT1A receptor;f;;Human;9205951;Antagonist
GR 218,231;5-HT1A receptor;f;;Human;10869410;Antagonist
haloperidol;5-HT1A receptor;f;;Human;9760039|9067310|8935801|9732398;Antagonist
iloperidone;5-HT1A receptor;f;;Human;11750183;Antagonist
iloperidone;5-HT1A receptor;f;;Rat;8997630;Antagonist
p-MPPI;5-HT1A receptor;f;;Human;15628665;Antagonist
(R)-flurocarazolol;5-HT1A receptor;f;;Human;11512051;Antagonist
(S)-flurocarazolol;5-HT1A receptor;f;;Human;11512051;Antagonist
ketanserin;5-HT1A receptor;f;;Human;1386736;Antagonist
mesoridazine;5-HT1A receptor;f;;Human;15357957;Antagonist
methiothepin;5-HT1A receptor;f;;Human;9760039|9550290;Antagonist
MPDT;5-HT1A receptor;f;;Human;10715164;Antagonist
NAN 190;5-HT1A receptor;f;;Human;9760039;Antagonist
pimozide;5-HT1A receptor;f;;Human;9760039;Antagonist
pindolol;5-HT1A receptor;f;;Human;9550290;Antagonist
pipamperone;5-HT1A receptor;f;;Human;8935801;Antagonist
pizotifen;5-HT1A receptor;f;;Human;9205951;Antagonist
(-)-propranolol;5-HT1A receptor;f;;Human;9205951;Antagonist
p-[18F]MPPF;5-HT1A receptor;f;;Human;16330560;Antagonist
raclopride;5-HT1A receptor;f;;Human;9760039;Antagonist
Rec 15/3079;5-HT1A receptor;f;;Human;11714892;Antagonist
repinotan;5-HT1A receptor;f;;Human;9495870;Antagonist
risperidone;5-HT1A receptor;f;;Rat;8997630;Antagonist
risperidone;5-HT1A receptor;f;;Human;9760039|8935801;Antagonist
ritanserin;5-HT1A receptor;f;;Human;9048968;Antagonist
robalzotan;5-HT1A receptor;f;;Human;9336327;Antagonist
SB 272183;5-HT1A receptor;f;;Human;11454652;Antagonist
SB 649915;5-HT1A receptor;f;;Human;15887956;Antagonist
SB 714786;5-HT1A receptor;f;;Human;15887956;Antagonist
SDZ-216525;5-HT1A receptor;f;;Human;9048968;Antagonist
sertindole;5-HT1A receptor;f;;Human;9760039|8935801;Antagonist
spiperone;5-HT1A receptor;f;;Human;1386736|9760039|9550290;Antagonist
(S)-UH 301;5-HT1A receptor;f;;Human;9760039;Antagonist
[11C]WAY100635;5-HT1A receptor;f;;Human;15689356;Antagonist
[3H]p-MPPF;5-HT1A receptor;f;;Human;15628665;Antagonist
[3H]robalzotan;5-HT1A receptor;f;;Human;9851589;Antagonist
[3H]WAY100635;5-HT1A receptor;f;;Human;9048968;Antagonist
(-)-tertatolol;5-HT1A receptor;f;;Human;9760039|9067310;Antagonist
thioridazine;5-HT1A receptor;f;;Human;9760039;Antagonist
tiospirone;5-HT1A receptor;f;;Human;9760039;Antagonist
WAY-100135;5-HT1A receptor;f;;Human;9550290;Antagonist
WAY-100635;5-HT1A receptor;f;;Human;9760039|9550290;Antagonist
yohimbine;5-HT1A receptor;f;;Human;10611634;Antagonist
zotepine;5-HT1A receptor;f;;Human;8935801;Antagonist
almotriptan;5-HT1B receptor;f;;Human;11134654;Agonist
avitriptan;5-HT1B receptor;f;;Human;9050026;Agonist
avitriptan;5-HT1B receptor;f;;Rat;9050026;Agonist
frovatriptan;5-HT1B receptor;f;;Human;9986723;Agonist
[125I]GTI;5-HT1B receptor;f;;Rat;1738002|8361548;Agonist
1-naphthylpiperazine;5-HT1B receptor;f;;Human;9397179|1565658|8863519;Full agonist
2-methyl-5-HT;5-HT1B receptor;f;;Human;1565658;Full agonist
5-CT;5-HT1B receptor;f;;Mouse;1557407;Full agonist
5-CT;5-HT1B receptor;f;;Human;1565658|8863519;Full agonist
5-hydroxytryptamine;5-HT1B receptor;t;;Human;1565658|8863519;Full agonist
5-hydroxytryptamine;5-HT1B receptor;t;;Mouse;1557407;Full agonist
5-hydroxytryptamine;5-HT1B receptor;t;;Human;10431754|1565658|9208142|9776361|11040052|8957260;Full agonist
5-MeOT;5-HT1B receptor;f;;Human;1565658|8863519;Full agonist
5-(nonyloxy)-tryptamine;5-HT1B receptor;f;;Human;10513577;Full agonist
7-methoxy-1-naphthylpiperazine;5-HT1B receptor;f;;Human;9397179;Full agonist
8-OH-DPAT;5-HT1B receptor;f;;Human;9303569;Full agonist
alniditan;5-HT1B receptor;f;;Human;8967979;Full agonist
aripiprazole;5-HT1B receptor;f;;Human;12784105;Full agonist
asenapine;5-HT1B receptor;f;;Human;8935801;Full agonist
cabergoline;5-HT1B receptor;f;;Human;12388666;Full agonist
CGS-12066;5-HT1B receptor;f;;Human;1565658|10513577;Full agonist
clozapine;5-HT1B receptor;f;;Human;8935801;Full agonist
CP-122288;5-HT1B receptor;f;;Human;9303569;Full agonist
CP94253;5-HT1B receptor;f;;Human;;Full agonist
dihydroergotamine;5-HT1B receptor;f;;Human;8863519|8967979;Full agonist
dipropyl-5-CT;5-HT1B receptor;f;;Human;1565658;Full agonist
donitriptan;5-HT1B receptor;f;;Human;10381763;Full agonist
eletriptan;5-HT1B receptor;f;;Human;10193663;Full agonist
L-694,247;5-HT1B receptor;f;;Human;10513577;Full agonist
L-772,405;5-HT1B receptor;f;;Human;10585208;Full agonist
LY344864;5-HT1B receptor;f;;Human;9395253;Full agonist
lysergol;5-HT1B receptor;f;;Human;1565658|8863519;Full agonist
olanzapine;5-HT1B receptor;f;;Human;8935801;Full agonist
oxymetazoline;5-HT1B receptor;f;;Human;9632357;Full agonist
pergolide;5-HT1B receptor;f;;Human;12388666;Full agonist
RU 24969;5-HT1B receptor;f;;Human;1557407;Full agonist
[3H]8-OH-DPAT;5-HT1B receptor;f;;Human;10431754;Full agonist
[3H]alniditan;5-HT1B receptor;f;;Human;9605573;Full agonist
TFMPP;5-HT1B receptor;f;;Human;1565658|8863519;Full agonist
tryptamine;5-HT1B receptor;t;;Human;1565658;Full agonist
xanomeline;5-HT1B receptor;f;;Human;9884068;Full agonist
ziprasidone;5-HT1B receptor;f;;Human;8935801;Full agonist
BMS 181,101;5-HT1B receptor;f;;Human;11040052;Partial agonist
BRL-15572;5-HT1B receptor;f;;Human;9303567;Partial agonist
bromocriptine;5-HT1B receptor;f;;Human;12388666;Partial agonist
capeserod;5-HT1B receptor;f;;Human;12130738;Partial agonist
donitriptan;5-HT1B receptor;f;;Rat;10381763;Partial agonist
GR 127935;5-HT1B receptor;f;;Human;9397179|9303567|9776361|8957260|9548813;Partial agonist
L-775,606;5-HT1B receptor;f;;Human;11040052;Partial agonist
lisuride;5-HT1B receptor;f;;Human;12388666;Partial agonist
naratriptan;5-HT1B receptor;f;;Human;10193663;Partial agonist
rizatriptan;5-HT1B receptor;f;;Human;10193663;Partial agonist
roxindole;5-HT1B receptor;f;;Human;10431754|12388666;Partial agonist
SB 216641;5-HT1B receptor;f;;Human;9303567;Partial agonist
sumatriptan;5-HT1B receptor;f;;Human;10611634|10193663|1565658|8863519|10513577|11040052|8967979;Partial agonist
[11C]AZ10419369;5-HT1B receptor;f;;Human;20424633;Partial agonist
[3H]eletriptan;5-HT1B receptor;f;;Human;10193663;Partial agonist
[3H]N-methyl-AZ10419369;5-HT1B receptor;f;;Human;19401496;Partial agonist
[3H]sumatriptan;5-HT1B receptor;f;;Human;10193663;Partial agonist
terguride;5-HT1B receptor;f;;Human;12388666;Partial agonist
vortioxetine;5-HT1B receptor;f;;Human;21486038;Partial agonist
zolmitriptan;5-HT1B receptor;f;;Human;10193663;Partial agonist
5-HT-moduline;5-HT1B receptor;t;;Human;9774213;Negative
5-OH-DPAT;5-HT1B receptor;f;;Mouse;1557407;Antagonist
9-OH-risperidone;5-HT1B receptor;f;;Human;8935801;Antagonist
cyanopindolol;5-HT1B receptor;f;;Mouse;1557407;Antagonist
GR 127935;5-HT1B receptor;f;;Human;10513577;Antagonist
GR-55562;5-HT1B receptor;f;;Human;10513577;Antagonist
GR-55562;5-HT1B receptor;f;;Human;11888546;Antagonist
(R)-flurocarazolol;5-HT1B receptor;f;;Human;11512051;Antagonist
(S)-flurocarazolol;5-HT1B receptor;f;;Human;11512051;Antagonist
ketanserin;5-HT1B receptor;f;;Mouse;1557407;Antagonist
ketanserin;5-HT1B receptor;f;;Human;9303569|9605573;Antagonist
metergoline;5-HT1B receptor;f;;Human;8863519;Antagonist
methysergide;5-HT1B receptor;f;;Human;1565658|8863519;Antagonist
mianserin;5-HT1B receptor;f;;Mouse;1557407;Antagonist
ocaperidone;5-HT1B receptor;f;;Human;9605573;Antagonist
(-)-pindolol;5-HT1B receptor;f;;Mouse;1557407;Antagonist
pipamperone;5-HT1B receptor;f;;Human;8935801;Antagonist
rauwolscine;5-HT1B receptor;f;;Human;1565658|8863519;Antagonist
risperidone;5-HT1B receptor;f;;Human;8935801|9605573|18308814;Antagonist
ritanserin;5-HT1B receptor;f;;Human;9303569|9605573;Antagonist
S33084;5-HT1B receptor;f;;Human;10869410;Antagonist
SB 272183;5-HT1B receptor;f;;Human;11454652;Antagonist
SB 649915;5-HT1B receptor;f;;Human;15887956;Antagonist
SB 714786;5-HT1B receptor;f;;Human;15887956;Antagonist
sertindole;5-HT1B receptor;f;;Human;8935801;Antagonist
spiperone;5-HT1B receptor;f;;Mouse;1557407;Antagonist
[3H]GR 125,743;5-HT1B receptor;f;;Human;10513577|10452531;Antagonist
(+)-WAY 100135;5-HT1B receptor;f;;Human;9208142;Antagonist
yohimbine;5-HT1B receptor;f;;Mouse;1557407;Antagonist
yohimbine;5-HT1B receptor;f;;Human;10611634|1565658;Antagonist
zotepine;5-HT1B receptor;f;;Human;8935801;Antagonist
methiothepin;5-HT1B receptor;f;;Human;8863519|10513577|11040052|8957260;Inverse agonist
SB 224289;5-HT1B receptor;f;;Human;9776361|11040052|9548813;Inverse agonist
SB236057;5-HT1B receptor;f;;Human;10443589;Inverse agonist
almotriptan;5-HT1D receptor;f;;Human;11134654;Agonist
avitriptan;5-HT1D receptor;f;;Human;9050026;Agonist
ergotamine;5-HT1D receptor;f;;Human;10715164;Agonist
frovatriptan;5-HT1D receptor;f;;Human;9986723;Agonist
L-694,247;5-HT1D receptor;f;;Human;9855638;Agonist
PNU109291;5-HT1D receptor;f;;Gorilla;9632349;Agonist
[125I]GTI;5-HT1D receptor;f;;Rat;1738002|8361548;Agonist
[3H]5-CT;5-HT1D receptor;f;;Human;10452531;Agonist
1-naphthylpiperazine;5-HT1D receptor;f;;Human;9397179|1565658;Full agonist
2-methyl-5-HT;5-HT1D receptor;f;;Human;1565658|8967979;Full agonist
5-CT;5-HT1D receptor;f;;Human;1565658|8967979|1652050;Full agonist
5-hydroxytryptamine;5-HT1D receptor;t;;Human;10431754|1565658|9208142|9776361|8957260|8967979|1652050;Full agonist
5-MeOT;5-HT1D receptor;f;;Human;1565658|8967979|1652050;Full agonist
7-methoxy-1-naphthylpiperazine;5-HT1D receptor;f;;Human;9397179;Full agonist
8-OH-DPAT;5-HT1D receptor;f;;Human;10193663|9303569|8967979;Full agonist
alniditan;5-HT1D receptor;f;;Human;9605573|8967979;Full agonist
α-methyl-5-HT;5-HT1D receptor;f;;Human;8967979;Full agonist
aripiprazole;5-HT1D receptor;f;;Human;12784105;Full agonist
asenapine;5-HT1D receptor;f;;Human;8935801;Full agonist
CGS-12066;5-HT1D receptor;f;;Human;1565658|1652050;Full agonist
clozapine;5-HT1D receptor;f;;Human;8935801;Full agonist
CP-122288;5-HT1D receptor;f;;Human;9303569;Full agonist
dihydroergotamine;5-HT1D receptor;f;;Human;9605573|8967979|1652050;Full agonist
dimethyltryptamine;5-HT1D receptor;f;;Human;8967979;Full agonist
dipropyl-5-CT;5-HT1D receptor;f;;Human;1565658;Full agonist
donitriptan;5-HT1D receptor;f;;Rat;10381763;Full agonist
donitriptan;5-HT1D receptor;f;;Human;10381763;Full agonist
eletriptan;5-HT1D receptor;f;;Human;10193663;Full agonist
EMDT;5-HT1D receptor;f;;Human;10715164;Full agonist
LY344864;5-HT1D receptor;f;;Human;9395253;Full agonist
lysergic acid;5-HT1D receptor;f;;Human;8967979;Full agonist
lysergol;5-HT1D receptor;f;;Human;1565658;Full agonist
naratriptan;5-HT1D receptor;f;;Human;10193663|9303569|7780656;Full agonist
olanzapine;5-HT1D receptor;f;;Human;8935801;Full agonist
quetiapine;5-HT1D receptor;f;;Human;8935801;Full agonist
rizatriptan;5-HT1D receptor;f;;Human;10193663;Full agonist
RU 24969;5-HT1D receptor;f;;Human;1652050;Full agonist
sumatriptan;5-HT1D receptor;f;;Human;10611634|10193663|1565658|8967979|1652050;Full agonist
[3H]5-HT;5-HT1D receptor;f;;Human;1565658|9776361|9605573;Full agonist
[3H]8-OH-DPAT;5-HT1D receptor;f;;Human;10431754;Full agonist
[3H]alniditan;5-HT1D receptor;f;;Human;9605573;Full agonist
[3H]eletriptan;5-HT1D receptor;f;;Human;10193663;Full agonist
[3H]sumatriptan;5-HT1D receptor;f;;Human;10193663;Full agonist
TFMPP;5-HT1D receptor;f;;Human;1565658|1652050;Full agonist
tryptamine;5-HT1D receptor;f;;Human;1565658|8967979;Full agonist
xanomeline;5-HT1D receptor;f;;Human;9884068;Full agonist
ziprasidone;5-HT1D receptor;f;;Human;8935801;Full agonist
zolmitriptan;5-HT1D receptor;f;;Human;10193663;Full agonist
BRL-15572;5-HT1D receptor;f;;Human;9303567;Partial agonist
bromocriptine;5-HT1D receptor;f;;Human;12388666;Partial agonist
cabergoline;5-HT1D receptor;f;;Human;12388666;Partial agonist
capeserod;5-HT1D receptor;f;;Human;12130738;Partial agonist
GR 127935;5-HT1D receptor;f;;Human;9397179|9303567|9776361|8957260|9548813;Partial agonist
lisuride;5-HT1D receptor;f;;Human;12388666;Partial agonist
oxymetazoline;5-HT1D receptor;f;;Human;9632357;Partial agonist
pergolide;5-HT1D receptor;f;;Human;12388666;Partial agonist
roxindole;5-HT1D receptor;f;;Human;10431754|12388666;Partial agonist
SB 216641;5-HT1D receptor;f;;Human;9303567;Partial agonist
terguride;5-HT1D receptor;f;;Human;12388666;Partial agonist
5-HT-moduline;5-HT1D receptor;t;;Human;9774213;Negative
9-OH-risperidone;5-HT1D receptor;f;;Human;8935801;Antagonist
bufotenine;5-HT1D receptor;f;;Human;8967979;Antagonist
cyanopindolol;5-HT1D receptor;f;;Human;1652050;Antagonist
fluspirilene;5-HT1D receptor;f;;Human;8935801;Antagonist
GR 127935;5-HT1D receptor;f;;Human;8967979;Antagonist
haloperidol;5-HT1D receptor;f;;Human;8935801;Antagonist
m-chlorophenylpiperazine;5-HT1D receptor;f;;Human;1652050;Antagonist
ketanserin;5-HT1D receptor;f;;Human;9303569|8967979;Antagonist
L-772,405;5-HT1D receptor;f;;Human;10585208;Antagonist
metergoline;5-HT1D receptor;f;;Human;9303569|8967979|1652050;Antagonist
methysergide;5-HT1D receptor;f;;Human;1565658|8967979;Antagonist
MPDT;5-HT1D receptor;f;;Human;10715164;Antagonist
ocaperidone;5-HT1D receptor;f;;Human;8967979;Antagonist
pipamperone;5-HT1D receptor;f;;Human;8935801;Antagonist
rauwolscine;5-HT1D receptor;f;;Human;1565658;Antagonist
risperidone;5-HT1D receptor;f;;Human;8935801|8967979;Antagonist
ritanserin;5-HT1D receptor;f;;Human;8967979;Antagonist
S33084;5-HT1D receptor;f;;Human;10869410;Antagonist
SB 224289;5-HT1D receptor;f;;Human;9776361|9548813;Antagonist
SB 272183;5-HT1D receptor;f;;Human;11454652;Antagonist
SB 277011-A;5-HT1D receptor;f;;Human;10945872;Antagonist
SB 649915;5-HT1D receptor;f;;Human;15887956;Antagonist
SB 714786;5-HT1D receptor;f;;Human;15887956;Antagonist
sertindole;5-HT1D receptor;f;;Human;8935801;Antagonist
spiperone;5-HT1D receptor;f;;Human;1565658|1652050;Antagonist
[3H]GR 125,743;5-HT1D receptor;f;;Human;10452531;Antagonist
vortioxetine;5-HT1D receptor;f;;Rat;15341484;Antagonist
(+)-WAY 100135;5-HT1D receptor;f;;Human;9208142;Antagonist
yohimbine;5-HT1D receptor;f;;Human;10611634|1565658|8967979|1652050;Antagonist
zotepine;5-HT1D receptor;f;;Human;8935801;Antagonist
methiothepin;5-HT1D receptor;f;;Human;8957260|9303569|8967979|1652050;Inverse agonist
5-BODMT;5-ht1e receptor;f;;Human;21422162;Agonist
2-methyl-5-HT;5-ht1e receptor;f;;Human;8380639;Full agonist
5-CT;5-ht1e receptor;f;;Human;8863519|1608964|8380639|14744596;Full agonist
5-fluorotryptamine;5-ht1e receptor;f;;Human;14744596;Full agonist
5-hydroxytryptamine;5-ht1e receptor;t;;Human;1608964|8380639|14744596|15110837;Full agonist
5-MeO-DMT;5-ht1e receptor;f;;Human;8380639|15110837;Full agonist
5-MeOT;5-ht1e receptor;f;;Human;8863519|8380639|14744596|15110837;Full agonist
8-OH-DPAT;5-ht1e receptor;f;;Human;8380639|14744596;Full agonist
α-methyl-5-HT;5-ht1e receptor;f;;Human;8380639|14744596;Full agonist
asenapine;5-ht1e receptor;f;;Human;8935801;Full agonist
BRL-54443;5-ht1e receptor;f;;Human;;Full agonist
clozapine;5-ht1e receptor;f;;Human;8935801;Full agonist
dihydroergotamine;5-ht1e receptor;f;;Human;8863519;Full agonist
DOI;5-ht1e receptor;f;;Human;8380639|14744596;Full agonist
donitriptan;5-ht1e receptor;f;;Human;10381763;Full agonist
eletriptan;5-ht1e receptor;f;;Human;10193663;Full agonist
EMDT;5-ht1e receptor;f;;Human;10715164;Full agonist
ergometrine;5-ht1e receptor;f;;Human;14744596;Full agonist
ergotamine;5-ht1e receptor;f;;Human;1608964|8380639;Full agonist
LY344864;5-ht1e receptor;f;;Human;9395253;Full agonist
lysergol;5-ht1e receptor;f;;Human;8863519;Full agonist
naratriptan;5-ht1e receptor;f;;Human;10193663;Full agonist
olanzapine;5-ht1e receptor;f;;Human;8935801;Full agonist
quetiapine;5-ht1e receptor;f;;Human;8935801;Full agonist
rizatriptan;5-ht1e receptor;f;;Human;10193663;Full agonist
sumatriptan;5-ht1e receptor;f;;Human;10193663|8863519|1608964|8380639|14744596;Full agonist
[3H]5-HT;5-ht1e receptor;f;;Human;8863519|1608964;Full agonist
TFMPP;5-ht1e receptor;f;;Human;8863519|8380639|14744596;Full agonist
tryptamine;5-ht1e receptor;t;;Human;8380639|14744596|15110837;Full agonist
xanomeline;5-ht1e receptor;f;;Human;9884068;Full agonist
ziprasidone;5-ht1e receptor;f;;Human;8935801;Full agonist
zolmitriptan;5-ht1e receptor;f;;Human;10193663;Full agonist
BRL-15572;5-ht1e receptor;f;;Human;9303567;Partial agonist
GR 127935;5-ht1e receptor;f;;Human;9303567;Partial agonist
m-chlorophenylpiperazine;5-ht1e receptor;f;;Human;14744596;Partial agonist
1-naphthylpiperazine;5-ht1e receptor;f;;Human;8863519|8380639|14744596;Antagonist
9-OH-risperidone;5-ht1e receptor;f;;Human;8935801;Antagonist
fluspirilene;5-ht1e receptor;f;;Human;8935801;Antagonist
metergoline;5-ht1e receptor;f;;Human;8863519|1608964|14744596;Antagonist
methiothepin;5-ht1e receptor;f;;Human;8863519|1608964|8380639|14744596;Antagonist
methylergonovine;5-ht1e receptor;f;;Human;8380639|15110837;Antagonist
methysergide;5-ht1e receptor;f;;Human;8863519|1608964|8380639|14744596|15110837;Antagonist
rauwolscine;5-ht1e receptor;f;;Human;8863519|14744596;Antagonist
risperidone;5-ht1e receptor;f;;Human;8935801;Antagonist
sertindole;5-ht1e receptor;f;;Human;8935801;Antagonist
yohimbine;5-ht1e receptor;f;;Human;8380639;Antagonist
zotepine;5-ht1e receptor;f;;Human;8935801;Antagonist
5-BODMT;5-HT1F receptor;f;;Human;21422162;Agonist
[125I]LSD;5-HT1F receptor;f;;Mouse;1328180;Agonist
2-methyl-5-HT;5-HT1F receptor;f;;Human;8380639;Full agonist
5-CT;5-HT1F receptor;f;;Rat;8384716;Full agonist
5-CT;5-HT1F receptor;f;;Human;8380639|9225282;Full agonist
5-hydroxytryptamine;5-HT1F receptor;t;;Human;8380639;Full agonist
5-hydroxytryptamine;5-HT1F receptor;t;;Rat;8384716;Full agonist
5-hydroxytryptamine;5-HT1F receptor;t;;Human;15900510|8380639|9225282;Full agonist
5-MeO-DMT;5-HT1F receptor;f;;Human;8380639;Full agonist
5-MeOT;5-HT1F receptor;f;;Human;8380639;Full agonist
8-OH-DPAT;5-HT1F receptor;f;;Human;8380639;Full agonist
α-methyl-5-HT;5-HT1F receptor;f;;Human;8380639;Full agonist
BRL-54443;5-HT1F receptor;f;;Human;;Full agonist
clozapine;5-HT1F receptor;f;;Human;8935801;Full agonist
dihydroergotamine;5-HT1F receptor;f;;Human;15900510|9225282;Full agonist
dipropyl-5-CT;5-HT1F receptor;f;;Human;8380639;Full agonist
DOI;5-HT1F receptor;f;;Human;8380639;Full agonist
donitriptan;5-HT1F receptor;f;;Human;10381763;Full agonist
eletriptan;5-HT1F receptor;f;;Human;10193663;Full agonist
ergotamine;5-HT1F receptor;f;;Human;8380639;Full agonist
ergotamine;5-HT1F receptor;f;;Rat;8384716;Full agonist
lasmiditan;5-HT1F receptor;f;;Human;20855361;Full agonist
LY334370;5-HT1F receptor;f;;Human;15900510;Full agonist
LY344864;5-HT1F receptor;f;;Human;9395253;Full agonist
naratriptan;5-HT1F receptor;f;;Human;15900510|10193663;Full agonist
olanzapine;5-HT1F receptor;f;;Human;8935801;Full agonist
quetiapine;5-HT1F receptor;f;;Human;8935801;Full agonist
rizatriptan;5-HT1F receptor;f;;Human;15900510|10193663;Full agonist
sumatriptan;5-HT1F receptor;f;;Human;15900510|10193663|8380639|9225282;Full agonist
sumatriptan;5-HT1F receptor;f;;Human;8384716;Full agonist
[3H]LY334370;5-HT1F receptor;f;;Human;15900510;Full agonist
TFMPP;5-HT1F receptor;f;;Human;8380639;Full agonist
tryptamine;5-HT1F receptor;f;;Human;8380639;Full agonist
xanomeline;5-HT1F receptor;f;;Human;9884068;Full agonist
zolmitriptan;5-HT1F receptor;f;;Human;15900510|10193663;Full agonist
BRL-15572;5-HT1F receptor;f;;Human;9303567;Partial agonist
GR 127935;5-HT1F receptor;f;;Human;9303567|15900510;Partial agonist
NAN 190;5-HT1F receptor;f;;Human;8380639;Partial agonist
1-naphthylpiperazine;5-HT1F receptor;f;;Human;8380639|9225282;Antagonist
metergoline;5-HT1F receptor;f;;Human;8380639|9225282;Antagonist
metergoline;5-HT1F receptor;f;;Rat;8384716;Antagonist
methiothepin;5-HT1F receptor;f;;Human;8380639|9225282;Antagonist
methylergonovine;5-HT1F receptor;f;;Human;8380639;Antagonist
methysergide;5-HT1F receptor;f;;Rat;8384716;Antagonist
methysergide;5-HT1F receptor;f;;Human;15900510|8380639;Antagonist
risperidone;5-HT1F receptor;f;;Human;8935801;Antagonist
sertindole;5-HT1F receptor;f;;Human;8935801;Antagonist
yohimbine;5-HT1F receptor;f;;Rat;8384716;Antagonist
yohimbine;5-HT1F receptor;f;;Human;8380639;Antagonist
LP-12;5-HT2A receptor;f;;Human;17649988;Agonist
LP-44;5-HT2A receptor;f;;Human;17649988;Agonist
psilocin;5-HT2A receptor;f;;Human;16061378;Agonist
relenopride;5-HT2A receptor;f;;Human;25316608;Agonist
5-CT;5-HT2A receptor;f;;Human;15322733;Full agonist
5-hydroxytryptamine;5-HT2A receptor;t;;Human;8534270;Full agonist
5-hydroxytryptamine;5-HT2A receptor;t;;Human;15322733|8534270|12954071|2233697|8114677|8663249;Full agonist
5-hydroxytryptamine;5-HT2A receptor;t;;Rat;11040033|11104741|9655845;Full agonist
5-MeOT;5-HT2A receptor;f;;Rat;8114677;Full agonist
5-MeOT;5-HT2A receptor;f;;Human;8114677;Full agonist
8-OH-DPAT;5-HT2A receptor;f;;Human;15322733;Full agonist
AL-37350A;5-HT2A receptor;f;;Human;12954071;Full agonist
α-methyl-5-HT;5-HT2A receptor;f;;Human;15322733;Full agonist
α-methyl-5-HT;5-HT2A receptor;f;;Rat;11040033;Full agonist
BRL-15572;5-HT2A receptor;f;;Human;9303567;Full agonist
brolamfetamine;5-HT2A receptor;f;;Human;15322733|9933142;Full agonist
brolamfetamine;5-HT2A receptor;f;;Rat;9655845;Full agonist
BW723C86;5-HT2A receptor;f;;Human;15322733;Full agonist
cabergoline;5-HT2A receptor;f;;Human;12388666;Full agonist
CGS-12066;5-HT2A receptor;f;;Human;15322733;Full agonist
DOI;5-HT2A receptor;f;;Human;8534270|2233697|9933142;Full agonist
DOI;5-HT2A receptor;f;;Rat;11040033;Full agonist
(+)-DOI;5-HT2A receptor;f;;Human;15322733;Full agonist
DOM;5-HT2A receptor;f;;Rat;9655845;Full agonist
donitriptan;5-HT2A receptor;f;;Human;10381763;Full agonist
ergometrine;5-HT2A receptor;f;;Rat;8114677;Full agonist
GR 127935;5-HT2A receptor;f;;Human;9303567|9548813;Full agonist
N-1-isopropyl-5-MeOT;5-HT2A receptor;f;;Human;8114677;Full agonist
N-1-isopropyl-5-MeOT;5-HT2A receptor;f;;Rat;8114677;Full agonist
N-1-isopropyltryptamine;5-HT2A receptor;f;;Human;8114677;Full agonist
N-1-isopropyltryptamine;5-HT2A receptor;f;;Rat;8114677;Full agonist
(R)-DOI;5-HT2A receptor;f;;Human;12954071;Full agonist
(R)-DOI;5-HT2A receptor;f;;Human;15322733|9857084;Full agonist
lorcaserin;5-HT2A receptor;f;;Human;18252809;Full agonist
lorcaserin;5-HT2A receptor;f;;Human;18252809;Full agonist
(+)-LSD;5-HT2A receptor;f;;Human;15322733;Full agonist
LY344864;5-HT2A receptor;f;;Human;9395253;Full agonist
Lysergide;5-HT2A receptor;f;;Human;8663249;Full agonist
Lysergide;5-HT2A receptor;f;;Rat;12213075;Full agonist
methylergonovine;5-HT2A receptor;f;;Rat;11104741;Full agonist
methylergonovine;5-HT2A receptor;f;;Human;15322733;Full agonist
MK-212;5-HT2A receptor;f;;Human;15322733;Full agonist
Org 12962;5-HT2A receptor;f;;Human;15322733;Full agonist
ORG-37684;5-HT2A receptor;f;;Human;15322733;Full agonist
pergolide;5-HT2A receptor;f;;Human;12388666;Full agonist
pindolol;5-HT2A receptor;f;;Human;15322733;Full agonist
quetiapine;5-HT2A receptor;f;;Human;8935801;Full agonist
quinpirole;5-HT2A receptor;f;;Human;12388666|15322733;Full agonist
quipazine;5-HT2A receptor;f;;Human;15322733;Full agonist
Ro 60-0175;5-HT2A receptor;f;;Human;15322733;Full agonist
RU 24969;5-HT2A receptor;f;;Human;15322733;Full agonist
S 16924;5-HT2A receptor;f;;Human;9732398;Full agonist
SB 216641;5-HT2A receptor;f;;Human;9303567;Full agonist
[125I]DOI;5-HT2A receptor;f;;Rat;11101361;Full agonist
[3H](+)DOB;5-HT2A receptor;f;;Human;11562430|8534270;Full agonist
TFMPP;5-HT2A receptor;f;;Human;15322733;Full agonist
tryptamine;5-HT2A receptor;t;;Rat;8114677;Full agonist
tryptamine;5-HT2A receptor;t;;Human;15322733|2233697|8114677;Full agonist
VER-3323;5-HT2A receptor;f;;Human;15322733;Full agonist
aripiprazole;5-HT2A receptor;f;;Human;12784105|12629531;Partial agonist
aripiprazole;5-HT2A receptor;f;;Rat;12784105;Partial agonist
bromocriptine;5-HT2A receptor;f;;Human;12388666;Partial agonist
capeserod;5-HT2A receptor;f;;Human;12130738;Partial agonist
ergotamine;5-HT2A receptor;f;;Human;15322733;Partial agonist
ergotamine;5-HT2A receptor;f;;Rat;11104741;Partial agonist
m-chlorophenylpiperazine;5-HT2A receptor;f;;Human;15322733|8534270|9933142;Partial agonist
m-chlorophenylpiperazine;5-HT2A receptor;f;;Rat;11104741;Partial agonist
lisuride;5-HT2A receptor;f;;Human;12388666;Partial agonist
methysergide;5-HT2A receptor;f;;Rat;11104741;Partial agonist
terguride;5-HT2A receptor;f;;Human;12388666;Partial agonist
9-OH-risperidone;5-HT2A receptor;f;;Human;8935801;Antagonist
agomelatine;5-HT2A receptor;f;;Human;12750432;Antagonist
amesergide;5-HT2A receptor;f;;Rat;8114677;Antagonist
amesergide;5-HT2A receptor;f;;Human;8114677;Antagonist
amitriptyline;5-HT2A receptor;f;;Rat;10379421;Antagonist
amitriptyline;5-HT2A receptor;f;;Rat;8876023;Antagonist
amoxapine;5-HT2A receptor;f;;Rat;8876023;Antagonist
apomorphine;5-HT2A receptor;f;;Human;12388666;Antagonist
asenapine;5-HT2A receptor;f;;Human;18308814;Antagonist
BF-1;5-HT2A receptor;f;;Human;25666387;Antagonist
blonanserin;5-HT2A receptor;f;;Human;15686911;Antagonist
bufotenine;5-HT2A receptor;f;;Human;8663249;Antagonist
(+)-butaclamol;5-HT2A receptor;f;;Human;2233697;Antagonist
compound 3b [PMID:28943244];5-HT2A receptor;f;;Human;28943244;Antagonist
cyamemazine;5-HT2A receptor;f;;Human;12527336;Antagonist
duloxetine;5-HT2A receptor;f;;Human;11750180;Antagonist
EGIS-7625;5-HT2A receptor;f;;Human;15107597;Antagonist
EGIS-7625;5-HT2A receptor;f;;Rat;15107597;Antagonist
flibanserin;5-HT2A receptor;f;;Human;12177684;Antagonist
fluoxetine;5-HT2A receptor;f;;Rat;11104741;Antagonist
fluphenazine;5-HT2A receptor;f;;Human;12629531;Antagonist
fluspirilene;5-HT2A receptor;f;;Human;8935801;Antagonist
glemanserin;5-HT2A receptor;f;;Human;15322733;Antagonist
H05;5-HT2A receptor;f;;Human;29615471;Antagonist
haloperidol;5-HT2A receptor;f;;Rat;9655845;Antagonist
haloperidol;5-HT2A receptor;f;;Human;8935801|9732398|12629531|15102927|18308814;Antagonist
ketanserin;5-HT2A receptor;f;;Rat;11040033|9655845;Antagonist
ketanserin;5-HT2A receptor;f;;Human;15322733|8845011|12738034;Antagonist
L-741,626;5-HT2A receptor;f;;Human;10869410;Antagonist
lumateperone;5-HT2A receptor;f;;Human;25120104|24559051;Antagonist
lurasidone;5-HT2A receptor;f;;Rat;20404009;Antagonist
LY063518;5-HT2A receptor;f;;Human;8845011;Antagonist
LY108742;5-HT2A receptor;f;;Rat;8114677;Antagonist
LY215840;5-HT2A receptor;f;;Human;8114677;Antagonist
LY215840;5-HT2A receptor;f;;Rat;8114677;Antagonist
LY314228;5-HT2A receptor;f;;Human;8845011;Antagonist
LY320954;5-HT2A receptor;f;;Human;8845011;Antagonist
LY53857;5-HT2A receptor;f;;Human;8114677;Antagonist
LY53857;5-HT2A receptor;f;;Rat;8114677;Antagonist
LY86057;5-HT2A receptor;f;;Human;8114677;Antagonist
LY86057;5-HT2A receptor;f;;Rat;8114677;Antagonist
mesoridazine;5-HT2A receptor;f;;Human;15357957;Antagonist
mesulergine;5-HT2A receptor;f;;Human;15322733|8534270;Antagonist
mesulergine;5-HT2A receptor;f;;Rat;8114677;Antagonist
metergoline;5-HT2A receptor;f;;Human;15322733;Antagonist
methiothepin;5-HT2A receptor;f;;Human;15322733;Antagonist
methysergide;5-HT2A receptor;f;;Rat;9655845|15107597;Antagonist
methysergide;5-HT2A receptor;f;;Human;15322733;Antagonist
mianserin;5-HT2A receptor;f;;Human;10611634|15322733|15107597;Antagonist
mianserin;5-HT2A receptor;f;;Rat;9655845|8876023;Antagonist
mirtazapine;5-HT2A receptor;f;;Human;15771415;Antagonist
molindone;5-HT2A receptor;f;;Human;12629531;Antagonist
MPDT;5-HT2A receptor;f;;Rat;10715164;Antagonist
nefazodone;5-HT2A receptor;f;;Human;21823597;Antagonist
norfluoxetine;5-HT2A receptor;f;;Rat;11104741;Antagonist
olanzapine;5-HT2A receptor;f;;Human;8935801|12629531|12176106|18308814;Antagonist
perospirone;5-HT2A receptor;f;;Rat;1060115;Antagonist
perphenazine;5-HT2A receptor;f;;Human;12629531;Antagonist
pimozide;5-HT2A receptor;f;;Human;12629531|12176106;Antagonist
pindolol;5-HT2A receptor;f;;Human;15322733;Antagonist
pipamperone;5-HT2A receptor;f;;Human;8935801;Antagonist
quetiapine;5-HT2A receptor;f;;Human;12629531|12176106;Antagonist
risperidone;5-HT2A receptor;f;;Rat;9655845;Antagonist
ritanserin;5-HT2A receptor;f;;Rat;11040033|10188965;Antagonist
ritanserin;5-HT2A receptor;f;;Human;10188965;Antagonist
ritanserin;5-HT2A receptor;f;;Human;15322733;Antagonist
roxindole;5-HT2A receptor;f;;Human;12388666;Antagonist
RS-102221;5-HT2A receptor;f;;Rat;9225287;Antagonist
RS-102221;5-HT2A receptor;f;;Human;15322733|9225287;Antagonist
RS-127445;5-HT2A receptor;f;;Human;15322733;Antagonist
S33084;5-HT2A receptor;f;;Human;10869410;Antagonist
sarpogrelate;5-HT2A receptor;f;;Human;12738034;Antagonist
SB 206553;5-HT2A receptor;f;;Human;15322733|8821530;Antagonist
SB 215505;5-HT2A receptor;f;;Human;10188965;Antagonist
SB 221284;5-HT2A receptor;f;;Human;15322733;Antagonist
SB 224289;5-HT2A receptor;f;;Human;15322733;Antagonist
SB 228357;5-HT2A receptor;f;;Human;10188965|10737744;Antagonist
SB 242084;5-HT2A receptor;f;;Human;15322733|9225286;Antagonist
SB 243213;5-HT2A receptor;f;;Human;10737744;Antagonist
SDZ SER-082;5-HT2A receptor;f;;Human;15322733;Antagonist
sergolexole;5-HT2A receptor;f;;Rat;8114677;Antagonist
sergolexole;5-HT2A receptor;f;;Human;8114677;Antagonist
sertindole;5-HT2A receptor;f;;Human;8935801|12629531|12176106;Antagonist
spiperone;5-HT2A receptor;f;;Rat;11040033|9655845;Antagonist
spiperone;5-HT2A receptor;f;;Human;15322733|8534270|2233697;Antagonist
spiramide;5-HT2A receptor;f;;Human;15322733;Antagonist
[11C]GSK215083;5-HT2A receptor;f;;Human;22223878;Antagonist
[11C]volinanserin;5-HT2A receptor;f;;Human;11044889;Antagonist
[18F]altanserin;5-HT2A receptor;f;;Human;9027929;Antagonist
[3H]fananserin;5-HT2A receptor;f;;Rat;8472747;Antagonist
[3H]N-methylspiperone;5-HT2A receptor;f;;Rat;11040033;Antagonist
[3H]ketanserin;5-HT2A receptor;f;;Human;15322733|12738034;Antagonist
[3H]ketanserin;5-HT2A receptor;f;;Rat;11040033;Antagonist
thioridazine;5-HT2A receptor;f;;Human;12629531|12176106;Antagonist
thiothixene;5-HT2A receptor;f;;Human;12629531;Antagonist
trazodone;5-HT2A receptor;f;;Rat;11104741|8876023;Antagonist
trazodone;5-HT2A receptor;f;;Human;15322733;Antagonist
trifluoperazine;5-HT2A receptor;f;;Human;12629531;Antagonist
volinanserin;5-HT2A receptor;f;;Human;15322733|11562430|10188965;Antagonist
vortioxetine;5-HT2A receptor;f;;Human;21486038;Antagonist
xanomeline;5-HT2A receptor;f;;Human;9884068;Antagonist
ziprasidone;5-HT2A receptor;f;;Human;8935801|12629531|12176106|18308814;Antagonist
zotepine;5-HT2A receptor;f;;Human;8935801;Antagonist
AC-90179;5-HT2A receptor;f;;Human;15102927;Inverse agonist
chlorpromazine;5-HT2A receptor;f;;Human;12629531;Inverse agonist
chlorpromazine;5-HT2A receptor;f;;Rat;9655845;Inverse agonist
clozapine;5-HT2A receptor;f;;Human;8935801|9732398|15322733|12629531|15102927;Inverse agonist
clozapine;5-HT2A receptor;f;;Rat;9655845;Inverse agonist
loxapine;5-HT2A receptor;f;;Human;12629531;Inverse agonist
pimavanserin;5-HT2A receptor;f;;Human;15102927|17519387;Inverse agonist
risperidone;5-HT2A receptor;f;;Human;8935801|12629531|12176106;Inverse agonist
relenopride;5-HT2B receptor;f;;Human;25316608;Agonist
dihydroergocryptine;5-HT2B receptor;f;;Human;23519215;Biased agonist
Lysergide;5-HT2B receptor;f;;Human;23519215;Biased agonist
2-methyl-5-HT;5-HT2B receptor;f;;Rat;8450835;Full agonist
5-CT;5-HT2B receptor;f;;Human;15322733|8078486;Full agonist
5-CT;5-HT2B receptor;f;;Rat;8078486|8450835;Full agonist
5-hydroxytryptamine;5-HT2B receptor;t;;Human;15322733|12954071|11104741|8078486|15466450;Full agonist
5-hydroxytryptamine;5-HT2B receptor;t;;Rat;8450835;Full agonist
5-MeOT;5-HT2B receptor;f;;Rat;8450835;Full agonist
8-OH-DPAT;5-HT2B receptor;f;;Human;15322733;Full agonist
8-OH-DPAT;5-HT2B receptor;f;;Rat;8450835;Full agonist
AL-37350A;5-HT2B receptor;f;;Human;12954071;Full agonist
α-methyl-5-HT;5-HT2B receptor;f;;Human;15322733|8078486|15466450;Full agonist
α-methyl-5-HT;5-HT2B receptor;f;;Rat;8450835;Full agonist
brolamfetamine;5-HT2B receptor;f;;Human;15322733|9933142;Full agonist
BW723C86;5-HT2B receptor;f;;Human;15322733|15466450|12970106;Full agonist
cabergoline;5-HT2B receptor;f;;Human;12388666;Full agonist
CGS-12066;5-HT2B receptor;f;;Human;15322733;Full agonist
DOI;5-HT2B receptor;f;;Human;9933142|8078486|12970106;Full agonist
DOI;5-HT2B receptor;f;;Rat;8078486|8450835;Full agonist
(+)-DOI;5-HT2B receptor;f;;Human;15322733;Full agonist
(R)-DOI;5-HT2B receptor;f;;Human;12954071;Full agonist
(R)-DOI;5-HT2B receptor;f;;Human;15322733|9857084;Full agonist
lorcaserin;5-HT2B receptor;f;;Human;18252809;Full agonist
lorcaserin;5-HT2B receptor;f;;Human;18252809;Full agonist
(+)-LSD;5-HT2B receptor;f;;Human;15322733;Full agonist
LY344864;5-HT2B receptor;f;;Human;9395253;Full agonist
Lysergide;5-HT2B receptor;f;;Rat;12213075;Full agonist
MK-212;5-HT2B receptor;f;;Human;15322733|12970106;Full agonist
MK-212;5-HT2B receptor;f;;Rat;8450835;Full agonist
norfenfluramine;5-HT2B receptor;f;;Human;11104741;Full agonist
(-)-norfenfluramine;5-HT2B receptor;f;;Human;11104741;Full agonist
(+)-norfenfluramine;5-HT2B receptor;f;;Human;11104741;Full agonist
Org 12962;5-HT2B receptor;f;;Human;15322733;Full agonist
ORG-37684;5-HT2B receptor;f;;Human;15322733;Full agonist
pergolide;5-HT2B receptor;f;;Human;12388666;Full agonist
pindolol;5-HT2B receptor;f;;Human;15322733;Full agonist
quinpirole;5-HT2B receptor;f;;Human;12388666|15322733;Full agonist
quipazine;5-HT2B receptor;f;;Human;15322733;Full agonist
quipazine;5-HT2B receptor;f;;Rat;8450835;Full agonist
Ro 60-0175;5-HT2B receptor;f;;Human;15322733;Full agonist
RU 24969;5-HT2B receptor;f;;Rat;8450835;Full agonist
RU 24969;5-HT2B receptor;f;;Human;15322733;Full agonist
S 16924;5-HT2B receptor;f;;Human;9732398;Full agonist
[125I]DOI;5-HT2B receptor;f;;Human;;Full agonist
[3H]5-HT;5-HT2B receptor;f;;Rat;8450835;Full agonist
[3H]LSD;5-HT2B receptor;f;;Human;12738034;Full agonist
TFMPP;5-HT2B receptor;f;;Human;15322733;Full agonist
TFMPP;5-HT2B receptor;f;;Rat;8450835;Full agonist
tryptamine;5-HT2B receptor;f;;Rat;8450835;Full agonist
tryptamine;5-HT2B receptor;f;;Human;15322733;Full agonist
VER-3323;5-HT2B receptor;f;;Human;15322733;Full agonist
BRL-15572;5-HT2B receptor;f;;Human;9303567;Partial agonist
capeserod;5-HT2B receptor;f;;Human;12130738;Partial agonist
ergotamine;5-HT2B receptor;f;;Human;15322733|11104741;Partial agonist
GR 127935;5-HT2B receptor;f;;Human;9303567;Partial agonist
m-chlorophenylpiperazine;5-HT2B receptor;f;;Rat;8450835;Partial agonist
m-chlorophenylpiperazine;5-HT2B receptor;f;;Human;15322733|11104741|9933142|9459568|12970106;Partial agonist
methylergonovine;5-HT2B receptor;f;;Human;15322733|11104741;Partial agonist
methysergide;5-HT2B receptor;f;;Human;15322733|11104741|9459568;Partial agonist
methysergide;5-HT2B receptor;f;;Rat;8450835;Partial agonist
SB 216641;5-HT2B receptor;f;;Human;9303567;Partial agonist
1-naphthylpiperazine;5-HT2B receptor;f;;Rat;8078486|8450835;Antagonist
1-naphthylpiperazine;5-HT2B receptor;f;;Human;8078486|9459568;Antagonist
agomelatine;5-HT2B receptor;f;;Human;12750432;Antagonist
amesergide;5-HT2B receptor;f;;Rat;8450835;Antagonist
apomorphine;5-HT2B receptor;f;;Human;12388666;Antagonist
balovaptan;5-HT2B receptor;f;;Human;31951127;Antagonist
BF-1;5-HT2B receptor;f;;Human;25666387;Antagonist
bromocriptine;5-HT2B receptor;f;;Human;12388666;Antagonist
clozapine;5-HT2B receptor;f;;Human;9732398|15322733|9459568;Antagonist
EGIS-7625;5-HT2B receptor;f;;Human;15107597;Antagonist
fluoxetine;5-HT2B receptor;f;;Human;11104741;Antagonist
glemanserin;5-HT2B receptor;f;;Human;15322733;Antagonist
haloperidol;5-HT2B receptor;f;;Human;9459568;Antagonist
ketanserin;5-HT2B receptor;f;;Human;15322733|8845011|12738034|8078486|9459568;Antagonist
ketanserin;5-HT2B receptor;f;;Rat;8450835;Antagonist
L-741,626;5-HT2B receptor;f;;Human;10869410;Antagonist
lisuride;5-HT2B receptor;f;;Human;12388666;Antagonist
LY53857;5-HT2B receptor;f;;Rat;8450835;Antagonist
LY53857;5-HT2B receptor;f;;Human;9459568;Antagonist
LY86057;5-HT2B receptor;f;;Rat;8450835;Antagonist
melatonin;5-HT2B receptor;f;;Human;12750432;Antagonist
mesulergine;5-HT2B receptor;f;;Human;15322733|15107597|9459568;Antagonist
mesulergine;5-HT2B receptor;f;;Rat;8450835;Antagonist
metergoline;5-HT2B receptor;f;;Human;15322733;Antagonist
metergoline;5-HT2B receptor;f;;Rat;8450835;Antagonist
methiothepin;5-HT2B receptor;f;;Human;15322733|9459568;Antagonist
mianserin;5-HT2B receptor;f;;Human;15322733|9459568|10455251;Antagonist
mianserin;5-HT2B receptor;f;;Rat;8450835;Antagonist
norfluoxetine;5-HT2B receptor;f;;Human;11104741;Antagonist
piboserod;5-HT2B receptor;f;;Human;11504648;Antagonist
piboserod;5-HT2B receptor;f;;Human;15466450;Antagonist
pindolol;5-HT2B receptor;f;;Human;15322733;Antagonist
piribedil;5-HT2B receptor;f;;Human;12388666;Antagonist
rauwolscine;5-HT2B receptor;f;;Rat;8450835;Antagonist
rauwolscine;5-HT2B receptor;f;;Human;9459568;Antagonist
ritanserin;5-HT2B receptor;f;;Rat;8450835;Antagonist
ritanserin;5-HT2B receptor;f;;Human;15322733|10188965|9459568|10455251;Antagonist
roxindole;5-HT2B receptor;f;;Human;12388666;Antagonist
RS-102221;5-HT2B receptor;f;;Human;15322733|9225287;Antagonist
RS-127445;5-HT2B receptor;f;;Human;15322733|10455251;Antagonist
S33084;5-HT2B receptor;f;;Human;10869410;Antagonist
sarpogrelate;5-HT2B receptor;f;;Human;12738034;Antagonist
SB 204741;5-HT2B receptor;f;;Human;15322733;Antagonist
SB 206553;5-HT2B receptor;f;;Human;15322733|15466450;Antagonist
SB 215505;5-HT2B receptor;f;;Human;10188965;Antagonist
SB 221284;5-HT2B receptor;f;;Human;15322733;Antagonist
SB 224289;5-HT2B receptor;f;;Human;15322733;Antagonist
SB 228357;5-HT2B receptor;f;;Human;10188965|10737744;Antagonist
SB 242084;5-HT2B receptor;f;;Human;15322733|9225286;Antagonist
SB 243213;5-HT2B receptor;f;;Human;10737744;Antagonist
SB 277011-A;5-HT2B receptor;f;;Human;10945872;Antagonist
SDZ SER-082;5-HT2B receptor;f;;Human;15322733;Antagonist
spiperone;5-HT2B receptor;f;;Human;15322733|8078486|9459568;Antagonist
spiperone;5-HT2B receptor;f;;Rat;8450835;Antagonist
spiramide;5-HT2B receptor;f;;Human;15322733;Antagonist
spiroxatrine;5-HT2B receptor;f;;Human;9459568;Antagonist
[3H]rauwolscine;5-HT2B receptor;f;;Human;9459568;Antagonist
tegaserod;5-HT2B receptor;f;;Human;15466450;Antagonist
terguride;5-HT2B receptor;f;;Human;12388666;Antagonist
trazodone;5-HT2B receptor;f;;Human;15322733|11104741;Antagonist
volinanserin;5-HT2B receptor;f;;Human;15322733|10188965;Antagonist
xanomeline;5-HT2B receptor;f;;Human;9884068;Antagonist
yohimbine;5-HT2B receptor;f;;Rat;8450835;Antagonist
yohimbine;5-HT2B receptor;f;;Human;8078486|9459568|10455251;Antagonist
[3H]mesulergine;5-HT2B receptor;f;;Human;15322733;Inverse agonist
lorcaserin;5-HT2C receptor;f;;Human;;Agonist
[3H]LSD;5-HT2C receptor;f;;Human;;Agonist
5-CT;5-HT2C receptor;f;;Human;15322733|10611640;Full agonist
5-hydroxytryptamine;5-HT2C receptor;t;;Rat;11104741|9282936;Full agonist
5-hydroxytryptamine;5-HT2C receptor;t;;Human;15322733|12954071|10217294|10611640|14709324;Full agonist
5-MeO-DMT;5-HT2C receptor;f;;Human;10217294;Full agonist
5-MeOT;5-HT2C receptor;f;;Human;10611640;Full agonist
5-MeOT;5-HT2C receptor;f;;Rat;9282936;Full agonist
8-OH-DPAT;5-HT2C receptor;f;;Human;15322733;Full agonist
AL-37350A;5-HT2C receptor;f;;Human;12954071;Full agonist
α-methyl-5-HT;5-HT2C receptor;f;;Human;15322733|10217294;Full agonist
brolamfetamine;5-HT2C receptor;f;;Rat;9282936;Full agonist
brolamfetamine;5-HT2C receptor;f;;Human;15322733|9933142|10611640;Full agonist
BW723C86;5-HT2C receptor;f;;Human;15322733|12970106;Full agonist
cabergoline;5-HT2C receptor;f;;Human;12388666;Full agonist
CGS-12066;5-HT2C receptor;f;;Human;15322733;Full agonist
DOI;5-HT2C receptor;f;;Human;9933142|12970106|10611640;Full agonist
(+)-DOI;5-HT2C receptor;f;;Human;15322733;Full agonist
(R)-DOI;5-HT2C receptor;f;;Human;12954071;Full agonist
(R)-DOI;5-HT2C receptor;f;;Human;15322733|9933142|10217294;Full agonist
lorcaserin;5-HT2C receptor;f;;Human;18252809;Full agonist
lorcaserin;5-HT2C receptor;f;;Human;18252809;Full agonist
(+)-LSD;5-HT2C receptor;f;;Human;15322733|10217294;Full agonist
LY344864;5-HT2C receptor;f;;Human;9395253;Full agonist
Lysergide;5-HT2C receptor;f;;Human;10611640;Full agonist
methylergonovine;5-HT2C receptor;f;;Human;15322733;Full agonist
methylergonovine;5-HT2C receptor;f;;Rat;11104741;Full agonist
MK-212;5-HT2C receptor;f;;Human;15322733|12970106|10611640;Full agonist
Org 12962;5-HT2C receptor;f;;Human;15322733;Full agonist
ORG-37684;5-HT2C receptor;f;;Human;15322733;Full agonist
oxymetazoline;5-HT2C receptor;f;;Human;10217294;Full agonist
quinpirole;5-HT2C receptor;f;;Human;12388666|15322733;Full agonist
quipazine;5-HT2C receptor;f;;Human;15322733|10217294|10611640;Full agonist
Ro 60-0175;5-HT2C receptor;f;;Human;15322733|14709324;Full agonist
RU 24969;5-HT2C receptor;f;;Human;15322733;Full agonist
S 16924;5-HT2C receptor;f;;Human;9732398;Full agonist
[125I]DOI;5-HT2C receptor;f;;Human;10217294;Full agonist
[125I]DOI;5-HT2C receptor;f;;Rat;11101361;Full agonist
TFMPP;5-HT2C receptor;f;;Human;15322733|10611640;Full agonist
tryptamine;5-HT2C receptor;f;;Human;15322733|10611640;Full agonist
VER-3323;5-HT2C receptor;f;;Human;15322733;Full agonist
WAY-163909;5-HT2C receptor;f;;Human;15705738;Full agonist
YM348;5-HT2C receptor;f;;Human;14709324;Full agonist
aripiprazole;5-HT2C receptor;f;;Human;12629531;Partial agonist
BRL-15572;5-HT2C receptor;f;;Human;9303567;Partial agonist
bromocriptine;5-HT2C receptor;f;;Human;12388666;Partial agonist
capeserod;5-HT2C receptor;f;;Human;12130738;Partial agonist
ergotamine;5-HT2C receptor;f;;Rat;11104741;Partial agonist
ergotamine;5-HT2C receptor;f;;Human;15322733;Partial agonist
GR 127935;5-HT2C receptor;f;;Human;9303567;Partial agonist
m-chlorophenylpiperazine;5-HT2C receptor;f;;Rat;11104741;Partial agonist
m-chlorophenylpiperazine;5-HT2C receptor;f;;Human;15322733|9933142|12970106|10217294|10611640|14709324;Partial agonist
lisuride;5-HT2C receptor;f;;Human;12388666|10217294|10611640;Partial agonist
methysergide;5-HT2C receptor;f;;Rat;11104741;Partial agonist
pergolide;5-HT2C receptor;f;;Human;12388666;Partial agonist
SB 216641;5-HT2C receptor;f;;Human;9303567;Partial agonist
agomelatine;5-HT2C receptor;f;;Human;12750432;Antagonist
amitriptyline;5-HT2C receptor;f;;Rat;10379421;Antagonist
amoxapine;5-HT2C receptor;f;;Rat;8876023;Antagonist
apomorphine;5-HT2C receptor;f;;Human;12388666;Antagonist
chlorpromazine;5-HT2C receptor;f;;Human;12629531|10991983;Antagonist
cyamemazine;5-HT2C receptor;f;;Human;12527336;Antagonist
duloxetine;5-HT2C receptor;f;;Human;11750180;Antagonist
EGIS-7625;5-HT2C receptor;f;;Human;15107597;Antagonist
fluoxetine;5-HT2C receptor;f;;Rat;11104741;Antagonist
FR260010;5-HT2C receptor;f;;Human;17074317;Antagonist
glemanserin;5-HT2C receptor;f;;Human;15322733;Antagonist
idalopirdine;5-HT2C receptor;f;;Human;24878269;Antagonist
ketanserin;5-HT2C receptor;f;;Human;15322733|8845011|12738034|10217294;Antagonist
LY334362;5-HT2C receptor;f;;Human;8845011;Antagonist
mesoridazine;5-HT2C receptor;f;;Human;15357957;Antagonist
methysergide;5-HT2C receptor;f;;Rat;9282936;Antagonist
methysergide;5-HT2C receptor;f;;Human;15322733|10611640;Antagonist
mianserin;5-HT2C receptor;f;;Rat;8876023|9282936;Antagonist
mirtazapine;5-HT2C receptor;f;;Human;15771415;Antagonist
MPDT;5-HT2C receptor;f;;Rat;10715164;Antagonist
norfluoxetine;5-HT2C receptor;f;;Rat;11104741;Antagonist
perphenazine;5-HT2C receptor;f;;Human;12629531;Antagonist
ritanserin;5-HT2C receptor;f;;Human;15322733;Antagonist
roxindole;5-HT2C receptor;f;;Human;12388666;Antagonist
RS-102221;5-HT2C receptor;f;;Human;15322733|9225287;Antagonist
RS-102221;5-HT2C receptor;f;;Rat;9225287;Antagonist
RS-127445;5-HT2C receptor;f;;Human;15322733;Antagonist
S33084;5-HT2C receptor;f;;Human;10869410;Antagonist
sarpogrelate;5-HT2C receptor;f;;Human;12738034;Antagonist
SB 204741;5-HT2C receptor;f;;Human;15322733;Antagonist
SB 206553;5-HT2C receptor;f;;Human;15322733|8821530;Antagonist
SB 215505;5-HT2C receptor;f;;Human;10188965;Antagonist
SB 221284;5-HT2C receptor;f;;Human;15322733;Antagonist
SB 224289;5-HT2C receptor;f;;Human;15322733;Antagonist
SB 224289;5-HT2C receptor;f;;Human;9776361;Antagonist
SB 228357;5-HT2C receptor;f;;Human;10188965|10737744;Antagonist
SB 242084;5-HT2C receptor;f;;Human;15322733|9225286;Antagonist
SB 243213;5-HT2C receptor;f;;Human;10737744;Antagonist
SDZ SER-082;5-HT2C receptor;f;;Human;15322733;Antagonist
spiperone;5-HT2C receptor;f;;Human;15322733|10991983|10217294;Antagonist
spiramide;5-HT2C receptor;f;;Human;15322733;Antagonist
terguride;5-HT2C receptor;f;;Human;12388666;Antagonist
thioridazine;5-HT2C receptor;f;;Human;12629531|10991983;Antagonist
trazodone;5-HT2C receptor;f;;Rat;11104741|8876023;Antagonist
trazodone;5-HT2C receptor;f;;Human;15322733;Antagonist
trifluoperazine;5-HT2C receptor;f;;Human;12629531;Antagonist
volinanserin;5-HT2C receptor;f;;Human;15322733|10188965;Antagonist
xanomeline;5-HT2C receptor;f;;Human;9884068;Antagonist
AC-90179;5-HT2C receptor;f;;Human;9395253;Inverse agonist
clozapine;5-HT2C receptor;f;;Human;9732398|15322733|12629531|15102927|10991983|10217294;Inverse agonist
loxapine;5-HT2C receptor;f;;Human;12629531|10991983;Inverse agonist
mesulergine;5-HT2C receptor;f;;Rat;9282936;Inverse agonist
mesulergine;5-HT2C receptor;f;;Human;12527336|15322733|15107597;Inverse agonist
metergoline;5-HT2C receptor;f;;Human;15322733;Inverse agonist
methiothepin;5-HT2C receptor;f;;Human;15322733;Inverse agonist
mianserin;5-HT2C receptor;f;;Human;10611634|15322733|10217294;Inverse agonist
olanzapine;5-HT2C receptor;f;;Human;12629531|10991983|18308814;Inverse agonist
risperidone;5-HT2C receptor;f;;Human;12629531|10991983;Inverse agonist
sertindole;5-HT2C receptor;f;;Human;12629531|10991983;Inverse agonist
[3H]mesulergine;5-HT2C receptor;f;;Human;12738034|10217294;Inverse agonist
tiospirone;5-HT2C receptor;f;;Human;10991983;Inverse agonist
ziprasidone;5-HT2C receptor;f;;Human;12629531|10991983|18308814;Inverse agonist
zotepine;5-HT2C receptor;f;;Human;10991983;Inverse agonist
1-phenylbiguanide;5-HT3A;f;;Human;7565620|9463477|11489465|7790853|8818349;Agonist
1-phenylbiguanide;5-HT3A;f;;Human;8848005;Agonist
2-methyl-5-HT;5-HT3A;f;;Human;7565620|9463477|8818349|11104834;Agonist
2-methyl-5-HT;5-HT3A;f;;Human;9950429|8848005|7565620|9463477;Agonist
5-hydroxytryptamine;5-HT3A;t;;Human;9950429|8848005|7565620|10521471|9463477|16081679|10825381;Agonist
5-hydroxytryptamine;5-HT3A;t;;Human;9463477|11489465|8818349|11104834;Agonist
meta-chlorphenylbiguanide;5-HT3A;f;;Rat;9756382|10204690;Agonist
meta-chlorphenylbiguanide;5-HT3A;f;;Human;7565620|9463477|11489465|8818349|11104834;Agonist
meta-chlorphenylbiguanide;5-HT3A;f;;Human;9950429|8848005|7565620|9463477|10204690;Agonist
meta-chlorphenylbiguanide;5-HT3A;f;;Rat;7565620|9517385;Agonist
SR57227A;5-HT3A;f;;Rat;8891244;Agonist
1-phenylbiguanide;5-HT3A;f;;Mouse;7790853;Partial agonist
1-phenylbiguanide;5-HT3A;f;;Mouse;7984286;Partial agonist
CSTI-300;5-HT3A;f;;Human;32102919;Partial agonist
quipazine;5-HT3A;f;;Human;11489465;Partial agonist
[3H]meta-chlorophenylbiguanide;5-HT3A;f;;Mouse;9517385;Partial agonist
Zn2+;5-HT3A;t;;Mouse;7620711|10771284;Biphasic
Ca2+;5-HT3A;t;;Mouse;7620711|16096341|11675031;Negative
Ca2+;5-HT3A;t;;Human;9508827|10582123;Negative
Mg2+;5-HT3A;t;;Human;10582123;Negative
Mg2+;5-HT3A;t;;Mouse;7620711|11675031;Negative
5-hydroxyindole;5-HT3A;f;;Mouse;10457085|7680589|9225290|18187416;Positive
ethanol;5-HT3A;f;;Mouse;16257471|7541281|9518697|16520747;Positive
trichloroethanol;5-HT3A;f;;Mouse;16257471|7541281|9518697|16520747|18094321;Positive
alosetron;5-HT3A;f;;Human;17652911;Antagonist
azasetron;5-HT3A;f;;Human;11489465;Antagonist
AZD0328;5-HT3A;f;;Human;21919481;Antagonist
cilansetron;5-HT3A;f;;Human;17652911;Antagonist
cocaine;5-HT3A;f;;Human;11489465|8818349;Antagonist
granisetron;5-HT3A;f;;Human;7565620|8818349;Antagonist
(R)-zacopride;5-HT3A;f;;Human;11489465;Antagonist
(S)-zacopride;5-HT3A;f;;Human;11489465;Antagonist
metoclopramide;5-HT3A;f;;Human;11489465|8818349;Antagonist
ondansetron;5-HT3A;f;;Human;7565620|11489465|8818349;Antagonist
palonosetron;5-HT3A;f;;Human;20724042;Antagonist
ramosetron;5-HT3A;f;;Human;17652911;Antagonist
ricasetron;5-HT3A;f;;Human;11489465;Antagonist
[3H]GR65630;5-HT3A;f;;Human;9463477|17652911;Antagonist
[3H]granisetron;5-HT3A;f;;Human;11489465|8818349;Antagonist
[3H](S)-zacopride;5-HT3A;f;;Human;8994113;Antagonist
[3H]LY278584;5-HT3A;f;;Human;8419547;Antagonist
[3H]ramosetron;5-HT3A;f;;Human;7565620;Antagonist
tropisetron;5-HT3A;f;;Human;7565620|9463477;Antagonist
tubocurarine;5-HT3A;f;;Human;11489465|8818349;Antagonist
tubocurarine;5-HT3A;f;;Mouse;7790853|9680250;Antagonist
vortioxetine;5-HT3A;f;;Human;21486038;Antagonist
bilobalide;5-HT3A;f;;Human;21505038;None
diltiazem;5-HT3A;f;;Mouse;10457085|19420755;None
diltiazem;5-HT3A;f;;Human;21505038;None
ginkgolide B;5-HT3A;f;;Human;21505038;None
picrotoxin;5-HT3A;f;;Mouse;14625088|12646280;None
picrotoxinin;5-HT3A;f;;Human;21505038;None
TMB-8;5-HT3A;f;;Mouse;10381768|19420755;None
TMB-8;5-HT3A;f;;Human;10381768;None
1-phenylbiguanide;5-HT3AB;f;;Human;11489465;Agonist
2-methyl-5-HT;5-HT3AB;f;;Human;9950429;Agonist
5-hydroxytryptamine;5-HT3AB;t;;Human;9950429|10521471|16081679|10825381;Agonist
5-hydroxytryptamine;5-HT3AB;t;;Human;11489465;Agonist
meta-chlorphenylbiguanide;5-HT3AB;f;;Human;9950429;Agonist
meta-chlorphenylbiguanide;5-HT3AB;f;;Human;11489465;Agonist
quipazine;5-HT3AB;f;;Human;11489465;Agonist
CSTI-300;5-HT3AB;f;;Human;32102919;Partial agonist
trichloroethanol;5-HT3AB;f;;Mouse;16257471;Positive
azasetron;5-HT3AB;f;;Human;11489465;Antagonist
cocaine;5-HT3AB;f;;Human;11489465;Antagonist
(R)-zacopride;5-HT3AB;f;;Human;11489465;Antagonist
(S)-zacopride;5-HT3AB;f;;Human;11489465;Antagonist
metoclopramide;5-HT3AB;f;;Human;11489465;Antagonist
ondansetron;5-HT3AB;f;;Human;11489465;Antagonist
[3H]granisetron;5-HT3AB;f;;Human;11489465;Antagonist
tubocurarine;5-HT3AB;f;;Human;11489465;Antagonist
bilobalide;5-HT3AB;f;;Human;21059362;None
ginkgolide B;5-HT3AB;f;;Human;21059362;None
picrotoxin;5-HT3AB;f;;Mouse;15814570|14625088;None
picrotoxinin;5-HT3AB;f;;Human;21059362;None
RS67506;5-HT4 receptor;f;;Rat;8903510;Agonist
TD-8954;5-HT4 receptor;f;;Human;23756062;Agonist
velusetrag;5-HT4 receptor;f;;Human;22959244|18415081;Agonist
vilazodone;5-HT4 receptor;f;;Human;15341484;Agonist
5-hydroxytryptamine;5-HT4 receptor;t;;Human;10646498;Full agonist
5-hydroxytryptamine;5-HT4 receptor;t;;Rat;7796807|8813606|9225293;Full agonist
5-hydroxytryptamine;5-HT4 receptor;t;;Rat;8813606;Full agonist
5-hydroxytryptamine;5-HT4 receptor;t;;Human;15466450|9349523|9603189|9351641|10646498|11218067|10683202|11030734|10821780|15351779;Full agonist
5-hydroxytryptamine;5-HT4 receptor;t;;Mouse;8946946;Full agonist
5-MeOT;5-HT4 receptor;f;;Rat;7796807|8813606|9225293;Full agonist
5-MeOT;5-HT4 receptor;f;;Human;9349523|9603189|10646498|11218067|10683202|11030734;Full agonist
5-MeOT;5-HT4 receptor;f;;Mouse;8946946;Full agonist
α-methyl-5-HT;5-HT4 receptor;f;;Rat;8813606|9225293;Full agonist
α-methyl-5-HT;5-HT4 receptor;f;;Human;15466450|7796807;Full agonist
BIMU 1;5-HT4 receptor;f;;Mouse;8946946;Full agonist
BIMU 1;5-HT4 receptor;f;;Human;9603189|10683202|11030734;Full agonist
BIMU 8;5-HT4 receptor;f;;Human;9351641;Full agonist
BIMU 8;5-HT4 receptor;f;;Mouse;8946946;Full agonist
BIMU 8;5-HT4 receptor;f;;Rat;9225293;Full agonist
cisapride;5-HT4 receptor;f;;Mouse;8946946;Full agonist
metoclopramide;5-HT4 receptor;f;;Mouse;8946946;Full agonist
mosapride;5-HT4 receptor;f;;Human;10646498;Full agonist
renzapride;5-HT4 receptor;f;;Rat;8813606|9225293;Full agonist
renzapride;5-HT4 receptor;f;;Human;7796807|9603189|9351641|11218067|10683202|11030734;Full agonist
renzapride;5-HT4 receptor;f;;Mouse;8946946;Full agonist
SC 53116;5-HT4 receptor;f;;Mouse;8946946;Full agonist
zacopride;5-HT4 receptor;f;;Rat;8813606|9225293;Full agonist
zacopride;5-HT4 receptor;f;;Mouse;8946946;Full agonist
zacopride;5-HT4 receptor;f;;Human;7796807|9603189|9351641;Full agonist
capeserod;5-HT4 receptor;f;;Human;12130738;Partial agonist
cisapride;5-HT4 receptor;f;;Human;9349523|7796807|10646498|11218067|10683202|11030734;Partial agonist
cisapride;5-HT4 receptor;f;;Rat;8813606|9225293;Partial agonist
donecopride;5-HT4 receptor;f;;Guinea pig;25157130;Partial agonist
ML 10302;5-HT4 receptor;f;;Human;9603189|10683202|11030734|10821780|12801225;Partial agonist
PF-04995274;5-HT4 receptor;f;;Human;22974325;Partial agonist
prucalopride;5-HT4 receptor;f;;Human;10646498|11438309;Partial agonist
relenopride;5-HT4 receptor;f;;Human;25316608;Partial agonist
RS 57639;5-HT4 receptor;f;;Rat;9225293;Partial agonist
RS 67333;5-HT4 receptor;f;;Human;10683202|11030734;Partial agonist
[3H]RS 57639;5-HT4 receptor;f;;Rat;9225293;Partial agonist
tegaserod;5-HT4 receptor;f;;Human;15466450|10646498;Partial agonist
DAU 6285;5-HT4 receptor;f;;Human;9351641;Antagonist
DAU 6285;5-HT4 receptor;f;;Mouse;8946946;Antagonist
GR 113808;5-HT4 receptor;f;;Mouse;8946946;Antagonist
GR 113808;5-HT4 receptor;f;;Human;9349523|9603189|9351641|10646498|11218067|11030734|15351779;Antagonist
GR 113808;5-HT4 receptor;f;;Rat;9225293;Antagonist
GR 125487;5-HT4 receptor;f;;Human;9349523|9351641;Antagonist
GR 125487;5-HT4 receptor;f;;Mouse;8946946;Antagonist
ML 10375;5-HT4 receptor;f;;Human;15466450|9603189|10683202|11030734|10821780;Antagonist
piboserod;5-HT4 receptor;f;;Human;15466450|11504648|9351641;Antagonist
RS 100235;5-HT4 receptor;f;;Human;9351641|15351779;Antagonist
RS 39604;5-HT4 receptor;f;;Human;10683202|11030734|15351779;Antagonist
SB 203186;5-HT4 receptor;f;;Human;11218067;Antagonist
SB 204070;5-HT4 receptor;f;;Rat;9225293;Antagonist
SB 204070;5-HT4 receptor;f;;Human;9349523|10646498|10683202|11030734;Antagonist
SB 207710;5-HT4 receptor;f;;Human;11218067;Antagonist
SDZ 205557;5-HT4 receptor;f;;Rat;9225293;Antagonist
SDZ 205557;5-HT4 receptor;f;;Mouse;7498967;Antagonist
[11C]SB207145;5-HT4 receptor;f;;Human;21831646;Antagonist
[123I]SB 207710;5-HT4 receptor;f;;Pig;;Antagonist
[3H]GR 113808;5-HT4 receptor;f;;Human;9349523|10646498|11218067|10821780;Antagonist
[3H]GR 113808;5-HT4 receptor;f;;Rat;8813606|9225293;Antagonist
[3H]RS 57639;5-HT4 receptor;f;;Guinea pig;9225293;Antagonist
tropisetron;5-HT4 receptor;f;;Rat;8813606;Antagonist
tropisetron;5-HT4 receptor;f;;Mouse;8946946;Antagonist
tropisetron;5-HT4 receptor;f;;Human;9349523|11218067;Antagonist
RO 116 1148;5-HT4 receptor;f;;Mouse;11976337;Inverse agonist
RS 116 0086;5-HT4 receptor;f;;Mouse;11976337;Inverse agonist
5-CT;5-HT5A receptor;f;;Mouse;8450829|11343685|8549774;Full agonist
5-CT;5-HT5A receptor;f;;Rat;7682702;Full agonist
5-CT;5-HT5A receptor;f;;Human;7988681|11343685;Full agonist
5-hydroxytryptamine;5-HT5A receptor;t;;Mouse;8450829|11343685|8549774;Full agonist
5-hydroxytryptamine;5-HT5A receptor;t;;Rat;7682702;Full agonist
5-hydroxytryptamine;5-HT5A receptor;t;;Human;7988681|11343685;Full agonist
8-OH-DPAT;5-HT5A receptor;f;;Human;7988681|11343685;Full agonist
8-OH-DPAT;5-HT5A receptor;f;;Mouse;8450829|11343685;Full agonist
donitriptan;5-HT5A receptor;f;;Human;10381763;Full agonist
EMDT;5-HT5A receptor;f;;Human;10715164;Full agonist
lysergic acid;5-HT5A receptor;f;;Mouse;8549774;Full agonist
RU 24969;5-HT5A receptor;f;;Mouse;8450829;Full agonist
RU 24969;5-HT5A receptor;f;;Human;7988681;Full agonist
sumatriptan;5-HT5A receptor;f;;Mouse;8450829|11343685;Full agonist
sumatriptan;5-HT5A receptor;f;;Human;7988681|11343685;Full agonist
[125I]LSD;5-HT5A receptor;f;;Human;11343685;Full agonist
[3H]5-CT;5-HT5A receptor;f;;Human;11343685;Full agonist
TFMPP;5-HT5A receptor;f;;Mouse;8450829;Full agonist
bufotenine;5-HT5A receptor;f;;Mouse;8450829|8549774;Antagonist
clozapine;5-HT5A receptor;f;;Mouse;11343685;Antagonist
clozapine;5-HT5A receptor;f;;Human;7988681|11343685;Antagonist
ergotamine;5-HT5A receptor;f;;Mouse;8450829|11343685|8549774;Antagonist
ergotamine;5-HT5A receptor;f;;Human;7988681|11343685;Antagonist
ergotamine;5-HT5A receptor;f;;Rat;7682702;Antagonist
ketanserin;5-HT5A receptor;f;;Human;7988681;Antagonist
metergoline;5-HT5A receptor;f;;Human;7988681;Antagonist
methiothepin;5-HT5A receptor;f;;Rat;7682702;Antagonist
methiothepin;5-HT5A receptor;f;;Mouse;8450829|11343685;Antagonist
methiothepin;5-HT5A receptor;f;;Human;7988681|11343685;Antagonist
methysergide;5-HT5A receptor;f;;Human;7988681;Antagonist
methysergide;5-HT5A receptor;f;;Mouse;8450829|8549774;Antagonist
methysergide;5-HT5A receptor;f;;Rat;7682702;Antagonist
MPDT;5-HT5A receptor;f;;Human;10715164;Antagonist
(-)-propranolol;5-HT5A receptor;f;;Human;7988681;Antagonist
ritanserin;5-HT5A receptor;f;;Human;11343685;Antagonist
ritanserin;5-HT5A receptor;f;;Mouse;11343685;Antagonist
SB 699551;5-HT5A receptor;f;;Human;16002289;Antagonist
vortioxetine;5-HT5A receptor;f;;Human;21486038;Antagonist
yohimbine;5-HT5A receptor;f;;Mouse;8450829|8549774;Antagonist
yohimbine;5-HT5A receptor;f;;Human;7988681;Antagonist
[125I]LSD;5-ht5b receptor;f;;Mouse;8450829;Full agonist
[3H]5-CT;5-ht5b receptor;f;;Mouse;9928243;Full agonist
EMD-386088;5-HT6 receptor;f;;Human;16055331;Agonist
[3H]5-CT;5-HT6 receptor;f;;Human;;Agonist
WAY-181187;5-HT6 receptor;f;;Human;17625499;Agonist
WAY-208466;5-HT6 receptor;f;;Human;19523834;Agonist
1-naphthylpiperazine;5-HT6 receptor;f;;Rat;7680751;Full agonist
2-methyl-5-HT;5-HT6 receptor;f;;Rat;9225298;Full agonist
5-benzyloxytryptamine;5-HT6 receptor;f;;Rat;7680751|9225298|9798944;Full agonist
5-CT;5-HT6 receptor;f;;Human;8522988;Full agonist
5-CT;5-HT6 receptor;f;;Rat;7680751|9225298|9798944;Full agonist
5-hydroxytryptamine;5-HT6 receptor;t;;Rat;9225298;Full agonist
5-hydroxytryptamine;5-HT6 receptor;t;;Rat;7680751|9225298|9798944|9730917;Full agonist
5-hydroxytryptamine;5-HT6 receptor;t;;Human;8522988|9730917|9284367;Full agonist
5-MeO-DMT;5-HT6 receptor;f;;Rat;9798944;Full agonist
5-MeOT;5-HT6 receptor;f;;Rat;7680751|9225298|9798944;Full agonist
5-MeOT;5-HT6 receptor;f;;Human;8522988;Full agonist
α-methyl-5-HT;5-HT6 receptor;f;;Rat;9798944;Full agonist
bromocriptine;5-HT6 receptor;f;;Human;8522988;Full agonist
CGS-12066;5-HT6 receptor;f;;Rat;7680751;Full agonist
dimethyltryptamine;5-HT6 receptor;f;;Human;8522988;Full agonist
DM-1451;5-HT6 receptor;f;;Rat;10327430;Full agonist
EMDT;5-HT6 receptor;f;;Human;10715164;Full agonist
ergotamine;5-HT6 receptor;f;;Rat;9225298|9798944|9730917;Full agonist
ergotamine;5-HT6 receptor;f;;Human;9730917|9284367;Full agonist
m-chlorophenylpiperazine;5-HT6 receptor;f;;Rat;7680751;Full agonist
lergotrile;5-HT6 receptor;f;;Rat;7680751;Full agonist
LY 165,163;5-HT6 receptor;f;;Rat;7680751;Full agonist
Lysergide;5-HT6 receptor;f;;Human;9730917;Full agonist
Lysergide;5-HT6 receptor;f;;Rat;9225298|9730917;Full agonist
OPC 4392;5-HT6 receptor;f;;Rat;10327430;Full agonist
pergolide;5-HT6 receptor;f;;Rat;7680751;Full agonist
RU 24969;5-HT6 receptor;f;;Human;8522988;Full agonist
S 16924;5-HT6 receptor;f;;Rat;9732398;Full agonist
[3H]LSD;5-HT6 receptor;f;;Human;9284367;Full agonist
[3H]LSD;5-HT6 receptor;f;;Rat;9225298|10327430;Full agonist
TFMPP;5-HT6 receptor;f;;Rat;7680751;Full agonist
TFMPP;5-HT6 receptor;f;;Human;8522988;Full agonist
tryptamine;5-HT6 receptor;f;;Rat;7680751|9225298;Full agonist
xanomeline;5-HT6 receptor;f;;Human;9884068;Full agonist
BRL-15572;5-HT6 receptor;f;;Human;9303567;Partial agonist
bromocriptine;5-HT6 receptor;f;;Rat;9798944;Partial agonist
capeserod;5-HT6 receptor;f;;Human;12130738;Partial agonist
donitriptan;5-HT6 receptor;f;;Human;10381763;Partial agonist
E6801;5-HT6 receptor;f;;Human;15771424;Partial agonist
GR 127935;5-HT6 receptor;f;;Human;9303567;Partial agonist
lisuride;5-HT6 receptor;f;;Rat;7680751|9225298|9798944|9730917;Partial agonist
lisuride;5-HT6 receptor;f;;Human;9730917|9284367;Partial agonist
2-bromo-LSD;5-HT6 receptor;f;;Rat;7680751;Antagonist
α-ergocryptine;5-HT6 receptor;f;;Rat;9798944;Antagonist
amitriptyline;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
amitriptyline;5-HT6 receptor;f;;Rat;7680751|9225298|9730917;Antagonist
amoxapine;5-HT6 receptor;f;;Human;8522988;Antagonist
amoxapine;5-HT6 receptor;f;;Rat;7680751|7908055;Antagonist
aripiprazole;5-HT6 receptor;f;;Rat;10327430;Antagonist
bufotenine;5-HT6 receptor;f;;Rat;9225298;Antagonist
cerlapirdine;5-HT6 receptor;f;;Human;;Antagonist
cyproheptadine;5-HT6 receptor;f;;Human;8522988;Antagonist
cyproheptadine;5-HT6 receptor;f;;Rat;7680751;Antagonist
dihydroergocristine;5-HT6 receptor;f;;Rat;9798944;Antagonist
dihydroergotamine;5-HT6 receptor;f;;Rat;7680751|9798944;Antagonist
duloxetine;5-HT6 receptor;f;;Human;11750180;Antagonist
fluoxetine;5-HT6 receptor;f;;Rat;7680751;Antagonist
ICI 169369;5-HT6 receptor;f;;Human;8522988;Antagonist
idalopirdine;5-HT6 receptor;f;;Human;24878269;Antagonist
iloperidone;5-HT6 receptor;f;;Rat;8997630;Antagonist
iloperidone;5-HT6 receptor;f;;Human;11750183;Antagonist
intepirdine;5-HT6 receptor;f;;Human;24878269;Antagonist
mesulergine;5-HT6 receptor;f;;Rat;7680751|9225298|9730917;Antagonist
mesulergine;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
metergoline;5-HT6 receptor;f;;Rat;7680751|9225298|9798944|9730917;Antagonist
metergoline;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
methiothepin;5-HT6 receptor;f;;Rat;7680751|9225298|9798944|9730917;Antagonist
methiothepin;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
methysergide;5-HT6 receptor;f;;Rat;7680751|9225298|9798944|9730917;Antagonist
methysergide;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
mianserin;5-HT6 receptor;f;;Rat;7680751|9225298|9730917;Antagonist
mianserin;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
MPDT;5-HT6 receptor;f;;Human;10715164;Antagonist
pimozide;5-HT6 receptor;f;;Rat;7908055;Antagonist
risperidone;5-HT6 receptor;f;;Human;8522988;Antagonist
ritanserin;5-HT6 receptor;f;;Rat;7680751|9225298|9798944|9730917;Antagonist
ritanserin;5-HT6 receptor;f;;Human;8522988|9730917|9284367;Antagonist
Ro 04-6790;5-HT6 receptor;f;;Human;9730917|9647481;Antagonist
Ro 04-6790;5-HT6 receptor;f;;Rat;9730917|9647481;Antagonist
Ro 63-0563;5-HT6 receptor;f;;Rat;9730917|9647481;Antagonist
Ro 63-0563;5-HT6 receptor;f;;Human;9730917|9647481;Antagonist
SB258585;5-HT6 receptor;f;;Human;10928963;Antagonist
SB 271046;5-HT6 receptor;f;;Human;9925723;Antagonist
SB357134;5-HT6 receptor;f;;Human;11140733;Antagonist
SB357134;5-HT6 receptor;f;;Human;11140733;Antagonist
SB399885;5-HT6 receptor;f;;Human;17069795;Antagonist
spiperone;5-HT6 receptor;f;;Rat;7908055;Antagonist
sumatriptan;5-HT6 receptor;f;;Human;8522988;Antagonist
sumatriptan;5-HT6 receptor;f;;Rat;9798944;Antagonist
[11C]GSK215083;5-HT6 receptor;f;;Human;22223878;Antagonist
[125I]SB258585;5-HT6 receptor;f;;Human;17069795;Antagonist
[3H]Ro 63-0563;5-HT6 receptor;f;;Human;9730917;Antagonist
tiospirone;5-HT6 receptor;f;;Human;8522988;Antagonist
tiospirone;5-HT6 receptor;f;;Rat;7908055;Antagonist
vortioxetine;5-HT6 receptor;f;;Human;21486038;Antagonist
chlorpromazine;5-HT6 receptor;f;;Rat;7908055;Inverse agonist
chlorpromazine;5-HT6 receptor;f;;Human;8522988|15821958;Inverse agonist
clozapine;5-HT6 receptor;f;;Rat;9732398|8997630|7680751|9225298|9798944|9730917|7908055;Inverse agonist
clozapine;5-HT6 receptor;f;;Human;8522988|9730917|9284367|15821958;Inverse agonist
fluperlapine;5-HT6 receptor;f;;Human;8522988|15821958;Inverse agonist
fluperlapine;5-HT6 receptor;f;;Rat;7908055;Inverse agonist
fluphenazine;5-HT6 receptor;f;;Human;15821958;Inverse agonist
fluphenazine;5-HT6 receptor;f;;Rat;7908055;Inverse agonist
loxapine;5-HT6 receptor;f;;Rat;7680751|7908055;Inverse agonist
loxapine;5-HT6 receptor;f;;Human;8522988|15821958;Inverse agonist
olanzapine;5-HT6 receptor;f;;Human;8522988|15821958;Inverse agonist
olanzapine;5-HT6 receptor;f;;Rat;8997630|7908055;Inverse agonist
perphenazine;5-HT6 receptor;f;;Rat;7908055;Inverse agonist
perphenazine;5-HT6 receptor;f;;Human;15821958;Inverse agonist
risperidone;5-HT6 receptor;f;;Rat;8997630|7908055;Inverse agonist
thioridazine;5-HT6 receptor;f;;Rat;7908055;Inverse agonist
thioridazine;5-HT6 receptor;f;;Human;15821958;Inverse agonist
zotepine;5-HT6 receptor;f;;Human;15821958;Inverse agonist
zotepine;5-HT6 receptor;f;;Rat;7908055;Inverse agonist
AS-19;5-HT7 receptor;f;;Human;23541835;Agonist
LP-12;5-HT7 receptor;f;;Human;17649988;Agonist
LP-211;5-HT7 receptor;f;;Rat;18800769;Agonist
LP-44;5-HT7 receptor;f;;Human;17649988;Agonist
[3H]5-CT;5-HT7 receptor;f;;Human;10807680;Agonist
1-naphthylpiperazine;5-HT7 receptor;f;;Human;8226867;Full agonist
1-naphthylpiperazine;5-HT7 receptor;f;;Rat;8394362;Full agonist
2-MPP;5-HT7 receptor;f;;Rat;8394362;Full agonist
5-CT;5-HT7 receptor;f;;Human;11414657|9298538|8226867|9720804;Full agonist
5-CT;5-HT7 receptor;f;;Mouse;8394987;Full agonist
5-CT;5-HT7 receptor;f;;Rat;8394362|8397408;Full agonist
5-hydroxytryptamine;5-HT7 receptor;t;;Rat;8394362|8397408;Full agonist
5-hydroxytryptamine;5-HT7 receptor;t;;Human;12527336|11414657|9298538|8226867|9720804;Full agonist
5-hydroxytryptamine;5-HT7 receptor;t;;Mouse;8394987;Full agonist
5-MeO-DMT;5-HT7 receptor;f;;Rat;8394362;Full agonist
5-MeOT;5-HT7 receptor;f;;Rat;8394362|8397408;Full agonist
5-MeOT;5-HT7 receptor;f;;Mouse;8394987;Full agonist
5-MeOT;5-HT7 receptor;f;;Human;11414657|9298538|8226867;Full agonist
8-OH-DPAT;5-HT7 receptor;f;;Mouse;8394987;Full agonist
8-OH-DPAT;5-HT7 receptor;f;;Human;11414657|9298538|8226867|9720804;Full agonist
8-OH-DPAT;5-HT7 receptor;f;;Rat;8394362|8397408;Full agonist
bromocriptine;5-HT7 receptor;f;;Rat;8394362;Full agonist
bufotenine;5-HT7 receptor;f;;Mouse;8394987;Full agonist
cisapride;5-HT7 receptor;f;;Mouse;8394987;Full agonist
dipropyl-5-CT;5-HT7 receptor;f;;Human;9298538;Full agonist
DM-1451;5-HT7 receptor;f;;Rat;10327430;Full agonist
E55888;5-HT7 receptor;f;;Human;19118950;Full agonist
EMDT;5-HT7 receptor;f;;Human;10715164;Full agonist
m-chlorophenylpiperazine;5-HT7 receptor;f;;Rat;8394362;Full agonist
lisuride;5-HT7 receptor;f;;Rat;8394362|8397408;Full agonist
(+)-LSD;5-HT7 receptor;f;;Human;8397408;Full agonist
LY344864;5-HT7 receptor;f;;Human;9395253;Full agonist
OPC 4392;5-HT7 receptor;f;;Rat;10327430;Full agonist
pergolide;5-HT7 receptor;f;;Rat;8394362;Full agonist
RU 24969;5-HT7 receptor;f;;Mouse;8394987;Full agonist
[125I]LSD;5-HT7 receptor;f;;Rat;8398139;Full agonist
[3H]5-HT;5-HT7 receptor;f;;Human;9303561|8226867;Full agonist
[3H]LSD;5-HT7 receptor;f;;Rat;10327430;Full agonist
[3H]LSD;5-HT7 receptor;f;;Human;9303561;Full agonist
TFMPP;5-HT7 receptor;f;;Rat;8394362;Full agonist
tryptamine;5-HT7 receptor;f;;Human;8226867;Full agonist
tryptamine;5-HT7 receptor;f;;Rat;8394362;Full agonist
xanomeline;5-HT7 receptor;f;;Human;9884068;Full agonist
aripiprazole;5-HT7 receptor;f;;Rat;10327430;Partial agonist
buspirone;5-HT7 receptor;f;;Rat;8397408;Partial agonist
capeserod;5-HT7 receptor;f;;Human;12130738;Partial agonist
oleamide;5-HT7 receptor;f;;Human;10571256;Negative
2-bromo-LSD;5-HT7 receptor;f;;Human;8226867;Antagonist
2-bromo-LSD;5-HT7 receptor;f;;Mouse;8394987;Antagonist
amitriptyline;5-HT7 receptor;f;;Rat;8394362;Antagonist
amitriptyline;5-HT7 receptor;f;;Mouse;8394987;Antagonist
amoxapine;5-HT7 receptor;f;;Rat;7908055;Antagonist
buspirone;5-HT7 receptor;f;;Mouse;8394987;Antagonist
(+)-butaclamol;5-HT7 receptor;f;;Mouse;8394987;Antagonist
(+)-butaclamol;5-HT7 receptor;f;;Rat;8397408;Antagonist
cyamemazine;5-HT7 receptor;f;;Human;12527336;Antagonist
cyproheptadine;5-HT7 receptor;f;;Rat;8394362|8397408;Antagonist
cyproheptadine;5-HT7 receptor;f;;Human;8226867;Antagonist
dihydroergocryptine;5-HT7 receptor;f;;Mouse;8394987;Antagonist
dihydroergocryptine;5-HT7 receptor;f;;Rat;8397408;Antagonist
dihydroergotamine;5-HT7 receptor;f;;Human;8226867;Antagonist
dihydroergotamine;5-HT7 receptor;f;;Rat;8397408;Antagonist
DR-4004;5-HT7 receptor;f;;Human;10052959|12825922;Antagonist
ergotamine;5-HT7 receptor;f;;Mouse;8394987;Antagonist
haloperidol;5-HT7 receptor;f;;Mouse;8394987;Antagonist
haloperidol;5-HT7 receptor;f;;Human;9298538;Antagonist
haloperidol;5-HT7 receptor;f;;Rat;8997630|7908055|8397408;Antagonist
iloperidone;5-HT7 receptor;f;;Rat;8997630;Antagonist
iloperidone;5-HT7 receptor;f;;Human;11750183;Antagonist
JNJ-18038683;5-HT7 receptor;f;;Human;22570363;Antagonist
ketanserin;5-HT7 receptor;f;;Human;11414657|9298538|8226867|9720804;Antagonist
ketanserin;5-HT7 receptor;f;;Rat;8394362;Antagonist
ketanserin;5-HT7 receptor;f;;Mouse;8394987;Antagonist
loxapine;5-HT7 receptor;f;;Rat;7908055|8394362;Antagonist
lurasidone;5-HT7 receptor;f;;Human;20404009;Antagonist
mesulergine;5-HT7 receptor;f;;Rat;8394362;Antagonist
mesulergine;5-HT7 receptor;f;;Mouse;8394987;Antagonist
mesulergine;5-HT7 receptor;f;;Human;11414657|9298538|8226867|9720804;Antagonist
metergoline;5-HT7 receptor;f;;Human;11414657|9298538|8226867;Antagonist
metergoline;5-HT7 receptor;f;;Rat;8394362|8397408;Antagonist
metergoline;5-HT7 receptor;f;;Mouse;8394987;Antagonist
methiothepin;5-HT7 receptor;f;;Mouse;8394987;Antagonist
methiothepin;5-HT7 receptor;f;;Human;11414657|9298538|8226867|9720804;Antagonist
methiothepin;5-HT7 receptor;f;;Rat;8394362;Antagonist
methysergide;5-HT7 receptor;f;;Mouse;8394987;Antagonist
methysergide;5-HT7 receptor;f;;Rat;8394362;Antagonist
methysergide;5-HT7 receptor;f;;Human;11414657|9298538|8226867;Antagonist
mianserin;5-HT7 receptor;f;;Rat;8394362|8397408;Antagonist
mianserin;5-HT7 receptor;f;;Human;9298538;Antagonist
mianserin;5-HT7 receptor;f;;Mouse;8394987;Antagonist
MPDT;5-HT7 receptor;f;;Human;10715164;Antagonist
olanzapine;5-HT7 receptor;f;;Human;9720804;Antagonist
olanzapine;5-HT7 receptor;f;;Rat;8997630|7908055;Antagonist
pimozide;5-HT7 receptor;f;;Rat;7908055;Antagonist
pirenperone;5-HT7 receptor;f;;Human;9298538;Antagonist
ritanserin;5-HT7 receptor;f;;Human;11414657|8226867;Antagonist
ritanserin;5-HT7 receptor;f;;Rat;8394362;Antagonist
SB 207710;5-HT7 receptor;f;;Human;11414657;Antagonist
SB269970;5-HT7 receptor;f;;Human;10807680;Antagonist
SB656104;5-HT7 receptor;f;;Human;12392747;Antagonist
spiperone;5-HT7 receptor;f;;Mouse;8394987;Antagonist
spiperone;5-HT7 receptor;f;;Rat;7908055|8397408;Antagonist
spiperone;5-HT7 receptor;f;;Human;11414657|9298538|8226867;Antagonist
sumatriptan;5-HT7 receptor;f;;Rat;8394362|8397408;Antagonist
sumatriptan;5-HT7 receptor;f;;Human;9298538|8226867;Antagonist
[3H]SB269970;5-HT7 receptor;f;;Human;10807680;Antagonist
TFMPP;5-HT7 receptor;f;;Mouse;8394987;Antagonist
tiospirone;5-HT7 receptor;f;;Rat;7908055;Antagonist
vortioxetine;5-HT7 receptor;f;;Human;21486038;Antagonist
yohimbine;5-HT7 receptor;f;;Human;8226867;Antagonist
chlorpromazine;5-HT7 receptor;f;;Mouse;8394987;Inverse agonist
chlorpromazine;5-HT7 receptor;f;;Rat;7908055;Inverse agonist
chlorpromazine;5-HT7 receptor;f;;Human;15821958;Inverse agonist
clozapine;5-HT7 receptor;f;;Rat;8997630|7908055|8394362|8397408;Inverse agonist
clozapine;5-HT7 receptor;f;;Mouse;8394987;Inverse agonist
clozapine;5-HT7 receptor;f;;Human;15821958|11414657|9720804;Inverse agonist
fluperlapine;5-HT7 receptor;f;;Human;15821958;Inverse agonist
fluperlapine;5-HT7 receptor;f;;Rat;7908055;Inverse agonist
fluphenazine;5-HT7 receptor;f;;Rat;7908055;Inverse agonist
fluphenazine;5-HT7 receptor;f;;Human;15821958;Inverse agonist
perphenazine;5-HT7 receptor;f;;Rat;7908055;Inverse agonist
perphenazine;5-HT7 receptor;f;;Human;15821958;Inverse agonist
risperidone;5-HT7 receptor;f;;Human;15821958|9720804;Inverse agonist
risperidone;5-HT7 receptor;f;;Rat;8997630|7908055;Inverse agonist
SB 258719;5-HT7 receptor;f;;Human;9720804;Inverse agonist
thioridazine;5-HT7 receptor;f;;Rat;7908055;Inverse agonist
thioridazine;5-HT7 receptor;f;;Human;15821958;Inverse agonist
ziprasidone;5-HT7 receptor;f;;Human;15821958;Inverse agonist
zotepine;5-HT7 receptor;f;;Human;15821958;Inverse agonist
zotepine;5-HT7 receptor;f;;Rat;7908055;Inverse agonist
5-LOX activating protein;5-LOX;t;Human;Human;;Activation
5-LOX inhibitor 2m [PMID: 30199704];5-LOX;f;;Human;30199704;Inhibition
CJ13610;5-LOX;f;;Human;15197110;Inhibition
PF-04191834;5-LOX;f;;Human;20378715;Inhibition
zileuton;5-LOX;f;;Human;24508141;Inhibition
zileuton;5-LOX;f;;Human;1848634;Inhibition
zileuton;5-LOX;f;;Human;30199704;Inhibition
PFK15;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3;f;;Human;23674815;Inhibition
PFKFB3 kinase Inhibitor 69;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3;f;;Human;30378281;Inhibition
TH5487;8-oxoguanine DNA glycosylase;f;;Human;30442810;Binding
probucol;ABCA1;f;;Human;15514211|15140889;Inhibition
bihelical apoA-I mimetic peptide 5A;ABCA1;f;;Human;18805791;Binding
compound 14 [PMID: 30925062];ABCB1;f;;Human;30925062;Competitive
compound 14 [PMID: 30925062];ABCB1;f;;Human;30925062;Competitive
glycochenodeoxycholic acid;ABCB11;f;;Human;12404239;Binding
compound 14 [PMID: 30925062];ABCC1;f;;Human;30925062;Competitive
WP814;ABCC1;f;;Human;9647783;Inhibition
PAK-104P;ABCC2;f;;Human;10570049;Inhibition
estradiol disulfate;ABCC4;f;;Human;12523936;Inhibition
compound 2 [PMID: 22380603];ABCC5;f;;Human;22380603;Inhibition
sildenafil;ABCC5;f;;Human;22380603;Inhibition
compound 13b [PMID: 19101153];ABCC9;f;;Human;19101153;Positive
cyclosporin A;ABCG2;f;;Human;11437380;Inhibition
Fumitremorgin C;ABCG2;f;;None;;Inhibition
Ko 143;ABCG2;f;;None;;Inhibition
KS 176;ABCG2;f;;None;;Inhibition
compound 14 [PMID: 30925062];ABCG2;f;;Human;30925062;Non-competitive
asciminib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;;Negative
bafetinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;17376680|16105974;Inhibition
BO1;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;18078752|20451394;Inhibition
bosutinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;12543790;Inhibition
compound 24 [PMID: 23441572];ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;23441572;Inhibition
compound 2c [PMID: 24900538];ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;24900538;Inhibition
compound 8h [PMID: 21561767];ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;21561767;Inhibition
dasatinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;23279183;Inhibition
dasatinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31539241;Inhibition
DDR1/2 inhibitor 5n;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;30075624;Inhibition
eCF506;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;27115835;Inhibition
flumatinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;20703259;Inhibition
GNF-5;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;20072125;Inhibition
GZD824;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;23301703;Inhibition
GZD824;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;23301703;Inhibition
imatinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;17376680;Inhibition
KW-2449;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;19541823;Inhibition
nilotinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;15930265;Inhibition
PD-173955;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;22037378;Inhibition
PD-173955;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;12154025;Inhibition
pexmetinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;27287719;Inhibition
PF-114;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;25394714;Inhibition
ponatinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;20513156;Inhibition
PP121;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;18849971;Inhibition
rebastinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;21481795;Inhibition
saracatinib;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;17064066;Inhibition
SCO-088;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31493432;Inhibition
SCO-088;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31493432;Inhibition
SCO-088;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31493432;Inhibition
SIAIS178;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31539241;Inhibition
ZAK inhibitor 6p;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31244114;Inhibition
ZAK inhibitor 6p;ABL proto-oncogene 1, non-receptor tyrosine kinase;f;;Human;31244114;Inhibition
compound 24 [PMID: 23441572];ABL proto-oncogene 2, non-receptor tyrosine kinase;f;;Human;23441572;Inhibition
pexmetinib;ABL proto-oncogene 2, non-receptor tyrosine kinase;f;;Human;27287719;Inhibition
BW284C51;acetylcholinesterase (Cartwright blood group);f;;Human;12675140;Inhibition
compound 2f [Jiang et al., 2018];acetylcholinesterase (Cartwright blood group);f;;Human;29541355;Inhibition
donecopride;acetylcholinesterase (Cartwright blood group);f;;Human;25157130;Inhibition
donepezil;acetylcholinesterase (Cartwright blood group);f;;Human;16570913|8039548|1738151;Inhibition
echothiophate;acetylcholinesterase (Cartwright blood group);f;;Human;;Inhibition
edrophonium;acetylcholinesterase (Cartwright blood group);f;;Human;9301662;Inhibition
galantamine;acetylcholinesterase (Cartwright blood group);f;;Human;12182861;Inhibition
neostigmine;acetylcholinesterase (Cartwright blood group);f;;Human;17888667;Inhibition
physostigmine;acetylcholinesterase (Cartwright blood group);f;;Human;16570913;Inhibition
pralidoxime;acetylcholinesterase (Cartwright blood group);f;;Human;21215642;Inhibition
pyridostigmine;acetylcholinesterase (Cartwright blood group);f;;Human;20627738;Inhibition
rivastigmine;acetylcholinesterase (Cartwright blood group);f;;Human;16570913;Inhibition
tacrine;acetylcholinesterase (Cartwright blood group);f;;Human;18479118;Inhibition
AChE reactivator 2;acetylcholinesterase (Cartwright blood group);f;;Human;30125110;None
compound 15a [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 15b [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 16 [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 18a [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 18b [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 22c [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 22d [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 26a [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 26b [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
compound 26c [PMID: 16242323];acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
K-604;acetyl-CoA acetyltransferase 1;f;;Human;16820149;Inhibition
SM-32504;acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
SMP-797;acetyl-CoA acetyltransferase 1;f;;Rat;16242323;Inhibition
K-604;acetyl-CoA acetyltransferase 2;f;;Human;16820149;Inhibition
firsocostat;Acetyl-CoA carboxylase 1;f;;Human;26976583;Negative
compound 21 [PMID: 23981033];Acetyl-CoA carboxylase 1;f;;Human;23981033;Inhibition
TOFA;Acetyl-CoA carboxylase 1;f;;Human;14612531;Inhibition
firsocostat;Acetyl-CoA carboxylase 2;f;;Human;26976583;Negative
A-908292;Acetyl-CoA carboxylase 2;f;;Human;18025247;Inhibition
compound 21 [PMID: 23981033];Acetyl-CoA carboxylase 2;f;;Human;23981033;Inhibition
compound 2e [PMID: 31900320];Acetyl-CoA carboxylase 2;f;;Human;31900320;Inhibition
TOFA;Acetyl-CoA carboxylase 2;f;;Human;14612531;Inhibition
[14C]acetylCoA;AcetylCoA transporter;f;;Human;;Binding
adrenomedullin;ACKR3;t;Rat;Rat;8554605;Agonist
α-CGRP;ACKR3;f;Mouse|Rat;Rat;8554605;Agonist
CXCL12α;ACKR3;t;Human;Human;20956518|23396314;Agonist
plerixafor;ACKR3;f;;Human;20956518|19255243;Agonist
TC14012;ACKR3;f;;Human;20956518;Agonist
CXCL11;ACKR3;t;Human;Human;;Full agonist
LIH383;ACKR3;f;;None;32561830;Antagonist
CCL19;ACKR4;t;Human;Human;23341447;Agonist
CCL19;ACKR4;t;Human;Human;23341447;Agonist
CCL21;ACKR4;t;Human;Human;23341447;Agonist
CCL21;ACKR4;t;Human;Human;23341447;Agonist
CCL25;ACKR4;t;Human;Human;23341447;Agonist
CCL25;ACKR4;t;Human;Human;23341447;Agonist
compound 9 [PMID: 3514912];acrosin;f;;Human;3514912;Inhibition
BMS-986260;activin A receptor type 1;f;;Human;32071685;Inhibition
compound 13a [PMID: 23639540];activin A receptor type 1;f;;Human;23639540;Inhibition
compound 13d [PMID: 23639540];activin A receptor type 1;f;;Human;23639540;Inhibition
compound 13r [PMID: 23639540];activin A receptor type 1;f;;Human;23639540;Inhibition
example 11 [WO2014151871A9];activin A receptor type 1;f;;Human;;Inhibition
LDN-214117;activin A receptor type 1;f;;Human;25101911;Inhibition
ML347;activin A receptor type 1;f;;Human;23639540;Inhibition
BMS-986260;activin A receptor type 1B;f;;Human;32071685;Inhibition
compound 13d [PMID: 23639540];activin A receptor type 1B;f;;Human;23639540;Inhibition
compound 13r [PMID: 23639540];activin A receptor type 1B;f;;Human;23639540;Inhibition
galunisertib;activin A receptor type 1B;f;;Human;29467918;Inhibition
vactosertib;activin A receptor type 1B;f;;Human;24786585;Inhibition
SB-431542;activin A receptor type 1C;f;;Human;23130626|19616940;Inhibition
bimagrumab;activin A receptor type 2A;f;;Human;;Binding
bimagrumab;activin A receptor type 2B;f;;Human;;Binding
compound 13a [PMID: 23639540];activin A receptor type IL;f;;Human;23639540;Inhibition
compound 13d [PMID: 23639540];activin A receptor type IL;f;;Human;23639540;Inhibition
compound 13r [PMID: 23639540];activin A receptor type IL;f;;Human;23639540;Inhibition
LDN-214117;activin A receptor type IL;f;;Human;25101911;Inhibition
ML347;activin A receptor type IL;f;;Human;23639540;Inhibition
panulisib;activin A receptor type IL;f;;Human;25700704;Inhibition
activin A;Activin receptors;t;Human;Human;;Agonist
activin AB;Activin receptors;t;Human;Human;;Agonist
activin B;Activin receptors;t;Human;Human;;Agonist
inhibin A;Activin receptors;t;Human;Human;;Agonist
ARI-3099;acylaminoacyl-peptide hydrolase;f;;Human;24997602;Inhibition
ADG-207;acyl-CoA synthetase short chain family member 2;f;;Mouse;;Inhibition
example 265 [WO2019097515A1];acyl-CoA synthetase short chain family member 2;f;;Human;;Inhibition
JZL195;acyloxyacyl hydrolase;f;;Human;24997602;Inhibition
compound 25 [PMID: 18068976];ADAM10;f;;Human;18068976;Inhibition
GI254023X;ADAM10;f;;Human;20197648;Inhibition
ilomastat;ADAM10;f;;Human;15546732;Inhibition
ilomastat;ADAM12;f;;Human;15546732;Inhibition
apratastat;ADAM17;f;;Human;16426848;Inhibition
BMS-561392;ADAM17;f;;Human;19095454;Inhibition
GI254023X;ADAM17;f;;Human;20197648;Inhibition
IK-862;ADAM17;f;;Human;18790648;Inhibition
ilomastat;ADAM17;f;;Human;15546732;Inhibition
SL422;ADAM17;f;;Pig;11472217;Inhibition
IK-862;ADAM33;f;;Human;18790648;Inhibition
INCB3619;ADAM33;f;;Human;18790648;Inhibition
INCB3619;ADAM8;f;;Human;18790648;Inhibition
ilomastat;ADAM9;f;;Human;15546732;Inhibition
compound 12c [PMID: 16516466];ADAMTS1;f;;Human;16516466;Inhibition
compound 15c [PMID: 21536437];ADAMTS4;f;;Human;21536437;Inhibition
compound 15c [PMID: 21536437];ADAMTS5;f;;Human;21536437;Inhibition
EHNA;Adenosine deaminase;f;;Human;849330;Inhibition
pentostatin;Adenosine deaminase;f;;Human;849330;Inhibition
A134974;Adenosine kinase;f;;Human;11160637;Inhibition
ABT702;Adenosine kinase;f;;Human;11082453;Inhibition
compound 45 [PMID: 8709105];adenylyl cyclase 1;f;;Bovine;8709105;Activation
ST034307;adenylyl cyclase 1;f;;Human;28223412;Inhibition
KH7;adenylyl cyclase 10;f;;Human;16054031;Inhibition
LRE1;adenylyl cyclase 10;f;;Human;27547922;Inhibition
FD1;adenylyl cyclase 2;f;;Human;11602596;Activation
SKF-83566;adenylyl cyclase 2;f;;Human;24008337;None
FD6;adenylyl cyclase 5;f;;Human;11602596;Activation
NKY80;adenylyl cyclase 5;f;;Human;11602596|24006339;Inhibition
NKY80;adenylyl cyclase 6;f;;Human;24006339;Inhibition
phosphatidylserine;ADGRB1;t;;Human;17960134;Agonist
beclometasone dipropionate;ADGRG3;f;;Human;22575658;Full agonist
α-latrotoxin;ADGRL1;f;;Rat;9208860|12782639;Full agonist
LTX(N4C);ADGRL1;f;;Rat;12782639;Full agonist
lasso D;ADGRL1;t;;Rat;21724987;Partial agonist
α-latrotoxin;ADGRL2;f;;Rat;10026162;Full agonist
FLRT3;ADGRL3;t;Rat;Rat;22405201;Full agonist
azeliragon;advanced glycosylation end-product specific receptor;f;;Human;25368578;Antagonist
compound 1 [Lolli et al., 2019];AKR1C3;f;;Human;30996776;Inhibition
KV-37;AKR1C3;f;;Human;29891491;Inhibition
tolfenamic acid;AKR1C3;f;;Human;17166832;Inhibition
miransertib;AKT serine/threonine kinase 1;f;;Human;27305487;Inhibition
Akt inhibitor VIII;AKT serine/threonine kinase 1;f;;Human;15664853;Negative
BAY1125976;AKT serine/threonine kinase 1;f;;Human;;Negative
MK-2206;AKT serine/threonine kinase 1;f;;Human;;Negative
A-443654;AKT serine/threonine kinase 1;f;;Human;15956255;Inhibition
A-674563;AKT serine/threonine kinase 1;f;;Human;15956255;Inhibition
A-674563;AKT serine/threonine kinase 1;f;;Human;22037378;Inhibition
afuresertib;AKT serine/threonine kinase 1;f;;Human;24978597;Inhibition
capivasertib;AKT serine/threonine kinase 1;f;;Human;31298542;Inhibition
capivasertib;AKT serine/threonine kinase 1;f;;Human;23394218;Inhibition
compound 1 [PMID: 20005102];AKT serine/threonine kinase 1;f;;Human;20005102;Inhibition
compound E22 [PMID: 31298542];AKT serine/threonine kinase 1;f;;Human;31298542;Inhibition
GSK690693;AKT serine/threonine kinase 1;f;;Human;22037378;Inhibition
GSK690693;AKT serine/threonine kinase 1;f;;Human;18800763;Inhibition
ipatasertib;AKT serine/threonine kinase 1;f;;Human;22934575;Inhibition
uprosertib;AKT serine/threonine kinase 1;f;;Human;24978597;Inhibition
miransertib;AKT serine/threonine kinase 2;f;;Human;27305487;Inhibition
Akt inhibitor VIII;AKT serine/threonine kinase 2;f;;Human;15664853;Negative
BAY1125976;AKT serine/threonine kinase 2;f;;Human;;Negative
MK-2206;AKT serine/threonine kinase 2;f;;Human;;Negative
A-443654;AKT serine/threonine kinase 2;f;;Human;15956255;Inhibition
afuresertib;AKT serine/threonine kinase 2;f;;Human;24978597;Inhibition
capivasertib;AKT serine/threonine kinase 2;f;;Human;23394218;Inhibition
compound 1 [PMID: 20005102];AKT serine/threonine kinase 2;f;;Human;20005102;Inhibition
compound E22 [PMID: 31298542];AKT serine/threonine kinase 2;f;;Human;31298542;Inhibition
GSK690693;AKT serine/threonine kinase 2;f;;Human;18800763;Inhibition
ipatasertib;AKT serine/threonine kinase 2;f;;Human;22934575;Inhibition
PHT-427;AKT serine/threonine kinase 2;f;;Human;20197390;Inhibition
uprosertib;AKT serine/threonine kinase 2;f;;Human;24978597;Inhibition
miransertib;AKT serine/threonine kinase 3;f;;Human;27305487;Inhibition
Akt inhibitor VIII;AKT serine/threonine kinase 3;f;;Human;15664853;Negative
MK-2206;AKT serine/threonine kinase 3;f;;Human;;Negative
A-443654;AKT serine/threonine kinase 3;f;;Human;15956255;Inhibition
afuresertib;AKT serine/threonine kinase 3;f;;Human;24978597;Inhibition
capivasertib;AKT serine/threonine kinase 3;f;;Human;23394218;Inhibition
compound 1 [PMID: 20005102];AKT serine/threonine kinase 3;f;;Human;20005102;Inhibition
compound E22 [PMID: 31298542];AKT serine/threonine kinase 3;f;;Human;31298542;Inhibition
GSK690693;AKT serine/threonine kinase 3;f;;Human;18800763;Inhibition
ipatasertib;AKT serine/threonine kinase 3;f;;Human;22934575;Inhibition
uprosertib;AKT serine/threonine kinase 3;f;;Human;24978597;Inhibition
benzylcysteine;Alanine/serine/cysteine transporter 2;f;;Human;15107471;Inhibition
benzylserine;Alanine/serine/cysteine transporter 2;f;;Human;15107471;Inhibition
p-nitrophenyl glutamyl anilide;Alanine/serine/cysteine transporter 2;f;;Rat;15670919;Inhibition
disulfiram;aldehyde dehydrogenase 2 family member;f;;Rat;10974203;Inhibition
prunetin;aldehyde dehydrogenase 2 family member;f;;Human;18613661;Inhibition
4-acryloylphenol;aldehyde dehydrogenase 5 family member A1;f;;Human;16290145;Inhibition
AK198;aldo-keto reductase family 1 member B;f;;Human;25919404;Inhibition
lidorestat;aldo-keto reductase family 1 member B;f;;Human;15857120;Inhibition
sorbinil;aldo-keto reductase family 1 member B;f;;Human;10882376;Inhibition
tolrestat;aldo-keto reductase family 1 member B;f;;Human;10737739;Inhibition
zenarestat;aldo-keto reductase family 1 member B;f;;Human;15857120;Inhibition
zopolrestat;aldo-keto reductase family 1 member B;f;;Human;15857120;Inhibition
alectinib;ALK receptor tyrosine kinase;f;;Human;22225917;Inhibition
AZD3463;ALK receptor tyrosine kinase;f;;Human;;Inhibition
belizatinib;ALK receptor tyrosine kinase;f;;Human;22734674;Inhibition
brigatinib;ALK receptor tyrosine kinase;f;;Human;21502504|27144831;Inhibition
brigatinib;ALK receptor tyrosine kinase;f;;Human;21502504;Inhibition
CEP-37440;ALK receptor tyrosine kinase;f;;Human;27527804;Inhibition
ceritinib;ALK receptor tyrosine kinase;f;;Human;23742252;Inhibition
compound 15 [PMID: 24900237];ALK receptor tyrosine kinase;f;;Human;24900237;Inhibition
compound 25b [PMID: 22564207];ALK receptor tyrosine kinase;f;;Human;22564207;Inhibition
compound 5g [PMID: 20483621];ALK receptor tyrosine kinase;f;;Human;20483621;Inhibition
compound 5m [PMID: 20483621];ALK receptor tyrosine kinase;f;;Human;20483621;Inhibition
compound 5n [PMID: 20483621];ALK receptor tyrosine kinase;f;;Human;20483621;Inhibition
compound 8e [PMID: 24432909];ALK receptor tyrosine kinase;f;;Human;24432909;Inhibition
crizotinib;ALK receptor tyrosine kinase;f;;Human;21812414;Inhibition
ensartinib;ALK receptor tyrosine kinase;f;;Human;21613408;Inhibition
gilteritinib;ALK receptor tyrosine kinase;f;;Human;27908881;Inhibition
GSK-1838705A;ALK receptor tyrosine kinase;f;;Human;19825801;Inhibition
lorlatinib;ALK receptor tyrosine kinase;f;;Human;24819116;Inhibition
NVP-TAE684;ALK receptor tyrosine kinase;f;;Human;22037378;Inhibition
repotrectinib;ALK receptor tyrosine kinase;f;;Human;30093503;Inhibition
TL13-112;ALK receptor tyrosine kinase;f;;Human;29660984;Inhibition
DO264;αβ-Hydrolase 12;f;;Human;30720278;Inhibition
orlistat;αβ-Hydrolase 12;f;;Human;18657971;Inhibition
ABX-1431;αβ-Hydrolase 6;f;;Human;30067909;Inhibition
KT-109;αβ-Hydrolase 6;f;;Human;23103940;Inhibition
WWL123;αβ-Hydrolase 6;f;;Human;21084632;Inhibition
WWL70;αβ-Hydrolase 6;f;;Human;17629278;Inhibition
dabuzalgron;α1A-adrenoceptor;f;;Human;14678390;Agonist
A61603;α1A-adrenoceptor;f;;Human;9249248|7616455;Full agonist
(-)-adrenaline;α1A-adrenoceptor;t;;Human;7651358|8564227;Full agonist
(+)-adrenaline;α1A-adrenoceptor;f;;Human;7651358;Full agonist
methoxamine;α1A-adrenoceptor;f;;Human;7651358|10433504;Full agonist
(-)-noradrenaline;α1A-adrenoceptor;t;;Human;7651358|10433504|8564227;Full agonist
oxymetazoline;α1A-adrenoceptor;f;;Human;7651358|8719417|10433504|8564227;Full agonist
phenylephrine;α1A-adrenoceptor;f;;Human;10433504;Full agonist
NS-49;α1A-adrenoceptor;f;;Human;8719417;Partial agonist
rho-TIA;α1A-adrenoceptor;f;;Rat;12824165;Negative
5-methylurapidil;α1A-adrenoceptor;f;;Rat;11331292;Antagonist
5-methylurapidil;α1A-adrenoceptor;f;;Human;9249248|7651358|9490024|8764344|11459121;Antagonist
A-119637;α1A-adrenoceptor;f;;Rat;11354357;Antagonist
A-119637;α1A-adrenoceptor;f;;Human;11354357;Antagonist
A-123189;α1A-adrenoceptor;f;;Rat;11354357;Antagonist
A-123189;α1A-adrenoceptor;f;;Human;11354357;Antagonist
alfuzosin;α1A-adrenoceptor;f;;Human;10812954;Antagonist
BMY-7378;α1A-adrenoceptor;f;;Human;11459121|11354357;Antagonist
BMY-7378;α1A-adrenoceptor;f;;Rat;11354357;Antagonist
cabergoline;α1A-adrenoceptor;f;;Human;12388666;Antagonist
clozapine;α1A-adrenoceptor;f;;Human;11459121;Antagonist
(+)-cyclazosin;α1A-adrenoceptor;f;;Human;8917649;Antagonist
cyproheptadine;α1A-adrenoceptor;f;;Human;11459121;Antagonist
doxazosin;α1A-adrenoceptor;f;;Human;;Antagonist
indoramin;α1A-adrenoceptor;f;;Human;9249248|10334511;Antagonist
ketanserin;α1A-adrenoceptor;f;;Human;11459121;Antagonist
KMUP-1;α1A-adrenoceptor;f;;Rat;17639498;Antagonist
lisuride;α1A-adrenoceptor;f;;Human;12388666;Antagonist
mianserin;α1A-adrenoceptor;f;;Human;11459121;Antagonist
NAN 190;α1A-adrenoceptor;f;;Human;11459121;Antagonist
olanzapine;α1A-adrenoceptor;f;;Rat;18542932;Antagonist
phentolamine;α1A-adrenoceptor;f;;Rat;11331292;Antagonist
phentolamine;α1A-adrenoceptor;f;;Human;7651358;Antagonist
piribedil;α1A-adrenoceptor;f;;Human;12388666;Antagonist
ρ-Da1a;α1A-adrenoceptor;f;;Human;20015090|23935897;Antagonist
risperidone;α1A-adrenoceptor;f;;Human;11459121;Antagonist
ritanserin;α1A-adrenoceptor;f;;Human;11459121;Antagonist
Ro-70-0004;α1A-adrenoceptor;f;;Human;10369480;Antagonist
roxindole;α1A-adrenoceptor;f;;Human;12388666;Antagonist
RS-100329;α1A-adrenoceptor;f;;Human;10369480;Antagonist
RS-17053;α1A-adrenoceptor;f;;Human;9249248|9490024|10334511|8632751;Antagonist
silodosin;α1A-adrenoceptor;f;;Human;7651358;Antagonist
SNAP5089;α1A-adrenoceptor;f;;Human;10812954|7752182|9190863;Antagonist
S(+)-niguldipine;α1A-adrenoceptor;f;;Rat;11331292;Antagonist
S(+)-niguldipine;α1A-adrenoceptor;f;;Human;9249248|7651358;Antagonist
spiperone;α1A-adrenoceptor;f;;Human;11459121;Antagonist
spiroxatrine;α1A-adrenoceptor;f;;Human;11459121;Antagonist
[125I]BE-2254;α1A-adrenoceptor;f;;Human;11337028|7815325;Antagonist
[125I]HEAT;α1A-adrenoceptor;f;;Human;7651358;Antagonist
tamsulosin;α1A-adrenoceptor;f;;Human;9249248|7651358|9490024|10369480|10334511;Antagonist
terazosin;α1A-adrenoceptor;f;;Human;9379432;Antagonist
terguride;α1A-adrenoceptor;f;;Human;12388666;Antagonist
upidosin;α1A-adrenoceptor;f;;Human;9249248;Antagonist
WB 4101;α1A-adrenoceptor;f;;Rat;11331292;Antagonist
WB 4101;α1A-adrenoceptor;f;;Human;9249248|7651358|9490024|10334511;Antagonist
prazosin;α1A-adrenoceptor;f;;Human;9249248|7651358|9490024|10369480|10334511;Inverse agonist
prazosin;α1A-adrenoceptor;f;;Rat;11331292;Inverse agonist
(-)-adrenaline;α1B-adrenoceptor;t;;Human;7651358;Full agonist
(+)-adrenaline;α1B-adrenoceptor;f;;Human;7651358;Full agonist
methoxamine;α1B-adrenoceptor;f;;Human;7651358;Full agonist
(-)-noradrenaline;α1B-adrenoceptor;t;;Human;7651358;Full agonist
oxymetazoline;α1B-adrenoceptor;f;;Human;7651358|8719417;Full agonist
phenylephrine;α1B-adrenoceptor;f;;Human;9249248|7969082;Full agonist
NS-49;α1B-adrenoceptor;f;;Human;8719417;Partial agonist
rho-TIA;α1B-adrenoceptor;f;;Rat;15680270;Negative
lorazepam;α1B-adrenoceptor;f;;Rat;10565838;Positive
midazolam;α1B-adrenoceptor;f;;Rat;10565838;Positive
5-methylurapidil;α1B-adrenoceptor;f;;Human;9249248|7651358|11459121;Antagonist
A-119637;α1B-adrenoceptor;f;;Human;11354357;Antagonist
A-123189;α1B-adrenoceptor;f;;Human;11354357;Antagonist
AH 11110;α1B-adrenoceptor;f;;Human;8764344;Antagonist
alfuzosin;α1B-adrenoceptor;f;;Human;7658428;Antagonist
BMY-7378;α1B-adrenoceptor;f;;Human;11459121|11354357;Antagonist
clozapine;α1B-adrenoceptor;f;;Human;11459121;Antagonist
cyproheptadine;α1B-adrenoceptor;f;;Human;11459121;Antagonist
doxazosin;α1B-adrenoceptor;f;;Human;;Antagonist
indoramin;α1B-adrenoceptor;f;;Human;9249248;Antagonist
ketanserin;α1B-adrenoceptor;f;;Human;11459121;Antagonist
KMUP-1;α1B-adrenoceptor;f;;Rat;17639498;Antagonist
L-765314;α1B-adrenoceptor;f;;Human;9548811;Antagonist
L-765314;α1B-adrenoceptor;f;;Rat;9548811;Antagonist
mianserin;α1B-adrenoceptor;f;;Human;11459121;Antagonist
NAN 190;α1B-adrenoceptor;f;;Human;11459121;Antagonist
phentolamine;α1B-adrenoceptor;f;;Human;7651358;Antagonist
Rec 15/2615;α1B-adrenoceptor;f;;Human;9190864;Antagonist
rho-TIA;α1B-adrenoceptor;f;;Human;15194691;Antagonist
risperidone;α1B-adrenoceptor;f;;Human;11459121;Antagonist
ritanserin;α1B-adrenoceptor;f;;Human;11459121;Antagonist
Ro-70-0004;α1B-adrenoceptor;f;;Human;10369480;Antagonist
silodosin;α1B-adrenoceptor;f;;Human;7651358;Antagonist
S(+)-niguldipine;α1B-adrenoceptor;f;;Human;9249248|7651358;Antagonist
spiroxatrine;α1B-adrenoceptor;f;;Human;11459121;Antagonist
[125I]HEAT;α1B-adrenoceptor;f;;Human;7651358;Antagonist
terazosin;α1B-adrenoceptor;f;;Human;9379432;Antagonist
upidosin;α1B-adrenoceptor;f;;Human;9249248;Antagonist
WB 4101;α1B-adrenoceptor;f;;Human;9249248|7651358;Antagonist
(+)-cyclazosin;α1B-adrenoceptor;f;;Human;8917649;Inverse agonist
prazosin;α1B-adrenoceptor;f;;Human;9249248|7651358|10369480;Inverse agonist
spiperone;α1B-adrenoceptor;f;;Human;11459121;Inverse agonist
[125I]BE-2254;α1B-adrenoceptor;f;;Human;11337028|7815325;Inverse agonist
tamsulosin;α1B-adrenoceptor;f;;Human;9249248|7651358|10369480;Inverse agonist
6-fluoro-noradrenaline;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
(-)-adrenaline;α1D-adrenoceptor;t;;Human;7651358|8564227;Full agonist
(-)-adrenaline;α1D-adrenoceptor;t;;Rat;7969082;Full agonist
(+)-adrenaline;α1D-adrenoceptor;f;;Human;7651358;Full agonist
amidephrine;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
cirazoline;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
clonidine;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
corbadrine;α1D-adrenoceptor;f;;Human;7969082;Full agonist
indanidine;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
methoxamine;α1D-adrenoceptor;f;;Human;7651358;Full agonist
methoxamine;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
(-)-noradrenaline;α1D-adrenoceptor;t;;Rat;7969082;Full agonist
(-)-noradrenaline;α1D-adrenoceptor;t;;Human;7651358|8564227;Full agonist
phenylephrine;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
SKF 89748;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
St 587;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
xylometazoline;α1D-adrenoceptor;f;;Rat;7969082;Full agonist
NS-49;α1D-adrenoceptor;f;;Human;8719417;Partial agonist
oxymetazoline;α1D-adrenoceptor;f;;Human;7651358|8719417;Partial agonist
oxymetazoline;α1D-adrenoceptor;f;;Rat;7969082;Partial agonist
5-methylurapidil;α1D-adrenoceptor;f;;Human;9249248|7651358|11459121;Antagonist
A-119637;α1D-adrenoceptor;f;;Rat;11354357;Antagonist
A-119637;α1D-adrenoceptor;f;;Human;11354357;Antagonist
A-123189;α1D-adrenoceptor;f;;Rat;11354357;Antagonist
A-123189;α1D-adrenoceptor;f;;Human;11354357;Antagonist
alfuzosin;α1D-adrenoceptor;f;;Human;10812954;Antagonist
BMY-7378;α1D-adrenoceptor;f;;Rat;11354357;Antagonist
BMY-7378;α1D-adrenoceptor;f;;Human;11459121|11354357;Antagonist
clozapine;α1D-adrenoceptor;f;;Human;11459121;Antagonist
cyproheptadine;α1D-adrenoceptor;f;;Human;11459121;Antagonist
dapiprazole;α1D-adrenoceptor;f;;Human;;Antagonist
doxazosin;α1D-adrenoceptor;f;;Human;;Antagonist
indoramin;α1D-adrenoceptor;f;;Human;9249248;Antagonist
ketanserin;α1D-adrenoceptor;f;;Human;11459121;Antagonist
KMUP-1;α1D-adrenoceptor;f;;Rat;17639498;Antagonist
labetalol;α1D-adrenoceptor;f;;Human;;Antagonist
mianserin;α1D-adrenoceptor;f;;Human;11459121;Antagonist
NAN 190;α1D-adrenoceptor;f;;Human;11459121;Antagonist
olanzapine;α1D-adrenoceptor;f;;Rat;18542932;Antagonist
risperidone;α1D-adrenoceptor;f;;Human;11459121;Antagonist
ritanserin;α1D-adrenoceptor;f;;Human;11459121;Antagonist
Ro-70-0004;α1D-adrenoceptor;f;;Human;10369480;Antagonist
RS-100329;α1D-adrenoceptor;f;;Human;10369480;Antagonist
RS-17053;α1D-adrenoceptor;f;;Human;9249248;Antagonist
silodosin;α1D-adrenoceptor;f;;Human;7651358;Antagonist
SKF 105854;α1D-adrenoceptor;f;;Human;7568329;Antagonist
S(+)-niguldipine;α1D-adrenoceptor;f;;Human;9249248|7651358;Antagonist
spiperone;α1D-adrenoceptor;f;;Human;11459121;Antagonist
spiroxatrine;α1D-adrenoceptor;f;;Human;11459121;Antagonist
[125I]BE-2254;α1D-adrenoceptor;f;;Human;7815325;Antagonist
[125I]HEAT;α1D-adrenoceptor;f;;Human;7651358;Antagonist
tamsulosin;α1D-adrenoceptor;f;;Human;9249248|7651358|10369480;Antagonist
terazosin;α1D-adrenoceptor;f;;Human;9379432;Antagonist
upidosin;α1D-adrenoceptor;f;;Human;9249248;Antagonist
WB 4101;α1D-adrenoceptor;f;;Human;9249248|7651358;Antagonist
(+)-cyclazosin;α1D-adrenoceptor;f;;Rat;8917649;Inverse agonist
(+)-cyclazosin;α1D-adrenoceptor;f;;Human;8917649;Inverse agonist
phentolamine;α1D-adrenoceptor;f;;Human;7651358;Inverse agonist
prazosin;α1D-adrenoceptor;f;;Human;9249248|7651358|10369480;Inverse agonist
apraclonidine;α2A-adrenoceptor;f;;Human;8784451;Agonist
guanabenz;α2A-adrenoceptor;f;;Human;;Agonist
lofexidine;α2A-adrenoceptor;f;;Human;22341244;Agonist
(-)-adrenaline;α2A-adrenoceptor;t;;Human;9824686|9605427;Full agonist
brimonidine;α2A-adrenoceptor;f;;Human;9824686|9605427|9760042|9227000;Full agonist
(-)-noradrenaline;α2A-adrenoceptor;t;;Human;9824686|9605427;Full agonist
apomorphine;α2A-adrenoceptor;f;;Human;12388666;Partial agonist
clonidine;α2A-adrenoceptor;f;;Human;9824686|9605427|9760042;Partial agonist
dexmedetomidine;α2A-adrenoceptor;f;;Human;9824686|9605427|9760042|9227000;Partial agonist
guanfacine;α2A-adrenoceptor;f;;Human;9605427|9283709;Partial agonist
oxymetazoline;α2A-adrenoceptor;f;;Human;9605427|7996470|9227000;Partial agonist
pergolide;α2A-adrenoceptor;f;;Human;12388666;Partial agonist
xylazine;α2A-adrenoceptor;f;;Human;9605427;Partial agonist
5-(N,N-hexamethylene)-amiloride;α2A-adrenoceptor;f;;Human;1325028|9584219;Negative
ethylisopropylamiloride;α2A-adrenoceptor;f;;Human;1325028;Positive
ARC-239;α2A-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
atropine;α2A-adrenoceptor;f;;Human;29860464;Antagonist
BRL 44408;α2A-adrenoceptor;f;;Human;7996470|2573535;Antagonist
bromocriptine;α2A-adrenoceptor;f;;Human;12388666;Antagonist
cabergoline;α2A-adrenoceptor;f;;Human;12388666;Antagonist
chlorpromazine;α2A-adrenoceptor;f;;Human;1353247|7908642;Antagonist
lisuride;α2A-adrenoceptor;f;;Human;12388666;Antagonist
lurasidone;α2A-adrenoceptor;f;;Human;20404009;Antagonist
mirtazapine;α2A-adrenoceptor;f;;Human;10636247;Antagonist
mirtazapine;α2A-adrenoceptor;f;;Human;15771415;Antagonist
muscarinic toxin 3;α2A-adrenoceptor;f;;Human;29860464;Antagonist
phentolamine;α2A-adrenoceptor;f;;Human;1353247|7908642;Antagonist
piribedil;α2A-adrenoceptor;f;;Human;12388666;Antagonist
prazosin;α2A-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
rauwolscine;α2A-adrenoceptor;f;;Human;7996470;Antagonist
RX821002;α2A-adrenoceptor;f;;Human;7996470;Antagonist
spiroxatrine;α2A-adrenoceptor;f;;Human;7996470;Antagonist
[3H]MK-912;α2A-adrenoceptor;f;;Human;7996470;Antagonist
[3H]rauwolscine;α2A-adrenoceptor;f;;Human;8819505|1353247;Antagonist
[3H]RX821002;α2A-adrenoceptor;f;;Human;8819505|7908642;Antagonist
terguride;α2A-adrenoceptor;f;;Human;12388666;Antagonist
tolazoline;α2A-adrenoceptor;f;;Human;9605427;Antagonist
WB 4101;α2A-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
yohimbine;α2A-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
(-)-adrenaline;α2B-adrenoceptor;t;;Human;9605427;Agonist
guanabenz;α2B-adrenoceptor;f;;Human;;Agonist
lofexidine;α2B-adrenoceptor;f;;Human;22341244;Agonist
dexmedetomidine;α2B-adrenoceptor;f;;Human;9824686|9605427|9760042|9227000;Full agonist
guanfacine;α2B-adrenoceptor;f;;Human;9605427;Full agonist
brimonidine;α2B-adrenoceptor;f;;Human;9824686|9605427|9760042;Partial agonist
clonidine;α2B-adrenoceptor;f;;Human;9824686|9605427|9760042;Partial agonist
(-)-noradrenaline;α2B-adrenoceptor;t;;Human;9824686|9605427;Partial agonist
oxymetazoline;α2B-adrenoceptor;f;;Human;9605427|7996470;Partial agonist
pergolide;α2B-adrenoceptor;f;;Human;12388666;Partial agonist
(±)-adrenaline;α2B-adrenoceptor;f;;Human;9605427;Partial agonist
xylazine;α2B-adrenoceptor;f;;Human;9605427;Partial agonist
apomorphine;α2B-adrenoceptor;f;;Human;12388666;Antagonist
ARC-239;α2B-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
BRL 44408;α2B-adrenoceptor;f;;Human;7996470;Antagonist
bromocriptine;α2B-adrenoceptor;f;;Human;12388666;Antagonist
cabergoline;α2B-adrenoceptor;f;;Human;12388666;Antagonist
chlorpromazine;α2B-adrenoceptor;f;;Human;1353247|7908642;Antagonist
imiloxan;α2B-adrenoceptor;f;;Rat;1970500;Antagonist
lisuride;α2B-adrenoceptor;f;;Human;12388666;Antagonist
mirtazapine;α2B-adrenoceptor;f;;Human;10636247;Antagonist
phenoxybenzamine;α2B-adrenoceptor;f;;Human;1834671;Antagonist
phentolamine;α2B-adrenoceptor;f;;Human;1353247|7908642;Antagonist
prazosin;α2B-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
rauwolscine;α2B-adrenoceptor;f;;Human;7996470;Antagonist
roxindole;α2B-adrenoceptor;f;;Human;12388666;Antagonist
RX821002;α2B-adrenoceptor;f;;Human;7996470;Antagonist
spiroxatrine;α2B-adrenoceptor;f;;Human;7996470;Antagonist
[3H]MK-912;α2B-adrenoceptor;f;;Human;7996470;Antagonist
[3H]rauwolscine;α2B-adrenoceptor;f;;Human;8819505|1353247;Antagonist
[3H]RX821002;α2B-adrenoceptor;f;;Human;8819505|7908642;Antagonist
terguride;α2B-adrenoceptor;f;;Human;12388666;Antagonist
tolazoline;α2B-adrenoceptor;f;;Human;9605427;Antagonist
WB 4101;α2B-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
yohimbine;α2B-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
zotepine;α2B-adrenoceptor;f;;Human;8935801;Antagonist
(-)-adrenaline;α2C-adrenoceptor;t;;Human;9605427;Agonist
apraclonidine;α2C-adrenoceptor;f;;Human;8784451;Agonist
guanabenz;α2C-adrenoceptor;f;;Human;;Agonist
lofexidine;α2C-adrenoceptor;f;;Human;22341244;Agonist
dexmedetomidine;α2C-adrenoceptor;f;;Human;9824686|9605427|9760042;Full agonist
(-)-noradrenaline;α2C-adrenoceptor;t;;Human;9824686|9605427;Full agonist
(±)-adrenaline;α2C-adrenoceptor;f;;Human;9605427;Full agonist
brimonidine;α2C-adrenoceptor;f;;Human;9824686|9605427|9760042|9227000;Partial agonist
clonidine;α2C-adrenoceptor;f;;Human;9824686|9605427|9760042;Partial agonist
guanfacine;α2C-adrenoceptor;f;;Human;9605427;Partial agonist
oxymetazoline;α2C-adrenoceptor;f;;Human;9605427|7996470;Partial agonist
pergolide;α2C-adrenoceptor;f;;Human;12388666;Partial agonist
xylazine;α2C-adrenoceptor;f;;Human;9605427;Partial agonist
all-trans-4-oxo-retinoic acid;α2C-adrenoceptor;f;;Human;15771415;Antagonist
apomorphine;α2C-adrenoceptor;f;;Human;12388666;Antagonist
ARC-239;α2C-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
BRL 44408;α2C-adrenoceptor;f;;Human;7996470;Antagonist
bromocriptine;α2C-adrenoceptor;f;;Human;12388666;Antagonist
cabergoline;α2C-adrenoceptor;f;;Human;12388666;Antagonist
chlorpromazine;α2C-adrenoceptor;f;;Human;1353247|7908642;Antagonist
JP1302;α2C-adrenoceptor;f;;Human;17220913;Antagonist
lisuride;α2C-adrenoceptor;f;;Human;12388666;Antagonist
lurasidone;α2C-adrenoceptor;f;;Human;20404009;Antagonist
mirtazapine;α2C-adrenoceptor;f;;Human;10636247;Antagonist
mirtazapine;α2C-adrenoceptor;f;;Human;15771415;Antagonist
phentolamine;α2C-adrenoceptor;f;;Human;1353247|7908642;Antagonist
piribedil;α2C-adrenoceptor;f;;Human;12388666;Antagonist
prazosin;α2C-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
rauwolscine;α2C-adrenoceptor;f;;Human;7996470;Antagonist
roxindole;α2C-adrenoceptor;f;;Human;12388666;Antagonist
RX821002;α2C-adrenoceptor;f;;Human;7996470;Antagonist
spiroxatrine;α2C-adrenoceptor;f;;Human;7996470;Antagonist
[3H]MK-912;α2C-adrenoceptor;f;;Human;7996470;Antagonist
[3H]rauwolscine;α2C-adrenoceptor;f;;Human;8819505|1353247;Antagonist
[3H]RX821002;α2C-adrenoceptor;f;;Human;8819505|7908642;Antagonist
terguride;α2C-adrenoceptor;f;;Human;12388666;Antagonist
tolazoline;α2C-adrenoceptor;f;;Human;9605427;Antagonist
WB 4101;α2C-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
yohimbine;α2C-adrenoceptor;f;;Human;7996470|1353247|7908642;Antagonist
timolumab;amine oxidase copper containing 3;f;;Human;;Binding
mofegiline;amine oxidase copper containing 3;f;;Human;23943052;Inhibition
phenelzine;amine oxidase copper containing 3;f;;Human;20690686;Inhibition
PXS-4728A;amine oxidase copper containing 3;f;;Human;25889951;Inhibition
PXS-4681A;amine oxidase copper containing 3;f;;Human;23943052;Irreversible inhibition
PXS-4681A;amine oxidase copper containing 3;f;;Human;23943052;Irreversible inhibition
compound 9 [PMID: 1738140];Aminopeptidase A;f;;Human;1738140;Inhibition
BTB07018;Aminopeptidase N;f;;Pig;28964831;Inhibition
BTB07018;Aminopeptidase N;f;;Human;28964831;Inhibition
compound 1a [PMID: 25692029];Aminopeptidase N;f;;Human;25692029|11585456;Inhibition
compound I3 [PMID: 23428964];Aminopeptidase N;f;;Human;23428964;Inhibition
compound I3 [PMID: 23428964];Aminopeptidase N;f;;Mouse;23428964;Inhibition
JFD00064;Aminopeptidase N;f;;Human;28964831;Inhibition
JFD00064;Aminopeptidase N;f;;Pig;28964831;Inhibition
[14C]methylamine;Ammonium transporter Rh type A;f;;Human;12846905;Binding
[14C]methylamine;Ammonium transporter Rh type C;f;;Mouse;16131648;Binding
A-769662;AMP kinase;f;;Rat;16753576;Activation
A-769662;AMP kinase;f;;Human;16753576;Activation
A-769662;AMP kinase;f;;Rat;17855357;Activation
acadesine;AMP kinase;f;;Human;7744080;Activation
adenosine 5'-monophosphate;AMP kinase;t;;Human;16753576;Activation
cerdulatinib;AMP kinase;f;;Human;25253883;Inhibition
compound 13a [PMID: 23639540];AMP kinase;f;;Human;23639540;Inhibition
dorsomorphin;AMP kinase;f;;Human;20932747;Inhibition
adrenomedullin;AM1 receptor;t;Human;Human;9620797|11693189;Full agonist
adrenomedullin;AM1 receptor;f;Rat;Mouse;14609735;Full agonist
adrenomedullin;AM1 receptor;t;Rat;Rat;10854696|10342881|10767413|11556887;Full agonist
adrenomedullin 2/intermedin;AM1 receptor;t;Human;Human;21658025;Full agonist
α-CGRP;AM1 receptor;t;Human;Human;9620797;Full agonist
α-CGRP;AM1 receptor;t;Mouse|Rat;Rat;10767413;Full agonist
AM-(11-50) (rat);AM1 receptor;f;;Rat;11556887;Full agonist
β-CGRP;AM1 receptor;t;Rat;Rat;10854696|10342881|10767413;Full agonist
β-CGRP;AM1 receptor;t;Human;Human;9620797|11693189;Full agonist
[125I]AM (rat);AM1 receptor;f;;Human;;Full agonist
α-CGRP-(8-37) (human);AM1 receptor;f;;Human;9620797|11693189;Antagonist
α-CGRP-(8-37) (rat);AM1 receptor;f;;Rat;10854696|10342881|10767413;Antagonist
AM-(20-50) (rat);AM1 receptor;f;;Rat;10854696|10342881|10767413|11556887;Antagonist
AM-(20-50) (rat);AM1 receptor;f;;Mouse;14609735;Antagonist
AM-(22-52) (human);AM1 receptor;f;;Human;12970090;Antagonist
adrenomedullin;AM2 receptor;t;Human;Human;11693189|10347248;Full agonist
adrenomedullin;AM2 receptor;t;Rat;Rat;10854696;Full agonist
adrenomedullin;AM2 receptor;f;Rat;Mouse;14609735;Full agonist
adrenomedullin 2/intermedin;AM2 receptor;t;Human;Human;21658025;Full agonist
α-CGRP;AM2 receptor;t;Human;Human;11693189|10347248;Full agonist
α-CGRP;AM2 receptor;t;Mouse|Rat;Mouse;14609735;Full agonist
α-CGRP;AM2 receptor;t;Mouse|Rat;Rat;10854696;Full agonist
β-CGRP;AM2 receptor;t;Rat;Rat;10854696;Full agonist
β-CGRP;AM2 receptor;t;Human;Human;11693189|10347248;Full agonist
[125I]AM (rat);AM2 receptor;f;;Human;;Full agonist
α-CGRP-(8-37) (human);AM2 receptor;f;;Human;11693189|10347248;Antagonist
α-CGRP-(8-37) (rat);AM2 receptor;f;;Mouse;14609735;Antagonist
α-CGRP-(8-37) (rat);AM2 receptor;t;;Rat;10854696;Antagonist
AM-(20-50) (rat);AM2 receptor;f;;Mouse;14609735;Antagonist
AM-(20-50) (rat);AM2 receptor;f;;Rat;10854696;Antagonist
AM-(22-52) (human);AM2 receptor;f;;Human;;Antagonist
AM-(22-52) (human);AM2 receptor;f;;Human;11693189|10347248;Antagonist
compound 8 [Avgoustou et al., 2020];AM2 receptor;f;;Human;;Antagonist
acarbose;amylase alpha 2A;f;;Pig;23102653;Inhibition
dezamizumab;amyloid P component, serum;f;;Human;20962779;Binding
CPHPC;amyloid P component, serum;f;;Human;14998318;Binding
pramlintide;AMY1 receptor;f;;Human;24169554;Agonist
[125I]αCGRP (human);AMY1 receptor;f;;Human;;Agonist
adrenomedullin;AMY1 receptor;t;Human;Human;15692146|12565884;Full agonist
adrenomedullin 2/intermedin;AMY1 receptor;t;Human;Human;21658025;Full agonist
α-CGRP;AMY1 receptor;t;Human;Human;15692146|11023820|14722252|12565884|26125036;Full agonist
amylin;AMY1 receptor;t;Human;Human;24169554;Full agonist
amylin;AMY1 receptor;f;Mouse|Rat;Human;15692146|14722252|11033437|24169554;Full agonist
β-CGRP;AMY1 receptor;t;Human;Human;15692146;Full agonist
calcitonin;AMY1 receptor;t;Human;Human;15692146|11023820|11033437;Full agonist
calcitonin (salmon);AMY1 receptor;f;;Rat;10385705;Full agonist
[Cys(Et)2,7]α-CGRP (human);AMY1 receptor;f;;Human;15692146|14722252;Full agonist
[125I]BH-AMY (rat, mouse);AMY1 receptor;f;;Human;;Full agonist
Tyr0α-CGRP (human);AMY1 receptor;f;;Human;15692146|14722252;Full agonist
β-CGRP;AMY1 receptor;t;Human;Human;;None
AC187;AMY1 receptor;f;;Human;15692146;Antagonist
α-CGRP-(8-37) (human);AMY1 receptor;f;;Human;15692146;Antagonist
CT-(8-32) (salmon);AMY1 receptor;f;;Human;15692146;Antagonist
olcegepant;AMY1 receptor;f;;Human;26125036;Antagonist
pramlintide;AMY2 receptor;f;;Human;24169554;Agonist
adrenomedullin;AMY2 receptor;t;Human;Human;12565884;Full agonist
adrenomedullin 2/intermedin;AMY2 receptor;t;Human;Human;21658025;Full agonist
α-CGRP;AMY2 receptor;t;Human;Human;15692146|14722252|12565884;Full agonist
amylin;AMY2 receptor;t;Human;Human;24169554;Full agonist
amylin;AMY2 receptor;f;Mouse|Rat;Human;14722252|11033437|24169554;Full agonist
calcitonin;AMY2 receptor;t;Human;Human;11033437;Full agonist
[125I]BH-AMY (rat, mouse);AMY2 receptor;f;;Human;;Full agonist
Tyr0α-CGRP (human);AMY2 receptor;f;;Human;14722252;Full agonist
davalintide;AMY3 receptor;f;;Human;26908506;Agonist
KBP-066;AMY3 receptor;f;;Human;31992608;Agonist
KBP-088;AMY3 receptor;f;;Human;26908506;Agonist
pramlintide;AMY3 receptor;f;;Human;24169554;Agonist
adrenomedullin;AMY3 receptor;t;Human;Human;15692146|12565884;Full agonist
adrenomedullin 2/intermedin;AMY3 receptor;t;Human;Human;21658025;Full agonist
α-CGRP;AMY3 receptor;t;Human;Human;15692146|14722252|12565884;Full agonist
amylin;AMY3 receptor;f;Mouse|Rat;Human;15692146|11033437|24169554;Full agonist
amylin;AMY3 receptor;t;Human;Human;24169554;Full agonist
β-CGRP;AMY3 receptor;t;Human;Human;15692146;Full agonist
calcitonin;AMY3 receptor;t;Human;Human;11033437;Full agonist
calcitonin (salmon);AMY3 receptor;f;;Rat;10385705;Full agonist
[125I]BH-AMY (rat, mouse);AMY3 receptor;f;;Human;;Full agonist
AC187;AMY3 receptor;f;;Human;15692146;Antagonist
α-CGRP-(8-37) (human);AMY3 receptor;f;;Human;15692146;Antagonist
CT-(8-32) (salmon);AMY3 receptor;f;;Human;15692146;Antagonist
andarine;Androgen receptor;f;;Human;19432422;Agonist
androstenedione;Androgen receptor;f;;Rat;14565775;Agonist
danazol;Androgen receptor;f;;Rat;7355922;Agonist
dihydrotestosterone;Androgen receptor;t;;Rat;14565775;Agonist
dihydrotestosterone;Androgen receptor;t;;Human;2911578;Agonist
dromostanolone propionate;Androgen receptor;f;;Human;;Agonist
ethylestrenol;Androgen receptor;f;;Human;;Agonist
fluoxymesterone;Androgen receptor;f;;Human;17439112;Agonist
GSK2881078;Androgen receptor;f;;Human;30825507;Agonist
methyltrienolone;Androgen receptor;f;;Rat;14565775;Agonist
methyltrienolone;Androgen receptor;f;;Human;10076535;Agonist
mibolerone;Androgen receptor;f;;Rat;14565775;Agonist
mibolerone;Androgen receptor;f;;Human;10852459;Agonist
nandrolone;Androgen receptor;f;;Human;;Agonist
stanozolol;Androgen receptor;f;;Rat;;Agonist
[3H]dihydrotestosterone;Androgen receptor;f;;Human;;Agonist
[3H]methyltrienolone;Androgen receptor;f;;Human;;Agonist
[3H]mibolerone;Androgen receptor;f;;Human;;Agonist
testosterone;Androgen receptor;t;;Rat;14565775;Agonist
testosterone propionate;Androgen receptor;f;;Human;17574413;Agonist
methyltestosterone;Androgen receptor;f;;Human;24177288;Full agonist
apalutamide;Androgen receptor;f;;Rat;26137992;Antagonist
apalutamide;Androgen receptor;f;;Human;20218717;Antagonist
apalutamide;Androgen receptor;f;;Human;26137992;Antagonist
ARD-266;Androgen receptor;f;;Human;31804827;Antagonist
ARD-69;Androgen receptor;f;;Human;21936524;Antagonist
bicalutamide;Androgen receptor;f;;Human;16420057;Antagonist
bicalutamide;Androgen receptor;f;;Human;20218717;Antagonist
bisphenol A;Androgen receptor;f;;Human;23768907;Antagonist
clascoterone;Androgen receptor;f;;Human;;Antagonist
cyproterone acetate;Androgen receptor;f;;Human;9484511;Antagonist
darolutamide;Androgen receptor;f;;Human;26137992;Antagonist
darolutamide;Androgen receptor;f;;Rat;26137992;Antagonist
enzalutamide;Androgen receptor;f;;Human;19359544;Antagonist
enzalutamide;Androgen receptor;f;;Human;26137992;Antagonist
enzalutamide;Androgen receptor;f;;Rat;26137992;Antagonist
flutamide;Androgen receptor;f;;Human;18571420;Antagonist
galeterone;Androgen receptor;f;;Human;15828836;Antagonist
hydroxyflutamide;Androgen receptor;f;;Human;10076535;Antagonist
mifepristone;Androgen receptor;f;;Human;15293993;Antagonist
nilutamide;Androgen receptor;f;;Human;9111629;Antagonist
PF-03882845;Androgen receptor;f;;Human;24738581;Antagonist
PF0998425;Androgen receptor;f;;Human;18921992;Antagonist
benazepril;Angiotensin-converting enzyme;f;;Human;2999394;Inhibition
benazeprilat;Angiotensin-converting enzyme;f;;Human;17506720;Inhibition
captopril;Angiotensin-converting enzyme;f;;Human;9187274;Inhibition
cilazapril;Angiotensin-converting enzyme;f;;Human;;Inhibition
cilazaprilat;Angiotensin-converting enzyme;f;;Rabbit;2527528;Inhibition
enalapril;Angiotensin-converting enzyme;f;;Human;7527095;Inhibition
enalaprilat;Angiotensin-converting enzyme;f;;Human;7527095;Inhibition
fasidotril;Angiotensin-converting enzyme;f;;Human;;Inhibition
fasidotrilat;Angiotensin-converting enzyme;f;;Human;16789888;Inhibition
fosinopril;Angiotensin-converting enzyme;f;;Human;;Inhibition
fosinoprilat;Angiotensin-converting enzyme;f;;Rabbit;2481187;Inhibition
imidapril;Angiotensin-converting enzyme;f;;Human;;Inhibition
imidaprilat;Angiotensin-converting enzyme;f;;Human;17547476;Inhibition
lisinopril;Angiotensin-converting enzyme;f;;Human;9187274;Inhibition
lisinopril-tryptophan;Angiotensin-converting enzyme;f;;Human;20233165;Inhibition
moexipril;Angiotensin-converting enzyme;f;;Human;;Inhibition
moexiprilat;Angiotensin-converting enzyme;f;;Rabbit;9079232;Inhibition
perindopril;Angiotensin-converting enzyme;f;;Human;;Inhibition
perindoprilat;Angiotensin-converting enzyme;f;;Human;17716647;Inhibition
quinapril;Angiotensin-converting enzyme;f;;Guinea pig;6323223;Inhibition
quinaprilat;Angiotensin-converting enzyme;f;;Human;1995872;Inhibition
ramipril;Angiotensin-converting enzyme;f;;Human;6097265;Inhibition
ramiprilat;Angiotensin-converting enzyme;f;;Human;6097265;Inhibition
RXP-407;Angiotensin-converting enzyme;f;;Human;22628311;Inhibition
spirapril;Angiotensin-converting enzyme;f;;Human;;Inhibition
spiraprilat;Angiotensin-converting enzyme;f;;Human;2544729;Inhibition
trandolapril;Angiotensin-converting enzyme;f;;Human;7527095;Inhibition
trandolaprilat;Angiotensin-converting enzyme;f;;Human;7527095;Inhibition
zofenopril;Angiotensin-converting enzyme;f;;Human;;Inhibition
zofenoprilat;Angiotensin-converting enzyme;f;;Rabbit;2836590;Inhibition
zofenoprilat;Angiotensin-converting enzyme;f;;Rat;2836590;Inhibition
XNT [PMID: 18391097];Angiotensin-converting enzyme 2;f;;Human;18391097;Activation
compound 28 [PMID: 18324760];Angiotensin-converting enzyme 2;f;;Human;18324760;Inhibition
MLN-4760;Angiotensin-converting enzyme 2;f;;Human;18324760;Inhibition
Abz-Ser-Pro-Tyr(NO2)-OH;Angiotensin-converting enzyme 2;f;;Human;12531198;Binding
Müllerian inhibiting substance;Anti-Müllerian hormone receptors;t;Human;Human;;Agonist
baricitinib;AP2 associated kinase 1;f;;Human;32113509;Inhibition
compound 21b [PMID: 31136173];AP2 associated kinase 1;f;;Human;31136173;Inhibition
apelin-17;apelin receptor;t;Human|Mouse|Rat;Human;12603839|15341513;Agonist
apelin receptor early endogenous ligand;apelin receptor;t;Human;Human;25995451;Agonist
azelaprag;apelin receptor;f;;Human;;Agonist
compound 15a;apelin receptor;f;;Human;31724863;Agonist
E339-3D6;apelin receptor;f;;Human;20040517;Agonist
Elabela/Toddler-11;apelin receptor;t;Human;Human;;Agonist
Elabela/Toddler-21;apelin receptor;t;Human;Human;;Agonist
Elabela/Toddler-32;apelin receptor;t;Human;Human;;Agonist
CMF-019;apelin receptor;f;;Human;27475715;Biased agonist
MM07;apelin receptor;f;;Human;25712721;Biased agonist
apelin-13;apelin receptor;t;Human|Mouse|Rat;Human;10777510|12603839|12939143;Full agonist
apelin-36;apelin receptor;t;Human;Human;10777510|11336787|12603839|12939143;Full agonist
compound 1 [PMID: 25241924];apelin receptor;f;;Human;25241924;Full agonist
cyclo apelin-12 (1-12);apelin receptor;f;;Human;18813863;Full agonist
cyclo apelin-12 (7-12);apelin receptor;f;;Human;18813863;Full agonist
cyclourea apelin-12 (1-7);apelin receptor;f;;Human;18813863;Full agonist
ML233;apelin receptor;f;;Human;22834038;Full agonist
[Pyr1]apelin-13;apelin receptor;t;Human|Mouse|Rat;Human;11336787|12603839;Full agonist
[125I]apelin-13;apelin receptor;f;;Human;12939143;Full agonist
[125I][Glp65Nle75,Tyr77]apelin-13;apelin receptor;f;;Human;10777510;Full agonist
[125I][Nle75,Tyr77]apelin-36 (human);apelin receptor;f;;Human;11336787;Full agonist
[125I](Pyr1)apelin-13;apelin receptor;f;;Human;11250876;Full agonist
[3H](Pyr1)[Met(0)11]-apelin-13;apelin receptor;f;;Human;12603839;Full agonist
ALX40-4C;apelin receptor;f;;Human;12667811;Antagonist
ML221;apelin receptor;f;;Human;23010269;Antagonist
MM54;apelin receptor;f;;Human;21560248;Antagonist
Hg2+;AQP0;f;;Human;;None
5-Hydroxymethyl-2-furfural;AQP1;f;;Human;32434851;Inhibition
Ag+;AQP1;f;;Human;;None
Hg2+;AQP1;f;;Human;;None
pCMBS;AQP1;f;;Human;;None
Hg2+;AQP10;f;;Human;;None
Hg2+;AQP2;f;;Human;;None
Audien;AQP3;f;;Human;22624030;None
Auphen;AQP3;f;;Human;22624030;None
Hg2+;AQP3;f;;Human;;None
Hg2+;AQP5;f;;Human;;None
Hg2+;AQP6;f;;Human;;None
Auphen;AQP7;f;;Human;;None
Hg2+;AQP7;f;;Human;;None
Hg2+;AQP8;f;;Human;;None
Hg2+;AQP9;f;;Human;;None
phloretin;AQP9;f;;Human;;None
lifirafenib;A-Raf proto-oncogene, serine/threonine kinase;f;;Human;26208524;Inhibition
LY3009120;A-Raf proto-oncogene, serine/threonine kinase;f;;Human;26343583;Inhibition
2(S)-amino-6-boronohexanoic acid;Arginase I;f;;Human;;Inhibition
A1P;Arginase I;f;;Human;20441173;Inhibition
A1P;Arginase I;f;;Human;20441173;Inhibition
compound 9 [PMID: 23472952];Arginase I;f;;Human;23472952;Inhibition
2(S)-amino-6-boronohexanoic acid;Arginase II;f;;Human;11478904;Inhibition
compound 9 [PMID: 23472952];Arginase II;f;;Human;23472952;Inhibition
Lys-thiol;Arginyl aminopeptidase;f;;None;3111463;Inhibition
indole-3-carbinol;Aryl hydrocarbon receptor;f;;Mouse;1658785;Agonist
indolo[3,2-b]carbazole;Aryl hydrocarbon receptor;f;;Mouse;1658785;Agonist
tapinarof;Aryl hydrocarbon receptor;f;;Human;28595996;Agonist
ezutromid;Aryl hydrocarbon receptor;f;;Human;31755636;Antagonist
TCDD;Aryl hydrocarbon receptor;f;;Human;;Binding
H+;ASIC1;t;;Human;;None
H+;ASIC1;t;;Human;;None
A-317567;ASIC1;f;;Rat;16061325;None
amiloride;ASIC1;f;;Human;;None
amiloride;ASIC1;f;;Human;9062189;None
benzamil;ASIC1;f;;Human;9062189;None
diminazene;ASIC1;f;;Human;29134638|29782492|29025967;None
ethylisopropylamiloride;ASIC1;f;;Human;9062189;None
flurbiprofen;ASIC1;f;;Rat;11588175;None
ibuprofen;ASIC1;f;;Human;11588175|28949138;None
mambalgin-1;ASIC1;f;;Human;23034652;None
mambalgin-1;ASIC1;f;;Human;23624383;None
nafamostat;ASIC1;f;;Human;17826743;None
Pb2+;ASIC1;f;;Human;16319075;None
Pb2+;ASIC1;f;;Human;;None
Pi-hexatoxin-Hi1a;ASIC1;f;;Human;28320947;None
Pi-theraphotoxin-Hm3a;ASIC1;f;;Human;28327374;None
psalmotoxin 1;ASIC1;f;;Human;10829030;None
Zn2+;ASIC1;f;;Human;15470133;None
[125I]psalmotoxin 1;ASIC1;f;;Human;16284080;None
H+;ASIC2;t;;Human;;None
A-317567;ASIC2;f;;Human;16061325;None
amiloride;ASIC2;f;;Human;8631835;None
Cd2+;ASIC2;f;;Human;17443775;None
diminazene;ASIC2;f;;Human;29134638;None
nafamostat;ASIC2;f;;Human;17826743;None
agmatine;ASIC3;f;;Human;21143836;None
arcaine;ASIC3;f;;Human;21143836;None
GMQ;ASIC3;f;;Human;20920791;None
H+;ASIC3;t;;Human;;None
H+;ASIC3;t;;Human;;None
A-317567;ASIC3;f;;Human;22778804;None
amiloride;ASIC3;f;;Human;9261094;None
APETx2;ASIC3;f;;Human;15044953;None
aspirin;ASIC3;f;;Human;11588175;None
diclofenac;ASIC3;f;;Human;11588175;None
diminazene;ASIC3;f;;Human;29134638;None
Gd3+;ASIC3;f;;Human;10842183;None
nafamostat;ASIC3;f;;Human;17826743;None
salicylic acid;ASIC3;f;;Human;11588175;None
Zn2+;ASIC3;f;;Human;20580786;None
2-chloroadenosine;A1 receptor;f;;Rat;8441759;Agonist
adenosine;A1 receptor;t;;Rat;14662005;Agonist
adenosine;A1 receptor;t;;Human;14662005;Agonist
apadenoson;A1 receptor;f;;Human;16518376;Agonist
BAY 60-6583;A1 receptor;f;;Human;17632123;Agonist
binodenoson;A1 receptor;f;;Human;16518376;Agonist
CCPA;A1 receptor;f;;Rat;;Agonist
CGS 21680;A1 receptor;f;;Rat;;Agonist
Cl-IB-MECA;A1 receptor;f;;Mouse;;Agonist
Cl-IB-MECA;A1 receptor;f;;Human;16518376;Agonist
Cl-IB-MECA;A1 receptor;f;;Rat;;Agonist
CP608,039;A1 receptor;f;;Human;16518376;Agonist
GR79236;A1 receptor;f;;Rat;16518376;Agonist
GS9667;A1 receptor;f;;Human;19012505;Agonist
HEMADO;A1 receptor;f;;Human;12109910|17126322;Agonist
MRS3558;A1 receptor;f;;Human;16518376;Agonist
MRS3558;A1 receptor;f;;Mouse;;Agonist
MRS3558;A1 receptor;f;;Rat;;Agonist
MRS5151;A1 receptor;f;;Mouse;18424135;Agonist
MRS5151;A1 receptor;f;;Human;18424135;Agonist
MRS7469;A1 receptor;f;;Human;30605331;Agonist
N(6)-cyclohexyladenosine;A1 receptor;f;;Rat;8441759;Agonist
NECA;A1 receptor;f;;Rat;;Agonist
piclidenoson;A1 receptor;f;;Human;16518376;Agonist
regadenoson;A1 receptor;f;;Human;16518376;Agonist
(R)-PIA;A1 receptor;f;;Rat;8441759;Agonist
TCPA;A1 receptor;f;;Human;12672250;Agonist
tecadenoson;A1 receptor;f;;Pig;16518376|21185259;Agonist
2-chloroadenosine;A1 receptor;f;;Human;7798201|9920910;Full agonist
2-hexynyl-NECA;A1 receptor;f;;Human;12109910;Full agonist
5-Cl-5-deoxy-(±)-ENBA;A1 receptor;f;;Human;19317449;Full agonist
CCPA;A1 receptor;f;;Human;16020631|16518376;Full agonist
CGS 21680;A1 receptor;f;;Human;15476669|16518376;Full agonist
cyclopentyladenosine;A1 receptor;f;;Human;7798201|9920910|15476669|16444290|15740718|9827575|16518376;Full agonist
(R,S)-PHPNECA;A1 receptor;f;;Human;12109910;Full agonist
NECA;A1 receptor;f;;Human;7798201|9920910|8300561|15476669|14662005;Full agonist
PENECA;A1 receptor;f;;Human;12109910;Full agonist
(R)-PIA;A1 receptor;f;;Human;7798201|9920910|8300561|15476669|9459566;Full agonist
(S)-PIA;A1 receptor;f;;Human;7798201|8300561;Full agonist
[3H]CCPA;A1 receptor;f;;Human;9920910|9459566;Full agonist
compound 10 [PMID: 31306001];A1 receptor;f;;Human;31306001;Inverse agonist
capadenoson;A1 receptor;f;;Human;22081230;Partial agonist
LUF5831;A1 receptor;f;;Human;16444290;Partial agonist
neladenoson;A1 receptor;f;;Human;28488817;Partial agonist
PD81723;A1 receptor;f;;Human;2174510;Positive
VPC171;A1 receptor;f;;Human;19514747|26104547;Positive
8-cyclopentyltheophylline;A1 receptor;f;;Human;9827575;Antagonist
AS100;A1 receptor;f;;Human;16219300;Antagonist
AS70;A1 receptor;f;;Human;16219300;Antagonist
AS99;A1 receptor;f;;Human;16219300;Antagonist
ATL802;A1 receptor;f;;Mouse;10737749;Antagonist
ATL802;A1 receptor;f;;Human;10737749;Antagonist
AZD4635;A1 receptor;f;;Human;32727810;Antagonist
caffeine;A1 receptor;f;;Rat;8182711|1658821;Antagonist
caffeine;A1 receptor;f;;Human;8469419|14563788;Antagonist
CGS 15943;A1 receptor;f;;Rat;;Antagonist
CGS 15943;A1 receptor;f;;Human;9933143;Antagonist
CPFPX;A1 receptor;f;;Rat;12408725;Antagonist
CPFPX;A1 receptor;f;;Human;12408725;Antagonist
CSC;A1 receptor;f;;Rat;8496902;Antagonist
CVT-6883;A1 receptor;f;;Human;18321039;Antagonist
derenofylline;A1 receptor;f;;Rat;17558436;Antagonist
derenofylline;A1 receptor;f;;Human;17558436;Antagonist
DPCPX;A1 receptor;f;;Human;9920910|16020631|15740718|16902942|8032613;Antagonist
DPCPX;A1 receptor;f;;Rat;16902942|12014951|2067592;Antagonist
DU172;A1 receptor;f;;Human;28235198;Antagonist
FK-453;A1 receptor;f;;Human;16518376;Antagonist
flavanone;A1 receptor;f;;Rat;8691424;Antagonist
flavone;A1 receptor;f;;Rat;8691424;Antagonist
FR194921;A1 receptor;f;;Human;15351792;Antagonist
galangin;A1 receptor;f;;Rat;8691424;Antagonist
isobutylmethylxanthine;A1 receptor;f;;Human;7798201;Antagonist
istradefylline;A1 receptor;f;;Rat;21303899;Antagonist
istradefylline;A1 receptor;f;;Human;21303899;Antagonist
KF26777;A1 receptor;f;;Human;12063073;Antagonist
L-97-1;A1 receptor;f;;Human;16020631;Antagonist
LAS38096;A1 receptor;f;;Human;17469811|20137946;Antagonist
LUF5962;A1 receptor;f;;Human;29486053;Antagonist
LUF5981;A1 receptor;f;;Human;17300165;Antagonist
LUF7602;A1 receptor;f;;Human;30869893;Antagonist
mefloquine;A1 receptor;f;;Human;14663021;Antagonist
morin;A1 receptor;f;;Rat;8691424;Antagonist
MRE 2029F20;A1 receptor;f;;Human;16219300|14998332;Antagonist
MRE 3008F20;A1 receptor;f;;Human;16219300|10779381|16518376;Antagonist
MRS1041;A1 receptor;f;;Rat;8691424;Antagonist
MRS1042;A1 receptor;f;;Rat;8691424;Antagonist
MRS1062;A1 receptor;f;;Rat;8691424;Antagonist
MRS1065;A1 receptor;f;;Rat;8691424;Antagonist
MRS1066;A1 receptor;f;;Rat;8691424;Antagonist
MRS1084;A1 receptor;f;;Rat;8691424;Antagonist
MRS1086;A1 receptor;f;;Rat;8691424;Antagonist
MRS1093;A1 receptor;f;;Rat;8691424;Antagonist
MRS1132;A1 receptor;f;;Rat;8691424;Antagonist
MRS1191;A1 receptor;f;;Rat;;Antagonist
MRS1191;A1 receptor;f;;Human;;Antagonist
MRS1523;A1 receptor;f;;Human;;Antagonist
MRS1523;A1 receptor;f;;Rat;;Antagonist
MRS1754;A1 receptor;f;;Human;10737749;Antagonist
MRS1754;A1 receptor;f;;Rat;10737749;Antagonist
MRS923;A1 receptor;f;;Rat;8691424;Antagonist
MRS928;A1 receptor;f;;Rat;8691424;Antagonist
MSX-2;A1 receptor;f;;Rat;10669571;Antagonist
MSX-2;A1 receptor;f;;Human;10669571;Antagonist
preladenant;A1 receptor;f;;Human;18221214;Antagonist
PSB-10;A1 receptor;f;;Rat;12139454;Antagonist
PSB-10;A1 receptor;f;;Human;12517430;Antagonist
PSB-11;A1 receptor;f;;Human;12517430;Antagonist
PSB-11;A1 receptor;f;;Rat;12517430;Antagonist
PSB1115;A1 receptor;f;;Rat;8230124;Antagonist
PSB1115;A1 receptor;f;;Human;11906291;Antagonist
PSB36;A1 receptor;f;;Rat;14563788;Antagonist
PSB603;A1 receptor;f;;Human;19569717;Antagonist
PSB603;A1 receptor;f;;Rat;19569717;Antagonist
rolofylline;A1 receptor;f;;Rat;9191953;Antagonist
rolofylline;A1 receptor;f;;Human;17125264|9191953;Antagonist
sakuranetin;A1 receptor;f;;Rat;8691424;Antagonist
SCH442416;A1 receptor;f;;Human;16518376;Antagonist
SCH 58261;A1 receptor;f;;Human;8300561|9933143|16518376;Antagonist
ST-1535;A1 receptor;f;;Human;16250647;Antagonist
[3H]DPCPX;A1 receptor;f;;Human;9920910|8300561|9459566|9827575|9933143|11705449;Antagonist
theophylline;A1 receptor;f;;Rat;8230124;Antagonist
theophylline;A1 receptor;f;;Human;7798201|9459566|16219300|11705449;Antagonist
tonapofylline;A1 receptor;f;;Human;17125264;Antagonist
tonapofylline;A1 receptor;f;;Rat;17125264;Antagonist
vipadenant;A1 receptor;f;;Human;19072055;Antagonist
VUF5574;A1 receptor;f;;Rat;9767636;Antagonist
WRC-0571;A1 receptor;f;;Human;8632314;Antagonist
xanthine amine congener;A1 receptor;f;;Human;7798201;Antagonist
xanthine amine congener;A1 receptor;f;;Human;19317449;Antagonist
ZM-241385;A1 receptor;f;;Human;9933143|16518376;Antagonist
2-chloroadenosine;A2A receptor;f;;Rat;8441759;Agonist
adenosine;A2A receptor;t;;Human;15822182|7746802|14662005;Agonist
adenosine;A2A receptor;f;;Rat;14662005;Agonist
apadenoson;A2A receptor;f;;Human;11406470;Agonist
BAY 60-6583;A2A receptor;f;;Human;17632123;Agonist
binodenoson;A2A receptor;f;;Human;16518376;Agonist
CCPA;A2A receptor;f;;Rat;;Agonist
CGS 21680;A2A receptor;f;;Rat;;Agonist
Cl-IB-MECA;A2A receptor;f;;Mouse;;Agonist
Cl-IB-MECA;A2A receptor;f;;Human;16518376;Agonist
Cl-IB-MECA;A2A receptor;f;;Rat;;Agonist
compound 4g [PMID: 22220592];A2A receptor;f;;Human;22220592;Agonist
cyclopentyladenosine;A2A receptor;f;;Rat;;Agonist
GR79236;A2A receptor;f;;Human;16518376;Agonist
GS9667;A2A receptor;f;;Human;19012505;Agonist
HEMADO;A2A receptor;f;;Human;12109910|17126322;Agonist
MRS3558;A2A receptor;f;;Rat;;Agonist
MRS3558;A2A receptor;f;;Mouse;;Agonist
MRS3558;A2A receptor;f;;Human;16518376;Agonist
MRS5151;A2A receptor;f;;Human;18424135;Agonist
MRS5151;A2A receptor;f;;Mouse;18424135;Agonist
N(6)-cyclohexyladenosine;A2A receptor;f;;Rat;8441759;Agonist
NECA;A2A receptor;f;;Rat;;Agonist
regadenoson;A2A receptor;f;;Human;16518376;Agonist
(R)-PIA;A2A receptor;f;;Rat;8441759;Agonist
TCPA;A2A receptor;f;;Human;12672250;Agonist
tecadenoson;A2A receptor;f;;Pig;16518376|21185259;Agonist
UK-432,097;A2A receptor;f;;Human;21393508|22324512;Agonist
2-chloroadenosine;A2A receptor;f;;Human;7775460|9920286;Full agonist
2-hexynyl-NECA;A2A receptor;f;;Human;12109910|9920286|9179373;Full agonist
AB-MECA;A2A receptor;f;;Human;9459566;Full agonist
APNEA;A2A receptor;f;;Human;9920286;Full agonist
CCPA;A2A receptor;f;;Human;9459566|16518376;Full agonist
CGS 21680;A2A receptor;f;;Human;15476669|16020631|9459566|15267242|7775460|9920286|9179373|16518376;Full agonist
CGS 24012;A2A receptor;f;;Human;7775460;Full agonist
CV-1674;A2A receptor;f;;Human;9920286;Full agonist
CV-1808;A2A receptor;f;;Human;9920286|9179373;Full agonist
cyclopentyladenosine;A2A receptor;f;;Human;15476669|9459566|16518376;Full agonist
(R,S)-PHPNECA;A2A receptor;f;;Human;12109910;Full agonist
metrifudil;A2A receptor;f;;Human;9920286;Full agonist
N(6)-cyclohexyladenosine;A2A receptor;f;;Human;9920286|9179373;Full agonist
NECA;A2A receptor;f;;Human;15476669|15267242|7775460|9920286|9179373|14662005;Full agonist
PENECA;A2A receptor;f;;Human;12109910;Full agonist
piclidenoson;A2A receptor;f;;Human;9459566|7775460|16518376;Full agonist
(R)-PIA;A2A receptor;f;;Human;15476669|9459566|7775460|9920286|9179373;Full agonist
(S)-PIA;A2A receptor;f;;Human;9459566|9179373;Full agonist
[3H]CGS 21680;A2A receptor;f;;Human;2213023|2600819;Full agonist
[3H]NECA;A2A receptor;f;;Human;9459566;Full agonist
AB928;A2A receptor;f;;Human;;Antagonist
ATL802;A2A receptor;f;;Human;10737749;Antagonist
ATL802;A2A receptor;f;;Mouse;10737749;Antagonist
AZD4635;A2A receptor;f;;Human;32727810;Antagonist
caffeine;A2A receptor;f;;Human;9920286|14563788;Antagonist
caffeine;A2A receptor;f;;Rat;1658821|10838015;Antagonist
CGS 15943;A2A receptor;f;;Human;9459566|9933143|7775460|9179373;Antagonist
ciforadenant;A2A receptor;f;;Human;30131376;Antagonist
compound 10 [PMID: 31306001];A2A receptor;f;;Human;31306001;Antagonist
CPFPX;A2A receptor;f;;Human;12408725;Antagonist
CPFPX;A2A receptor;f;;Rat;12408725;Antagonist
CPX;A2A receptor;f;;Human;7775460;Antagonist
CSC;A2A receptor;f;;Rat;8496902;Antagonist
CVT-6883;A2A receptor;f;;Human;18321039;Antagonist
derenofylline;A2A receptor;f;;Human;17558436;Antagonist
DPCPX;A2A receptor;f;;Human;9459566|9933143|9920286|9179373|16902942;Antagonist
DPCPX;A2A receptor;f;;Rat;12014951|10838015;Antagonist
FK-453;A2A receptor;f;;Human;16518376;Antagonist
flavone;A2A receptor;f;;Human;8691424;Antagonist
galangin;A2A receptor;f;;Human;8691424;Antagonist
istradefylline;A2A receptor;f;;Rat;18723354;Antagonist
istradefylline;A2A receptor;f;;Human;17300165|21303899;Antagonist
KF 17837S;A2A receptor;f;;Human;9179373;Antagonist
KF26777;A2A receptor;f;;Human;12063073;Antagonist
LAS38096;A2A receptor;f;;Human;17469811|20137946;Antagonist
LUF5981;A2A receptor;f;;Human;17300165;Antagonist
LUF7602;A2A receptor;f;;Human;30869893;Antagonist
mefloquine;A2A receptor;f;;Human;14663021;Antagonist
morin;A2A receptor;f;;Human;8691424;Antagonist
MRE 2029F20;A2A receptor;f;;Human;14998332;Antagonist
MRE 3008F20;A2A receptor;f;;Human;16219300|10779381|16518376;Antagonist
MRS1041;A2A receptor;f;;Human;8691424;Antagonist
MRS1042;A2A receptor;f;;Human;8691424;Antagonist
MRS1065;A2A receptor;f;;Human;8691424;Antagonist
MRS1066;A2A receptor;f;;Human;8691424;Antagonist
MRS1084;A2A receptor;f;;Human;8691424;Antagonist
MRS1086;A2A receptor;f;;Human;8691424;Antagonist
MRS1088;A2A receptor;f;;Human;8691424;Antagonist
MRS1093;A2A receptor;f;;Human;8691424;Antagonist
MRS1132;A2A receptor;f;;Human;8691424;Antagonist
MRS1191;A2A receptor;f;;Rat;;Antagonist
MRS1191;A2A receptor;f;;Human;;Antagonist
MRS1523;A2A receptor;f;;Human;;Antagonist
MRS1523;A2A receptor;f;;Rat;;Antagonist
MRS1754;A2A receptor;f;;Human;10737749;Antagonist
MRS1754;A2A receptor;f;;Rat;10737749;Antagonist
MRS923;A2A receptor;f;;Human;8691424;Antagonist
MRS928;A2A receptor;f;;Human;8691424;Antagonist
MSX-2;A2A receptor;f;;Human;10669571;Antagonist
MSX-2;A2A receptor;f;;Rat;10669571|10838015;Antagonist
PBF-509;A2A receptor;f;;Human;28582704;Antagonist
PBF-509;A2A receptor;f;;Human;28582704;Antagonist
preladenant;A2A receptor;f;;Human;18221214;Antagonist
PSB-10;A2A receptor;f;;Human;12517430;Antagonist
PSB-10;A2A receptor;f;;Rat;12139454;Antagonist
PSB-11;A2A receptor;f;;Rat;12517430;Antagonist
PSB-11;A2A receptor;f;;Human;12517430;Antagonist
PSB1115;A2A receptor;f;;Rat;8230124;Antagonist
PSB36;A2A receptor;f;;Rat;16902942;Antagonist
PSB36;A2A receptor;f;;Human;16902942;Antagonist
PSB603;A2A receptor;f;;Rat;19569717;Antagonist
PSB603;A2A receptor;f;;Human;19569717;Antagonist
rolofylline;A2A receptor;f;;Human;14532289|17125264;Antagonist
rolofylline;A2A receptor;f;;Rat;9191953|16458010;Antagonist
sakuranetin;A2A receptor;f;;Human;8691424;Antagonist
SCH442416;A2A receptor;f;;Human;11087559|20801028;Antagonist
SCH 58261;A2A receptor;f;;Human;9933143|9920286|9179373;Antagonist
ST-1535;A2A receptor;f;;Human;16250647;Antagonist
[125I]ZM-241385;A2A receptor;f;;Rat;8848012;Antagonist
[3H]SCH 58261;A2A receptor;f;;Human;9933143|9920286;Antagonist
[3H]XAC;A2A receptor;f;;Human;7775460;Antagonist
[3H]ZM 241385;A2A receptor;f;;Human;11164377|10927024;Antagonist
theophylline;A2A receptor;f;;Human;9459566|16219300|9179373;Antagonist
theophylline;A2A receptor;f;;Rat;8230124;Antagonist
tonapofylline;A2A receptor;f;;Human;17125264;Antagonist
tonapofylline;A2A receptor;f;;Rat;17125264;Antagonist
tozadenant;A2A receptor;f;;Human;24164628;Antagonist
vipadenant;A2A receptor;f;;Human;19072055;Antagonist
visnagin;A2A receptor;f;;Human;8691424;Antagonist
VUF5574;A2A receptor;f;;Rat;9767636;Antagonist
xanthine amine congener;A2A receptor;f;;Human;9459566|9179373;Antagonist
ZM-241385;A2A receptor;f;;Human;9933143;Antagonist
adenosine;A2B receptor;t;;Human;15822182|7746802|14662005;Agonist
adenosine;A2B receptor;t;;Rat;14662005;Agonist
BAY 60-6583;A2B receptor;f;;Human;17353435;Agonist
BAY 60-6583;A2B receptor;f;;Mouse;17632123;Agonist
binodenoson;A2B receptor;f;;Human;16518376;Agonist
CGS 21680;A2B receptor;f;;Rat;;Agonist
Cl-IB-MECA;A2B receptor;f;;Mouse;;Agonist
Cl-IB-MECA;A2B receptor;f;;Human;;Agonist
GS9667;A2B receptor;f;;Human;19012505;Agonist
HEMADO;A2B receptor;f;;Human;12109910|17126322;Agonist
MRS3558;A2B receptor;f;;Human;16518376;Agonist
N(6)-cyclohexyladenosine;A2B receptor;f;;Human;6253037;Agonist
NECA;A2B receptor;f;;Mouse;;Agonist
regadenoson;A2B receptor;f;;Human;16518376;Agonist
(R)-PIA;A2B receptor;f;;Mouse;8135856;Agonist
TCPA;A2B receptor;f;;Human;9384502;Agonist
2-chloroadenosine;A2B receptor;f;;Human;10496952|11093773|6253037;Full agonist
2-hexynyl-NECA;A2B receptor;f;;Human;16219300;Full agonist
AB-NECA;A2B receptor;f;;Human;10496952;Full agonist
CCPA;A2B receptor;f;;Human;10496952|16518376;Full agonist
CGS 21680;A2B receptor;f;;Human;10496952|11093773|16518376;Full agonist
cyclopentyladenosine;A2B receptor;f;;Human;10496952|16518376;Full agonist
NECA;A2B receptor;f;;Human;16219300|15267242|10496952|11266650|11093773|15194002|14662005;Full agonist
piclidenoson;A2B receptor;f;;Human;10496952|16518376;Full agonist
(R)-PIA;A2B receptor;f;;Human;16219300|10496952|11266650|11093773|6253037;Full agonist
(S)-PIA;A2B receptor;f;;Human;16219300|10496952;Full agonist
3-isobutyl-8-pyrrolidinoxanthine;A2B receptor;f;;Human;11705449;Antagonist
alloxazine;A2B receptor;f;;Human;11266650|10624567;Antagonist
AS100;A2B receptor;f;;Human;16219300;Antagonist
AS101;A2B receptor;f;;Human;16219300;Antagonist
AS16;A2B receptor;f;;Human;16219300;Antagonist
AS70;A2B receptor;f;;Human;16219300;Antagonist
AS74;A2B receptor;f;;Human;16219300;Antagonist
AS94;A2B receptor;f;;Human;16219300;Antagonist
AS95;A2B receptor;f;;Human;16219300;Antagonist
AS96;A2B receptor;f;;Human;16219300;Antagonist
AS99;A2B receptor;f;;Human;16219300;Antagonist
ATL802;A2B receptor;f;;Human;10737749;Antagonist
ATL802;A2B receptor;f;;Mouse;10737749;Antagonist
AZD4635;A2B receptor;f;;Human;32727810;Antagonist
BAY-545;A2B receptor;f;;Mouse;30576906;Antagonist
BAY-545;A2B receptor;f;;Human;30576906;Antagonist
BAY-545;A2B receptor;f;;Rat;30576906;Antagonist
BW-A1433;A2B receptor;f;;Human;10496952;Antagonist
caffeine;A2B receptor;f;;Mouse;8135856;Antagonist
caffeine;A2B receptor;f;;Rat;8135856;Antagonist
caffeine;A2B receptor;f;;Human;19569717|12014951|18404493;Antagonist
CGS 15943;A2B receptor;f;;Human;9459566|9933143|11266650|15194002|10624567|19141710;Antagonist
CGS 15943;A2B receptor;f;;Human;8937736;Antagonist
CGS 15943;A2B receptor;f;;Mouse;19141710;Antagonist
CPX;A2B receptor;f;;Human;10496952|11266650;Antagonist
CSC;A2B receptor;f;;Rat;;Antagonist
CVT-6883;A2B receptor;f;;Human;18321039;Antagonist
DAX;A2B receptor;f;;Human;11266650;Antagonist
DEPX;A2B receptor;f;;Human;10496952;Antagonist
derenofylline;A2B receptor;f;;Rat;17558436;Antagonist
derenofylline;A2B receptor;f;;Human;17558436;Antagonist
DPCPX;A2B receptor;f;;Human;16020631|15194002|16902942|12014951;Antagonist
DPCPX;A2B receptor;f;;Rat;12014951|12954362;Antagonist
DPCPX;A2B receptor;f;;Mouse;19141710;Antagonist
FK-453;A2B receptor;f;;Human;16518376;Antagonist
I-ABOPX;A2B receptor;f;;Human;10496952;Antagonist
ISAM-140;A2B receptor;f;;Human;26824742;Antagonist
istradefylline;A2B receptor;f;;Human;21303899;Antagonist
KF26777;A2B receptor;f;;Human;12063073;Antagonist
LAS38096;A2B receptor;f;;Human;17469811|20137946;Antagonist
LUF5981;A2B receptor;f;;Human;14663020;Antagonist
MRE 2029F20;A2B receptor;f;;Human;16219300|14998332;Antagonist
MRE 3008F20;A2B receptor;f;;Human;16219300|10779381|16518376;Antagonist
MRS1191;A2B receptor;f;;Human;;Antagonist
MRS1220;A2B receptor;f;;Human;15194002;Antagonist
MRS1523;A2B receptor;f;;Human;;Antagonist
MRS1523;A2B receptor;f;;Mouse;;Antagonist
MRS1706;A2B receptor;f;;Unknown;10737749;Antagonist
MRS1754;A2B receptor;f;;Human;11266650|10737749;Antagonist
MRS1754;A2B receptor;f;;Mouse;19141710;Antagonist
MRS1754;A2B receptor;f;;Rat;10737749|12954362;Antagonist
MSX-2;A2B receptor;f;;Human;10669571|15696333;Antagonist
OSIP339391;A2B receptor;f;;Human;15194002;Antagonist
pentoxifylline;A2B receptor;f;;Human;12014951;Antagonist
preladenant;A2B receptor;f;;Human;18221214;Antagonist
PSB-0788;A2B receptor;f;;Human;19569717;Antagonist
PSB-10;A2B receptor;f;;Mouse;12139454;Antagonist
PSB-11;A2B receptor;f;;Mouse;12139454;Antagonist
PSB1115;A2B receptor;f;;Human;11906291;Antagonist
PSB36;A2B receptor;f;;Human;16458010;Antagonist
PSB603;A2B receptor;f;;Human;19569717;Antagonist
PSB603;A2B receptor;f;;Human;19569717;Antagonist
PSB603;A2B receptor;f;;Mouse;19569717;Antagonist
rolofylline;A2B receptor;f;;Human;17125264;Antagonist
SCH442416;A2B receptor;f;;Human;16518376;Antagonist
SCH 58261;A2B receptor;f;;Human;11093773|16518376;Antagonist
ST-1535;A2B receptor;f;;Human;16250647;Antagonist
[125I]ABOPX;A2B receptor;f;;Human;10496952;Antagonist
[3H]DPCPX;A2B receptor;f;;Human;15194002;Antagonist
[3H]MRS1754;A2B receptor;f;;Human;11266650;Antagonist
[3H]OSIP339391;A2B receptor;f;;Human;15194002;Antagonist
[3H]PSB603;A2B receptor;f;;Mouse;19569717;Antagonist
[3H]PSB603;A2B receptor;f;;Human;19569717;Antagonist
[3H]ZM 241385;A2B receptor;f;;Human;11705449|15194002|10624567;Antagonist
theophylline;A2B receptor;f;;Human;16219300|11705449|12014951|18404493;Antagonist
theophylline;A2B receptor;f;;Mouse;19141710;Antagonist
tonapofylline;A2B receptor;f;;Human;17125264;Antagonist
vipadenant;A2B receptor;f;;Human;19072055;Antagonist
xanthine amine congener;A2B receptor;f;;Human;9459566|10496952|11266650|11093773|15194002|10624567;Antagonist
xanthine amine congener;A2B receptor;f;;Human;8937736;Antagonist
XCC;A2B receptor;f;;Human;11266650;Antagonist
ZM-241385;A2B receptor;f;;Human;10496952|11266650|11093773|15194002;Antagonist
2-chloroadenosine;A3 receptor;f;;Rat;8022403;Agonist
2'-Me-CCPA;A3 receptor;f;;Rat;9572897;Agonist
2-phenylethylyl-adenosine derivative;A3 receptor;f;;Human;19839592;Agonist
adenosine;A3 receptor;t;;Human;15822182|7746802|14662005;Agonist
adenosine;A3 receptor;t;;Rat;14662005;Agonist
apadenoson;A3 receptor;f;;Human;16518376;Agonist
BAY 60-6583;A3 receptor;f;;Human;17632123;Agonist
binodenoson;A3 receptor;f;;Human;16518376;Agonist
CCPA;A3 receptor;f;;Rat;;Agonist
CGS 21680;A3 receptor;f;;Rat;;Agonist
Cl-IB-MECA;A3 receptor;f;;Rat;;Agonist
Cl-IB-MECA;A3 receptor;f;;Mouse;;Agonist
CP608,039;A3 receptor;f;;Human;12919933;Agonist
GS9667;A3 receptor;f;;Human;19012505;Agonist
HEMADO;A3 receptor;f;;Human;12109910|17126322;Agonist
MRS3558;A3 receptor;f;;Human;16518376;Agonist
MRS3558;A3 receptor;f;;Rat;;Agonist
MRS3558;A3 receptor;f;;Mouse;;Agonist
MRS5151;A3 receptor;f;;Mouse;18424135;Agonist
MRS5151;A3 receptor;f;;Human;18424135;Agonist
MRS5698;A3 receptor;f;;Human;22559880;Agonist
N(6)-cyclohexyladenosine;A3 receptor;f;;Human;8617970;Agonist
N(6)-cyclohexyladenosine;A3 receptor;f;;Rat;8022403;Agonist
regadenoson;A3 receptor;f;;Human;16518376;Agonist
TCPA;A3 receptor;f;;Human;12672250;Agonist
2-hexynyl-NECA;A3 receptor;f;;Human;12109910;Full agonist
AB-MECA;A3 receptor;f;;Human;9459566|10779381;Full agonist
CCPA;A3 receptor;f;;Human;9459566|16518376;Full agonist
CGS 21680;A3 receptor;f;;Human;15476669|9459566|10779381|15267242|16518376;Full agonist
Cl-IB-MECA;A3 receptor;f;;Human;10731034|9364471|7932588;Full agonist
cyclopentyladenosine;A3 receptor;f;;Human;8234299|15476669|9459566|16518376;Full agonist
I-ABA;A3 receptor;f;;Human;8234299;Full agonist
(R,S)-PHPNECA;A3 receptor;f;;Human;12109910;Full agonist
MPC-MECA;A3 receptor;f;;Human;10779381;Full agonist
MRE 3008F20;A3 receptor;f;;Human;10779381;Full agonist
NECA;A3 receptor;f;;Rat;7929142;Full agonist
NECA;A3 receptor;f;;Human;8234299|15476669|10779381|15267242|9364471|14662005;Full agonist
PENECA;A3 receptor;f;;Human;12109910;Full agonist
piclidenoson;A3 receptor;f;;Human;9459566|10779381|11705449|8126704;Full agonist
(R)-PIA;A3 receptor;f;;Rat;7929142|8441759;Full agonist
(R)-PIA;A3 receptor;f;;Human;8234299|15476669|9459566|10779381|9364471;Full agonist
(S)-PIA;A3 receptor;f;;Human;8234299|9459566|10779381;Full agonist
[125I]AB-MECA;A3 receptor;f;;Human;9933143|10779381;Full agonist
[125I]AB-MECA;A3 receptor;f;;Rat;7929142;Full agonist
[125I]APNEA;A3 receptor;f;;Human;1323836;Full agonist
[3H]HEMADO;A3 receptor;f;;Human;17126322;Full agonist
[3H]NECA;A3 receptor;f;;Human;9459566|11705449;Full agonist
LUF6000;A3 receptor;f;;Human;16722654;Positive
LUF6096;A3 receptor;f;;Human;19161279;Positive
ATL802;A3 receptor;f;;Human;10737749;Antagonist
ATL802;A3 receptor;f;;Mouse;10737749;Antagonist
BW-A1433;A3 receptor;f;;Rat;7929142;Antagonist
BW-A1433;A3 receptor;f;;Human;8234299;Antagonist
caffeine;A3 receptor;f;;Human;;Antagonist
caffeine;A3 receptor;f;;Rat;19569717;Antagonist
CGS 15943;A3 receptor;f;;Human;9459566|9933143|10779381|8863790;Antagonist
CSC;A3 receptor;f;;Rat;8022403;Antagonist
CVT-6883;A3 receptor;f;;Human;18321039;Antagonist
derenofylline;A3 receptor;f;;Human;17558436;Antagonist
dexniguldipine;A3 receptor;f;;Human;8709132;Antagonist
DPCPX;A3 receptor;f;;Human;8234299|9459566|10779381|16902942|11906291|9351976;Antagonist
DPCPX;A3 receptor;f;;Rat;7929142|16902942|9351976;Antagonist
FK-453;A3 receptor;f;;Human;16518376;Antagonist
flavanone;A3 receptor;f;;Human;8691424;Antagonist
flavone;A3 receptor;f;;Human;8691424;Antagonist
galangin;A3 receptor;f;;Human;8691424;Antagonist
I-ABOPX;A3 receptor;f;;Human;8234299;Antagonist
istradefylline;A3 receptor;f;;Human;21303899;Antagonist
KF26777;A3 receptor;f;;Human;12063073;Antagonist
LAS38096;A3 receptor;f;;Human;17469811|20137946;Antagonist
LUF5981;A3 receptor;f;;Human;17300165;Antagonist
LUF7602;A3 receptor;f;;Human;30869893;Antagonist
MRE 2029F20;A3 receptor;f;;Human;14998332;Antagonist
MRE 3008F20;A3 receptor;f;;Human;16219300|10779381|16518376;Antagonist
MRE 3010F20;A3 receptor;f;;Human;10779381;Antagonist
MRS1041;A3 receptor;f;;Human;8691424;Antagonist
MRS1042;A3 receptor;f;;Human;8691424;Antagonist
MRS1067;A3 receptor;f;;Human;8691424|9364471;Antagonist
MRS1088;A3 receptor;f;;Human;8691424;Antagonist
MRS1093;A3 receptor;f;;Human;8691424;Antagonist
MRS1097;A3 receptor;f;;Human;9364471|8709132;Antagonist
MRS1177;A3 receptor;f;;Human;8863790;Antagonist
MRS1186;A3 receptor;f;;Human;8863790;Antagonist
MRS1191;A3 receptor;f;;Rat;9703464;Antagonist
MRS1191;A3 receptor;f;;Human;9364471|8917655;Antagonist
MRS1220;A3 receptor;f;;Human;9364471|8863790|16553647|11226132;Antagonist
MRS1476;A3 receptor;f;;Human;9703464;Antagonist
MRS1486;A3 receptor;f;;Human;9703464;Antagonist
MRS1505;A3 receptor;f;;Human;9703464;Antagonist
MRS1523;A3 receptor;f;;Human;9703464;Antagonist
MRS1523;A3 receptor;f;;Rat;;Antagonist
MRS1523;A3 receptor;f;;Mouse;;Antagonist
MRS1754;A3 receptor;f;;Human;10737749;Antagonist
MRS928;A3 receptor;f;;Human;8691424;Antagonist
MSX-2;A3 receptor;f;;Human;10669571;Antagonist
nicardipine;A3 receptor;f;;Human;8709132;Antagonist
preladenant;A3 receptor;f;;Human;18221214;Antagonist
PSB-10;A3 receptor;f;;Human;12139454;Antagonist
PSB-11;A3 receptor;f;;Human;11814828;Antagonist
PSB-11;A3 receptor;f;;Human;12517430;Antagonist
PSB1115;A3 receptor;f;;Human;11906291;Antagonist
PSB36;A3 receptor;f;;Human;16902942;Antagonist
PSB36;A3 receptor;f;;Rat;16902942;Antagonist
PSB603;A3 receptor;f;;Human;19569717;Antagonist
rolofylline;A3 receptor;f;;Human;17125264;Antagonist
sakuranetin;A3 receptor;f;;Human;8691424;Antagonist
SCH442416;A3 receptor;f;;Human;16518376;Antagonist
SCH 58261;A3 receptor;f;;Human;16518376;Antagonist
ST-1535;A3 receptor;f;;Human;16250647;Antagonist
[3H]MRE 3008F20;A3 receptor;f;;Human;10779381|10698437;Antagonist
[3H]PSB-11;A3 receptor;f;;Human;11814828;Antagonist
theophylline;A3 receptor;f;;Human;9459566;Antagonist
theophylline;A3 receptor;f;;Rat;8022403|7632796;Antagonist
tonapofylline;A3 receptor;f;;Human;17125264;Antagonist
vipadenant;A3 receptor;f;;Human;19072055;Antagonist
visnagin;A3 receptor;f;;Human;8691424;Antagonist
VUF5574;A3 receptor;f;;Human;10841801;Antagonist
VUF8504;A3 receptor;f;;Human;9767637;Antagonist
VUF8507;A3 receptor;f;;Human;9767637;Antagonist
xanthine amine congener;A3 receptor;f;;Rat;7929142;Antagonist
xanthine amine congener;A3 receptor;f;;Human;8234299|9459566|10779381;Antagonist
ZM-241385;A3 receptor;f;;Human;16518376;Antagonist
α-methyl-D,L-tryptophan;ATB0,+;f;;Human;18522536;Inhibition
AZD0156;ATM serine/threonine kinase;f;;Human;29683659;Inhibition
AZD1390;ATM serine/threonine kinase;f;;Human;29938225;Inhibition
berzosertib;ATM serine/threonine kinase;f;;Human;23222511;Inhibition
CP466722;ATM serine/threonine kinase;f;;Human;18794134;Inhibition
KU-55933;ATM serine/threonine kinase;f;;Human;15604286;Inhibition
KU-55933;ATM serine/threonine kinase;f;;Human;15604286;Inhibition
KU-60019;ATM serine/threonine kinase;f;;Human;19808981;Inhibition
esomeprazole;ATP4A;f;;Human;;Inhibition
ilaprazole;ATP4A;f;;Rabbit;11304936;Inhibition
omeprazole;ATP4A;f;;Human;;Inhibition
compound 23 [PMID: 31398032];ATPase family AAA domain containing 2;f;;Human;31398032;Inhibition
compound 33 [PMID: 26230603];ATPase family AAA domain containing 2;f;;Human;26230603;Inhibition
compound 57 [PMID: 26155854];ATPase family AAA domain containing 2;f;;Human;26155854;Inhibition
compound 60 [PMID: 26155854];ATPase family AAA domain containing 2;f;;Human;26155854;Inhibition
GSK8814;ATPase family AAA domain containing 2;f;;Human;27530368;Inhibition
GSK8814;ATPase family AAA domain containing 2;f;;Human;27530368;Inhibition
GSK8814;ATPase family AAA domain containing 2;f;;Human;27530368;Inhibition
compound 23 [PMID: 31398032];ATPase family AAA domain containing 2B;f;;Human;31398032;Inhibition
GSK8814;ATPase family AAA domain containing 2B;f;;Human;27530368;Inhibition
chlorpropamide;ATP-binding cassette, sub-family C (CFTR/MRP), member 8;f;;Human;;Inhibition
repaglinide;ATP-binding cassette, sub-family C (CFTR/MRP), member 8;f;;Human;15380228;Inhibition
AZ20;ATR serine/threonine kinase;f;;Human;23394205;Inhibition
BAY1895344;ATR serine/threonine kinase;f;;Human;;Inhibition
berzosertib;ATR serine/threonine kinase;f;;Human;23222511;Inhibition
ceralasertib;ATR serine/threonine kinase;f;;Human;26517239;Inhibition
dactolisib;ATR serine/threonine kinase;f;;Human;21552262;Inhibition
VE-821;ATR serine/threonine kinase;f;;Human;21490603;Inhibition
L-163,101;AT1 receptor;f;;Human;9383393;Agonist
[Sar1,Cha4]Ang-II;AT1 receptor;f;;Rat;11901215|10066768;Agonist
angiotensin A;AT1 receptor;t;Human;Human;21464395;Full agonist
angiotensin A;AT1 receptor;t;Human;Human;21464395;Full agonist
angiotensin II;AT1 receptor;t;Human|Mouse|Rat;Human;10193788;Full agonist
angiotensin III;AT1 receptor;t;Human|Mouse|Rat;Human;;Full agonist
L-162,313;AT1 receptor;f;;Human;7829475;Full agonist
[125I][Sar1]Ang-II;AT1 receptor;f;;Rat;7759541;Full agonist
angiotensin A;AT1 receptor;t;Human;Rat;17138938;Partial agonist
angiotensin IV;AT1 receptor;t;Human|Mouse|Rat;Human;12006574;Partial agonist
[Sar1,Cha8]Ang-II;AT1 receptor;f;;Rat;11901215|10066768;Partial agonist
[Sar1,Ile8]Ang-II;AT1 receptor;f;;Rat;7499361;Partial agonist
[125I][Sar1,Ile8]Ang-II;AT1 receptor;f;;Rat;7759541;Partial agonist
5-butyl-methyl immidazole carboxylate 30;AT1 receptor;f;;Human;22889560;Antagonist
5-butyl-methyl immidazole carboxylate 30;AT1 receptor;f;;Human;22889560;Antagonist
5-oxo-1-2-4-oxadiazol biphenyl;AT1 receptor;f;;Rat;22410249;Antagonist
5-oxo-1-2-4-oxadiazol biphenyl;AT1 receptor;f;;Rat;22410249;Antagonist
azilsartan;AT1 receptor;f;;Human;24742498|24739538;Antagonist
candesartan;AT1 receptor;f;;Human;10193788;Antagonist
eprosartan;AT1 receptor;f;;Human;1309870;Antagonist
EXP3174;AT1 receptor;f;;Human;10193788|8372104;Antagonist
forasartan;AT1 receptor;f;;Rat;7505365;Antagonist
irbesartan;AT1 receptor;f;;Human;10193788;Antagonist
losartan;AT1 receptor;f;;Human;8372104;Antagonist
LY301875;AT1 receptor;f;;Human;11303957;Antagonist
LY303336;AT1 receptor;f;;Human;11303957;Antagonist
N,N`-bis-alkyl butylimmidazole 12b;AT1 receptor;f;;Human;23376252;Antagonist
olmesartan;AT1 receptor;f;;Human;11451212;Antagonist
saprisartan;AT1 receptor;f;;Rat;7853190;Antagonist
[Sar1,Ala8]Ang-II;AT1 receptor;f;;Human;11901215;Antagonist
[Sar1,Gly4,Gly8]Ang-II;AT1 receptor;f;;Human;11901215;Antagonist
[Sar1,Ile4,Ile8]Ang-II;AT1 receptor;f;;Human;12949261;Antagonist
[Sar1,Ile8]Ang-II;AT1 receptor;f;;Human;11901215;Antagonist
sparsentan;AT1 receptor;f;;Human;16220969;Antagonist
[125I]EXP985;AT1 receptor;f;;Rat;1445340;Antagonist
[3H]A81988;AT1 receptor;f;;Rat;8206129;Antagonist
[3H]candesartan;AT1 receptor;f;;Human;10079018;Antagonist
[3H]eprosartan;AT1 receptor;f;;Rat;8463997;Antagonist
[3H]irbesartan;AT1 receptor;f;;Human;11967808;Antagonist
[3H]L158809;AT1 receptor;f;;Rat;1480133;Antagonist
[3H]losartan;AT1 receptor;f;;Rat;8282008;Antagonist
[3H]valsartan;AT1 receptor;f;;Human;11206708;Antagonist
tasosartan;AT1 receptor;f;;Human;11046101;Antagonist
telmisartan;AT1 receptor;f;;Human;9878991;Antagonist
TRV027;AT1 receptor;f;;Human;20801892;Antagonist
valsartan;AT1 receptor;f;;Human;8577935;Antagonist
ZD-7155;AT1 receptor;f;;Guinea pig;8576904;Antagonist
angiotensin-(1-7);AT2 receptor;t;Human|Mouse|Rat;Human;21542804;Agonist
angiotensin A;AT2 receptor;f;Human;Human;17138938;Agonist
angiotensin A;AT2 receptor;f;Human;Human;21464395;Agonist
novokinin;AT2 receptor;f;;Human;18207609;Agonist
angiotensin II;AT2 receptor;t;Human|Mouse|Rat;Human;2775266|7850406;Full agonist
angiotensin III;AT2 receptor;t;Human|Mouse|Rat;Human;8242249|2775266;Full agonist
CGP42112;AT2 receptor;f;;Human;21542804;Full agonist
compound 21 [PMID: 22802221];AT2 receptor;f;;Human;22802221;Full agonist
compound 21 [PMID: 22802221];AT2 receptor;f;;Rat;22802221;Full agonist
[p-aminoPhe6]ang II;AT2 receptor;f;;Rat;2194459;Full agonist
[125I]CGP42112;AT2 receptor;f;;Human;2775266|1764088;Full agonist
[125I][Sar1,Ile8]Ang-II;AT2 receptor;f;;Rat;10024318;Full agonist
olodanrigan;AT2 receptor;f;;Rat;23489258;Antagonist
olodanrigan;AT2 receptor;f;;Human;24507377|23489258|24507378;Antagonist
PD123177;AT2 receptor;f;;Rat;2590220|8469774|2314387;Antagonist
PD123319;AT2 receptor;f;;Human;2402226|1709220;Antagonist
saralasin;AT2 receptor;f;;Rat;2590220;Antagonist
alisertib;aurora kinase A;f;;Human;19320489;Inhibition
AMG-900;aurora kinase A;f;;Human;20935223;Inhibition
AT-9283;aurora kinase A;f;;Human;19143567;Inhibition
aurora kinase inhibitor II;aurora kinase A;f;;Human;18077363;Inhibition
aurora kinase inhibitor III;aurora kinase A;f;;Human;17157005;Inhibition
barasertib;aurora kinase A;f;;Human;17495131;Inhibition
Cdk2 inhibitor IV;aurora kinase A;f;;Human;30234987;Inhibition
compound 10 [PMID: 19402633];aurora kinase A;f;;Human;19402633;Inhibition
compound 16 [PMID: 18945615];aurora kinase A;f;;Human;18945615;Inhibition
compound 25 [PMID: 20855207];aurora kinase A;f;;Human;20855207;Inhibition
compound 38 [PMID: 20817473];aurora kinase A;f;;Human;20817473;Inhibition
compound 46 [PMID: 16451062];aurora kinase A;f;;Human;16451062;Inhibition
danusertib;aurora kinase A;f;;Human;17125279;Inhibition
dubermatinib;aurora kinase A;f;;Human;22247788;Inhibition
ENMD-2076;aurora kinase A;f;;Human;19320489;Inhibition
GSK1070916;aurora kinase A;f;;Human;20420387;Inhibition
GSK143;aurora kinase A;f;;Human;21903390;Inhibition
GSK2334470;aurora kinase A;f;;Human;21341675;Inhibition
GSK2646264;aurora kinase A;f;;Human;30249354;Inhibition
GSK-3 inhibitor XIII;aurora kinase A;f;;Human;19447622;Inhibition
ilorasertib;aurora kinase A;f;;Human;22935731;Inhibition
JNJ-7706621;aurora kinase A;f;;Human;30234987;Inhibition
KW-2449;aurora kinase A;f;;Human;19541823;Inhibition
MK-5108;aurora kinase A;f;;Human;20053775;Inhibition
MLN-8054;aurora kinase A;f;;Human;22037378;Inhibition
MLN-8054;aurora kinase A;f;;Human;17360485|19402633;Inhibition
PF-562271;aurora kinase A;f;;Human;18339875;Inhibition
RG-1530;aurora kinase A;f;;Human;20814247;Inhibition
Rho kinase inhibitor IV;aurora kinase A;f;;Human;16213195;Inhibition
SNS-314;aurora kinase A;f;;Human;18678489;Inhibition
tozasertib;aurora kinase A;f;;Human;22037378;Inhibition
tozasertib;aurora kinase A;f;;Human;14981513;Inhibition
VTX-11e;aurora kinase A;f;;Human;19827834;Inhibition
ZM447439;aurora kinase A;f;;Human;12719470;Inhibition
AMG-900;aurora kinase B;f;;Human;20935223;Inhibition
AT-9283;aurora kinase B;f;;Human;19143567;Inhibition
aurora kinase inhibitor II;aurora kinase B;f;;Human;18077363;Inhibition
barasertib;aurora kinase B;f;;Human;17495131;Inhibition
barasertib-hQPA;aurora kinase B;f;;Human;22037378;Inhibition
barasertib-hQPA;aurora kinase B;f;;Human;19320489;Inhibition
Cdk2 inhibitor IV;aurora kinase B;f;;Human;30234987;Inhibition
cenisertib;aurora kinase B;f;;Human;22695126;Inhibition
cenisertib;aurora kinase B;f;;Human;;Inhibition
compound 10 [PMID: 19402633];aurora kinase B;f;;Human;19402633;Inhibition
compound 1 [PMID: 21742770];aurora kinase B;f;;Human;23256033;Inhibition
compound 25 [PMID: 20855207];aurora kinase B;f;;Human;20855207;Inhibition
compound 38 [PMID: 20817473];aurora kinase B;f;;Human;20817473;Inhibition
compound 46 [PMID: 16451062];aurora kinase B;f;;Human;16451062;Inhibition
CS2164;aurora kinase B;f;;Human;28004478;Inhibition
danusertib;aurora kinase B;f;;Human;17125279;Inhibition
dubermatinib;aurora kinase B;f;;Human;22247788;Inhibition
GSK1070916;aurora kinase B;f;;Human;20420387;Inhibition
GSK2334470;aurora kinase B;f;;Human;21341675;Inhibition
GSK2646264;aurora kinase B;f;;Human;30249354;Inhibition
hesperadin;aurora kinase B;f;;Human;12707311;Inhibition
ilorasertib;aurora kinase B;f;;Human;22935731;Inhibition
JNJ-7706621;aurora kinase B;f;;Human;30234987;Inhibition
KW-2449;aurora kinase B;f;;Human;19541823;Inhibition
MK-5108;aurora kinase B;f;;Human;20053775;Inhibition
MLN-8054;aurora kinase B;f;;Human;19402633;Inhibition
NIK inhibitor 12f;aurora kinase B;f;;Human;32479083;Inhibition
SNS-314;aurora kinase B;f;;Human;18678489;Inhibition
SU6656;aurora kinase B;f;;Human;17850214;Inhibition
TAK-632;aurora kinase B;f;;Human;23906342;Inhibition
tozasertib;aurora kinase B;f;;Human;14981513;Inhibition
ZM447439;aurora kinase B;f;;Human;12719470;Inhibition
AMG-900;aurora kinase C;f;;Human;20935223;Inhibition
compound 38 [PMID: 20817473];aurora kinase C;f;;Human;20817473;Inhibition
danusertib;aurora kinase C;f;;Human;17125279;Inhibition
GSK1070916;aurora kinase C;f;;Human;20420387;Inhibition
ilorasertib;aurora kinase C;f;;Human;22935731;Inhibition
MK-5108;aurora kinase C;f;;Human;20053775;Inhibition
SU6656;aurora kinase C;f;;Human;17850214;Inhibition
tozasertib;aurora kinase C;f;;Human;14981513;Inhibition
BI-2545;autotaxin;f;;Rat;29259743;Inhibition
BI-2545;autotaxin;f;;Human;29259743;Inhibition
example 1.11 [WO2014139978];autotaxin;f;;Human;;Inhibition
example 2 [WO2013054185];autotaxin;f;;Human;;Inhibition
example 31 (24) [WO2012005227];autotaxin;f;;Rat;29197066;Inhibition
example 31 (24) [WO2012005227];autotaxin;f;;Rat;29197066;Inhibition
inhibitor 32 [PMID: 29620892];autotaxin;f;;Mouse;29620892;Inhibition
PF-8380;autotaxin;f;;Human;20392816|23300119;Inhibition
X-165;autotaxin;f;;Human;32584034;Inhibition
ziritaxestat;autotaxin;f;;Human;28414242;Inhibition
belizatinib;AXL receptor tyrosine kinase;f;;Human;22734674;Inhibition
bemcentinib;AXL receptor tyrosine kinase;f;;Human;20145120;Inhibition
BMS-777607;AXL receptor tyrosine kinase;f;;Human;19260711;Inhibition
compound 19a [PMID: 30503936];AXL receptor tyrosine kinase;f;;Human;30503936;Inhibition
compound 1 [Cruz-López et al., 2019];AXL receptor tyrosine kinase;f;;Human;31867559;Inhibition
compound 8i [PMID: 22765894];AXL receptor tyrosine kinase;f;;Human;21613405;Inhibition
dubermatinib;AXL receptor tyrosine kinase;f;;Human;22247788;Inhibition
gilteritinib;AXL receptor tyrosine kinase;f;;Human;27908881;Inhibition
LDC1267;AXL receptor tyrosine kinase;f;;Human;24553136;Inhibition
merestinib;AXL receptor tyrosine kinase;f;;Human;23275061;Inhibition
RIPK1 inhibitor 22b;AXL receptor tyrosine kinase;f;;Human;30480444;Inhibition
sitravatinib;AXL receptor tyrosine kinase;f;;Human;26675259;Inhibition
UNC4203;AXL receptor tyrosine kinase;f;;Human;30347155;Inhibition
growth arrest specific protein 6;AXL receptor tyrosine kinase;t;Human;Human;8939948;None
protein S;AXL receptor tyrosine kinase;t;Human;Human;7867073;None
enoblituzumab;B7-H3 (CD276);f;;Human;22615450;Binding
enoblituzumab;B7-H3 (CD276);f;;Monkey;22615450;Binding
AZD5582;baculoviral IAP repeat containing 2;f;;Human;24320998;Antagonist
birinapant;baculoviral IAP repeat containing 2;f;;Human;23225169;Antagonist
GDC-0152;baculoviral IAP repeat containing 2;f;;Human;22413863;Antagonist
SM-337;baculoviral IAP repeat containing 2;f;;Human;19049347;Antagonist
xevinapant;baculoviral IAP repeat containing 2;f;;Human;21443232;Antagonist
BV-6;baculoviral IAP repeat containing 2;f;;Human;18022362;Inhibition
LCL161;baculoviral IAP repeat containing 2;f;;Human;24083782;Inhibition
SM-122;baculoviral IAP repeat containing 2;f;;Human;19049347;Inhibition
AZD5582;baculoviral IAP repeat containing 3;f;;Human;24320998;Antagonist
GDC-0152;baculoviral IAP repeat containing 3;f;;Human;22413863;Antagonist
SM-337;baculoviral IAP repeat containing 3;f;;Human;19049347;Antagonist
xevinapant;baculoviral IAP repeat containing 3;f;;Human;21443232;Antagonist
SM-122;baculoviral IAP repeat containing 3;f;;Human;19049347;Inhibition
compound III [PMID: 24080463];baculoviral IAP repeat containing 5;f;;Human;24080463;Inhibition
GDC-0152;baculoviral IAP repeat containing 7;f;;Human;22413863;Antagonist
ianalumab;BAFF receptor;f;;Human;;Antagonist
BAFF;BAFF receptor;t;Human;Human;;None
meplazumab;basigin (Ok blood group);f;;Human;;Binding
bumetanide;Basolateral Na-K-Cl symporter;f;;Human;11882915;Inhibition
furosemide;Basolateral Na-K-Cl symporter;f;;Human;11882915;Inhibition
piretanide;Basolateral Na-K-Cl symporter;f;;Human;11882915;Inhibition
bombesin;BB1 receptor;f;;Human;21729729;Full agonist
bombesin;BB1 receptor;f;;Rat;10454496|7838118;Full agonist
bombesin;BB1 receptor;f;;Human;10454496|7838118;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB1 receptor;f;;Human;10454496|21729729;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB1 receptor;f;;Human;21729729;Full agonist
gastrin-releasing peptide;BB1 receptor;f;Human;Rat;10454496|7838118|9325344|10353842;Full agonist
gastrin releasing peptide(14-27) (human);BB1 receptor;t;;Human;21729729;Full agonist
gastrin releasing peptide(14-27) (human);BB1 receptor;f;;Rat;21729729;Full agonist
[Leu8]-phyllolitorin;BB1 receptor;f;;Rat;21729729;Full agonist
[Leu8]-phyllolitorin;BB1 receptor;f;;Human;;Full agonist
[Leu8]-phyllolitorin;BB1 receptor;f;;Rat;9325344|10353842;Full agonist
litorin;BB1 receptor;f;;Rat;9325344|10353842;Full agonist
MK-5046;BB1 receptor;f;;Human;23892571|21036912;Full agonist
neuromedin B;BB1 receptor;t;Human|Mouse|Pig|Rat;Human;18055507|21729729|25976083;Full agonist
neuromedin B (1-30) (human);BB1 receptor;f;;Human;21729729;Full agonist
[Phe13]bombesin;BB1 receptor;f;;Rat;10454496|9325344|10353842;Full agonist
phyllolitorin;BB1 receptor;f;;Rat;9325344|10353842;Full agonist
phyllolitorin;BB1 receptor;f;;Human;21729729;Full agonist
phyllolitorin;BB1 receptor;f;;Rat;21729729;Full agonist
ranatensin;BB1 receptor;f;;Rat;9325344|10353842;Full agonist
ranatensin;BB1 receptor;f;;Human;21729729;Full agonist
Rhodei-litorin;BB1 receptor;f;;Rat;21729729;Full agonist
Rhodei-litorin;BB1 receptor;f;;Rat;9325344|10353842;Full agonist
Rhodei-litorin;BB1 receptor;f;;Human;21729729;Full agonist
[125I]BH-NMB (human, mouse, rat);BB1 receptor;f;;Human;;Full agonist
[125I][Tyr4]bombesin;BB1 receptor;f;;Human;;Full agonist
bantag-1;BB1 receptor;f;;Human;20096642|23892571;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB1 receptor;f;;Human;19463875;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB1 receptor;f;;Rat;10454496;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB1 receptor;f;;Rat;7901752;Antagonist
D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH2  ;BB1 receptor;f;;Human;19463875;Antagonist
dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2;BB1 receptor;f;;Human;;Antagonist
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14);BB1 receptor;f;;Human;19463875;Antagonist
JMV594;BB1 receptor;f;;Rat;11463790;Antagonist
JMV641;BB1 receptor;f;;Rat;11463790;Antagonist
kuwanon H;BB1 receptor;f;;Rat;7646517;Antagonist
PD 165929;BB1 receptor;f;;Human;;Antagonist
PD 168368;BB1 receptor;f;;Rat;10454496;Antagonist
PD 168368;BB1 receptor;f;;Human;19463875;Antagonist
PD 176252;BB1 receptor;f;;Human;19463875;Antagonist
bombesin;BB2 receptor;f;;Human;21729729;Agonist
[Leu14]bombesin;BB2 receptor;f;;Human;21729729;Agonist
litorin;BB2 receptor;f;;Human;21729729;Agonist
bombesin;BB2 receptor;f;;Human;10454496|7838118;Full agonist
bombesin;BB2 receptor;f;;Mouse;7838118;Full agonist
bombesin;BB2 receptor;f;;Rat;7838118;Full agonist
(D-Ala11]bombesin;BB2 receptor;f;;Human;21729729;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB2 receptor;f;;Human;10454496|31743956;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB2 receptor;f;;Human;21729729;Full agonist
gastrin-releasing peptide;BB2 receptor;t;Human;Human;10454496|7838118|21729729;Full agonist
gastrin-releasing peptide;BB2 receptor;f;Human;Rat;7838118|9325344;Full agonist
gastrin-releasing peptide;BB2 receptor;f;Human;Mouse;10353842;Full agonist
gastrin-releasing peptide;BB2 receptor;f;Human;Human;19463875;Full agonist
gastrin releasing peptide(14-27) (human);BB2 receptor;t;;Human;21729729;Full agonist
[Leu8]-phyllolitorin;BB2 receptor;f;;Human;21729729;Full agonist
[Leu8]-phyllolitorin;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
[Leu8]-phyllolitorin;BB2 receptor;f;;Rat;21729729;Full agonist
litorin;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
litorin;BB2 receptor;f;;Rat;21729729;Full agonist
MK-5046;BB2 receptor;f;;Human;23892571;Full agonist
neuromedin B;BB2 receptor;t;Human|Mouse|Pig|Rat;Human;10454496|7838118;Full agonist
neuromedin B;BB2 receptor;f;Human|Mouse|Pig|Rat;Human;21729729|19463875;Full agonist
neuromedin B;BB2 receptor;f;Human|Mouse|Pig|Rat;Rat;10454496;Full agonist
neuromedin B;BB2 receptor;f;Human|Mouse|Pig|Rat;Mouse;7838118;Full agonist
neuromedin B (1-30) (human);BB2 receptor;f;;Human;21729729;Full agonist
neuromedin C;BB2 receptor;f;;Rat;21729729;Full agonist
neuromedin C;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
neuromedin C;BB2 receptor;t;;Human;21729729;Full agonist
[Phe13]bombesin;BB2 receptor;f;;Human;10454496;Full agonist
[Phe13]bombesin;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
phyllolitorin;BB2 receptor;f;;Human;21729729;Full agonist
phyllolitorin;BB2 receptor;f;;Rat;21729729;Full agonist
phyllolitorin;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
ranatensin;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
ranatensin;BB2 receptor;f;;Human;21729729;Full agonist
ranatensin;BB2 receptor;f;;Rat;21729729;Full agonist
Rhodei-litorin;BB2 receptor;f;;Rat;21729729;Full agonist
Rhodei-litorin;BB2 receptor;f;;Rat;9325344|10353842;Full agonist
Rhodei-litorin;BB2 receptor;f;;Human;21729729;Full agonist
[125I]GRP (human);BB2 receptor;f;;Human;;Full agonist
[125I][Tyr4]bombesin;BB2 receptor;f;;Human;7838118;Full agonist
[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14);BB2 receptor;f;;Human;8446610|19463875;Antagonist
[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14);BB2 receptor;f;;Mouse;8446610;Antagonist
Ac-GRP-(20-26)-methylester;BB2 receptor;f;;Human;19463875;Antagonist
Ac-GRP-(20-26)-methylester;BB2 receptor;f;;Mouse;2544588;Antagonist
AM-37;BB2 receptor;f;;Human;28785244;Antagonist
bantag-1;BB2 receptor;f;;Human;20096642|23892571;Antagonist
BAY86-7548;BB2 receptor;f;;Human;21729729|23935037;Antagonist
[D-Arg1,D-Trp7,9,Leu11]substance P;BB2 receptor;f;;Human;19463875;Antagonist
[D-Arg1,D-Trp7,9,Leu11]substance P;BB2 receptor;f;;Rat;10353842;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB2 receptor;f;;Human;19463875;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB2 receptor;f;;Human;19463875;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB2 receptor;f;;Human;10454496;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB2 receptor;f;;Rat;10353842;Antagonist
D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH2  ;BB2 receptor;f;;Human;19463875;Antagonist
[D-Phe12]bombesin;BB2 receptor;f;;Rat;10353842;Antagonist
[D-Phe6]bombesin(6-13)methyl ester;BB2 receptor;f;;Human;10454496;Antagonist
[D-Phe6]bombesin(6-13)methyl ester;BB2 receptor;f;;Rat;10353842;Antagonist
[D-Phe6]bombesin(6-13)methyl ester;BB2 receptor;f;;Human;19463875;Antagonist
[D-Phe6]bombesin(6-13)propylamide;BB2 receptor;f;;Human;19463875;Antagonist
[D-Phe6]bombesin(6-13)propylamide;BB2 receptor;f;;Rat;10353842;Antagonist
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14);BB2 receptor;f;;Human;19463875;Antagonist
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14);BB2 receptor;f;;Rat;10353842;Antagonist
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14);BB2 receptor;f;;Human;19463875;Antagonist
[D-Pro4,D-Trp7,9,10]substance P (4-11);BB2 receptor;f;;Human;19463875;Antagonist
[D-Pro4,D-Trp7,9,10]substance P (4-11);BB2 receptor;f;;Rat;10353842;Antagonist
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14);BB2 receptor;f;;Human;19463875;Antagonist
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14);BB2 receptor;f;;Human;19463875;Antagonist
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14);BB2 receptor;f;;Mouse;1726427;Antagonist
JMV594;BB2 receptor;f;;Mouse;10231715|11463790;Antagonist
JMV641;BB2 receptor;f;;Mouse;11463790;Antagonist
kuwanon H;BB2 receptor;f;;Mouse;7646517;Antagonist
[Leu14, ψ 13-14)]bombesin;BB2 receptor;f;;Human;19463875;Antagonist
[Leu14, ψ 13-14)]bombesin;BB2 receptor;f;;Human;7838118;Antagonist
PD 168368;BB2 receptor;f;;Human;19463875;Antagonist
PD 168368;BB2 receptor;f;;Human;10454496;Antagonist
PD 176252;BB2 receptor;f;;Human;19463875;Antagonist
PD 176252;BB2 receptor;f;;Human;9873586;Antagonist
PD 176252;BB2 receptor;f;;Human;19463875;Antagonist
[125I][D-Tyr6]bombesin-(6-13)-methyl ester;BB2 receptor;f;;Mouse;7684815;Antagonist
[125I][D-Tyr6]bombesin-(6-13)-methyl ester;BB2 receptor;f;;Rat;7684815;Antagonist
bag-1;BB3 receptor;f;;Human;20096642;Agonist
bag-2;BB3 receptor;f;;Human;20096642;Agonist
compound 17c [PMID: 25497965];BB3 receptor;f;;Human;25497965;Agonist
compound 22e [PMID: 20167483];BB3 receptor;f;;Human;20167483;Agonist
compound 8a [PMID: 24900283];BB3 receptor;f;;Human;24900283;Agonist
compound 9f [PMID: 24412111];BB3 receptor;f;;Human;24412111;Agonist
compound 9g [PMID: 24412111];BB3 receptor;f;;Human;24412111|26524625;Agonist
compound A [PMID: 28324017];BB3 receptor;f;;Rat;28324017;Agonist
compound A [PMID: 28324017];BB3 receptor;f;;Human;28324017;Agonist
MK-5046;BB3 receptor;f;;Human;23892571|24900253;Agonist
MK-7725;BB3 receptor;f;;Human;24900461;Agonist
NMU (104-114);BB3 receptor;f;;Human;31675498;Agonist
[3H]bag-2;BB3 receptor;f;;Mouse;20096642;Agonist
Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2;BB3 receptor;f;;Human;15635635|20438784|18006692;Full agonist
Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2;BB3 receptor;f;;Human;20438784|18006692;Full agonist
bag-1;BB3 receptor;f;;Rat;20096642;Full agonist
bag-1;BB3 receptor;f;;Mouse;20096642;Full agonist
bag-2;BB3 receptor;f;;Rat;20096642;Full agonist
bag-2;BB3 receptor;f;;Mouse;20096642;Full agonist
compound 21b [PMID: 12723954];BB3 receptor;f;;Human;12723954;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Rat;10454496;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Human;9325344;Full agonist
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Mouse;10454496;Full agonist
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Human;15102928;Full agonist
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Human;20438784|18006692;Full agonist
[D-Tyr6,(R)-APA11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Human;11112777;Full agonist
[D-Tyr6,(R)-APA11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Human;20438784|18006692;Full agonist
MK-5046;BB3 receptor;f;;Mouse;21036912;Full agonist
MK-5046;BB3 receptor;f;;Human;23892571|24900253;Full agonist
MK-5046;BB3 receptor;f;;Human;24900253;Full agonist
phenylacetyl-Ala,DTrp-phenthylamide;BB3 receptor;f;;Human;12212809|19580790;Full agonist
phenylacetyl-Ala,DTrp-phenthylamide;BB3 receptor;f;;Human;20438784;Full agonist
phenylacetyl-Ala,DTrp-phenthylamide;BB3 receptor;f;;Rat;19580790;Full agonist
phenylacetyl-Ala,DTrp-phenthylamide;BB3 receptor;f;;Mouse;19580790;Full agonist
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14);BB3 receptor;f;;Human;9325344|23892571;Full agonist
bantag-1;BB3 receptor;f;;Rat;20096642;Antagonist
bantag-1;BB3 receptor;f;;Human;20096642|23892571|30971479;Antagonist
bantag-1;BB3 receptor;f;;Mouse;20096642;Antagonist
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2;BB3 receptor;f;;Human;9325344|9765358|9593699;Antagonist
ML-18;BB3 receptor;f;;Human;25554218;Antagonist
belantamab mafodotin;B cell maturation antigen;f;;Human;;Binding
APRIL;B cell maturation antigen;t;Human;Human;;None
BAFF;B cell maturation antigen;t;Human;Human;;None
ABT-737;BCL2 apoptosis regulator;f;;Human;17256834;Antagonist
navitoclax;BCL2 apoptosis regulator;f;;Human;18841882;Antagonist
obatoclax;BCL2 apoptosis regulator;f;;Human;29407973;Antagonist
venetoclax;BCL2 apoptosis regulator;f;;Human;23291630;Antagonist
ABT-737;Bcl-2-like 1;f;;Human;17256834;Antagonist
navitoclax;Bcl-2-like 1;f;;Human;18841882;Antagonist
obatoclax;Bcl-2-like 1;f;;Human;29407973;Antagonist
venetoclax;Bcl-2-like 1;f;;Human;23291630;Antagonist
A-1331852;Bcl-2-like 1;f;;Human;;Inhibition
ABT-737;Bcl-2-like 2;f;;Human;17256834;Antagonist
venetoclax;Bcl-2-like 2;f;;Human;23291630;Antagonist
compound 8c [PMID: 28760529];BCL6 transcription repressor;f;;Human;28760529;Binding
compound 8c [PMID: 28760529];BCL6 transcription repressor;f;;Human;28760529;Binding
FX1;BCL6 transcription repressor;f;;Human;27482887;Binding
balanol;beta adrenergic receptor kinase 1;f;;Human;20128603;Inhibition
CCG258747;beta adrenergic receptor kinase 1;f;;Human;32234810;Inhibition
compound 101 [PMID: 21596927];beta adrenergic receptor kinase 1;f;;Human;21596927;Inhibition
compound 1o [PMID: 24210504];beta adrenergic receptor kinase 1;f;;Human;24210504;Inhibition
balanol;beta adrenergic receptor kinase 2;f;;Human;20128603;Inhibition
compound 101 [PMID: 21596927];beta adrenergic receptor kinase 2;f;;Human;21596927;Inhibition
AZ3971;beta-secretase 1;f;;Human;;Competitive
AZ-4217;beta-secretase 1;f;;Human;23761903;Competitive
AZD3839;beta-secretase 1;f;;Human;23048024;Competitive
compound 11d  [PMID: 23981898];beta-secretase 1;f;;Human;23981898;Competitive
compound 16 [PMID: 23412139];beta-secretase 1;f;;Human;23412139;Competitive
compound 2 [PMID: 22911925];beta-secretase 1;f;;Human;22911925;Competitive
lanabecestat;beta-secretase 1;f;;Human;24900397;Competitive
LY2811376;beta-secretase 1;f;;Human;22090477;Competitive
LY2886721;beta-secretase 1;f;;Human;;Competitive
oxazine 89;beta-secretase 1;f;;Human;23590342;Competitive
verubecestat;beta-secretase 1;f;;Human;;Competitive
AM-6494;beta-secretase 1;f;;Rat;31589043;Inhibition
AM-6494;beta-secretase 1;f;;Human;31589043;Inhibition
AM-6494;beta-secretase 1;f;;Mouse;31589043;Inhibition
AMG-8718;beta-secretase 1;f;;Human;25363711;Inhibition
atabecestat;beta-secretase 1;f;;Human;;Inhibition
Compound 12 [PMID:28626832];beta-secretase 1;f;;Human;28626832;Inhibition
compound 13 [PMID: 23412139];beta-secretase 1;f;;Human;23412139;Inhibition
compound 15 [PMID: 25699151];beta-secretase 1;f;;Human;25699151;Inhibition
compound 3l [PMID: 30637955];beta-secretase 1;f;;Human;30637955;Inhibition
compound 9 [PMID: 26937601];beta-secretase 1;f;;Human;26937601;Inhibition
compound J [PMID: 21907142];beta-secretase 1;f;;Human;21907142;Inhibition
elenbecestat;beta-secretase 1;f;;Human;;Inhibition
example 2 [WO2013004676];beta-secretase 1;f;;Human;24900681;Inhibition
NB-360;beta-secretase 1;f;;Human;26336937;Inhibition
PF-06684511;beta-secretase 1;f;;Human;29356535;Inhibition
PF-06751979;beta-secretase 1;f;;Human;29613789;Inhibition
RO5508887;beta-secretase 1;f;;Human;25164658;Inhibition
TAK-070;beta-secretase 1;f;;Human;20720123;Non-competitive
AM-6494;beta-secretase 2;f;;Human;31589043;Inhibition
compound 3l [PMID: 30637955];beta-secretase 2;f;;Human;30637955;Inhibition
compound 3 [PMID: 27347366];beta-secretase 2;f;;Human;27347366;Inhibition
compound J [PMID: 21907142];beta-secretase 2;f;;Human;21907142;Inhibition
example 20 [WO2010128058];beta-secretase 2;f;;Human;;Inhibition
example 2 [WO2013004676];beta-secretase 2;f;;Human;24900681;Inhibition
example 41 [WO2012028563];beta-secretase 2;f;;Human;;Inhibition
example 92 [WO2012095521];beta-secretase 2;f;;Human;;Inhibition
example 98 [WO2011020806];beta-secretase 2;f;;Human;23506624;Inhibition
hydroxyethylamine transition-state inhibitor 1;beta-secretase 2;f;;Human;16305800;Inhibition
NB-360;beta-secretase 2;f;;Human;26336937;Inhibition
RO5508887;beta-secretase 2;f;;Human;25164658;Inhibition
verubecestat;beta-secretase 2;f;;Human;;Inhibition
abediterol;β1-adrenoceptor;f;;Human;22588259;Agonist
(-)-adrenaline;β1-adrenoceptor;t;;Human;2849109|14730417;Agonist
arformoterol;β1-adrenoceptor;f;;Human;20655218;Agonist
indacaterol;β1-adrenoceptor;f;;Human;22932315;Agonist
mirabegron;β1-adrenoceptor;f;;Human;17293563;Agonist
(-)-noradrenaline;β1-adrenoceptor;t;;Human;2849109|14730417;Agonist
(-)-Ro 363;β1-adrenoceptor;f;;Human;9117106;Agonist
solabegron;β1-adrenoceptor;f;;Human;16640337;Agonist
isoprenaline;β1-adrenoceptor;f;;Human;8982677|2849109;Full agonist
noradrenaline;β1-adrenoceptor;t;;Human;2849109;Full agonist
(±)-adrenaline;β1-adrenoceptor;f;;Human;2849109;Full agonist
T-0509;β1-adrenoceptor;f;;Human;8982677;Full agonist
CGP 12177;β1-adrenoceptor;f;;Human;10079020;Partial agonist
denopamine;β1-adrenoceptor;f;;Human;10531390|7902433;Partial agonist
dobutamine;β1-adrenoceptor;f;;Human;10531390;Partial agonist
pindolol;β1-adrenoceptor;f;;Human;17804228;Partial agonist
prenalterol;β1-adrenoceptor;f;;Human;10531390|2564629;Partial agonist
[3H](-)CGP 12177;β1-adrenoceptor;f;;Human;15060759;Partial agonist
xamoterol;β1-adrenoceptor;f;;Human;10531390;Partial agonist
acebutolol;β1-adrenoceptor;f;;Human;;Antagonist
atenolol;β1-adrenoceptor;f;;Human;15060759|10079020|15655528;Antagonist
betaxolol;β1-adrenoceptor;f;;Human;10079020;Antagonist
bupranolol;β1-adrenoceptor;f;;Human;10079020|10411574;Antagonist
carvedilol;β1-adrenoceptor;f;;Human;10411574;Antagonist
CGP 12177;β1-adrenoceptor;f;;Human;15060759|15655528;Antagonist
CGP 20712A;β1-adrenoceptor;f;;Human;10079020|15655528|10411574;Antagonist
cicloprolol;β1-adrenoceptor;f;;Human;10079020;Antagonist
esmolol;β1-adrenoceptor;f;;Human;;Antagonist
H87/07;β1-adrenoceptor;f;;Human;10079020;Antagonist
labetalol;β1-adrenoceptor;f;;Human;;Antagonist
levobetaxolol;β1-adrenoceptor;f;;Human;11572462;Antagonist
levobunolol;β1-adrenoceptor;f;;Human;;Antagonist
LK 204-545;β1-adrenoceptor;f;;Human;10079020;Antagonist
metoprolol;β1-adrenoceptor;f;;Human;10079020|15655528|10411574|14730417;Antagonist
nadolol;β1-adrenoceptor;f;;Human;10411574;Antagonist
nebivolol;β1-adrenoceptor;f;;Human;21172342;Antagonist
nebivolol;β1-adrenoceptor;f;;Rabbit;2462161;Antagonist
NIHP;β1-adrenoceptor;f;;Human;10079020;Antagonist
NIP;β1-adrenoceptor;f;;Human;10079020;Antagonist
practolol;β1-adrenoceptor;f;;Human;10079020|15655528;Antagonist
propafenone;β1-adrenoceptor;f;;Human;;Antagonist
(-)-propranolol;β1-adrenoceptor;f;;Human;15060759|10079020|15655528;Antagonist
sotalol;β1-adrenoceptor;f;;Human;;Antagonist
SR59230A;β1-adrenoceptor;f;;Human;10411574;Antagonist
[125I]ICYP;β1-adrenoceptor;f;;Human;8982677|10079020|10531390;Antagonist
[125I](-)ICYP;β1-adrenoceptor;f;;Human;8982677|10079020|15037517;Antagonist
[3H](-)CGP 12177;β1-adrenoceptor;f;;Human;15060759|15655528;Antagonist
arformoterol;β2-adrenoceptor;f;;Human;15324892;Agonist
fenoterol;β2-adrenoceptor;f;;Human;24454993;Agonist
formoterol;β2-adrenoceptor;f;;Human;20590599;Agonist
indacaterol;β2-adrenoceptor;f;;Human;22932315;Agonist
mirabegron;β2-adrenoceptor;f;;Human;17293563;Agonist
(-)-noradrenaline;β2-adrenoceptor;t;;Human;2849109|14730417;Agonist
olodaterol;β2-adrenoceptor;f;;Human;20371707;Agonist
orciprenaline;β2-adrenoceptor;f;;Human;19168263;Agonist
procaterol;β2-adrenoceptor;f;;Human;20590599;Agonist
ractopamine;β2-adrenoceptor;f;;Human;19245211;Agonist
solabegron;β2-adrenoceptor;f;;Human;16640337;Agonist
vilanterol;β2-adrenoceptor;f;;Human;20462258;Agonist
zinterol;β2-adrenoceptor;f;;Human;20590599;Agonist
abediterol;β2-adrenoceptor;f;;Human;22588259;Full agonist
(-)-adrenaline;β2-adrenoceptor;t;;Human;2849109|9295336|14730417;Full agonist
isoprenaline;β2-adrenoceptor;f;;Human;8982677;Full agonist
noradrenaline;β2-adrenoceptor;t;;Human;15102946;Full agonist
salmeterol;β2-adrenoceptor;f;;Human;20590599;Full agonist
ephedrine;β2-adrenoceptor;f;;Human;9295336;Partial agonist
levosalbutamol;β2-adrenoceptor;f;;Human;22182578;Partial agonist
pindolol;β2-adrenoceptor;f;;Human;17804228;Partial agonist
salbutamol;β2-adrenoceptor;f;;Human;10531390|15655528;Partial agonist
[3H]CGP12177;β2-adrenoceptor;f;;Human;12237261;Partial agonist
terbutaline;β2-adrenoceptor;f;;Human;15655528;Partial agonist
Zn2+;β2-adrenoceptor;t;;Human;12409304|11752207;Negative
AS408;β2-adrenoceptor;f;;None;32483378;None
Zn2+;β2-adrenoceptor;t;;Human;12409304|11752207;Positive
alprenolol;β2-adrenoceptor;f;;Human;15655528;Antagonist
atenolol;β2-adrenoceptor;f;;Human;10079020|15655528;Antagonist
betaxolol;β2-adrenoceptor;f;;Human;10079020;Antagonist
bupranolol;β2-adrenoceptor;f;;Human;10079020|10411574;Antagonist
butoxamine;β2-adrenoceptor;f;;Rat;1968985|6140042;Antagonist
butoxamine;β2-adrenoceptor;f;;Rat;15908513;Antagonist
carazolol;β2-adrenoceptor;f;;Human;18829308;Antagonist
carvedilol;β2-adrenoceptor;f;;Human;15655528|10411574;Antagonist
CGP 12177;β2-adrenoceptor;f;;Human;10079020|15655528;Antagonist
cicloprolol;β2-adrenoceptor;f;;Human;10079020;Antagonist
labetalol;β2-adrenoceptor;f;;Human;;Antagonist
levobetaxolol;β2-adrenoceptor;f;;Human;11572462;Antagonist
levobunolol;β2-adrenoceptor;f;;Human;;Antagonist
LK 204-545;β2-adrenoceptor;f;;Human;10079020;Antagonist
metoprolol;β2-adrenoceptor;f;;Human;10079020;Antagonist
nadolol;β2-adrenoceptor;f;;Human;15655528|10411574;Antagonist
nebivolol;β2-adrenoceptor;f;;Human;21172342;Antagonist
NIHP;β2-adrenoceptor;f;;Human;10079020;Antagonist
NIP;β2-adrenoceptor;f;;Human;10079020;Antagonist
propafenone;β2-adrenoceptor;f;;Human;;Antagonist
propranolol;β2-adrenoceptor;f;;Human;10079020|10531390|15655528|12920204;Antagonist
sotalol;β2-adrenoceptor;f;;Human;;Antagonist
SR59230A;β2-adrenoceptor;f;;Human;10411574;Antagonist
[125I]ICYP;β2-adrenoceptor;f;;Human;8982677|10079020;Antagonist
timolol;β2-adrenoceptor;f;;Human;15655528;Antagonist
ICI 118551;β2-adrenoceptor;f;;Human;10079020|15655528|12920204;Inverse agonist
abediterol;β3-adrenoceptor;f;;Human;22588259;Agonist
(-)-adrenaline;β3-adrenoceptor;t;;Human;14730417;Agonist
CL316243;β3-adrenoceptor;f;;Mouse;17717109;Agonist
CL316243;β3-adrenoceptor;f;;Human;11249148;Agonist
CL316243;β3-adrenoceptor;f;;Mouse;17717109|16601951;Agonist
L742791;β3-adrenoceptor;f;;Human;9873496;Agonist
mirabegron;β3-adrenoceptor;f;;Human;17293563;Agonist
SB251023;β3-adrenoceptor;f;;Mouse;11959793;Agonist
solabegron;β3-adrenoceptor;f;;Human;16640337;Agonist
vibegron;β3-adrenoceptor;f;;Human;26709102;Agonist
vibegron;β3-adrenoceptor;f;;Monkey;26709102;Agonist
vibegron;β3-adrenoceptor;f;;Rat;26709102;Agonist
vibegron;β3-adrenoceptor;f;;Dog;26709102;Agonist
amibegron;β3-adrenoceptor;f;;Human;7903415;Full agonist
BRL 37344;β3-adrenoceptor;f;;Mouse;8719421;Full agonist
BRL 37344;β3-adrenoceptor;f;;Rat;8719421;Full agonist
BRL 37344;β3-adrenoceptor;f;;Human;8719421|7903415|7912272|14730417;Full agonist
carazolol;β3-adrenoceptor;f;;Mouse;8719421;Full agonist
carazolol;β3-adrenoceptor;f;;Rat;8719421;Full agonist
carazolol;β3-adrenoceptor;f;;Human;8719421;Full agonist
isoprenaline;β3-adrenoceptor;f;;Rat;8719421;Full agonist
isoprenaline;β3-adrenoceptor;f;;Mouse;8719421|14744619;Full agonist
isoprenaline;β3-adrenoceptor;f;;Human;8982677|9131260|8719421|9117106|14730417|14744619;Full agonist
L 755507;β3-adrenoceptor;f;;Human;20590599;Full agonist
(-)-noradrenaline;β3-adrenoceptor;t;;Mouse;14744619;Full agonist
(-)-noradrenaline;β3-adrenoceptor;t;;Rat;14744619;Full agonist
(-)-noradrenaline;β3-adrenoceptor;t;;Human;9131260|14730417|14744619;Full agonist
(±)-adrenaline;β3-adrenoceptor;t;;Mouse;8719421;Full agonist
(±)-adrenaline;β3-adrenoceptor;t;;Human;8719421|7903415|14730417;Full agonist
(±)-adrenaline;β3-adrenoceptor;t;;Rat;8719421;Full agonist
CGP 12177;β3-adrenoceptor;f;;Human;10079020|8719421|7903415|9117106;Partial agonist
CGP 12177;β3-adrenoceptor;f;;Mouse;8719421;Partial agonist
CGP 12177;β3-adrenoceptor;f;;Rat;8719421;Partial agonist
[125I]ICYP;β3-adrenoceptor;f;;Human;8982677|10079020|9131260|9117106|14744619;Partial agonist
[125I]ICYP;β3-adrenoceptor;f;;Mouse;14744619;Partial agonist
[125I]ICYP;β3-adrenoceptor;f;;Rat;14744619;Partial agonist
bupranolol;β3-adrenoceptor;f;;Human;10079020|10411574|8719421|7903415;Antagonist
CGP 20712A;β3-adrenoceptor;f;;Human;10079020|15655528|10411574|8719421;Antagonist
ICI 118551;β3-adrenoceptor;f;;Human;10079020|15655528|8719421|14730417;Antagonist
L748328;β3-adrenoceptor;f;;Human;10411574;Antagonist
L-748337;β3-adrenoceptor;f;;Human;10411574;Antagonist
levobunolol;β3-adrenoceptor;f;;Mouse;14744619;Antagonist
levobunolol;β3-adrenoceptor;f;;Human;14744619;Antagonist
levobunolol;β3-adrenoceptor;f;;Rat;14744619;Antagonist
nadolol;β3-adrenoceptor;f;;Human;10411574;Antagonist
nebivolol;β3-adrenoceptor;f;;Human;21172342;Antagonist
propranolol;β3-adrenoceptor;f;;Mouse;14744619;Antagonist
propranolol;β3-adrenoceptor;f;;Rat;14744619;Antagonist
propranolol;β3-adrenoceptor;f;;Human;10079020|14744619;Antagonist
SR59230A;β3-adrenoceptor;f;;Human;10411574|14730417|8730727;Antagonist
tertatolol;β3-adrenoceptor;f;;Human;14744619;Antagonist
tertatolol;β3-adrenoceptor;f;;Rat;14744619;Antagonist
tertatolol;β3-adrenoceptor;f;;Mouse;14744619;Antagonist
LU32-176B;BGT1;f;;Mouse;15550575;Inhibition
NNC052090;BGT1;f;;Mouse;9134205;Inhibition
(R)-EF-1520;BGT1;f;;Human;;Inhibition
(R/S) EF-1500;BGT1;f;;Human;;Inhibition
(S)-EF-1520;BGT1;f;;Human;;Inhibition
acalabrutinib;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
CEP-11981;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;22148921;Inhibition
compound 25 [PMID: 31260299];BLK proto-oncogene, Src family tyrosine kinase;f;;Human;31260299;Inhibition
compound 2 [PMID: 15546730];BLK proto-oncogene, Src family tyrosine kinase;f;;Human;15546730;Inhibition
compound 31 [PMID: 24915291];BLK proto-oncogene, Src family tyrosine kinase;f;;Human;24915291;Inhibition
compound 38 [PMID: 24915291];BLK proto-oncogene, Src family tyrosine kinase;f;;Human;24915291;Inhibition
compound 9 [PMID: 26006010];BLK proto-oncogene, Src family tyrosine kinase;f;;Human;26006010;Inhibition
eCF506;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;27115835;Inhibition
ibrutinib;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
ibrutinib;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;22394077;Inhibition
PRN694;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;25593320;Inhibition
WZ4002;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;20033049;Inhibition
ZAK inhibitor 6p;BLK proto-oncogene, Src family tyrosine kinase;f;;Human;31244114;Inhibition
12R-HETE;BLT1 receptor;t;;Human;9177352;Full agonist
20-hydroxy-LTB4;BLT1 receptor;t;;Human;9177352;Full agonist
LTB4;BLT1 receptor;t;;Human;;Full agonist
[3H]LTB4;BLT1 receptor;f;;Rat;10471406;Full agonist
[3H]LTB4;BLT1 receptor;f;;Mouse;9743525;Full agonist
[3H]LTB4;BLT1 receptor;f;;Human;9177352;Full agonist
BIIL 260;BLT1 receptor;f;;Human;11259574|17170051;Antagonist
BIIL 260;BLT1 receptor;f;;Human;11259574|17170051;Antagonist
CP105696;BLT1 receptor;f;;Human;7714764;Antagonist
CP-195543;BLT1 receptor;f;;Human;9618393;Antagonist
CP-195543;BLT1 receptor;f;;Human;9618393;Antagonist
etalocib;BLT1 receptor;f;;Human;9862783;Antagonist
etalocib;BLT1 receptor;f;;Human;9862783;Antagonist
LY255283;BLT1 receptor;f;;Human;1659282;Antagonist
ONO-4057;BLT1 receptor;f;;Human;1332129;Antagonist
ONO-4057;BLT1 receptor;f;;Human;1332129;Antagonist
RO5101576;BLT1 receptor;f;;Human;20214997;Antagonist
SC-41930;BLT1 receptor;f;;Human;7786309;Antagonist
SC-41930;BLT1 receptor;f;;Human;7786309;Antagonist
[3H]CGS23131;BLT1 receptor;f;;Human;1320692;Antagonist
U75302;BLT1 receptor;f;;Human;10513580;Antagonist
12-hydroxyheptadecatrienoic acid;BLT2 receptor;t;;Human;18378794;Full agonist
12-hydroxyheptadecatrienoic acid;BLT2 receptor;t;;Human;18378794;Full agonist
CAY10583;BLT2 receptor;f;;Mouse;15866883;Full agonist
CAY10583;BLT2 receptor;f;;Human;15866883;Full agonist
12-epi LTB4;BLT2 receptor;t;;Human;11278893;Partial agonist
12S-HETE;BLT2 receptor;t;;Human;11278893;Partial agonist
15S-HETE;BLT2 receptor;t;;Human;11278893;Partial agonist
CP-195543;BLT2 receptor;f;;Human;11278893;Partial agonist
LTB4;BLT2 receptor;t;;Human;18378794;Partial agonist
LTB4;BLT2 receptor;t;;Human;18378794;Partial agonist
LTB4;BLT2 receptor;t;;Human;10934230;Partial agonist
CP-195543;BLT2 receptor;f;;Human;11278893;Antagonist
LY255283;BLT2 receptor;f;;Human;11278893|1316967;Antagonist
ZK-158252;BLT2 receptor;f;;Human;11278893;Antagonist
[3H]LTB4;BLT2 receptor;f;;Human;;None
baricitinib;BMP2 inducible kinase;f;;Human;32113509;Inhibition
compound 5m [PMID: 20483621];BMP2 inducible kinase;f;;Human;20483621;Inhibition
acalabrutinib;BMX non-receptor tyrosine kinase;f;;Human;26641137;Inhibition
BMX-IN-1;BMX non-receptor tyrosine kinase;f;;Human;23594111;Inhibition
compound 31 [PMID: 24915291];BMX non-receptor tyrosine kinase;f;;Human;24915291;Inhibition
compound 38 [PMID: 24915291];BMX non-receptor tyrosine kinase;f;;Human;24915291;Inhibition
compound 9 [PMID: 26006010];BMX non-receptor tyrosine kinase;f;;Human;26006010;Inhibition
ibrutinib;BMX non-receptor tyrosine kinase;f;;Human;22394077;Inhibition
ibrutinib;BMX non-receptor tyrosine kinase;f;;Human;26641137;Inhibition
PRN694;BMX non-receptor tyrosine kinase;f;;Human;25593320;Inhibition
ZYBT1;BMX non-receptor tyrosine kinase;f;;Human;32790160;Inhibition
compound 2 [PMID: 11934595];bone morphogenetic protein 1;f;;Human;11934595;Inhibition
BMP-10;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-2;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-4;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-5;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-6;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-7;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-8A;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-8B;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMP-9;Bone morphogenetic protein receptors;t;Human;Human;;Agonist
BMS-986165;bone morphogenetic protein receptor type 2;f;;Human;31318208;Inhibition
compound 13a [PMID: 23639540];bone morphogenetic protein receptor type 2;f;;Human;23639540;Inhibition
compound 13a [PMID: 23639540];bone morphogenetic protein receptor type IA;f;;Human;23639540;Inhibition
compound 13d [PMID: 23639540];bone morphogenetic protein receptor type IA;f;;Human;23639540;Inhibition
compound 13r [PMID: 23639540];bone morphogenetic protein receptor type IA;f;;Human;23639540;Inhibition
LDN-214117;bone morphogenetic protein receptor type IA;f;;Human;25101911;Inhibition
ML347;bone morphogenetic protein receptor type IA;f;;Human;23639540;Inhibition
compound 13a [PMID: 23639540];bone morphogenetic protein receptor type IB;f;;Human;23639540;Inhibition
compound 13d [PMID: 23639540];bone morphogenetic protein receptor type IB;f;;Human;23639540;Inhibition
compound 13r [PMID: 23639540];bone morphogenetic protein receptor type IB;f;;Human;23639540;Inhibition
galunisertib;bone morphogenetic protein receptor type IB;f;;Human;29467918;Inhibition
agerafenib;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;22168626;Inhibition
AZ628;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;18020980;Inhibition
CCT196969;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;25500121;Inhibition
CCT241161;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;25500121;Inhibition
CHIR-265;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;22037378;Inhibition
compound 2 [PMID: 26061392];B-Raf proto-oncogene, serine/threonine kinase;f;;Human;26061392;Inhibition
dabrafenib;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;;Inhibition
GDC-0879;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;22037378|18676143;Inhibition
L779450;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;16260133;Inhibition
lifirafenib;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;26208524;Inhibition
LXH254;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;31059256;Inhibition
LY3009120;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;26343583;Inhibition
PLX-4720;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;22037378;Inhibition
PLX-4720;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;18287029;Inhibition
PLX8394;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;26466569;Inhibition
regorafenib;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;22222036;Inhibition
SB590885;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;17145850;Inhibition
sorafenib;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;15466206;Inhibition
SZM594;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;30825190;Inhibition
TAK-580;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;28082416;Inhibition
TAK-632;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;23906342;Inhibition
TAK-632;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;23906342;Inhibition
vemurafenib;B-Raf proto-oncogene, serine/threonine kinase;f;;Human;22808911;Inhibition
compound 27 [PMID: 26938474];Branched chain amino acid transaminase 2;f;;Human;26938474;Inhibition
compound 42 [PMID: 26938474];Branched chain amino acid transaminase 2;f;;Human;26938474;Inhibition
BAZ2-ICR;bromodomain adjacent to zinc finger domain 2A;f;;Human;25719566;Inhibition
GSK2801;bromodomain adjacent to zinc finger domain 2A;f;;Human;;Inhibition
GSK2801;bromodomain adjacent to zinc finger domain 2B;f;;Human;;Binding
BAZ2-ICR;bromodomain adjacent to zinc finger domain 2B;f;;Human;25719566;Inhibition
compound 1 [PMID: 25719566];bromodomain adjacent to zinc finger domain 2B;f;;Human;25719566;Inhibition
compound 7 [PMID: 25719566];bromodomain adjacent to zinc finger domain 2B;f;;Human;25719566;Inhibition
compound 1 [PMID: 25408830];bromodomain and PHD finger containing 1;f;;Human;25408830;Binding
compound 2 [PMID: 25408830];bromodomain and PHD finger containing 1;f;;Human;25408830;Binding
compound 34 [PMID: 25974391];bromodomain and PHD finger containing 1;f;;Human;25974391;Binding
compound 3 [PMID: 25408830];bromodomain and PHD finger containing 1;f;;Human;25408830;Binding
NI-57;bromodomain and PHD finger containing 1;f;;Human;;Binding
OF-1;bromodomain and PHD finger containing 1;f;;Human;;Binding
PFI-4;bromodomain and PHD finger containing 1;f;;Human;;Binding
NI-57;bromodomain and PHD finger containing 3;f;;Human;;Binding
OF-1;bromodomain and PHD finger containing 3;f;;Human;;Binding
NI-57;bromodomain containing 1;f;;Human;;Binding
BAY-299;bromodomain containing 1;f;;Human;;Inhibition
RVX 208;bromodomain containing 2;f;;Human;24391744;Antagonist
ARV-771;bromodomain containing 2;f;;Human;27274052;Inhibition
BIC1;bromodomain containing 2;f;;Human;21513886;Inhibition
compound 36 [PMID: 24000170];bromodomain containing 2;f;;Human;24000170;Inhibition
compound 38 [PMID: 24000170];bromodomain containing 2;f;;Human;24000170;Inhibition
compound 4d [PMID: 21851057];bromodomain containing 2;f;;Human;21851057;Inhibition
ET bromodomain inhibitor;bromodomain containing 2;f;;Human;25323695;Inhibition
GW841819X;bromodomain containing 2;f;;Human;21568322;Inhibition
I-BET151;bromodomain containing 2;f;;Human;21964340;Inhibition
LY 294002;bromodomain containing 2;f;;Human;24533473;Inhibition
ME bromodomain inhibitor;bromodomain containing 2;f;;Human;25323695;Inhibition
molibresib;bromodomain containing 2;f;;Human;21568322;Inhibition
XD14;bromodomain containing 2;f;;Human;24272870;Inhibition
RVX 208;bromodomain containing 3;f;;Human;24391744;Antagonist
ARV-771;bromodomain containing 3;f;;Human;27274052;Inhibition
compound 36 [PMID: 24000170];bromodomain containing 3;f;;Human;24000170;Inhibition
compound 38 [PMID: 24000170];bromodomain containing 3;f;;Human;24000170;Inhibition
GW841819X;bromodomain containing 3;f;;Human;21568322;Inhibition
I-BET151;bromodomain containing 3;f;;Human;21964340;Inhibition
LY 294002;bromodomain containing 3;f;;Human;24533473;Inhibition
molibresib;bromodomain containing 3;f;;Human;21568322;Inhibition
MS363;bromodomain containing 3;f;;Human;24144283;Inhibition
RVX 208;bromodomain containing 3;f;;Human;24248379;Inhibition
RVX 208;bromodomain containing 3;f;;Human;24248379;Inhibition
XD14;bromodomain containing 3;f;;Human;24272870;Inhibition
RVX 208;bromodomain containing 4;f;;Human;24391744;Antagonist
MZ1;bromodomain containing 4;f;;Human;28595007;Binding
ARV-771;bromodomain containing 4;f;;Human;27274052;Inhibition
BI-2536;bromodomain containing 4;f;;Human;24584101;Inhibition
BzT-7;bromodomain containing 4;f;;Human;22137933;Inhibition
colchicine;bromodomain containing 4;f;;Human;24272870;Inhibition
compound 11h [PMID: 29808961];bromodomain containing 4;f;;Human;29808961;Inhibition
compound 15 [Hay et al., 2013];bromodomain containing 4;f;;Human;;Inhibition
compound 1 [PMID: 25408830];bromodomain containing 4;f;;Human;25408830;Inhibition
compound 2 [PMID: 25408830];bromodomain containing 4;f;;Human;25408830;Inhibition
compound 36 [PMID: 24000170];bromodomain containing 4;f;;Human;24000170;Inhibition
compound 38 [PMID: 24000170];bromodomain containing 4;f;;Human;24000170;Inhibition
compound 3 [PMID: 25408830];bromodomain containing 4;f;;Human;25408830;Inhibition
compound 4d [PMID: 21851057];bromodomain containing 4;f;;Human;21851057;Inhibition
compound 6 [PMID: 30125504];bromodomain containing 4;f;;Human;30125504;Inhibition
compound 7d [PMID: 25703523];bromodomain containing 4;f;;Human;25703523;Inhibition
compound 9 [PMID: 23517011];bromodomain containing 4;f;;Human;23517011;Inhibition
CPI-0610;bromodomain containing 4;f;;Human;26815195;Inhibition
CPI-203;bromodomain containing 4;f;;Human;22509028;Inhibition
dBET6;bromodomain containing 4;f;;Human;28673542;Inhibition
dual BRD4/PLK1 inhibitor 23;bromodomain containing 4;f;;Human;30125504;Inhibition
fedratinib;bromodomain containing 4;f;;Human;24584101;Inhibition
GW841819X;bromodomain containing 4;f;;Human;21568322;Inhibition
I-BET151;bromodomain containing 4;f;;Human;21964340;Inhibition
isoxazole azepine compound 3;bromodomain containing 4;f;;Human;24900758;Inhibition
(+)-JQ1;bromodomain containing 4;f;;Human;20871596;Inhibition
LY 294002;bromodomain containing 4;f;;Human;24533473;Inhibition
mivebresib;bromodomain containing 4;f;;Human;;Inhibition
molibresib;bromodomain containing 4;f;;Human;21568322;Inhibition
molibresib;bromodomain containing 4;f;;Human;21568322;Inhibition
MS417;bromodomain containing 4;f;;Human;22645123;Inhibition
MS436;bromodomain containing 4;f;;Human;24144283;Inhibition
NHWD-870;bromodomain containing 4;f;;Human;32286255;Inhibition
N-methyl-2-pyrrolidone;bromodomain containing 4;f;;Human;24813887;Inhibition
PFI-1;bromodomain containing 4;f;;Human;23095041;Inhibition
XD1;bromodomain containing 4;f;;Human;24272870;Inhibition
XD14;bromodomain containing 4;f;;Human;24272870;Inhibition
BI-9564;bromodomain containing 7;f;;Human;;Inhibition
LP99;bromodomain containing 7;f;;Human;25864491;Inhibition
TP-472;bromodomain containing 7;f;;Human;;Inhibition
I-BRD9;bromodomain containing 9;f;;Human;25856009;Binding
BI-7273;bromodomain containing 9;f;;Human;26914985;Inhibition
BI-9564;bromodomain containing 9;f;;Human;;Inhibition
compound 50 [PMID: 24313754];bromodomain containing 9;f;;Human;24313754;Inhibition
LP99;bromodomain containing 9;f;;Human;25864491;Inhibition
TP-472;bromodomain containing 9;f;;Human;;Inhibition
dBRD9;bromodomain containing 9;f;;Human;28418626;Binding
dBRD9-A;bromodomain containing 9;f;;Human;30431433;Binding
MS363;bromodomain PHD finger transcription factor;f;;Human;24144283;Inhibition
(+)-JQ1;bromodomain testis associated;f;;Mouse;22901802;Inhibition
(+)-JQ1;bromodomain testis associated;f;;Human;22901802;Inhibition
XD14;bromodomain testis associated;f;;Human;24272870;Inhibition
CCT244747;BR serine/threonine kinase 1;f;;Human;23082860;Inhibition
CCT244747;BR serine/threonine kinase 2;f;;Human;23082860;Inhibition
SU6656;BR serine/threonine kinase 2;f;;Human;17850214;Inhibition
abivertinib;Bruton tyrosine kinase;f;;Human;27573423;Inhibition
acalabrutinib;Bruton tyrosine kinase;f;;Human;26641137;Inhibition
acalabrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
BIIB068;Bruton tyrosine kinase;f;;Human;32696648;Inhibition
BIIB068;Bruton tyrosine kinase;f;;Human;32696648;Inhibition
BIIB091;Bruton tyrosine kinase;f;;Human;;Inhibition
BMS-986142;Bruton tyrosine kinase;f;;Human;27583770;Inhibition
branebrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
BTK inhibitor 16 [PMID: 30122225];Bruton tyrosine kinase;f;;Human;30122225;Inhibition
BTK inhibitor 4b;Bruton tyrosine kinase;f;;Human;30216722;Inhibition
CGI1746;Bruton tyrosine kinase;f;;Human;21113169;Inhibition
CGI560;Bruton tyrosine kinase;f;;Human;22394077;Inhibition
CNX-774;Bruton tyrosine kinase;f;;Human;22621397;Inhibition
compound 25 [PMID: 31260299];Bruton tyrosine kinase;f;;Human;31260299;Inhibition
compound 2c [PMID: 24900538];Bruton tyrosine kinase;f;;Human;24900538;Inhibition
compound 31 [PMID: 24915291];Bruton tyrosine kinase;f;;Human;24915291;Inhibition
compound 36 [PMID: 21958547];Bruton tyrosine kinase;f;;Human;21958547;Inhibition
compound 38 [PMID: 24915291];Bruton tyrosine kinase;f;;Human;24915291;Inhibition
compound 9 [PMID: 26006010];Bruton tyrosine kinase;f;;Human;26006010;Inhibition
DD-03-171;Bruton tyrosine kinase;f;;Human;30545835;Inhibition
elsubrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
evobrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
example 3 [WO2016196840A1];Bruton tyrosine kinase;f;;Human;;Inhibition
fenebrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
GDC-0834;Bruton tyrosine kinase;f;;Human;25701252;Inhibition
ibrutinib;Bruton tyrosine kinase;f;;Human;17154430;Inhibition
ibrutinib;Bruton tyrosine kinase;f;;Human;26641137;Inhibition
ICP-022;Bruton tyrosine kinase;f;;Human;;Inhibition
LFM-A13;Bruton tyrosine kinase;f;;Human;10092645;Inhibition
poseltinib;Bruton tyrosine kinase;f;;Human;;Inhibition
PRN694;Bruton tyrosine kinase;f;;Human;25593320;Inhibition
remibrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
rilzabrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
RN486;Bruton tyrosine kinase;f;;Human;22228807;Inhibition
spebrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
tirabrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
vecabrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
WZ4002;Bruton tyrosine kinase;f;;Human;20033049;Inhibition
zanubrutinib;Bruton tyrosine kinase;f;;Human;;Inhibition
CHMFL-BTK-11;Bruton tyrosine kinase;f;;Human;28352114;Irreversible inhibition
ZYBT1;Bruton tyrosine kinase;f;;Human;32790160;Irreversible inhibition
ZYBT1;Bruton tyrosine kinase;f;;Human;32790160;Irreversible inhibition
bradykinin;B1 receptor;t;Human|Mouse|Rat;Rat;10422787;Full agonist
bradykinin;B1 receptor;t;Human|Mouse|Rat;Mouse;8856107;Full agonist
bradykinin;B1 receptor;t;Human|Mouse|Rat;Human;9111052;Full agonist
[des-Arg10]kallidin;B1 receptor;t;Human;Rat;10422787;Full agonist
[des-Arg10]kallidin;B1 receptor;t;Human;Mouse;8856107;Full agonist
[des-Arg10]kallidin;B1 receptor;t;Human;Human;9111052|10422787|9313952|8735629;Full agonist
[des-Arg11]T-kinin;B1 receptor;f;;Rat;10422787;Full agonist
[des-Arg11]T-kinin;B1 receptor;f;;Human;10422787;Full agonist
[des-Arg9]bradykinin;B1 receptor;t;Human|Mouse|Rat;Human;10422787|9313952;Full agonist
[des-Arg9]bradykinin;B1 receptor;t;Human|Mouse|Rat;Mouse;8856107;Full agonist
[des-Phe9,des-Arg10]kallidin;B1 receptor;f;;Human;9111052;Full agonist
[des-Pro8,des-Phe9,des-Arg10]kallidin;B1 receptor;f;;Human;9111052;Full agonist
kallidin;B1 receptor;f;Human;Mouse;8856107|8302267;Full agonist
kallidin;B1 receptor;t;Human;Human;9111052|10422787|9313952;Full agonist
kallidin;B1 receptor;f;Human;Rat;10422787;Full agonist
Lys-kallidin;B1 receptor;f;;Human;9111052;Full agonist
Met-Lys-bradykinin;B1 receptor;f;;Human;8063797;Full agonist
NG29;B1 receptor;f;;Human;26565554;Full agonist
[Sar,D-Phe8,des-Arg9]bradykinin;B1 receptor;f;;Rat;10422787;Full agonist
[Sar,D-Phe8,des-Arg9]bradykinin;B1 receptor;f;;Human;10422787;Full agonist
D-Lys0-[des-Arg10]kallidin;B1 receptor;f;;Human;9111052;Full agonist
[D-Lys1,des-Arg10]kallidin;B1 receptor;f;;Human;9111052;Full agonist
[3H]Lys-[des-Arg9]BK;B1 receptor;f;;Human;;Full agonist
T-kinin;B1 receptor;t;Human|Rat;Rat;10422787;Full agonist
T-kinin;B1 receptor;t;Human|Rat;Human;10422787;Full agonist
[Leu8,des-Arg9]bradykinin;B1 receptor;f;;Mouse;9276157;Partial agonist
Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin;B1 receptor;f;;Human;9276157;Antagonist
B-10356;B1 receptor;f;;Human;16368899;Antagonist
B-9430;B1 receptor;f;;Human;9276157|8856115;Antagonist
B-9430;B1 receptor;f;;Mouse;9276157;Antagonist
B-9858;B1 receptor;f;;Human;10422787|9276157|8995263;Antagonist
B-9858;B1 receptor;f;;Rat;10422787;Antagonist
B-9858;B1 receptor;f;;Mouse;9276157;Antagonist
B-9958;B1 receptor;f;;Human;16368899|9650825;Antagonist
chroman 28;B1 receptor;f;;Human;17243660;Antagonist
chroman 28;B1 receptor;f;;Rat;17243660;Antagonist
compound 11 [PMID: 12812482];B1 receptor;f;;Human;12812482;Antagonist
compound 11 [PMID: 12812482];B1 receptor;f;;Rat;12812482;Antagonist
compound 12 [PMID: 12723943];B1 receptor;f;;Rat;12723943;Antagonist
compound 12 [PMID: 12723943];B1 receptor;f;;Human;12723943;Antagonist
[des-Arg10]icatibant;B1 receptor;f;;Human;10422787|9313952;Antagonist
[des-Arg10]icatibant;B1 receptor;f;;Rat;10422787;Antagonist
[des-Arg10]icatibant;B1 receptor;f;;Mouse;8856107;Antagonist
icatibant;B1 receptor;f;;Rat;10422787;Antagonist
icatibant;B1 receptor;f;;Human;10422787|9313952;Antagonist
JMV1431;B1 receptor;f;;Human;10882364;Antagonist
[Leu8,des-Arg9]bradykinin;B1 receptor;f;;Mouse;8856107;Antagonist
[Leu8,des-Arg9]bradykinin;B1 receptor;f;;Human;9111052|8063797|10422787|9313952|9203620;Antagonist
[Leu8,des-Arg9]bradykinin;B1 receptor;f;;Rat;10422787;Antagonist
[Leu9,des-Arg10]kallidin;B1 receptor;f;;Human;9111052|9313952;Antagonist
[Leu9,des-Arg10]kallidin;B1 receptor;f;;Mouse;8856107;Antagonist
[Leu9,des-Arg10]kallidin;B1 receptor;f;;Human;8063797;Antagonist
NPC 17731;B1 receptor;f;;Human;8995263;Antagonist
NPC 18565;B1 receptor;f;;Human;8995263;Antagonist
NVP-SAA164;B1 receptor;f;;Human;15685199|15341478;Antagonist
PS020990;B1 receptor;f;;Human;10596850;Antagonist
R-715;B1 receptor;f;;Human;8901831;Antagonist
R-715;B1 receptor;f;;Mouse;9276157;Antagonist
R-715;B1 receptor;f;;Human;9276157;Antagonist
R-954;B1 receptor;f;;Human;24361511;Antagonist
SSR240612;B1 receptor;f;;Human;14747609;Antagonist
[3H]Lys-[Leu8][des-Arg9]BK;B1 receptor;f;;Human;;Antagonist
[125I]Hpp-desArg10HOE140;B1 receptor;f;;Human;;None
NG291;B2 receptor;f;;Human;23362191;Agonist
bradykinin;B2 receptor;t;Human|Mouse|Rat;Mouse;8302267;Full agonist
bradykinin;B2 receptor;t;Human|Mouse|Rat;Human;8302267|9203620;Full agonist
[des-Arg9]bradykinin;B2 receptor;t;Human|Mouse|Rat;Human;8302267;Full agonist
[des-Arg9]bradykinin;B2 receptor;t;Human|Mouse|Rat;Mouse;8302267;Full agonist
FR190997;B2 receptor;f;;Human;9224807;Full agonist
FR191413;B2 receptor;f;;Human;15139763;Full agonist
[Hyp3,Tyr(Me)8]BK;B2 receptor;f;;Human;;Full agonist
JMV1116;B2 receptor;f;;Rat;10514288;Full agonist
JMV1116;B2 receptor;f;;Human;10514288;Full agonist
kallidin;B2 receptor;t;Human;Human;8302267;Full agonist
kallidin;B2 receptor;f;Human;Mouse;8302267;Full agonist
labradimil;B2 receptor;f;;Rat;10514288|7965719;Full agonist
labradimil;B2 receptor;f;;Human;23362191;Full agonist
Met-Lys-bradykinin;B2 receptor;f;;Mouse;8302267;Full agonist
Met-Lys-bradykinin;B2 receptor;f;;Human;8302267;Full agonist
[Phe8,ψ(CH2-NH)Arg9]BK;B2 receptor;f;;Human;;Full agonist
[125I][Tyr8]bradykinin;B2 receptor;f;;Human;;Full agonist
[3H]BK (human, mouse, rat);B2 receptor;f;;Mouse;9333122;Full agonist
[Tyr8]bradykinin;B2 receptor;f;;Human;8302267;Full agonist
[Tyr8]bradykinin;B2 receptor;f;;Mouse;8302267;Full agonist
[des-Arg10]kallidin;B2 receptor;f;Human;Mouse;8302267;Partial agonist
anatibant;B2 receptor;f;;Human;10596852;Antagonist
anatibant;B2 receptor;f;;Rat;10596852;Antagonist
B-9430;B2 receptor;f;;Mouse;9276157;Antagonist
B-9430;B2 receptor;f;;Human;9276157|8856115;Antagonist
bradyzide;B2 receptor;f;;Rat;10694205;Antagonist
bradyzide;B2 receptor;f;;Human;10694205;Antagonist
compound 3 [PMID: 32636746];B2 receptor;f;;Human;32636746;Antagonist
FR167344;B2 receptor;f;;Human;9203620;Antagonist
FR173657;B2 receptor;f;;Human;9095082;Antagonist
FR173657;B2 receptor;f;;Human;9203620;Antagonist
icatibant;B2 receptor;f;;Human;10514288;Antagonist
icatibant;B2 receptor;f;;Mouse;8302267;Antagonist
icatibant;B2 receptor;f;;Human;8735629;Antagonist
icatibant;B2 receptor;f;;Rat;10694205;Antagonist
icatibant;B2 receptor;f;;Human;8302267|9203620;Antagonist
JMV1431;B2 receptor;f;;Human;10882364;Antagonist
NPC 17731;B2 receptor;f;;Human;8995263;Antagonist
NPC 18565;B2 receptor;f;;Human;8995263;Antagonist
NPC-349;B2 receptor;f;;Mouse;8302267;Antagonist
NPC-349;B2 receptor;f;;Human;8302267;Antagonist
NPC-567;B2 receptor;f;;Human;8302267;Antagonist
NPC-567;B2 receptor;f;;Mouse;8302267;Antagonist
[125I]-HPP-icatibant;B2 receptor;f;;Rat;11934804;Antagonist
[3H]NPC17731;B2 receptor;f;;Human;11379050|9651119;Antagonist
[Thi5,8,D-Phe7]bradykinin;B2 receptor;f;;Mouse;8302267;Antagonist
[Thi5,8,D-Phe7]bradykinin;B2 receptor;f;;Human;8302267;Antagonist
WIN 64338;B2 receptor;f;;Human;8197121|8394936;Antagonist
benzatropine;B0AT1;f;;Human;28176326;Inhibition
cinromide;B0AT1;f;;Human;30589598;Inhibition
inhibitor CB3;B0AT1;f;;Human;32180718;Inhibition
inhibitor E18;B0AT1;f;;Human;32180718;Inhibition
inhibitor E4;B0AT1;f;;Human;32180718;Inhibition
nimesulide;B0AT1;f;;Rat;24704252;Inhibition
loratadine;B0AT2;f;;Human;25318072;Inhibition
BAY-320;BUB1 mitotic checkpoint serine/threonine kinase;f;;Human;26885717;Inhibition
BAY-524;BUB1 mitotic checkpoint serine/threonine kinase;f;;Human;26885717;Inhibition
compound 2-1-1 [PMID: 24900824];BUB1 mitotic checkpoint serine/threonine kinase;f;;Human;24900824;Inhibition
compound 2-13-1 [PMID: 24900824];BUB1 mitotic checkpoint serine/threonine kinase;f;;Human;24900824;Inhibition
compound 2-3-1 [PMID: 24900824];BUB1 mitotic checkpoint serine/threonine kinase;f;;Human;24900824;Inhibition
compound 2-3-2 [PMID: 24900824];BUB1 mitotic checkpoint serine/threonine kinase;f;;Human;24900824;Inhibition
POM2-C-HMBP;butyrophilin subfamily 3 member A1;f;;Human;27271567;Binding
bambuterol;butyrylcholinesterase;f;;Human;12675140;Inhibition
physostigmine;butyrylcholinesterase;f;;Human;16570913;Inhibition
pyridostigmine;butyrylcholinesterase;f;;Human;20627738;Inhibition
rivastigmine;butyrylcholinesterase;f;;Human;16570913;Inhibition
tacrine;butyrylcholinesterase;f;;Human;18479118;Inhibition
albutensin A;C3a receptor;f;;Human;26297549;Agonist
C3a;C3a receptor;t;Human;Human;9476119;Agonist
C3a receptor agonist;C3a receptor;f;;Human;17459702;Agonist
casoxin C;C3a receptor;f;;Human;9145417|26297549;Agonist
compound 17 [PMID: 24257095];C3a receptor;f;;Human;24257095;Agonist
Eu-DTPA-hC3a;C3a receptor;f;;Human;28562031;Agonist
oryzatensin;C3a receptor;f;;Human;7804141|11179594|26297549;Agonist
Ac-RHYPLWR;C3a receptor;f;;Human;25446428;Full agonist
C3a;C3a receptor;t;Human;Human;20527893;Full agonist
compound 21 [PMID: 25259874];C3a receptor;f;;Human;25259874;Full agonist
E7;C3a receptor;f;;Human;9476119;Full agonist
FLPLAR;C3a receptor;f;;Human;20527893;Full agonist
[125I]C3a (human);C3a receptor;f;;Human;10092660;Full agonist
WWGKKYRASKLGLAR;C3a receptor;f;;Human;20527893;Full agonist
WWGKKYRASKLGLAR;C3a receptor;f;;Human;20527893;Full agonist
YSFKPMPLaR;C3a receptor;f;;Human;20527893;Full agonist
SQ007-5;C3a receptor;f;;Human;22500977;Partial agonist
compound 4 [PMID: 25259874];C3a receptor;f;;Human;25259874;Antagonist
FLTChaAR;C3a receptor;f;;Human;20527893;Antagonist
JR14a;C3a receptor;f;;Human;31910011;Antagonist
SB290157;C3a receptor;f;;Human;11342658;Antagonist
lactomedin 1;C5a1 receptor;f;;Human;26297549;Agonist
YSFKPMPLaR;C5a1 receptor;f;;Human;11403208;Agonist
C5a;C5a1 receptor;t;Human;Human;15661745|10602324;Full agonist
C5a;C5a1 receptor;f;Human;Human;10602324|9881961;Full agonist
N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H;C5a1 receptor;f;;Human;1732540|7930622;Full agonist
ribosomal protein S19;C5a1 receptor;t;Human;Human;11107061;Full agonist
[125I]C5a (human);C5a1 receptor;f;;Human;4020139;Full agonist
YSFKPMPLaR;C5a1 receptor;f;;Human;9083476;Full agonist
NDT9513727;C5a1 receptor;f;;Human;18753409;Inverse agonist
C5a des-Arg;C5a1 receptor;t;Human;Human;15661745|11773063;Partial agonist
A8Δ71-73;C5a1 receptor;f;;Mouse;14570896;Antagonist
AcPhe-Orn-Pro-D-Cha-Trp-Arg;C5a1 receptor;f;;Human;9719594;Antagonist
avacopan;C5a1 receptor;f;;Human;27768695;Antagonist
C089;C5a1 receptor;f;;Human;7930622;Antagonist
CHIPS;C5a1 receptor;f;;Human;15153520;Antagonist
DF2593A;C5a1 receptor;f;;Human;25385614;Antagonist
N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H;C5a1 receptor;f;;Human;7930622;Antagonist
JPE1375;C5a1 receptor;f;;Human;16876401;Antagonist
L-156,602;C5a1 receptor;f;;Human;7768675;Antagonist
NDT9520492;C5a1 receptor;f;;Human;16230349;Antagonist
PMX205;C5a1 receptor;f;;Human;15044616;Antagonist
PMX53;C5a1 receptor;f;;Human;11403208|15044616;Antagonist
RPR121154;C5a1 receptor;f;;Human;;Antagonist
W54011;C5a1 receptor;f;;Human;12384495;Antagonist
C5a des-Arg;C5a2 receptor;t;Human;Human;11773063|12899627;Agonist
C5a hexapeptide analogue;C5a2 receptor;f;;Human;12899627;Agonist
P32 [PMID: 27108698];C5a2 receptor;f;;Human;27108698;Biased agonist
P59 [PMID: 27108698];C5a2 receptor;f;;Human;27108698;Biased agonist
C5a;C5a2 receptor;t;Human;Human;11773063|12899627;Full agonist
C5a;C5a2 receptor;t;Human;Human;;Full agonist
C5a des-Arg;C5a2 receptor;t;Human;Human;;Full agonist
[125I]C5a (human);C5a2 receptor;f;;Human;;Full agonist
A8Δ71-73;C5a2 receptor;f;;Mouse;14570896;Antagonist
CHIPS-(28-149);C5a2 receptor;f;;Human;17258808;Antagonist
Ca2+;CaCC;t;;Human;;None
9-anthroic acid;CaCC;f;;Human;;None
DCDPC;CaCC;f;;Human;;None
DIDS;CaCC;f;;Human;;None
flufenamic acid;CaCC;f;;Human;;None
fluoxetine;CaCC;f;;Human;;None
Ins(3,4,5,6)P4;CaCC;t;;Human;;None
mibefradil;CaCC;f;;Human;;None
niflumic acid;CaCC;f;;Human;;None
NPPB;CaCC;f;;Human;;None
SITS;CaCC;f;;Human;;None
tannic acid;CaCC;f;;Human;;None
Ani9;CaCC;f;;Human;27219012;Inhibition
crofelemer;CaCC;f;;Human;19808995;Inhibition
bosutinib;calcium/calmodulin dependent protein kinase ID;f;;Human;19039322;Inhibition
KN-93;calcium/calmodulin-dependent protein kinase II alpha subunit;f;;Rat;11806708;Inhibition
KN-93;calcium/calmodulin-dependent protein kinase II alpha subunit;f;;Mouse;21292482|1662507;Inhibition
staurosporine;calcium/calmodulin-dependent protein kinase II beta subunit;f;;Human;19397322;Inhibition
compound 15b [PMID: 18334293];calcium/calmodulin-dependent protein kinase II delta subunit;f;;Human;18334293;Inhibition
compound 27 [PMID: 18337095];calcium/calmodulin-dependent protein kinase II delta subunit;f;;Human;18337095;Inhibition
MELK-TI;calcium/calmodulin-dependent protein kinase II delta subunit;f;;Human;25589925;Inhibition
bosutinib;calcium/calmodulin-dependent protein kinase II gamma subunit;f;;Human;19039322;Inhibition
STO609;calcium/calmodulin dependent protein kinase kinase 1;f;;Human;11867640;Inhibition
STO609;calcium/calmodulin dependent protein kinase kinase 2;f;;Human;11867640;Inhibition
calmodulin;Calmodulin-dependent kinase II;t;Human;Human;;Activation
compound 20 [PMID: 22136433];Calmodulin-dependent kinase II;f;;Human;22136433;Inhibition
K-252a;Calmodulin-dependent kinase II;f;;Human;1659814;Inhibition
KN62;Calmodulin-dependent kinase II;f;;Human;2155222;Inhibition
compound 4b [PMID: 20690647];calpain 1;f;;Pig;20690647;Inhibition
mercaptoacrylate inhibitor of calpain 1;calpain 1;f;;Pig;;Inhibition
compound 19 [PMID: 8831774];calpain 2;f;;Human;8831774;Inhibition
compound 5a [PMID: 20690647];calpain 2;f;;Pig;20690647;Inhibition
(-)-adrenaline;carbonic anhydrase 1;f;;Human;17127057;Activation
histamine;carbonic anhydrase 1;f;;Human;30928874;Activation
L-histidine;carbonic anhydrase 1;f;;Human;16807956;Activation
acetazolamide;carbonic anhydrase 1;f;;Human;15546717|15686894|20605094;Inhibition
benzolamide;carbonic anhydrase 1;f;;Human;15686894;Inhibition
brinzolamide;carbonic anhydrase 1;f;;Human;23965175;Inhibition
chlorthalidone;carbonic anhydrase 1;f;;Human;;Inhibition
compound 5a [PMID: 31287314];carbonic anhydrase 1;f;;Human;31287314;Inhibition
compound 5b  [PMID: 31287314];carbonic anhydrase 1;f;;Human;31287314;Inhibition
diclofenamide;carbonic anhydrase 1;f;;Human;17125255|15686894;Inhibition
dorzolamide;carbonic anhydrase 1;f;;Human;15686894;Inhibition
ethoxzolamide;carbonic anhydrase 1;f;;Human;15686931|15686894;Inhibition
gallic acid;carbonic anhydrase 1;f;;Human;20185318;Inhibition
indisulam;carbonic anhydrase 1;f;;Human;23965175;Inhibition
methazolamide;carbonic anhydrase 1;f;;Human;16039848|15686894;Inhibition
methocarbamol;carbonic anhydrase 1;f;;Human;17125255;Inhibition
SLC-0111;carbonic anhydrase 1;f;;Human;26233435;Inhibition
sulpiride;carbonic anhydrase 1;f;;Human;15686894;Inhibition
topiramate;carbonic anhydrase 1;f;;Human;15686894;Inhibition
zonisamide;carbonic anhydrase 1;f;;Human;23965175;Inhibition
acetazolamide;carbonic anhydrase 12;f;;Human;15686894|20605094;Inhibition
benzolamide;carbonic anhydrase 12;f;;Human;15686894;Inhibition
brinzolamide;carbonic anhydrase 12;f;;Human;15686894;Inhibition
celecoxib;carbonic anhydrase 12;f;;Human;23965175;Inhibition
chlorthalidone;carbonic anhydrase 12;f;;Human;19119014;Inhibition
compound 5a [PMID: 31287314];carbonic anhydrase 12;f;;Human;31287314;Inhibition
compound 5b  [PMID: 31287314];carbonic anhydrase 12;f;;Human;31287314;Inhibition
diclofenamide;carbonic anhydrase 12;f;;Human;15686894;Inhibition
dorzolamide;carbonic anhydrase 12;f;;Human;15686894;Inhibition
ethoxzolamide;carbonic anhydrase 12;f;;Human;15686894;Inhibition
indisulam;carbonic anhydrase 12;f;;Human;23965175;Inhibition
methazolamide;carbonic anhydrase 12;f;;Human;15686894;Inhibition
SLC-0111;carbonic anhydrase 12;f;;Human;26233435;Inhibition
sulpiride;carbonic anhydrase 12;f;;Human;15686894;Inhibition
topiramate;carbonic anhydrase 12;f;;Human;15686894;Inhibition
valdecoxib;carbonic anhydrase 12;f;;Human;23965175;Inhibition
zonisamide;carbonic anhydrase 12;f;;Human;23965175;Inhibition
acetazolamide;carbonic anhydrase 13;f;;Mouse;20605094;Inhibition
L-histidine;carbonic anhydrase 14;f;;Human;16807956;Activation
acetazolamide;carbonic anhydrase 14;f;;Human;15454239|20605094;Inhibition
brinzolamide;carbonic anhydrase 14;f;;Human;1460006;Inhibition
chlorthalidone;carbonic anhydrase 14;f;;Human;19119014;Inhibition
dorzolamide;carbonic anhydrase 14;f;;Human;15686931;Inhibition
ethoxzolamide;carbonic anhydrase 14;f;;Human;16039848;Inhibition
methazolamide;carbonic anhydrase 14;f;;Human;16039848;Inhibition
compound 5a [PMID: 31287314];carbonic anhydrase 2;f;;Human;31287314;Inhibition
compound 5b  [PMID: 31287314];carbonic anhydrase 2;f;;Human;31287314;Inhibition
acetazolamide;carbonic anhydrase 4;f;;Human;15603956|20605094;Inhibition
chlorthalidone;carbonic anhydrase 4;f;;Human;19119014;Inhibition
compound 5a [PMID: 31287314];carbonic anhydrase 4;f;;Human;31287314;Inhibition
compound 5b  [PMID: 31287314];carbonic anhydrase 4;f;;Human;31287314;Inhibition
diclofenamide;carbonic anhydrase 4;f;;Human;17125255;Inhibition
methazolamide;carbonic anhydrase 4;f;;Human;16039848;Inhibition
topiramate;carbonic anhydrase 4;f;;Human;16039848;Inhibition
amphetamine;carbonic anhydrase 5A;f;;Human;30928874;Activation
histamine;carbonic anhydrase 5A;f;;Human;30928874;Activation
L-histidine;carbonic anhydrase 5A;f;;Human;16807956;Activation
amphetamine;carbonic anhydrase 7;f;;Human;30928874;Activation
histamine;carbonic anhydrase 7;f;;Human;30928874;Activation
L-histidine;carbonic anhydrase 7;f;;Human;16807956;Activation
acetazolamide;carbonic anhydrase 7;f;;Human;20605094;Inhibition
brinzolamide;carbonic anhydrase 7;f;;Human;23965175;Inhibition
chlorthalidone;carbonic anhydrase 7;f;;Human;19119014;Inhibition
dorzolamide;carbonic anhydrase 7;f;;Human;23965175;Inhibition
ethoxzolamide;carbonic anhydrase 7;f;;Human;23965175;Inhibition
indisulam;carbonic anhydrase 7;f;;Human;23965175;Inhibition
methazolamide;carbonic anhydrase 7;f;;Human;23965175;Inhibition
sulpiride;carbonic anhydrase 7;f;;Human;23965175;Inhibition
topiramate;carbonic anhydrase 7;f;;Human;23965175;Inhibition
zonisamide;carbonic anhydrase 7;f;;Human;23965175;Inhibition
compound 5a [PMID: 31287314];carbonic anhydrase 9;f;;Human;31287314;Inhibition
compound 5b  [PMID: 31287314];carbonic anhydrase 9;f;;Human;31287314;Inhibition
SLC-0111;carbonic anhydrase 9;f;;Human;26233435;Inhibition
GR148672X;carboxylesterase 1;f;;Human;;Inhibition
compound 10f [PMID: 24556381];carboxyl ester lipase;f;;Pig;24556381;Inhibition
compound 10l [PMID: 24556381];carboxyl ester lipase;f;;Pig;24556381;Inhibition
compound 1b [PMID: 18078750];Carboxypeptidase A1 (pancreatic);f;;Human;18078750;Inhibition
S-BMPA;Carboxypeptidase A1 (pancreatic);f;;Bovine;;Inhibition
compound 3 [PMID: 14640538];Carboxypeptidase B1 (tissue);f;;Human;14640538;Inhibition
compound 4 [PMID: 19954973];Carboxypeptidase B1 (tissue);f;;Human;19954973;Inhibition
compound 3 [PMID: 14640538];Carboxypeptidase B2 (plasma);f;;Human;14640538;Inhibition
compound 4 [PMID: 19954973];Carboxypeptidase B2 (plasma);f;;Human;19954973;Inhibition
SQ-24,798;Carboxypeptidase B2 (plasma);f;;Human;17990866;Inhibition
UK-396,082;Carboxypeptidase B2 (plasma);f;;Human;17990866;Inhibition
compound 3 [PMID: 14640538];Carboxypeptidase M;f;;Human;14640538;Inhibition
compound 3 [PMID: 14640538];Carboxypeptidase N, polypeptide 1;f;;Human;14640538;Inhibition
SQ-24,798;Carboxypeptidase N, polypeptide 1;f;;Human;17990866;Inhibition
compound 14 [PMID: 24900428];casein kinase 1 alpha 1;f;;Human;24900428;Inhibition
D4476;casein kinase 1 alpha 1;f;;Human;22944772;Inhibition
IC261;casein kinase 1 alpha 1;f;;Human;10749871;Inhibition
CDK inhibitor 4.35;casein kinase 1 delta;f;;Human;30943029;Inhibition
compound 14 [PMID: 24900428];casein kinase 1 delta;f;;Human;24900428;Inhibition
D4476;casein kinase 1 delta;f;;Human;17850214;Inhibition
IC261;casein kinase 1 delta;f;;Human;10749871;Inhibition
PF-4800567;casein kinase 1 delta;f;;Human;19458106;Inhibition
PF-670462;casein kinase 1 delta;f;;Human;17502429;Inhibition
IC261;casein kinase 1 epsilon;f;;Human;10749871;Inhibition
PF-4800567;casein kinase 1 epsilon;f;;Human;19458106;Inhibition
PF-670462;casein kinase 1 epsilon;f;;Human;17502429;Inhibition
umbralisib;casein kinase 1 epsilon;f;;Human;27784673;Inhibition
compound 33 [PMID: 19364658];casein kinase 1 gamma 1;f;;Human;19364658;Inhibition
voruciclib;casein kinase 1 gamma 1;f;;Human;26606677;Inhibition
compound 14 [PMID: 24900428];casein kinase 1 gamma 2;f;;Human;24900428;Inhibition
compound 14k [PMID: 21982499];casein kinase 1 gamma 3;f;;Human;21982499;Inhibition
casein kinase II inhibitor III;Casein kinase 2;f;;Human;17133643;Inhibition
compound 2 [PMID: 22560567];Casein kinase 2;f;;Human;22560567|21295469;Inhibition
compound 5b [PMID: 24900464];Casein kinase 2;f;;Human;24900464;Inhibition
CX-5011;Casein kinase 2;f;;Human;21870818;Inhibition
CX-5011;Casein kinase 2;f;;Rat;21870818;Inhibition
CX-5279;Casein kinase 2;f;;Rat;21870818;Inhibition
CX-5279;Casein kinase 2;f;;Human;21870818;Inhibition
DMAT;Casein kinase 2;f;;Rat;;Inhibition
DRB;Casein kinase 2;f;;Human;3456346;Inhibition
TBBt;Casein kinase 2;f;;Rat;12816539;Inhibition
XL413;Casein kinase 2;f;;Human;22560567;Inhibition
compound 1a [PMID: 24900749];casein kinase 2, alpha 1 polypeptide subunit;f;;Human;24900749;Inhibition
compound 2c [PMID: 22115617];casein kinase 2, alpha 1 polypeptide subunit;f;;Human;22115617;Inhibition
silmitasertib;casein kinase 2, alpha 1 polypeptide subunit;f;;Human;21174434;Inhibition
compound 2c [PMID: 22115617];casein kinase 2, alpha prime polypeptide subunit;f;;Human;22115617;Inhibition
silmitasertib;casein kinase 2, alpha prime polypeptide subunit;f;;Human;21174434;Inhibition
AS101;Caspase 1;f;;Human;17572009;Inhibition
M826;Caspase 1;f;;Human;15686936;Inhibition
pralnacasan;Caspase 1;f;;Human;16375749;Inhibition
uracil 20;Caspase 1;f;;Human;29648825;Inhibition
VRT-043198;Caspase 1;f;;Human;17289835;Inhibition
Z-YVAD-FMK;Caspase 1;f;;Human;12097652;Inhibition
grassystatin A;Caspase 14;f;;Human;19715320;Inhibition
compound 4 [PMID: 12408711];Caspase 2;f;;Human;12408711;Inhibition
Z-VDVAD-FMK;Caspase 2;f;;Human;10912804;Inhibition
PAC1;Caspase 3;f;;Human;16936720;Activation
PETCM;Caspase 3;f;;Human;12522243;Activation
Ac-DEVD-CHO;Caspase 3;f;;Human;20541849;Inhibition
AZ10417808;Caspase 3;f;;Human;12490620;Inhibition
compound 4 [PMID: 12408711];Caspase 3;f;;Human;12408711;Inhibition
M826;Caspase 3;f;;Human;15686936;Inhibition
Z-DEVD-FMK;Caspase 3;f;;Human;9774422;Inhibition
Z-DQMD-FMK;Caspase 3;f;;Human;11301346;Inhibition
casp 4 inhib;Caspase 4;f;;Human;11384246;Inhibition
M826;Caspase 4;f;;Human;15686936;Inhibition
VRT-043198;Caspase 4;f;;Human;17289835;Inhibition
M826;Caspase 5;f;;Human;15686936;Inhibition
uracil 20;Caspase 5;f;;Human;29648825;Inhibition
Z-WEHD-FMK;Caspase 5;f;;Human;12903195;Inhibition
Ac-VEID-CHO;Caspase 6;f;;Human;19326941;Inhibition
Z-VEID-FMK;Caspase 6;f;;Human;11953316;Inhibition
compound 4 [PMID: 12408711];Caspase 7;f;;Human;12408711;Inhibition
isatin sulfonamide 34 [PMID: 11384246];Caspase 7;f;;Human;11384246;Inhibition
M826;Caspase 7;f;;Human;15686936;Inhibition
compound 4 [PMID: 12408711];Caspase 8;f;;Human;12408711;Inhibition
emricasan;Caspase 8;f;;Human;16250635;Inhibition
Z-IETD-FMK;Caspase 8;f;;Human;10048577;Inhibition
isatin sulfonamide 34 [PMID: 11384246];Caspase 9;f;;Human;11384246;Inhibition
Z-LEHD-FMK;Caspase 9;f;;Human;10807653;Inhibition
etelcalcetide;CaS receptor;f;;Human;23674604;Agonist
evocalcet;CaS receptor;f;;Human;;Agonist
Ca2+;CaS receptor;t;;Mouse;16199532;Full agonist
Ca2+;CaS receptor;t;;Rat;7816802;Full agonist
Ca2+;CaS receptor;t;;Human;7531693;Full agonist
neomycin;CaS receptor;f;;Rat;7816802;Full agonist
spermine;CaS receptor;t;;Human;9357776;Full agonist
Mg2+;CaS receptor;t;;Rat;7816802|2655774;Partial agonist
ATF936;CaS receptor;f;;Human;20158186;Negative
calhex 231;CaS receptor;f;;Human;14506236;Negative
compound 18c [PMID:19143533];CaS receptor;f;;Human;19143533;Negative
encaleret;CaS receptor;f;;Human;24900301;Negative
NPS 2143;CaS receptor;f;;Human;15686947|11561095;Negative
NPS 2143;CaS receptor;f;;Human;22210744|27002221|23372019;Negative
(R)-2h [PMID:19625189];CaS receptor;f;;Human;19625189;Negative
ronacaleret;CaS receptor;f;;Human;19442519;Negative
SB-423562;CaS receptor;f;;Human;19786130;Negative
AC265347;CaS receptor;f;;Human;21239511;Positive
AC265347;CaS receptor;f;;Human;25220431|27002221;Positive
calindol;CaS receptor;f;;Human;15149704|14976203;Positive
calindol;CaS receptor;f;;Human;25220431;Positive
cinacalcet;CaS receptor;f;;Human;14593085;Positive
cinacalcet;CaS receptor;f;;Human;22210744|25220431|27002221|23372019;Positive
L-tryptophan;CaS receptor;t;;Human;10781086|15234970;Positive
tecalcet;CaS receptor;f;;Human;22210744|25220431;Positive
tecalcet;CaS receptor;f;;Human;9520489;Positive
1-arylmethylpyrrolidin-2-yl ethanol amine;CaS receptor;f;;Rat;16216508;Antagonist
2-methyl-3-phenethyl-3H-pyrimidin-4-one;CaS receptor;f;;Human;15863312;Antagonist
compound 17 [PMID: 15300839];CaS receptor;f;;Rat;15300839;Antagonist
compound (S)-3h [PMID: 15686947];CaS receptor;f;;Human;15686947;Antagonist
BAYK 8644;Cav1.1;f;;Mouse;2155469|2451745;None
FPL64176;Cav1.1;f;;Human;;None
(-)-(S)-BayK8644;Cav1.1;f;;Human;;None
SZ(+)-(S)-202-791;Cav1.1;f;;Human;;None
calciseptine;Cav1.1;f;;Human;;Antagonist
Cd2+;Cav1.1;f;;Rat;2458429;Antagonist
diltiazem;Cav1.1;f;;Human;;Antagonist
verapamil;Cav1.1;f;;Human;;Antagonist
(+)-isradipine;Cav1.1;f;;Rat;2458429;Antagonist
nifedipine;Cav1.1;f;;Rat;2451745;Antagonist
nimodipine;Cav1.1;f;;Human;;Antagonist
nitrendipine;Cav1.1;f;;Rat;2458429;Antagonist
[3H](-)devapamil;Cav1.1;f;;Rabbit;9103495|6092142;Antagonist
[3H](+)-isradipine;Cav1.1;f;;Human;2411596;Antagonist
[3H](+)-isradipine;Cav1.1;f;;Rat;7476334;Antagonist
[3H](+)-cis-diltiazem;Cav1.1;f;;Rabbit;8395510|9103495;None
BAYK 8644;Cav1.2;f;;Rat;7514140;None
FPL64176;Cav1.2;f;;Rat;12842134;None
(-)-(S)-BayK8644;Cav1.2;f;;Human;;None
SZ(+)-(S)-202-791;Cav1.2;f;;Human;;None
benidipine;Cav1.2;f;;Human;22761000;Antagonist
calciseptine;Cav1.2;f;;Human;;Antagonist
diltiazem;Cav1.2;f;;Human;6694106;Antagonist
(-)-(R)-efonidipine;Cav1.2;f;;Rat;15545287;Antagonist
mibefradil;Cav1.2;f;;Human;10991994;Antagonist
Pb2+;Cav1.2;f;;Human;12435810;Antagonist
verapamil;Cav1.2;f;;Human;8913371;Antagonist
Cd2+;Cav1.2;f;;Rabbit;9176282;None
(-)-devapamil;Cav1.2;f;;Rat;8913371|7673189;Antagonist
nifedipine;Cav1.2;f;;Rat;11045961|7506331;Antagonist
nimodipine;Cav1.2;f;;Rat;11487617;Antagonist
[3H](-)devapamil;Cav1.2;f;;Rat;2147036|1719369;Antagonist
[3H](+)-cis-diltiazem;Cav1.2;f;;Rat;2147036;Antagonist
amlodipine;Cav1.2;f;;Rabbit;;None
isradipine;Cav1.2;f;;Mouse;15146240;None
isradipine;Cav1.2;f;;Human;28592699;None
isradipine;Cav1.2;f;;Human;28592699;None
nisoldipine;Cav1.2;f;;Mouse;10973973;None
nisoldipine;Cav1.2;f;;Human;15454078;None
nitrendipine;Cav1.2;f;;Dog;6093100;None
[3H](+)-isradipine;Cav1.2;f;;Mouse;15146240;None
[3H](+)-isradipine;Cav1.2;f;;Human;10072735;None
verapamil;Cav1.2;f;;Rat;8913371;None
BAYK 8644;Cav1.3;f;;Rat;11487617;None
BAYK 8644;Cav1.3;f;;Human;10929716|11285265;None
FPL64176;Cav1.3;f;;Human;;None
(-)-(S)-BayK8644;Cav1.3;f;;Human;;None
Cd2+;Cav1.3;f;;None;11435619;Antagonist
verapamil;Cav1.3;f;;Human;;Antagonist
nifedipine;Cav1.3;f;;Human;19029287;Antagonist
nimodipine;Cav1.3;f;;Rat;11487617|11514547;Antagonist
amlodipine;Cav1.3;f;;Human;19029287;Inhibition
azidopine;Cav1.3;f;;Human;19029287;Inhibition
nitrendipine;Cav1.3;f;;Human;19029287;Inhibition
isradipine;Cav1.3;f;;Human;19029287;None
isradipine;Cav1.3;f;;Human;11285265;None
isradipine;Cav1.3;f;;Human;28592699;None
nisoldipine;Cav1.3;f;;Mouse;12900400;None
[3H](+)-isradipine;Cav1.3;f;;Human;11285265;None
BAYK 8644;Cav1.4;f;;Human;12853422|14973233|16476079;None
BAYK 8644;Cav1.4;f;;Mouse;14744918;None
(-)-(S)-BayK8644;Cav1.4;f;;Human;;None
diltiazem;Cav1.4;f;;Mouse;14744918;None
verapamil;Cav1.4;f;;Mouse;14744918;None
nifedipine;Cav1.4;f;;Human;14973233;Antagonist
nimodipine;Cav1.4;f;;Human;;Antagonist
nitrendipine;Cav1.4;f;;Human;;Antagonist
isradipine;Cav1.4;f;;Human;12853422;None
isradipine;Cav1.4;f;;Mouse;14744918;None
L-(cis)-diltiazem;Cav1.4;f;;Mouse;14744918;None
ω-conotoxin CVIA;Cav2.1;f;;Rat;10938268;Antagonist
ω-conotoxin CVIB;Cav2.1;f;;Rat;10938268;Antagonist
ω-conotoxin CVIC;Cav2.1;f;;Rat;10938268;Antagonist
ω-conotoxin CVID;Cav2.1;f;;Rat;10938268;Antagonist
ω-conotoxin GVIA;Cav2.1;f;;Rat;10938268;Antagonist
ω-conotoxin MVIIA;Cav2.1;f;;Rat;10938268;Antagonist
Cd2+;Cav2.1;f;;Rabbit;;None
DW13.3;Cav2.1;f;;Rat;9687583;None
Ni2+;Cav2.1;f;;Rat;8661496;None
ω-conotoxin MVIIC;Cav2.1;f;;Rat;10938268;None
ω-conotoxin MVIID;Cav2.1;f;;Bovine;;None
ω-phonetoxin-IIA;Cav2.1;f;;Rat;9683727;None
ω-PnTx3-3;Cav2.1;f;;Rat;10884557;None
PnTx-3-6;Cav2.1;f;;Rat;15933156;None
kurtoxin;Cav2.1;f;;Rat;11896142;Antagonist
ω-grammotoxin SIA;Cav2.1;f;;Rat;9415720|8394998;Antagonist
mibefradil;Cav2.1;f;;Rat;10665814;None
ω-agatoxin IIIA;Cav2.1;f;;Rat;8182443|11929883;None
ω-agatoxin IVA;Cav2.1;f;;Rat;10321243|1311418;None
ω-agatoxin IVB;Cav2.1;f;;Rat;8232218;None
DW13.3;Cav2.2;f;;Rat;9687583;Antagonist
ω-conotoxin CVIA;Cav2.2;f;;Rat;10938268;Antagonist
ω-conotoxin CVIB;Cav2.2;f;;Rat;10938268;Antagonist
ω-conotoxin CVIC;Cav2.2;f;;Rat;10938268;Antagonist
ω-conotoxin CVID;Cav2.2;f;;Rat;10938268;Antagonist
ω-conotoxin GVIA;Cav2.2;f;;Rat;10938268;Antagonist
ω-conotoxin MVIIA;Cav2.2;f;;Rat;10938268|16844100;Antagonist
ω-conotoxin MVIIA;Cav2.2;f;;Human;11756491;Antagonist
ω-conotoxin MVIIC;Cav2.2;f;;Rat;1352986|10938268|8786437;Antagonist
Pb2+;Cav2.2;f;;Human;12435810;Antagonist
cilnidipine;Cav2.2;f;;Rat;9067302;Pore blocker
kurtoxin;Cav2.2;f;;Rat;11896142;Antagonist
ω-grammotoxin SIA;Cav2.2;f;;Rat;9415720;Antagonist
NP118809;Cav2.2;f;;Rat;19815411;None
TROX-1;Cav2.2;f;;Human;22188924|20439438;None
Cd2+;Cav2.3;f;;Human;8071363;Antagonist
DW13.3;Cav2.3;f;;Rat;9687583;Antagonist
Ni2+;Cav2.3;f;;Human;8071363;Antagonist
ω-phonetoxin-IIA;Cav2.3;f;;Rat;11827974;Antagonist
ω-PnTx3-3;Cav2.3;f;;Rat;10884557;Antagonist
Pb2+;Cav2.3;f;;Human;12435810;Antagonist
PnTx-3-6;Cav2.3;f;;Rat;15933156;Antagonist
Ni2+;Cav2.3;f;;Rat;8661496|8388125;Antagonist
SNX482;Cav2.3;f;;Rat;10627594|11423396;Antagonist
SNX482;Cav2.3;f;;Human;9799496;Antagonist
mibefradil;Cav2.3;f;;Rat;10665814;None
anandamide;Cav3.1;t;;Human;11742980;Antagonist
(-)-(R)-efonidipine;Cav3.1;f;;Rat;15545287;Antagonist
mibefradil;Cav3.1;f;;Human;10991994;Antagonist
Ni2+;Cav3.1;f;;Rat;10585925;Antagonist
pimozide;Cav3.1;f;;Rat;11784784;Antagonist
ABT-639;Cav3.1;f;;Human;24726441;Pore blocker
ML218;Cav3.1;f;;Human;22368764;Pore blocker
TTA-A2;Cav3.1;f;;Human;23257507;Pore blocker
TTA-P2;Cav3.1;f;;Rat;21821734;Pore blocker
Z944;Cav3.1;f;;Human;22344687;Pore blocker
kurtoxin;Cav3.1;f;;Rat;11896142|10196582;Antagonist
3β-OH;Cav3.2;f;;Rat;29576117;Antagonist
anandamide;Cav3.2;t;;Human;11742980;Antagonist
mibefradil;Cav3.2;f;;Human;10991994;Antagonist
Ni2+;Cav3.2;f;;Human;10585925;Antagonist
pimozide;Cav3.2;f;;Rat;11784784;Antagonist
ABT-639;Cav3.2;f;;Human;24726441;Pore blocker
ML218;Cav3.2;f;;Human;22368764;Pore blocker
TTA-A2;Cav3.2;f;;Human;23257507;Pore blocker
TTA-P2;Cav3.2;f;;Rat;21821734;Pore blocker
Z944;Cav3.2;f;;Human;22344687;Pore blocker
kurtoxin;Cav3.2;f;;Rat;11896142|10196582;Antagonist
3β-OH;Cav3.3;f;;Rat;29576117;Antagonist
anandamide;Cav3.3;f;;Human;11742980;Antagonist
mibefradil;Cav3.3;f;;Human;10991994;Antagonist
Ni2+;Cav3.3;f;;Rat;10585925;Antagonist
pimozide;Cav3.3;f;;Human;11784784;Antagonist
ABT-639;Cav3.3;f;;Human;24726441;Pore blocker
ML218;Cav3.3;f;;Human;22368764;Pore blocker
TTA-A2;Cav3.3;f;;Human;23257507;Pore blocker
TTA-P2;Cav3.3;f;;Rat;21821734;Pore blocker
Z944;Cav3.3;f;;Human;22344687;Pore blocker
tectorigenin;catalase;f;;Hamster;28053960;Activation
entacapone;Catechol-O-methyltransferase;f;;Human;7703232;Inhibition
entacapone;Catechol-O-methyltransferase;f;;Human;7703232;Inhibition
opicapone;Catechol-O-methyltransferase;f;;Human;24847974;Inhibition
opicapone;Catechol-O-methyltransferase;f;;Mouse;24847974;Inhibition
opicapone;Catechol-O-methyltransferase;f;;Rat;24847974;Inhibition
tolcapone;Catechol-O-methyltransferase;f;;Human;7703232;Inhibition
tolcapone;Catechol-O-methyltransferase;f;;Human;7703232;Inhibition
boceprevir;Cathepsin A;f;;Human;;Inhibition
compound 8a [PMID: 22861813];Cathepsin A;f;;Human;22861813;Inhibition
example 166  [WO2014154727];Cathepsin A;f;;Human;;Inhibition
telaprevir;Cathepsin A;f;;Human;;Inhibition
LHVS;cathepsin B;f;;Human;17535802;Inhibition
poststatin;cathepsin B;f;;Human;8931723;Inhibition
VBY-825;cathepsin B;f;;Human;20447439;Inhibition
Z-Arg-Leu-Val-Agly-Ile-Val-OMe;cathepsin B;f;;Human;12213061;Inhibition
brensocatib;cathepsin C;f;;Human;27690432;Inhibition
brensocatib;cathepsin C;f;;Rat;27690432;Inhibition
brensocatib;cathepsin C;f;;Human;27690432;Inhibition
brensocatib;cathepsin C;f;;Mouse;27690432;Inhibition
compound 3d [PMID: 3941405];cathepsin C;f;;Human;3941405;Inhibition
IcatCXPZ-01;cathepsin C;f;;Human;30978322;Inhibition
compound 1 [PMID: 10498202];cathepsin D;f;;Human;10498202;Inhibition
compound 33 [PMID: 32003991];cathepsin D;f;;Human;32003991;Inhibition
compound 3 [PMID: 8410973];cathepsin D;f;;Human;8410973;Inhibition
grassystatin A;cathepsin D;f;;Human;19715320;Inhibition
compound 2 [PMID: 8410973];cathepsin E;f;;Human;8410973;Inhibition
compound 3 [PMID: 8410973];cathepsin E;f;;Human;8410973;Inhibition
grassystatin A;cathepsin E;f;;Human;19715320;Inhibition
compound (R)-26 [PMID: 22686657];cathepsin F;f;;Human;22686657;Inhibition
VBY-825;cathepsin F;f;;Human;20447439;Inhibition
aloxistatin;cathepsin G;f;;Human;17535802;Inhibition
compound 1 [PMID: 11425539];cathepsin G;f;;Human;11425539;Inhibition
compound 4g [PMID: 22595175];cathepsin G;f;;Human;22595175;Inhibition
compound 1b [PMID: 16290936];cathepsin H;f;;Human;16290936;Inhibition
compound 1e [PMID: 27285276];cathepsin H;f;;Human;27285276;Inhibition
balicatib;cathepsin K;f;;Human;20218623;Inhibition
compound 1b [PMID: 16290936];cathepsin K;f;;Human;16290936;Inhibition
L873724;cathepsin K;f;;Human;19453281;Inhibition
odanacatib;cathepsin K;f;;Human;18226527;Inhibition
relacatib;cathepsin K;f;;Human;20218623;Inhibition
CAA0225;cathepsin L;f;;Rat;19252298;Inhibition
KGP94;cathepsin L;f;;Human;20933415;Inhibition
LHVS;cathepsin L;f;;Human;17535802;Inhibition
VBY-825;cathepsin L;f;;Human;20447439;Inhibition
compound (R)-26 [PMID: 22686657];cathepsin S;f;;Human;22686657;Inhibition
LHVS;cathepsin S;f;;Human;17535802;Inhibition
odanacatib;cathepsin S;f;;Human;18226527;Inhibition
petesicatib;cathepsin S;f;;Human;28584258;Inhibition
petesicatib;cathepsin S;f;;Mouse;28584258;Inhibition
VBY-825;cathepsin S;f;;Rat;20447439;Inhibition
VBY-825;cathepsin S;f;;Mouse;20447439;Inhibition
VBY-825;cathepsin S;f;;Human;20447439;Inhibition
citibrasine;cathepsin V;f;;Human;21277783;Inhibition
petesicatib;cathepsin V;f;;Human;28584258;Inhibition
VBY-825;cathepsin V;f;;Human;20447439;Inhibition
odanacatib;cathepsin Z;f;;Human;18226527;Inhibition
PGE1;CatSper1;t;;Human;21412339;Full agonist
PGE2;CatSper1;t;;Human;21412339;Full agonist
PGF1α;CatSper1;t;;Human;21412339;Full agonist
progesterone;CatSper1;t;;Human;21412339|21412338;Full agonist
Cd2+;CatSper1;f;;Mouse;16467839;Inhibition
mibefradil;CatSper1;f;;Human;21412338;Inhibition
Ni2+;CatSper1;f;;Mouse;16467839;Inhibition
NNC55-0396;CatSper1;f;;Mouse;21412339;Inhibition
NNC55-0396;CatSper1;f;;Human;21412339|21412338;Inhibition
ruthenium red;CatSper1;f;;Mouse;16467839;Inhibition
HC-056456;CatSper1;f;;Human;19718436;None
PGE1;CatSper2;t;;Human;21412339;Full agonist
PGE2;CatSper2;t;;Human;21412339;Full agonist
PGF1α;CatSper2;t;;Human;21412339;Full agonist
progesterone;CatSper2;t;;Human;21412339|21412338;Full agonist
Ni2+;CatSper2;f;;Mouse;21642646;Antagonist
ruthenium red;CatSper2;f;;Mouse;21642646;Antagonist
Cd2+;CatSper2;f;;Mouse;21642646;Inhibition
mibefradil;CatSper2;f;;Human;21412338;Inhibition
NNC55-0396;CatSper2;f;;Human;21412339|21412338;Inhibition
NNC55-0396;CatSper2;f;;Mouse;21412339;Inhibition
PGE1;CatSper3;t;;Human;21412339;Full agonist
PGE2;CatSper3;t;;Human;21412339;Full agonist
PGF1α;CatSper3;t;;Human;21412339;Full agonist
progesterone;CatSper3;t;;Human;21412339|21412338;Full agonist
Cd2+;CatSper3;f;;Mouse;16467839;Antagonist
Ni2+;CatSper3;f;;Mouse;16467839;Antagonist
ruthenium red;CatSper3;f;;Mouse;16467839;Antagonist
mibefradil;CatSper3;f;;Human;21412338;Inhibition
NNC55-0396;CatSper3;f;;Mouse;21412339;Inhibition
NNC55-0396;CatSper3;f;;Human;21412339|21412338;Inhibition
PGE1;CatSper4;t;;Human;21412339;Full agonist
PGE2;CatSper4;t;;Human;21412339;Full agonist
PGF1α;CatSper4;t;;Human;21412339;Full agonist
progesterone;CatSper4;t;;Human;21412339|21412338;Full agonist
Cd2+;CatSper4;f;;Mouse;16467839;Antagonist
Ni2+;CatSper4;f;;Mouse;16467839;Antagonist
ruthenium red;CatSper4;f;;Mouse;16467839;Antagonist
mibefradil;CatSper4;f;;Human;21412338;Inhibition
NNC55-0396;CatSper4;f;;Human;21412339|21412338;Inhibition
NNC55-0396;CatSper4;f;;Mouse;21412339;Inhibition
wedelolactone;CBR1;f;;Human;19097799;Inhibition
AM11542;CB1 receptor;f;;Human;28678776;Agonist
AM1710;CB1 receptor;f;;Rat;18038967;Agonist
AM2201;CB1 receptor;f;;Human;25921407;Agonist
AM2201;CB1 receptor;f;;Rat;;Agonist
AM7499;CB1 receptor;f;;Rat;27367336;Agonist
AM841;CB1 receptor;f;;Human;28678776;Agonist
BMS-202;CB1 receptor;f;;Human;25921407;Agonist
R-(+)-methanandamide;CB1 receptor;f;;Rat;8893848;Agonist
lenabasum;CB1 receptor;f;;Human;23865723|9379442;Agonist
MDMB-Fubinaca;CB1 receptor;f;;Human;29963207;Agonist
nabilone;CB1 receptor;f;;Human;21885167;Agonist
olorinab;CB1 receptor;f;;Rat;29259753;Agonist
olorinab;CB1 receptor;f;;Human;29259753;Agonist
2-arachidonoylglycerol;CB1 receptor;t;;Rat;7605349|9721036;Full agonist
arachidonyl-2-chloroethylamide;CB1 receptor;f;;Rat;10336536;Full agonist
arachidonylcyclopropylamide;CB1 receptor;f;;Rat;10336536;Full agonist
CP55940;CB1 receptor;f;;Human;7565624|8819477|10188977;Full agonist
HU-210;CB1 receptor;f;;Human;7565624|8819477;Full agonist
JWH-018;CB1 receptor;f;;Human;10525107;Full agonist
O-1812;CB1 receptor;f;;Rat;11181068;Full agonist
[3H]CP55940;CB1 receptor;f;;Human;7775459|8819477|8526880|1718258|1331766|8636122;Full agonist
[3H]HU-243;CB1 receptor;f;;Rat;1317925;Full agonist
[3H]WIN55212-2;CB1 receptor;f;;Human;8622639|9422383;Full agonist
WIN55212-2;CB1 receptor;f;;Human;7565624|8819477|8679694;Full agonist
MRI-1867;CB1 receptor;f;;Human;27525312;Inverse agonist
Sch.336;CB1 receptor;f;;Human;15664857;Inverse agonist
Sch.336;CB1 receptor;f;;Human;16258021;Inverse agonist
anandamide;CB1 receptor;t;;Human;7565624|8819477;Partial agonist
BAY-593074;CB1 receptor;f;;Human;15140913;Partial agonist
BAY-593074;CB1 receptor;f;;Rat;15140913;Partial agonist
cannabinol;CB1 receptor;f;;Human;7565624|8819477;Partial agonist
Δ9-tetrahydrocannabinol;CB1 receptor;f;;Human;7565624|8819477;Partial agonist
cannabidiol;CB1 receptor;f;;Human;26218440;Negative
GAT100;CB1 receptor;f;;Human;27046127;Negative
GAT100;CB1 receptor;f;;Human;26529344;Negative
pepcan-12;CB1 receptor;f;;Human;22952224;Negative
GAT211;CB1 receptor;f;;Human;28103441;Positive
Org27569;CB1 receptor;f;;Human;22571451;Positive
ZCZ011;CB1 receptor;f;;Mouse;26052038;Positive
ZCZ011;CB1 receptor;f;;Mouse;26052038;Positive
AM251;CB1 receptor;f;;Rat;10052983;Antagonist
AM281;CB1 receptor;f;;Rat;11741201;Antagonist
AM6538;CB1 receptor;f;;Human;27768894;Antagonist
AM6545;CB1 receptor;f;;Human;25535367;Antagonist
compound 70 [PMID: 26161824];CB1 receptor;f;;Human;26161824;Antagonist
ibipinabant;CB1 receptor;f;;Human;14736243;Antagonist
JD5037;CB1 receptor;f;;Human;22841573;Antagonist
LY320135;CB1 receptor;f;;Human;9435190;Antagonist
rimonabant;CB1 receptor;f;;Human;7565624|8819477|9435190|8070571|12663689;Antagonist
[123I]AM251;CB1 receptor;f;;Mouse;9335234;Antagonist
[3H]rimonabant;CB1 receptor;f;;Rat;8614277|8733746|8978752|8987831|8981483|9316881|9536023;Antagonist
surinabant;CB1 receptor;f;;Human;15131245;Antagonist
TM-38837;CB1 receptor;f;;Human;20652930;Antagonist
VCE-004.3;CB1 receptor;f;;Human;30033591;Antagonist
otenabant;CB1 receptor;f;;Human;19102698;Inverse agonist
otenabant;CB1 receptor;f;;Rat;19102698;Inverse agonist
taranabant;CB1 receptor;f;;Human;19520572;Inverse agonist
AM1241;CB2 receptor;f;;Human;16894349;Agonist
AM1710;CB2 receptor;f;;Mouse;18038967;Agonist
AM2201;CB2 receptor;f;;Human;25921407;Agonist
AM2201;CB2 receptor;f;;Mouse;;Agonist
AM7499;CB2 receptor;f;;Mouse;27367336;Agonist
AM7499;CB2 receptor;f;;Human;27367336;Agonist
BMS-202;CB2 receptor;f;;Human;25921407;Agonist
lenabasum;CB2 receptor;f;;Human;23865723|9379442;Agonist
MDMB-Fubinaca;CB2 receptor;f;;Human;29963207;Agonist
nabilone;CB2 receptor;f;;Human;21885167;Agonist
phenylacetylrinvanil;CB2 receptor;f;;Human;15356216;Agonist
VCE-004.3;CB2 receptor;f;;Human;30033591;Agonist
CP55940;CB2 receptor;f;;Human;7565624|8819477|10188977;Full agonist
HU-210;CB2 receptor;f;;Human;7565624|8819477|9379442;Full agonist
HU-308;CB2 receptor;f;;Human;10588688;Full agonist
JWH-018;CB2 receptor;f;;Human;10525107;Full agonist
JWH-133;CB2 receptor;f;;Human;10658595|11060760;Full agonist
L-759,633;CB2 receptor;f;;Human;10188977;Full agonist
L-759,656;CB2 receptor;f;;Human;10188977;Full agonist
olorinab;CB2 receptor;f;;Rat;29259753;Full agonist
olorinab;CB2 receptor;f;;Human;29259753;Full agonist
[3H]CP55940;CB2 receptor;f;;Human;7565624|8819477|8679694|8636122|7689702|8647116;Full agonist
[3H]HU-243;CB2 receptor;f;;Human;7498464;Full agonist
[3H]WIN55212-2;CB2 receptor;f;;Human;7689702|7651369;Full agonist
WIN55212-2;CB2 receptor;f;;Human;7565624|8819477|8679694;Full agonist
Sch.336;CB2 receptor;f;;Human;15664857;Inverse agonist
Sch.336;CB2 receptor;f;;Human;16258021;Inverse agonist
taranabant;CB2 receptor;f;;Human;19520572;None
2-arachidonoylglycerol;CB2 receptor;t;;Human;7605349|9721036;Partial agonist
anandamide;CB2 receptor;t;;Human;7565624|8819477|7605349;Partial agonist
BAY-593074;CB2 receptor;f;;Human;15140913;Partial agonist
Δ9-tetrahydrocannabinol;CB2 receptor;f;;Human;7565624|8819477|9379442|8626625;Partial agonist
GW405833;CB2 receptor;f;;Human;23711022;Partial agonist
compound C2 [PMID: 29990428];CB2 receptor;f;;Human;29990428;Positive
pepcan-12;CB2 receptor;f;;Human;28842619;Positive
AM10257;CB2 receptor;f;;Human;30639103;Antagonist
AM-630;CB2 receptor;f;;Human;10188977;Antagonist
ibipinabant;CB2 receptor;f;;Human;14736243;Antagonist
SR144528;CB2 receptor;f;;Human;10188977|9454810;Antagonist
TM-38837;CB2 receptor;f;;Human;20652930;Antagonist
surinabant;CB2 receptor;f;;Human;15131245;Full agonist
CCK-33;CCK1 receptor;t;Human;Human;;Agonist
CCK-39;CCK1 receptor;t;Human;Human;;Agonist
CCK-58;CCK1 receptor;t;Human;Human;;Agonist
CCK-8;CCK1 receptor;t;Human|Mouse|Rat;Human;;Agonist
CE-326597;CCK1 receptor;f;;Human;20851601;Agonist
A-71623;CCK1 receptor;f;;Rat;1636779;Full agonist
ARL-15849;CCK1 receptor;f;;Rat;9476993;Full agonist
CCK-33;CCK1 receptor;f;Human;Rat;6256771;Full agonist
CCK-4;CCK1 receptor;f;Human;Rat;1975695;Full agonist
CCK-58;CCK1 receptor;f;Dog;Mouse;12370550;Full agonist
CCK-8;CCK1 receptor;t;Human|Mouse|Rat;Rat;1975695;Full agonist
CCK-8;CCK1 receptor;t;Human|Mouse|Rat;Rat;1975695;Full agonist
gastrin-17;CCK1 receptor;f;Human;Rat;1975695;Full agonist
Glaxo-11p;CCK1 receptor;f;;Human;8558528;Full agonist
GW-5823;CCK1 receptor;f;;Human;9276016;Full agonist
JMV180;CCK1 receptor;f;;Human;7654246;Full agonist
PD136450;CCK1 receptor;f;;Rat;7516969;Full agonist
pentagastrin;CCK1 receptor;f;;Rat;1975695;Full agonist
rebamipide;CCK1 receptor;f;;Rat;15556137;Full agonist
SR146131;CCK1 receptor;f;;Human;10215648;Full agonist
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33;CCK1 receptor;f;;Human;3410633;Full agonist
CI-1015;CCK1 receptor;f;;Rat;9438020;Antagonist
CI-988;CCK1 receptor;f;;Rat;1975695;Antagonist
devazepide;CCK1 receptor;f;;Rat;1975695;Antagonist
dexloxiglumide;CCK1 receptor;f;;Human;17684117;Antagonist
IQM-97423;CCK1 receptor;f;;Rat;15331911;Antagonist
JNJ-17156516;CCK1 receptor;f;;Human;17684117;Antagonist
L-365260;CCK1 receptor;f;;Rat;1975695;Antagonist
L-736380;CCK1 receptor;f;;Rat;8632408;Antagonist
L-740093;CCK1 receptor;f;;Rat;7969084;Antagonist
lintitript;CCK1 receptor;f;;Human;10988332;Antagonist
lintitript;CCK1 receptor;f;;Rat;7681406;Antagonist
lorglumide;CCK1 receptor;f;;Rat;1975695|2437574;Antagonist
loxiglumide;CCK1 receptor;f;;Rat;3663268;Antagonist
PD-135158;CCK1 receptor;f;;Rat;1975695;Antagonist
PD-140548;CCK1 receptor;f;;Rat;8605955;Antagonist
pranazepide;CCK1 receptor;f;;Rat;7509389;Antagonist
proglumide;CCK1 receptor;f;;Rat;3440035;Antagonist
SC-50998;CCK1 receptor;f;;Rat;;Antagonist
[3H]devazepide;CCK1 receptor;f;;Human;3018478;Antagonist
T-0632;CCK1 receptor;f;;Rat;8813597;Antagonist
TP-680;CCK1 receptor;f;;Rat;8730754;Antagonist
VL-0395;CCK1 receptor;f;;Rat;12538004;Antagonist
YF-476;CCK1 receptor;f;;Rat;9022799;Antagonist
YM-022;CCK1 receptor;f;;Rat;7910212;Antagonist
desulfated gastrin-14;CCK2 receptor;t;Human;Human;;Agonist
desulfated gastrin-17;CCK2 receptor;t;Human;Human;;Agonist
desulfated gastrin-34;CCK2 receptor;t;Human;Human;;Agonist
desulfated gastrin-71;CCK2 receptor;t;Human;Human;;Agonist
gastrin-14;CCK2 receptor;t;Human;Human;;Agonist
gastrin-34;CCK2 receptor;t;Human;Human;;Agonist
gastrin-71;CCK2 receptor;t;Human;Human;;Agonist
A-71378;CCK2 receptor;f;;Human;8914862;Full agonist
ARL-15849;CCK2 receptor;f;;Rat;9476993;Full agonist
BBL-454;CCK2 receptor;f;;Rat;14698161;Full agonist
BC-254;CCK2 receptor;f;;Rat;1614411;Full agonist
BC-264;CCK2 receptor;f;;Rat;14698161;Full agonist
CCK-33;CCK2 receptor;t;Human;Human;8349705;Full agonist
CCK-4;CCK2 receptor;t;Human;Human;8349705;Full agonist
CCK-58;CCK2 receptor;f;Dog;Mouse;12370550;Full agonist
CCK-8;CCK2 receptor;t;Human|Mouse|Rat;Human;7681836|8349705;Full agonist
desulfated cholecystokinin-8;CCK2 receptor;t;;Human;7681836;Full agonist
gastrin-17;CCK2 receptor;t;Human;Mouse;1975695;Full agonist
JMV310;CCK2 receptor;f;;Rat;1698251;Full agonist
PBC-264;CCK2 receptor;f;;Rat;8720482;Full agonist
pentagastrin;CCK2 receptor;f;;Mouse;1975695;Full agonist
RB-400;CCK2 receptor;f;;Rat;14698161;Full agonist
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33;CCK2 receptor;f;;Human;3410633;Full agonist
[125I]gastrin;CCK2 receptor;f;;Human;;Full agonist
[3H]gastrin;CCK2 receptor;f;;Human;;Full agonist
[3H]PBC-264;CCK2 receptor;f;;Rat;1614411;Full agonist
AG-041R;CCK2 receptor;f;;Human;11738246;Antagonist
CI-1015;CCK2 receptor;f;;Mouse;9438020;Antagonist
CI-988;CCK2 receptor;f;;Mouse;1975695;Antagonist
CI-988;CCK2 receptor;f;;Human;8914862;Antagonist
devazepide;CCK2 receptor;f;;Human;7681836;Antagonist
GV150013;CCK2 receptor;f;;Human;11020274;Antagonist
GW-5823;CCK2 receptor;f;;Human;9276016;Antagonist
itriglumide;CCK2 receptor;f;;Rat;10204685;Antagonist
JNJ-26070109;CCK2 receptor;f;;Human;21493750;Antagonist
L-365260;CCK2 receptor;f;;Human;7681836;Antagonist
L-740093;CCK2 receptor;f;;Human;11738246;Antagonist
lorglumide;CCK2 receptor;f;;Human;8914862;Antagonist
LY262691;CCK2 receptor;f;;Rat;21228869;Antagonist
LY-288513;CCK2 receptor;f;;Human;8914862;Antagonist
PD-135158;CCK2 receptor;f;;Human;8914862;Antagonist
PD-135666;CCK2 receptor;f;;Mouse;8605955;Antagonist
PD-140548;CCK2 receptor;f;;Rat;7684452;Antagonist
PD-149164;CCK2 receptor;f;;Mouse;8931944;Antagonist
RP-69758;CCK2 receptor;f;;Rat;7813588;Antagonist
RP73870;CCK2 receptor;f;;Rat;10385255;Antagonist
[125I]-BDZ2;CCK2 receptor;f;;Human;19271701;Antagonist
[125I]PD142308;CCK2 receptor;f;;Guinea pig;;Antagonist
[3H]JB-93182;CCK2 receptor;f;;Rat;10217546;Antagonist
[3H]L365260;CCK2 receptor;f;;Human;11738246;Antagonist
[3H]PD140376;CCK2 receptor;f;;Guinea pig;8474432;Antagonist
tetronothiodin;CCK2 receptor;f;;Human;8233061;Antagonist
TP-680;CCK2 receptor;f;;Rat;8730754;Antagonist
YF-476;CCK2 receptor;f;;Human;22607579|9042983;Antagonist
YF-476;CCK2 receptor;f;;Human;11738246;Antagonist
YM-022;CCK2 receptor;f;;Human;11738246;Antagonist
Z-360;CCK2 receptor;f;;Human;17901954;Antagonist
CCL13;CCR1;t;Human;Human;;Agonist
CCL8;CCR1;t;Human;Human;;Agonist
BP-CCL3;CCR1;f;;Human;11170631;Full agonist
CCL14;CCR1;t;Human;Human;12381680;Full agonist
CCL15;CCR1;t;Human;Human;9346309;Full agonist
CCL23;CCR1;t;Human;Human;12381680;Full agonist
CCL3;CCR1;t;Human;Human;12381680|11170631|9624164|8530354;Full agonist
CCL5;CCR1;t;Human;Human;9624164|8530354;Full agonist
CCL7;CCR1;t;Human;Human;12381680|11994538;Full agonist
Flu-CCL3;CCR1;f;;Human;11170631;Full agonist
[125I]CCL2 (human);CCR1;f;;Human;9336350;Full agonist
[125I]CCL3 (human);CCR1;f;;Human;9336350|9115216|7545673;Full agonist
[125I]CCL5 (human);CCR1;f;;Human;9336350;Full agonist
[125I]CCL7 (human);CCR1;f;;Human;7545673;Full agonist
[125I]CCL8 (human);CCR1;f;;Human;9115216;Full agonist
BMS-817399;CCR1;f;;Human;25101488;Antagonist
BX 471;CCR1;f;;Human;10748002;Antagonist
CCL18;CCR1;f;Human;Human;23951310;Antagonist
CCL4;CCR1;t;Human;Human;12381680|8530354;Antagonist
CCX354;CCR1;f;;Human;;Antagonist
compound 2b-1 [PMID: 12614873];CCR1;f;;Human;12614873;Antagonist
CP-481,715;CCR1;f;;Human;12909630;Antagonist
MLN-3897;CCR1;f;;Human;;Antagonist
UCB35625;CCR1;f;;Human;10854442;Antagonist
viral macrophage inflammatory protein-II;CCR1;f;;Human;9287217;Antagonist
CCL27;CCR10;t;Human;Human;10725697;Full agonist
CCL28;CCR10;t;Human;Human;;Full agonist
BI-6901;CCR10;f;;Mouse;27692854;Antagonist
BI-6901;CCR10;f;;Human;27692854;Antagonist
HIV-Tat;CCR2;f;;Human;;Agonist
[125I]CCL7 (human);CCR2;f;;Human;;Agonist
CCL13;CCR2;t;Human;Human;9276730|12554737;Full agonist
CCL16;CCR2;t;Human;Human;;Full agonist
CCL2;CCR2;t;Human;Human;9276730|9346309|12554737|15207250|10770925;Full agonist
CCL7;CCR2;t;Human;Human;9276730|9346309|12554737;Full agonist
CCL8;CCR2;t;Human;Human;12554737;Full agonist
HIV-Tat;CCR2;f;;Human;9789057;Full agonist
[125I]CCL2 (human);CCR2;f;;Human;;Full agonist
vCCL4;CCR2;f;;Human;12554737;Full agonist
CCL11;CCR2;t;Human;Human;12554737|15207250;Partial agonist
CCR2-RA-[R];CCR2;f;;Human;;Antagonist
compound 39 [PMID: 31742400];CCR2;f;;Human;31742400;Antagonist
JNJ-27141491;CCR2;f;;Human;18599682;Antagonist
AZD2423;CCR2;f;;Human;;Negative
BMS-681;CCR2;f;;Human;25893046;Antagonist
CCL24;CCR2;t;Human;Human;15207250;Antagonist
CCL26;CCR2;t;Human;Human;15207250;Antagonist
CCX140B;CCR2;f;;Human;;Antagonist
GSK Compound 34;CCR2;f;;Human;;Antagonist
INCB3284;CCR2;f;;Human;24900329;Antagonist
INCB3344;CCR2;f;;Mouse;16210643;Antagonist
INCB8761;CCR2;f;;Human;24900280;Antagonist
MC148R;CCR2;f;;Human;9600978;Antagonist
MK-0812;CCR2;f;;Monkey;19913021;Antagonist
PF-04634817;CCR2;f;;Human;;Antagonist
RS-102895;CCR2;f;;Human;10770925;Antagonist
RS-136270;CCR2;f;;Human;10770925;Antagonist
RS-504393;CCR2;f;;Human;12954060;Antagonist
SB-282241;CCR2;f;;Human;12954060;Antagonist
TAK-779;CCR2;f;;Human;12954060;Antagonist
TAK-779;CCR2;f;;Human;12954060|10318947;Antagonist
Teijin-lead_cmp_5;CCR2;f;;Human;12954060;Antagonist
viral macrophage inflammatory protein-II;CCR2;f;;Human;9287217;Antagonist
plozalizumab;CCR2;f;;Human;;Binding
HIV-Tat;CCR3;f;;Human;;Agonist
[125I]CCL5 (human);CCR3;f;;Human;;Agonist
[125I]CCL7 (human);CCR3;f;;Human;;Agonist
CCL11;CCR3;t;Human;Human;8642344;Full agonist
CCL11;CCR3;t;Human;Human;9276730|10488147|16339911|12761559|10854442;Full agonist
CCL11;CCR3;f;Mouse;Human;8642344;Full agonist
CCL13;CCR3;t;Human;Human;9276730|16339911;Full agonist
CCL15;CCR3;t;Human;Human;9346309;Full agonist
CCL2;CCR3;t;Human;Human;8642344;Full agonist
CCL24;CCR3;t;Human;Human;15207250|16339911;Full agonist
CCL26;CCR3;t;Human;Human;15207250|10488147|16339911;Full agonist
CCL28;CCR3;t;Human;Human;;Full agonist
CCL5;CCR3;t;Human;Human;8642344;Full agonist
CCL7;CCR3;t;Human;Human;8642344;Full agonist
CCL8;CCR3;t;Human;Human;;Full agonist
HIV-Tat;CCR3;f;;Human;9789057;Full agonist
AKST4290;CCR3;f;;Human;;Antagonist
AZD3778;CCR3;f;;Human;23031591;Antagonist
BMS compound 87b;CCR3;f;;Human;12067561;Antagonist
CCL18;CCR3;f;Human;Human;23951310;Antagonist
CXCL10;CCR3;t;Human;Human;;Antagonist
CXCL11;CCR3;t;Human;Human;;Antagonist
CXCL9;CCR3;t;Human;Human;;Antagonist
GW766994;CCR3;f;;Human;22931505;Antagonist
Met-Ckβ7;CCR3;f;;Human;10640766;Antagonist
RO116-4875/608;CCR3;f;;Human;12070060;Antagonist
RO116-9132/238;CCR3;f;;Human;12070060;Antagonist
RO320-2947/001;CCR3;f;;Human;12070060;Antagonist
RO330-0802/001;CCR3;f;;Human;12070060;Antagonist
SB328437;CCR3;f;;Human;;Antagonist
[125I]CCL11 (human);CCR3;f;;Human;12450563;Antagonist
UCB35625;CCR3;f;;Human;10854442;Antagonist
YM-355179;CCR3;f;;Human;16339911;Antagonist
banyu (I);CCR3;f;;Human;12450563;Inverse agonist
[3H]banyu (I);CCR3;f;;Human;12450563;Inverse agonist
[125I]CCL27 (human);CCR4;f;;Human;;Agonist
vMIP-III;CCR4;f;;Human;;Agonist
CCL17;CCR4;t;Human;Human;9430724;Full agonist
CCL22;CCR4;t;Human;Human;9430724;Full agonist
[125I]CCL17 (human);CCR4;f;;Human;;Full agonist
AZD1678;CCR4;f;;Rat;28947948;Antagonist
AZD1678;CCR4;f;;Human;28947948;Antagonist
AZD1678;CCR4;f;;Dog;28947948;Antagonist
AZD1678;CCR4;f;;Mouse;28947948;Antagonist
AZD2098;CCR4;f;;Dog;28947948;Antagonist
AZD2098;CCR4;f;;Rat;28947948;Antagonist
AZD2098;CCR4;f;;Mouse;28947948;Antagonist
AZD2098;CCR4;f;;Human;28947948;Antagonist
compound 31 [PMID: 31259550];CCR4;f;;Human;31259550;Antagonist
compound 8ic [PMID: 19081254];CCR4;f;;Human;19081254;Antagonist
GSK2239633A;CCR4;f;;Human;23409871;Antagonist
mogamulizumab;CCR4;f;;Human;21154168;Inhibition
[125I]CCL3 (human);CCR5;f;;Human;;Agonist
[125I]CCL5 (human);CCR5;f;;Human;;Agonist
[125I]CCL8 (human);CCR5;f;;Human;;Agonist
BP-CCL3;CCR5;f;;Human;11170631;Full agonist
CCL11;CCR5;t;Human;Human;10477718;Full agonist
CCL13;CCR5;t;Human;Human;9790730;Full agonist
CCL14;CCR5;t;Human;Human;16298345;Full agonist
CCL16;CCR5;t;Human;Human;;Full agonist
CCL2;CCR5;t;Human;Human;16298345;Full agonist
CCL3;CCR5;t;Human;Human;11170631|16298345|9790730;Full agonist
CCL4;CCR5;t;Human;Human;16298345|9790730;Full agonist
CCL5;CCR5;t;Human;Human;10318947|16298345|9790730;Full agonist
CCL8;CCR5;t;Human;Human;9790730;Full agonist
Flu-CCL3;CCR5;f;;Human;11170631;Full agonist
R5-HIV-1 gp120;CCR5;f;;Human;;Full agonist
[125I]CCL4 (human);CCR5;f;;Human;16298345;Full agonist
compound 39 [PMID: 31742400];CCR5;f;;Human;31742400;Antagonist
ancriviroc;CCR5;f;;Human;16476734|16304152|11585437;Antagonist
aplaviroc;CCR5;f;;Human;16476734;Antagonist
AZD5672;CCR5;f;;Human;22266038;Antagonist
BMS-681;CCR5;f;;Human;25893046;Antagonist
CCL7;CCR5;t;Human;Human;16298345;Antagonist
CCR5 antagonist 34;CCR5;f;;Human;30234300;Antagonist
cenicriviroc;CCR5;f;;Human;16251299;Antagonist
E913;CCR5;f;;Human;11454872;Antagonist
GSK2239633A;CCR5;f;;Human;23409871;Antagonist
maraviroc;CCR5;f;;Human;16298345;Antagonist
MLN-3897;CCR5;f;;Human;17715391;Antagonist
MRK-1;CCR5;f;;Rat;12604693;Antagonist
[3H]ancriviroc;CCR5;f;;Human;16304152;Antagonist
[3H]maraviroc;CCR5;f;;Human;16298345;Antagonist
TAK-220;CCR5;f;;Human;16640339;Antagonist
TAK-779;CCR5;f;;Human;16476734;Antagonist
vicriviroc;CCR5;f;;Human;16304152;Antagonist
viral macrophage inflammatory protein-II;CCR5;f;;Human;9287217;Antagonist
leronlimab;CCR5;f;;Human;;Binding
beta-defensin 4A;CCR6;t;Human;Human;10521347;Full agonist
CCL20;CCR6;t;Human;Human;9169459|9294137|12081481;Full agonist
CCL20-SEAP(His)6;CCR6;f;;Human;9169459;Full agonist
[125I]CCL20 (human);CCR6;f;;Human;9294138;Full agonist
CCL19;CCR7;t;Human;Human;9153236|9507024|16904643;Agonist
CCL19;CCR7;t;Mouse;Mouse;11148224;Agonist
CCL19;CCR7;t;Human;Human;10512740;Agonist
CCL21;CCR7;t;Human;Human;9507024;Agonist
Ccl21a;CCR7;t;Mouse;Mouse;11148224;Agonist
Ccl21b;CCR7;t;Mouse;Mouse;11148224;Agonist
Ccl21b;CCR7;t;Mouse;Human;10512740;Agonist
Ccl21b;CCR7;t;Mouse;Human;16904643;Agonist
[125I]CCL19 (human);CCR7;f;;Human;;Agonist
[125I]CCL21 (human);CCR7;f;;Human;10201891;Agonist
CCL8;CCR8;t;Mouse;Human;;Agonist
CCL1;CCR8;t;Human;Human;11154210|16221874|10419462;Full agonist
[125I]CCL1 (human);CCR8;f;;Human;11154210|9211859;Full agonist
[125I]CCL1 (mouse);CCR8;f;;Mouse;9469461;Full agonist
vMIP-I;CCR8;f;;Human;11154210|10419462;Full agonist
ZK 756326;CCR8;f;;Human;16221874;Full agonist
viral macrophage inflammatory protein-II;CCR8;f;;Human;10419462;Antagonist
vMCC-I;CCR8;f;;Human;10419462;Antagonist
CCL25;CCR9;t;Human;Human;;Full agonist
[125I]CCL25 (human);CCR9;f;;Human;;Full agonist
vercirnon;CCR9;f;;Human;20660125;Antagonist
compound 24 [PMID: 26987013 ];CCR9;f;;Human;26987013;Antagonist
CCL19;CCRL2;t;Human;Human;20002784;Unknown
atibuclimab;CD14 molecule;f;;Human;11717588|15190957;Binding
blinatumomab;CD19;f;;Human;12209608;Binding
inebilizumab;CD19;f;;Human;;Binding
tafasitamab;CD19;f;;Human;18829563;Binding
AH10-7;CD1d molecule;f;;Human;29576533;Binding
alefacept;CD2;f;;Human;12089534|11970990;Inhibition
BsAb (CD89-CD20);CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;29296544;Binding
ibritumomab tiuxetan;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;;Binding
obinutuzumab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;23537278|21378274;Binding
ocrelizumab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;;Binding
ofatumumab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;;Binding
rituximab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;15102696;Binding
tositumomab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;;Binding
ublituximab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;20975664;Binding
veltuzumab;CD20 (membrane-spanning 4-domains, subfamily A, member 1);f;;Human;15102696;Binding
inotuzumab ozogamicin;CD22;f;;Human;14615373;Binding
moxetumomab pasudotox;CD22;f;;Human;22355053|22003067;Binding
CD70;CD27;t;Human;Human;;None
lulizumab pegol;CD28;f;;Human;24081989;Binding
AFM13;CD30;f;;Human;24670809;Binding
brentuximab vedotin;CD30;f;;Human;;Inhibition
CD30 ligand;CD30;t;Human;Human;;None
gemtuzumab ozogamicin;CD33;f;;Human;10720144;Binding
lintuzumab;CD33;f;;Human;1458463;Binding
vadastuximab talirine;CD33;f;;Human;23770776;Binding
compound 3c [PMID: 30360354];CD36 molecule;f;;Rat;22712585;Antagonist
peptide 1 [PMID: 31774287];CD36 molecule;f;;Rat;31774287;Antagonist
peptide 5A;CD36 molecule;f;;Human;26994575;Antagonist
lilotomab;CD37 molecule;f;;Human;23267131;Binding
naratuximab emtansine;CD37 molecule;f;;Human;24002446;Binding
otlertuzumab;CD37 molecule;f;;Human;23883821;Binding
daratumumab;CD38;f;;Human;;Antagonist
isatuximab;CD38;f;;Human;;Binding
mezagitamab;CD38;f;;Human;;Binding
blinatumomab;CD3e;f;;Human;12209608;Binding
catumaxomab;CD3e;f;;Human;20190561;Binding
muromonab-CD3;CD3e;f;;Human;3105134;Binding
otelixizumab;CD3e;f;;Human;8436176;Binding
PF-07062119;CD3e;f;;Monkey;31996389;Binding
PF-07062119;CD3e;f;;Human;31996389;Binding
tepoditamab;CD3e;f;;Human;;Binding
AX-024;CD3e;f;;Human;28003549;Binding
ibalizumab;CD4;f;;Human;1380539;Binding
tregalizumab;CD4;f;;Human;;Binding
CFZ533;CD40;f;;Human;;Binding
CD40 ligand;CD40;t;Human;Human;;None
alemtuzumab;CD52;f;;Human;9593475;Binding
itolizumab;CD6;f;;Human;18707547;Binding
labetuzumab;CD66e (CEACAM5);f;;Human;;Binding
labetuzumab govitecan;CD66e (CEACAM5);f;;Human;;Binding
milatuzumab;CD74;f;;Human;16033844;Binding
polatuzumab vedotin;CD79B;f;;Human;;Binding
abatacept;CD80;f;;Human;23899231|1714933;Inhibition
belatacept;CD80;f;;Human;19300198;Inhibition
abatacept;CD86;f;;Human;23899231|1714933;Inhibition
belatacept;CD86;f;;Human;19300198;Inhibition
compound 11d [DOI: 10.1039/c0md00194e];CDC42 binding protein kinase alpha;f;;Human;;Inhibition
RKI-1447;CDC42 binding protein kinase alpha;f;;Human;23275831;Inhibition
A-443654;CDC42 binding protein kinase beta;f;;Human;19465931;Inhibition
Cdc2-like kinase inhibitor;CDC like kinase 1;f;;Mouse;18077363;Inhibition
Cdc2-like kinase inhibitor;CDC like kinase 1;f;;Mouse;18077363;Inhibition
compound 17 [PMID: 23642479];CDC like kinase 1;f;;Human;23642479;Inhibition
compound 2 [PMID: 22560567];CDC like kinase 1;f;;Human;21295469;Inhibition
compound 3b [PMID: 23454515];CDC like kinase 1;f;;Mouse;23454515;Inhibition
KH-CB19;CDC like kinase 1;f;;Human;21276940;Inhibition
leucettine L41;CDC like kinase 1;f;;Mouse;21615147;Inhibition
ML315;CDC like kinase 1;f;;Human;23642479;Inhibition
Cdc2-like kinase inhibitor;CDC like kinase 2;f;;Mouse;18077363;Inhibition
compound 17 [PMID: 23642479];CDC like kinase 2;f;;Human;23642479;Inhibition
compound 20 [PMID: 30998356];CDC like kinase 2;f;;Human;30998356;Inhibition
compound 3b [PMID: 23454515];CDC like kinase 2;f;;Mouse;23454515;Inhibition
lorecivivint;CDC like kinase 2;f;;Human;28888902;Inhibition
ML315;CDC like kinase 2;f;;Human;23642479;Inhibition
Takinib;CDC like kinase 2;f;;Human;28820959;Inhibition
compound 3b [PMID: 23454515];CDC like kinase 3;f;;Mouse;23454515;Inhibition
KH-CB19;CDC like kinase 3;f;;Human;21276940;Inhibition
leucettine L41;CDC like kinase 3;f;;Mouse;21615147;Inhibition
compound 17 [PMID: 23642479];CDC like kinase 4;f;;Human;23642479;Inhibition
compound 3b [PMID: 23454515];CDC like kinase 4;f;;Mouse;23454515;Inhibition
kinase inhibitor 2 [PMID: 30199702];CDC like kinase 4;f;;Human;30199702;Inhibition
ML315;CDC like kinase 4;f;;Human;23642479;Inhibition
tomivosertib;CDC like kinase 4;f;;Human;29526098;Inhibition
compound 50 [PMID: 24313754];CECR2 histone acetyl-lysine reader;f;;Human;24313754;Inhibition
NVS-1;CECR2 histone acetyl-lysine reader;f;;Human;;Inhibition
compound 18 [PMID: 20873740];cell division cycle 7;f;;Human;20873740;Inhibition
compound 1 [PMID: 24793884];cell division cycle 7;f;;Human;24793884;Inhibition
compound 2 [PMID: 22560567];cell division cycle 7;f;;Human;22560567;Inhibition
compound 74 [PMID: 24793884];cell division cycle 7;f;;Human;24793884;Inhibition
compound 77 [PMID: 24793884];cell division cycle 7;f;;Human;24793884;Inhibition
compound 89S [PMID: 19115845];cell division cycle 7;f;;Human;19115845;Inhibition
compound 89S [PMID: 19115845];cell division cycle 7;f;;Human;19115845;Inhibition
simurosertib;cell division cycle 7;f;;Human;;Inhibition
XL413;cell division cycle 7;f;;Human;22560567;Inhibition
NVP 231;ceramide kinase;f;;Human;18612076;Inhibition
avadomide;cereblon;f;;Human;26002965;Binding
compound 7f [PMID: 31251063];cereblon;f;;None;31251063|25448889;Binding
dBRD9;cereblon;f;;Human;28418626;Binding
dTAG-13;cereblon;f;;Human;29581585;Binding
iberdomide;cereblon;f;;Human;28425720;Binding
lenalidomide;cereblon;f;;Human;28425720;Binding
pomalidomide;cereblon;f;;Human;28425720;Binding
thalidomide;cereblon;f;;Human;20223979;Binding
apigenin;CFTR;f;;Human;;Potentiation
capsaicin;CFTR;f;;Human;;Potentiation
CBIQ;CFTR;f;;Human;;Potentiation
felodipine;CFTR;f;;Human;17452495;Potentiation
genistein;CFTR;f;;Human;;Potentiation
ivacaftor;CFTR;f;;Human;;Potentiation
nimodipine;CFTR;f;;Human;;Potentiation
NS004;CFTR;f;;Human;;Potentiation
phenylglycine-01;CFTR;f;;Human;;Potentiation
sulfonamide-01;CFTR;f;;Human;;Potentiation
UCCF-029;CFTR;f;;Human;;Potentiation
UCCF-339;CFTR;f;;Human;;Potentiation
UCCF-853;CFTR;f;;Human;;Potentiation
CFTRinh-172;CFTR;f;;Human;;None
GaTx1;CFTR;f;;Human;;None
glibenclamide;CFTR;f;;Human;1281220;None
GlyH-101;CFTR;f;;Human;;None
crofelemer;CFTR;f;;Human;19808995;Inhibition
ABBV-3221;CFTR;f;;Human;31749908;Binding
bamocaftor;CFTR;f;;Human;30334693;Binding
elexacaftor;CFTR;f;;Human;30334692;Binding
lumacaftor;CFTR;f;;Human;26561003;Binding
tezacaftor;CFTR;f;;Human;;Binding
adrenomedullin;CGRP receptor;f;Rat;Mouse;14609735;Full agonist
adrenomedullin;CGRP receptor;t;Human;Human;9620797|11693189;Full agonist
adrenomedullin;CGRP receptor;t;Rat;Rat;10854696|11556887;Full agonist
adrenomedullin 2/intermedin;CGRP receptor;t;Human;Human;21658025;Full agonist
α-CGRP;CGRP receptor;t;Mouse|Rat;Rat;10854696|10342881|10767413|11556887;Full agonist
α-CGRP;CGRP receptor;t;Human;Human;9620797|11693189;Full agonist
α-CGRP;CGRP receptor;t;Mouse|Rat;Mouse;14609735;Full agonist
β-CGRP;CGRP receptor;t;Rat;Rat;10854696|10342881|10767413|11556887;Full agonist
β-CGRP;CGRP receptor;t;Human;Human;9620797|11693189;Full agonist
[Cys(Et)2,7]α-CGRP (human);CGRP receptor;f;;Human;15794944;Full agonist
[125I]αCGRP (mouse, rat);CGRP receptor;f;;Human;;Full agonist
[125I]αCGRP (human);CGRP receptor;f;;Human;;Full agonist
[Cys(ACM)2,7]CGRP;CGRP receptor;f;;Human;11693189;Partial agonist
α-CGRP-(8-37) (human);CGRP receptor;f;;Human;9620797|11693189;Antagonist
α-CGRP-(8-37) (rat);CGRP receptor;t;;Rat;10854696|10342881|10767413|11556887;Antagonist
atogepant;CGRP receptor;f;;Human;;Antagonist
compound 49 [PMID: 24405707];CGRP receptor;f;;Human;24405707;Antagonist
compound 8 [Avgoustou et al., 2020];CGRP receptor;f;;Human;;Antagonist
HTL22562;CGRP receptor;f;;Human;32558564;Antagonist
olcegepant;CGRP receptor;f;;Human;11847213|10711339|12970090|16959943|24405707;Antagonist
rimegepant;CGRP receptor;f;;Human;23153230;Antagonist
telcagepant;CGRP receptor;f;;Human;18039958;Antagonist
ubrogepant;CGRP receptor;f;;Human;;Antagonist
erenumab;CGRP receptor;f;;Human;26559125;Antagonist
7-hydroxystaurosporine;checkpoint kinase 1;f;;Human;15486189|17292828|10786669;Inhibition
AZD7762;checkpoint kinase 1;f;;Human;22551018;Inhibition
BX-795;checkpoint kinase 1;f;;Human;15772071;Inhibition
BX-912;checkpoint kinase 1;f;;Human;15772071;Inhibition
CCT241533;checkpoint kinase 1;f;;Human;21239475;Inhibition
CCT244747;checkpoint kinase 1;f;;Human;23082860;Inhibition
CCT245737;checkpoint kinase 1;f;;Human;27167172;Inhibition
CHIR-124;checkpoint kinase 1;f;;Human;16603354;Inhibition
compound 25 [PMID: 17935989];checkpoint kinase 1;f;;Human;17935989;Inhibition
compound 25 [PMID: 20855207];checkpoint kinase 1;f;;Human;20855207;Inhibition
compound 33 [PMID: 19364658];checkpoint kinase 1;f;;Human;19364658;Inhibition
isogranulatimide;checkpoint kinase 1;f;;Human;18321713|15486189;Inhibition
MK-8776;checkpoint kinase 1;f;;Human;21094607;Inhibition
PF-477736;checkpoint kinase 1;f;;Human;18723486;Inhibition
prexasertib;checkpoint kinase 1;f;;Human;26141948;Inhibition
rabusertib;checkpoint kinase 1;f;;Human;24114124;Inhibition
SB 218078;checkpoint kinase 1;f;;Human;10676638;Inhibition
7-hydroxystaurosporine;checkpoint kinase 2;f;;Human;10786669;Inhibition
AZD7762;checkpoint kinase 2;f;;Human;22551018;Inhibition
CCT241533;checkpoint kinase 2;f;;Human;21239475;Inhibition
CCT245737;checkpoint kinase 2;f;;Human;27167172;Inhibition
CDK inhibitor 4.35;checkpoint kinase 2;f;;Human;30943029;Inhibition
Chk2 inhibitor II;checkpoint kinase 2;f;;Human;18077363;Inhibition
compound 25b [PMID: 22564207];checkpoint kinase 2;f;;Human;22564207;Inhibition
isogranulatimide;checkpoint kinase 2;f;;Human;18077363;Inhibition
PF-477736;checkpoint kinase 2;f;;Human;18723486;Inhibition
prexasertib;checkpoint kinase 2;f;;Human;26141948;Inhibition
[3H]resolvin E1;chemerin receptor 1;f;;Human;15753205|17339491;Agonist
tethered chemerin 9;chemerin receptor 1;f;;Human;14530373|24659779;Agonist
chemerin;chemerin receptor 1;t;Human;Human;18165312;Full agonist
chemerin;chemerin receptor 1;t;Human;Human;18165312|14530373|14701797|23396314;Full agonist
chemerin;chemerin receptor 1;f;Human;Human;25437209;Full agonist
chemerin C-terminal peptide;chemerin receptor 1;f;;Human;18165312|14701797;Full agonist
resolvin E1;chemerin receptor 1;f;;Human;;Full agonist
resolvin E1;chemerin receptor 1;t;;Human;15753205|20887750|17339491;Full agonist
α-NETA;chemerin receptor 1;f;;Human;25437209;Antagonist
chemerin C-terminal peptide;chemerin receptor 2;f;;Human;18165312;Agonist
OSTN (81-102);chemerin receptor 2;f;;Human;31675498;Agonist
chemerin;chemerin receptor 2;t;Human;Human;18165312|23396314;Full agonist
chemerin;chemerin receptor 2;t;Human;Human;18165312;Full agonist
compound 7f [PMID: 29283260];chitinase acidic;f;;Mouse;29283260;Inhibition
compound 7f [PMID: 29283260];chitinase acidic;f;;Human;29283260;Inhibition
naphthylvinylmethylpyridine;choline O-acetyltransferase;f;;Mouse;3351860;Inhibition
hemicholinium-3;Choline transporter-like 1;f;;Human;;Inhibition
hemicholinium-3;CHT;f;;Human;12675135;Inhibition
[3H]hemicholinium-3;CHT;f;;Human;;None
compound 7f [PMID: 29191554];chymase 1;f;;Human;29191554;Inhibition
JNJ-10311795;chymase 1;f;;Human;17361995;Inhibition
NK3201;chymase 1;f;;Human;14960660;Inhibition
TY-51469;chymase 1;f;;Human;21128860|17895529;Inhibition
compound 20 [PMID: 12372533];chymotrypsin C;f;;Human;12372533;Inhibition
telaprevir;chymotrypsin like elastase 1;f;;Human;19841155;Inhibition
ciliary neurotrophic factor;Ciliary neutrophic factor receptor;t;Human;Human;;Agonist
CRCF1/CLCF1 heterodimer;Ciliary neutrophic factor receptor;t;Human;Human;;Agonist
IMAB362;claudin 18;f;;Human;19047087;Binding
9-anthroic acid;ClC-1;f;;Human;;None
Cd2+;ClC-1;f;;Human;;None
fenofibric acid;ClC-1;f;;Human;;None
S-(-)CPB;ClC-1;f;;Human;;None
S-(-)CPP;ClC-1;f;;Human;;None
niflumic acid;ClC-1;f;;Human;;None
Zn2+;ClC-1;f;;Human;;None
arachidonic acid;ClC-2;t;;Human;;None
lubiprostone;ClC-2;f;;Human;;None
omeprazole;ClC-2;f;;Human;;None
Cd2+;ClC-2;f;;Human;;None
diphenylamine-2-carboxylic acid;ClC-2;f;;Human;;None
GaTx2;ClC-2;f;;Human;;None
NPPB;ClC-2;f;;Human;;None
Zn2+;ClC-2;f;;Human;;None
phloretin;ClC-3;f;;Human;;None
Cd2+;ClC-4;f;;Human;18658230;None
Zn2+;ClC-4;f;;Human;18658230;None
DIDS;ClC-6;f;;Human;;None
DIDS;ClC-7;f;;Human;20830208;None
NPPB;ClC-7;f;;Human;20830208;None
NS5818;ClC-7;f;;Human;20830208;None
niflumic acid;ClC-Ka;f;;Human;;None
3-phenyl-CPP;ClC-Ka;f;;Human;;None
DIDS;ClC-Ka;f;;Human;;None
niflumic acid;ClC-Ka;f;;Human;;None
niflumic acid;ClC-Kb;f;;Human;;None
3-phenyl-CPP;ClC-Kb;f;;Human;;None
DIDS;ClC-Kb;f;;Human;;None
cyclic GMP;CNGA1;t;;Human;12467592|7530019|1379636|7479749|9512030|7526403|9874685;Agonist
dequalinium;CNGA1;f;;Human;12508052;Antagonist
H-8;CNGA1;f;;Rat;9324234;Antagonist
L-(cis)-diltiazem;CNGA1;f;;Human;7682292;Antagonist
cyclic AMP;CNGA2;t;;Rat;10377344|7522482|7522325|22786723;Agonist
cyclic GMP;CNGA2;t;;Rat;7522482|7522325|22786723;Agonist
dequalinium;CNGA2;f;;Human;14981138;Antagonist
L-(cis)-diltiazem;CNGA2;f;;Rat;1697649;Antagonist
pseudechetoxin;CNGA2;f;;Rat;9892706|14638933;Antagonist
all-trans-retinal;CNGA2;f;;Rat;12034887;Antagonist
calmodulin;CNGA2;f;Human;Rat;7511217|7526466;Antagonist
PIP3;CNGA2;f;;Rat;17032767;Antagonist
cyclic AMP;CNGA3;t;;Human;8814292|12730238;Agonist
cyclic AMP;CNGA3;t;;Rat;11387380;Agonist
cyclic GMP;CNGA3;t;;Human;8814292|9517456|12730238;Agonist
cyclic GMP;CNGA3;t;;Rat;11387380;Agonist
L-(cis)-diltiazem;CNGA3;f;;Human;;None
L-(cis)-diltiazem;CNGB3;f;;Mouse;10662822;Antagonist
BIIB021;coactivator associated arginine methyltransferase 1;f;;Human;;Inhibition
BMS pyrazole inhibitor 7f;coactivator associated arginine methyltransferase 1;f;;Human;19419866;Inhibition
compound 17f [PMID: 19632837];coactivator associated arginine methyltransferase 1;f;;Human;19632837;Inhibition
MS023;coactivator associated arginine methyltransferase 1;f;;Human;;Inhibition
MS049;coactivator associated arginine methyltransferase 1;f;;Human;27584694;Inhibition
MS049;coactivator associated arginine methyltransferase 1;f;;Human;27584694;Inhibition
SGC2085;coactivator associated arginine methyltransferase 1;f;;Human;27390919;Inhibition
argatroban;coagulation factor II, thrombin;f;;Human;9361377;Inhibition
AR-H067637;coagulation factor II, thrombin;f;;Human;19492147;Inhibition
AZ12971554;coagulation factor II, thrombin;f;;Human;;Inhibition
bivalirudin;coagulation factor II, thrombin;f;;Human;1290488;Inhibition
dabigatran;coagulation factor II, thrombin;f;;Human;11960487;Inhibition
desirudin;coagulation factor II, thrombin;f;;Human;1894196;Inhibition
Dup-714;coagulation factor II, thrombin;f;;Human;;Inhibition
lepirudin;coagulation factor II, thrombin;f;;Human;16363236;Inhibition
melagatran;coagulation factor II, thrombin;f;;Human;9459334;Inhibition
ximelagatran;coagulation factor II, thrombin;f;;Human;;Inhibition
emicizumab;coagulation factor IX;f;;Human;28451690;Binding
compound 57 [PMID: 20121197];coagulation factor IX;f;;Human;20121197;Inhibition
drotrecogin alfa;coagulation factor V;f;;Human;11463021|11714212;Inhibition
compound 11 [PMID: 16413183];coagulation factor VII;f;;Human;16413183;Inhibition
compound 1 [PMID: 16650987];coagulation factor VII;f;;Human;16650987;Inhibition
drotrecogin alfa;coagulation factor VIII;f;;Human;11463021|11714212;Inhibition
emicizumab;coagulation factor X;f;;Human;28451690;Binding
apixaban;coagulation factor X;f;;Human;18315548;Inhibition
betrixaban;coagulation factor X;f;;Human;19297154;Inhibition
edoxaban;coagulation factor X;f;;Human;20503967;Inhibition
eribaxaban;coagulation factor X;f;;Human;19231206;Inhibition
otamixaban;coagulation factor X;f;;Human;12039587;Inhibition
rivaroxaban;coagulation factor X;f;;Human;20139357;Inhibition
zifaxaban;coagulation factor X;f;;Human;30298304;Inhibition
alpha-ketothiazole analogue 36;coagulation factor XI;f;;Human;18053726;Inhibition
methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1,2,4-triazole-3-carboxylate;coagulation factor XII;f;;Human;;Inhibition
IL-34;colony stimulating factor 1 receptor;f;Human;Human;18467591;Agonist
AMG820;colony stimulating factor 1 receptor;f;;Human;;Binding
cabiralizumab;colony stimulating factor 1 receptor;f;;Human;;Binding
emactuzumab;colony stimulating factor 1 receptor;f;;Human;;Binding
LY3022855;colony stimulating factor 1 receptor;f;;Human;;Binding
AC710;colony stimulating factor 1 receptor;f;;Human;24900421;Inhibition
ARRY-382;colony stimulating factor 1 receptor;f;;Human;;Inhibition
AZD6495;colony stimulating factor 1 receptor;f;;Human;19114305;Inhibition
BLZ945;colony stimulating factor 1 receptor;f;;Human;32787110;Inhibition
BLZ945;colony stimulating factor 1 receptor;f;;Human;24498562;Inhibition
CC-223;colony stimulating factor 1 receptor;f;;Human;26083478;Inhibition
cediranib;colony stimulating factor 1 receptor;f;;Human;15899831;Inhibition
cerdulatinib;colony stimulating factor 1 receptor;f;;Human;25253883;Inhibition
CHMFL-KIT-64;colony stimulating factor 1 receptor;f;;Human;31250638;Inhibition
compound 29 [PMID: 31934767];colony stimulating factor 1 receptor;f;;Human;31934767;Inhibition
crenolanib;colony stimulating factor 1 receptor;f;;Human;22745105;Inhibition
CS2164;colony stimulating factor 1 receptor;f;;Human;28004478;Inhibition
DCC-3014;colony stimulating factor 1 receptor;f;;Human;;Inhibition
dovitinib;colony stimulating factor 1 receptor;f;;Human;19113866|15598814;Inhibition
edicotinib;colony stimulating factor 1 receptor;f;;Human;26233509;Inhibition
GR-389988;colony stimulating factor 1 receptor;f;;Human;;Inhibition
GTP-14564;colony stimulating factor 1 receptor;f;;Human;12815052;Inhibition
GW-2580;colony stimulating factor 1 receptor;f;;Human;16249345;Inhibition
GW-2580;colony stimulating factor 1 receptor;f;;Human;22037378;Inhibition
IACS-9439;colony stimulating factor 1 receptor;f;;Human;32787110;Inhibition
IACS-9439;colony stimulating factor 1 receptor;f;;Human;32787110;Inhibition
ilorasertib;colony stimulating factor 1 receptor;f;;Human;22935731;Inhibition
JNJ-28312141;colony stimulating factor 1 receptor;f;;Human;19887542;Inhibition
JNJ-28312141;colony stimulating factor 1 receptor;f;;Human;22037378;Inhibition
Ki-20227;colony stimulating factor 1 receptor;f;;Human;22037378;Inhibition
Ki-20227;colony stimulating factor 1 receptor;f;;Human;17121910;Inhibition
linifanib;colony stimulating factor 1 receptor;f;;Human;16648571;Inhibition
OSI-930;colony stimulating factor 1 receptor;f;;Human;16424037;Inhibition
pazopanib;colony stimulating factor 1 receptor;f;;Human;18620382;Inhibition
pexidartinib;colony stimulating factor 1 receptor;f;;Human;26222558;Inhibition
quizartinib;colony stimulating factor 1 receptor;f;;Human;19754199;Inhibition
tandutinib;colony stimulating factor 1 receptor;f;;Human;12124172;Inhibition
TG02;colony stimulating factor 1 receptor;f;;Human;21860433;Inhibition
G-CSF;colony stimulating factor 1 receptor;t;Human;Human;;None
GM-CSF;colony stimulating factor 1 receptor;t;Human;Human;;None
M-CSF;colony stimulating factor 1 receptor;t;Human;Human;;None
nafamostat;complement C1r;f;;Human;9544206;Inhibition
sutimlimab;complement C1s;f;;Human;;Binding
compound 28 [PMID: 16460935];complement C1s;f;;Human;16460935;Inhibition
compound 51 [PMID: 19743866];complement factor B;f;;Human;19743866;Inhibition
LNP023;complement factor B;f;;Human;32073845;Inhibition
lampalizumab;complement factor D;f;;Human;25232192;Binding
compound 2 [PMID: 28621538];complement factor D;f;;Human;28621538;Inhibition
example 373 [WO2012093101];complement factor D;f;;Human;24900375;Inhibition
BMS-345541;component of inhibitor of nuclear factor kappa B kinase complex;f;;Human;12403772;Negative
BAY 61-3606;component of inhibitor of nuclear factor kappa B kinase complex;f;;Human;26930276;Inhibition
compound 47 [PMID: 28737909];component of inhibitor of nuclear factor kappa B kinase complex;f;;Human;28737909;Inhibition
PHA-408;component of inhibitor of nuclear factor kappa B kinase complex;f;;Human;19168710;Inhibition
5β-pregnane-3,20-dione;Constitutive androstane receptor;f;;Human;10748001;Agonist
CITCO;Constitutive androstane receptor;f;;Human;12611900;Agonist
meclizine;Constitutive androstane receptor;f;;Mouse;15272053;Agonist
TCPOBOP;Constitutive androstane receptor;f;;Mouse;10757780;Agonist
clotrimazole;Constitutive androstane receptor;f;;Human;10748001;Antagonist
meclizine;Constitutive androstane receptor;f;;Human;15272053;Antagonist
androstanol;Constitutive androstane receptor;f;;Mouse;9783588;Inverse agonist
androstenol;Constitutive androstane receptor;f;;Mouse;9783588;Inverse agonist
ALP-POS-c59291d4-5;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
ALP-POS-c59291d4-5;CoV 3C-like (main) protease;f;;SARS-CoV;18796354;Inhibition
boceprevir;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
boceprevir;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
boceprevir;CoV 3C-like (main) protease;f;;SARS-CoV;;Inhibition
compound 11a [PMID: 32321856];CoV 3C-like (main) protease;f;;SARS-CoV-2;32321856;Inhibition
compound 11b [PMID: 32321856];CoV 3C-like (main) protease;f;;SARS-CoV-2;32321856;Inhibition
compound 11r [PMID: 32045235];CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
compound 13b [PMID: 32198291];CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
compound 6e [PMID: 32747425];CoV 3C-like (main) protease;f;;SARS-CoV;32747425;Inhibition
compound 6e [PMID: 32747425];CoV 3C-like (main) protease;f;;SARS-CoV-2;32747425;Inhibition
compound 6j [PMID: 32747425];CoV 3C-like (main) protease;f;;SARS-CoV-2;32747425;Inhibition
compound 6j [PMID: 32747425];CoV 3C-like (main) protease;f;;SARS-CoV;32747425;Inhibition
DAV-CRI-14a23e73-1;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
GC-376;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
MP13;CoV 3C-like (main) protease;f;;SARS-CoV-2;32766582;Inhibition
PF-00835231;CoV 3C-like (main) protease;f;;SARS-CoV;;Inhibition
PRD_002214;CoV 3C-like (main) protease;f;;SARS-CoV;16128623;Inhibition
TG-0203770;CoV 3C-like (main) protease;f;;SARS-CoV;19144641;Inhibition
TG-0205221;CoV 3C-like (main) protease;f;;SARS-CoV;16884309;Inhibition
walrycin B;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
Z-FA-FMK;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Inhibition
PRD_002214;CoV 3C-like (main) protease;f;;SARS-CoV-2;;Irreversible inhibition
ebselen;CoV Papain-like protease;f;;SARS-CoV-2;;Inhibition
GRL-0617;CoV Papain-like protease;f;;SARS-CoV-2;32428392;Inhibition
remdesivir;CoV RNA-dependent RNA polymerase;f;;SARS-CoV-2;32284326;Inhibition
remdesivir;CoV RNA-dependent RNA polymerase;f;;SARS-CoV;32284326;Inhibition
bamlanivimab;CoV Spike glycoprotein;f;;SARS-CoV-2;;Binding
cilgavimab;CoV Spike glycoprotein;f;;SARS-CoV-2;32668443;Binding
CR3022;CoV Spike glycoprotein;f;;SARS-CoV-2;32065055;Binding
etesevimab;CoV Spike glycoprotein;f;;SARS-CoV-2;;Binding
mAb 4A8;CoV Spike glycoprotein;f;;SARS-CoV-2;;Binding
regdanvimab;CoV Spike glycoprotein;f;;SARS-CoV-2;;Binding
sotrovimab;CoV Spike glycoprotein;f;;SARS-CoV-2;;Binding
tixagevimab;CoV Spike glycoprotein;f;;SARS-CoV-2;32668443;Binding
casirivimab;CoV Spike glycoprotein;f;;SARS-CoV-2;32540901;None
imdevimab;CoV Spike glycoprotein;f;;SARS-CoV-2;32540901;None
alunacedase alfa;CoV Spike glycoprotein;f;;SARS-CoV-2;;Binding
heparin;CoV Spike glycoprotein;f;;SARS-CoV-2;32653452;Binding
LCB1;CoV Spike glycoprotein;f;;SARS-CoV-2;32907861;Binding
LCB3;CoV Spike glycoprotein;f;;SARS-CoV-2;32907861;Binding
aspirin;COX-1 ;f;;Human;19884005;Inhibition
bromfenac;COX-1 ;f;;Human;;Inhibition
celecoxib;COX-1 ;f;;Human;29031075;Inhibition
compound 12a [PMID: 29031075];COX-1 ;f;;Human;29031075;Inhibition
compound 9 [Kumar et al., 2019];COX-1 ;f;;Sheep;31445233;Inhibition
diclofenac;COX-1 ;f;;Human;16252917;Inhibition
fenoprofen;COX-1 ;f;;Human;;Inhibition
FK-881;COX-1 ;f;;Human;21745460;Inhibition
flurbiprofen;COX-1 ;f;;Human;10377455;Inhibition
FR122047;COX-1 ;f;;Human;10720634;Inhibition
GW406381;COX-1 ;f;;Human;15454242;Inhibition
ibuprofen;COX-1 ;f;;Human;9544212;Inhibition
indomethacin;COX-1 ;f;;Human;29031075;Inhibition
(R)-ARN2508;COX-1 ;f;;Human;26774927;Inhibition
(S)-ARN2508;COX-1 ;f;;Human;26774927;Inhibition
ketoprofen;COX-1 ;f;;Human;18667313;Inhibition
ketorolac;COX-1 ;f;;Human;10377455;Inhibition
ketorolac;COX-1 ;f;;Human;22091869;Inhibition
meclofenamic acid;COX-1 ;f;;Human;11844663;Inhibition
mefenamic acid;COX-1 ;f;;Human;23454516;Inhibition
meloxicam;COX-1 ;f;;Human;9083488;Inhibition
naproxcinod;COX-1 ;f;;Human;19392579;Inhibition
naproxen;COX-1 ;f;;Human;9057869;Inhibition
nimesulide;COX-1 ;f;;Human;15993594;Inhibition
oxaprozin;COX-1 ;f;;Human;9650852;Inhibition
paracetamol;COX-1 ;f;;Human;17884974;Inhibition
peptide 30 [PMID: 27019010];COX-1 ;f;;Human;27019010;Inhibition
phenylbutazone;COX-1 ;f;;Human;;Inhibition
piroxicam;COX-1 ;f;;Human;9083488;Inhibition
SC-236;COX-1 ;f;;Human;9135032;Inhibition
SC-560;COX-1 ;f;;Human;9789085;Inhibition
sulindac;COX-1 ;f;;Human;20541701;Inhibition
suprofen;COX-1 ;f;;Human;18667313;Inhibition
SWE101;COX-1 ;f;;Human;31436984;Inhibition
SC-236;COX-2 ;f;;Human;9135032;Inhibition
aspirin;COX-2 ;f;;Human;22386242;Inhibition
benzquinamide;COX-2 ;f;;Human;;Inhibition
carprofen;COX-2 ;f;;Human;21873070;Inhibition
celecoxib;COX-2 ;f;;Human;12643942;Inhibition
celecoxib;COX-2 ;f;;Human;29031075;Inhibition
compound 12a [PMID: 29031075];COX-2 ;f;;Human;29031075;Inhibition
compound 3 [Uddin et al., 2020];COX-2 ;f;;Mouse;;Inhibition
compound 9 [Kumar et al., 2019];COX-2 ;f;;Human;31445233;Inhibition
diclofenac;COX-2 ;f;;Human;17341061;Inhibition
esflurbiprofen;COX-2 ;f;;Human;8809636;Inhibition
etodolac;COX-2 ;f;;Human;11804398;Inhibition
etoricoxib;COX-2 ;f;;Human;11160644;Inhibition
FK-881;COX-2 ;f;;Human;21745460;Inhibition
flurbiprofen;COX-2 ;f;;Human;10091674;Inhibition
GW406381;COX-2 ;f;;Human;15454242;Inhibition
ibuprofen;COX-2 ;f;;Human;22091869;Inhibition
indomethacin;COX-2 ;f;;Human;29031075;Inhibition
(R)-ARN2508;COX-2 ;f;;Human;26774927;Inhibition
(S)-ARN2508;COX-2 ;f;;Human;26774927;Inhibition
ketoprofen;COX-2 ;f;;Human;18667313;Inhibition
ketorolac;COX-2 ;f;;Human;22091869;Inhibition
ketorolac;COX-2 ;f;;Human;22091869;Inhibition
lumiracoxib;COX-2 ;f;;Human;17434872;Inhibition
meclofenamic acid;COX-2 ;f;;Human;11844663;Inhibition
mefenamic acid;COX-2 ;f;;Human;23454516;Inhibition
meloxicam;COX-2 ;f;;Human;9083488;Inhibition
naproxcinod;COX-2 ;f;;Human;19392579;Inhibition
naproxen;COX-2 ;f;;Human;9057869;Inhibition
nimesulide;COX-2 ;f;;Human;15993594;Inhibition
NS-398;COX-2 ;f;;Human;10821716;Inhibition
oxaprozin;COX-2 ;f;;Human;9650852;Inhibition
paracetamol;COX-2 ;f;;Human;17884974;Inhibition
peptide 30 [PMID: 27019010];COX-2 ;f;;Human;27019010;Inhibition
phenylbutazone;COX-2 ;f;;Human;7562922;Inhibition
piroxicam;COX-2 ;f;;Human;7562922;Inhibition
resveratrol;COX-2 ;f;;Human;20527891;Inhibition
rofecoxib;COX-2 ;f;;Human;10377455;Inhibition
SC-560;COX-2 ;f;;Human;9789085;Inhibition
sulindac;COX-2 ;f;;Human;20541701;Inhibition
suprofen;COX-2 ;f;;Human;18667313;Inhibition
SWE101;COX-2 ;f;;Human;31436984;Inhibition
valdecoxib;COX-2 ;f;;Human;10715145;Inhibition
compound 57 [PMID: 16610804];cPLA2-4A;f;;Human;16610804;Inhibition
compound 50 [PMID: 24313754];CREB binding protein;f;;Human;24313754;Inhibition
I-CBP112;CREB binding protein;f;;Human;;Inhibition
ischemin;CREB binding protein;f;;Human;21513889;Inhibition
SGC-CBP30;CREB binding protein;f;;Human;24497428;Inhibition
corticotrophin-releasing hormone;CRF1 receptor;t;Human|Mouse|Rat;Human;7692441|9326293|9851694|11123370|8612563|7477349;Full agonist
corticotropin-releasing factor;CRF1 receptor;f;Sheep;Human;9326293|9851694|15450949|11123370;Full agonist
sauvagine;CRF1 receptor;f;;Human;9326293|15450949|11123370|8612563|7477349|9918582;Full agonist
[125I]CRF (ovine);CRF1 receptor;f;;Human;7692441|9326293;Full agonist
[125I]sauvagine (frog);CRF1 receptor;f;;Human;15450949|11123370;Full agonist
[125I]Tyr0-CRF (human, rat, mouse);CRF1 receptor;f;;Human;11123370;Full agonist
[125I]urocortin 1 (mouse, rat);CRF1 receptor;f;;Human;9918582;Full agonist
urocortin 1;CRF1 receptor;f;Mouse|Rat;Human;11123370|8612563|7477349|9918582|11416224;Full agonist
urocortin 1;CRF1 receptor;t;Human;Human;15450949|11123370|8612563;Full agonist
urocortin 2;CRF1 receptor;t;Human;Human;15450949;Full agonist
urotensin 1 (fish);CRF1 receptor;f;;Human;11123370|7477349;Full agonist
α-helical CRF;CRF1 receptor;f;;Human;9918582;Antagonist
antalarmin;CRF1 receptor;f;;Human;8940412;Antagonist
astressin;CRF1 receptor;f;;Human;9851694|11123370|9918582;Antagonist
astressin;CRF1 receptor;f;;Human;12361401;Antagonist
astressin;CRF1 receptor;f;;Human;24269930;Antagonist
astressin 2B;CRF1 receptor;f;;Human;12361401;Antagonist
CP 154,526;CRF1 receptor;f;;Rat;8874139;Antagonist
CP-316,311;CRF1 receptor;f;;Rat;18260619;Antagonist
CP-316,311;CRF1 receptor;f;;Human;18260619;Antagonist
CP 376,395;CRF1 receptor;f;;Rat;18288792;Antagonist
CRA1000;CRF1 receptor;f;;Human;10357258;Antagonist
DMP696;CRF1 receptor;f;;Human;10669572;Antagonist
NBI27914;CRF1 receptor;f;;Human;8893829;Antagonist
NBI-34041;CRF1 receptor;f;;Human;16078829;Antagonist
NBI-35965;CRF1 receptor;f;;Rat;12957366;Antagonist
ONO-2333MS;CRF1 receptor;f;;Human;21865047;Antagonist
pexacerfont;CRF1 receptor;f;;Rat;28174066;Antagonist
pexacerfont;CRF1 receptor;f;;Human;28174066;Antagonist
R121919;CRF1 receptor;f;;Human;10867111;Antagonist
SSR125543A;CRF1 receptor;f;;Human;11907190;Antagonist
[125I]astressin;CRF1 receptor;f;;Human;15450949|11123370;Antagonist
verucerfont;CRF1 receptor;f;;Human;21074436;Antagonist
corticotrophin-releasing hormone;CRF2 receptor;t;Human|Mouse|Rat;Rat;8612563;Full agonist
corticotrophin-releasing hormone;CRF2 receptor;t;Human|Mouse|Rat;Human;11123370;Full agonist
corticotrophin-releasing hormone;CRF2 receptor;t;Human|Mouse|Rat;Mouse;8612563|7477349;Full agonist
corticotropin-releasing factor;CRF2 receptor;f;Sheep;Human;15450949|11123370;Full agonist
sauvagine;CRF2 receptor;f;;Mouse;8612563|7477349|9918582;Full agonist
sauvagine;CRF2 receptor;f;;Human;15450949|11123370;Full agonist
sauvagine;CRF2 receptor;f;;Rat;8612563|9918582;Full agonist
[125I]sauvagine (frog);CRF2 receptor;f;;Human;15450949|11123370;Full agonist
[125I]urocortin 1 (mouse, rat);CRF2 receptor;f;;Human;9918582;Full agonist
urocortin 1;CRF2 receptor;t;Mouse|Rat;Mouse;11123370|8612563|7477349|9918582|11416224;Full agonist
urocortin 1;CRF2 receptor;t;Mouse|Rat;Mouse;8612563|9918582|11416224;Full agonist
urocortin 1;CRF2 receptor;f;Human;Rat;8612563;Full agonist
urocortin 1;CRF2 receptor;f;Human;Mouse;8612563;Full agonist
urocortin 1;CRF2 receptor;t;Human;Human;15450949|11123370;Full agonist
urocortin 1;CRF2 receptor;f;Mouse|Rat;Human;11123370;Full agonist
urocortin 2;CRF2 receptor;f;Human;Mouse;11416224|11226328;Full agonist
urocortin 2;CRF2 receptor;t;Mouse;Mouse;11416224;Full agonist
urocortin 2;CRF2 receptor;f;Mouse;Rat;11416224;Full agonist
urocortin 2;CRF2 receptor;f;Human;Rat;11416224;Full agonist
urocortin 2;CRF2 receptor;t;Human;Human;15450949;Full agonist
urocortin 3;CRF2 receptor;t;Mouse|Rat;Mouse;11416224;Full agonist
urocortin 3;CRF2 receptor;f;Human;Rat;11416224;Full agonist
urocortin 3;CRF2 receptor;f;Human;Mouse;11416224;Full agonist
urocortin 3;CRF2 receptor;t;Mouse|Rat;Rat;11416224;Full agonist
urocortin 3;CRF2 receptor;t;Human;Human;15450949;Full agonist
urotensin 1 (fish);CRF2 receptor;f;;Human;11123370;Full agonist
urotensin 1 (fish);CRF2 receptor;f;;Mouse;7477349;Full agonist
α-helical CRF;CRF2 receptor;f;;Mouse;9918582;Antagonist
α-helical CRF;CRF2 receptor;f;;Rat;9918582;Antagonist
antisauvagine;CRF2 receptor;f;;Human;11123370;Antagonist
astressin;CRF2 receptor;f;;Mouse;9918582;Antagonist
astressin;CRF2 receptor;f;;Human;12361401;Antagonist
astressin;CRF2 receptor;f;;Human;11123370;Antagonist
astressin;CRF2 receptor;f;;Rat;9918582;Antagonist
astressin 2B;CRF2 receptor;f;;Human;12361401;Antagonist
K31440;CRF2 receptor;f;;Human;11835994;Antagonist
K41498;CRF2 receptor;f;;Human;12110614;Antagonist
[125I]antisauvagine;CRF2 receptor;f;;Human;11123370;Antagonist
[125I]astressin;CRF2 receptor;f;;Human;15450949|11123370;Antagonist
compound 8e [PMID: 24432909];c-ros oncogene 1, receptor tyrosine kinase;f;;Human;24432909;Inhibition
DS-6051b;c-ros oncogene 1, receptor tyrosine kinase;f;;Human;31399568;Inhibition
gilteritinib;c-ros oncogene 1, receptor tyrosine kinase;f;;Human;27908881;Inhibition
lorlatinib;c-ros oncogene 1, receptor tyrosine kinase;f;;Human;;Inhibition
repotrectinib;c-ros oncogene 1, receptor tyrosine kinase;f;;Human;30093503;Inhibition
KL044;cryptochrome circadian regulator 1;f;;Human;26174033;Binding
elotuzumab;CS1 (CD319);f;;Human;;Binding
NG-25;C-terminal Src kinase;f;;Human;25075558;Inhibition
PP1;C-terminal Src kinase;f;;Human;12534346;Inhibition
rivoceranib;C-terminal Src kinase;f;;Human;21443688;Inhibition
davalintide;CT receptor;f;;Human;26908506;Agonist
KBP-066;CT receptor;f;;Human;31992608;Agonist
KBP-088;CT receptor;f;;Human;26908506;Agonist
pramlintide;CT receptor;f;;Human;24169554;Agonist
adrenomedullin;CT receptor;t;Human;Human;15692146|12565884;Full agonist
adrenomedullin 2/intermedin;CT receptor;t;Human;Human;15692146;Full agonist
α-CGRP;CT receptor;t;Human;Human;15692146|11023820|9487987|14722252;Full agonist
amylin;CT receptor;t;Human;Human;9487987|10342886|24169554;Full agonist
amylin;CT receptor;f;Mouse|Rat;Human;15692146|9487987|11033437;Full agonist
β-CGRP;CT receptor;t;Human;Human;15692146;Full agonist
calcitonin;CT receptor;t;Human;Human;15692146|7588285|11023820|12565884|10342886|11033437;Full agonist
calcitonin (salmon);CT receptor;f;;Human;14623894|7769107|7588285|8828514;Full agonist
[125I]CT (human);CT receptor;f;;Human;;Full agonist
[125I]CT (salmon);CT receptor;f;;Human;;Full agonist
AC187;CT receptor;f;;Human;15692146;Antagonist
CT-(8-32) (salmon);CT receptor;f;;Human;10856900;Antagonist
CT-(8-32) (salmon);CT receptor;f;;Human;15692146;Antagonist
tepoditamab;C-type lectin domain family 12 member A;f;;Human;;Binding
BIIB059;C-type lectin domain family 4 member C;f;;Human;30645203;Binding
GlcC14C18;C-type lectin domain family 4 member E;f;;Human;28223515;Agonist
carbenoxolone;Cx23;f;;Human;;None
Ca2+;Cx23;t;;Human;;None
flufenamic acid;Cx23;f;;Human;;None
octanol;Cx23;f;;Human;;None
carbenoxolone;Cx25;f;;Human;;None
Ca2+;Cx25;t;;Human;;None
flufenamic acid;Cx25;f;;Human;;None
octanol;Cx25;f;;Human;;None
carbenoxolone;Cx26;f;;Human;;None
Ca2+;Cx26;t;;Human;;None
flufenamic acid;Cx26;f;;Human;;None
octanol;Cx26;f;;Human;;None
carbenoxolone;Cx30;f;;Human;;None
Ca2+;Cx30;t;;Human;;None
flufenamic acid;Cx30;f;;Human;;None
octanol;Cx30;f;;Human;;None
carbenoxolone;Cx30.2;f;;Human;;None
Ca2+;Cx30.2;t;;Human;;None
flufenamic acid;Cx30.2;f;;Human;;None
octanol;Cx30.2;f;;Human;;None
carbenoxolone;Cx30.3;f;;Human;;None
Ca2+;Cx30.3;t;;Human;;None
flufenamic acid;Cx30.3;f;;Human;;None
octanol;Cx30.3;f;;Human;;None
carbenoxolone;Cx31;f;;Human;;None
Ca2+;Cx31;t;;Human;;None
flufenamic acid;Cx31;f;;Human;;None
octanol;Cx31;f;;Human;;None
carbenoxolone;Cx31.1;f;;Human;;None
Ca2+;Cx31.1;t;;Human;;None
flufenamic acid;Cx31.1;f;;Human;;None
octanol;Cx31.1;f;;Human;;None
carbenoxolone;Cx31.9;f;;Human;;None
Ca2+;Cx31.9;t;;Human;;None
flufenamic acid;Cx31.9;f;;Human;;None
octanol;Cx31.9;f;;Human;;None
carbenoxolone;Cx32;f;;Human;;None
Ca2+;Cx32;t;;Human;;None
flufenamic acid;Cx32;f;;Human;;None
octanol;Cx32;f;;Human;;None
carbenoxolone;Cx36;f;;Human;;None
Ca2+;Cx36;t;;Human;;None
flufenamic acid;Cx36;f;;Human;;None
octanol;Cx36;f;;Human;;None
carbenoxolone;Cx37;f;;Human;;None
Ca2+;Cx37;t;;Human;;None
flufenamic acid;Cx37;f;;Human;;None
octanol;Cx37;f;;Human;;None
carbenoxolone;Cx40;f;;Human;;None
Ca2+;Cx40;t;;Human;;None
flufenamic acid;Cx40;f;;Human;;None
octanol;Cx40;f;;Human;;None
carbenoxolone;Cx40.1;f;;Human;;None
Ca2+;Cx40.1;t;;Human;;None
flufenamic acid;Cx40.1;f;;Human;;None
octanol;Cx40.1;f;;Human;;None
carbenoxolone;Cx43;f;;Human;;None
Ca2+;Cx43;t;;Human;;None
flufenamic acid;Cx43;f;;Human;;None
octanol;Cx43;f;;Human;;None
carbenoxolone;Cx45;f;;Human;;None
Ca2+;Cx45;t;;Human;;None
flufenamic acid;Cx45;f;;Human;;None
octanol;Cx45;f;;Human;;None
carbenoxolone;Cx46;f;;Human;;None
Ca2+;Cx46;t;;Human;;None
flufenamic acid;Cx46;f;;Human;;None
octanol;Cx46;f;;Human;;None
carbenoxolone;Cx47;f;;Human;;None
Ca2+;Cx47;t;;Human;;None
flufenamic acid;Cx47;f;;Human;;None
octanol;Cx47;f;;Human;;None
carbenoxolone;Cx50;f;;Human;;None
Ca2+;Cx50;t;;Human;;None
flufenamic acid;Cx50;f;;Human;;None
octanol;Cx50;f;;Human;;None
carbenoxolone;Cx59;f;;Human;;None
Ca2+;Cx59;t;;Human;;None
flufenamic acid;Cx59;f;;Human;;None
octanol;Cx59;f;;Human;;None
carbenoxolone;Cx62;f;;Human;;None
Ca2+;Cx62;t;;Human;;None
flufenamic acid;Cx62;f;;Human;;None
octanol;Cx62;f;;Human;;None
CXCL8;CXCR1;f;Human;Human;22262769;Agonist
cytokine domain of tyrosyl tRNA synthetase;CXCR1;t;Human;Human;;Agonist
HIV-1 matrix protein p17;CXCR1;f;;Human;22262769;Agonist
vCXCL1;CXCR1;f;;Human;20044480;Agonist
CXCL1;CXCR1;t;Human;Human;1379593;Full agonist
CXCL6;CXCR1;t;Human;Human;9692902;Full agonist
CXCL8;CXCR1;t;Human;Human;1379593|10188995|15946947|8940121|15282370;Full agonist
mini-TyrRS;CXCR1;f;;Human;10102815;Full agonist
[125I]CXCL8 (human);CXCR1;f;;Human;10188995|12626541;Full agonist
[125I]mini-TyrRS;CXCR1;f;;Human;10102815;Full agonist
reparixin;CXCR1;f;;Human;15282370;Negative
AZD5069;CXCR1;f;;Human;25736418;Antagonist
navarixin;CXCR1;f;;Human;24218476|17181143;Antagonist
HIV-1 matrix protein p17;CXCR2;f;;Human;22262769;Agonist
vCXCL1;CXCR2;f;;Human;20044480;Agonist
CXCL1;CXCR2;f;Rat;Mouse;7961909;Full agonist
CXCL1;CXCR2;f;Rat;Mouse;7961909;Full agonist
CXCL1;CXCR2;t;Human;Human;1379593|10188995|8940121;Full agonist
CXCL1;CXCR2;f;Human;Mouse;7961909;Full agonist
CXCL2;CXCR2;t;Human;Human;8702798;Full agonist
CXCL3;CXCR2;t;Human;Human;8702798;Full agonist
CXCL5;CXCR2;t;Human;Human;8702798;Full agonist
CXCL6;CXCR2;t;Human;Human;9692902;Full agonist
CXCL7;CXCR2;t;Human;Human;8702798;Full agonist
CXCL8;CXCR2;t;Human;Human;1379593|10188995|15946947|8940121|15282370;Full agonist
CXCL8;CXCR2;f;Human;Mouse;7961909;Full agonist
[125I]CXCL1 (human);CXCR2;f;;Human;;Full agonist
[125I]CXCL5 (human);CXCR2;f;;Human;;Full agonist
[125I]CXCL7 (human);CXCR2;f;;Human;;Full agonist
[125I]CXCL8 (human);CXCR2;f;;Human;10188995|12626541;Full agonist
[125I]KC-Tyr;CXCR2;f;;Mouse;7961909;Full agonist
reparixin;CXCR2;f;;Human;15282370;Negative
AZD5069;CXCR2;f;;Human;25736418;Antagonist
danirixin;CXCR2;f;;Human;26092545;Antagonist
elubirixin;CXCR2;f;;Human;24218476;Antagonist
navarixin;CXCR2;f;;Human;24218476|17181143;Antagonist
NSC 157449;CXCR2;f;;Human;9553055;Antagonist
SB 225002;CXCR2;f;;Human;9553055;Antagonist
SX-517;CXCR2;f;;Human;25254640;Antagonist
CCL13;CXCR3;t;Human;Human;9660793;Full agonist
CCL19;CXCR3;t;Human;Human;9660793;Full agonist
CCL20;CXCR3;t;Human;Human;9660793;Full agonist
CCL5;CXCR3;t;Human;Human;9660793;Full agonist
CXCL10;CXCR3;t;Human;Human;9660793|15761110;Full agonist
CXCL11;CXCR3;t;Human;Human;15761110;Full agonist
CXCL12α;CXCR3;t;Human;Human;9660793;Full agonist
CXCL9;CXCR3;t;Human;Human;9660793|15761110;Full agonist
[125I]CXCL10 (human);CXCR3;f;;Human;;Full agonist
[125I]CXCL11 (human);CXCR3;f;;Human;;Full agonist
CCL11;CXCR3;t;Human;Human;9660793;Antagonist
CCL7;CXCR3;t;Human;Human;9660793;Antagonist
dioscin;CXCR3;f;;Human;15789559;Antagonist
duramycin;CXCR3;f;;Human;15789559;Antagonist
hypoglaucin A;CXCR3;f;;Human;15789559;Antagonist
kallstroemin D;CXCR3;f;;Human;15789559;Antagonist
NBI-74330;CXCR3;f;;Human;15761110;Antagonist
CXCL12α;CXCR4;t;Human;Human;30476826;Agonist
CXCL12δ;CXCR4;t;Human;Human;16626895;Agonist
CXCL12ε;CXCR4;t;Human;Human;16626895;Agonist
CXCL12γ;CXCR4;t;Human;Human;16626895|18648536;Agonist
CXCL12φ;CXCR4;t;Human;Human;16626895;Agonist
CXCL12H25R (monomer);CXCR4;f;;Human;21990345;Agonist
X4-HIV-1 gp120;CXCR4;f;;Human;;Agonist
X4-HIV-1 gp120;CXCR4;f;;Human;;Agonist
CXCL12-(1-17);CXCR4;f;;Human;9712844;Full agonist
CXCL12-(1-9);CXCR4;f;;Human;9712844;Full agonist
CXCL12-(1-9) dimer;CXCR4;f;;Human;9712844;Full agonist
CXCL12α;CXCR4;t;Human;Human;9551924|9712844;Full agonist
CXCL12β;CXCR4;t;Human;Human;9551924;Full agonist
[125I]CXCL12α (human);CXCR4;f;;Human;9551924|11104827;Full agonist
[125I]CXCL12α (human);CXCR4;f;;Human;18768385;Full agonist
[125I]CXCL12β (human);CXCR4;f;;Human;9551924;Full agonist
ALX40-4C;CXCR4;f;;Human;11923301;Partial agonist
CXCL122 (dimer);CXCR4;f;;Human;21990345;Partial agonist
compound 46c [PMID: 29350534];CXCR4;f;;Mouse;29350534;Antagonist
compound 46c [PMID: 29350534];CXCR4;f;;Human;29350534;Antagonist
CX549;CXCR4;f;;Human;27938478;Antagonist
CXCR4 antagonist 22;CXCR4;f;;Human;30476826;Antagonist
HIV-Tat;CXCR4;f;;Human;;Antagonist
isothiourea-1a;CXCR4;f;;Rat;19053768;Antagonist
isothiourea-1a;CXCR4;f;;Human;19053768;Antagonist
isothiourea-1a;CXCR4;f;;Human;19053768;Antagonist
isothiourea-1t;CXCR4;f;;Human;19053768|30476826;Antagonist
isothiourea-1t;CXCR4;f;;Rat;19053768;Antagonist
isothiourea-1t;CXCR4;f;;Human;19053768;Antagonist
mavorixafor;CXCR4;f;;Human;18768385;Antagonist
mavorixafor;CXCR4;f;;Human;20297846;Antagonist
motixafortide;CXCR4;f;;Human;14649897;Antagonist
plerixafor;CXCR4;f;;Human;30476826;Antagonist
plerixafor;CXCR4;f;;Human;16815309;Antagonist
plerixafor;CXCR4;f;;Human;11923301;Antagonist
SDF-1, 1-9[P2G] dimer;CXCR4;f;;Human;9712844;Antagonist
SDF1 P2G;CXCR4;f;;Human;9384579;Antagonist
T134;CXCR4;f;;Human;9918823;Antagonist
T22;CXCR4;f;;Human;9918823;Antagonist
TIQ-15;CXCR4;f;;Human;29350534;Antagonist
viral macrophage inflammatory protein-II;CXCR4;f;;Human;9287217;Antagonist
T140;CXCR4;f;;Human;11923301|9918823;Inverse agonist
ulocuplumab;CXCR4;f;;Human;;Binding
[125I]CXCL13 (mouse);CXCR5;f;;Mouse;24190631;Agonist
CXCL13;CXCR5;t;Human;Human;22913878;Full agonist
CXCL16;CXCR6;t;Human;Human;11290797;Full agonist
[125I]CXCL16 (human);CXCR6;f;;Human;;Full agonist
CX3CL1;CX3CR1;t;Human;Human;14607932;Full agonist
[125I]CX3CL1 (human);CX3CR1;f;;Human;;Full agonist
JMS-17-2;CX3CR1;f;;Human;27001765;Antagonist
PF‐06928215;Cyclic GMP-AMP synthase;f;;Human;28934246;Inhibition
PF‐06928215;Cyclic GMP-AMP synthase;f;;Human;28934246;Inhibition
1-azakenpaullone;cyclin dependent kinase 1;f;;Human;14698171;Inhibition
7-hydroxystaurosporine;cyclin dependent kinase 1;f;;Human;15486189;Inhibition
aloisine A;cyclin dependent kinase 1;f;;Human;12519061;Inhibition
alsterpaullone;cyclin dependent kinase 1;f;;Human;10998059;Inhibition
alsterpaullone 2-cyanoethyl;cyclin dependent kinase 1;f;;Human;18077363;Inhibition
aminopurvalanol A;cyclin dependent kinase 1;f;;Human;18077363;Inhibition
AT-7519;cyclin dependent kinase 1;f;;Human;19174555;Inhibition
AZD5438;cyclin dependent kinase 1;f;;Human;19509270;Inhibition
BMS-265246;cyclin dependent kinase 1;f;;Human;21216932;Inhibition
BMS-387032;cyclin dependent kinase 1;f;;Human;23252711;Inhibition
bohemine;cyclin dependent kinase 1;f;;Human;11896531;Inhibition
BS-194;cyclin dependent kinase 1;f;;Human;21080703;Inhibition
Cdk1/2 inhibitor III;cyclin dependent kinase 1;f;;Human;15974571;Inhibition
Cdk1/5 inhibitor;cyclin dependent kinase 1;f;;Human;18077363;Inhibition
Cdk1 inhibitor;cyclin dependent kinase 1;f;;Human;18077363;Inhibition
Cdk2 inhibitor III;cyclin dependent kinase 1;f;;Human;18077363;Inhibition
Cdk2 inhibitor IV;cyclin dependent kinase 1;f;;Human;16170024;Inhibition
Cdk4 inhibitor;cyclin dependent kinase 1;f;;Human;12747775;Inhibition
CDK inhibitor 4.35;cyclin dependent kinase 1;f;;Human;30943029;Inhibition
CGP74514A;cyclin dependent kinase 1;f;;Human;9990463;Inhibition
CGP74514A;cyclin dependent kinase 1;f;;Human;30234987;Inhibition
CHIR-99021;cyclin dependent kinase 1;f;;Human;12606497;Inhibition
compound 52 [PMID: 9677190];cyclin dependent kinase 1;f;;Human;9677190;Inhibition
compound 89S [PMID: 19115845];cyclin dependent kinase 1;f;;Human;19115845;Inhibition
compound 9b [PMID: 18986805];cyclin dependent kinase 1;f;;Human;18986805;Inhibition
dinaciclib;cyclin dependent kinase 1;f;;Human;24007471;Inhibition
GSK-3 inhibitor IX;cyclin dependent kinase 1;f;;Human;14761195|14700633;Inhibition
ICEC0942;cyclin dependent kinase 1;f;;Human;29545334;Inhibition
JNJ-7706621;cyclin dependent kinase 1;f;;Human;15974571;Inhibition
kenpaullone;cyclin dependent kinase 1;f;;spiny starfish;10363974;Inhibition
kinase inhibitor 2 [PMID: 30199702];cyclin dependent kinase 1;f;;Human;30199702;Inhibition
milciclib;cyclin dependent kinase 1;f;;Human;30234987;Inhibition
R547;cyclin dependent kinase 1;f;;Human;17121911;Inhibition
(R)-CR8;cyclin dependent kinase 1;f;;Human;18574471;Inhibition
RGB-286638;cyclin dependent kinase 1;f;;Human;23807770;Inhibition
riviciclib;cyclin dependent kinase 1;f;;Human;17363486;Inhibition
RO3306;cyclin dependent kinase 1;f;;Human;30234987;Inhibition
roniciclib;cyclin dependent kinase 1;f;;Human;23671017;Inhibition
(S)-CR8;cyclin dependent kinase 1;f;;Human;18574471;Inhibition
SU9516;cyclin dependent kinase 1;f;;Human;11507069;Inhibition
SU9516;cyclin dependent kinase 1;f;;Human;30234987;Inhibition
TG02;cyclin dependent kinase 1;f;;Human;21860433;Inhibition
THAL-SNS-032;cyclin dependent kinase 1;f;;Human;29251720;Inhibition
voruciclib;cyclin dependent kinase 1;f;;Human;26606677;Inhibition
CDK12 inhibitor 2;cyclin dependent kinase 12;f;;Human;30067358;Inhibition
CDK12 inhibitor 2;cyclin dependent kinase 13;f;;Human;30067358;Inhibition
compound 77 [PMID: 24793884];cyclin dependent kinase 18;f;;Human;24793884;Inhibition
CCT251545;cyclin dependent kinase 19;f;;Human;26502155;Inhibition
compound 51 [Mallinger et al., 2016];cyclin dependent kinase 19;f;;Human;27326329;Inhibition
cortistatin A;cyclin dependent kinase 19;f;;Human;19844931;Inhibition
JH-VIII-49;cyclin dependent kinase 19;f;;Human;29937979;Inhibition
linifanib;cyclin dependent kinase 19;f;;Human;26502155;Inhibition
pexidartinib;cyclin dependent kinase 19;f;;Human;26222558;Inhibition
ponatinib;cyclin dependent kinase 19;f;;Human;26502155;Inhibition
sorafenib;cyclin dependent kinase 19;f;;Human;26502155;Inhibition
aloisine;cyclin dependent kinase 2;f;;Human;22289061;Inhibition
aloisine A;cyclin dependent kinase 2;f;;Human;12519061;Inhibition
alvocidib;cyclin dependent kinase 2;f;;Human;8674031|8002990;Inhibition
aminopurvalanol A;cyclin dependent kinase 2;f;;Human;18077363;Inhibition
AT-7519;cyclin dependent kinase 2;f;;Human;19174555;Inhibition
AZD5438;cyclin dependent kinase 2;f;;Human;19509270;Inhibition
BMS-265246;cyclin dependent kinase 2;f;;Human;21216932;Inhibition
BMS-387032;cyclin dependent kinase 2;f;;Human;23252711;Inhibition
BMS-387032;cyclin dependent kinase 2;f;;Human;22037378;Inhibition
bohemine;cyclin dependent kinase 2;f;;Human;11896531;Inhibition
BS-181;cyclin dependent kinase 2;f;;Human;19638587;Inhibition
BS-194;cyclin dependent kinase 2;f;;Human;21080703;Inhibition
BX-795;cyclin dependent kinase 2;f;;Human;15772071;Inhibition
BX-912;cyclin dependent kinase 2;f;;Human;15772071;Inhibition
Cdk1/2 inhibitor III;cyclin dependent kinase 2;f;;Human;15974571;Inhibition
Cdk2 inhibitor III;cyclin dependent kinase 2;f;;Human;;Inhibition
Cdk2 inhibitor IV;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
Cdk2 inhibitor IV;cyclin dependent kinase 2;f;;Human;16170024;Inhibition
Cdk4 inhibitor;cyclin dependent kinase 2;f;;Human;12747775;Inhibition
Cdk4 inhibitor II;cyclin dependent kinase 2;f;;Human;10632371;Inhibition
Cdk4 inhibitor III;cyclin dependent kinase 2;f;;Human;10743948;Inhibition
CDK inhibitor 4.35;cyclin dependent kinase 2;f;;Human;30943029;Inhibition
CDK inhibitor 4.35;cyclin dependent kinase 2;f;;Human;30943029;Inhibition
CGP74514A;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
CGP74514A;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
compound 3 [PMID: 19097791];cyclin dependent kinase 2;f;;Human;19097791;Inhibition
compound 89S [PMID: 19115845];cyclin dependent kinase 2;f;;Human;19115845;Inhibition
compound 9b [PMID: 18986805];cyclin dependent kinase 2;f;;Human;18986805;Inhibition
dinaciclib;cyclin dependent kinase 2;f;;Human;30943029;Inhibition
dinaciclib;cyclin dependent kinase 2;f;;Human;24007471;Inhibition
example 10 [WO2018033815];cyclin dependent kinase 2;f;;Human;;Inhibition
fadraciclib;cyclin dependent kinase 2;f;;Human;;Inhibition
fadraciclib;cyclin dependent kinase 2;f;;Human;;Inhibition
ICEC0942;cyclin dependent kinase 2;f;;Human;29545334;Inhibition
JNJ-7706621;cyclin dependent kinase 2;f;;Human;15974571;Inhibition
kenpaullone;cyclin dependent kinase 2;f;;spiny starfish;10363974;Inhibition
kinase inhibitor 2 [PMID: 30199702];cyclin dependent kinase 2;f;;Human;30199702;Inhibition
milciclib;cyclin dependent kinase 2;f;;Human;19603809;Inhibition
milciclib;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
milciclib;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
MK-8776;cyclin dependent kinase 2;f;;Human;21094607;Inhibition
purvalanol A;cyclin dependent kinase 2;f;;Human;9677190;Inhibition
purvalanol B;cyclin dependent kinase 2;f;;Human;9677190;Inhibition
R547;cyclin dependent kinase 2;f;;Human;17121911;Inhibition
R547;cyclin dependent kinase 2;f;;Human;22037378;Inhibition
RGB-286638;cyclin dependent kinase 2;f;;Human;23807770;Inhibition
RO3306;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
RO3306;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
roniciclib;cyclin dependent kinase 2;f;;Human;23671017;Inhibition
seliciclib;cyclin dependent kinase 2;f;;Human;23252711;Inhibition
SU9516;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
SU9516;cyclin dependent kinase 2;f;;Human;30234987;Inhibition
SU9516;cyclin dependent kinase 2;f;;Human;11507069;Inhibition
TG02;cyclin dependent kinase 2;f;;Human;22148278|21860433;Inhibition
THAL-SNS-032;cyclin dependent kinase 2;f;;Human;29251720;Inhibition
trilaciclib;cyclin dependent kinase 2;f;;Human;26826116;Inhibition
voruciclib;cyclin dependent kinase 2;f;;Human;26606677;Inhibition
VTX-11e;cyclin dependent kinase 2;f;;Human;19827834;Inhibition
AT-7519;cyclin dependent kinase 2;f;;Human;22037378;None
RGB-286638;cyclin dependent kinase 3;f;;Human;23807770;Inhibition
TG02;cyclin dependent kinase 3;f;;Human;21860433;Inhibition
abemaciclib;cyclin dependent kinase 4;f;;Human;24919854;Inhibition
alvocidib;cyclin dependent kinase 4;f;;Human;8674031;Inhibition
AT-7519;cyclin dependent kinase 4;f;;Human;19174555;Inhibition
BMS-387032;cyclin dependent kinase 4;f;;Human;23252711;Inhibition
BSJ-03-123;cyclin dependent kinase 4;f;;Human;30802347;Inhibition
BSJ-03-204;cyclin dependent kinase 4;f;;Human;30802347;Inhibition
BSJ-04-132;cyclin dependent kinase 4;f;;Human;30802347;Inhibition
Cdk2 inhibitor IV;cyclin dependent kinase 4;f;;Human;16170024;Inhibition
Cdk4 inhibitor;cyclin dependent kinase 4;f;;Human;12747775;Inhibition
Cdk4 inhibitor II;cyclin dependent kinase 4;f;;Human;10632371;Inhibition
Cdk4 inhibitor III;cyclin dependent kinase 4;f;;Human;10743948;Inhibition
CDK inhibitor 4.35;cyclin dependent kinase 4;f;;Human;30943029;Inhibition
CGP74514A;cyclin dependent kinase 4;f;;Human;30234987;Inhibition
compound 9b [PMID: 18986805];cyclin dependent kinase 4;f;;Human;18986805;Inhibition
example 10 [WO2018033815];cyclin dependent kinase 4;f;;Human;;Inhibition
fascaplysin;cyclin dependent kinase 4;f;;Human;10973815;Inhibition
lerociclib;cyclin dependent kinase 4;f;;Human;;Inhibition
milciclib;cyclin dependent kinase 4;f;;Human;19603809;Inhibition
milciclib;cyclin dependent kinase 4;f;;Human;30234987;Inhibition
palbociclib;cyclin dependent kinase 4;f;;Human;15542782;Inhibition
palbociclib;cyclin dependent kinase 4;f;;Human;;Inhibition
purvalanol A;cyclin dependent kinase 4;f;;Human;9677190;Inhibition
purvalanol B;cyclin dependent kinase 4;f;;Human;9677190;Inhibition
R547;cyclin dependent kinase 4;f;;Human;17121911;Inhibition
RGB-286638;cyclin dependent kinase 4;f;;Human;23807770;Inhibition
ribociclib;cyclin dependent kinase 4;f;;Human;;Inhibition
riviciclib;cyclin dependent kinase 4;f;;Human;17363486;Inhibition
Ro-0505124;cyclin dependent kinase 4;f;;Human;;Inhibition
SHR6390;cyclin dependent kinase 4;f;;Human;;Inhibition
SU9516;cyclin dependent kinase 4;f;;Human;11507069;Inhibition
SU9516;cyclin dependent kinase 4;f;;Human;30234987;Inhibition
trilaciclib;cyclin dependent kinase 4;f;;Human;26826116;Inhibition
trilaciclib;cyclin dependent kinase 4;f;;Human;26826116;Inhibition
voruciclib;cyclin dependent kinase 4;f;;Human;26606677;Inhibition
1-azakenpaullone;cyclin dependent kinase 5;f;;Human;14698171;Inhibition
aloisine A;cyclin dependent kinase 5;f;;Human;12519061;Inhibition
aminopurvalanol A;cyclin dependent kinase 5;f;;Human;18077363;Inhibition
AT-7519;cyclin dependent kinase 5;f;;Human;19174555;Inhibition
BS-194;cyclin dependent kinase 5;f;;Human;21080703;Inhibition
Cdk1/5 inhibitor;cyclin dependent kinase 5;f;;Human;18077363;Inhibition
Cdk2 inhibitor IV;cyclin dependent kinase 5;f;;Human;16170024;Inhibition
CDK inhibitor 4.35;cyclin dependent kinase 5;f;;Human;30943029;Inhibition
CGP74514A;cyclin dependent kinase 5;f;;Human;30234987;Inhibition
dinaciclib;cyclin dependent kinase 5;f;;Human;24007471;Inhibition
GSK-3 inhibitor IX;cyclin dependent kinase 5;f;;Human;14761195|14700633;Inhibition
kenpaullone;cyclin dependent kinase 5;f;;Bovine;10363974;Inhibition
kinase inhibitor 2 [PMID: 30199702];cyclin dependent kinase 5;f;;Human;30199702;Inhibition
milciclib;cyclin dependent kinase 5;f;;Human;30234987;Inhibition
purvalanol A;cyclin dependent kinase 5;f;;Human;9677190;Inhibition
purvalanol B;cyclin dependent kinase 5;f;;Human;9677190;Inhibition
(R)-CR8;cyclin dependent kinase 5;f;;Human;18574471;Inhibition
RGB-286638;cyclin dependent kinase 5;f;;Human;23807770;Inhibition
RO3306;cyclin dependent kinase 5;f;;Human;30234987;Inhibition
(S)-CR8;cyclin dependent kinase 5;f;;Human;18574471;Inhibition
SU9516;cyclin dependent kinase 5;f;;Human;30234987;Inhibition
TG02;cyclin dependent kinase 5;f;;Human;21860433;Inhibition
voruciclib;cyclin dependent kinase 5;f;;Human;26606677;Inhibition
abemaciclib;cyclin dependent kinase 6;f;;Human;24919854;Inhibition
AT-7519;cyclin dependent kinase 6;f;;Human;19174555;Inhibition
BSJ-03-123;cyclin dependent kinase 6;f;;Human;30802347;Inhibition
BSJ-03-204;cyclin dependent kinase 6;f;;Human;30802347;Inhibition
BSJ-04-132;cyclin dependent kinase 6;f;;Human;30802347;Inhibition
Cdk/Crk inhibitor;cyclin dependent kinase 6;f;;Human;18077363;Inhibition
example 10 [WO2018033815];cyclin dependent kinase 6;f;;Human;;Inhibition
lerociclib;cyclin dependent kinase 6;f;;Human;;Inhibition
palbociclib;cyclin dependent kinase 6;f;;Human;;Inhibition
palbociclib;cyclin dependent kinase 6;f;;Human;15542782;Inhibition
RGB-286638;cyclin dependent kinase 6;f;;Human;23807770;Inhibition
SHR6390;cyclin dependent kinase 6;f;;Human;;Inhibition
trilaciclib;cyclin dependent kinase 6;f;;Human;26826116;Inhibition
voruciclib;cyclin dependent kinase 6;f;;Human;26606677;Inhibition
BS-181;cyclin dependent kinase 7;f;;Human;19638587;Inhibition
BS-194;cyclin dependent kinase 7;f;;Human;21080703;Inhibition
CDK12 inhibitor 2;cyclin dependent kinase 7;f;;Human;30067358;Inhibition
Cdk2 inhibitor IV;cyclin dependent kinase 7;f;;Human;16170024;Inhibition
Cdk/Crk inhibitor;cyclin dependent kinase 7;f;;Human;18077363;Inhibition
CGP74514A;cyclin dependent kinase 7;f;;Human;30234987;Inhibition
ICEC0942;cyclin dependent kinase 7;f;;Human;29545334;Inhibition
mevociclib;cyclin dependent kinase 7;f;;Human;31064851;Inhibition
milciclib;cyclin dependent kinase 7;f;;Human;30234987;Inhibition
milciclib;cyclin dependent kinase 7;f;;Human;19603809;Inhibition
RGB-286638;cyclin dependent kinase 7;f;;Human;23807770;Inhibition
SU9516;cyclin dependent kinase 7;f;;Human;30234987;Inhibition
THAL-SNS-032;cyclin dependent kinase 7;f;;Human;29251720;Inhibition
THZ1;cyclin dependent kinase 7;f;;Human;25043025;Inhibition
trilaciclib;cyclin dependent kinase 7;f;;Human;26826116;Inhibition
CCT251545;cyclin dependent kinase 8;f;;Human;26502155;Inhibition
CDK12 inhibitor 2;cyclin dependent kinase 8;f;;Human;30067358;Inhibition
compound 1 [PMID: 24793884];cyclin dependent kinase 8;f;;Human;24793884;Inhibition
compound 20 [Bergeron et al., 2016];cyclin dependent kinase 8;f;;Human;27326333;Inhibition
compound 51 [Mallinger et al., 2016];cyclin dependent kinase 8;f;;Human;27326329;Inhibition
cortistatin A;cyclin dependent kinase 8;f;;Human;19844931;Inhibition
JH-VIII-49;cyclin dependent kinase 8;f;;Human;29937979;Inhibition
JH-XI-10-02;cyclin dependent kinase 8;f;;Human;29937979;Inhibition
linifanib;cyclin dependent kinase 8;f;;Human;26502155;Inhibition
ponatinib;cyclin dependent kinase 8;f;;Human;26502155;Inhibition
sorafenib;cyclin dependent kinase 8;f;;Human;26502155;Inhibition
voruciclib;cyclin dependent kinase 8;f;;Human;26606677;Inhibition
AT-7519;cyclin dependent kinase 9;f;;Human;19174555;Inhibition
AZD5438;cyclin dependent kinase 9;f;;Human;19509270;Inhibition
BMS-387032;cyclin dependent kinase 9;f;;Human;23252711;Inhibition
BS-194;cyclin dependent kinase 9;f;;Human;21080703;Inhibition
CDK12 inhibitor 2;cyclin dependent kinase 9;f;;Human;30067358;Inhibition
CDK inhibitor 4.35;cyclin dependent kinase 9;f;;Human;30943029;Inhibition
CGP74514A;cyclin dependent kinase 9;f;;Human;30234987;Inhibition
compound 18 [PMID: 20873740];cyclin dependent kinase 9;f;;Human;20873740;Inhibition
compound 89S [PMID: 19115845];cyclin dependent kinase 9;f;;Human;19115845;Inhibition
dinaciclib;cyclin dependent kinase 9;f;;Human;24007471;Inhibition
fadraciclib;cyclin dependent kinase 9;f;;Human;;Inhibition
ICEC0942;cyclin dependent kinase 9;f;;Human;29545334;Inhibition
kinase inhibitor 2 [PMID: 30199702];cyclin dependent kinase 9;f;;Human;30199702;Inhibition
milciclib;cyclin dependent kinase 9;f;;Human;30234987;Inhibition
NVP-2;cyclin dependent kinase 9;f;;Human;;Inhibition
RGB-286638;cyclin dependent kinase 9;f;;Human;23807770;Inhibition
riviciclib;cyclin dependent kinase 9;f;;Human;17363486;Inhibition
seliciclib;cyclin dependent kinase 9;f;;Human;23252711;Inhibition
SU9516;cyclin dependent kinase 9;f;;Human;30234987;Inhibition
TG02;cyclin dependent kinase 9;f;;Human;21860433;Inhibition
THAL-SNS-032;cyclin dependent kinase 9;f;;Human;29251720;Inhibition
trilaciclib;cyclin dependent kinase 9;f;;Human;26826116;Inhibition
voruciclib;cyclin dependent kinase 9;f;;Human;26606677;Inhibition
compound 9b [PMID: 18986805];cyclin dependent kinase like 1;f;;Human;18986805;Inhibition
URMC-099;cyclin dependent kinase like 2;f;;Human;24044867;Inhibition
baricitinib;cyclin G associated kinase;f;;Human;32113509;Inhibition
SB203580;cyclin G associated kinase;f;;Human;;Inhibition
aminoglutethimide;CYP11A1;f;;Hamster;1825337;Inhibition
mitotane;CYP11A1;f;;Human;23254310|17395972;Inhibition
azalanstat;CYP11B1;f;;Bovine;8340925;Inhibition
fadrozole;CYP11B1;f;;Human;19622340;Inhibition
metyrapone;CYP11B1;f;;Human;21129965;Inhibition
mitotane;CYP11B1;f;;Human;;Inhibition
osilodrostat;CYP11B1;f;;Human;24899257;Inhibition
fadrozole;CYP11B2;f;;Human;19622340;Inhibition
osilodrostat;CYP11B2;f;;Human;24899257;Inhibition
abiraterone;CYP17A1;f;;Human;7608911|18672868;Inhibition
galeterone;CYP17A1;f;;Human;15828836;Inhibition
aminoglutethimide;CYP19A1;f;;Human;19470632;Inhibition
anastrozole;CYP19A1;f;;Human;20413308;Inhibition
azalanstat;CYP19A1;f;;Human;8340925;Inhibition
endoxifen;CYP19A1;f;;Human;21814747;Inhibition
endoxifen;CYP19A1;f;;Human;21390495;Inhibition
exemestane;CYP19A1;f;;Human;2951074;Inhibition
fadrozole;CYP19A1;f;;Human;1825337;Inhibition
letrozole;CYP19A1;f;;Human;22386564;Inhibition
norendoxifen;CYP19A1;f;;Human;23731360;Inhibition
testolactone;CYP19A1;f;;Human;7083195;Inhibition
5H3'FPE;CYP1A1;f;;Human;23600958;Inhibition
chrysin;CYP1A1;f;;Human;21482471;Inhibition
5H3'FPE;CYP1A2;f;;Human;23600958;Inhibition
5H3'FPE;CYP1B1;f;;Human;23600958;Inhibition
chrysin;CYP1B1;f;;Human;21482471;Inhibition
(2S,4S)-ketoconazole;CYP21A2;f;;Rat;1495014;Inhibition
compound 3a [PMID: 15615534];CYP24A1;f;;Human;15615534;Inhibition
compound 4d [PMID: 20655626];CYP24A1;f;;Human;20655626;Inhibition
MK-24;CYP24A1;f;;Human;15615534;Inhibition
compound 5 [PMID: 21838328];CYP26A1;f;;Human;21838328;Inhibition
compound 4d [PMID: 20655626];CYP27A1;f;;Human;20655626;Inhibition
MK-24;CYP27A1;f;;Human;15615534;Inhibition
MK-24;CYP27B1;f;;Human;15615534;Inhibition
compound 23 [PMID: 17125252];CYP2A6;f;;Human;17125252;Inhibition
compound 38a [PMID: 15634016];CYP2A6;f;;Human;15634016;Inhibition
compound 39a [PMID: 15634016];CYP2A6;f;;Human;15634016;Inhibition
sibutramine;CYP2B6;f;;Human;23777987;Inhibition
thiotepa;CYP2B6;f;;Human;17682072;Inhibition
ticlopidine;CYP2B6;f;;Human;16248836;Inhibition
compound 9 [PMID: 11606127];CYP2C18;f;;Human;11606127;Inhibition
compound 30 [PMID: 22239545];CYP2C19;f;;Human;22239545;Inhibition
compound 51 [Crosignani et al., 2011];CYP2C19;f;;Human;24900284;Inhibition
compound 51 [Crosignani et al., 2011];CYP2C8;f;;Human;24900284;Inhibition
phenelzine;CYP2C8;f;;Human;16248836;Inhibition
voxelotor;CYP2C8;f;;Human;28337324;Inhibition
compound 3 [PMID: 18255300];CYP2C9;f;;Human;18255300;Inhibition
compound 51 [Crosignani et al., 2011];CYP2C9;f;;Human;24900284;Inhibition
noscapine;CYP2C9;f;;None;;Inhibition
voxelotor;CYP2C9;f;;Human;28337324;Inhibition
ajmalicine;CYP2D6;f;;Human;8487254;Inhibition
compound 46c [PMID: 29350534];CYP2D6;f;;Human;29350534;Inhibition
TIQ-15;CYP2D6;f;;Human;29350534;Inhibition
compound 23 [PMID: 17125252];CYP2E1;f;;Human;17125252;Inhibition
compound 4 [PMID: 16495056];CYP2J2;f;;Human;16495056;Inhibition
terfenadine;CYP2J2;f;;Human;16495056;Inhibition
AMG-337;CYP3A4;f;;Human;19819693;Inhibition
BMS-536924;CYP3A4;f;;Human;16134929;Inhibition
compound 1a [PMID: 18573659];CYP3A4;f;;Human;18573659;Inhibition
efavirenz;CYP3A4;f;;Human;11225565;Inhibition
ketoconazole;CYP3A4;f;;Human;25923589;Inhibition
nefazodone;CYP3A4;f;;Human;22409598|10445380;Inhibition
noscapine;CYP3A4;f;;None;;Inhibition
ritonavir;CYP3A4;f;;Human;18285471;Inhibition
troleandomycin;CYP3A4;f;;Human;26002732;Inhibition
verapamil;CYP3A4;f;;Human;11422004;Inhibition
voxelotor;CYP3A4;f;;Human;28337324;Inhibition
azalanstat;CYP3A4;f;;None;8340925;None
ritonavir;CYP3A5;f;;Human;16248836;Inhibition
17-octadecynoic acid;CYP4F2;f;;Human;2997155;Inhibition
azalanstat;CYP51A1;f;;Human;8340925;Inhibition
compound 10 [PMID: 31663733];CYP51A1;f;;Human;31663733;Irreversible inhibition
compound 10a [PMID: 1447738];CYP5A1;f;;Human;1447738;Inhibition
compound 7p [PMID: 7861416];CYP5A1;f;;Human;7861416;Inhibition
ozagrel;CYP5A1;f;;Human;3093741;Inhibition
ozagrel;CYP5A1;f;;Human;8759636;Inhibition
compound 7p [PMID: 7861416];CYP8A1;f;;Human;7861416;Inhibition
[3H]LTD4;CysLT1 receptor;f;;Human;;Agonist
LTC4;CysLT1 receptor;t;;Human;10391245;Full agonist
LTC4;CysLT1 receptor;t;;Human;9547367;Full agonist
LTC4;CysLT1 receptor;t;;Human;10391245;Full agonist
LTC4;CysLT1 receptor;t;;Human;10462554|10913337|11093801;Full agonist
LTD4;CysLT1 receptor;t;;Human;10391245;Full agonist
LTD4;CysLT1 receptor;t;;Human;10391245|10462554|10913337|11093801|21753081|17558309;Full agonist
LTD4;CysLT1 receptor;t;;Human;14518564;Full agonist
LTD4;CysLT1 receptor;t;;Human;10462554;Full agonist
LTD4;CysLT1 receptor;t;;Human;10391245;Full agonist
[3H]LTD4;CysLT1 receptor;f;;Human;9547367|9504401;Full agonist
[3H]LTD4;CysLT1 receptor;f;;Human;10391245|16306225;Full agonist
[3H]LTD4;CysLT1 receptor;f;;Human;14518564;Full agonist
LTE4;CysLT1 receptor;t;;Human;9547367;Partial agonist
LTE4;CysLT1 receptor;t;;Human;21078884;Partial agonist
LTE4;CysLT1 receptor;t;;Human;10462554|10913337|11093801;Partial agonist
LTE4;CysLT1 receptor;t;;Human;10391245;Partial agonist
LTE4;CysLT1 receptor;t;;Human;10391245;Partial agonist
N-methyl LTC4;CysLT1 receptor;f;;Human;21078884;Partial agonist
BayCysLT2;CysLT1 receptor;f;;Human;21753081;Antagonist
BAYu9773;CysLT1 receptor;f;;Human;11093801;Antagonist
BAYu9773;CysLT1 receptor;f;;Human;20423349;Antagonist
compound 13e [PMID: 31811124];CysLT1 receptor;f;;Human;31811124;Antagonist
compound 15b [PMID: 31811124];CysLT1 receptor;f;;Human;31811124;Antagonist
ICI198615;CysLT1 receptor;f;;Guinea pig;2170649;Antagonist
iralukast;CysLT1 receptor;f;;Human;9504401;Antagonist
MK-571;CysLT1 receptor;f;;Human;10391245;Antagonist
montelukast;CysLT1 receptor;f;;Human;11996896;Antagonist
montelukast;CysLT1 receptor;f;;Human;10462554;Antagonist
montelukast;CysLT1 receptor;f;;Human;10391245|10462554;Antagonist
pobilukast;CysLT1 receptor;f;;Human;10462554;Antagonist
pobilukast;CysLT1 receptor;f;;Human;10462554;Antagonist
pobilukast;CysLT1 receptor;f;;Human;9547367;Antagonist
pranlukast;CysLT1 receptor;f;;Human;11996896|9504401;Antagonist
pranlukast;CysLT1 receptor;f;;Human;10462554;Antagonist
pranlukast;CysLT1 receptor;f;;Human;10391245|10462554;Antagonist
SR2640;CysLT1 receptor;f;;Human;;Antagonist
sulukast;CysLT1 receptor;f;;Human;;Antagonist
[3H]ICI-198615;CysLT1 receptor;f;;Human;1329767;Antagonist
triple modulator 10 [PMID: 29878767];CysLT1 receptor;f;;Human;29878767;Antagonist
verlukast;CysLT1 receptor;f;;Human;1666333;Antagonist
verlukast;CysLT1 receptor;f;;Human;1666333;Antagonist
zafirlukast;CysLT1 receptor;f;;Human;11996896|9504401;Antagonist
zafirlukast;CysLT1 receptor;f;;Human;20423349;Antagonist
zafirlukast;CysLT1 receptor;f;;Human;10391245|10462554;Antagonist
zafirlukast;CysLT1 receptor;f;;Human;10462554;Antagonist
LTC4;CysLT2 receptor;t;;Human;10913337|11093801;Full agonist
LTC4;CysLT2 receptor;t;;Human;10851239|11093801;Full agonist
LTC4;CysLT2 receptor;t;;Human;21078884;Full agonist
LTC4;CysLT2 receptor;t;;Human;21753081;Full agonist
LTC4;CysLT2 receptor;t;;Human;10851239|21078884;Full agonist
LTD4;CysLT2 receptor;t;;Human;9547367;Full agonist
LTD4;CysLT2 receptor;t;;Human;10851239|21078884;Full agonist
LTD4;CysLT2 receptor;t;;Human;10913337;Full agonist
LTD4;CysLT2 receptor;t;;Human;21753081;Full agonist
LTD4;CysLT2 receptor;t;;Human;10913337|11093801|21753081;Full agonist
LTD4;CysLT2 receptor;t;;Human;21078884;Full agonist
LTD4;CysLT2 receptor;t;;Human;11093801;Full agonist
N-methyl LTC4;CysLT2 receptor;f;;Human;21078884;Full agonist
N-methyl LTC4;CysLT2 receptor;f;;Human;21078884;Full agonist
[3H]LTC4;CysLT2 receptor;f;;Human;10913337;Full agonist
[3H]LTC4;CysLT2 receptor;f;;Human;9547367;Full agonist
[3H]LTC4;CysLT2 receptor;f;;Human;21753081;Full agonist
[3H]LTD4;CysLT2 receptor;f;;Human;10851239;Full agonist
BAYu9773;CysLT2 receptor;f;;Human;20423349;Partial agonist
BAYu9773;CysLT2 receptor;f;;Human;10851239|11093801|20423349;Partial agonist
BAYu9773;CysLT2 receptor;f;;Human;11093801;Partial agonist
LTE4;CysLT2 receptor;t;;Human;10913337|11093801;Partial agonist
LTE4;CysLT2 receptor;t;;Human;10913337;Partial agonist
LTE4;CysLT2 receptor;t;;Human;10851239|11093801;Partial agonist
LTE4;CysLT2 receptor;t;;Human;10851239|21078884;Partial agonist
LTE4;CysLT2 receptor;t;;Human;9547367;Partial agonist
BayCysLT2;CysLT2 receptor;f;;Human;21753081;Antagonist
BayCysLT2;CysLT2 receptor;f;;Human;21903747;Antagonist
BayCysLT2;CysLT2 receptor;f;;Human;21753081;Antagonist
BAYu9773;CysLT2 receptor;f;;Human;20423349;Antagonist
BAYu9773;CysLT2 receptor;f;;Rat;7698171;Antagonist
BAYu9773;CysLT2 receptor;f;;Human;11093801;Antagonist
BAYu9773;CysLT2 receptor;f;;Human;1331415;Antagonist
BAYu9773;CysLT2 receptor;f;;Human;21903747;Antagonist
compound 13e [PMID: 31811124];CysLT2 receptor;f;;Human;31811124;Antagonist
compound 15b [PMID: 31811124];CysLT2 receptor;f;;Human;31811124;Antagonist
HAMI3379;CysLT2 receptor;f;;Human;20423349;Antagonist
HAMI3379;CysLT2 receptor;f;;Human;20423349;Antagonist
iralukast;CysLT2 receptor;f;;Human;25839425;Antagonist
ONO-2570366;CysLT2 receptor;f;;Human;31811124;Antagonist
pobilukast;CysLT2 receptor;f;;Human;25839425;Antagonist
pranlukast;CysLT2 receptor;f;;Human;10851239;Antagonist
pranlukast;CysLT2 receptor;f;;Human;25839425;Antagonist
[3H]ICI-198615;CysLT2 receptor;f;;Human;1329767;Antagonist
zafirlukast;CysLT2 receptor;f;;Human;25839425;Antagonist
zafirlukast;CysLT2 receptor;f;;Human;10851239;Antagonist
zafirlukast;CysLT2 receptor;f;;Human;20423349;Antagonist
aminooxyacetic acid;Cystathionine β-synthase;f;;Human;23488457;Inhibition
aminoethoxyvinylglycine;Cystathionine γ-lyase;f;;Human;23488457;Inhibition
aminooxyacetic acid;Cystathionine γ-lyase;f;;Human;23488457;Inhibition
β-Cyano-L-alanine;Cystathionine γ-lyase;f;;Human;23488457;Inhibition
propargylglycine;Cystathionine γ-lyase;f;;Human;23488457;Inhibition
quisqualate;Cystine/glutamate transporter;f;;Human;20303751;Inhibition
cedazuridine;cytidine deaminase;f;;Human;24520856;Inhibition
compound 7c [PMID: 22041175];cytochrome b-245 beta chain;f;;Human;22041175;Inhibition
GKT136901;cytochrome b-245 beta chain;f;;Human;20942471;Inhibition
NSC 780521;cytochrome b-245 beta chain;f;;Human;28709950;Inhibition
setanaxib;cytochrome b-245 beta chain;f;;Human;22806357;Inhibition
ipilimumab;cytotoxic T-lymphocyte-associated protein 4 (CD152);f;;Human;;Binding
tremelimumab;cytotoxic T-lymphocyte-associated protein 4 (CD152);f;;Human;;Binding
atomoxetine;DAT;f;;Human;9871604;Inhibition
benzatropine;DAT;f;;Rat;7562926;Inhibition
bupropion;DAT;f;;Human;19821577;Inhibition
clomipramine;DAT;f;;Human;9537821;Inhibition
cocaine;DAT;f;;Rat;15566309;Inhibition
compound 58 [PMID: 25037917];DAT;f;;Human;25037917;Inhibition
desvenlafaxine;DAT;f;;Human;24900709;Inhibition
dexamfetamine;DAT;f;;Human;23602445;Inhibition
dexmethylphenidate;DAT;f;;Human;21129986;Inhibition
GBR12935;DAT;f;;Human;;Inhibition
levomilnacipran;DAT;f;;Human;18468895;Inhibition
mazindol;DAT;f;;Human;;Inhibition
methylphenidate;DAT;f;;Human;17228864;Inhibition
modafinil;DAT;f;;Rat;15537337;Inhibition
nomifensine;DAT;f;;Human;;Inhibition
phenelzine;DAT;f;;Human;9537821;Inhibition
sibutramine;DAT;f;;Human;;Inhibition
solriamfetol;DAT;f;;Human;29891587;Inhibition
solriamfetol;DAT;f;;Human;29891587;Inhibition
[3H]GBR12935;DAT;f;;Human;8302271;Inhibition
[3H]WIN35428;DAT;f;;Human;8302271;Inhibition
trimipramine;DAT;f;;Human;9537821;Inhibition
vanoxerine;DAT;f;;Human;2530094|6237922|1678014;Inhibition
WIN35428;DAT;f;;Human;8878059;Inhibition
staurosporine;death associated protein kinase 1;f;;Human;19397322;Inhibition
DAPK inhibitor 13;death associated protein kinase 3;f;;Human;20206532;Inhibition
silmitasertib;death associated protein kinase 3;f;;Human;21174434;Inhibition
URMC-099;death associated protein kinase 3;f;;Human;24044867;Inhibition
TL1A;death receptor 3;t;Human;Human;;None
SC-67655;death receptor 4;f;;Human;;Agonist
TRAIL;death receptor 4;t;Human;Human;;None
TRAIL;death receptor 5;t;Human;Human;;Agonist
tigatuzumab;death receptor 5;f;;Human;;Agonist
RBM2-1B;delta 4-desaturase, sphingolipid 1;f;;Human;22537678;Inhibition
SKI II;delta 4-desaturase, sphingolipid 1;f;;Human;24875537;Inhibition
ADL5747;δ receptor;f;;Human;19694468;Agonist
ADL5859;δ receptor;f;;Human;18788723;Agonist
AR-M1000390;δ receptor;f;;Human;;Agonist
AR-M1000390;δ receptor;f;;Human;12875901;Agonist
AZD7268;δ receptor;f;;Human;;Agonist
bilorphin;δ receptor;f;;Human;31611414;Agonist
BW373U86;δ receptor;f;;Rat;8246159;Agonist
BW373U86;δ receptor;f;;Human;18788723;Agonist
carfentanil;δ receptor;f;;Guinea pig;1310142;Agonist
cebranopadol;δ receptor;f;;Human;24713140;Agonist
hydromorphone;δ receptor;f;;Human;19282177;Agonist
nalbuphine;δ receptor;f;;Human;19282177;Agonist
oxycodegol;δ receptor;f;;Human;28778859;Agonist
pethidine;δ receptor;f;;Human;11585443;Agonist
SCH221510;δ receptor;f;;Human;18492950;Agonist
[3H][D-Ala2]deltorphin I;δ receptor;f;;Human;1329092;Agonist
TAN-67;δ receptor;f;;Mouse;11765135;Agonist
tramadol;δ receptor;f;;Human;19027293;Agonist
UFP-512;δ receptor;f;;Human;18069089;Agonist
PN6047;δ receptor;f;;Human;31594792;Biased agonist
α-neoendorphin;δ receptor;t;Human|Mouse|Rat;Mouse;8393575;Full agonist
β-endorphin;δ receptor;t;Human;Human;9686407;Full agonist
β-endorphin;δ receptor;f;Human;Mouse;8114680;Full agonist
(-)-bremazocine;δ receptor;f;;Human;9686407;Full agonist
DADLE;δ receptor;f;;Human;9686407;Full agonist
DADLE;δ receptor;f;;Mouse;8114680;Full agonist
[D-Ala2]deltorphin II;δ receptor;f;;Human;2544892;Full agonist
deltorphin II;δ receptor;f;;Mouse;8114680;Full agonist
deltorphin II;δ receptor;f;;Human;9686407;Full agonist
dihydromorphine;δ receptor;f;;Human;9686407;Full agonist
diprenorphine;δ receptor;f;;Human;9686407;Full agonist
DPDPE;δ receptor;f;;Human;9686407|6310598;Full agonist
DPDPE;δ receptor;f;;Mouse;8114680;Full agonist
DSLET;δ receptor;f;;Human;9686407;Full agonist
DSLET;δ receptor;f;;Mouse;8114680;Full agonist
DSTBULET;δ receptor;f;;Human;2831220;Full agonist
dynorphin-(1-11);δ receptor;f;;Human;9686407;Full agonist
dynorphin A;δ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
dynorphin A-(1-13);δ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
dynorphin B;δ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
endomorphin-1;δ receptor;t;Human;Human;9849897;Full agonist
ethyketazocine;δ receptor;f;;Mouse;8393575;Full agonist
ethylketocyclazocine;δ receptor;f;;Human;9686407;Full agonist
etonitazene;δ receptor;f;;Human;9686407;Full agonist
etorphine;δ receptor;f;;Human;9686407;Full agonist
fentanyl;δ receptor;f;;Human;9686407;Full agonist
[Leu]enkephalin;δ receptor;t;Human|Mouse|Rat;Mouse;8114680;Full agonist
[Leu]enkephalin;δ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
[Met]enkephalin;δ receptor;t;Human|Mouse|Rat;Mouse;8393575;Full agonist
(-)-methadone;δ receptor;f;;Human;9686407;Full agonist
morphine;δ receptor;f;;Human;9686407;Full agonist
normorphine;δ receptor;f;;Human;9686407;Full agonist
(-)-pentazocine;δ receptor;f;;Human;9686407;Full agonist
SNC80;δ receptor;f;;Human;9178661|8035418;Full agonist
[3H]deltorphin II;δ receptor;f;;Human;1313131;Full agonist
[3H]diprenorphine;δ receptor;f;;Human;9686407|1313812;Full agonist
[3H]DPDPE;δ receptor;f;;Human;2986120;Full agonist
BU08028;δ receptor;f;;Human;21177476;Partial agonist
(-)-cyclazocine;δ receptor;f;;Human;9686407;Partial agonist
dynorphin A-(1-8);δ receptor;t;Human|Mouse|Rat;Human;9686407;Partial agonist
nalmefene;δ receptor;f;;Human;9686407;Partial agonist
nalorphine;δ receptor;f;;Human;9686407;Partial agonist
BMS-986187;δ receptor;f;;Human;;Positive
alvimopan;δ receptor;f;;Human;18313920;Antagonist
AT-076;δ receptor;f;;Human;9686407|12801588;Antagonist
β-FNA;δ receptor;f;;Human;9686407;Antagonist
BNTX;δ receptor;f;;Human;9686407;Antagonist
BNTX;δ receptor;f;;Mouse;8114680;Antagonist
BTRX-335140;δ receptor;f;;Human;30707578;Antagonist
CTAP;δ receptor;f;;Human;9686407;Antagonist
eluxadoline;δ receptor;f;;Rat;22695132;Antagonist
LY2456302;δ receptor;f;;Human;24071566;Antagonist
methylnaltrexone;δ receptor;f;;Human;19282177;Antagonist
naldemedine;δ receptor;f;;Human;30446313;Antagonist
naloxone;δ receptor;f;;Mouse;8114680;Antagonist
naloxone;δ receptor;f;;Human;9686407;Antagonist
naloxone;δ receptor;f;;Mouse;8393575;Antagonist
naltrexone;δ receptor;f;;Human;9686407;Antagonist
naltrexone;δ receptor;f;;Mouse;8114680;Antagonist
naltriben;δ receptor;f;;Human;9686407|1851833;Antagonist
naltriben;δ receptor;f;;Mouse;8114680;Antagonist
naltrindole;δ receptor;f;;Human;9686407|2832195;Antagonist
naltrindole;δ receptor;f;;Mouse;8114680;Antagonist
NFP;δ receptor;f;;Human;30608693;Antagonist
nor-binaltorphimine;δ receptor;f;;Human;9686407;Antagonist
nor-binaltorphimine;δ receptor;f;;Mouse;8393575;Antagonist
quadazocine;δ receptor;f;;Human;9686407;Antagonist
samidorphan;δ receptor;f;;Human;15808478;Antagonist
[3H]naltriben;δ receptor;f;;Human;9696425;Antagonist
[3H]naltrindole;δ receptor;f;;Rat;1313133;Antagonist
UFP-505;δ receptor;f;;Human;22194444|29524334;Antagonist
zyklophin;δ receptor;f;;Human;15999987;Antagonist
BNTX;δ receptor;f;;Rat;10516632;Inverse agonist
ICI 174,864;δ receptor;f;;Rat;10516632;Inverse agonist
naltriben;δ receptor;f;;Rat;10516632;Inverse agonist
TIPPψ;δ receptor;f;;Human;9686407|8230106;Inverse agonist
compound 16 [PMID: 31498617];δ receptor;f;;Human;31498617;Binding
DH376;Diacylglycerol lipase α;f;;Human;27992221;Inhibition
DH376;Diacylglycerol lipase α;f;;Human;26668358;Inhibition
DO34;Diacylglycerol lipase α;f;;Human;26668358;Inhibition
KT-109;Diacylglycerol lipase α;f;;Human;23103940;Inhibition
LEI105;Diacylglycerol lipase α;f;;Human;26083464;Inhibition
LEI105;Diacylglycerol lipase α;f;;Human;26083464;Inhibition
orlistat;Diacylglycerol lipase α;f;;Human;14610053;Inhibition
RHC80267;Diacylglycerol lipase α;f;;Human;22738638;Inhibition
DH376;Diacylglycerol lipase β;f;;Human;26668358;Inhibition
DO34;Diacylglycerol lipase β;f;;Human;26668358;Inhibition
KT-109;Diacylglycerol lipase β;f;;Human;23103940;Inhibition
KT-109;Diacylglycerol lipase β;f;;Human;23103940;Inhibition
LEI105;Diacylglycerol lipase β;f;;Human;26083464;Inhibition
orlistat;Diacylglycerol lipase β;f;;Human;14610053;Inhibition
RHC80267;Diacylglycerol lipase β;f;;Human;;Inhibition
AZD7687;diacylglycerol O-acyltransferase 1;f;;Human;23116186;Inhibition
compound 23n [PMID: 24900877];diacylglycerol O-acyltransferase 1;f;;Human;24900877;Inhibition
compound 5B [PMID: 25349648];diacylglycerol O-acyltransferase 1;f;;Human;25349648;Inhibition
PF-04620110;diacylglycerol O-acyltransferase 1;f;;Human;24900321;Inhibition
T863;diacylglycerol O-acyltransferase 1;f;;Human;19256504;Inhibition
compound 9 [PMID: 15615544];dihydrofolate reductase;f;;Human;15615544;Inhibition
diflunisal;dihydrofolate reductase;f;;Human;;Inhibition
iclaprim;dihydrofolate reductase;f;;Human;;Inhibition
methotrexate;dihydrofolate reductase;f;;Human;7877140;Inhibition
pemetrexed;dihydrofolate reductase;f;;Human;16078850|9762351;Inhibition
pralatrexate;dihydrofolate reductase;f;;Human;19221750;Inhibition
trimetrexate;dihydrofolate reductase;f;;Human;7877140;Inhibition
S312;dihydroorotate dehydrogenase (quinone);f;;Human;32754890;Binding
S416;dihydroorotate dehydrogenase (quinone);f;;Human;32754890;Binding
brequinar;dihydroorotate dehydrogenase (quinone);f;;Human;2822596;Inhibition
DSM421;dihydroorotate dehydrogenase (quinone);f;;Human;27641613;Inhibition
DSM421;dihydroorotate dehydrogenase (quinone);f;;Rat;27641613;Inhibition
DSM421;dihydroorotate dehydrogenase (quinone);f;;Mouse;27641613;Inhibition
leflunomide;dihydroorotate dehydrogenase (quinone);f;;Human;9719606;Inhibition
S312;dihydroorotate dehydrogenase (quinone);f;;Human;32754890;Inhibition
S416;dihydroorotate dehydrogenase (quinone);f;;Human;32754890;Inhibition
teriflunomide;dihydroorotate dehydrogenase (quinone);f;;Human;17228860;Inhibition
teriflunomide;dihydroorotate dehydrogenase (quinone);f;;Human;32754890;Inhibition
vidofludimus;dihydroorotate dehydrogenase (quinone);f;;Human;20413687;Inhibition
vidofludimus;dihydroorotate dehydrogenase (quinone);f;;Mouse;20413687;Inhibition
vidofludimus;dihydroorotate dehydrogenase (quinone);f;;Rat;20413687;Inhibition
RO0094889;dihydropyrimidine dehydrogenase;f;;Human;12617910;Inhibition
cilastatin;Dipeptidase 1;f;;Unknown;3495664;Inhibition
begelomab;dipeptidyl peptidase 4;f;;Human;;Binding
ZY15557;dipeptidyl peptidase 4;f;;Human;28452143;Competitive
alogliptin;dipeptidyl peptidase 4;f;;Human;22475866;Inhibition
compound 1 [Xiao et al. 2014];dipeptidyl peptidase 4;f;;Human;;Inhibition
compound 24dd [PMID: 20684603];dipeptidyl peptidase 4;f;;Human;20684603;Inhibition
compound 9 [PMID: 20718420];dipeptidyl peptidase 4;f;;Human;20718420;Inhibition
linagliptin;dipeptidyl peptidase 4;f;;Human;18052023;Inhibition
omarigliptin;dipeptidyl peptidase 4;f;;Human;24660890;Inhibition
saxagliptin;dipeptidyl peptidase 4;f;;Human;19149538;Inhibition
sitagliptin;dipeptidyl peptidase 4;f;;Human;20927248;Inhibition
talabostat;dipeptidyl peptidase 4;f;;Human;18783201;Inhibition
teneligliptin;dipeptidyl peptidase 4;f;;Human;22959556;Inhibition
vildagliptin;dipeptidyl peptidase 4;f;;Human;19149538;Inhibition
UAMC00039;Dipeptidyl-peptidase 7;f;;Human;16725115;Inhibition
1G244;dipeptidyl peptidase 8;f;;Human;19439267;Inhibition
compound 18 [PMID: 15664838];dipeptidyl peptidase 8;f;;Human;15664838;Inhibition
compound 24dd [PMID: 20684603];dipeptidyl peptidase 8;f;;Human;20684603;Inhibition
compound 9 [PMID: 20718420];dipeptidyl peptidase 8;f;;Human;20718420;Inhibition
talabostat;dipeptidyl peptidase 8;f;;Human;18783201;Inhibition
teneligliptin;dipeptidyl peptidase 8;f;;Human;22959556;Inhibition
1G244;dipeptidyl peptidase 9;f;;Human;19439267;Inhibition
compound 24dd [PMID: 20684603];dipeptidyl peptidase 9;f;;Human;20684603;Inhibition
compound 9 [PMID: 20718420];dipeptidyl peptidase 9;f;;Human;20718420;Inhibition
talabostat;dipeptidyl peptidase 9;f;;Human;18783201;Inhibition
teneligliptin;dipeptidyl peptidase 9;f;;Human;22959556;Inhibition
2,2-difluoromevalonate 5-diphosphate;diphosphomevalonate decarboxylase;f;;Rat;17888661;Competitive
6-fluoromevalonate 5-diphosphate;diphosphomevalonate decarboxylase;f;;Human;18823933;Competitive
6-fluoromevalonate pyrophosphate;diphosphomevalonate decarboxylase;f;;Human;;Competitive
analog 3 [Vlattas et al., 1996];diphosphomevalonate decarboxylase;f;;Human;;Competitive
compound 18 [PMID: 17888661];diphosphomevalonate decarboxylase;f;;Rat;17888661;Competitive
compound 19 [PMID: 17888661];diphosphomevalonate decarboxylase;f;;Rat;17888661;Competitive
diphosphoglycolyl proline;diphosphomevalonate decarboxylase;f;;Human;18823933;Competitive
P'-geranyl 2-fluoromevalonate 5-diphosphate;diphosphomevalonate decarboxylase;f;;Rat;17888661;Competitive
P'-geranyl 2-fluoromevalonate 5-diphosphate;diphosphomevalonate decarboxylase;f;;Human;18823933;Competitive
P'-geranyl 3,5,7-trihydroxy-3-methylheptanate 7-diphosphate;diphosphomevalonate decarboxylase;f;;Rat;16524256;Competitive
P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate;diphosphomevalonate decarboxylase;f;;Rat;16524256;Competitive
P'-geranyl 3,5,9-trihydroxy-3-methylnonanate 9-diphosphate;diphosphomevalonate decarboxylase;f;;Rat;16524256;Competitive
geranyl diphosphate;diphosphomevalonate decarboxylase;t;;Rat;16626865|16524256;Feedback inhibition
2-fluoromevalonate 5-diphosphate;diphosphomevalonate decarboxylase;f;;Rat;16626865;Irreversible inhibition
CHMFL-KIT-64;discoidin domain receptor tyrosine kinase 1;f;;Human;31250638;Inhibition
compound 1 [PMID: 31477924];discoidin domain receptor tyrosine kinase 1;f;;Human;31477924;Inhibition
compound 4 [PMID: 26191369];discoidin domain receptor tyrosine kinase 1;f;;Human;26191369;Inhibition
compound 6j [PMID: 27219676];discoidin domain receptor tyrosine kinase 1;f;;Human;27219676;Inhibition
compound 6j [PMID: 27219676];discoidin domain receptor tyrosine kinase 1;f;;Human;27219676;Inhibition
compound 7k [PMID: 23521020];discoidin domain receptor tyrosine kinase 1;f;;Human;23521020;Inhibition
DDR1/2 inhibitor 5n;discoidin domain receptor tyrosine kinase 1;f;;Human;30075624;Inhibition
DDR-IN-1;discoidin domain receptor tyrosine kinase 1;f;;Human;23899692;Inhibition
imatinib;discoidin domain receptor tyrosine kinase 1;f;;Human;23899692;Inhibition
LXH254;discoidin domain receptor tyrosine kinase 1;f;;Human;31059256;Inhibition
merestinib;discoidin domain receptor tyrosine kinase 1;f;;Human;23275061;Inhibition
nilotinib;discoidin domain receptor tyrosine kinase 1;f;;Human;23899692;Inhibition
RIPK1 inhibitor 22b;discoidin domain receptor tyrosine kinase 1;f;;Human;30480444;Inhibition
DDR1/2 inhibitor 5n;discoidin domain receptor tyrosine kinase 1;f;;Human;30075624;Potentiation
compound 1 [PMID: 31477924];discoidin domain receptor tyrosine kinase 2;f;;Human;31477924;Inhibition
DDR1/2 inhibitor 5n;discoidin domain receptor tyrosine kinase 2;f;;Human;30075624;Inhibition
DDR1/2 inhibitor 5n;discoidin domain receptor tyrosine kinase 2;f;;Human;30075624;Inhibition
DDR-IN-1;discoidin domain receptor tyrosine kinase 2;f;;Human;23899692;Inhibition
imatinib;discoidin domain receptor tyrosine kinase 2;f;;Human;23899692;Inhibition
LXH254;discoidin domain receptor tyrosine kinase 2;f;;Human;31059256;Inhibition
nilotinib;discoidin domain receptor tyrosine kinase 2;f;;Human;23899692;Inhibition
RIPK3 inhibitor 18;discoidin domain receptor tyrosine kinase 2;f;;Human;;Inhibition
sitravatinib;discoidin domain receptor tyrosine kinase 2;f;;Human;26675259;Inhibition
sorafenib;discoidin domain receptor tyrosine kinase 2;f;;Human;23279183;Inhibition
RKI-1447;DM1 protein kinase;f;;Human;23275831;Inhibition
compound 6b [PMID: 22749870];DMT1;f;;Human;22749870;Inhibition
bromo-deaza-SAH;DNA methyltransferase 1;f;;Human;23433670;Inhibition
SGI-1027;DNA methyltransferase 1;f;;Human;24387159;Inhibition
compound 19 [PMID: 7707314];DNA topoisomerase I;f;;Bovine;7707314;Inhibition
compound 5z [PMID: 8410981];DNA topoisomerase I;f;;Bovine;8410981;Inhibition
irinotecan;DNA topoisomerase I;f;;Bovine;9655905|8182764;Inhibition
(S)-DRF-1042;DNA topoisomerase I;f;;Human;;Inhibition
doxorubicin;DNA topoisomerase II alpha;f;;Human;11430001;Inhibition
etoposide;DNA topoisomerase II alpha;f;;Human;;Inhibition
mitoxantrone;DNA topoisomerase II alpha;f;;Human;18258442;Inhibition
teniposide;DNA topoisomerase II alpha;f;;Mouse;2557897;Inhibition
nepicastat;Dopamine beta-hydroxylase (dopamine beta-monooxygenase);f;;Human;9283721;Inhibition
bromo-deaza-SAH;DOT1 like histone lysine methyltransferase;f;;Human;23433670;Inhibition
bromo-deaza-SAH;DOT1 like histone lysine methyltransferase;f;;Human;23433670;Inhibition
compound 13 [Chen et al., 2016];DOT1 like histone lysine methyltransferase;f;;Human;27563395;Inhibition
EPZ004777;DOT1 like histone lysine methyltransferase;f;;Human;21741596;Inhibition
pinometostat;DOT1 like histone lysine methyltransferase;f;;Human;23801631;Inhibition
SGC0946;DOT1 like histone lysine methyltransferase;f;;Human;23250418;Inhibition
compound 5g [PMID: 20483621];doublecortin like kinase 1;f;;Human;20483621;Inhibition
DCLK1-IN-1;doublecortin like kinase 1;f;;Human;32251410;Inhibition
DCLK1-IN-1;doublecortin like kinase 1;f;;Human;32251410;Inhibition
DCLK1-IN-1;doublecortin like kinase 1;f;;Human;32251410;Inhibition
DCLK1-IN-1;doublecortin like kinase 2;f;;Human;32251410;Inhibition
XMD8-92;doublecortin like kinase 2;f;;Human;20832753;Inhibition
compound 5n [PMID: 20483621];doublecortin like kinase 3;f;;Human;;Inhibition
[3H]PGE2;DP1 receptor;f;;Unknown;;Agonist
15-deoxy-Δ12,14-PGJ2;DP1 receptor;f;;Human;9579725;Full agonist
butaprost (free acid form);DP1 receptor;f;;Human;10634944;Full agonist
BW 245C;DP1 receptor;f;;Mouse;9313928;Full agonist
BW 245C;DP1 receptor;f;;Human;10448933|7642548|9579725;Full agonist
BW 245C;DP1 receptor;f;;Rat;10448933;Full agonist
carbacyclin;DP1 receptor;f;;Human;10634944;Full agonist
cloprostenol;DP1 receptor;f;;Human;10634944;Full agonist
Δ12-PGJ2;DP1 receptor;f;;Human;9579725;Full agonist
iloprost;DP1 receptor;f;;Human;9579725|10634944|22480736;Full agonist
L-644,698;DP1 receptor;f;;Human;10448933|9579725;Full agonist
L-644,698;DP1 receptor;f;;Rat;10448933;Full agonist
L-888,291;DP1 receptor;f;;Human;15755909;Full agonist
PGD2;DP1 receptor;t;;Mouse;9313928;Full agonist
PGD2;DP1 receptor;t;;Rat;10448933;Full agonist
PGD2;DP1 receptor;t;;Human;10448933|7642548|9579725|16604093;Full agonist
PGE1;DP1 receptor;t;;Human;9579725;Full agonist
PGE2;DP1 receptor;t;;Human;7642548|9579725|10634944;Full agonist
PGF2α;DP1 receptor;t;;Human;9579725|10634944;Full agonist
PGJ2;DP1 receptor;t;;Human;9579725;Full agonist
SQ-27986;DP1 receptor;f;;Human;10772998;Full agonist
[3H]PGD2;DP1 receptor;f;;Human;9579725|16604093;Full agonist
treprostinil;DP1 receptor;f;;Human;22480736|25542069;Full agonist
U46619;DP1 receptor;f;;Human;9579725|10634944;Full agonist
ZK110841;DP1 receptor;f;;Human;9579725;Full agonist
ZK118182;DP1 receptor;f;;Human;10772998;Full agonist
RS 93520;DP1 receptor;f;;Human;10772998;Partial agonist
AH6809;DP1 receptor;f;;Human;10634944;Antagonist
BWA868C;DP1 receptor;f;;Human;7642548|2924081|9579725;Antagonist
BWA868C;DP1 receptor;f;;Mouse;9313928;Antagonist
laropiprant;DP1 receptor;f;;Unknown;17300164;Antagonist
ONO-AE3-237;DP1 receptor;f;;Human;15388164|21819041|18178816;Antagonist
S-5751;DP1 receptor;f;;Human;11454901;Antagonist
[3H]BWA868C;DP1 receptor;f;;Human;11082108;Antagonist
TG11-77;DP1 receptor;f;;Human;31904232;Antagonist
TG6-129;DP1 receptor;f;;Human;23914286;Antagonist
vidupiprant;DP1 receptor;f;;Human;24900313;Antagonist
13,14-dihydro-15-keto-PGD2;DP2 receptor;f;;Human;12721327|12466225|16256979;Full agonist
13,14-dihydro-15-keto-PGD2;DP2 receptor;f;;Mouse;12721327|16030019;Full agonist
13,14-dihydro-15-keto-PGF2α;DP2 receptor;f;;Human;12466225;Full agonist
15-deoxy-Δ12,14-PGD2;DP2 receptor;f;;Mouse;12721327;Full agonist
15-deoxy-Δ12,14-PGJ2;DP2 receptor;f;;Mouse;12721327;Full agonist
15-deoxy-Δ12,14-PGJ2;DP2 receptor;f;;Human;12466225;Full agonist
15(R)-15-methyl-PGD2;DP2 receptor;f;;Human;12721327|12490611|16256979;Full agonist
15(S)-15-methyl-PGD2;DP2 receptor;f;;Human;12466225;Full agonist
Δ12-PGJ2;DP2 receptor;f;;Human;12466225;Full agonist
Δ12-PGJ2;DP2 receptor;f;;Mouse;12721327;Full agonist
indomethacin;DP2 receptor;f;;Mouse;12721327|16030019;Full agonist
indomethacin;DP2 receptor;f;;Human;12466225|16256979;Full agonist
L-888,291;DP2 receptor;f;;Human;15755909;Full agonist
L-888,607;DP2 receptor;f;;Human;15755909;Full agonist
PGD2;DP2 receptor;t;;Mouse;12721327|16030019;Full agonist
PGD2;DP2 receptor;t;;Human;12466225|16256979;Full agonist
PGD2;DP2 receptor;t;;Rat;12975488;Full agonist
PGD3;DP2 receptor;t;;Mouse;12721327;Full agonist
PGE2;DP2 receptor;t;;Mouse;12721327;Full agonist
PGE2;DP2 receptor;t;;Human;12466225;Full agonist
PGF2α;DP2 receptor;t;;Human;12466225;Full agonist
PGF2α;DP2 receptor;t;;Mouse;12721327;Full agonist
PGJ2;DP2 receptor;t;;Human;12466225;Full agonist
PGJ2;DP2 receptor;t;;Mouse;12721327;Full agonist
[3H]PGD2;DP2 receptor;f;;Human;12975488|16418339;Full agonist
[3H]PGD2;DP2 receptor;f;;Rat;12975488;Full agonist
U46619;DP2 receptor;f;;Human;12466225;Full agonist
AM-461;DP2 receptor;f;;Mouse;;Antagonist
AM-461;DP2 receptor;f;;Rat;;Antagonist
AM-461;DP2 receptor;f;;Human;;Antagonist
ARRY-502;DP2 receptor;f;;Human;;Antagonist
AZD1981;DP2 receptor;f;;Human;21944852;Antagonist
CAY 10471;DP2 receptor;f;;Human;15715457;Antagonist
CAY 10471;DP2 receptor;f;;Human;15715457|17714552;Antagonist
compound 51 [Crosignani et al., 2011];DP2 receptor;f;;Human;24900284;Antagonist
fevipiprant;DP2 receptor;f;;Human;26916831;Antagonist
QAV680;DP2 receptor;f;;Human;;Antagonist
ramatroban;DP2 receptor;f;;Mouse;16030019;Antagonist
ramatroban;DP2 receptor;f;;Human;16256979;Antagonist
ramatroban;DP2 receptor;f;;Rat;12975488;Antagonist
setipiprant;DP2 receptor;f;;Human;23721423;Antagonist
[3H]ramatroban;DP2 receptor;f;;Human;16256979;Antagonist
timapiprant;DP2 receptor;f;;Rat;22106101;Antagonist
timapiprant;DP2 receptor;f;;Human;22106101;Antagonist
vidupiprant;DP2 receptor;f;;Human;24900313;Antagonist
A68930;D1 receptor;f;;Human;16318870;Agonist
SKF-82958;D1 receptor;f;;Human;9152408;Agonist
SKF-83959;D1 receptor;f;;Human;25660762;Biased agonist
A77636;D1 receptor;f;;Human;17067639;Full agonist
(+)-ADTN;D1 receptor;f;;Human;12388666|1826762;Full agonist
apomorphine;D1 receptor;f;;Human;1826762|7525564;Full agonist
cabergoline;D1 receptor;f;;Human;12388666;Full agonist
dihydrexidine;D1 receptor;f;;Rat;2572425;Full agonist
dopamine;D1 receptor;t;;Human;1826762|7525564;Full agonist
fenoldopam;D1 receptor;f;;Human;7525564;Full agonist
noradrenaline;D1 receptor;t;;Human;1826762;Full agonist
N-propylnorapomorphine;D1 receptor;f;;Human;1826762;Full agonist
pergolide;D1 receptor;f;;Human;12388666|1826762;Full agonist
rotigotine;D1 receptor;f;;Human;1826762;Full agonist
SKF-75670;D1 receptor;f;;Rat;1973652;Full agonist
SKF-76783;D1 receptor;f;;Human;1826762;Full agonist
SKF-81297;D1 receptor;f;;Rat;1973652;Full agonist
(+)-SKF-82526;D1 receptor;f;;Human;1826762;Full agonist
5-hydroxytryptamine;D1 receptor;t;;Human;1826762;Partial agonist
bromocriptine;D1 receptor;f;;Human;12388666|1826762;Partial agonist
lisuride;D1 receptor;f;;Human;12388666;Partial agonist
SKF-38393;D1 receptor;f;;Human;1826762|7525564;Partial agonist
(-)-SKF-82526;D1 receptor;f;;Human;1826762;Partial agonist
LY3154207;D1 receptor;f;;Human;31532644;Positive
LY3154207;D1 receptor;f;;Mouse;31532644;Positive
(+)-butaclamol;D1 receptor;f;;Human;1826762|7525564;Antagonist
chlorpromazine;D1 receptor;f;;Human;1826762;Antagonist
clozapine;D1 receptor;f;;Human;1826762;Antagonist
ecopipam;D1 receptor;f;;Human;7862709;Antagonist
flupentixol;D1 receptor;f;;Human;1826762|7525564;Antagonist
fluphenazine;D1 receptor;f;;Human;1826762;Antagonist
haloperidol;D1 receptor;f;;Human;1826762|18308814;Antagonist
ketanserin;D1 receptor;f;;Human;1826762;Antagonist
mesoridazine;D1 receptor;f;;Human;15357957;Antagonist
periciazine;D1 receptor;f;;Human;7918347;Antagonist
prochlorperazine;D1 receptor;f;;Human;;Antagonist
SCH-23390;D1 receptor;f;;Human;1826762|7525564;Antagonist
SKF-83566;D1 receptor;f;;Human;1826762;Antagonist
spiperone;D1 receptor;f;;Human;1826762;Antagonist
[125I]SCH23982;D1 receptor;f;;Human;2144334;Antagonist
[3H]SCH-23390;D1 receptor;f;;Human;2168520;Antagonist
thioridazine;D1 receptor;f;;Human;1826762;Antagonist
benzquinamide;D2 receptor;f;;Human;22711801;Agonist
compound 3 [PMID: 23134120];D2 receptor;f;;Human;23134120;Agonist
HS665;D2 receptor;f;;Human;23134120;Agonist
LP-12;D2 receptor;f;;Human;17649988;Agonist
LP-211;D2 receptor;f;;Human;18800769;Agonist
LP-44;D2 receptor;f;;Human;17649988;Agonist
ropinirole;D2 receptor;f;;Human;9057850;Agonist
rotigotine;D2 receptor;f;;Human;12086487;Agonist
vilazodone;D2 receptor;f;;Human;15341484;Agonist
MLS1547;D2 receptor;f;;Human;24755247;Biased agonist
UNC0006;D2 receptor;f;;Human;22025698;Biased agonist
UNC0006;D2 receptor;f;;Human;22025698;Biased agonist
UNC9975;D2 receptor;f;;Human;22025698;Biased agonist
UNC9975;D2 receptor;f;;Human;22025698;Biased agonist
UNC9994;D2 receptor;f;;Human;22025698;Biased agonist
UNC9994;D2 receptor;f;;Human;22025698;Biased agonist
7-OH-DPAT;D2 receptor;f;;Rat;7990123;Full agonist
7-OH-DPAT;D2 receptor;f;;Human;8301582|7907989|7576010;Full agonist
7-trans-OH-PIPAT;D2 receptor;f;;Human;7990123;Full agonist
bromocriptine;D2 receptor;f;;Human;12388666|8301582|7756621;Full agonist
dopamine;D2 receptor;t;;Rat;1975644|10617689;Full agonist
dopamine;D2 receptor;t;;Human;8301582|7756621|7576010;Full agonist
(-)-N-porphynorapomorphine;D2 receptor;f;;Human;8301582|7756621;Full agonist
PD 128907;D2 receptor;f;;Human;7756621|8531103;Full agonist
pergolide;D2 receptor;f;;Human;12388666;Full agonist
pramipexole;D2 receptor;f;;Human;7756621|7664822;Full agonist
quinelorane;D2 receptor;f;;Human;1354163|7473180;Full agonist
quinpirole;D2 receptor;f;;Rat;1975644;Full agonist
quinpirole;D2 receptor;f;;Human;7576010|1354163|1975644|7664822|1840645|8967990;Full agonist
sumanirole;D2 receptor;f;;Human;15980060;Full agonist
apomorphine;D2 receptor;f;;Rat;1975644;Partial agonist
apomorphine;D2 receptor;f;;Human;12388666|8301582|7756621|7576010|1354163;Partial agonist
aripiprazole;D2 receptor;f;;Rat;10617689;Partial agonist
aripiprazole;D2 receptor;f;;Human;23279866;Partial agonist
aripiprazole;D2 receptor;f;;Human;22025698;Partial agonist
brexpiprazole;D2 receptor;f;;Human;24947465;Partial agonist
bromocriptine;D2 receptor;f;;Rat;1975644;Partial agonist
cabergoline;D2 receptor;f;;Human;12388666;Partial agonist
cariprazine;D2 receptor;f;;Human;22537450;Partial agonist
lisuride;D2 receptor;f;;Human;12388666;Partial agonist
piribedil;D2 receptor;f;;Human;12388666;Partial agonist
roxindole;D2 receptor;f;;Human;12388666;Partial agonist
terguride;D2 receptor;f;;Human;12388666;Partial agonist
SB269652;D2 receptor;f;;Human;25108820;Negative
alizapride;D2 receptor;f;;None;;Antagonist
amisulpride;D2 receptor;f;;Human;1354163|8099194;Antagonist
amisulpride;D2 receptor;f;;Human;1975644;Antagonist
asenapine;D2 receptor;f;;Human;18308814;Antagonist
benperidol;D2 receptor;f;;Human;9577836;Antagonist
blonanserin;D2 receptor;f;;Human;15686911;Antagonist
(+)-butaclamol;D2 receptor;f;;Human;8301582|7907989|7576010|8301592;Antagonist
chlorpromazine;D2 receptor;f;;Rat;1975644;Antagonist
chlorpromazine;D2 receptor;f;;Human;8301582|1354163;Antagonist
clozapine;D2 receptor;f;;Human;8301582|7907989|1354163|8301592|18308814;Antagonist
clozapine;D2 receptor;f;;Rat;1975644;Antagonist
domperidone;D2 receptor;f;;Rat;1975644;Antagonist
domperidone;D2 receptor;f;;Human;8301582|1354163;Antagonist
eticlopride;D2 receptor;f;;Human;7907989|8301592;Antagonist
flupentixol;D2 receptor;f;;Human;8301582;Antagonist
fluphenazine;D2 receptor;f;;Human;17826096;Antagonist
haloperidol;D2 receptor;f;;Human;8301582|7907989|1354163|7664822|7862709;Antagonist
haloperidol;D2 receptor;f;;Rat;1975644;Antagonist
iloperidone;D2 receptor;f;;Rat;7707315;Antagonist
trans-flupenthixol;D2 receptor;f;;Human;8301582;Antagonist
L-741,626;D2 receptor;f;;Human;8642550|17095222;Antagonist
loxapine;D2 receptor;f;;Human;12629531|9015795;Antagonist
lumateperone;D2 receptor;f;;Human;25120104|24559051;Antagonist
lurasidone;D2 receptor;f;;Rat;20404009;Antagonist
mesoridazine;D2 receptor;f;;Human;15357957;Antagonist
metoclopramide;D2 receptor;f;;Mouse;9808703;Antagonist
metopimazine;D2 receptor;f;;None;;Antagonist
ML321;D2 receptor;f;;Human;24666157|24260782;Antagonist
nafadotride;D2 receptor;f;;Human;8531087;Antagonist
nafadotride;D2 receptor;f;;Rat;10617689;Antagonist
olanzapine;D2 receptor;f;;Human;9430133;Antagonist
perospirone;D2 receptor;f;;Human;1060115;Antagonist
perphenazine;D2 receptor;f;;Human;12629531;Antagonist
pimozide;D2 receptor;f;;Rat;1975644;Antagonist
pimozide;D2 receptor;f;;Human;8301582|1354163;Antagonist
pipotiazine;D2 receptor;f;;Human;1586393;Antagonist
prochlorperazine;D2 receptor;f;;Human;;Antagonist
promazine;D2 receptor;f;;Human;16135699;Antagonist
quetiapine;D2 receptor;f;;Human;9430133;Antagonist
raclopride;D2 receptor;f;;Human;7473180;Antagonist
raclopride;D2 receptor;f;;Rat;1975644|10617689;Antagonist
risperidone;D2 receptor;f;;Human;9430133;Antagonist
roxindole;D2 receptor;f;;Human;12388666;Antagonist
R-VK4-40;D2 receptor;f;;Human;30974107;Antagonist
(+)-S-14297;D2 receptor;f;;Human;7473180;Antagonist
(+)-SCH-23390;D2 receptor;f;;Human;8301582;Antagonist
sertindole;D2 receptor;f;;Human;12629531|12176106;Antagonist
spiperone;D2 receptor;f;;Rat;7907989|1975644|7473180|8301592;Antagonist
(-)-stepholidine;D2 receptor;f;;Human;25231919;Antagonist
sulpiride;D2 receptor;f;;Human;7576010;Antagonist
(-)-sulpiride;D2 receptor;f;;Human;8301582|1354163|8301592;Antagonist
(+)-sulpiride;D2 receptor;f;;Rat;1975644;Antagonist
(+)-sulpiride;D2 receptor;f;;Human;8301582;Antagonist
[3H]N-methylspiperone;D2 receptor;f;;Rat;10617689;Antagonist
[3H]nemonapride;D2 receptor;f;;Human;14535946;Antagonist
[3H]raclopride;D2 receptor;f;;Rat;4015674;Antagonist
[3H]spiperone;D2 receptor;f;;Rat;2974511|20122961|10882389;Antagonist
terguride;D2 receptor;f;;Human;12388666;Antagonist
trifluoperazine;D2 receptor;f;;Human;12629531|9015795;Antagonist
(+)-UH232;D2 receptor;f;;Human;8301582|1975644;Antagonist
(+)-UH232;D2 receptor;f;;Rat;1975644;Antagonist
ziprasidone;D2 receptor;f;;Human;9430133;Antagonist
zotepine;D2 receptor;f;;Human;8935801;Antagonist
compound 3 [PMID: 23134120];D3 receptor;f;;Human;23134120;Agonist
HS665;D3 receptor;f;;Human;23134120;Agonist
PF-592379;D3 receptor;f;;Human;22470105;Agonist
ropinirole;D3 receptor;f;;Human;9057850;Agonist
rotigotine;D3 receptor;f;;Human;12086487;Agonist
[3H]7-OH-DPAT;D3 receptor;f;;Human;7759603;Agonist
[3H]7-OH-DPAT;D3 receptor;f;;Rat;1518841;Agonist
[3H]PD128907;D3 receptor;f;;Human;7674830;Agonist
vilazodone;D3 receptor;f;;Human;15341484;Agonist
7-OH-DPAT;D3 receptor;f;;Human;8301582|7756621|7907989|7576010|7990123;Full agonist
7-trans-OH-PIPAT;D3 receptor;f;;Human;7990123;Full agonist
bromocriptine;D3 receptor;f;;Rat;1975644;Full agonist
dopamine;D3 receptor;t;;Human;8301582|7756621|7576010|1975644;Full agonist
(-)-N-porphynorapomorphine;D3 receptor;f;;Human;8301582|7756621;Full agonist
PD 128907;D3 receptor;f;;Human;7756621|8531103;Full agonist
pramipexole;D3 receptor;f;;Human;7756621|7664822;Full agonist
quinelorane;D3 receptor;f;;Human;1354163|7473180;Full agonist
quinpirole;D3 receptor;f;;Rat;7576010|1975644;Full agonist
quinpirole;D3 receptor;f;;Human;7756621|7576010|1354163|1975644|7664822|7473180|1840645|8967990;Full agonist
apomorphine;D3 receptor;f;;Human;12388666|8301582|7756621|7576010|1354163;Partial agonist
apomorphine;D3 receptor;f;;Rat;1975644;Partial agonist
BP 897;D3 receptor;f;;Human;10432116;Partial agonist
bromocriptine;D3 receptor;f;;Human;12388666|8301582|7756621;Partial agonist
cabergoline;D3 receptor;f;;Human;12388666;Partial agonist
cariprazine;D3 receptor;f;;Human;22537450;Partial agonist
lisuride;D3 receptor;f;;Human;12388666;Partial agonist
pergolide;D3 receptor;f;;Human;12388666|1354163;Partial agonist
piribedil;D3 receptor;f;;Human;12388666;Partial agonist
roxindole;D3 receptor;f;;Human;12388666;Partial agonist
terguride;D3 receptor;f;;Human;12388666;Partial agonist
SB269652;D3 receptor;f;;Human;25583363;Negative
(+)-AJ76;D3 receptor;f;;Rat;1975644;Antagonist
(+)-AJ76;D3 receptor;f;;Human;1354163|7473180;Antagonist
amisulpride;D3 receptor;f;;Rat;1975644;Antagonist
(+)-butaclamol;D3 receptor;f;;Rat;7576010;Antagonist
(+)-butaclamol;D3 receptor;f;;Human;8301582|8531103|8301592;Antagonist
chlorpromazine;D3 receptor;f;;Human;8301582|1354163;Antagonist
chlorpromazine;D3 receptor;f;;Rat;1975644;Antagonist
clozapine;D3 receptor;f;;Human;8301582|1354163;Antagonist
clozapine;D3 receptor;f;;Rat;1975644;Antagonist
domperidone;D3 receptor;f;;Human;8301582|1354163;Antagonist
domperidone;D3 receptor;f;;Rat;1975644;Antagonist
eticlopride;D3 receptor;f;;Human;7907989|8301592;Antagonist
flupentixol;D3 receptor;f;;Human;8301582;Antagonist
haloperidol;D3 receptor;f;;Rat;1975644;Antagonist
haloperidol;D3 receptor;f;;Human;8301582|1354163|7862709|18308814;Antagonist
trans-flupenthixol;D3 receptor;f;;Human;8301582;Antagonist
loxapine;D3 receptor;f;;Human;;Antagonist
mesoridazine;D3 receptor;f;;Human;15357957;Antagonist
nafadotride;D3 receptor;f;;Human;8531087;Antagonist
nemonapride;D3 receptor;f;;Human;7907989|8301592;Antagonist
NGB 2904;D3 receptor;f;;Human;17627675;Antagonist
perospirone;D3 receptor;f;;Human;1354163;Antagonist
PG01037;D3 receptor;f;;Human;17672446;Antagonist
pimozide;D3 receptor;f;;Human;8301582|1354163;Antagonist
pimozide;D3 receptor;f;;Rat;1975644;Antagonist
prochlorperazine;D3 receptor;f;;Human;;Antagonist
promazine;D3 receptor;f;;Human;16135699;Antagonist
raclopride;D3 receptor;f;;Rat;1975644;Antagonist
raclopride;D3 receptor;f;;Human;7473180;Antagonist
risperidone;D3 receptor;f;;Human;7473180;Antagonist
R-VK4-40;D3 receptor;f;;Human;30974107;Antagonist
(+)-S-14297;D3 receptor;f;;Human;7473180|7988633;Antagonist
S33084;D3 receptor;f;;Human;10869410;Antagonist
SB 277011-A;D3 receptor;f;;Human;10945872;Antagonist
sertindole;D3 receptor;f;;Human;8935801|9430133;Antagonist
spiperone;D3 receptor;f;;Human;1975644;Antagonist
sulpiride;D3 receptor;f;;Human;7576010;Antagonist
(-)-sulpiride;D3 receptor;f;;Human;8301582|1354163|8301592;Antagonist
(+)-sulpiride;D3 receptor;f;;Human;8099194;Antagonist
(+)-sulpiride;D3 receptor;f;;Rat;1975644;Antagonist
[3H]nemonapride;D3 receptor;f;;Human;14535946;Antagonist
[3H]spiperone;D3 receptor;f;;Rat;20122961|10882389;Antagonist
(+)-UH232;D3 receptor;f;;Rat;1975644;Antagonist
(+)-UH232;D3 receptor;f;;Human;8301582|1975644;Antagonist
zotepine;D3 receptor;f;;Human;8935801;Antagonist
A412997;D4 receptor;f;;Rat;16153699;Agonist
PF-592379;D4 receptor;f;;Human;22470105;Agonist
rotigotine;D4 receptor;f;;Human;8863800;Agonist
A412997;D4 receptor;f;;Human;16153699;Full agonist
ABT-670;D4 receptor;f;;Human;17149874;Full agonist
dopamine;D4 receptor;t;;Rat;10617689;Full agonist
dopamine;D4 receptor;t;;Human;1840645;Full agonist
fenoldopam;D4 receptor;f;;Human;1840645;Full agonist
quinpirole;D4 receptor;f;;Human;12388666|1840645|8967990;Full agonist
WAY-100635;D4 receptor;f;;Human;21520940;Full agonist
apomorphine;D4 receptor;f;;Human;12388666;Partial agonist
cabergoline;D4 receptor;f;;Human;12388666;Partial agonist
CP-226269;D4 receptor;f;;Rat;15448188;Partial agonist
FAUC213;D4 receptor;f;;Rat;15448188;Partial agonist
lisuride;D4 receptor;f;;Human;12388666;Partial agonist
PD168,077;D4 receptor;f;;Rat;15448188;Partial agonist
pergolide;D4 receptor;f;;Human;12388666;Partial agonist
roxindole;D4 receptor;f;;Human;12388666;Partial agonist
A-381393;D4 receptor;f;;Human;15992586;Antagonist
aripiprazole;D4 receptor;f;;Rat;10617689;Antagonist
benperidol;D4 receptor;f;;Human;9577836;Antagonist
bromocriptine;D4 receptor;f;;Human;12388666;Antagonist
(+)-butaclamol;D4 receptor;f;;Human;8967990;Antagonist
chlorpromazine;D4 receptor;f;;Human;8102973;Antagonist
clozapine;D4 receptor;f;;Human;8102973;Antagonist
CP-293019;D4 receptor;f;;Rat;15448188;Antagonist
eticlopride;D4 receptor;f;;Human;7475902;Antagonist
FAUC213;D4 receptor;f;;Rat;15448188;Antagonist
haloperidol;D4 receptor;f;;Human;8102973|7862709|18308814;Antagonist
L741742;D4 receptor;f;;Human;8642551;Antagonist
L745870;D4 receptor;f;;Human;8642550;Antagonist
L-750,667;D4 receptor;f;;Rat;10617689;Antagonist
loxapine;D4 receptor;f;;Human;9015795;Antagonist
ML398;D4 receptor;f;;Human;25221667;Antagonist
nafadotride;D4 receptor;f;;Rat;10617689;Antagonist
nemonapride;D4 receptor;f;;Human;8248849;Antagonist
NGD 94-1;D4 receptor;f;;Rat;15448188;Antagonist
perospirone;D4 receptor;f;;Human;9577836;Antagonist
piribedil;D4 receptor;f;;Human;12388666;Antagonist
prochlorperazine;D4 receptor;f;;Human;;Antagonist
raclopride;D4 receptor;f;;Rat;10617689;Antagonist
RBI257;D4 receptor;f;;Rat;15448188;Antagonist
Ro 10-4548;D4 receptor;f;;Rat;15448188;Antagonist
sertindole;D4 receptor;f;;Human;16135699|9577836|9015795;Antagonist
sonepiprazole;D4 receptor;f;;Rat;15448188;Antagonist
sonepiprazole;D4 receptor;f;;Human;9098699;Antagonist
spiperone;D4 receptor;f;;Human;7475902;Antagonist
(-)-sulpiride;D4 receptor;f;;Human;8301592|8967990;Antagonist
(+)-sulpiride;D4 receptor;f;;Human;8967990;Antagonist
[125I]L750667;D4 receptor;f;;Human;8967990;Antagonist
[3H]N-methylspiperone;D4 receptor;f;;Rat;10617689;Antagonist
[3H]NGD941;D4 receptor;f;;Human;9262371;Antagonist
[3H]spiperone;D4 receptor;f;;Human;1840645|7777184;Antagonist
terguride;D4 receptor;f;;Human;12388666;Antagonist
trifluoperazine;D4 receptor;f;;Human;9015795;Antagonist
U101958;D4 receptor;f;;Human;9098699;Antagonist
zotepine;D4 receptor;f;;Human;8935801;Antagonist
A68930;D5 receptor;f;;Human;16318870;Agonist
5-hydroxytryptamine;D5 receptor;t;;Human;1826762;Full agonist
(+)-ADTN;D5 receptor;f;;Human;1826762;Full agonist
beta-ergocriptine;D5 receptor;f;;Human;1826762;Full agonist
bromocriptine;D5 receptor;f;;Human;12388666|1826762;Full agonist
cabergoline;D5 receptor;f;;Human;12388666;Full agonist
dopamine;D5 receptor;t;;Human;1826762;Full agonist
noradrenaline;D5 receptor;t;;Human;1826762;Full agonist
N-propylnorapomorphine;D5 receptor;f;;Human;1826762;Full agonist
pergolide;D5 receptor;f;;Human;12388666|1826762;Full agonist
rotigotine;D5 receptor;f;;Human;1826762;Full agonist
SKF-76783;D5 receptor;f;;Human;1826762;Full agonist
(-)-SKF-82526;D5 receptor;f;;Human;1826762;Full agonist
(+)-SKF-82526;D5 receptor;f;;Human;1826762;Full agonist
apomorphine;D5 receptor;f;;Human;12388666|1826762;Partial agonist
lisuride;D5 receptor;f;;Human;12388666;Partial agonist
SKF-38393;D5 receptor;f;;Human;1826762;Partial agonist
(+)-butaclamol;D5 receptor;f;;Human;1826762;Antagonist
chlorpromazine;D5 receptor;f;;Human;1826762;Antagonist
clozapine;D5 receptor;f;;Human;1826762;Antagonist
ecopipam;D5 receptor;f;;Human;1826762;Antagonist
flupentixol;D5 receptor;f;;Human;1826762;Antagonist
fluphenazine;D5 receptor;f;;Human;1826762;Antagonist
haloperidol;D5 receptor;f;;Human;1826762;Antagonist
ketanserin;D5 receptor;f;;Human;1826762;Antagonist
SCH-23390;D5 receptor;f;;Human;1826762;Antagonist
SKF-83566;D5 receptor;f;;Human;1826762;Antagonist
spiperone;D5 receptor;f;;Human;1826762;Antagonist
[125I]SCH23982;D5 receptor;f;;Unknown;;Antagonist
[3H]SCH-23390;D5 receptor;f;;Human;8051291;Antagonist
thioridazine;D5 receptor;f;;Human;1826762;Antagonist
NSC 780521;dual oxidase 2;f;;Human;28709950;Inhibition
compound 17 [PMID: 23642479];dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;23642479;Inhibition
compound 2-2c [PMID: 32003560];dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;32003560;Inhibition
compound 3b [PMID: 23454515];dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;23454515;Inhibition
compound 68 [PMID: 24900699];dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;24900699;Inhibition
compound 72 [WO2013026806];dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;;Inhibition
epigallocatechin-3-gallate;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;30332747;Inhibition
GNF2133;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;32077280;Inhibition
GNF4877;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;26496802;Inhibition
harmine;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;19796173;Inhibition
KH-CB19;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;21276940;Inhibition
leucettine L41;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Rat;21615147;Inhibition
lorecivivint;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;28888902;Inhibition
ML315;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;23642479;Inhibition
(S)-CR8;dual specificity tyrosine phosphorylation regulated kinase 1A;f;;Human;29985601;Inhibition
AZ191;dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;25738750;Inhibition
compound 17 [PMID: 23642479];dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;23642479;Inhibition
compound 3b [PMID: 23454515];dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;23454515;Inhibition
compound 68 [PMID: 24900699];dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;24900699;Inhibition
compound 72 [WO2013026806];dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;;Inhibition
harmine;dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;19796173;Inhibition
voruciclib;dual specificity tyrosine phosphorylation regulated kinase 1B;f;;Human;26606677;Inhibition
compound 3b [PMID: 23454515];dual specificity tyrosine phosphorylation regulated kinase 2;f;;Human;23454515;Inhibition
compound 5b [PMID: 24900464];dual specificity tyrosine phosphorylation regulated kinase 2;f;;Human;24900464;Inhibition
leucettine L41;dual specificity tyrosine phosphorylation regulated kinase 2;f;;Human;21615147;Inhibition
compound 1a [PMID: 24900749];dual specificity tyrosine phosphorylation regulated kinase 3;f;;Human;24900749;Inhibition
compound 20 [PMID: 30998356];dual specificity tyrosine phosphorylation regulated kinase 3;f;;Human;30998356;Inhibition
compound 3b [PMID: 23454515];dual specificity tyrosine phosphorylation regulated kinase 3;f;;Human;23454515;Inhibition
kinase inhibitor 2 [PMID: 30199702];dual specificity tyrosine phosphorylation regulated kinase 3;f;;Human;30199702;Inhibition
leucettine L41;dual specificity tyrosine phosphorylation regulated kinase 4;f;;Human;22998443;Inhibition
anacardic acid;E1A binding protein p300;f;;Human;12624111;Inhibition
C646;E1A binding protein p300;f;;Human;20534345;Inhibition
curcumin;E1A binding protein p300;f;;Human;15383533;Inhibition
epigallocatechin-3-gallate;E1A binding protein p300;f;;Human;19147572;Inhibition
garcinol;E1A binding protein p300;f;;Human;15155757;Inhibition
H3-CoA-20;E1A binding protein p300;f;;Human;10882143;Inhibition
I-CBP112;E1A binding protein p300;f;;Human;;Inhibition
Lys-CoA;E1A binding protein p300;f;;Human;10882143;Inhibition
plumbagin;E1A binding protein p300;f;;Human;19570987;Inhibition
SGC-CBP30;E1A binding protein p300;f;;Human;24497428;Inhibition
oleclumab;Ecto-5'-Nucleotidase;f;;Human;26854859;Binding
AB680;Ecto-5'-Nucleotidase;f;;Human;31334635;Inhibition
αβ-methyleneADP;Ecto-5'-Nucleotidase;f;;Human;1169962;Inhibition
compound 15 [PMID: 32045236];Ecto-5'-Nucleotidase;f;;Human;32045236;Inhibition
compound 15 [PMID: 32045236];Ecto-5'-Nucleotidase;f;;Rat;32045236;Inhibition
compound 15 [PMID: 32045236];Ecto-5'-Nucleotidase;f;;Human;32045236;Inhibition
PSB-0963;Ecto-5'-Nucleotidase;f;;Rat;20146483;Inhibition
ectodysplasin A1;ectodysplasin 1, anhidrotic receptor;t;Human;Human;11039935;None
ectodysplasin A2;ectodysplasin A2 isoform receptor;t;Human;Human;11039935;None
ARL 67156;ectonucleoside triphosphate diphosphohydrolase 1;f;;Rat;18630897;Inhibition
PSB-0963;ectonucleoside triphosphate diphosphohydrolase 1;f;;Human;20146483;Inhibition
PSB-6426;ectonucleoside triphosphate diphosphohydrolase 2;f;;Human;18630897;Inhibition
compound 6ee [PMID: 22364528];egl-9 family hypoxia inducible factor 1;f;;Human;22364528;Inhibition
IOX1;egl-9 family hypoxia inducible factor 1;f;;Human;24504543;Inhibition
IOX2;egl-9 family hypoxia inducible factor 1;f;;Human;23683440;Inhibition
compound 6ee [PMID: 22364528];egl-9 family hypoxia inducible factor 2;f;;Human;22364528;Inhibition
compound 6ee [PMID: 22364528];egl-9 family hypoxia inducible factor 3;f;;Human;22364528;Inhibition
molidustat;egl-9 family hypoxia inducible factor 3;f;;Human;;Inhibition
alpha1-proteinase inhibitor;elastase, neutrophil expressed;f;;Human;;Inhibition
alvelestat;elastase, neutrophil expressed;f;;Human;21791628;Inhibition
BAY-678;elastase, neutrophil expressed;f;;Human;26083237;Inhibition
compound 10f [PMID: 24556381];elastase, neutrophil expressed;f;;Human;24556381;Inhibition
compound 10l [PMID: 24556381];elastase, neutrophil expressed;f;;Human;24556381;Inhibition
compound 4g [PMID: 22595175];elastase, neutrophil expressed;f;;Human;22595175;Inhibition
poststatin;elastase, neutrophil expressed;f;;Human;8931723;Inhibition
sivelestat;elastase, neutrophil expressed;f;;Human;21741848;Inhibition
MAK683;embryonic ectoderm development;f;;Human;;Negative
A-395;embryonic ectoderm development;f;;Human;28135237;Binding
S3969;ENaCαβγ;f;;Human;18326490;None
amiloride;ENaCαβγ;f;;Human;;None
benzamil;ENaCαβγ;f;;Human;;None
P552-02;ENaCαβγ;f;;Human;;None
triamterene;ENaCαβγ;f;;Human;8107805|14500741;None
carotuximab;endoglin (CD105);f;;Human;;Binding
compound 17 [PMID: 23916253];Endoplasmic reticulum aminopeptidase 1;f;;Human;23916253;Inhibition
compound 2g [PMID: 27390066];Endoplasmic reticulum aminopeptidase 1;f;;Human;27390066;Inhibition
compound 3v [PMID: 27390066];Endoplasmic reticulum aminopeptidase 1;f;;Human;27390066;Inhibition
compound 17 [PMID: 23916253];Endoplasmic reticulum aminopeptidase 2;f;;Human;23916253;Inhibition
compound 2g [PMID: 27390066];Endoplasmic reticulum aminopeptidase 2;f;;Human;27390066;Inhibition
compound 3v [PMID: 27390066];Endoplasmic reticulum aminopeptidase 2;f;;Human;27390066;Inhibition
compound 34 [PMID: 24749861];endoplasmic reticulum to nucleus signaling 1;f;;Human;24749861;Inhibition
GW274150;Endothelial NOS;f;;Human;15163211;Inhibition
L-NNA;Endothelial NOS;f;;Human;9667974;Inhibition
belzutifan;endothelial PAS domain protein 1;f;;Human;31282155;Binding
compound 22 [PMID: 19899765];Endothelin-converting enzyme 1;f;;Human;19899765;Inhibition
daglutril;Endothelin-converting enzyme 1;f;;Human;;Inhibition
KC-12615;Endothelin-converting enzyme 1;f;;Human;22480515;Inhibition
PD159790;Endothelin-converting enzyme 1;f;;Human;;Inhibition
SM19712;Endothelin-converting enzyme 1;f;;Rat;11043447;Inhibition
compound 1 [PMID: 18507370];Endothelin-converting enzyme 2;f;;Human;18507370;Inhibition
S136492;Endothelin-converting enzyme 2;f;;Human;18507370;Inhibition
GSK343;enhancer of zeste 1 polycomb repressive complex 2 subunit;f;;Human;24900432;Inhibition
CPI-1205;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;27739677;Inhibition
EBI-2511;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;29456795;Inhibition
EI1;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;23236167;Inhibition
EPZ005687;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;23023262;Inhibition
EPZ011989;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;26005520;Inhibition
GSK126;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;23051747|22904200;Inhibition
GSK343;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;24900432;Inhibition
JQEZ5;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;27135738;Inhibition
PF-06821497;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;29211475;Inhibition
tazemetostat;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;23620515;Inhibition
UNC1999;enhancer of zeste 2 polycomb repressive complex 2 subunit;f;;Human;23614352;Inhibition
compound 20 [PMID: 23489211];EPH receptor A1;f;;Human;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A1;f;;Human;19788238;Inhibition
DDR1/2 inhibitor 5n;EPH receptor A2;f;;Human;30075624;Inhibition
compound 20 [PMID: 23489211];EPH receptor A2;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A2;f;;Human;19788238;Inhibition
compound 8h [PMID: 21561767];EPH receptor A2;f;;Human;21561767;Inhibition
dorsomorphin;EPH receptor A2;f;;Human;20932747;Inhibition
fibatuzumab;EPH receptor A3;f;;Mouse;;Binding
fibatuzumab;EPH receptor A3;f;;Human;;Binding
compound 20 [PMID: 23489211];EPH receptor A3;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A3;f;;Human;19788238;Inhibition
compound 8h [PMID: 21561767];EPH receptor A3;f;;Human;21561767;Inhibition
sitravatinib;EPH receptor A3;f;;Human;26675259;Inhibition
compound 20 [PMID: 23489211];EPH receptor A4;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A4;f;;Human;19788238;Inhibition
compound 20 [PMID: 23489211];EPH receptor A5;f;;Rat;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A5;f;;Human;19788238;Inhibition
RIPK3 inhibitor 18;EPH receptor A5;f;;Human;;Inhibition
compound 20 [PMID: 23489211];EPH receptor A6;f;;Mouse;23489211;Inhibition
compound 20 [PMID: 23489211];EPH receptor A7;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A7;f;;Human;19788238;Inhibition
compound 8h [PMID: 21561767];EPH receptor A7;f;;Human;21561767;Inhibition
DDR1/2 inhibitor 5n;EPH receptor A7;f;;Human;30075624;Inhibition
compound 20 [PMID: 23489211];EPH receptor A8;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor A8;f;;Human;19788238;Inhibition
DDR1/2 inhibitor 5n;EPH receptor A8;f;;Human;30075624;Inhibition
RIPK3 inhibitor 18;EPH receptor A8;f;;Human;;Inhibition
compound 20 [PMID: 23489211];EPH receptor B1;f;;Rat;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor B1;f;;Human;19788238;Inhibition
compound 20 [PMID: 23489211];EPH receptor B2;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor B2;f;;Human;19788238;Inhibition
DDR1/2 inhibitor 5n;EPH receptor B2;f;;Human;30075624;Inhibition
RIPK3 inhibitor 18;EPH receptor B2;f;;Human;;Inhibition
compound 20 [PMID: 23489211];EPH receptor B3;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor B3;f;;Human;19788238;Inhibition
compound 20 [PMID: 23489211];EPH receptor B4;f;;Mouse;23489211;Inhibition
compound 66 [PMID: 19788238];EPH receptor B4;f;;Human;19788238;Inhibition
tesevatinib;EPH receptor B4;f;;Human;17575237;Inhibition
compound 20 [PMID: 23489211];EPH receptor B6;f;;Mouse;23489211;Inhibition
EAI045;epidermal growth factor receptor;f;;Human;27251290;Inhibition
panitumumab;epidermal growth factor receptor;f;;Human;14967460;Antagonist
amivantamab;epidermal growth factor receptor;f;;Human;26260789;Binding
cetuximab;epidermal growth factor receptor;f;;Human;;Binding
MM-151;epidermal growth factor receptor;f;;Human;25911688|22208982;Binding
necitumumab;epidermal growth factor receptor;f;;Human;;Binding
abivertinib;epidermal growth factor receptor;f;;Human;27573423;Inhibition
acalabrutinib;epidermal growth factor receptor;f;;Human;26641137;Inhibition
AEE788;epidermal growth factor receptor;f;;Human;15256466;Inhibition
afatinib;epidermal growth factor receptor;f;;Human;20550212|18408761;Inhibition
afatinib;epidermal growth factor receptor;f;;Human;22037378;Inhibition
AG 112;epidermal growth factor receptor;f;;Human;2552117;Inhibition
AG1478;epidermal growth factor receptor;f;;Human;10090785;Inhibition
AG 490;epidermal growth factor receptor;f;;Human;1676428;Inhibition
AG 9;epidermal growth factor receptor;f;;Human;2552117;Inhibition
allitinib;epidermal growth factor receptor;f;;Human;21789172;Inhibition
AST2818;epidermal growth factor receptor;f;;Human;;Inhibition
BMS-599626;epidermal growth factor receptor;f;;Human;19821562;Inhibition
BMS-690514;epidermal growth factor receptor;f;;Human;20166197;Inhibition
BPIQ-I;epidermal growth factor receptor;f;;Human;8632415;Inhibition
brigatinib;epidermal growth factor receptor;f;;Human;21502504;Inhibition
canertinib;epidermal growth factor receptor;f;;Human;10753475;Inhibition
canertinib;epidermal growth factor receptor;f;;Human;22037378;Inhibition
compound 19a [PMID: 30503936];epidermal growth factor receptor;f;;Human;30503936;Inhibition
compound 38 [PMID: 24915291];epidermal growth factor receptor;f;;Human;24915291;Inhibition
compound 56 [PMID: 8568816];epidermal growth factor receptor;f;;Human;8568816;Inhibition
compound 6g [PMID: 30633509];epidermal growth factor receptor;f;;Human;30633509;Inhibition
CUDC-101;epidermal growth factor receptor;f;;Human;20143778;Inhibition
dacomitinib;epidermal growth factor receptor;f;;Human;22621397;Inhibition
dovitinib;epidermal growth factor receptor;f;;Human;15598814;Inhibition
EGFR/ErbB-2/ErbB-4 inhibitor;epidermal growth factor receptor;f;;Human;16480284;Inhibition
EGFR/ErbB-2 inhibitor;epidermal growth factor receptor;f;;Human;11378364;Inhibition
EGFR inhibitor;epidermal growth factor receptor;f;;Human;18077363;Inhibition
erlotinib;epidermal growth factor receptor;f;;Human;14684309;Inhibition
erlotinib;epidermal growth factor receptor;f;;Human;22037378;Inhibition
example 1 [WO2016094821A2];epidermal growth factor receptor;f;;Human;;Inhibition
falnidamol;epidermal growth factor receptor;f;;Human;15199094;Inhibition
gefitinib;epidermal growth factor receptor;f;;Human;31895569;Inhibition
gefitinib;epidermal growth factor receptor;f;;Human;22037378;Inhibition
gefitinib;epidermal growth factor receptor;f;;Human;17416531;Inhibition
HS-10296;epidermal growth factor receptor;f;;Human;;Inhibition
ibrutinib;epidermal growth factor receptor;f;;Human;26641137;Inhibition
icotinib;epidermal growth factor receptor;f;;Human;22959248;Inhibition
JAK3 inhibitor II;epidermal growth factor receptor;f;;Human;18094329;Inhibition
lapatinib;epidermal growth factor receptor;f;;Human;12467226;Inhibition
lazertinib;epidermal growth factor receptor;f;;Human;;Inhibition
lifirafenib;epidermal growth factor receptor;f;;Human;26208524;Inhibition
mavelertinib;epidermal growth factor receptor;f;;Human;28287730;Inhibition
mobocertinib;epidermal growth factor receptor;f;;Human;;Inhibition
MS154;epidermal growth factor receptor;f;;Human;31895569;Inhibition
MS39;epidermal growth factor receptor;f;;Human;31895569;Inhibition
naquotinib;epidermal growth factor receptor;f;;Human;;Inhibition
nazartinib;epidermal growth factor receptor;f;;Human;;Inhibition
neratinib;epidermal growth factor receptor;f;;Human;15173008;Inhibition
olmutinib;epidermal growth factor receptor;f;;Human;;Inhibition
orantinib;epidermal growth factor receptor;f;;Human;19110422;Inhibition
osimertinib;epidermal growth factor receptor;f;;Human;27071706;Inhibition
PD 158780;epidermal growth factor receptor;f;;Human;9191958;Inhibition
PD166285;epidermal growth factor receptor;f;;Human;9400019;Inhibition
PD 174265;epidermal growth factor receptor;f;;Human;9751783;Inhibition
pelitinib;epidermal growth factor receptor;f;;Human;17416531|15006373;Inhibition
PF-670462;epidermal growth factor receptor;f;;Human;17502429;Inhibition
PKI166;epidermal growth factor receptor;f;;Human;22018877;Inhibition
poziotinib;epidermal growth factor receptor;f;;Human;21306821;Inhibition
PP1;epidermal growth factor receptor;f;;Human;8557675;Inhibition
PP121;epidermal growth factor receptor;f;;Human;18849971;Inhibition
rociletinib;epidermal growth factor receptor;f;;Human;24065731;Inhibition
sapitinib;epidermal growth factor receptor;f;;Human;24900741;Inhibition
selatinib;epidermal growth factor receptor;f;;Human;24121234;Inhibition
tarloxotinib;epidermal growth factor receptor;f;;Human;26811177;Inhibition
tesevatinib;epidermal growth factor receptor;f;;Human;17575237;Inhibition
tucatinib;epidermal growth factor receptor;f;;Human;32241871;Inhibition
vandetanib;epidermal growth factor receptor;f;;Human;12499271;Inhibition
WZ4002;epidermal growth factor receptor;f;;Human;20033049;Inhibition
xiliertinib;epidermal growth factor receptor;f;;Human;28881608;Inhibition
ZM-306416;epidermal growth factor receptor;f;;Human;22573732;Inhibition
zorifertinib;epidermal growth factor receptor;f;;Human;26313252;Inhibition
zorifertinib;epidermal growth factor receptor;f;;Human;26313252;Inhibition
pyrotinib;epidermal growth factor receptor;f;;Human;28115222;Irreversible inhibition
amphiregulin;epidermal growth factor receptor;t;Human;Human;;Binding
betacellulin;epidermal growth factor receptor;t;Human;Human;;Binding
EGF;epidermal growth factor receptor;t;Human;Human;;Binding
epigen;epidermal growth factor receptor;t;Human;Human;;Binding
epiregulin;epidermal growth factor receptor;t;Human;Human;;Binding
HB-EGF;epidermal growth factor receptor;t;Human;Human;;Binding
TGFα;epidermal growth factor receptor;t;Human;Human;;Binding
BI-1935;epoxide hydrolase 2;f;;Human;19758802;Inhibition
diflapolin;epoxide hydrolase 2;f;;Human;28839250;Inhibition
dual sEH/FAAH inhibitor 11;epoxide hydrolase 2;f;;Human;;Inhibition
dual sEH/FAAH inhibitor 11;epoxide hydrolase 2;f;;Mouse;30411058;Inhibition
dual sEH/FAAH inhibitor 11;epoxide hydrolase 2;f;;Rat;30411058;Inhibition
GSK2256294;epoxide hydrolase 2;f;;Human;;Inhibition
MPPA;epoxide hydrolase 2;f;;Rat;29614224;Inhibition
MPPA;epoxide hydrolase 2;f;;Human;29614224;Inhibition
oxaprozin;epoxide hydrolase 2;f;;Human;27009944;Inhibition
PF750;epoxide hydrolase 2;f;;Human;30411058;Inhibition
PF750;epoxide hydrolase 2;f;;Human;30411058;Inhibition
SWE101;epoxide hydrolase 2;f;;Human;31436984;Inhibition
SWE101;epoxide hydrolase 2;f;;Human;31436984;Inhibition
triple modulator 10 [PMID: 29878767];epoxide hydrolase 2;f;;Human;29878767;Inhibition
zafirlukast;epoxide hydrolase 2;f;;Human;29878767;Inhibition
17-phenyl-ω-trinor-PGE2;EP1 receptor;f;;Rat;9537820;Full agonist
17-phenyl-ω-trinor-PGE2;EP1 receptor;f;;Human;11999132;Full agonist
17-phenyl-ω-trinor-PGE2;EP1 receptor;f;;Mouse;9313928;Full agonist
carbacyclin;EP1 receptor;f;;Human;10634944;Full agonist
cicaprost;EP1 receptor;f;;Human;10634944;Full agonist
cloprostenol;EP1 receptor;f;;Human;10634944|11999132;Full agonist
enprostil;EP1 receptor;f;;Human;10634944|11999132;Full agonist
enprostil;EP1 receptor;f;;Rat;9537820;Full agonist
iloprost;EP1 receptor;f;;Human;10634944|11999132;Full agonist
iloprost;EP1 receptor;f;;Mouse;9313928;Full agonist
MB-28767;EP1 receptor;f;;Rat;9537820;Full agonist
MB-28767;EP1 receptor;f;;Human;10634944;Full agonist
MB-28767;EP1 receptor;f;;Mouse;9313928;Full agonist
ONO-DI-004;EP1 receptor;f;;Mouse;10746663;Full agonist
PGD2;EP1 receptor;t;;Rat;9537820;Full agonist
PGD2;EP1 receptor;t;;Human;11999132;Full agonist
PGE1;EP1 receptor;t;;Human;11999132;Full agonist
PGE1;EP1 receptor;t;;Rat;9537820;Full agonist
PGE1;EP1 receptor;t;;Mouse;9313928;Full agonist
PGE2;EP1 receptor;t;;Human;16604093|10634944|11999132;Full agonist
PGE2;EP1 receptor;t;;Mouse;9313928|10746663;Full agonist
PGE2;EP1 receptor;t;;Rat;9537820;Full agonist
PGF2α;EP1 receptor;t;;Mouse;9313928;Full agonist
PGF2α;EP1 receptor;t;;Rat;9537820;Full agonist
PGF2α;EP1 receptor;t;;Human;10634944|11999132;Full agonist
PGI2;EP1 receptor;t;;Human;11999132;Full agonist
sulprostone;EP1 receptor;f;;Mouse;9313928;Full agonist
sulprostone;EP1 receptor;f;;Rat;9537820;Full agonist
sulprostone;EP1 receptor;f;;Human;10634944|11999132;Full agonist
[3H]PGE2;EP1 receptor;f;;Human;16604093|10634944|11999132;Full agonist
[3H]PGE2;EP1 receptor;f;;Rat;8940129|9537820;Full agonist
treprostinil;EP1 receptor;f;;Human;22480736;Full agonist
U46619;EP1 receptor;f;;Rat;9537820;Full agonist
U46619;EP1 receptor;f;;Human;10634944;Full agonist
iloprost;EP1 receptor;f;;Rat;9537820;Partial agonist
ZK110841;EP1 receptor;f;;Human;11999132;Partial agonist
ZK118182;EP1 receptor;f;;Human;11999132;Partial agonist
AH6809;EP1 receptor;f;;Human;10634944|11999132;Antagonist
AH6809;EP1 receptor;f;;Rat;9537820;Antagonist
GW848687X;EP1 receptor;f;;Human;17084082;Antagonist
MF266-1;EP1 receptor;f;;Human;18287210;Antagonist
ONO-8711;EP1 receptor;f;;Mouse;10537280;Antagonist
ONO-8711;EP1 receptor;f;;Human;10537280;Antagonist
ONO-8713;EP1 receptor;f;;Mouse;10840160;Antagonist
ONO-8713;EP1 receptor;f;;Human;10509919;Antagonist
SC-19220;EP1 receptor;f;;Rat;9537820;Antagonist
SC-19220;EP1 receptor;f;;Human;11999132;Antagonist
SC-51089;EP1 receptor;f;;Human;10634944;Antagonist
SC-51322;EP1 receptor;f;;Human;10634944;Antagonist
MRE-269;EP2 receptor;f;;Human;17545310;Agonist
omidenepag;EP2 receptor;f;;Human;29332128;Agonist
PGN-9856;EP2 receptor;f;;Human;30341781;Agonist
11-deoxy-PGE1;EP2 receptor;f;;Rat;9537820;Full agonist
11-deoxy-PGE1;EP2 receptor;f;;Mouse;9313928;Full agonist
16,16-dimethyl-PGE2;EP2 receptor;f;;Mouse;9313928;Full agonist
17-phenyl-ω-trinor-PGE2;EP2 receptor;f;;Rat;9537820;Full agonist
19(R)-OH-PGE2;EP2 receptor;f;;Rat;9537820;Full agonist
19(R)-OH-PGE2;EP2 receptor;f;;Human;8078484;Full agonist
AH13205;EP2 receptor;f;;Mouse;9313928;Full agonist
AH13205;EP2 receptor;f;;Human;10462542;Full agonist
butaprost (free acid form);EP2 receptor;f;;Human;10634944|10462542;Full agonist
butaprost (free acid form);EP2 receptor;f;;Rat;9537820;Full agonist
carbacyclin;EP2 receptor;f;;Mouse;9313928;Full agonist
carbacyclin;EP2 receptor;f;;Human;10634944;Full agonist
cicaprost;EP2 receptor;f;;Mouse;9313928;Full agonist
evatanepag;EP2 receptor;f;;Rat;19250823;Full agonist
evatanepag;EP2 receptor;f;;Rat;19250823;Full agonist
iloprost;EP2 receptor;f;;Rat;9537820;Full agonist
iloprost;EP2 receptor;f;;Human;10634944;Full agonist
iloprost;EP2 receptor;f;;Mouse;9313928;Full agonist
isocarbacyclin;EP2 receptor;f;;Mouse;9313928;Full agonist
MB-28767;EP2 receptor;f;;Human;10634944|10462542;Full agonist
MB-28767;EP2 receptor;f;;Rat;9537820;Full agonist
misoprostol (free acid form);EP2 receptor;f;;Human;10634944;Full agonist
misoprostol (methyl ester);EP2 receptor;f;;Human;10634944;Full agonist
ONO-AE1-259;EP2 receptor;f;;Mouse;10746663;Full agonist
ONO-AE1-329;EP2 receptor;f;;Mouse;10746663;Full agonist
ONO-AE-248;EP2 receptor;f;;Mouse;10746663;Full agonist
PGD2;EP2 receptor;t;;Human;10462542;Full agonist
PGD2;EP2 receptor;t;;Rat;9537820;Full agonist
PGE1;EP2 receptor;f;;Human;8163486;Full agonist
PGE1;EP2 receptor;t;;Rat;9537820;Full agonist
PGE1;EP2 receptor;t;;Mouse;9313928;Full agonist
PGE2;EP2 receptor;t;;Human;16604093|10634944|10462542;Full agonist
PGE2;EP2 receptor;t;;Rat;9537820;Full agonist
PGE2;EP2 receptor;t;;Mouse;9313928|10746663|14607240;Full agonist
PGF2α;EP2 receptor;t;;Human;10634944|10462542;Full agonist
PGF2α;EP2 receptor;t;;Rat;9537820;Full agonist
rivenprost;EP2 receptor;f;;Mouse;11917107;Full agonist
[3H]PGE2;EP2 receptor;f;;Human;16604093|10634944;Full agonist
[3H]PGE2;EP2 receptor;f;;Rat;9537820|9440134;Full agonist
[3H]PGE2;EP2 receptor;f;;Mouse;14699136;Full agonist
taprenepag;EP2 receptor;f;;Human;21376717;Full agonist
taprenepag;EP2 receptor;f;;Rat;21376717;Full agonist
treprostinil;EP2 receptor;f;;Human;22480736|25542069;Full agonist
U46619;EP2 receptor;f;;Rat;9537820;Full agonist
U46619;EP2 receptor;f;;Human;10634944;Full agonist
compound 1 [PMID: 20080612];EP2 receptor;f;;Human;20080612;Positive
AH6809;EP2 receptor;f;;Mouse;9313928;Antagonist
AH6809;EP2 receptor;f;;Human;10634944;Antagonist
AH6809;EP2 receptor;f;;Rat;9537820;Antagonist
PF-04418948;EP2 receptor;f;;Human;21595651|22747912;Antagonist
PF-04418948;EP2 receptor;f;;Mouse;22747912;Antagonist
PF-04852946;EP2 receptor;f;;Human;23786281;Antagonist
TG11-77;EP2 receptor;f;;Human;31904232;Antagonist
TG4-155;EP2 receptor;f;;Human;22323596;Antagonist
TG6-129;EP2 receptor;f;;Human;23914286;Antagonist
TG7-171;EP2 receptor;f;;Human;24937185;Antagonist
beraprost;EP3 receptor;f;;Human;17545310;Agonist
GR 63799;EP3 receptor;f;;Rat;9537820;Agonist
GR 63799;EP3 receptor;f;;Human;10634944;Agonist
11-deoxy-PGE1;EP3 receptor;f;;Rat;9537820;Full agonist
17-phenyl-ω-trinor-PGE2;EP3 receptor;f;;Rat;9537820;Full agonist
17-phenyl-ω-trinor-PGE2;EP3 receptor;f;;Mouse;9313928;Full agonist
butaprost (free acid form);EP3 receptor;f;;Rat;9537820;Full agonist
butaprost (free acid form);EP3 receptor;f;;Human;10634944;Full agonist
carbacyclin;EP3 receptor;f;;Mouse;9313928;Full agonist
carbacyclin;EP3 receptor;f;;Human;10634944;Full agonist
cicaprost;EP3 receptor;f;;Mouse;9313928;Full agonist
cicaprost;EP3 receptor;f;;Human;10634944;Full agonist
cloprostenol;EP3 receptor;f;;Human;10634944;Full agonist
cloprostenol;EP3 receptor;f;;Human;9694973;Full agonist
enprostil;EP3 receptor;f;;Rat;9537820;Full agonist
enprostil;EP3 receptor;f;;Human;9694973;Full agonist
enprostil;EP3 receptor;f;;Human;10634944;Full agonist
fluprostenol;EP3 receptor;f;;Human;10634944;Full agonist
I-BOP;EP3 receptor;f;;Mouse;9313928;Full agonist
iloprost;EP3 receptor;f;;Human;22480736;Full agonist
iloprost;EP3 receptor;f;;Mouse;9313928;Full agonist
iloprost;EP3 receptor;f;;Human;10634944;Full agonist
iloprost;EP3 receptor;f;;Rat;9537820;Full agonist
iloprost;EP3 receptor;f;;Rat;9537820;Full agonist
isocarbacyclin;EP3 receptor;f;;Mouse;9313928;Full agonist
MB-28767;EP3 receptor;f;;Rat;9537820;Full agonist
MB-28767;EP3 receptor;f;;Mouse;9313928;Full agonist
MB-28767;EP3 receptor;f;;Human;10634944;Full agonist
misoprostol (free acid form);EP3 receptor;f;;Human;10634944;Full agonist
misoprostol (methyl ester);EP3 receptor;f;;Human;10634944;Full agonist
ONO-8713;EP3 receptor;f;;Rat;9537820;Full agonist
ONO-AE1-329;EP3 receptor;f;;Mouse;10746663;Full agonist
ONO-AE-248;EP3 receptor;f;;Mouse;10746663|10479656;Full agonist
ONO-AE-248;EP3 receptor;f;;Human;22342278|21323896;Full agonist
PGD2;EP3 receptor;t;;Mouse;9313928;Full agonist
PGD2;EP3 receptor;t;;Rat;9537820;Full agonist
PGD2;EP3 receptor;t;;Rat;9537820;Full agonist
PGD2;EP3 receptor;t;;Rat;9537820;Full agonist
PGE1;EP3 receptor;t;;Mouse;9313928;Full agonist
PGE1;EP3 receptor;t;;Rat;9537820;Full agonist
PGE1;EP3 receptor;t;;Rat;9537820;Full agonist
PGE2;EP3 receptor;t;;Rat;8076679|15937517;Full agonist
PGE2;EP3 receptor;t;;Human;10634944;Full agonist
PGE2;EP3 receptor;t;;Mouse;9313928;Full agonist
PGE2;EP3 receptor;t;;Rat;9537820;Full agonist
PGE2;EP3 receptor;t;;Rat;9537820;Full agonist
PGE2;EP3 receptor;t;;Human;16604093|22480736|18632791;Full agonist
PGE2;EP3 receptor;t;;Mouse;9313928;Full agonist
PGE2;EP3 receptor;t;;Human;18632791;Full agonist
PGE2;EP3 receptor;t;;Rat;9537820|15937517|18632791;Full agonist
PGE2;EP3 receptor;t;;Rat;18632791;Full agonist
PGF2α;EP3 receptor;t;;Mouse;9313928;Full agonist
PGF2α;EP3 receptor;t;;Human;10634944;Full agonist
PGF2α;EP3 receptor;t;;Rat;9537820;Full agonist
PGF2α;EP3 receptor;t;;Rat;9537820;Full agonist
SC46275;EP3 receptor;f;;Dog;7562572;Full agonist
SC46275;EP3 receptor;f;;Guinea pig;8140121;Full agonist
SC46275;EP3 receptor;f;;Rat;16737803;Full agonist
STA2;EP3 receptor;f;;Mouse;9313928;Full agonist
sulprostone;EP3 receptor;f;;Mouse;9313928;Full agonist
sulprostone;EP3 receptor;f;;Human;9694973;Full agonist
sulprostone;EP3 receptor;f;;Rat;9537820;Full agonist
sulprostone;EP3 receptor;f;;Rat;9537820;Full agonist
sulprostone;EP3 receptor;f;;Human;10634944;Full agonist
[3H]PGE2;EP3 receptor;f;;Rat;9537820;Full agonist
[3H]PGE2;EP3 receptor;f;;Human;16604093|10634944;Full agonist
treprostinil;EP3 receptor;f;;Human;22480736;Full agonist
U46619;EP3 receptor;f;;Human;10634944;Full agonist
U46619;EP3 receptor;f;;Rat;9537820;Full agonist
U46619;EP3 receptor;f;;Rat;9537820;Full agonist
11-deoxy-PGE1;EP3 receptor;f;;Mouse;9313928;Partial agonist
16,16-dimethyl-PGE2;EP3 receptor;f;;Mouse;9313928;Partial agonist
GR 63799;EP3 receptor;f;;Mouse;9313928;Partial agonist
ONO-AP-324;EP3 receptor;f;;Mouse;9863659;Partial agonist
rivenprost;EP3 receptor;f;;Mouse;11917107;Partial agonist
AH6809;EP3 receptor;f;;Human;10634944;Antagonist
DG-041;EP3 receptor;f;;Human;18632791;Antagonist
DG-041;EP3 receptor;f;;Human;18632791;Antagonist
DG-041;EP3 receptor;f;;Human;18632791;Antagonist
DG-041;EP3 receptor;f;;Human;19486006;Antagonist
L-798,106;EP3 receptor;f;;Human;11504634|18632791|19486006;Antagonist
L-826266;EP3 receptor;f;;Human;18287210;Antagonist
L-826266;EP3 receptor;f;;Human;11504634;Antagonist
L-826266;EP3 receptor;f;;Human;18287210|20973775;Antagonist
ONO-8711;EP3 receptor;f;;Mouse;10840160;Antagonist
ONO-8713;EP3 receptor;f;;Mouse;10840160;Antagonist
ONO-AE2-227;EP3 receptor;f;;Mouse;11782353;Antagonist
ONO-AE2-227;EP3 receptor;f;;Mouse;11782353;Antagonist
ONO-AE3-208;EP3 receptor;f;;Mouse;11927615;Antagonist
ONO-AE3-240;EP3 receptor;f;;Mouse;12538661;Antagonist
ONO-AE3-240;EP3 receptor;f;;Mouse;12538661;Antagonist
ONO-AE5-599;EP3 receptor;f;;Mouse;17512019;Antagonist
SC-51322;EP3 receptor;f;;Human;10634944;Antagonist
11-deoxy-PGE1;EP4 receptor;f;;Human;19584306;Agonist
17-phenyl-ω-trinor-PGE2;EP4 receptor;f;;Human;27664754;Agonist
beraprost;EP4 receptor;f;;Human;17545310;Agonist
CP734432;EP4 receptor;f;;Human;19445930;Agonist
L902688;EP4 receptor;f;;Human;;Agonist
L902688;EP4 receptor;f;;Human;19584306|18516068;Agonist
MRE-269;EP4 receptor;f;;Human;17545310;Agonist
ONO-AE1-437;EP4 receptor;f;;Mouse;12954235;Agonist
TCS 2510;EP4 receptor;f;;Human;;Agonist
treprostinil;EP4 receptor;f;;Human;22480736;Agonist
treprostinil;EP4 receptor;f;;Human;22480736;Agonist
11-deoxy-PGE1;EP4 receptor;f;;Human;10952683;Full agonist
11-deoxy-PGE1;EP4 receptor;f;;Mouse;9313928;Full agonist
11-deoxy-PGE2;EP4 receptor;f;;Rat;9537820;Full agonist
13,14-dihydro-PGE1;EP4 receptor;f;;Human;10952683;Full agonist
16,16-dimethyl-PGE2;EP4 receptor;f;;Mouse;9313928;Full agonist
19(R)-OH-PGE2;EP4 receptor;f;;Rat;9537820;Full agonist
1-OH-PGE1;EP4 receptor;f;;Mouse;9313928;Full agonist
butaprost (free acid form);EP4 receptor;f;;Rat;9537820;Full agonist
butaprost (free acid form);EP4 receptor;f;;Human;10634944;Full agonist
carbacyclin;EP4 receptor;f;;Mouse;9313928;Full agonist
carbacyclin;EP4 receptor;f;;Human;10634944;Full agonist
cicaprost;EP4 receptor;f;;Human;10634944;Full agonist
CP734432;EP4 receptor;f;;Human;19445930;Full agonist
enprostil;EP4 receptor;f;;Human;10952683;Full agonist
iloprost;EP4 receptor;f;;Human;22480736;Full agonist
iloprost;EP4 receptor;f;;Mouse;9313928;Full agonist
iloprost;EP4 receptor;f;;Human;10634944|10952683|22480736;Full agonist
MB-28767;EP4 receptor;f;;Human;10634944|10462542;Full agonist
MB-28767;EP4 receptor;f;;Mouse;9313928;Full agonist
MB-28767;EP4 receptor;f;;Rat;9537820;Full agonist
MB-28767;EP4 receptor;f;;Human;19584306;Full agonist
misoprostol (free acid form);EP4 receptor;f;;Human;10634944;Full agonist
misoprostol (methyl ester);EP4 receptor;f;;Human;10634944;Full agonist
ONO-AE1-329;EP4 receptor;f;;Mouse;10746663;Full agonist
ONO-AE1-329;EP4 receptor;f;;Human;21323896|18516068;Full agonist
PGD2;EP4 receptor;t;;Human;10462542|10952683;Full agonist
PGD2;EP4 receptor;t;;Human;19584306;Full agonist
PGD2;EP4 receptor;t;;Rat;9537820;Full agonist
PGE1;EP4 receptor;t;;Human;19584306;Full agonist
PGE1;EP4 receptor;t;;Rat;9537820;Full agonist
PGE1;EP4 receptor;t;;Human;10952683;Full agonist
PGE1;EP4 receptor;t;;Mouse;9313928;Full agonist
PGE2;EP4 receptor;t;;Human;16604093|10634944|10462542|10952683|17495127;Full agonist
PGE2;EP4 receptor;t;;Rat;9537820;Full agonist
PGE2;EP4 receptor;t;;Mouse;9313928;Full agonist
PGE2;EP4 receptor;t;;Mouse;9313928|10746663;Full agonist
PGE2;EP4 receptor;t;;Human;19584306;Full agonist
PGF2α;EP4 receptor;t;;Human;10634944|10462542|10952683;Full agonist
PGF2α;EP4 receptor;t;;Human;19584306;Full agonist
PGF2α;EP4 receptor;t;;Rat;9537820;Full agonist
PGI2;EP4 receptor;t;;Human;10952683;Full agonist
rivenprost;EP4 receptor;f;;Mouse;11917107;Full agonist
[3H]PGE2;EP4 receptor;f;;Human;16604093|10634944|10952683|22480736;Full agonist
[3H]PGE2;EP4 receptor;f;;Rat;9537820;Full agonist
U46619;EP4 receptor;f;;Human;10634944;Full agonist
U46619;EP4 receptor;f;;Rat;9537820;Full agonist
THG213.29;EP4 receptor;f;;Rat;23152113;Negative
AH23848;EP4 receptor;f;;Rat;9537820;Antagonist
AH23848;EP4 receptor;f;;Human;10634944|10952683;Antagonist
AH23848;EP4 receptor;f;;Human;10634944;Antagonist
AH23848 (racemic);EP4 receptor;f;;Rat;9537820;Antagonist
BGC201531;EP4 receptor;f;;Human;19154437;Antagonist
CJ-042794;EP4 receptor;f;;Human;18031725;Antagonist
CR6086;EP4 receptor;f;;Human;29490676;Antagonist
CR6086;EP4 receptor;f;;Human;29490676;Antagonist
CR6086;EP4 receptor;f;;Mouse;29490676;Antagonist
CR6086;EP4 receptor;f;;Rat;29490676;Antagonist
EP4A;EP4 receptor;f;;Rat;11408598;Antagonist
EP4A;EP4 receptor;f;;Human;11408598;Antagonist
ER819762;EP4 receptor;f;;Human;20423341;Antagonist
ER819762;EP4 receptor;f;;Human;20163116;Antagonist
evatanepag;EP4 receptor;f;;Human;18155068;Antagonist
grapiprant;EP4 receptor;f;;Human;17495127;Antagonist
GW 627368;EP4 receptor;f;;Human;16604093|15655509;Antagonist
MF 498;EP4 receptor;f;;Human;18287210;Antagonist
MK-2894;EP4 receptor;f;;Human;10634944|20163116|18287210;Antagonist
ONO-AE2-227;EP4 receptor;f;;Mouse;11782353;Antagonist
ONO-AE3-208;EP4 receptor;f;;Mouse;11927615;Antagonist
ONO-AE3-208;EP4 receptor;f;;Human;;Antagonist
ONO-AE3-240;EP4 receptor;f;;Mouse;12538661;Antagonist
TG11-77;EP4 receptor;f;;Human;31904232;Antagonist
TG6-129;EP4 receptor;f;;Human;23914286;Antagonist
dilazep;Equilibrative nucleoside transporter 1;f;;Human;;Inhibition
dipyridamole;Equilibrative nucleoside transporter 1;f;;Human;14634039;Inhibition
draflazine;Equilibrative nucleoside transporter 1;f;;Human;10763851;Inhibition
KF24345;Equilibrative nucleoside transporter 1;f;;Human;14634039;Inhibition
NBTGR ;Equilibrative nucleoside transporter 1;f;;Human;;Inhibition
nitrobenzylmercaptopurine ribonucleoside;Equilibrative nucleoside transporter 1;f;;Human;;Inhibition
ticagrelor;Equilibrative nucleoside transporter 1;f;;Human;24414167;Inhibition
[3H]nitrobenzylmercaptopurine ribonucleoside;Equilibrative nucleoside transporter 1;f;;Human;;None
margetuximab;erb-b2 receptor tyrosine kinase 2;f;;Human;;Binding
MM-111;erb-b2 receptor tyrosine kinase 2;f;;Human;22248472;Binding
pertuzumab;erb-b2 receptor tyrosine kinase 2;f;;Human;;Inhibition
trastuzumab;erb-b2 receptor tyrosine kinase 2;f;;Human;;Inhibition
acalabrutinib;erb-b2 receptor tyrosine kinase 2;f;;Human;26641137;Inhibition
AEE788;erb-b2 receptor tyrosine kinase 2;f;;Human;15256466;Inhibition
afatinib;erb-b2 receptor tyrosine kinase 2;f;;Human;18408761;Inhibition
allitinib;erb-b2 receptor tyrosine kinase 2;f;;Human;21789172;Inhibition
BMS-599626;erb-b2 receptor tyrosine kinase 2;f;;Human;19821562;Inhibition
BMS-690514;erb-b2 receptor tyrosine kinase 2;f;;Human;20166197;Inhibition
canertinib;erb-b2 receptor tyrosine kinase 2;f;;Human;10753475;Inhibition
compound 38 [PMID: 24915291];erb-b2 receptor tyrosine kinase 2;f;;Human;24915291;Inhibition
CP-724714;erb-b2 receptor tyrosine kinase 2;f;;Human;18500794;Inhibition
CUDC-101;erb-b2 receptor tyrosine kinase 2;f;;Human;20143778;Inhibition
dacomitinib;erb-b2 receptor tyrosine kinase 2;f;;Human;22621397;Inhibition
EGFR/ErbB-2/ErbB-4 inhibitor;erb-b2 receptor tyrosine kinase 2;f;;Human;16480284;Inhibition
EGFR/ErbB-2 inhibitor;erb-b2 receptor tyrosine kinase 2;f;;Human;11378364;Inhibition
falnidamol;erb-b2 receptor tyrosine kinase 2;f;;Human;15199094;Inhibition
ibrutinib;erb-b2 receptor tyrosine kinase 2;f;;Human;26641137;Inhibition
lapatinib;erb-b2 receptor tyrosine kinase 2;f;;Human;22037378;Inhibition
lapatinib;erb-b2 receptor tyrosine kinase 2;f;;Human;12467226;Inhibition
mubritinib;erb-b2 receptor tyrosine kinase 2;f;;Human;16771730;Inhibition
neratinib;erb-b2 receptor tyrosine kinase 2;f;;Human;15173008;Inhibition
neratinib;erb-b2 receptor tyrosine kinase 2;f;;Human;22037378;Inhibition
poziotinib;erb-b2 receptor tyrosine kinase 2;f;;Human;21306821;Inhibition
sapitinib;erb-b2 receptor tyrosine kinase 2;f;;Human;24900741;Inhibition
selatinib;erb-b2 receptor tyrosine kinase 2;f;;Human;24121234;Inhibition
tesevatinib;erb-b2 receptor tyrosine kinase 2;f;;Human;17575237;Inhibition
tucatinib;erb-b2 receptor tyrosine kinase 2;f;;Human;32241871;Inhibition
pyrotinib;erb-b2 receptor tyrosine kinase 2;f;;Human;28115222;Irreversible inhibition
elgemtumab;erb-b2 receptor tyrosine kinase 3;f;;Human;;Binding
istiratumab;erb-b2 receptor tyrosine kinase 3;f;;Human;24282274;Binding
MM-111;erb-b2 receptor tyrosine kinase 3;f;;Human;22248472;Binding
seribantumab;erb-b2 receptor tyrosine kinase 3;f;;Human;19567914;Binding
TX2-121-1;erb-b2 receptor tyrosine kinase 3;f;;Human;26094118;Binding
sapitinib;erb-b2 receptor tyrosine kinase 3;f;;Human;24900741;Inhibition
TX1-85-1;erb-b2 receptor tyrosine kinase 3;f;;Human;26094118;Binding
neuregulin-1;erb-b2 receptor tyrosine kinase 3;t;Human;Human;;None
neuregulin-2;erb-b2 receptor tyrosine kinase 3;t;Human;Human;;None
acalabrutinib;erb-b2 receptor tyrosine kinase 4;f;;Human;26641137;Inhibition
AEE788;erb-b2 receptor tyrosine kinase 4;f;;Human;15256466;Inhibition
allitinib;erb-b2 receptor tyrosine kinase 4;f;;Human;21789172;Inhibition
BMS-599626;erb-b2 receptor tyrosine kinase 4;f;;Human;19821562;Inhibition
compound 38 [PMID: 24915291];erb-b2 receptor tyrosine kinase 4;f;;Human;24915291;Inhibition
compound 9 [PMID: 26006010];erb-b2 receptor tyrosine kinase 4;f;;Human;26006010;Inhibition
dacomitinib;erb-b2 receptor tyrosine kinase 4;f;;Human;22621397;Inhibition
EGFR/ErbB-2/ErbB-4 inhibitor;erb-b2 receptor tyrosine kinase 4;f;;Human;16480284;Inhibition
ibrutinib;erb-b2 receptor tyrosine kinase 4;f;;Human;26641137;Inhibition
poziotinib;erb-b2 receptor tyrosine kinase 4;f;;Human;21306821;Inhibition
tucatinib;erb-b2 receptor tyrosine kinase 4;f;;Human;32241871;Inhibition
WZ4002;erb-b2 receptor tyrosine kinase 4;f;;Human;20033049;Inhibition
xiliertinib;erb-b2 receptor tyrosine kinase 4;f;;Human;28881608;Inhibition
betacellulin;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
epiregulin;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
HB-EGF;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
neuregulin-1;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
neuregulin-2;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
neuregulin-3;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
neuregulin-4;erb-b2 receptor tyrosine kinase 4;t;Human;Human;;None
compound 1a [PMID: 23597791];Erythrocyte urea transporter;f;;Mouse;23597791;Inhibition
compound 1a [PMID: 23597791];Erythrocyte urea transporter;f;;Human;23597791;Inhibition
compound 8ay [PMID: 29589443];Erythrocyte urea transporter;f;;Rat;29589443;Inhibition
17β-estradiol;Estrogen receptor-α;t;;Human;9048584;Agonist
4-hydroxytamoxifen;Estrogen receptor-α;f;;Human;9048584;Agonist
AC-186;Estrogen receptor-α;f;;Human;23898966;Agonist
diarylpropionitrile;Estrogen receptor-α;f;;Human;19596275;Agonist
diethylstilbestrol;Estrogen receptor-α;f;;Human;9048584;Agonist
estriol;Estrogen receptor-α;t;;Human;9048584;Agonist
estrone;Estrogen receptor-α;t;;Human;9048584;Agonist
ethinylestradiol;Estrogen receptor-α;f;;Human;16722623;Agonist
prinaberel;Estrogen receptor-α;f;;Human;18097065;Agonist
prinaberel;Estrogen receptor-α;f;;Mouse;18097065;Agonist
prinaberel;Estrogen receptor-α;f;;Rat;18097065;Agonist
propylpyrazoletriol;Estrogen receptor-α;f;;Human;11150164|11014206;Agonist
raloxifene;Estrogen receptor-α;f;;Human;11150164;Agonist
R,R-THC;Estrogen receptor-α;f;;Human;9927308;Agonist
stanozolol;Estrogen receptor-α;f;;Human;;Agonist
tamoxifen;Estrogen receptor-α;f;;Human;9048584;Agonist
tibolone;Estrogen receptor-α;f;;Human;19464167;Agonist
WAY200070;Estrogen receptor-α;f;;Human;18423777;Agonist
lasofoxifene;Estrogen receptor-α;f;;Human;15658851;Partial agonist
4-hydroxytamoxifen;Estrogen receptor-α;f;;Human;9048584;Antagonist
4-hydroxytamoxifen;Estrogen receptor-α;f;;Human;16307879;Antagonist
bazedoxifene;Estrogen receptor-α;f;;Human;11356100;Antagonist
clomiphene;Estrogen receptor-α;f;;Human;;Antagonist
ERD-308;Estrogen receptor-α;f;;Human;30990042;Antagonist
fulvestrant;Estrogen receptor-α;f;;Human;12672240;Antagonist
GSK5182;Estrogen receptor-α;f;;Human;16307879;Antagonist
hexestrol;Estrogen receptor-α;f;;Human;9048584;Antagonist
methyl-piperidino-pyrazole;Estrogen receptor-α;f;;Human;11861516;Antagonist
norendoxifen;Estrogen receptor-α;f;;Human;23731360;Antagonist
raloxifene;Estrogen receptor-α;f;;Human;9048584;Antagonist
SAR439859;Estrogen receptor-α;f;;Human;31721572;Antagonist
tamoxifen;Estrogen receptor-α;f;;Human;9048584;Antagonist
17β-estradiol;Estrogen receptor-β;t;;Human;9048584;Agonist
AC-186;Estrogen receptor-β;f;;Human;23898966;Agonist
diarylpropionitrile;Estrogen receptor-β;f;;Human;11150164|11708925;Agonist
diarylpropionitrile;Estrogen receptor-β;f;;Human;19596275;Agonist
diethylstilbestrol;Estrogen receptor-β;f;;Human;9048584;Agonist
estriol;Estrogen receptor-β;f;;Human;9048584;Agonist
estrone;Estrogen receptor-β;t;;Human;9048584;Agonist
ethinylestradiol;Estrogen receptor-β;f;;Human;16722623;Agonist
FERb 033;Estrogen receptor-β;f;;Human;19128016;Agonist
FERb 033;Estrogen receptor-β;f;;Human;19128016;Agonist
genistein;Estrogen receptor-β;f;;Human;9048584;Agonist
liquiritigenin;Estrogen receptor-β;f;;Human;18177995;Agonist
norendoxifen;Estrogen receptor-β;f;;Human;23731360;Agonist
prinaberel;Estrogen receptor-β;f;;Mouse;18097065;Agonist
prinaberel;Estrogen receptor-β;f;;Human;15456246|18097065;Agonist
prinaberel;Estrogen receptor-β;f;;Rat;18097065;Agonist
tamoxifen;Estrogen receptor-β;f;;Human;9048584;Agonist
WAY200070;Estrogen receptor-β;f;;Human;18423777;Agonist
WAY200070;Estrogen receptor-β;f;;Human;15456246;Full agonist
bisphenol A;Estrogen receptor-β;f;;Human;23768907;Partial agonist
lasofoxifene;Estrogen receptor-β;f;;Human;15658851;Partial agonist
4-hydroxytamoxifen;Estrogen receptor-β;f;;Human;9048584;Antagonist
bazedoxifene;Estrogen receptor-β;f;;Human;11356100;Antagonist
fulvestrant;Estrogen receptor-β;f;;Human;12672240;Antagonist
HPTE;Estrogen receptor-β;f;;Human;10188995;Antagonist
PHTPP;Estrogen receptor-β;f;;Human;17228884;Antagonist
raloxifene;Estrogen receptor-β;f;;Human;11459665;Antagonist
R,R-THC;Estrogen receptor-β;f;;Human;9927308|10395487;Antagonist
tamoxifen;Estrogen receptor-β;f;;Human;9048584;Antagonist
biochanin A;Estrogen-related receptor-α;f;;Human;14638870;Agonist
daidzein;Estrogen-related receptor-α;f;;Human;14638870;Agonist
genistein;Estrogen-related receptor-α;f;;Human;14638870;Agonist
chlordane;Estrogen-related receptor-α;f;;Mouse;10493499;Antagonist
diethylstilbestrol;Estrogen-related receptor-α;f;;Mouse;11297507;Antagonist
toxaphene;Estrogen-related receptor-α;f;;Mouse;10493499;Antagonist
XCT790;Estrogen-related receptor-α;f;;Human;15184675;Antagonist
compound 1a [PMID: 17556356];Estrogen-related receptor-α;f;;Human;17556356;Inverse agonist
biochanin A;Estrogen-related receptor-β;f;;Human;14638870;Agonist
daidzein;Estrogen-related receptor-β;f;;Human;14638870;Agonist
DY131;Estrogen-related receptor-β;f;;Human;15713377;Agonist
genistein;Estrogen-related receptor-β;f;;Human;14638870;Agonist
diethylstilbestrol;Estrogen-related receptor-β;f;;Human;11297507;Antagonist
biochanin A;Estrogen-related receptor-γ;f;;Human;14638870;Agonist
daidzein;Estrogen-related receptor-γ;f;;Human;14638870;Agonist
DY131;Estrogen-related receptor-γ;f;;Human;15713377|15857113;Agonist
genistein;Estrogen-related receptor-γ;f;;Human;14638870;Agonist
GSK4716;Estrogen-related receptor-γ;f;;Human;15857113;Agonist
4-hydroxytamoxifen;Estrogen-related receptor-γ;f;;Human;11447273;Inverse agonist
4-hydroxytamoxifen;Estrogen-related receptor-γ;f;;Human;16307879;Inverse agonist
GSK5182;Estrogen-related receptor-γ;f;;Human;16307879;Inverse agonist
diethylstilbestrol;Estrogen-related receptor-γ;f;;Human;11297507|11447273;Antagonist
endothelin-1;ETA receptor;t;Human|Mouse|Rat;Human;7647976;Full agonist
endothelin-2;ETA receptor;t;Human;Human;7647976;Full agonist
sarafotoxin S6b;ETA receptor;f;;Human;7647976;Full agonist
[125I]ET-1 (human, mouse, rat);ETA receptor;f;;Human;7620699|8355464|7524189;Full agonist
[125I]ET-2 (human);ETA receptor;f;;Human;8851522;Full agonist
[125I]sarafotoxin S6b;ETA receptor;f;;Human;8851522;Full agonist
[18F]ET-1 (human, mouse, rat);ETA receptor;f;;Human;12193043;Full agonist
ambrisentan;ETA receptor;f;;Human;15139756;Antagonist
ambrisentan;ETA receptor;f;;Human;15139756;Antagonist
aprocitentan;ETA receptor;f;;Human;18780830;Antagonist
atrasentan;ETA receptor;f;;Human;8632312|8676339;Antagonist
atrasentan;ETA receptor;f;;Human;8632312;Antagonist
avosentan;ETA receptor;f;;Human;;Antagonist
bosentan;ETA receptor;f;;Rat;8035319;Antagonist
BQ123;ETA receptor;f;;Human;7647976;Antagonist
darusentan;ETA receptor;f;;Human;8667356;Antagonist
macitentan;ETA receptor;f;;Human;22862294;Antagonist
PD-156707;ETA receptor;f;;Human;10066864|9023329;Antagonist
PD-156707;ETA receptor;f;;Human;9023329;Antagonist
PD164333;ETA receptor;f;;Human;9489609;Antagonist
SB209670;ETA receptor;f;;Rat;8201588;Antagonist
SB234551;ETA receptor;f;;Human;9694916;Antagonist
sitaxsentan;ETA receptor;f;;Human;9171878;Antagonist
sparsentan;ETA receptor;f;;Human;16220969;Antagonist
[125I]PD151242;ETA receptor;f;;Human;8012722;Antagonist
[125I]PD164333;ETA receptor;f;;Human;9489609;Antagonist
[3H]BQ123;ETA receptor;f;;Human;7768260;Antagonist
[3H]S0139;ETA receptor;f;;Human;;Antagonist
TAK 044;ETA receptor;f;;Rat;7780649;Antagonist
zibotentan;ETA receptor;f;;Human;15956965;Antagonist
FR139317;ETA receptor;f;;Human;7647976;Inverse agonist
[Ala1,3,11,15]ET-1;ETB receptor;f;;Human;1472961;Full agonist
BQ 3020;ETB receptor;f;;Human;7733918;Full agonist
endothelin-3;ETB receptor;t;Human|Mouse|Rat;Human;7524189|8460684|8904635;Full agonist
endothelin-3;ETB receptor;t;Human|Mouse|Rat;Rat;8904635|1850245;Full agonist
IRL 1620;ETB receptor;f;;Human;1320877;Full agonist
sarafotoxin S6c;ETB receptor;f;;Human;8904635|8587419;Full agonist
sarafotoxin S6c;ETB receptor;f;;Rat;8904635|1850245;Full agonist
[125I][Ala1,3,11,15]ET-1;ETB receptor;f;;Human;1472961;Full agonist
[125I]BQ3020;ETB receptor;f;;Human;7881728|8587429|1472961;Full agonist
[125I]ET-1 (human, mouse, rat);ETB receptor;f;;Human;7620699|8355464|7524189|8460684|8477528;Full agonist
[125I]IRL1620;ETB receptor;f;;Human;8301559;Full agonist
[125I]IRL1620;ETB receptor;f;;Rat;8301559;Full agonist
A192621;ETB receptor;f;;Human;10479298;Antagonist
ambrisentan;ETB receptor;f;;Human;15139756;Antagonist
aprocitentan;ETB receptor;f;;Human;18780830;Antagonist
atrasentan;ETB receptor;f;;Human;8676339;Antagonist
bosentan;ETB receptor;f;;Human;12502366;Antagonist
bosentan;ETB receptor;f;;Rat;8035319;Antagonist
BQ788;ETB receptor;f;;Rat;8904635;Antagonist
BQ788;ETB receptor;f;;Human;8904635;Antagonist
IRL 2500;ETB receptor;f;;Human;8904635;Antagonist
K-8794;ETB receptor;f;;Human;28805809;Antagonist
macitentan;ETB receptor;f;;Human;22862294;Antagonist
RES7011;ETB receptor;f;;Human;8183252;Antagonist
Ro 46-8443;ETB receptor;f;;Human;8612786;Antagonist
SB209670;ETB receptor;f;;Rat;8201588;Antagonist
TAK 044;ETB receptor;f;;Rat;7780649;Antagonist
A-366;euchromatic histone lysine methyltransferase 1;f;;Human;24900801;Inhibition
BIX-01294;euchromatic histone lysine methyltransferase 1;f;;Human;17289593;Inhibition
UNC0638;euchromatic histone lysine methyltransferase 1;f;;Human;21743462;Inhibition
UNC0642;euchromatic histone lysine methyltransferase 1;f;;Human;24102134;Inhibition
A-366;euchromatic histone lysine methyltransferase 2;f;;Human;24900801;Inhibition
BIX-01294;euchromatic histone lysine methyltransferase 2;f;;Human;17289593;Inhibition
BRD9539;euchromatic histone lysine methyltransferase 2;f;;Human;22536950;Inhibition
UNC0321;euchromatic histone lysine methyltransferase 2;f;;Human;20614940;Inhibition
UNC0638;euchromatic histone lysine methyltransferase 2;f;;Human;21743462;Inhibition
UNC0638;euchromatic histone lysine methyltransferase 2;f;;Human;21743462;Inhibition
UNC0642;euchromatic histone lysine methyltransferase 2;f;;Human;24102134;Inhibition
compound 34 [PMID: 20189382];eukaryotic elongation factor 2 kinase;f;;Human;20189382;Inhibition
compound 27 [PMID: 19854648];eukaryotic translation initiation factor 2 alpha kinase 1;f;;Human;19854648;Inhibition
RIPK1 inhibitor 22b;eukaryotic translation initiation factor 2 alpha kinase 1;f;;Human;30480444;Inhibition
Cdk2 inhibitor IV;eukaryotic translation initiation factor 2 alpha kinase 2;f;;Human;21632247;Inhibition
indirubin derivative E804;eukaryotic translation initiation factor 2 alpha kinase 2;f;;Human;21632247;Inhibition
PKR inhibitor;eukaryotic translation initiation factor 2 alpha kinase 2;f;;Human;12890478;Inhibition
GSK2606414;eukaryotic translation initiation factor 2 alpha kinase 3;f;;Human;22827572;Inhibition
GSK2656157;eukaryotic translation initiation factor 2 alpha kinase 3;f;;Human;24900593;Inhibition
compound A127 [WO2013110309];eukaryotic translation initiation factor 2 alpha kinase 4;f;;Human;24900825;Inhibition
DL-TBOA;Excitatory amino acid transporter 1;f;;Human;9463476;Inhibition
UCPH-101;Excitatory amino acid transporter 1;f;;Human;19161278;Inhibition
[3H]ETB-TBOA;Excitatory amino acid transporter 1;f;;Rat;17047096;Binding
[3H]D-aspartic acid;Excitatory amino acid transporter 1;f;;Human;;None
[3H]L-aspartic acid;Excitatory amino acid transporter 1;f;;Human;;None
[3H]SYM2081;Excitatory amino acid transporter 1;f;;Human;;None
dihydrokainate;Excitatory amino acid transporter 2;f;;Human;;Inhibition
DL-TBOA;Excitatory amino acid transporter 2;f;;Human;9463476;Inhibition
SYM2081;Excitatory amino acid transporter 2;f;;Human;9145919;Inhibition
threo-3-methylglutamate;Excitatory amino acid transporter 2;f;;Human;9145919;Inhibition
WAY-213613;Excitatory amino acid transporter 2;f;;Human;16014807;Inhibition
[3H]ETB-TBOA;Excitatory amino acid transporter 2;f;;Rat;17047096;Binding
[3H]D-aspartic acid;Excitatory amino acid transporter 2;f;;Human;;None
[3H]L-aspartic acid;Excitatory amino acid transporter 2;f;;Human;;None
[3H]SYM2081;Excitatory amino acid transporter 2;f;;Human;;None
DL-TBOA;Excitatory amino acid transporter 3;f;;Human;11078189;Inhibition
L-β-BA;Excitatory amino acid transporter 3;f;;Human;16183084;Inhibition
NBI-59159;Excitatory amino acid transporter 3;f;;Human;17017964;Inhibition
[3H]ETB-TBOA;Excitatory amino acid transporter 3;f;;Rat;17047096;Binding
[3H]D-aspartic acid;Excitatory amino acid transporter 3;f;;Human;;None
[3H]L-aspartic acid;Excitatory amino acid transporter 3;f;;Human;;None
DL-TBOA;Excitatory amino acid transporter 4;f;;Human;11677257;Inhibition
threo-3-methylglutamate;Excitatory amino acid transporter 4;f;;Human;11299317;Inhibition
[3H]ETB-TBOA;Excitatory amino acid transporter 4;f;;Rat;17047096;Binding
[3H]D-aspartic acid;Excitatory amino acid transporter 4;f;;Human;;None
[3H]L-aspartic acid;Excitatory amino acid transporter 4;f;;Human;;None
DL-TBOA;Excitatory amino acid transporter 5;f;;Human;11677257;Inhibition
[3H]ETB-TBOA;Excitatory amino acid transporter 5;f;;Rat;17047096;Binding
[3H]D-aspartic acid;Excitatory amino acid transporter 5;f;;Human;;None
[3H]L-aspartic acid;Excitatory amino acid transporter 5;f;;Human;;None
eltanexor;exportin 1;f;;Human;27211268|27780859|27323910;Inhibition
selinexor;exportin 1;f;;Human;;Inhibition
cibinetide;Eythropoietin receptor;f;;Human;;Agonist
erythropoietin;Eythropoietin receptor;t;Human;Human;16982323;Agonist
peginesatide;Eythropoietin receptor;f;;Human;16982323;Agonist
22R-hydroxycholesterol;Farnesoid X receptor;t;;Human;16371446;Agonist
chenodeoxycholic acid;Farnesoid X receptor;t;;Human;10334993|10360171;Agonist
cholic acid;Farnesoid X receptor;t;;None;10334993|10360171;Agonist
cilofexor;Farnesoid X receptor;f;;Human;;Agonist
compound 25 [PMID: 32687365];Farnesoid X receptor;f;;Human;32687365;Agonist
deoxycholic acid;Farnesoid X receptor;t;;None;7898771|10334993|10360171;Agonist
fexaramine;Farnesoid X receptor;f;;Human;12718892;Agonist
GW4064;Farnesoid X receptor;f;;Human;10956205;Agonist
INT-767;Farnesoid X receptor;f;;Human;20631053;Agonist
lithocholic acid;Farnesoid X receptor;t;;None;10334993|10360171|10334992;Agonist
obeticholic acid;Farnesoid X receptor;f;;Human;12166927;Agonist
tropifexor;Farnesoid X receptor;f;;Human;29148806;Agonist
nidufexor;Farnesoid X receptor;f;;Human;31940200;Partial agonist
compound 3f [Festa et al., 2019];Farnesoid X receptor;f;;Human;30996787;Antagonist
guggulsterone;Farnesoid X receptor;f;;Human;12089353;Antagonist
guggulsterone;Farnesoid X receptor;f;;Mouse;11988537;Antagonist
cholesten;Farnesoid X receptor-β;t;;Mouse;12529392;Agonist
desmosterol;Farnesoid X receptor-β;t;;Mouse;12529392;Agonist
lanosterol;Farnesoid X receptor-β;t;;Mouse;12529392;Agonist
vitamin D3;Farnesoid X receptor-β;t;;Mouse;12529392;Agonist
alendronate;farnesyl diphosphate synthase;f;;Human;11160603;Inhibition
alendronate;farnesyl diphosphate synthase;f;;Human;10620343;Inhibition
cimadronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
cimadronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
cimadronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
cimadronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
compound 2 [PMID: 18295483];farnesyl diphosphate synthase;f;;Human;18295483;Inhibition
compound 31 [PMID: 17963374];farnesyl diphosphate synthase;f;;Human;17963374;Inhibition
compound 5e [PMID: 17975902];farnesyl diphosphate synthase;f;;Human;17975902;Inhibition
diphosphoric acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
diphosphoric acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
geranyl biphosphonate;farnesyl diphosphate synthase;f;;Human;18308574;Inhibition
ibandronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
ibandronic acid;farnesyl diphosphate synthase;f;;Rat;18325729;Inhibition
isopentenyl diphosphate;farnesyl diphosphate synthase;t;;Human;4021811;Inhibition
minodronic acid;farnesyl diphosphate synthase;f;;Human;20394422;Inhibition
NE10575;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE10575;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE10575;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE10575;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE10790;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE10790;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE11808;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE11808;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE11808;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE11808;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE21650;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE21650;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE21650;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE21650;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58018;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58018;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58018;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58018;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58027;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58027;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58027;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58027;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58043;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58043;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58043;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58043;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58062;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58062;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58062;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE58062;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE97220;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE97220;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE97220;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
NE97220;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
pamidronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
piridronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
piridronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
piridronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
piridronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;10620343;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;11160603;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;11160603;Inhibition
risedronate;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
zoledronic acid;farnesyl diphosphate synthase;f;;Rat;18325729;Inhibition
zoledronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
zoledronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
zoledronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
zoledronic acid;farnesyl diphosphate synthase;f;;Human;18327899;Inhibition
zoledronic acid;farnesyl diphosphate synthase;f;;Human;18937434;Inhibition
BMS-214662;farnesyltransferase, CAAX box, beta;f;;Human;11020273;Inhibition
FTI 276;farnesyltransferase, CAAX box, beta;f;;Human;7592920;Inhibition
L-739,750;farnesyltransferase, CAAX box, beta;f;;Human;8090782;Inhibition
LB42908;farnesyltransferase, CAAX box, beta;f;;Human;11714612;Inhibition
tipifarnib;farnesyltransferase, CAAX box, beta;f;;Human;12699751|11196150;Inhibition
Fas ligand;Fas;t;Human;Human;;None
ASP8477;Fatty acid amide hydrolase;f;;Human;29017758;Inhibition
BIA 10-2474;Fatty acid amide hydrolase;f;;Rat;;Inhibition
BIA 10-2474;Fatty acid amide hydrolase;f;;Human;28596366;Inhibition
BIA 10-2639;Fatty acid amide hydrolase;f;;Human;28596366;Inhibition
compound 19y [Kiss et al., 2011];Fatty acid amide hydrolase;f;;Rat;;Inhibition
dual sEH/FAAH inhibitor 11;Fatty acid amide hydrolase;f;;Human;;Inhibition
dual sEH/FAAH inhibitor 11;Fatty acid amide hydrolase;f;;Mouse;30411058;Inhibition
dual sEH/FAAH inhibitor 11;Fatty acid amide hydrolase;f;;Human;30411058;Inhibition
dual sEH/FAAH inhibitor 11;Fatty acid amide hydrolase;f;;Rat;30411058;Inhibition
example 13 [WO2009109743];Fatty acid amide hydrolase;f;;Human;;Inhibition
(R)-ARN2508;Fatty acid amide hydrolase;f;;Human;26774927;Inhibition
(S)-ARN2508;Fatty acid amide hydrolase;f;;Human;26774927;Inhibition
JNJ1661010;Fatty acid amide hydrolase;f;;Human;18693015;Inhibition
JNJ40355003;Fatty acid amide hydrolase;f;;Rat;24900385;Inhibition
JNJ40355003;Fatty acid amide hydrolase;f;;Human;24900385;Inhibition
JNJ-42165279;Fatty acid amide hydrolase;f;;Rat;;Inhibition
JNJ-42165279;Fatty acid amide hydrolase;f;;Human;;Inhibition
JZL195;Fatty acid amide hydrolase;f;;Human;19918051;Inhibition
MM-433593;Fatty acid amide hydrolase;f;;Human;;Inhibition
OL135;Fatty acid amide hydrolase;f;;Human;17015445;Inhibition
PF-04457845;Fatty acid amide hydrolase;f;;Human;21666860|28596366;Inhibition
PF3845;Fatty acid amide hydrolase;f;;Human;19389627;Inhibition
PF750;Fatty acid amide hydrolase;f;;Human;30411058;Inhibition
PF750;Fatty acid amide hydrolase;f;;Human;17949010;Inhibition
URB597;Fatty acid amide hydrolase;f;;Human;17015445;Inhibition
ASP8477;Fatty acid amide hydrolase-2;f;;Human;29017758;Inhibition
JNJ1661010;Fatty acid amide hydrolase-2;f;;Human;19095868;Inhibition
LY2077855;Fatty acid amide hydrolase-2;f;;Human;19095868;Inhibition
OL135;Fatty acid amide hydrolase-2;f;;Human;17015445|19095868;Inhibition
URB597;Fatty acid amide hydrolase-2;f;;Human;17015445|19095868;Inhibition
fenofibrate;fatty acid binding protein 1;f;;Rat;18533710;Inhibition
fenofibric acid;fatty acid binding protein 1;f;;Rat;18533710;Inhibition
HTS01037;fatty acid binding protein 1;f;;Mouse;19754198;Inhibition
compound 13 [PMID: 17502136];fatty acid binding protein 3;f;;Human;17502136;Inhibition
bindarit;fatty acid binding protein 4;f;;Human;31641194;Binding
compound 13 [PMID: 17502136];fatty acid binding protein 4;f;;Human;17502136;Inhibition
HM50316;fatty acid binding protein 4;f;;Human;21481589;Inhibition
HTS01037;fatty acid binding protein 4;f;;Mouse;19754198;Inhibition
compound 13 [PMID: 17502136];fatty acid binding protein 5;f;;Human;17502136;Inhibition
GSK2194069;fatty acid synthase;f;;Human;25086508;Inhibition
compound 5k [PMID: 23528296];Fatty acid transport protein 1;f;;Human;23528296;Inhibition
compound 1l [PMID: 16644217];Fatty acid transport protein 4;f;;Human;16644217;Inhibition
BsAb (CD89-CD20);Fc fragment of IgA receptor;f;;Human;29296544;Binding
IgE heavy chain;Fc fragment of IgE receptor Ia;f;;Human;;Binding
IgE heavy chain;Fc fragment of IgE receptor II;f;;Human;;Binding
DX-2507;Fc fragment of IgG receptor and transporter;f;;Human;25954273;Antagonist
efgartigimod alfa;Fc fragment of IgG receptor and transporter;f;;Human;;Binding
rozanolixizumab;Fc fragment of IgG receptor and transporter;f;;Human;;Binding
AFM13;Fc fragment of IgG receptor IIIa;f;;Human;24670809;Binding
bemarituzumab;Fc fragment of IgG receptor IIIa;f;;Human;32965540;Binding
LY2928057;Ferroportin;f;;Human;;Binding
VIT-2763;Ferroportin;f;;Mouse;31638596;Antagonist
compound 25b [PMID: 22564207];FER tyrosine kinase;f;;Human;22564207;Inhibition
compound 8e [PMID: 24432909];FER tyrosine kinase;f;;Human;24432909;Inhibition
DS21360717;FER tyrosine kinase;f;;Human;31097992;Inhibition
Ro3280;FER tyrosine kinase;f;;Human;22172702;Inhibition
compound 25b [PMID: 22564207];FES proto-oncogene, tyrosine kinase;f;;Human;22564207;Inhibition
compound 8e [PMID: 24432909];FES proto-oncogene, tyrosine kinase;f;;Human;24432909;Inhibition
lorlatinib;FES proto-oncogene, tyrosine kinase;f;;Human;24819116;Inhibition
AMG-837;FFA1 receptor;f;;Human;22859723;Agonist
compound 4 [PMID: 27074625];FFA1 receptor;f;;Human;27074625;Agonist
fasiglifam;FFA1 receptor;f;;Human;21752941|25043059|25787200|24900210;Agonist
HWL-088;FFA1 receptor;f;;Human;31971610;Agonist
setogepram;FFA1 receptor;f;;Human;29454750;Agonist
TUG-905;FFA1 receptor;f;;Human;22724451;Agonist
α-linolenic acid;FFA1 receptor;t;;Human;12496284|12565875|12629551;Full agonist
compound B [PMID:18477808];FFA1 receptor;f;;Human;18477808;Full agonist
docosahexaenoic acid;FFA1 receptor;t;;Human;12496284|12629551;Full agonist
linoleic acid;FFA1 receptor;f;;Human;12496284|12565875|12629551;Full agonist
medica 16;FFA1 receptor;f;;Human;12565875;Full agonist
myristic acid;FFA1 receptor;t;;Human;12496284|12565875|12629551;Full agonist
oleic acid;FFA1 receptor;t;;Human;12496284|12565875|12629551;Full agonist
palmitic acid;FFA1 receptor;f;;Human;12496284|12565875|12629551;Full agonist
rosiglitazone;FFA1 receptor;f;;Human;12565875;Full agonist
TUG-424;FFA1 receptor;f;;Human;18947221;Full agonist
TUG-770;FFA1 receptor;f;;Human;23687558;Full agonist
GW9508;FFA1 receptor;f;;Human;16702987;Partial agonist
GW1100;FFA1 receptor;f;;Human;16702987|17200419;Antagonist
1-methylcyclopropanecarboxylic acid;FFA2 receptor;t;;Human;21220428;Agonist
compound 1 [PMID: 23589301];FFA2 receptor;f;;Rat;23589301;Agonist
TUG-1375;FFA2 receptor;f;;Human;30247908;Agonist
TUG-1375;FFA2 receptor;f;;Human;30247908;Agonist
TUG-1375;FFA2 receptor;f;;Mouse;30247908;Agonist
TUG-1375;FFA2 receptor;f;;Human;30247908;Agonist
acetic acid;FFA2 receptor;t;;Human;12496283|12684041|12711604|21220428;Full agonist
butyric acid;FFA2 receptor;t;;Human;12496283|12684041|12711604|21220428;Full agonist
isobutyric acid;FFA2 receptor;f;;Human;12711604;Full agonist
trans-2-methylcrotonic acid;FFA2 receptor;t;;Human;21220428;Full agonist
pentanoic acid;FFA2 receptor;f;;Human;12496283;Full agonist
propanoic acid;FFA2 receptor;t;;Human;12496283|12684041|12711604|21220428;Full agonist
(S)-4-CMTB;FFA2 receptor;f;;Human;18818303|23066016;Full agonist
AMG7703;FFA2 receptor;f;;Human;18818303|21498659;Positive
CATPB;FFA2 receptor;f;;Human;23066016;Antagonist
GLPG0974;FFA2 receptor;f;;Human;25380412|26852904;Antagonist
(S)-4-CMTB;FFA3 receptor;f;;Unknown;18818303;Agonist
1-methylcyclopropanecarboxylic acid;FFA3 receptor;t;;Human;21220428;Full agonist
acetic acid;FFA3 receptor;f;;Human;12496283|12711604|14722361|21220428;Full agonist
butyric acid;FFA3 receptor;t;;Human;12496283|12711604|14722361|21220428;Full agonist
isobutyric acid;FFA3 receptor;f;;Human;12496283|14722361;Full agonist
pentanoic acid;FFA3 receptor;f;;Human;12496283|14722361;Full agonist
propanoic acid;FFA3 receptor;t;;Human;12496283|12711604|14722361|21220428;Full agonist
compound A [PMID 24997608];FFA4 receptor;f;;Human;24997608;Agonist
TUG-1197;FFA4 receptor;f;;Human;27570890;Agonist
TUG-1197;FFA4 receptor;f;;Mouse;27570890;Agonist
α-linolenic acid;FFA4 receptor;t;;Rat;18320172;Full agonist
α-linolenic acid;FFA4 receptor;t;;Human;22519963;Full agonist
linoleic acid;FFA4 receptor;t;;Human;16702987;Full agonist
myristic acid;FFA4 receptor;t;;Human;22282525;Full agonist
NCG21;FFA4 receptor;f;;Human;19007110;Full agonist
oleic acid;FFA4 receptor;t;;Human;22282525;Full agonist
TUG-891;FFA4 receptor;f;;Unknown;22519963;Full agonist
grifolic acid;FFA4 receptor;f;;Human;19471906;Partial agonist
grifolic acid methyl ether;FFA4 receptor;f;;Human;20685848|19471906;Partial agonist
GW9508;FFA4 receptor;f;;Human;16702987|18827341;Partial agonist
apitolisib;FGR proto-oncogene, Src family tyrosine kinase;f;;Human;21981714;Inhibition
compound 2c [PMID: 24900538];FGR proto-oncogene, Src family tyrosine kinase;f;;Human;24900538;Inhibition
compound 2 [PMID: 15546730];FGR proto-oncogene, Src family tyrosine kinase;f;;Human;15546730;Inhibition
eCF506;FGR proto-oncogene, Src family tyrosine kinase;f;;Human;27115835;Inhibition
P505-15;FGR proto-oncogene, Src family tyrosine kinase;f;;Human;22040680;Inhibition
RIPK3 inhibitor 18;FGR proto-oncogene, Src family tyrosine kinase;f;;Human;;Inhibition
ARI-3099;fibroblast activation protein alpha;f;;Human;23594271;Inhibition
compound 9 [PMID: 20718420];fibroblast activation protein alpha;f;;Human;20718420;Inhibition
AZD4547;fibroblast growth factor receptor 1;f;;Human;26080733;Inhibition
BLU-9931;fibroblast growth factor receptor 1;f;;Human;25776529;Inhibition
brivanib;fibroblast growth factor receptor 1;f;;Human;16570908;Inhibition
brivanib;fibroblast growth factor receptor 1;f;;Human;22037378;Inhibition
catequentinib;fibroblast growth factor receptor 1;f;;Human;;Inhibition
CEP-11981;fibroblast growth factor receptor 1;f;;Human;22148921;Inhibition
compound 2c [PMID: 24900538];fibroblast growth factor receptor 1;f;;Human;24900538;Inhibition
compound 7r [PMID: 26080733];fibroblast growth factor receptor 1;f;;Human;26080733;Inhibition
compound 8h [PMID: 22765894];fibroblast growth factor receptor 1;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];fibroblast growth factor receptor 1;f;;Human;21613405;Inhibition
compound 8i [PMID: 22765894];fibroblast growth factor receptor 1;f;;Human;22765894;Inhibition
DEBIO1347;fibroblast growth factor receptor 1;f;;Human;25169980;Inhibition
derazantinib;fibroblast growth factor receptor 1;f;;Human;27627808;Inhibition
dovitinib;fibroblast growth factor receptor 1;f;;Human;19113866|15598814;Inhibition
erdafitinib;fibroblast growth factor receptor 1;f;;Human;;Inhibition
futibatinib;fibroblast growth factor receptor 1;f;;Human;;Inhibition
infigratinib;fibroblast growth factor receptor 1;f;;Human;21936542;Inhibition
lucitanib;fibroblast growth factor receptor 1;f;;Human;22304225;Inhibition
LY2874455;fibroblast growth factor receptor 1;f;;Human;21900693;Inhibition
MK-2461;fibroblast growth factor receptor 1;f;;Human;20145145;Inhibition
nintedanib;fibroblast growth factor receptor 1;f;;Human;18559524;Inhibition
orantinib;fibroblast growth factor receptor 1;f;;Human;19110422;Inhibition
pazopanib;fibroblast growth factor receptor 1;f;;Human;18620382;Inhibition
PD166285;fibroblast growth factor receptor 1;f;;Human;9400019;Inhibition
pemigatinib;fibroblast growth factor receptor 1;f;;Human;;Inhibition
pexmetinib;fibroblast growth factor receptor 1;f;;Human;27287719;Inhibition
PRN1371;fibroblast growth factor receptor 1;f;;Human;28665128;Inhibition
PRN1371;fibroblast growth factor receptor 1;f;;Human;28665128;Inhibition
rogaratinib;fibroblast growth factor receptor 1;f;;Human;;Inhibition
sorafenib;fibroblast growth factor receptor 1;f;;Human;21613405;Inhibition
sorafenib;fibroblast growth factor receptor 1;f;;Human;15466206;Inhibition
SU11652;fibroblast growth factor receptor 1;f;;Human;12646019;Inhibition
SU-14813;fibroblast growth factor receptor 1;f;;Human;16891463;Inhibition
sunitinib;fibroblast growth factor receptor 1;f;;Human;12538485;Inhibition
surufatinib;fibroblast growth factor receptor 1;f;;Human;;Inhibition
pemigatinib;fibroblast growth factor receptor 2;f;;Human;;Inhibition
palifermin;fibroblast growth factor receptor 2;f;;Human;;Agonist
bemarituzumab;fibroblast growth factor receptor 2;f;;Human;32965540;Binding
AZD4547;fibroblast growth factor receptor 2;f;;Human;;Inhibition
BLU-9931;fibroblast growth factor receptor 2;f;;Human;25776529;Inhibition
DEBIO1347;fibroblast growth factor receptor 2;f;;Human;25169980;Inhibition
derazantinib;fibroblast growth factor receptor 2;f;;Human;27627808;Inhibition
erdafitinib;fibroblast growth factor receptor 2;f;;Human;;Inhibition
futibatinib;fibroblast growth factor receptor 2;f;;Human;;Inhibition
infigratinib;fibroblast growth factor receptor 2;f;;Human;21936542;Inhibition
LY2874455;fibroblast growth factor receptor 2;f;;Human;21900693;Inhibition
MK-2461;fibroblast growth factor receptor 2;f;;Human;20145145;Inhibition
nintedanib;fibroblast growth factor receptor 2;f;;Human;18559524;Inhibition
PRN1371;fibroblast growth factor receptor 2;f;;Human;28665128;Inhibition
AZD4547;fibroblast growth factor receptor 3;f;;Human;;Inhibition
BLU-9931;fibroblast growth factor receptor 3;f;;Human;25776529;Inhibition
compound 1d [PMID: 21493067];fibroblast growth factor receptor 3;f;;Human;21493067;Inhibition
DEBIO1347;fibroblast growth factor receptor 3;f;;Human;25169980;Inhibition
derazantinib;fibroblast growth factor receptor 3;f;;Human;27627808;Inhibition
dovitinib;fibroblast growth factor receptor 3;f;;Human;19113866|15598814;Inhibition
erdafitinib;fibroblast growth factor receptor 3;f;;Human;;Inhibition
futibatinib;fibroblast growth factor receptor 3;f;;Human;;Inhibition
infigratinib;fibroblast growth factor receptor 3;f;;Human;21936542;Inhibition
LY2874455;fibroblast growth factor receptor 3;f;;Human;21900693;Inhibition
MK-2461;fibroblast growth factor receptor 3;f;;Human;20145145;Inhibition
nintedanib;fibroblast growth factor receptor 3;f;;Human;18559524;Inhibition
pemigatinib;fibroblast growth factor receptor 3;f;;Human;;Inhibition
PRN1371;fibroblast growth factor receptor 3;f;;Human;28665128;Inhibition
rogaratinib;fibroblast growth factor receptor 3;f;;Human;;Inhibition
TAK-632;fibroblast growth factor receptor 3;f;;Human;23906342;Inhibition
AZD4547;fibroblast growth factor receptor 4;f;;Human;;Inhibition
DEBIO1347;fibroblast growth factor receptor 4;f;;Human;25169980;Inhibition
erdafitinib;fibroblast growth factor receptor 4;f;;Human;;Inhibition
futibatinib;fibroblast growth factor receptor 4;f;;Human;;Inhibition
infigratinib;fibroblast growth factor receptor 4;f;;Human;21936542;Inhibition
LY2874455;fibroblast growth factor receptor 4;f;;Human;21900693;Inhibition
nintedanib;fibroblast growth factor receptor 4;f;;Human;18559524;Inhibition
PRN1371;fibroblast growth factor receptor 4;f;;Human;28665128;Inhibition
roblitinib;fibroblast growth factor receptor 4;f;;Human;;Inhibition
BLU-9931;fibroblast growth factor receptor 4;f;;Human;25776529;Irreversible inhibition
fisogatinib;fibroblast growth factor receptor 4;f;;Human;;Irreversible inhibition
zotarolimus;FKBP prolyl isomerase 1A;f;;Human;16449248;Binding
pimecrolimus;FKBP prolyl isomerase 1A;f;;Rat;9808344;Inhibition
sirolimus;FKBP prolyl isomerase 1A;f;;Human;9857082;Inhibition
tacrolimus;FKBP prolyl isomerase 1A;f;;Human;9857082;Inhibition
brivanib;fms related receptor tyrosine kinase 1;f;;Human;16570908;Inhibition
catequentinib;fms related receptor tyrosine kinase 1;f;;Human;;Inhibition
Cdk1/2 inhibitor III;fms related receptor tyrosine kinase 1;f;;Human;15974571;Inhibition
cediranib;fms related receptor tyrosine kinase 1;f;;Human;15899831;Inhibition
CEP-11981;fms related receptor tyrosine kinase 1;f;;Human;22148921;Inhibition
compound 25 [PMID: 17935989];fms related receptor tyrosine kinase 1;f;;Human;17935989;Inhibition
compound 8h [PMID: 22765894];fms related receptor tyrosine kinase 1;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];fms related receptor tyrosine kinase 1;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];fms related receptor tyrosine kinase 1;f;;Human;21613405;Inhibition
CS2164;fms related receptor tyrosine kinase 1;f;;Human;28004478;Inhibition
dorsomorphin;fms related receptor tyrosine kinase 1;f;;Human;20932747;Inhibition
dovitinib;fms related receptor tyrosine kinase 1;f;;Human;19113866|15598814;Inhibition
foretinib;fms related receptor tyrosine kinase 1;f;;Human;23098265;Inhibition
fruquintinib;fms related receptor tyrosine kinase 1;f;;Human;25482937;Inhibition
ilorasertib;fms related receptor tyrosine kinase 1;f;;Human;22935731;Inhibition
linifanib;fms related receptor tyrosine kinase 1;f;;Human;16648571;Inhibition
lucitanib;fms related receptor tyrosine kinase 1;f;;Human;22304225;Inhibition
MK-2461;fms related receptor tyrosine kinase 1;f;;Human;20145145;Inhibition
motesanib;fms related receptor tyrosine kinase 1;f;;Human;23098265;Inhibition
nintedanib;fms related receptor tyrosine kinase 1;f;;Human;18559524;Inhibition
OSI-930;fms related receptor tyrosine kinase 1;f;;Human;16424037;Inhibition
pazopanib;fms related receptor tyrosine kinase 1;f;;Human;18620382;Inhibition
pexidartinib;fms related receptor tyrosine kinase 1;f;;Human;26222558;Inhibition
pexmetinib;fms related receptor tyrosine kinase 1;f;;Human;27287719;Inhibition
RG-1530;fms related receptor tyrosine kinase 1;f;;Human;20814247;Inhibition
semaxanib;fms related receptor tyrosine kinase 1;f;;Human;10882357;Inhibition
sitravatinib;fms related receptor tyrosine kinase 1;f;;Human;26675259;Inhibition
SU-14813;fms related receptor tyrosine kinase 1;f;;Human;16891463;Inhibition
tivozanib;fms related receptor tyrosine kinase 1;f;;Human;23098265;Inhibition
vatalanib;fms related receptor tyrosine kinase 1;f;;Human;16321531;Inhibition
VEGF receptor tyrosine kinase inhibitor III;fms related receptor tyrosine kinase 1;f;;Human;18077363;Inhibition
ZM-306416;fms related receptor tyrosine kinase 1;f;;Human;22573732|10639280;Inhibition
VEGFA;fms related receptor tyrosine kinase 1;t;Human;Human;;None
VEGFB;fms related receptor tyrosine kinase 1;t;Human;Human;;None
AC710;fms related receptor tyrosine kinase 3;f;;Human;24900421;Inhibition
AKN-028;fms related receptor tyrosine kinase 3;f;;Human;22864397;Inhibition
AST-487;fms related receptor tyrosine kinase 3;f;;Human;17638907;Inhibition
AST-487;fms related receptor tyrosine kinase 3;f;;Human;18820131;Inhibition
AST-487;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
BAY-985;fms related receptor tyrosine kinase 3;f;;Human;31859507;Inhibition
belizatinib;fms related receptor tyrosine kinase 3;f;;Human;22734674;Inhibition
BMS-690514;fms related receptor tyrosine kinase 3;f;;Human;20166197;Inhibition
cediranib;fms related receptor tyrosine kinase 3;f;;Human;15899831;Inhibition
ceritinib;fms related receptor tyrosine kinase 3;f;;Human;23742252;Inhibition
compound 14k [PMID: 21982499];fms related receptor tyrosine kinase 3;f;;Human;21982499;Inhibition
compound 18e [PMID: 31670517];fms related receptor tyrosine kinase 3;f;;Human;31670517;Inhibition
compound 1 [Cruz-López et al., 2019];fms related receptor tyrosine kinase 3;f;;Human;31867559;Inhibition
compound 2c [PMID: 24900538];fms related receptor tyrosine kinase 3;f;;Human;24900538;Inhibition
compound 5e [PMID: 28580438];fms related receptor tyrosine kinase 3;f;;Human;28580438;Inhibition
compound 7d [PMID: 29672049];fms related receptor tyrosine kinase 3;f;;Human;29672049;Inhibition
compound 8h [PMID: 22765894];fms related receptor tyrosine kinase 3;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];fms related receptor tyrosine kinase 3;f;;Human;21613405;Inhibition
crenolanib;fms related receptor tyrosine kinase 3;f;;Human;22745105;Inhibition
dorsomorphin;fms related receptor tyrosine kinase 3;f;;Human;20932747;Inhibition
dovitinib;fms related receptor tyrosine kinase 3;f;;Human;19113866|15598814;Inhibition
dovitinib;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
edicotinib;fms related receptor tyrosine kinase 3;f;;Human;26233509;Inhibition
ENMD-2076;fms related receptor tyrosine kinase 3;f;;Human;19320489;Inhibition
Flt-3 inhibitor;fms related receptor tyrosine kinase 3;f;;Human;16580199;Inhibition
Flt-3 inhibitor II;fms related receptor tyrosine kinase 3;f;;Human;16722630;Inhibition
Flt-3 inhibitor III;fms related receptor tyrosine kinase 3;f;;Human;16854049;Inhibition
G749;fms related receptor tyrosine kinase 3;f;;Human;24532805;Inhibition
gilteritinib;fms related receptor tyrosine kinase 3;f;;Human;27908881;Inhibition
Gö 6976;fms related receptor tyrosine kinase 3;f;;Human;24735609;Inhibition
GTP-14564;fms related receptor tyrosine kinase 3;f;;Human;12815052;Inhibition
ilorasertib;fms related receptor tyrosine kinase 3;f;;Human;22935731;Inhibition
JNJ-28312141;fms related receptor tyrosine kinase 3;f;;Human;19887542;Inhibition
KW-2449;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
KW-2449;fms related receptor tyrosine kinase 3;f;;Human;19541823;Inhibition
lestaurtinib;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
linifanib;fms related receptor tyrosine kinase 3;f;;Human;16648571;Inhibition
linifanib;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
MELK-TI;fms related receptor tyrosine kinase 3;f;;Human;25589925;Inhibition
merestinib;fms related receptor tyrosine kinase 3;f;;Human;23275061;Inhibition
midostaurin;fms related receptor tyrosine kinase 3;f;;Human;12124173;Inhibition
midostaurin;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
mivavotinib;fms related receptor tyrosine kinase 3;f;;Human;27839918;Inhibition
MK-2461;fms related receptor tyrosine kinase 3;f;;Human;20145145;Inhibition
NMS-P937;fms related receptor tyrosine kinase 3;f;;Human;21470862;Inhibition
pacritinib;fms related receptor tyrosine kinase 3;f;;Human;21604762;Inhibition
pexidartinib;fms related receptor tyrosine kinase 3;f;;Human;26222558;Inhibition
PF-562271;fms related receptor tyrosine kinase 3;f;;Human;18339875;Inhibition
quizartinib;fms related receptor tyrosine kinase 3;f;;Human;22037378|19754199;Inhibition
quizartinib;fms related receptor tyrosine kinase 3;f;;Human;19654408;Inhibition
RG-1530;fms related receptor tyrosine kinase 3;f;;Human;20814247;Inhibition
RGB-286638;fms related receptor tyrosine kinase 3;f;;Human;23807770;Inhibition
SGI-1776;fms related receptor tyrosine kinase 3;f;;Human;22924342;Inhibition
sitravatinib;fms related receptor tyrosine kinase 3;f;;Human;26675259;Inhibition
sorafenib;fms related receptor tyrosine kinase 3;f;;Human;15466206;Inhibition
sorafenib;fms related receptor tyrosine kinase 3;f;;Human;21613405;Inhibition
sunitinib;fms related receptor tyrosine kinase 3;f;;Human;20570526;Inhibition
tafetinib;fms related receptor tyrosine kinase 3;f;;Human;21638122;Inhibition
tandutinib;fms related receptor tyrosine kinase 3;f;;Human;12124172;Inhibition
tandutinib;fms related receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
TG02;fms related receptor tyrosine kinase 3;f;;Human;22148278|21860433;Inhibition
TTT-3002;fms related receptor tyrosine kinase 3;f;;Human;24408321;Inhibition
UNC4203;fms related receptor tyrosine kinase 3;f;;Human;30347155;Inhibition
URMC-099;fms related receptor tyrosine kinase 3;f;;Human;24044867;Inhibition
Fms-related tyrosine kinase 3 ligand;fms related receptor tyrosine kinase 3;t;Human;Human;;None
catequentinib;fms related receptor tyrosine kinase 4;f;;Human;;Inhibition
CC-223;fms related receptor tyrosine kinase 4;f;;Human;26083478;Inhibition
cediranib;fms related receptor tyrosine kinase 4;f;;Human;15899831;Inhibition
CHMFL-KIT-64;fms related receptor tyrosine kinase 4;f;;Human;31250638;Inhibition
compound 8h [PMID: 22765894];fms related receptor tyrosine kinase 4;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];fms related receptor tyrosine kinase 4;f;;Human;21613405;Inhibition
CS2164;fms related receptor tyrosine kinase 4;f;;Human;28004478;Inhibition
dovitinib;fms related receptor tyrosine kinase 4;f;;Human;19113866|15598814;Inhibition
foretinib;fms related receptor tyrosine kinase 4;f;;Human;23098265;Inhibition
fruquintinib;fms related receptor tyrosine kinase 4;f;;Human;25482937;Inhibition
ilorasertib;fms related receptor tyrosine kinase 4;f;;Human;22935731;Inhibition
lenvatinib;fms related receptor tyrosine kinase 4;f;;Human;23098265;Inhibition
linifanib;fms related receptor tyrosine kinase 4;f;;Human;16648571;Inhibition
MK-2461;fms related receptor tyrosine kinase 4;f;;Human;20145145;Inhibition
motesanib;fms related receptor tyrosine kinase 4;f;;Human;23098265;Inhibition
nintedanib;fms related receptor tyrosine kinase 4;f;;Human;18559524;Inhibition
pazopanib;fms related receptor tyrosine kinase 4;f;;Human;18620382;Inhibition
pexmetinib;fms related receptor tyrosine kinase 4;f;;Human;27287719;Inhibition
RIPK1 inhibitor 22b;fms related receptor tyrosine kinase 4;f;;Human;30480444;Inhibition
sitravatinib;fms related receptor tyrosine kinase 4;f;;Human;26675259;Inhibition
sorafenib;fms related receptor tyrosine kinase 4;f;;Mouse;15466206;Inhibition
sunitinib;fms related receptor tyrosine kinase 4;f;;Human;20570526;Inhibition
tafetinib;fms related receptor tyrosine kinase 4;f;;Human;21638122;Inhibition
tesevatinib;fms related receptor tyrosine kinase 4;f;;Human;17575237;Inhibition
tivozanib;fms related receptor tyrosine kinase 4;f;;Human;23098265;Inhibition
vatalanib;fms related receptor tyrosine kinase 4;f;;Human;12477352;Inhibition
VEGF receptor tyrosine kinase inhibitor III;fms related receptor tyrosine kinase 4;f;;Human;18077363;Inhibition
VEGFC;fms related receptor tyrosine kinase 4;t;Human;Human;;None
VEGFD;fms related receptor tyrosine kinase 4;t;Human;Human;;None
VEGFE;fms related receptor tyrosine kinase 4;t;Human;Human;;None
capromab;Folate hydrolase (prostate-specific membrane antigen) 1;f;;Human;;Binding
compound 8d [PMID: 15027864];Folate hydrolase (prostate-specific membrane antigen) 1;f;;Human;15027864;Inhibition
BMS-986235;FPR1;f;;Human;32407089;Agonist
BMS-986235;FPR1;f;;Mouse;32407089;Agonist
AG-09/1;FPR1;f;;Human;19903830;Full agonist
AG-11/03;FPR1;f;;Human;22127612;Full agonist
AG-14;FPR1;f;;Human;17229869;Full agonist
annexin I;FPR1;f;Human;Mouse;17948261|11395373;Full agonist
annexin I-(2-26);FPR1;f;Human;Human;10882119|12560218;Full agonist
compound R-(-)-5f [PMID: 22607879];FPR1;f;;Human;22607879;Full agonist
fMet-Ile-Phe-Leu;FPR1;f;;Human;2825171;Full agonist
fMet-Ile-Phe-Leu;FPR1;f;;Mouse;23160941;Full agonist
fMet-Ile-Val-Ile-Leu;FPR1;f;;Human;16025565;Full agonist
fMet-Ile-Val-Thr-Leu-Phe;FPR1;f;;Mouse;23160941;Full agonist
fMet-Ile-Val-Thr-Leu-Phe;FPR1;f;;Human;16025565;Full agonist
fMet-Leu-Phe;FPR1;f;;Human;1262785|7387981;Full agonist
fMet-Leu-Phe;FPR1;f;;Mouse;10477558|18606697;Full agonist
fMet-Leu-Phe-Glu;FPR1;f;;Mouse;23160941;Full agonist
fMet-Leu-Phe-Ile-Ile-Lys-FITC;FPR1;f;;Mouse;23160941;Full agonist
fMet-Met-Trp-Leu-Leu;FPR1;f;;Human;7559498;Full agonist
fMet-Met-Tyr-Ala-Leu-Phe;FPR1;f;;Human;16025565;Full agonist
fMet-Met-Tyr-Ala-Leu-Phe;FPR1;f;;Mouse;23160941;Full agonist
gG-2p20;FPR1;f;;Human;15699157;Full agonist
Met-Met-Trp-Leu-Leu;FPR1;f;;Human;7559498;Full agonist
pyrazolone, 1;FPR1;f;;Mouse;23160941;Full agonist
[125I]cathepsin G (human);FPR1;f;;Human;15210802;Full agonist
[3H]fMet-Leu-Phe;FPR1;f;;Human;6285921;Full agonist
T20(DP178);FPR1;f;;Human;10339497|10860818;Full agonist
WKYMVm;FPR1;f;;Human;10586077;Full agonist
WKYMVm;FPR1;f;;Mouse;23160941|11035102;Full agonist
spinorphin;FPR1;f;;Mouse;11714831;Partial agonist
3570-0208 [PMID:19807662];FPR1;f;;Human;19807662;Antagonist
BVT173187;FPR1;f;;Human;22410002;Antagonist
chenodeoxycholic acid;FPR1;f;;Human;11211928;Antagonist
cyclosporin A;FPR1;f;;Human;9310346;Antagonist
cyclosporin H;FPR1;f;;Human;17082621|8387097;Antagonist
deoxycholic acid;FPR1;f;;Human;11853704;Antagonist
diamide 7;FPR1;f;;Human;21486695;Antagonist
group E 1682-2106 [PMID:16118363];FPR1;f;;Human;16118363;Antagonist
i-Boc-Met-Leu-Phe;FPR1;f;;Human;8573582;Antagonist
methionine benzimidazole 6;FPR1;f;;Human;21486695;Antagonist
spinorphin;FPR1;t;;Human;11714831|1373134;Antagonist
sufinpyrazone;FPR1;f;;Human;15964939;Antagonist
[125I]CHIPS;FPR1;f;;Human;15494522;Antagonist
t-Boc-FLFLF;FPR1;f;;Human;8387097;Antagonist
t-Boc-FLFLF;FPR1;f;;Human;1653806;Antagonist
t-Boc-Met-Leu-Phe;FPR1;f;;Human;1653806;Antagonist
1R-11;FPR2/ALX;f;;Human;30419493;Agonist
ACT-389949;FPR2/ALX;f;;Human;27730665;Agonist
BMS-986235;FPR2/ALX;f;;Mouse;32407089;Agonist
BMS-986235;FPR2/ALX;f;;Human;32407089;Agonist
Hp(2-20);FPR2/ALX;f;;Human;11602630;Agonist
PrP106-126;FPR2/ALX;t;;Human;23549262;Agonist
[125I-Tyr]Ac2-26;FPR2/ALX;f;;Human;12368905;Agonist
AG-26;FPR2/ALX;f;;Human;19903830;Full agonist
amyloid β;FPR2/ALX;f;Human;Human;11316806|11160457;Full agonist
annexin I;FPR2/ALX;t;Human;Human;12368905;Full agonist
annexin I-(2-26);FPR2/ALX;f;Human;Human;10882119|12560218|12368905|16278303;Full agonist
aspirin triggered lipoxin A4;FPR2/ALX;t;;Human;;Full agonist
aspirin-triggered resolvin D1;FPR2/ALX;t;;Human;22449948;Full agonist
ATLa2;FPR2/ALX;f;;Human;15056011;Full agonist
CGEN-855A;FPR2/ALX;f;;Human;19023040;Full agonist
CGEN-855A;FPR2/ALX;f;;Human;19023040;Full agonist
compound R-(-)-5f [PMID: 22607879];FPR2/ALX;f;;Human;22607879;Full agonist
CRAMP;FPR2/ALX;t;Mouse;Mouse;15879124;Full agonist
F2L;FPR2/ALX;f;Human;Mouse;17237393;Full agonist
fMet-Ile-Val-Thr-Leu-Phe;FPR2/ALX;f;;Human;16025565;Full agonist
fMet-Ile-Val-Thr-Leu-Phe;FPR2/ALX;f;;Mouse;23160941|18606697;Full agonist
fMet-Leu-Phe;FPR2/ALX;f;;Human;8349692;Full agonist
fMet-Met-Tyr-Ala-Leu-Phe;FPR2/ALX;f;;Human;16025565;Full agonist
fMet-Met-Tyr-Ala-Leu-Phe;FPR2/ALX;f;;Mouse;23160941;Full agonist
F peptide;FPR2/ALX;f;;Human;10438703;Full agonist
humanin;FPR2/ALX;t;Human;Human;15465011;Full agonist
humanin;FPR2/ALX;f;Human;Mouse;15153530;Full agonist
LL-37;FPR2/ALX;t;Human;Human;11015447;Full agonist
LXA4;FPR2/ALX;t;;Human;20080636;Full agonist
MHC binding peptide;FPR2/ALX;f;;Human;10748237;Full agonist
MMK-1;FPR2/ALX;f;;Human;9853614|11435499;Full agonist
N36;FPR2/ALX;f;;Human;10964542;Full agonist
PSMα3;FPR2/ALX;f;;Human;20542250;Full agonist
pyrazolone, 1;FPR2/ALX;f;;Human;16697190;Full agonist
pyrazolone, 1;FPR2/ALX;f;;Mouse;23160941;Full agonist
quin-C1;FPR2/ALX;f;;Human;15308762;Full agonist
quin-C1;FPR2/ALX;f;;Mouse;23160941;Full agonist
resolvin D1;FPR2/ALX;t;;Human;20080636;Full agonist
RvD1-ME;FPR2/ALX;f;;Human;22449948;Full agonist
sCKβ8-1;FPR2/ALX;f;;Human;14662730;Full agonist
serum amyloid A;FPR2/ALX;t;Human;Human;9892621;Full agonist
SHAAGtide;FPR2/ALX;f;;Human;14662730|17513790;Full agonist
[125I-Tyr]Ac2-26;FPR2/ALX;f;;Rat;12746227;Full agonist
[3H]LXA4;FPR2/ALX;f;;Rat;12746227;Full agonist
[3H]LXA4;FPR2/ALX;f;;Mouse;9151906;Full agonist
[3H]LXA4;FPR2/ALX;f;;Human;8006586|1322894;Full agonist
T21/DP107;FPR2/ALX;f;;Human;10229829;Full agonist
uPar fragment;FPR2/ALX;f;;Human;11818541;Full agonist
V3 peptide;FPR2/ALX;f;;Human;10872839;Full agonist
WKYMVm;FPR2/ALX;f;;Human;10586077|11285256|23160941|11035102;Full agonist
WKYMVm;FPR2/ALX;f;;Mouse;23160941|11035102;Full agonist
LXA4;FPR2/ALX;t;;Human;8006586|1322894;Partial agonist
PBP10;FPR2/ALX;f;;Human;16025565;Positive
compound 1754-31 [PMID: 23788657];FPR2/ALX;f;;Human;23788657;Antagonist
FPRL1-inhibitor protein;FPR2/ALX;f;;Human;17114475;Antagonist
isopropylureido-FLFLF;FPR2/ALX;f;;Human;8573582;Antagonist
quin-C7;FPR2/ALX;f;;Human;17652444;Antagonist
t-Boc-FLFLF;FPR2/ALX;f;;Human;10882119|6280748|17687636;Antagonist
WRWWWW;FPR2/ALX;f;;Human;15210823;Antagonist
annexin I-(2-26);FPR3;t;Human;Human;15187149;Full agonist
F2L;FPR3;t;Human;Human;15623572;Full agonist
F2L-[125I]Tyr;FPR3;f;;Human;15623572;Full agonist
fMet-Met-Tyr-Ala-Leu-Phe;FPR3;f;;Human;16025565;Full agonist
Hp(2-20);FPR3;f;;Human;11602630;Full agonist
humanin;FPR3;t;Human;Human;15465011;Full agonist
LXA4;FPR3;f;;Mouse;9151906;Full agonist
WKYMVm;FPR3;f;;Human;11285256;Full agonist
WRWWWW;FPR3;f;;Human;16476585;Antagonist
AL12180;FP receptor;f;;Human;17076623;Agonist
latanoprostene bunod;FP receptor;f;;Human;10634944|21396362;Agonist
ONO-9054;FP receptor;f;;Human;25788650;Agonist
ONO-9054;FP receptor;f;;Human;25788650;Agonist
[3H](+)-fluprostenol;FP receptor;f;;Unknown;;Agonist
tafluprost;FP receptor;f;;Human;15037111;Agonist
tafluprost acid;FP receptor;f;;Human;15037111;Agonist
13,14-dihydro-16-m-chlorophenoxy-w-tetranor-PGF1α;FP receptor;f;;Human;10715159;Full agonist
bimatoprost;FP receptor;f;;Human;12606640;Full agonist
bimatoprost (free acid form);FP receptor;f;;Human;10952685;Full agonist
carbacyclin;FP receptor;f;;Mouse;9313928;Full agonist
carbacyclin;FP receptor;f;;Human;10634944;Full agonist
cloprostenol;FP receptor;f;;Human;10634944;Full agonist
enprostil;FP receptor;f;;Human;10634944;Full agonist
fluprostenol;FP receptor;f;;Human;10634944;Full agonist
fluprostenol;FP receptor;f;;Mouse;9313928;Full agonist
I-BOP;FP receptor;f;;Mouse;9313928;Full agonist
iloprost;FP receptor;f;;Human;10634944;Full agonist
L-888,607;FP receptor;f;;Human;15755909;Full agonist
latanoprost (free acid form);FP receptor;f;;Human;10634944;Full agonist
latanoprost (isopropyl ester);FP receptor;f;;Human;10634944;Full agonist
MB-28767;FP receptor;f;;Mouse;9313928;Full agonist
MB-28767;FP receptor;f;;Human;10634944;Full agonist
PGD2;FP receptor;t;;Mouse;9313928;Full agonist
PGD2;FP receptor;t;;Human;12519077;Full agonist
PGE2;FP receptor;t;;Human;10634944|12519077;Full agonist
PGE2;FP receptor;t;;Mouse;9313928;Full agonist
PGF2α;FP receptor;t;;Human;16604093|10634944|12519077;Full agonist
PGF2α;FP receptor;t;;Mouse;9313928;Full agonist
sulprostone;FP receptor;f;;Human;10634944;Full agonist
[3H]PGF2α;FP receptor;f;;Mouse;8288601;Full agonist
[3H]PGF2α;FP receptor;f;;Human;16604093|10634944|8300593;Full agonist
U46619;FP receptor;f;;Human;10634944;Full agonist
U46619;FP receptor;f;;Mouse;9313928;Full agonist
AL-8810;FP receptor;f;;Mouse;10454504;Partial agonist
AL-8810;FP receptor;f;;Rat;10454504;Partial agonist
AS604872;FP receptor;f;;Human;17618756;Antagonist
BAY-6672;FP receptor;f;;Human;32969660;Antagonist
FSH;FSH receptor;t;Human;Human;;Agonist
[125I]FSH (human);FSH receptor;f;;Human;;Full agonist
FSH deglycosylated α/β;FSH receptor;f;;Human;8188681;Antagonist
furin inhibitor peptide;furin, paired basic amino acid cleaving enzyme;f;;Human;17537721;Inhibition
MI-1148;furin, paired basic amino acid cleaving enzyme;f;;Human;25974265;Inhibition
peptide 18 [PMID: 24350995];furin, paired basic amino acid cleaving enzyme;f;;Human;24350995;Inhibition
phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide;furin, paired basic amino acid cleaving enzyme;f;;Human;20038105;Inhibition
acalabrutinib;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;;Inhibition
bosutinib;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;19039322;Inhibition
compound 25 [PMID: 31260299];FYN proto-oncogene, Src family tyrosine kinase;f;;Human;31260299;Inhibition
compound 2 [PMID: 15546730];FYN proto-oncogene, Src family tyrosine kinase;f;;Human;15546730;Inhibition
eCF506;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;27115835;Inhibition
ibrutinib;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
pexmetinib;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;27287719;Inhibition
PP1;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;8557675;Inhibition
PP2;FYN proto-oncogene, Src family tyrosine kinase;f;;Human;8557675;Inhibition
bosutinib;fyn related Src family tyrosine kinase;f;;Human;19039322;Inhibition
eCF506;fyn related Src family tyrosine kinase;f;;Human;27115835;Inhibition
vantictumab;FZD1;f;;Human;22753465;Antagonist
vantictumab;FZD2;f;;Human;22753465;Antagonist
norrin;FZD4;t;Mouse;Mouse;15035989;Full agonist
FzM1;FZD4;f;;Human;29293331|25751279;Negative
FzM1.8;FZD4;f;;Human;25751279;Negative
FzM1.8;FZD4;f;;Human;29293331;Positive
vantictumab;FZD5;f;;Human;22753465;Antagonist
Wnt-3a;FZD6;t;Human;Human;21665003|21128903;Agonist
Wnt-4;FZD6;t;Human;Human;21541287|15265686;Agonist
Wnt-5a;FZD6;t;Human;Human;21665003;Agonist
SAG1.3;FZD6;f;;Human;31964872;Partial agonist
Fz7-21;FZD7;f;;Human;29632413;Antagonist
SRI37892;FZD7;f;;Human;29207657;Antagonist
vantictumab;FZD7;f;;Human;22753465;Antagonist
carbamazepine;FZD8;f;;Human;32049522;Negative
vantictumab;FZD8;f;;Human;22753465;Antagonist
gaboxadol;GABAA receptor α1 subunit;f;;Human;;Agonist
isonipecotic acid;GABAA receptor α1 subunit;f;;Human;;Agonist
isoguvacine;GABAA receptor α1 subunit;f;;Human;;Full agonist
muscimol;GABAA receptor α1 subunit;f;;Human;;Full agonist
piperidine-4-sulphonic acid;GABAA receptor α1 subunit;f;;Human;;Full agonist
[3H]muscimol;GABAA receptor α1 subunit;f;;Human;;Full agonist
CGS8216;GABAA receptor α1 subunit;f;;Human;10633039;Inverse agonist
ZK93423;GABAA receptor α1 subunit;f;;Human;9651158;Partial agonist
flumazenil;GABAA receptor α1 subunit;f;;Human;9767648;Antagonist
L838417;GABAA receptor α1 subunit;f;;Human;;Antagonist
[11C]flumazenil;GABAA receptor α1 subunit;f;;Human;;Antagonist
[18F]fluoroethylflumazenil;GABAA receptor α1 subunit;f;;Human;;Antagonist
TP003;GABAA receptor α1 subunit;f;;Human;;Antagonist
TPA023;GABAA receptor α1 subunit;f;;Human;;Antagonist
ZK93426;GABAA receptor α1 subunit;f;;Human;;Antagonist
bretazenil;GABAA receptor α1 subunit;f;;Human;;Full agonist
indiplon;GABAA receptor α1 subunit;f;;Human;;Full agonist
ocinaplon;GABAA receptor α1 subunit;f;;Human;;Full agonist
Zn2+;GABAA receptor α1 subunit;t;;Human;;Inhibition
α3IA;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
α5IA;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
DMCM;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
MRK016;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
Ro15-4513;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
Ro19-4603;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
RO4938581;GABAA receptor α1 subunit;f;;Human;;Inverse agonist
[3H]CGS8216;GABAA receptor α1 subunit;f;;Human;;Mixed
alprazolam;GABAA receptor α1 subunit;f;;Human;12408715;Positive
clonazepam;GABAA receptor α1 subunit;f;;Human;2551039;Positive
diazepam;GABAA receptor α1 subunit;f;;Human;2551039;Positive
flunitrazepam;GABAA receptor α1 subunit;f;;Human;8632757;Positive
[3H]flunitrazepam;GABAA receptor α1 subunit;f;;Human;;Positive
[3H]zolpidem;GABAA receptor α1 subunit;f;;Human;;Positive
triazolam;GABAA receptor α1 subunit;f;;Human;18537233;Positive
triazolam;GABAA receptor α1 subunit;f;;Human;10633039;Positive
zolpidem;GABAA receptor α1 subunit;f;;Human;8719414|8813598;Positive
5α-pregnan-3α-ol-20-one;GABAA receptor α1 subunit;t;;Human;;Potentiation
tetrahydrodeoxycorticosterone;GABAA receptor α1 subunit;t;;Human;;Potentiation
bicuculline;GABAA receptor α1 subunit;f;;Human;;Antagonist
gabazine;GABAA receptor α1 subunit;f;;Human;;Antagonist
[3H]gabazine;GABAA receptor α1 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor α1 subunit;f;;Human;;None
[35S]TBPS;GABAA receptor α1 subunit;f;;Human;;None
TBPS;GABAA receptor α1 subunit;f;;Human;;None
gaboxadol;GABAA receptor α2 subunit;f;;Human;;Agonist
isonipecotic acid;GABAA receptor α2 subunit;f;;Human;;Agonist
[3H]muscimol;GABAA receptor α2 subunit;f;;Human;;Agonist
isoguvacine;GABAA receptor α2 subunit;f;;Human;;Full agonist
muscimol;GABAA receptor α2 subunit;f;;Human;;Full agonist
piperidine-4-sulphonic acid;GABAA receptor α2 subunit;f;;Human;;Full agonist
CGS8216;GABAA receptor α2 subunit;f;;Human;10633039;Inverse agonist
ZK93423;GABAA receptor α2 subunit;f;;Human;9651158;Partial agonist
flumazenil;GABAA receptor α2 subunit;f;;Human;9767648;Antagonist
[11C]flumazenil;GABAA receptor α2 subunit;f;;Human;;Antagonist
[18F]fluoroethylflumazenil;GABAA receptor α2 subunit;f;;Human;;Antagonist
TP003;GABAA receptor α2 subunit;f;;Human;;Antagonist
ZK93426;GABAA receptor α2 subunit;f;;Human;;Antagonist
bretazenil;GABAA receptor α2 subunit;f;;Human;;Full agonist
[3H]flunitrazepam;GABAA receptor α2 subunit;f;;Human;;Full agonist
Zn2+;GABAA receptor α2 subunit;t;;Human;;Inhibition
α3IA;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
α5IA;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
DMCM;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
MRK016;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
Ro15-4513;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
Ro19-4603;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
RO4938581;GABAA receptor α2 subunit;f;;Human;;Inverse agonist
[3H]CGS8216;GABAA receptor α2 subunit;f;;Human;;Mixed
L838417;GABAA receptor α2 subunit;f;;Human;;Partial agonist
ocinaplon;GABAA receptor α2 subunit;f;;Human;;Partial agonist
TPA023;GABAA receptor α2 subunit;f;;Human;;Partial agonist
alprazolam;GABAA receptor α2 subunit;f;;Human;12408715;Positive
AZD7325;GABAA receptor α2 subunit;f;;Human;;Positive
clonazepam;GABAA receptor α2 subunit;f;;Human;2551039;Positive
diazepam;GABAA receptor α2 subunit;f;;Human;2551039;Positive
flunitrazepam;GABAA receptor α2 subunit;f;;Human;8632757;Positive
PF-06372865;GABAA receptor α2 subunit;f;;Human;;Positive
triazolam;GABAA receptor α2 subunit;f;;Human;10633039;Positive
zolpidem;GABAA receptor α2 subunit;f;;Human;8391122;Positive
5α-pregnan-3α-ol-20-one;GABAA receptor α2 subunit;t;;Human;;Potentiation
tetrahydrodeoxycorticosterone;GABAA receptor α2 subunit;t;;Human;;Potentiation
bicuculline;GABAA receptor α2 subunit;f;;Human;;Antagonist
gabazine;GABAA receptor α2 subunit;f;;Human;;Antagonist
[3H]gabazine;GABAA receptor α2 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor α2 subunit;f;;Human;;None
[35S]TBPS;GABAA receptor α2 subunit;f;;Human;;None
TBPS;GABAA receptor α2 subunit;f;;Human;;None
gaboxadol;GABAA receptor α3 subunit;f;;Human;;Agonist
isonipecotic acid;GABAA receptor α3 subunit;f;;Human;;Agonist
[3H]muscimol;GABAA receptor α3 subunit;f;;Human;;Agonist
isoguvacine;GABAA receptor α3 subunit;f;;Human;;Full agonist
muscimol;GABAA receptor α3 subunit;f;;Human;;Full agonist
piperidine-4-sulphonic acid;GABAA receptor α3 subunit;f;;Human;;Full agonist
ZK93423;GABAA receptor α3 subunit;f;;Human;9651158;Full agonist
CGS8216;GABAA receptor α3 subunit;f;;Human;10633039;Inverse agonist
flumazenil;GABAA receptor α3 subunit;f;;Human;9767648;Antagonist
[11C]flumazenil;GABAA receptor α3 subunit;f;;Human;;Antagonist
[18F]fluoroethylflumazenil;GABAA receptor α3 subunit;f;;Human;;Antagonist
ZK93426;GABAA receptor α3 subunit;f;;Human;;Antagonist
bretazenil;GABAA receptor α3 subunit;f;;Human;;Full agonist
[3H]flunitrazepam;GABAA receptor α3 subunit;f;;Human;;Full agonist
Zn2+;GABAA receptor α3 subunit;t;;Human;;Inhibition
α5IA;GABAA receptor α3 subunit;f;;Human;;Inverse agonist
DMCM;GABAA receptor α3 subunit;f;;Human;;Inverse agonist
MRK016;GABAA receptor α3 subunit;f;;Human;;Inverse agonist
Ro15-4513;GABAA receptor α3 subunit;f;;Human;;Inverse agonist
Ro19-4603;GABAA receptor α3 subunit;f;;Human;;Inverse agonist
RO4938581;GABAA receptor α3 subunit;f;;Human;;Inverse agonist
[3H]CGS8216;GABAA receptor α3 subunit;f;;Human;;Mixed
α3IA;GABAA receptor α3 subunit;f;;Human;;None
L838417;GABAA receptor α3 subunit;f;;Human;;Partial agonist
ocinaplon;GABAA receptor α3 subunit;f;;Human;;Partial agonist
TP003;GABAA receptor α3 subunit;f;;Human;;Partial agonist
TPA023;GABAA receptor α3 subunit;f;;Human;;Partial agonist
alprazolam;GABAA receptor α3 subunit;f;;Human;12408715;Positive
AZD7325;GABAA receptor α3 subunit;f;;Human;;Positive
clonazepam;GABAA receptor α3 subunit;f;;Human;2551039;Positive
diazepam;GABAA receptor α3 subunit;f;;Human;2551039;Positive
flunitrazepam;GABAA receptor α3 subunit;f;;Human;8632757;Positive
triazolam;GABAA receptor α3 subunit;f;;Human;10633039;Positive
zolpidem;GABAA receptor α3 subunit;f;;Human;8391122;Positive
5α-pregnan-3α-ol-20-one;GABAA receptor α3 subunit;t;;Human;;Potentiation
tetrahydrodeoxycorticosterone;GABAA receptor α3 subunit;t;;Human;;Potentiation
bicuculline;GABAA receptor α3 subunit;f;;Human;;Antagonist
gabazine;GABAA receptor α3 subunit;f;;Human;;Antagonist
[3H]gabazine;GABAA receptor α3 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor α3 subunit;f;;Human;;None
[35S]TBPS;GABAA receptor α3 subunit;f;;Human;;None
TBPS;GABAA receptor α3 subunit;f;;Human;;None
gaboxadol;GABAA receptor α4 subunit;f;;Human;;Agonist
isoguvacine;GABAA receptor α4 subunit;f;;Human;;Full agonist
isonipecotic acid;GABAA receptor α4 subunit;f;;Human;;Full agonist
muscimol;GABAA receptor α4 subunit;f;;Human;;Full agonist
piperidine-4-sulphonic acid;GABAA receptor α4 subunit;f;;Human;;Full agonist
[3H]muscimol;GABAA receptor α4 subunit;f;;Human;;Full agonist
[18F]fluoroethylflumazenil;GABAA receptor α4 subunit;f;;Human;;Antagonist
bretazenil;GABAA receptor α4 subunit;f;;Human;;Full agonist
Ro15-4513;GABAA receptor α4 subunit;f;;Human;;Full agonist
[3H]Ro154513;GABAA receptor α4 subunit;f;;Human;;Full agonist
Zn2+;GABAA receptor α4 subunit;t;;Human;;Inhibition
[3H]CGS8216;GABAA receptor α4 subunit;f;;Human;;Mixed
[11C]flumazenil;GABAA receptor α4 subunit;f;;Human;;Partial agonist
cenobamate;GABAA receptor α4 subunit;f;;Human;32325146;Positive
flumazenil;GABAA receptor α4 subunit;f;;Rat;7799410;Positive
5α-pregnan-3α-ol-20-one;GABAA receptor α4 subunit;t;;Human;;Potentiation
tetrahydrodeoxycorticosterone;GABAA receptor α4 subunit;t;;Human;;Potentiation
bicuculline;GABAA receptor α4 subunit;f;;Human;;Antagonist
gabazine;GABAA receptor α4 subunit;f;;Human;;Antagonist
[3H]gabazine;GABAA receptor α4 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor α4 subunit;f;;Human;;None
[35S]TBPS;GABAA receptor α4 subunit;f;;Human;;None
TBPS;GABAA receptor α4 subunit;f;;Human;;None
gaboxadol;GABAA receptor α5 subunit;f;;Human;;Agonist
isonipecotic acid;GABAA receptor α5 subunit;f;;Human;;Agonist
isoguvacine;GABAA receptor α5 subunit;f;;Human;;Full agonist
muscimol;GABAA receptor α5 subunit;f;;Human;;Full agonist
piperidine-4-sulphonic acid;GABAA receptor α5 subunit;f;;Human;;Full agonist
[3H]muscimol;GABAA receptor α5 subunit;f;;Human;;Full agonist
CGS8216;GABAA receptor α5 subunit;f;;Human;10633039;Inverse agonist
ZK93423;GABAA receptor α5 subunit;f;;Human;9651158;Partial agonist
flumazenil;GABAA receptor α5 subunit;f;;Human;9767648;Antagonist
[11C]flumazenil;GABAA receptor α5 subunit;f;;Human;;Antagonist
[18F]fluoroethylflumazenil;GABAA receptor α5 subunit;f;;Human;;Antagonist
TP003;GABAA receptor α5 subunit;f;;Human;;Antagonist
TPA023;GABAA receptor α5 subunit;f;;Human;;Antagonist
ZK93426;GABAA receptor α5 subunit;f;;Human;;Antagonist
bretazenil;GABAA receptor α5 subunit;f;;Human;;Full agonist
[3H]flunitrazepam;GABAA receptor α5 subunit;f;;Human;;Full agonist
Zn2+;GABAA receptor α5 subunit;t;;Human;;Inhibition
α3IA;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
α5IA;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
DMCM;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
L655708;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
MRK016;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
Ro15-4513;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
Ro19-4603;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
RO4938581;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
RY024;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
[3H]L655708;GABAA receptor α5 subunit;f;;Human;;Inverse agonist
[3H]CGS8216;GABAA receptor α5 subunit;f;;Human;;Mixed
basmisanil;GABAA receptor α5 subunit;f;;Human;;Negative
ONO-8590580;GABAA receptor α5 subunit;f;;Human;29674331;Negative
L838417;GABAA receptor α5 subunit;f;;Human;;Partial agonist
ocinaplon;GABAA receptor α5 subunit;f;;Human;;Partial agonist
alprazolam;GABAA receptor α5 subunit;f;;Human;12408715;Positive
flunitrazepam;GABAA receptor α5 subunit;f;;Human;8632757;Positive
triazolam;GABAA receptor α5 subunit;f;;Human;18537233;Positive
triazolam;GABAA receptor α5 subunit;f;;Human;10633039;Positive
5α-pregnan-3α-ol-20-one;GABAA receptor α5 subunit;t;;Human;;Potentiation
tetrahydrodeoxycorticosterone;GABAA receptor α5 subunit;t;;Human;;Potentiation
bicuculline;GABAA receptor α5 subunit;f;;Human;;Antagonist
gabazine;GABAA receptor α5 subunit;f;;Human;;Antagonist
[3H]gabazine;GABAA receptor α5 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor α5 subunit;f;;Human;;None
[35S]TBPS;GABAA receptor α5 subunit;f;;Human;;None
TBPS;GABAA receptor α5 subunit;f;;Human;;None
[3H]RY80;GABAA receptor α5 subunit;f;;Rat;9353361;Binding
gaboxadol;GABAA receptor α6 subunit;f;;Human;;Agonist
isoguvacine;GABAA receptor α6 subunit;f;;Human;;Full agonist
isonipecotic acid;GABAA receptor α6 subunit;f;;Human;;Full agonist
muscimol;GABAA receptor α6 subunit;f;;Human;;Full agonist
piperidine-4-sulphonic acid;GABAA receptor α6 subunit;f;;Human;;Full agonist
[3H]muscimol;GABAA receptor α6 subunit;f;;Human;;Full agonist
CGS8216;GABAA receptor α6 subunit;f;;Human;;Inverse agonist
[18F]fluoroethylflumazenil;GABAA receptor α6 subunit;f;;Human;;Antagonist
bretazenil;GABAA receptor α6 subunit;f;;Human;;Full agonist
Ro15-4513;GABAA receptor α6 subunit;f;;Human;;Full agonist
[3H]Ro154513;GABAA receptor α6 subunit;f;;Human;;Full agonist
Zn2+;GABAA receptor α6 subunit;t;;Human;;Inhibition
[3H]CGS8216;GABAA receptor α6 subunit;f;;Human;;Mixed
flumazenil;GABAA receptor α6 subunit;f;;Human;9767648;Partial agonist
[11C]flumazenil;GABAA receptor α6 subunit;f;;Human;;Partial agonist
cenobamate;GABAA receptor α6 subunit;f;;Human;32325146;Positive
5α-pregnan-3α-ol-20-one;GABAA receptor α6 subunit;t;;Human;;Potentiation
tetrahydrodeoxycorticosterone;GABAA receptor α6 subunit;t;;Human;;Potentiation
bicuculline;GABAA receptor α6 subunit;f;;Human;;Antagonist
gabazine;GABAA receptor α6 subunit;f;;Human;;Antagonist
[3H]gabazine;GABAA receptor α6 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor α6 subunit;f;;Human;;None
[35S]TBPS;GABAA receptor α6 subunit;f;;Human;;None
TBPS;GABAA receptor α6 subunit;f;;Human;;None
picrotoxin;GABAA receptor β1 subunit;f;;Human;;None
TBPS;GABAA receptor β1 subunit;f;;Human;;None
picrotoxin;GABAA receptor β2 subunit;f;;Human;;None
TBPS;GABAA receptor β2 subunit;f;;Human;;None
etazolate;GABAA receptor β3 subunit;f;;Human;8773466;Binding
picrotoxin;GABAA receptor β3 subunit;f;;Human;;None
TBPS;GABAA receptor β3 subunit;f;;Human;;None
gaboxadol;GABAA receptor δ subunit;f;;Human;;Full agonist
picrotoxin;GABAA receptor δ subunit;f;;Human;;None
TBPS;GABAA receptor δ subunit;f;;Human;;None
picrotoxin;GABAA receptor ε subunit;f;;Human;;None
TBPS;GABAA receptor ε subunit;f;;Human;;None
picrotoxin;GABAA receptor γ1 subunit;f;;Human;;None
TBPS;GABAA receptor γ1 subunit;f;;Human;;None
picrotoxin;GABAA receptor γ2 subunit;f;;Human;;None
TBPS;GABAA receptor γ2 subunit;f;;Human;;None
picrotoxin;GABAA receptor γ3 subunit;f;;Human;;None
TBPS;GABAA receptor γ3 subunit;f;;Human;;None
picrotoxin;GABAA receptor π subunit;f;;Human;;None
TBPS;GABAA receptor π subunit;f;;Human;;None
CACA;GABAA receptor ρ1 subunit;f;;Rat;8386310;Agonist
5-Me-IAA;GABAA receptor ρ1 subunit;f;;Human;;Full agonist
(±)-cis-2-CAMP;GABAA receptor ρ1 subunit;f;;Human;;Full agonist
isoguvacine;GABAA receptor ρ1 subunit;f;;Human;;Partial agonist
muscimol;GABAA receptor ρ1 subunit;f;;Human;;Partial agonist
aza-THIP;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
gaboxadol;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
cis-3-ACPBPA;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
isonipecotic acid;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
trans-3-ACPBPA;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
piperidine-4-sulphonic acid;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
TPMPA;GABAA receptor ρ1 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor ρ1 subunit;f;;Human;;None
TBPS;GABAA receptor ρ1 subunit;f;;Human;;None
5-Me-IAA;GABAA receptor ρ2 subunit;f;;Human;;Full agonist
(±)-cis-2-CAMP;GABAA receptor ρ2 subunit;f;;Human;;Full agonist
isoguvacine;GABAA receptor ρ2 subunit;f;;Human;;Partial agonist
muscimol;GABAA receptor ρ2 subunit;f;;Human;;Partial agonist
aza-THIP;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
gaboxadol;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
cis-3-ACPBPA;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
isonipecotic acid;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
trans-3-ACPBPA;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
piperidine-4-sulphonic acid;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
TPMPA;GABAA receptor ρ2 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor ρ2 subunit;f;;Human;;None
TBPS;GABAA receptor ρ2 subunit;f;;Human;;None
5-Me-IAA;GABAA receptor ρ3 subunit;f;;Human;;Full agonist
(±)-cis-2-CAMP;GABAA receptor ρ3 subunit;f;;Human;;Full agonist
isoguvacine;GABAA receptor ρ3 subunit;f;;Human;;Partial agonist
muscimol;GABAA receptor ρ3 subunit;f;;Human;;Partial agonist
aza-THIP;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
gaboxadol;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
cis-3-ACPBPA;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
isonipecotic acid;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
trans-3-ACPBPA;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
piperidine-4-sulphonic acid;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
TPMPA;GABAA receptor ρ3 subunit;f;;Human;;Antagonist
picrotoxin;GABAA receptor ρ3 subunit;f;;Human;;None
TBPS;GABAA receptor ρ3 subunit;f;;Human;;None
picrotoxin;GABAA receptor θ subunit;f;;Human;;None
TBPS;GABAA receptor θ subunit;f;;Human;;None
3-APPA;GABAB1;f;;Rat;9069281;Agonist
lesogaberan;GABAB1;f;;Human;;Agonist
(-)-baclofen;GABAB1;f;;Rat;9069281;Full agonist
CGP 47656;GABAB1;f;;Human;9069281;Full agonist
GABA;GABAB1;t;;Rat;9069281;Full agonist
2-hydroxy-saclofen;GABAB1;f;;Rat;9069281;Antagonist
CGP 35348;GABAB1;f;;Rat;9069281|7650685;Antagonist
CGP 54626A;GABAB1;f;;Rat;9069281;Antagonist
CGP 56999A;GABAB1;f;;Rat;9069281;Antagonist
CGP 62349;GABAB1;f;;Rat;9069281;Antagonist
CGP 64213;GABAB1;f;;Rat;9069281;Antagonist
CGP 71872;GABAB1;f;;Rat;9069281;Antagonist
saclofen;GABAB1;f;;Rat;9069281;Antagonist
SCH 50911;GABAB1;f;;Rat;7562513;Antagonist
[125I]CGP 64213;GABAB1;f;;Rat;9069281;Antagonist
[125I]CGP 71872;GABAB1;f;;Rat;9069281;Antagonist
CGP7930;GABAB2;f;;Rat;15126507|11641424;Positive
3-APPA;GABAB receptor;f;;Rat;;Agonist
[3H](R)-(-)-baclofen;GABAB receptor;f;;None;;Agonist
3-APMPA;GABAB receptor;f;;Rat;;Full agonist
3-APMPA;GABAB receptor;f;;Human;11082110;Full agonist
3-APPA;GABAB receptor;f;;Human;12663046;Full agonist
baclofen;GABAB receptor;f;;Human;11082110|12663046;Full agonist
(-)-baclofen;GABAB receptor;f;;Rat;;Full agonist
CGP 44532;GABAB receptor;f;;Rat;;Full agonist
GABA;GABAB receptor;t;;Human;11082110|12663046;Full agonist
GABA;GABAB receptor;t;;Rat;;Full agonist
compound 14 [PMID: 25050158];GABAB receptor;f;;Human;25050158;Negative
CGP7930;GABAB receptor;f;;Human;11641424;Positive
GS39783;GABAB receptor;f;;Human;12954816|29514854;Positive
rac-BHFF;GABAB receptor;f;;Human;18536733;Positive
2-hydroxy-saclofen;GABAB receptor;f;;Rat;9069281;Antagonist
CGP 35348;GABAB receptor;f;;Rat;12037141;Antagonist
CGP 35348;GABAB receptor;f;;Human;11082110;Antagonist
CGP 36742;GABAB receptor;f;;Rat;12037141;Antagonist
CGP 46381;GABAB receptor;f;;Human;11082110;Antagonist
CGP 54626A;GABAB receptor;f;;Human;11082110|12663046;Antagonist
CGP 55845;GABAB receptor;f;;Rat;12037141;Antagonist
CGP 55845;GABAB receptor;f;;Human;11082110;Antagonist
CGP 62349;GABAB receptor;f;;Human;11082110|12663046;Antagonist
phaclofen;GABAB receptor;f;;Rat;12037141;Antagonist
phaclofen;GABAB receptor;f;;Human;11082110;Antagonist
saclofen;GABAB receptor;f;;Human;11082110|12663046;Antagonist
saclofen;GABAB receptor;f;;Rat;12037141;Antagonist
SCH 50911;GABAB receptor;f;;Human;11082110|12663046;Antagonist
SCH 50911;GABAB receptor;f;;Rat;7562513;Antagonist
[125I]CGP 64213;GABAB receptor;f;;Rat;10692480;Antagonist
[125I]CGP 71872;GABAB receptor;f;;Rat;9069281;Antagonist
[3H]CGP 54626;GABAB receptor;f;;Rat;9872315;Antagonist
[3H]CGP 62349;GABAB receptor;f;;Rat;10521582;Antagonist
alarin;GAL1 receptor;f;Rat;Rat;20880399;Agonist
galanin(10-29) (pig);GAL1 receptor;f;;Rat;8750821;Agonist
galanin(10-29) (rat/mouse);GAL1 receptor;f;;Mouse;9832122;Agonist
galanin(1-11);GAL1 receptor;f;;Human;11481429;Agonist
galanin(1-13)amide;GAL1 receptor;f;;Rat;8738882;Agonist
galanin(1-15);GAL1 receptor;f;;Rat;9305929|8750821;Agonist
galanin(1-15);GAL1 receptor;f;;Human;9685625;Agonist
galanin(1-16) (rat/mouse/pig);GAL1 receptor;f;;Human;9808667|9880084|7524088|19053761;Agonist
galanin(1-16) (rat/mouse/pig);GAL1 receptor;f;;Rat;9168941|9108306;Agonist
galanin(1-16) (rat/mouse/pig);GAL1 receptor;f;;Human;9168941|9685625;Agonist
galanin(1-16) (rat/mouse/pig);GAL1 receptor;f;;Rat;9305929|9722565|9281594|8750821|8562318|9405385|9742938;Agonist
galanin(1-16) (rat/mouse/pig);GAL1 receptor;f;;Mouse;9271210|9832122;Agonist
galanin(1-19) (human);GAL1 receptor;f;;Human;9168941;Agonist
galanin(1-19) (human);GAL1 receptor;f;;Rat;9168941;Agonist
galanin(2-11);GAL1 receptor;f;;Human;15944002;Agonist
galanin(2-11);GAL1 receptor;f;;Human;11481429;Agonist
galanin(2-30) (human);GAL1 receptor;f;;Human;11983932;Agonist
galanin(3-29) (pig);GAL1 receptor;f;;Human;9880084|7524088;Agonist
galanin(3-29) (pig);GAL1 receptor;f;;Rat;9305929|9722565|8750821|8562318;Agonist
galanin(3-29) (pig);GAL1 receptor;f;;Human;9685625;Agonist
galanin(3-29) (rat/mouse);GAL1 receptor;f;;Rat;9405385|9742938;Agonist
galanin(3-29) (rat/mouse);GAL1 receptor;f;;Human;9168941;Agonist
galanin(3-29) (rat/mouse);GAL1 receptor;f;;Rat;9168941|9108306;Agonist
galanin(3-29) (rat/mouse);GAL1 receptor;f;;Mouse;9832122;Agonist
galanin(7-29) (pig);GAL1 receptor;f;;Rat;9722565;Agonist
galanin(7-29) (pig);GAL1 receptor;f;;Human;9880084;Agonist
galanin(D-Trp2) (pig);GAL1 receptor;f;;Rat;9305929|9722565;Agonist
galanin(D-Trp2) (pig);GAL1 receptor;f;;Human;9880084;Agonist
galanin-like peptide;GAL1 receptor;f;Pig;Rat;10601261;Agonist
galanin-like peptide;GAL1 receptor;f;Pig;Rat;10601261;Agonist
galanin-like peptide;GAL1 receptor;f;Human;Human;15944009;Agonist
galanin-like peptide;GAL1 receptor;f;Rat;Rat;20880399;Agonist
Gal-B2;GAL1 receptor;f;;Human;19053761;Agonist
Gal-B2-C10;GAL1 receptor;f;;Human;19199479;Agonist
Gal-B2-C12;GAL1 receptor;f;;Human;19199479;Agonist
Gal-B2-C14;GAL1 receptor;f;;Human;19199479;Agonist
Gal-B2-C18;GAL1 receptor;f;;Human;19199479;Agonist
Gal-B2-C8;GAL1 receptor;f;;Human;19199479;Agonist
Gal-B2-dPEG24;GAL1 receptor;f;;Human;23259957;Agonist
Gal-B2-MPEG4;GAL1 receptor;f;;Human;19199479;Agonist
Gal-B5;GAL1 receptor;f;;Human;19053761;Agonist
Gal-(K)4;GAL1 receptor;f;;Human;19199479;Agonist
galmic;GAL1 receptor;f;;Human;15944006|15240875;Agonist
galnon;GAL1 receptor;f;;Human;15944006|15240875;Agonist
GALP(1-32) (human);GAL1 receptor;f;;Human;15944009;Agonist
GALP(3-32) (human);GAL1 receptor;f;;Human;15944009;Agonist
galparan;GAL1 receptor;f;;Rat;8738882;Agonist
J18 (galanin analogue);GAL1 receptor;f;;Human;23600864;Agonist
J20 (galanin analogue);GAL1 receptor;f;;Human;23600864;Agonist
M1145;GAL1 receptor;f;;Human;19467704;Agonist
M1151;GAL1 receptor;f;;Human;21333705;Agonist
M1152;GAL1 receptor;f;;Human;21333705;Agonist
M1153;GAL1 receptor;f;;Human;21333705;Agonist
M1160;GAL1 receptor;f;;Human;23192661;Agonist
M242;GAL1 receptor;f;;Human;11600206;Agonist
M617;GAL1 receptor;f;;Human;;Agonist
[N-Me,des-Sar]Gal-B2;GAL1 receptor;f;;Human;20121116;Agonist
[Sar1, D-Ala12]galanin(1-16);GAL1 receptor;f;;Human;11491429;Agonist
[125I][Tyr26]galanin (human);GAL1 receptor;f;;Human;9808667;Agonist
[125I][Tyr26]galanin (human);GAL1 receptor;f;;Human;9808667;Agonist
[125I][Tyr26]galanin (pig);GAL1 receptor;f;;Rat;9305929|9722565|8750821|9685625|8562318|9578584;Agonist
[125I][Tyr26]galanin (pig);GAL1 receptor;f;;Human;9880084;Agonist
[125I][Tyr26]galanin (rat/mouse);GAL1 receptor;f;;Mouse;9271210;Agonist
[19Lys,26Leu]-galparan;GAL1 receptor;f;;Rat;8738882;Agonist
[2Ala]-galparan;GAL1 receptor;f;;Rat;8738882;Agonist
galanin;GAL1 receptor;t;Human;Human;11481429|9168941|9685625;Full agonist
galanin;GAL1 receptor;t;Mouse|Rat;Rat;10601261|20880399;Full agonist
galanin;GAL1 receptor;t;Human;Human;9808667|9880084|7524088|11600206;Full agonist
galanin;GAL1 receptor;f;Human;Rat;9168941|9108306;Full agonist
galanin;GAL1 receptor;f;Mouse|Rat;Human;9880084|7524088|19467704|21333705|15944002;Full agonist
galanin;GAL1 receptor;f;Mouse|Rat;Human;9685625;Full agonist
galanin;GAL1 receptor;t;Mouse|Rat;Rat;9722565|9281594|8562318|9405385|9742938;Full agonist
galanin;GAL1 receptor;t;Mouse|Rat;Rat;10601261;Full agonist
galanin;GAL1 receptor;t;Mouse|Rat;Mouse;9271210|9832122;Full agonist
galanin;GAL1 receptor;f;Pig;Human;9808667|9880084|7524088;Full agonist
galanin;GAL1 receptor;f;Pig;Human;7524088;Full agonist
galanin;GAL1 receptor;f;Pig;Rat;9305929|9722565|8750821|8562318;Full agonist
galanin;GAL1 receptor;f;Pig;Rat;9168941|9108306;Full agonist
galanin;GAL1 receptor;f;Human;Rat;9722565|8562318;Full agonist
galanin;GAL1 receptor;f;Pig;Human;9168941|9685625;Full agonist
galanin;GAL1 receptor;f;Pig;Rat;8738882;Full agonist
galanin(2-29) (pig);GAL1 receptor;f;;Human;9685625;Full agonist
galanin(2-29) (pig);GAL1 receptor;f;;Human;9880084;Full agonist
galanin(2-29) (pig);GAL1 receptor;f;;Rat;8750821|8562318;Full agonist
galanin(2-29) (rat/mouse);GAL1 receptor;f;;Rat;9168941|9108306;Full agonist
galanin(2-29) (rat/mouse);GAL1 receptor;f;;Mouse;9271210|9832122;Full agonist
galanin(2-29) (rat/mouse);GAL1 receptor;f;;Rat;9281594|9405385|9742938;Full agonist
galanin(2-29) (rat/mouse);GAL1 receptor;f;;Human;9168941;Full agonist
2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide;GAL1 receptor;f;;Human;10896115;Antagonist
C7;GAL1 receptor;f;;Mouse;9271210|9832122;Antagonist
C7;GAL1 receptor;f;;Human;9808667|9880084;Antagonist
C7;GAL1 receptor;f;;Human;9168941|9685625;Antagonist
C7;GAL1 receptor;f;;Rat;9305929|9722565|8750821;Antagonist
C7;GAL1 receptor;f;;Rat;9168941|9108306;Antagonist
dithiipin-1,1,4,4-tetroxide analogue 7;GAL1 receptor;f;;Human;10896115;Antagonist
GalR3ant;GAL1 receptor;f;;Human;15944007;Antagonist
M15;GAL1 receptor;f;;Human;9808667|9880084|15944002;Antagonist
M15;GAL1 receptor;f;;Human;9168941|9685625;Antagonist
M15;GAL1 receptor;f;;Rat;9168941|9108306;Antagonist
M15;GAL1 receptor;f;;Mouse;9271210|9832122;Antagonist
M15;GAL1 receptor;f;;Rat;9305929|9722565|9281594|8750821;Antagonist
M32;GAL1 receptor;f;;Human;9880084|11600206;Antagonist
M32;GAL1 receptor;f;;Rat;9305929|9722565;Antagonist
M35;GAL1 receptor;f;;Human;9168941;Antagonist
M35;GAL1 receptor;f;;Human;9808667|9880084|15944002;Antagonist
M35;GAL1 receptor;f;;Rat;9305929|9722565|8750821;Antagonist
M35;GAL1 receptor;f;;Rat;9168941|9108306;Antagonist
M40;GAL1 receptor;f;;Rat;9168941|9108306;Antagonist
M40;GAL1 receptor;f;;Mouse;9271210|9832122;Antagonist
M40;GAL1 receptor;f;;Human;9808667|9880084|15944002;Antagonist
M40;GAL1 receptor;f;;Human;9168941;Antagonist
M40;GAL1 receptor;f;;Rat;9305929|9722565|8750821;Antagonist
M871;GAL1 receptor;f;;Human;;Antagonist
Sch 202596;GAL1 receptor;f;;Human;;Antagonist
alarin;GAL2 receptor;f;Rat;Rat;20880399;Agonist
(D-Thr6, D-Trp8,9)galanin(1-15)ol;GAL2 receptor;f;;Rat;9281594;Agonist
galanin(10-29) (pig);GAL2 receptor;f;;Rat;9427506;Agonist
galanin(10-29) (pig);GAL2 receptor;f;;Human;9685625;Agonist
galanin(10-29) (rat/mouse);GAL2 receptor;f;;Human;9480833;Agonist
galanin(10-29) (rat/mouse);GAL2 receptor;f;;Mouse;9832122;Agonist
galanin(1-10);GAL2 receptor;f;;Human;9480833;Agonist
galanin(1-11);GAL2 receptor;f;;Rat;11481429;Agonist
galanin(1-12);GAL2 receptor;f;;Human;9480833;Agonist
galanin(1-15);GAL2 receptor;f;;Human;9480833;Agonist
galanin(1-15);GAL2 receptor;f;;Human;9685625;Agonist
galanin(1-15);GAL2 receptor;f;;Human;9685625;Agonist
galanin(1-15);GAL2 receptor;f;;Rat;9305929;Agonist
galanin(1-15);GAL2 receptor;f;;Rat;9427506;Agonist
galanin(1-15);GAL2 receptor;f;;Rat;9305929;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Mouse;9832122;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Rat;9427506|9108306;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Human;9880084|9685625;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Human;9685625;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Human;9880084|19053761|9480833;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Rat;9305929|9722565|9281594|9405385|9742938|9832122;Agonist
galanin(1-16) (rat/mouse/pig);GAL2 receptor;f;;Rat;9305929;Agonist
galanin(1-19) (rat/mouse);GAL2 receptor;f;;Rat;9405385;Agonist
galanin(1-20)  (human);GAL2 receptor;f;;Human;9480833;Agonist
galanin(2-11);GAL2 receptor;f;;Rat;11481429;Agonist
galanin(2-11);GAL2 receptor;f;;Rat;15944007;Agonist
galanin(2-11);GAL2 receptor;f;;Human;19467704;Agonist
galanin(3-29) (pig);GAL2 receptor;f;;Rat;9305929|9722565;Agonist
galanin(3-29) (pig);GAL2 receptor;f;;Human;9880084;Agonist
galanin(3-29) (pig);GAL2 receptor;f;;Human;9880084;Agonist
galanin(3-29) (pig);GAL2 receptor;f;;Human;9427506|9685625;Agonist
galanin(3-29) (pig);GAL2 receptor;f;;Rat;9305929;Agonist
galanin(3-29) (rat/mouse);GAL2 receptor;f;;Mouse;9832122;Agonist
galanin(3-29) (rat/mouse);GAL2 receptor;f;;Rat;9405385|9742938|9832122;Agonist
galanin(3-29) (rat/mouse);GAL2 receptor;f;;Human;9480833;Agonist
galanin(3-29) (rat/mouse);GAL2 receptor;f;;Rat;9108306;Agonist
galanin(3-30) (human);GAL2 receptor;f;;Human;9480833;Agonist
galanin(5-29) (pig);GAL2 receptor;f;;Rat;7683428;Agonist
galanin(5-29) (rat/mouse);GAL2 receptor;f;;Human;9480833;Agonist
galanin(7-29) (pig);GAL2 receptor;f;;Rat;9480833;Agonist
galanin(7-29) (pig);GAL2 receptor;f;;Human;9880084;Agonist
galanin(9-25) (rat/mouse);GAL2 receptor;f;;Human;9480833;Agonist
galanin(9-29) (rat/mouse);GAL2 receptor;f;;Human;9480833;Agonist
galanin(D-Trp2) (pig);GAL2 receptor;f;;Human;9880084;Agonist
galanin(D-Trp2) (pig);GAL2 receptor;f;;Human;9880084;Agonist
galanin(D-Trp2) (pig);GAL2 receptor;f;;Rat;9305929;Agonist
galanin(D-Trp2) (pig);GAL2 receptor;f;;Rat;9305929|9722565;Agonist
galanin-like peptide;GAL2 receptor;f;Pig;Rat;10601261;Agonist
galanin-like peptide;GAL2 receptor;f;Pig;Rat;10601261;Agonist
galanin-like peptide;GAL2 receptor;f;Human;Human;15944009|20880399;Agonist
Gal-B2;GAL2 receptor;f;;Human;19053761;Agonist
Gal-B2-C10;GAL2 receptor;f;;Human;19199479;Agonist
Gal-B2-C12;GAL2 receptor;f;;Human;19199479;Agonist
Gal-B2-C14;GAL2 receptor;f;;Human;19199479;Agonist
Gal-B2-C18;GAL2 receptor;f;;Human;19199479;Agonist
Gal-B2-C8;GAL2 receptor;f;;Human;19199479;Agonist
Gal-B2-dPEG24;GAL2 receptor;f;;Human;23259957;Agonist
Gal-B2-MPEG4;GAL2 receptor;f;;Human;19199479;Agonist
Gal-B5;GAL2 receptor;f;;Human;19053761;Agonist
Gal-(K)4;GAL2 receptor;f;;Human;19199479;Agonist
galmic;GAL2 receptor;f;;Rat;15240875|15944002;Agonist
galnon;GAL2 receptor;f;;Rat;15240875|15944002;Agonist
GALP(1-32) (human);GAL2 receptor;f;;Human;15944009;Agonist
GALP(3-32) (human);GAL2 receptor;f;;Human;15944009;Agonist
Gal-R2-dPEG24;GAL2 receptor;f;;Human;23259957;Agonist
GMAP(1-41);GAL2 receptor;f;Pig;Rat;9281594;Agonist
GMAP(44-59);GAL2 receptor;f;Pig;Rat;9405385;Agonist
J18 (galanin analogue);GAL2 receptor;f;;Human;23600864;Agonist
J20 (galanin analogue);GAL2 receptor;f;;Human;23600864;Agonist
M1151;GAL2 receptor;f;;Human;21333705;Agonist
M1152;GAL2 receptor;f;;Human;21333705;Agonist
M1153;GAL2 receptor;f;;Human;21333705;Agonist
M1160;GAL2 receptor;f;;Human;23192661;Agonist
M242;GAL2 receptor;f;;Human;11600206;Agonist
M617;GAL2 receptor;f;;Human;;Agonist
[N-Me,des-Sar]Gal-B2;GAL2 receptor;f;;Human;20121116;Agonist
[Sar1, D-Ala12]galanin(1-16);GAL2 receptor;f;;Rat;11481429;Agonist
[125I][Tyr26]galanin (human);GAL2 receptor;f;;Human;9480833|9832121;Agonist
[125I][Tyr26]galanin (human);GAL2 receptor;f;;Mouse;9832122;Agonist
[125I][Tyr26]galanin (human);GAL2 receptor;f;;Rat;9281594;Agonist
[125I][Tyr26]galanin (pig);GAL2 receptor;f;;Human;9880084;Agonist
[125I][Tyr26]galanin (pig);GAL2 receptor;f;;Human;9685625;Agonist
[125I][Tyr26]galanin (pig);GAL2 receptor;f;;Rat;9722565|9281594|9427506|9578584;Agonist
[D-Trp2]galanin-(1-29);GAL2 receptor;f;;Rat;9305929;Full agonist
galanin;GAL2 receptor;f;Mouse|Rat;Human;9685625;Full agonist
galanin;GAL2 receptor;t;Human;Human;9880084|9685625;Full agonist
galanin;GAL2 receptor;t;Human;Human;9685625;Full agonist
galanin;GAL2 receptor;f;Human;Rat;9722565;Full agonist
galanin;GAL2 receptor;f;Human;Rat;9427506|11481429|9108306;Full agonist
galanin;GAL2 receptor;t;Mouse|Rat;Rat;9722565|9281594|9405385|9742938|9832122|15944002;Full agonist
galanin;GAL2 receptor;f;Pig;Rat;9305929;Full agonist
galanin;GAL2 receptor;f;Mouse|Rat;Rat;10601261|9427506|20880399;Full agonist
galanin;GAL2 receptor;f;Mouse|Rat;Human;9880084|19467704|21333705|9480833;Full agonist
galanin;GAL2 receptor;f;Pig;Human;9880084;Full agonist
galanin;GAL2 receptor;f;Pig;Human;9880084;Full agonist
galanin;GAL2 receptor;f;Pig;Human;9685625;Full agonist
galanin;GAL2 receptor;f;Pig;Rat;9427506|9108306;Full agonist
galanin;GAL2 receptor;t;Human;Human;9880084|11600206|9480833;Full agonist
galanin;GAL2 receptor;t;Mouse|Rat;Rat;10601261;Full agonist
galanin;GAL2 receptor;t;Mouse|Rat;Mouse;9832122;Full agonist
galanin;GAL2 receptor;f;Pig;Rat;9305929|9722565;Full agonist
galanin;GAL2 receptor;f;Mouse|Rat;Human;9880084|9685625;Full agonist
galanin(2-29) (pig);GAL2 receptor;f;;Human;9880084|9685625;Full agonist
galanin(2-29) (pig);GAL2 receptor;f;;Human;9427506|9685625;Full agonist
galanin(2-29) (pig);GAL2 receptor;f;;Human;9880084;Full agonist
galanin(2-29) (rat/mouse);GAL2 receptor;f;;Human;9480833;Full agonist
galanin(2-29) (rat/mouse);GAL2 receptor;f;;Rat;9108306;Full agonist
galanin(2-29) (rat/mouse);GAL2 receptor;f;;Mouse;9832122;Full agonist
galanin(2-29) (rat/mouse);GAL2 receptor;f;;Rat;9281594|9405385|9742938|9832122;Full agonist
galanin(2-30) (human);GAL2 receptor;f;;Human;11983932|9480833;Full agonist
galanin(7-29) (pig);GAL2 receptor;f;;Human;9880084;Full agonist
M1145;GAL2 receptor;f;;Human;19467704;Full agonist
CYM2503;GAL2 receptor;f;;Rat;20660766;Positive
C7;GAL2 receptor;f;;Human;9880084;Antagonist
C7;GAL2 receptor;f;;Human;9685625;Antagonist
C7;GAL2 receptor;f;;Rat;9305929|9722565|9281594|9832122;Antagonist
C7;GAL2 receptor;f;;Mouse;9832122;Antagonist
C7;GAL2 receptor;f;;Rat;9427506|9108306;Antagonist
C7;GAL2 receptor;f;;Human;9880084|9480833;Antagonist
C7;GAL2 receptor;f;;Rat;9305929;Antagonist
dithiipin-1,1,4,4-tetroxide analogue 7;GAL2 receptor;f;;Human;10896115;Antagonist
GalR3ant;GAL2 receptor;f;;Rat;15944002;Antagonist
M15;GAL2 receptor;f;;Rat;9427506|9108306;Antagonist
M15;GAL2 receptor;f;;Rat;9305929|9722565|9281594|9405385|9832122|15944002;Antagonist
M15;GAL2 receptor;f;;Honeybee;9880084;Antagonist
M15;GAL2 receptor;f;;Mouse;9832122;Antagonist
M15;GAL2 receptor;f;;Rat;9305929;Antagonist
M15;GAL2 receptor;f;;Human;9880084|9685625|9480833;Antagonist
M15;GAL2 receptor;f;;Human;9685625;Antagonist
M32;GAL2 receptor;f;;Rat;9305929;Antagonist
M32;GAL2 receptor;f;;Human;9880084|9685625;Antagonist
M32;GAL2 receptor;f;;Human;9880084|11600206;Antagonist
M32;GAL2 receptor;f;;Rat;9305929|9722565;Antagonist
M35;GAL2 receptor;f;;Rat;9427506|9108306;Antagonist
M35;GAL2 receptor;f;;Mouse;9832122;Antagonist
M35;GAL2 receptor;f;;Human;9880084|9685625;Antagonist
M35;GAL2 receptor;f;;Rat;9305929|9722565|9281594|9832122|15944002;Antagonist
M35;GAL2 receptor;f;;Human;9880084|9480833;Antagonist
M35;GAL2 receptor;f;;Rat;9305929;Antagonist
M40;GAL2 receptor;f;;Human;9880084|9480833;Antagonist
M40;GAL2 receptor;f;;Human;9880084;Antagonist
M40;GAL2 receptor;f;;Rat;9427506|9108306;Antagonist
M40;GAL2 receptor;f;;Rat;9305929|9722565|9281594|9405385|9832122|15944002;Antagonist
M40;GAL2 receptor;f;;Mouse;9832122;Antagonist
M40;GAL2 receptor;f;;Rat;9305929;Antagonist
M871;GAL2 receptor;f;;Human;;Antagonist
SNAP 37889;GAL2 receptor;f;;Human;16287967;Antagonist
SNAP 398299;GAL2 receptor;f;;Human;16287967;Antagonist
alarin;GAL3 receptor;f;Rat;Rat;20880399;Agonist
(D-Thr6, D-Trp8,9)galanin(1-15)ol;GAL3 receptor;f;;Rat;9405385;Agonist
galanin(10-29) (pig);GAL3 receptor;f;;Rat;9405385;Agonist
galanin(1-16) (rat/mouse/pig);GAL3 receptor;f;;Human;9722565|9880084;Agonist
galanin(1-16) (rat/mouse/pig);GAL3 receptor;f;;Rat;9722565|9405385|9742938;Agonist
galanin(1-19) (rat/mouse);GAL3 receptor;f;;Rat;9405385;Agonist
galanin(2-11);GAL3 receptor;f;;Human;19467704;Agonist
galanin(2-11);GAL3 receptor;f;;Rat;15944007;Agonist
galanin(2-29) (pig);GAL3 receptor;f;;Human;9880084;Agonist
galanin(2-29) (rat/mouse);GAL3 receptor;f;;Rat;9405385|9742938;Agonist
galanin(3-29) (pig);GAL3 receptor;f;;Rat;9722565;Agonist
galanin(3-29) (pig);GAL3 receptor;f;;Human;9722565|9880084;Agonist
galanin(3-29) (rat/mouse);GAL3 receptor;f;;Rat;9405385|9742938;Agonist
galanin(7-29) (pig);GAL3 receptor;f;;Rat;9722565;Agonist
galanin(7-29) (pig);GAL3 receptor;f;;Human;9722565|9880084;Agonist
galanin(D-Trp2) (pig);GAL3 receptor;f;;Human;9722565;Agonist
galanin(D-Trp2) (pig);GAL3 receptor;f;;Rat;9722565|9880084;Agonist
galanin-like peptide;GAL3 receptor;f;Rat;Rat;20880399;Agonist
galanin-like peptide;GAL3 receptor;f;Human;Human;15944009;Agonist
J18 (galanin analogue);GAL3 receptor;f;;Human;23600864;Agonist
J20 (galanin analogue);GAL3 receptor;f;;Human;23600864;Agonist
M1145;GAL3 receptor;f;;Human;19467704;Agonist
M1151;GAL3 receptor;f;;Human;21333705;Agonist
M1152;GAL3 receptor;f;;Human;21333705;Agonist
M1153;GAL3 receptor;f;;Human;21333705;Agonist
M1160;GAL3 receptor;f;;Human;23192661;Agonist
M1160;GAL3 receptor;f;;Human;23192661;Agonist
M617;GAL3 receptor;f;;Human;;Agonist
[125I][Tyr26]galanin (pig);GAL3 receptor;f;;Rat;9722565|9405385;Agonist
[125I][Tyr26]galanin (pig);GAL3 receptor;f;;Human;9722565|9880084;Agonist
galanin;GAL3 receptor;f;Pig;Human;9722565|9880084;Full agonist
galanin;GAL3 receptor;f;Human;Rat;9722565;Full agonist
galanin;GAL3 receptor;t;Mouse|Rat;Rat;20880399;Full agonist
galanin;GAL3 receptor;f;Mouse|Rat;Human;9722565|9880084|19467704|21333705;Full agonist
galanin;GAL3 receptor;t;Human;Human;9832121;Full agonist
galanin;GAL3 receptor;f;Pig;Human;9832121;Full agonist
galanin;GAL3 receptor;t;Human;Human;9722565|9880084;Full agonist
galanin;GAL3 receptor;f;Pig;Rat;9722565;Full agonist
galanin;GAL3 receptor;t;Mouse|Rat;Rat;9722565|9405385|9742938|15944002;Partial agonist
[Ala6, D-Trp8]galanin-(1-15)-ol;GAL3 receptor;f;;Rat;9405385;Antagonist
C7;GAL3 receptor;f;;Rat;9722565|9405385;Antagonist
C7;GAL3 receptor;f;;Human;9722565|9880084;Antagonist
GalR3ant;GAL3 receptor;f;;Rat;15944002;Antagonist
M15;GAL3 receptor;f;;Human;9722565|9880084;Antagonist
M15;GAL3 receptor;f;;Rat;9722565|9405385|15944002;Antagonist
M32;GAL3 receptor;f;;Human;9722565|9880084;Antagonist
M32;GAL3 receptor;f;;Rat;9722565;Antagonist
M35;GAL3 receptor;f;;Rat;9722565|9405385|15944002;Antagonist
M35;GAL3 receptor;f;;Human;9722565|9880084;Antagonist
M40;GAL3 receptor;f;;Human;9722565|9880084;Antagonist
M40;GAL3 receptor;f;;Rat;9722565|9405385|15944002;Antagonist
M871;GAL3 receptor;f;;Human;;Antagonist
SNAP 37889;GAL3 receptor;f;;Human;16287967|16789730|16730981;Antagonist
SNAP 398299;GAL3 receptor;f;;Human;16287967|16789730|16730981;Antagonist
anisindione;γ-Glutamyl carboxylase;f;;Human;;Inhibition
GGsTop;γ-Glutamyltransferase;f;;Human;17260973;Inhibition
CI-966;GAT1;f;;Human;7851497;Inhibition
LU32-176B;GAT1;f;;Mouse;15550575;Inhibition
NNC-711;GAT1;f;;Human;7851497;Inhibition
(R)-EF-1520;GAT1;f;;Human;;Inhibition
(R/S) EF-1500;GAT1;f;;Human;;Inhibition
(S)-EF-1520;GAT1;f;;Human;;Inhibition
SKF89976A;GAT1;f;;Human;;Inhibition
[3H]tiagabine;GAT1;f;;Human;;Inhibition
tiagabine;GAT1;f;;Human;7851497;Inhibition
SNAP-5114;GAT2;f;;Rat;7874447;Inhibition
SNAP-5114;GAT3;f;;None;7874447;Inhibition
[125I]GDNF (rat);GDNF family receptor α1;f;;Human;8657309|9192898;None
growth differentiation factor 15;GDNF family receptor alpha like;t;Human;Human;28846098;Agonist
geranylgeranyl diphosphate;geranylgeranyl diphosphate synthase;t;;Human;16698791;Feedback inhibition
(2E, 6E)-farnesylbisphosphonate;geranylgeranyl diphosphate synthase;f;;Human;17905588;Inhibition
3-azageranylgeranyl diphosphate;geranylgeranyl diphosphate synthase;f;;Human;12014956;Inhibition
BPH-252;geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
BPH-252;geranylgeranyl diphosphate synthase;f;;Human;12014956;Inhibition
BPH-608;geranylgeranyl diphosphate synthase;f;;Human;17535895;Inhibition
BPH-628;geranylgeranyl diphosphate synthase;f;;Human;17535895;Inhibition
BPH-628;geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
BPH-629;geranylgeranyl diphosphate synthase;f;;Human;17535895;Inhibition
BPH-675;geranylgeranyl diphosphate synthase;f;;Human;17535895;Inhibition
BPH-676;geranylgeranyl diphosphate synthase;f;;Human;17535895;Inhibition
BPH-715;geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
BPH-742;geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
compound 11 [PMID: 18800762];geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
compound 12  [PMID: 12014956];geranylgeranyl diphosphate synthase;f;;Human;12014956;Inhibition
compound 14 [PMID: 18800762];geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
compound 16 [PMID: 18800762];geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
compound 19 [PMID: 18800762];geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
compound 47 [PMID: 18800762];geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
compound 51 [PMID: 18800762];geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
digeranyl bisphosphonate;geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
digeranyl bisphosphonate;geranylgeranyl diphosphate synthase;f;;Human;17208200;Inhibition
minodronic acid;geranylgeranyl diphosphate synthase;f;;Human;18800762;Inhibition
minodronic acid;geranylgeranyl diphosphate synthase;f;;Human;20394422;Inhibition
HM01;ghrelin receptor;f;;Human;25327342;Agonist
L-692,429;ghrelin receptor;f;;Human;15905359;Agonist
L-692,429;ghrelin receptor;f;;Rat;8503009;Agonist
macimorelin;ghrelin receptor;f;;Human;12240910;Agonist
[des-octanoyl]ghrelin;ghrelin receptor;f;Human;Rat;11314756|14763915;Full agonist
examorelin;ghrelin receptor;f;;Human;11061542;Full agonist
ghrelin;ghrelin receptor;t;Human;Human;11314756;Full agonist
ghrelin;ghrelin receptor;t;Human;Human;15905359|10628755;Full agonist
ghrelin;ghrelin receptor;t;Human;Human;12907757|21402696;Full agonist
ghrelin;ghrelin receptor;t;Human;Human;12907757|15905359;Full agonist
ghrelin;ghrelin receptor;f;Human;Human;29233536;Full agonist
GHRP-6;ghrelin receptor;f;;Human;15905359;Full agonist
GHRP-6;ghrelin receptor;f;;Rat;9092793;Full agonist
GHRP-6;ghrelin receptor;f;;Human;9092793|15905359;Full agonist
GHRP-6;ghrelin receptor;f;;Human;15905359;Full agonist
ibutamoren;ghrelin receptor;f;;Human;10427162;Full agonist
ibutamoren;ghrelin receptor;f;;Human;15905359|10427162;Full agonist
pralmorelin;ghrelin receptor;f;;Rat;9092793;Full agonist
[125I][His9]ghrelin (human);ghrelin receptor;f;;Rat;11522606;Full agonist
[125I][His9]ghrelin (human);ghrelin receptor;f;;Human;11522606;Full agonist
[125I]Tyr-Ala-hexarelin;ghrelin receptor;f;;Human;11061542;Full agonist
[125I][Tyr4]ghrelin (human);ghrelin receptor;f;;Human;11314756;Full agonist
[35S]ibutamoren;ghrelin receptor;f;;Human;9092793;Full agonist
SM-130,686;ghrelin receptor;f;;Human;11741481;Partial agonist
SM-130,686;ghrelin receptor;f;;Human;18923064;Partial agonist
wFw-Isn-NH2;ghrelin receptor;f;;Human;21402696;Partial agonist
L-692,429;ghrelin receptor;f;;Human;15905359;Positive
Abbott 14c;ghrelin receptor;f;;Human;16854051;Antagonist
BIM 28163;ghrelin receptor;f;;Human;15339248;Antagonist
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P;ghrelin receptor;f;;Human;12907757;Antagonist
GSK1614343;ghrelin receptor;f;;Human;20593439;Antagonist
GSK1614343;ghrelin receptor;f;;Rat;21034740;Antagonist
JMV3008;ghrelin receptor;f;;Human;17927165;Antagonist
liver enriched antimicrobial peptide 2;ghrelin receptor;f;Human;Human;29233536;Antagonist
PF-05190457;ghrelin receptor;f;;Human;26784385;Antagonist
PF-05190457;ghrelin receptor;f;;Mouse;26784385;Antagonist
PF-05190457;ghrelin receptor;f;;Rat;26784385;Antagonist
YIL781;ghrelin receptor;f;;Human;17656463;Antagonist
GHRH;GHRH receptor;t;Human;Human;;Agonist
JI-38;GHRH receptor;f;;Human;24373935;Agonist
JI-38;GHRH receptor;f;;Rat;20133784;Agonist
JMR-132;GHRH receptor;f;;Human;17261802;Agonist
sermorelin;GHRH receptor;f;;Human;;Agonist
tesamorelin;GHRH receptor;f;;Human;;Agonist
BIM28011;GHRH receptor;f;;Human;8993400;Full agonist
GHRH-(1-29)-NH2 (human);GHRH receptor;f;;Rat;1534126;Full agonist
GHRH-(1-29)-NH2 (rat);GHRH receptor;f;;Rat;1534126;Full agonist
GHRH-(1-29)-OH (human);GHRH receptor;f;;Rat;1534126;Full agonist
[125I]GHRH (human);GHRH receptor;f;;Rat;11814616;Full agonist
[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human);GHRH receptor;f;;Rat;9892695|14755056|7991622|9145431;Antagonist
JV-1-10;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-36;GHRH receptor;f;;Rat;9892695|14755056|10542394;Antagonist
JV-1-37;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-38;GHRH receptor;f;;Rat;9892695|14755056|10542394;Antagonist
JV-1-39;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-40;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-41;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-42;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-43;GHRH receptor;f;;Rat;9892695;Antagonist
JV-1-62;GHRH receptor;f;;Rat;14755056;Antagonist
JV-1-63;GHRH receptor;f;;Rat;14755056;Antagonist
MZ-4-169;GHRH receptor;f;;Rat;7991622;Antagonist
MZ-4-181;GHRH receptor;f;;Rat;7991622;Antagonist
MZ-4-243;GHRH receptor;f;;Rat;7991622;Antagonist
MZ-4-71;GHRH receptor;f;;Rat;7991622|9145431;Antagonist
MZ-5-156;GHRH receptor;f;;Rat;9145431;Antagonist
MZ-5-192;GHRH receptor;f;;Rat;9145431;Antagonist
MZ-5-78;GHRH receptor;f;;Rat;9145431;Antagonist
MZ-6-55;GHRH receptor;f;;Rat;9892695;Antagonist
gastric inhibitory polypeptide;GIP receptor;f;Human;Human;26572091;Agonist
human GIP(1-30)NH2;GIP receptor;f;;Human;26572091;Agonist
gastric inhibitory polypeptide;GIP receptor;t;Human;Human;7589426;Full agonist
gastric inhibitory polypeptide;GIP receptor;t;Rat;Rat;8795084;Full agonist
gastric inhibitory polypeptide;GIP receptor;f;Human;Rat;9226399;Full agonist
GIP-(6-30)-amide;GIP receptor;f;;Rat;9226399;Full agonist
[125I]GIP (human);GIP receptor;f;;Rat;8795084;Full agonist
GIP-(10-30);GIP receptor;f;;Rat;9226399;Partial agonist
GIP-(7-30);GIP receptor;f;;Rat;9226399;Partial agonist
human GIP(3-30)NH2;GIP receptor;f;;Human;26572091;Antagonist
human GIP(3-42)NH2;GIP receptor;f;;Human;16608883;Antagonist
human GIP(5-30)NH2;GIP receptor;f;;Human;26572091;Antagonist
MK-0893;GIP receptor;f;;Human;22708876;Antagonist
[Pro3]GIP;GIP receptor;f;;Mouse;12627321;Antagonist
human GIP(3-42)NH2;GIP receptor;f;;Human;16608883;Binding
albiglutide;GLP-1 receptor;f;;Rat;15331566;Agonist
exendin-4;GLP-1 receptor;f;;Human;18412318;Agonist
lixisenatide;GLP-1 receptor;f;;Human;20570597;Agonist
Peptide 5 [PMID: 28562585];GLP-1 receptor;f;;Human;28562585;Agonist
Peptide 5 [PMID: 28562585];GLP-1 receptor;f;;Human;28562585;Agonist
semaglutide;GLP-1 receptor;f;;Human;26308095;Agonist
semaglutide;GLP-1 receptor;f;;Human;26308095;Agonist
WB4-24;GLP-1 receptor;f;;Human;25176008;Agonist
exendin-3;GLP-1 receptor;f;;Human;1704369;Full agonist
exendin-4;GLP-1 receptor;f;;Human;15528268;Full agonist
glucagon;GLP-1 receptor;t;Human|Mouse|Rat;Human;15528268;Full agonist
glucagon-like peptide 1-(7-36) amide;GLP-1 receptor;t;Human|Mouse|Rat;Human;15528268;Full agonist
glucagon-like peptide 1-(7-37);GLP-1 receptor;t;Human|Mouse|Rat;Human;8404634;Full agonist
liraglutide;GLP-1 receptor;f;;Human;10794683;Full agonist
[125I]GLP-1-(7-36)-amide;GLP-1 receptor;f;;Human;15528268;Full agonist
[125I]GLP-1-(7-37) (human);GLP-1 receptor;f;;Human;;Full agonist
BETP;GLP-1 receptor;f;;Human;24997604;Positive
exendin-(9-39);GLP-1 receptor;f;;Human;15528268;Antagonist
GLP-1-(9-36);GLP-1 receptor;f;;Rat;9261127;Antagonist
[125I]exendin-(9-39);GLP-1 receptor;f;;Human;15528268;Antagonist
T-0632;GLP-1 receptor;f;;Human;11498540;Antagonist
apraglutide;GLP-2 receptor;f;;Human;30614011|32075870;Agonist
GLP-2 analogue 10;GLP-2 receptor;f;;Human;29528634;Agonist
teduglutide;GLP-2 receptor;f;;Human;25859983;Agonist
glucagon-like peptide 2;GLP-2 receptor;t;Rat;Rat;9990065;Full agonist
glucagon-like peptide 2;GLP-2 receptor;t;Human;Human;11738243;Full agonist
glucagon-like peptide 2;GLP-2 receptor;f;Human;Rat;9990065;Full agonist
[Tyr34]GLP-2 (human);GLP-2 receptor;f;;Rat;9990065;Full agonist
GLP-2-(1-29) (rat);GLP-2 receptor;f;;Rat;9990065;Partial agonist
glucagon-like peptide 2-(2-33);GLP-2 receptor;t;Rat;Rat;9990065;Partial agonist
glucagon-like peptide 2-(3-33);GLP-2 receptor;t;Rat;Rat;9990065;Partial agonist
glucagon-like peptide 2-(3-33);GLP-2 receptor;t;Human;Human;11738243;Partial agonist
AMPA;GluA1;f;;Human;;Full agonist
(S)-5-fluorowillardiine;GluA1;f;;Human;;Full agonist
[3H]AMPA;GluA1;f;;Human;;Full agonist
aniracetam;GluA1;f;;Human;;Positive
CX516;GluA1;f;;Human;;Positive
CX546;GluA1;f;;Human;;Positive
cyclothiazide;GluA1;f;;Human;11406188;Positive
IDRA-21;GluA1;f;;Human;;Positive
LY392098;GluA1;f;;Human;11406188;Positive
LY404187;GluA1;f;;Human;11406188;Positive
LY503430;GluA1;f;;Human;;Positive
piracetam;GluA1;f;;Human;;Positive
S18986;GluA1;f;;Human;;Positive
ATPO;GluA1;f;;Human;;Antagonist
GYKI53655;GluA1;f;;Human;;Antagonist
GYKI53784;GluA1;f;;Human;;Antagonist
NBQX;GluA1;f;;Human;;Antagonist
[3H]CNQX;GluA1;f;;Human;;Antagonist
tezampanel;GluA1;f;;Human;;Antagonist
argiotoxin;GluA1;f;;Human;;None
joro toxin;GluA1;f;;Human;;None
AMPA;GluA2;f;;Human;;Full agonist
(S)-5-fluorowillardiine;GluA2;f;;Human;;Full agonist
[3H]AMPA;GluA2;f;;Human;;Full agonist
aniracetam;GluA2;f;;Human;;Positive
CX516;GluA2;f;;Human;;Positive
CX546;GluA2;f;;Human;;Positive
cyclothiazide;GluA2;f;;Human;11406188;Positive
IDRA-21;GluA2;f;;Human;;Positive
LY392098;GluA2;f;;Human;11406188;Positive
LY404187;GluA2;f;;Human;11406188;Positive
LY503430;GluA2;f;;Human;;Positive
piracetam;GluA2;f;;Human;;Positive
S18986;GluA2;f;;Human;;Positive
4‐BCCA;GluA2;f;;Human;32959886;Antagonist
ATPO;GluA2;f;;Human;;Antagonist
GYKI53655;GluA2;f;;Human;;Antagonist
GYKI53784;GluA2;f;;Human;;Antagonist
NBQX;GluA2;f;;Human;;Antagonist
[3H]CNQX;GluA2;f;;Human;;Antagonist
talampanel;GluA2;f;;Rat;23402301;Antagonist
tezampanel;GluA2;f;;Human;;Antagonist
argiotoxin;GluA2;f;;Human;;None
AMPA;GluA3;f;;Human;;Full agonist
(S)-5-fluorowillardiine;GluA3;f;;Human;;Full agonist
aniracetam;GluA3;f;;Human;;Positive
CX516;GluA3;f;;Human;;Positive
CX546;GluA3;f;;Human;;Positive
cyclothiazide;GluA3;f;;Human;11406188;Positive
IDRA-21;GluA3;f;;Human;;Positive
LY392098;GluA3;f;;Human;11406188;Positive
LY404187;GluA3;f;;Human;11406188;Positive
LY503430;GluA3;f;;Human;;Positive
piracetam;GluA3;f;;Human;;Positive
S18986;GluA3;f;;Human;;Positive
ATPO;GluA3;f;;Human;;Antagonist
GYKI53655;GluA3;f;;Human;;Antagonist
GYKI53784;GluA3;f;;Human;;Antagonist
NBQX;GluA3;f;;Human;;Antagonist
tezampanel;GluA3;f;;Human;;Antagonist
argiotoxin;GluA3;f;;Human;;None
joro toxin;GluA3;f;;Human;;None
[3H]AMPA;GluA3;f;;Human;;None
[3H]CNQX;GluA3;f;;Human;;None
[3H]AMPA;GluA4;f;;Human;;Agonist
AMPA;GluA4;f;;Human;;Full agonist
(S)-5-fluorowillardiine;GluA4;f;;Human;;Full agonist
aniracetam;GluA4;f;;Human;;Positive
CX516;GluA4;f;;Human;;Positive
CX546;GluA4;f;;Human;;Positive
cyclothiazide;GluA4;f;;Human;11406188;Positive
IDRA-21;GluA4;f;;Human;;Positive
LY392098;GluA4;f;;Human;11406188;Positive
LY404187;GluA4;f;;Human;11406188;Positive
LY503430;GluA4;f;;Human;;Positive
piracetam;GluA4;f;;Human;;Positive
S18986;GluA4;f;;Human;;Positive
ATPO;GluA4;f;;Human;;Antagonist
GYKI53655;GluA4;f;;Human;;Antagonist
GYKI53784;GluA4;f;;Human;;Antagonist
NBQX;GluA4;f;;Human;;Antagonist
tezampanel;GluA4;f;;Human;;Antagonist
argiotoxin;GluA4;f;;Human;;None
joro toxin;GluA4;f;;Human;;None
[3H]CNQX;GluA4;f;;Human;;None
NNC1702;glucagon receptor;f;;Human;29300013;Agonist
glucagon;glucagon receptor;t;Human|Mouse|Rat;Human;4305077;Full agonist
glucagon-(1-21);glucagon receptor;f;;Rat;210180;Full agonist
[125I]glucagon (human, mouse, rat);glucagon receptor;f;;Human;;Full agonist
glucagon-(1-6);glucagon receptor;f;;Rat;216670;Partial agonist
MK-0893;glucagon receptor;f;;Human;22708876;Negative
NNC0640;glucagon receptor;f;;Human;28514451;Negative
adomeglivant;glucagon receptor;f;;Human;26681715|25656305;Antagonist
BAY27-9955;glucagon receptor;f;;Human;11719833;Antagonist
des-His1-[Glu9]glucagon-NH2;glucagon receptor;f;;Rat;3035568|2560175;Antagonist
des-His1-[Leu4-Glu9]glucagon-NH2;glucagon receptor;f;;Rat;11532074;Antagonist
hGCGR antagonist;glucagon receptor;f;;Human;15713396;Antagonist
hGCGR antagonist;glucagon receptor;f;;Human;15561959;Antagonist
L-168,049;glucagon receptor;f;;Human;10085108;Antagonist
NNC 92-1687;glucagon receptor;f;;Human;9857085;Antagonist
crotedumab;glucagon receptor;f;;Rat;26020795;Antagonist
crotedumab;glucagon receptor;f;;Human;26020795;Antagonist
crotedumab;glucagon receptor;f;;Monkey;26020795;Antagonist
crotedumab;glucagon receptor;f;;Mouse;26020795;Antagonist
TL6;glucocorticoid-induced TNF receptor;t;Human;Human;;None
benzodrocortisone;Glucocorticoid receptor;f;;Human;;Agonist
BI 653048;Glucocorticoid receptor;f;;Human;25516791;Agonist
budesonide;Glucocorticoid receptor;f;;Human;21880489;Agonist
budesonide;Glucocorticoid receptor;f;;Human;28937774;Agonist
C108297;Glucocorticoid receptor;f;;Human;18226897;Agonist
ciclesonide;Glucocorticoid receptor;f;;Human;15878996;Agonist
clobetasol propionate;Glucocorticoid receptor;f;;Human;;Agonist
compound 17 [PMID: 29741897];Glucocorticoid receptor;f;;Human;29741897;Agonist
corticosterone;Glucocorticoid receptor;t;;Mouse;8282004|10611474|10747884;Agonist
cortisol;Glucocorticoid receptor;t;;Human;8282004|10611474|10747884;Agonist
CpdA (parent molecule);Glucocorticoid receptor;f;;Mouse;16243974;Agonist
deoxycorticosterone;Glucocorticoid receptor;t;;Human;8282004|10747884;Agonist
desoximetasone;Glucocorticoid receptor;f;;Human;;Agonist
dexamethasone;Glucocorticoid receptor;f;;Human;8282004|10611474|10747884;Agonist
diflorasone diacetate;Glucocorticoid receptor;f;;Human;;Agonist
difluprednate;Glucocorticoid receptor;f;;Human;21182429;Agonist
flunisolide;Glucocorticoid receptor;f;;Human;;Agonist
fluocinolone acetonide;Glucocorticoid receptor;f;;Human;;Agonist
fluocinonide;Glucocorticoid receptor;f;;Human;;Agonist
fluorometholone;Glucocorticoid receptor;f;;Human;;Agonist
fluticasone;Glucocorticoid receptor;f;;Human;;Agonist
fluticasone propionate;Glucocorticoid receptor;f;;Human;28937774;Agonist
fluticasone propionate;Glucocorticoid receptor;f;;Human;10633034;Agonist
GSK866;Glucocorticoid receptor;f;;Human;18952422;Agonist
mapracorat;Glucocorticoid receptor;f;;Human;19422381;Agonist
methylprednisolone;Glucocorticoid receptor;f;;Human;;Agonist
mometasone;Glucocorticoid receptor;f;;Human;;Agonist
RU26988;Glucocorticoid receptor;f;;Unknown;;Agonist
RU28362;Glucocorticoid receptor;f;;Human;;Agonist
[3H]dexamethasone;Glucocorticoid receptor;f;;Human;;Agonist
triamcinolone;Glucocorticoid receptor;f;;Human;10747884;Agonist
triamcinolone acetonide;Glucocorticoid receptor;f;;Human;7472274|7583234;Agonist
velsecorat;Glucocorticoid receptor;f;;Human;28937774;Agonist
ZK216348;Glucocorticoid receptor;f;;Human;14694204;Agonist
beclometasone;Glucocorticoid receptor;f;;Human;;Full agonist
betamethasone;Glucocorticoid receptor;f;;Human;;Full agonist
prednisolone;Glucocorticoid receptor;f;;Human;29424542;Full agonist
prednisolone;Glucocorticoid receptor;f;;Human;11520196;Full agonist
prednisolone;Glucocorticoid receptor;f;;Human;10747884;Full agonist
prednisone;Glucocorticoid receptor;f;;Human;;Full agonist
AZD9567;Glucocorticoid receptor;f;;Human;29424542;Partial agonist
AZD9567;Glucocorticoid receptor;f;;Human;29424542;Partial agonist
dagrocorat;Glucocorticoid receptor;f;;Human;;Partial agonist
fosdagrocorat;Glucocorticoid receptor;f;;Human;;Partial agonist
ORG 214007-0;Glucocorticoid receptor;f;;Human;23152771;Partial agonist
ORG 214007-0;Glucocorticoid receptor;f;;Human;23152771;Partial agonist
mifepristone;Glucocorticoid receptor;f;;Human;8282004|3560943;Antagonist
miricorilant;Glucocorticoid receptor;f;;Human;23131342;Antagonist
onapristone;Glucocorticoid receptor;f;;Human;12781198;Antagonist
ZK112993;Glucocorticoid receptor;f;;Human;;Antagonist
vamorolone;Glucocorticoid receptor;f;;Human;24014378|23498916;Binding
AZD1656;Glucokinase;f;;Human;;Activation
S-4048;Glucose-6-phosphate transporter;f;;Rat;;Inhibition
compound 30 [PMID: 22468970];Glucose transporter  1;f;;Human;22468970;Negative
[3H]2-deoxyglucose;Glucose transporter  1;f;;Human;;None
[3H]2-deoxyglucose;Glucose transporter  2;f;;Human;;None
[3H]2-deoxyglucose;Glucose transporter  3;f;;Human;;None
[3H]2-deoxyglucose;Glucose transporter  4;f;;Human;;None
migalastat;glucosidase alpha, acid;f;;Human;10866822;Binding
1-deoxynojirimycin;glucosidase alpha, acid;f;;Human;;Inhibition
miglitol;glucosidase alpha, acid;f;;Human;18595718;Inhibition
ambroxol;glucosylceramidase beta;f;;Human;19578116;Binding
NCGC607;glucosylceramidase beta;f;;Human;27413154;Binding
(S)-5-iodowillardiine;GluK1;f;;Human;;Agonist
LY339434;GluK1;f;;Human;9849663;Agonist
SYM2081;GluK1;f;;Rat;18578478;Agonist
8-deoxy-neodysiherbaine;GluK1;f;;Human;;Full agonist
ATPA;GluK1;f;;Human;;Full agonist
domoic acid;GluK1;f;;Human;;Full agonist
dysiherbaine;GluK1;f;;Rat;11160654;Full agonist
(S)-4-AHCP;GluK1;f;;Human;;Full agonist
kainate;GluK1;f;;Human;9849663;Full agonist
[3H]kainate;GluK1;f;;Human;;Full agonist
[3H]SYM2081;GluK1;f;;Human;;Full agonist
SYM2081;GluK1;f;;Human;10821708;Full agonist
concanavalin A;GluK1;f;;Human;;Positive
2,4-epi-neodysiherbaine;GluK1;f;;Human;;Antagonist
ACET;GluK1;f;;Human;;Antagonist
LY382884;GluK1;f;;Human;;Antagonist
LY466195;GluK1;f;;Human;;Antagonist
MSVIII-19;GluK1;f;;Human;;Antagonist
NS3763;GluK1;f;;Human;;Antagonist
[3H]UBP310;GluK1;f;;Human;20837679;Antagonist
UBP302;GluK1;f;;Human;;Antagonist
UBP310;GluK1;f;;Human;;Antagonist
kainate;GluK2;f;;Rat;8996224|8809152;Agonist
LY339434;GluK2;f;;Human;9849663;Agonist
SYM2081;GluK2;f;;Human;10821708;Agonist
SYM2081;GluK2;f;;Rat;8996224|18578478;Agonist
domoic acid;GluK2;f;;Human;8809152;Full agonist
dysiherbaine;GluK2;f;;Rat;11160654;Full agonist
kainate;GluK2;f;;Human;8809152|9849663;Full agonist
[3H]kainate;GluK2;f;;Rat;8996224;Full agonist
[3H]SYM2081;GluK2;f;;Human;;Full agonist
SYM2081;GluK2;f;;Rat;8996224;Full agonist
concanavalin A;GluK2;f;;Human;;Positive
2,4-epi-neodysiherbaine;GluK2;f;;Human;;Antagonist
domoic acid;GluK3;f;;Rat;18578478;Agonist
dysiherbaine;GluK3;f;;Human;;Full agonist
kainate;GluK3;f;;Rat;18578478;Full agonist
[3H]kainate;GluK3;f;;Human;;Full agonist
[3H]SYM2081;GluK3;f;;Human;;Full agonist
SYM2081;GluK3;f;;Rat;18578478;Full agonist
[3H]UBP310;GluK3;f;;Human;20837679;Antagonist
domoic acid;GluK4;f;;Human;;Full agonist
dysiherbaine;GluK4;f;;Human;;Full agonist
kainate;GluK4;f;;Human;;Full agonist
[3H]kainate;GluK4;f;;Human;;Full agonist
[3H]SYM2081;GluK4;f;;Human;;Full agonist
SYM2081;GluK4;f;;Human;;Full agonist
domoic acid;GluK5;f;;Human;;Full agonist
dysiherbaine;GluK5;f;;Human;;Full agonist
kainate;GluK5;f;;Human;;Full agonist
[3H]kainate;GluK5;f;;Human;;Full agonist
[3H]SYM2081;GluK5;f;;Human;;Full agonist
SYM2081;GluK5;f;;Human;;Full agonist
D-aspartic acid;GluN1;t;;Human;;Agonist
D-serine;GluN1;t;;Human;;Agonist
glycine;GluN1;t;;Human;;Agonist
L-aspartic acid;GluN1;t;;Human;;Agonist
(RS)-(tetrazol-5-yl)glycine;GluN1;f;;Human;;Full agonist
NMDA;GluN1;f;;Human;;Full agonist
[3H]glycine;GluN1;f;;Human;;Full agonist
(+)-HA966;GluN1;f;;Human;;Partial agonist
homoquinolinic acid;GluN1;f;;Human;;Partial agonist
5,7-dichlorokynurenic acid;GluN1;f;;Human;;Antagonist
compound 8 [PMID: 17562362};GluN1;f;;Human;17562362;Antagonist
GV196771A;GluN1;f;;Rat;10780999;Antagonist
L689560;GluN1;f;;Rat;1534584;Antagonist
L701324;GluN1;f;;Rat;8182696;Antagonist
[3H]CGP39653;GluN1;f;;Human;;Antagonist
[3H]CGP61594;GluN1;f;;Human;;Antagonist
[3H]CGS19755;GluN1;f;;Human;;Antagonist
[3H]CPP;GluN1;f;;Human;;Antagonist
[3H]dizocilpine;GluN1;f;;Human;;Antagonist
[3H]L689560;GluN1;f;;Human;;Antagonist
[3H]MDL105519;GluN1;f;;Rat;9721050;Antagonist
D-aspartic acid;GluN2A;t;;Human;;Agonist
D-serine;GluN2A;t;;Human;;Agonist
glycine;GluN2A;t;;Human;;Agonist
L-aspartic acid;GluN2A;t;;Human;;Agonist
[3H]glycine;GluN2A;f;;Human;;Agonist
homoquinolinic acid;GluN2A;f;;Human;;Full agonist
(RS)-(tetrazol-5-yl)glycine;GluN2A;f;;Human;;Full agonist
NMDA;GluN2A;f;;Human;;Full agonist
(+)-HA966;GluN2A;f;;Human;;Partial agonist
TCN-201;GluN2A;f;;Human;22553026;Negative
NYX-2925;GluN2A;f;;Human;29099938;Positive
5,7-dichlorokynurenic acid;GluN2A;f;;Human;;Antagonist
CGP37849;GluN2A;f;;Human;;Antagonist
conantokin-G;GluN2A;f;;Human;;Antagonist
d-AP5;GluN2A;f;;Human;;Antagonist
d-CCPene;GluN2A;f;;Human;;Antagonist
GV196771A;GluN2A;f;;Human;;Antagonist
L689560;GluN2A;f;;Human;;Antagonist
L701324;GluN2A;f;;Human;;Antagonist
LY233053;GluN2A;f;;Human;;Antagonist
NVP-AAM077;GluN2A;f;;Human;11909726|14718249|16778008|16452656;Antagonist
selfotel;GluN2A;f;;Human;;Antagonist
[3H]CGP39653;GluN2A;f;;Human;;Antagonist
[3H]CGP61594;GluN2A;f;;Human;;Antagonist
[3H]CGS19755;GluN2A;f;;Human;;Antagonist
[3H]CPP;GluN2A;f;;Human;;Antagonist
[3H]L689560;GluN2A;f;;Human;;Antagonist
[3H]MDL105519;GluN2A;f;;Human;;Antagonist
UBP141;GluN2A;f;;Human;15801853;Antagonist
amantadine;GluN2A;f;;Human;;None
dizocilpine;GluN2A;f;;Human;;None
ketamine;GluN2A;f;;Human;;None
Mg2+;GluN2A;f;;Human;;None
N1-dansyl-spermine;GluN2A;f;;Human;;None
phencyclidine;GluN2A;f;;Human;;None
[3H]dizocilpine;GluN2A;f;;Human;;None
D-aspartic acid;GluN2B;t;;Human;;Agonist
D-serine;GluN2B;t;;Human;;Agonist
glycine;GluN2B;t;;Human;;Agonist
L-aspartic acid;GluN2B;t;;Human;;Agonist
[3H]glycine;GluN2B;f;;Human;;Agonist
homoquinolinic acid;GluN2B;f;;Human;;Full agonist
(RS)-(tetrazol-5-yl)glycine;GluN2B;f;;Human;;Full agonist
NMDA;GluN2B;f;;Human;;Full agonist
(+)-HA966;GluN2B;f;;Human;;Partial agonist
DQP-1105;GluN2B;f;;Rat;21807990;Negative
5,7-dichlorokynurenic acid;GluN2B;f;;Human;;Antagonist
CGP37849;GluN2B;f;;Human;;Antagonist
conantokin-G;GluN2B;f;;Human;;Antagonist
d-AP5;GluN2B;f;;Human;;Antagonist
d-CCPene;GluN2B;f;;Human;;Antagonist
GV196771A;GluN2B;f;;Human;;Antagonist
L689560;GluN2B;f;;Human;;Antagonist
L701324;GluN2B;f;;Human;;Antagonist
LY233053;GluN2B;f;;Human;;Antagonist
NVP-AAM077;GluN2B;f;;Human;11909726|14718249|16778008|16452656;Antagonist
selfotel;GluN2B;f;;Human;;Antagonist
[3H]CGP39653;GluN2B;f;;Human;;Antagonist
[3H]CGP61594;GluN2B;f;;Human;;Antagonist
[3H]CGS19755;GluN2B;f;;Human;;Antagonist
[3H]CPP;GluN2B;f;;Human;;Antagonist
[3H]L689560;GluN2B;f;;Human;;Antagonist
[3H]MDL105519;GluN2B;f;;Human;;Antagonist
UBP141;GluN2B;f;;Human;15801853;Antagonist
amantadine;GluN2B;f;;Human;;None
dizocilpine;GluN2B;f;;Human;;None
ketamine;GluN2B;f;;Human;;None
Mg2+;GluN2B;f;;Human;;None
N1-dansyl-spermine;GluN2B;f;;Human;;None
phencyclidine;GluN2B;f;;Human;;None
[3H]dizocilpine;GluN2B;f;;Human;;None
D-aspartic acid;GluN2C;t;;Human;;Agonist
D-serine;GluN2C;t;;Human;;Agonist
glycine;GluN2C;t;;Human;;Agonist
L-aspartic acid;GluN2C;t;;Human;;Agonist
[3H]glycine;GluN2C;f;;Human;;Agonist
homoquinolinic acid;GluN2C;f;;Human;;Full agonist
(RS)-(tetrazol-5-yl)glycine;GluN2C;f;;Human;;Full agonist
NMDA;GluN2C;f;;Human;;Full agonist
DQP-1105;GluN2C;f;;Rat;21807990;Negative
5,7-dichlorokynurenic acid;GluN2C;f;;Human;;Antagonist
CGP37849;GluN2C;f;;Human;;Antagonist
conantokin-G;GluN2C;f;;Human;;Antagonist
d-AP5;GluN2C;f;;Human;;Antagonist
d-CCPene;GluN2C;f;;Human;;Antagonist
GV196771A;GluN2C;f;;Human;;Antagonist
L689560;GluN2C;f;;Human;;Antagonist
L701324;GluN2C;f;;Human;;Antagonist
LY233053;GluN2C;f;;Human;;Antagonist
memantine;GluN2C;f;;Rat;10229619;Antagonist
selfotel;GluN2C;f;;Human;;Antagonist
[3H]CGP39653;GluN2C;f;;Human;;Antagonist
[3H]CGP61594;GluN2C;f;;Human;;Antagonist
[3H]CGS19755;GluN2C;f;;Human;;Antagonist
[3H]CPP;GluN2C;f;;Human;;Antagonist
[3H]L689560;GluN2C;f;;Human;;Antagonist
[3H]MDL105519;GluN2C;f;;Human;;Antagonist
UBP141;GluN2C;f;;Human;15801853;Antagonist
amantadine;GluN2C;f;;Human;17303642;None
dextromethorphan;GluN2C;f;;Human;17303642;None
dextrorphan;GluN2C;f;;Human;17303642;None
dizocilpine;GluN2C;f;;Human;;None
ketamine;GluN2C;f;;Human;17303642;None
levorphanol;GluN2C;f;;Human;17303642;None
Mg2+;GluN2C;f;;Human;;None
N1-dansyl-spermine;GluN2C;f;;Human;;None
phencyclidine;GluN2C;f;;Human;17303642;None
[3H]dizocilpine;GluN2C;f;;Human;;None
D-aspartic acid;GluN2D;t;;Human;;Agonist
D-serine;GluN2D;t;;Human;;Agonist
glycine;GluN2D;t;;Human;;Agonist
L-aspartic acid;GluN2D;t;;Human;;Agonist
[3H]glycine;GluN2D;f;;Human;;Agonist
homoquinolinic acid;GluN2D;f;;Human;;Full agonist
(RS)-(tetrazol-5-yl)glycine;GluN2D;f;;Human;;Full agonist
NMDA;GluN2D;f;;Human;;Full agonist
DQP-1105;GluN2D;f;;Rat;21807990;Negative
QNZ 46;GluN2D;f;;Rat;21389220;Negative
5,7-dichlorokynurenic acid;GluN2D;f;;Human;;Antagonist
CGP37849;GluN2D;f;;Human;;Antagonist
conantokin-G;GluN2D;f;;Human;;Antagonist
d-AP5;GluN2D;f;;Human;;Antagonist
d-CCPene;GluN2D;f;;Human;;Antagonist
GV196771A;GluN2D;f;;Human;;Antagonist
L689560;GluN2D;f;;Human;;Antagonist
L701324;GluN2D;f;;Human;;Antagonist
LY233053;GluN2D;f;;Human;;Antagonist
selfotel;GluN2D;f;;Human;;Antagonist
[3H]CGP39653;GluN2D;f;;Human;;Antagonist
[3H]CGP61594;GluN2D;f;;Human;;Antagonist
[3H]CGS19755;GluN2D;f;;Human;;Antagonist
[3H]CPP;GluN2D;f;;Human;;Antagonist
[3H]L689560;GluN2D;f;;Human;;Antagonist
[3H]MDL105519;GluN2D;f;;Human;;Antagonist
UBP141;GluN2D;f;;Human;15801853;Antagonist
amantadine;GluN2D;f;;Human;;None
dizocilpine;GluN2D;f;;Human;;None
ketamine;GluN2D;f;;Human;;None
Mg2+;GluN2D;f;;Human;;None
N1-dansyl-spermine;GluN2D;f;;Human;;None
phencyclidine;GluN2D;f;;Human;;None
[3H]dizocilpine;GluN2D;f;;Human;;None
s-allylglycine;Glutamic acid decarboxylase 1;f;;Human;;Inhibition
s-allylglycine;Glutamic acid decarboxylase 2;f;;Human;;Inhibition
telaglenastat;glutaminase;f;;Human;;Inhibition
PBD150;glutaminyl-peptide cyclotransferase;f;;Human;16420052;Inhibition
compound 40 [PMID: 10602705];Glutamyl aminopeptidase;f;;Mouse;10602705;Inhibition
carmustine;glutathione-disulfide reductase;f;;None;19668867;Inhibition
oxiglutatione;glutathione-disulfide reductase;f;;Human;;Inhibition
C1-27;glutathione S-transferase omega 1;f;;Human;32105470;Inhibition
compound 25 [PMID: 32105470];glutathione S-transferase omega 1;f;;Human;32105470;Inhibition
glycine;Glycine Receptor (All subtypes);t;;Human;8404844|9009272;Agonist
taurine;Glycine Receptor (All subtypes);t;;Human;9009272;Agonist
ivermectin;Glycine Receptor (All subtypes);f;;Human;11278873;Irreversible agonist
β-alanine;Glycine Receptor (All subtypes);f;;Human;9009272;Partial agonist
GABA;Glycine Receptor (All subtypes);f;;Rat;11559772|8211147;Partial agonist
Zn2+;Glycine Receptor (All subtypes);t;;Human;16144831|7776247|9798943;Inhibition
ethanol;Glycine Receptor (All subtypes);f;;Human;8700149;Potentiation
Zn2+;Glycine Receptor (All subtypes);t;;Human;16144831|7808436|7776247|9798943;Potentiation
atropine;Glycine Receptor (All subtypes);f;;Human;10428078|17181559;Antagonist
RU5135;Glycine Receptor (All subtypes);f;;Rat;4007055|3986429;Antagonist
[3H]strychnine;Glycine Receptor (All subtypes);f;;Rat;1326295;Antagonist
[3H]strychnine;Glycine Receptor (All subtypes);f;;Human;3037383|1326295;Antagonist
tropisetron;Glycine Receptor (All subtypes);f;;Human;10428078|17181559;Antagonist
cyanotriphenylborate;Glycine Receptor (All subtypes);f;;Human;8090751;None
picrotoxinin;Glycine Receptor (All subtypes);f;;Human;1385113|7775436|17714449;None
5,7-dichlorokynurenic acid;Glycine Receptor (All subtypes);f;;None;14645455;Inhibition
alkylbenzene sulfonate;Glycine Receptor (All subtypes);f;;None;9435157;Inhibition
atropine;Glycine Receptor (All subtypes);f;;None;10428078;Inhibition
bilobalide;Glycine Receptor (All subtypes);f;;None;16805834;Inhibition
colchicine;Glycine Receptor (All subtypes);f;;None;9681937;Inhibition
cyanotriphenylborate;Glycine Receptor (All subtypes);f;;None;8090751;Inhibition
dehydroepiandrosterone;Glycine Receptor (All subtypes);f;;None;11522328;Inhibition
ginkgolide A;Glycine Receptor (All subtypes);f;;None;16805834;Inhibition
ginkgolide B;Glycine Receptor (All subtypes);f;;None;18221374|16805834;Inhibition
ginkgolide C;Glycine Receptor (All subtypes);f;;None;16805834;Inhibition
ginkgolide J;Glycine Receptor (All subtypes);f;;None;18221374;Inhibition
HU-210;Glycine Receptor (All subtypes);f;;None;18755158;Inhibition
HU-308;Glycine Receptor (All subtypes);f;;None;18755158;Inhibition
NBBCC;Glycine Receptor (All subtypes);f;;None;15722459;Inhibition
picrotoxinin;Glycine Receptor (All subtypes);f;;None;1385113|17714449;Inhibition
progesterone;Glycine Receptor (All subtypes);f;;None;11522328;Inhibition
WIN55212-2;Glycine Receptor (All subtypes);f;;None;18755158;Inhibition
Zn2+;Glycine Receptor (All subtypes);t;;None;15905212;Inhibition
α-Emtbl;Glycine Receptor (All subtypes);f;;None;10860922;Mixed
anandamide;Glycine Receptor (All subtypes);f;;None;18755158;Potentiation
HU-210;Glycine Receptor (All subtypes);f;;None;18755158;Potentiation
NV-31;Glycine Receptor (All subtypes);f;;None;18329806;Potentiation
pregnenolone;Glycine Receptor (All subtypes);f;;None;11522328;Potentiation
tropisetron;Glycine Receptor (All subtypes);f;;None;10999946;Potentiation
Zn2+;Glycine Receptor (All subtypes);t;;None;16144831;Potentiation
Cu2+;glycine receptor α1 subunit;t;;Human;;Inhibition
H+;glycine receptor α1 subunit;t;;Human;;Inhibition
Zn2+;glycine receptor α1 subunit;t;;Human;;Inhibition
anandamide;glycine receptor α1 subunit;f;;Human;;Potentiation
Δ9-tetrahydrocannabinol;glycine receptor α1 subunit;f;;Human;;Potentiation
HU-210;glycine receptor α1 subunit;f;;Human;;Potentiation
Zn2+;glycine receptor α1 subunit;t;;Human;;Potentiation
bilobalide;glycine receptor α1 subunit;f;;Human;;Antagonist
colchicine;glycine receptor α1 subunit;f;;Human;;Antagonist
ginkgolide X;glycine receptor α1 subunit;f;;Human;;Antagonist
HU-308;glycine receptor α1 subunit;f;;Human;;Antagonist
nifedipine;glycine receptor α1 subunit;f;;Human;;Antagonist
PMBA;glycine receptor α1 subunit;f;;Human;;Antagonist
pregnenolone sulphate;glycine receptor α1 subunit;f;;Human;;Antagonist
strychnine;glycine receptor α1 subunit;f;;Human;;Antagonist
[3H]strychnine;glycine receptor α1 subunit;f;;Human;;Antagonist
tropisetron;glycine receptor α1 subunit;f;;Human;;Antagonist
cyanotriphenylborate;glycine receptor α1 subunit;f;;Human;8090751;None
ginkgolide B;glycine receptor α1 subunit;f;;Human;;None
picrotin;glycine receptor α1 subunit;f;;Human;;None
picrotoxin;glycine receptor α1 subunit;f;;Human;;None
picrotoxinin;glycine receptor α1 subunit;f;;Human;;None
Cu2+;glycine receptor α2 subunit;t;;Human;;Inhibition
Zn2+;glycine receptor α2 subunit;t;;Human;;Inhibition
Δ9-tetrahydrocannabinol;glycine receptor α2 subunit;f;;Human;;Potentiation
Zn2+;glycine receptor α2 subunit;t;;Human;;Potentiation
5,7-dichlorokynurenic acid;glycine receptor α2 subunit;f;;Human;;Antagonist
bilobalide;glycine receptor α2 subunit;f;;Human;;Antagonist
colchicine;glycine receptor α2 subunit;f;;Human;;Antagonist
ginkgolide X;glycine receptor α2 subunit;f;;Human;;Antagonist
HU-210;glycine receptor α2 subunit;f;;Human;;Antagonist
HU-308;glycine receptor α2 subunit;f;;Human;;Antagonist
PMBA;glycine receptor α2 subunit;f;;Human;;Antagonist
pregnenolone sulphate;glycine receptor α2 subunit;f;;Human;;Antagonist
strychnine;glycine receptor α2 subunit;f;;Human;;Antagonist
[3H]strychnine;glycine receptor α2 subunit;f;;Human;;Antagonist
tropisetron;glycine receptor α2 subunit;f;;Human;;Antagonist
WIN55212-2;glycine receptor α2 subunit;f;;Human;;Antagonist
cyanotriphenylborate;glycine receptor α2 subunit;f;;Human;8090751;None
ginkgolide B;glycine receptor α2 subunit;f;;Human;;None
picrotin;glycine receptor α2 subunit;f;;Human;;None
picrotoxin;glycine receptor α2 subunit;f;;Human;;None
picrotoxinin;glycine receptor α2 subunit;f;;Human;;None
Cu2+;glycine receptor α3 subunit;t;;Human;;Inhibition
Zn2+;glycine receptor α3 subunit;t;;Human;;Inhibition
Δ9-tetrahydrocannabinol;glycine receptor α3 subunit;f;;Human;;Potentiation
(12E,20Z,18S)-8-hydroxyvariabilin;glycine receptor α3 subunit;f;;Human;;Antagonist
HU-210;glycine receptor α3 subunit;f;;Human;;Antagonist
HU-308;glycine receptor α3 subunit;f;;Human;;Antagonist
nifedipine;glycine receptor α3 subunit;f;;Human;;Antagonist
strychnine;glycine receptor α3 subunit;f;;Human;;Antagonist
[3H]strychnine;glycine receptor α3 subunit;f;;Human;;Antagonist
WIN55212-2;glycine receptor α3 subunit;f;;Human;;Antagonist
ginkgolide B;glycine receptor α3 subunit;f;;Human;;None
picrotin;glycine receptor α3 subunit;f;;Human;;None
picrotoxin;glycine receptor α3 subunit;f;;Human;;None
picrotoxinin;glycine receptor α3 subunit;f;;Human;;None
Zn2+;glycine receptor β subunit;t;;Human;;Inhibition
Zn2+;glycine receptor β subunit;t;;Human;;Inhibition
bilobalide;glycine receptor β subunit;f;;Human;;Antagonist
bilobalide;glycine receptor β subunit;f;;Human;;Antagonist
ginkgolide X;glycine receptor β subunit;f;;Human;;Antagonist
ginkgolide X;glycine receptor β subunit;f;;Human;;Antagonist
nifedipine;glycine receptor β subunit;f;;Human;;Antagonist
nifedipine;glycine receptor β subunit;f;;Human;;Antagonist
pregnenolone sulphate;glycine receptor β subunit;f;;Human;;Antagonist
pregnenolone sulphate;glycine receptor β subunit;f;;Human;;Antagonist
tropisetron;glycine receptor β subunit;f;;Human;;Antagonist
cyanotriphenylborate;glycine receptor β subunit;f;;Rat;8090751;None
cyanotriphenylborate;glycine receptor β subunit;f;;Rat;8090751;None
ginkgolide B;glycine receptor β subunit;f;;Human;;None
ginkgolide B;glycine receptor β subunit;f;;Human;;None
ginkgolide B;glycine receptor β subunit;f;;Human;;None
picrotin;glycine receptor β subunit;f;;Human;;None
picrotin;glycine receptor β subunit;f;;Human;;None
picrotoxin;glycine receptor β subunit;f;;Human;;None
picrotoxin;glycine receptor β subunit;f;;Human;;None
picrotoxinin;glycine receptor β subunit;f;;Human;;None
picrotoxinin;glycine receptor β subunit;f;;Human;;None
voruciclib;glycogen synthase kinase 3 alpha;f;;Human;26606677;Inhibition
aloisine A;glycogen synthase kinase 3 alpha;f;;Human;12519061;Inhibition
AZD1080;glycogen synthase kinase 3 alpha;f;;Human;23410232;Inhibition
CHIR-98014;glycogen synthase kinase 3 alpha;f;;Human;12606497;Inhibition
CHIR-99021;glycogen synthase kinase 3 alpha;f;;Human;12606497;Inhibition
GSK-3 inhibitor IX;glycogen synthase kinase 3 alpha;f;;Pig;14761195|14700633;Inhibition
GSK-3 inhibitor X;glycogen synthase kinase 3 alpha;f;;Pig;14761195;Inhibition
SB 216763;glycogen synthase kinase 3 alpha;f;;Human;11033082;Inhibition
SB-415286;glycogen synthase kinase 3 alpha;f;;Human;11033082;Inhibition
1-azakenpaullone;glycogen synthase kinase 3 beta;f;;Human;14698171;Inhibition
7-hydroxystaurosporine;glycogen synthase kinase 3 beta;f;;Human;15486189;Inhibition
alsterpaullone;glycogen synthase kinase 3 beta;f;;Human;10998059;Inhibition
alsterpaullone 2-cyanoethyl;glycogen synthase kinase 3 beta;f;;Human;18077363;Inhibition
AZD1080;glycogen synthase kinase 3 beta;f;;Human;23410232;Inhibition
AZD2858;glycogen synthase kinase 3 beta;f;;Human;22489897;Inhibition
BX-795;glycogen synthase kinase 3 beta;f;;Human;15772071;Inhibition
BX-912;glycogen synthase kinase 3 beta;f;;Human;15772071;Inhibition
Cdk1/5 inhibitor;glycogen synthase kinase 3 beta;f;;Human;18077363;Inhibition
Cdk/Crk inhibitor;glycogen synthase kinase 3 beta;f;;Human;18077363;Inhibition
CHIR-98014;glycogen synthase kinase 3 beta;f;;Human;12606497;Inhibition
CHIR-99021;glycogen synthase kinase 3 beta;f;;Human;12606497;Inhibition
compound 2f [Jiang et al., 2018];glycogen synthase kinase 3 beta;f;;Human;29541355;Inhibition
compound 2 [PMID: 22560567];glycogen synthase kinase 3 beta;f;;Human;21295469;Inhibition
compound 4g [PMID: 2680437];glycogen synthase kinase 3 beta;f;;Human;26804375;Inhibition
compound 52 [PMID: 9677190];glycogen synthase kinase 3 beta;f;;Human;18077363;Inhibition
compound 5b [PMID: 24900464];glycogen synthase kinase 3 beta;f;;Human;24900464;Inhibition
compound 89S [PMID: 19115845];glycogen synthase kinase 3 beta;f;;Human;19115845;Inhibition
GNF4877;glycogen synthase kinase 3 beta;f;;Human;26496802;Inhibition
GSK2646264;glycogen synthase kinase 3 beta;f;;Human;30249354;Inhibition
GSK-3β inhibitor 3 [PMID: 25845281];glycogen synthase kinase 3 beta;f;;Human;25845281;Inhibition
GSK-3beta inhibitor I;glycogen synthase kinase 3 beta;f;;Human;23099099;Inhibition
GSK-3beta inhibitor II;glycogen synthase kinase 3 beta;f;;Human;12031334;Inhibition
GSK-3beta inhibitor VIII;glycogen synthase kinase 3 beta;f;;Human;12928438;Inhibition
GSK-3beta inhibitor XI;glycogen synthase kinase 3 beta;f;;Rabbit;15158785;Inhibition
GSK-3 inhibitor IX;glycogen synthase kinase 3 beta;f;;Pig;14761195|14700633;Inhibition
GSK-3 inhibitor X;glycogen synthase kinase 3 beta;f;;Pig;14761195;Inhibition
GSK-3 inhibitor XIII;glycogen synthase kinase 3 beta;f;;Human;19447622;Inhibition
IM-12;glycogen synthase kinase 3 beta;f;;Human;20708937;Inhibition
indirubin-3'-monoxime;glycogen synthase kinase 3 beta;f;;Human;11013232;Inhibition
isogranulatimide;glycogen synthase kinase 3 beta;f;;Human;18077363|15486189;Inhibition
kenpaullone;glycogen synthase kinase 3 beta;f;;Human;11013232;Inhibition
Li+;glycogen synthase kinase 3 beta;f;;Human;11162580;Inhibition
LY2090314;glycogen synthase kinase 3 beta;f;;Human;15267232;Inhibition
RGB-286638;glycogen synthase kinase 3 beta;f;;Human;23807770;Inhibition
SB 216763;glycogen synthase kinase 3 beta;f;;Human;11033082;Inhibition
SB-415286;glycogen synthase kinase 3 beta;f;;Human;11033082;Inhibition
TWS119;glycogen synthase kinase 3 beta;f;;Human;12794184;Inhibition
voruciclib;glycogen synthase kinase 3 beta;f;;Human;26606677;Inhibition
tideglusib;glycogen synthase kinase 3 beta;f;;Human;22102280;Irreversible inhibition
codrituzumab;glypican 3;f;;Human;20847643;Binding
GlyT1 inhibitor 51b;GlyT1;f;;Human;30080045;Inhibition
ASP2535;GlyT1;f;;Rat;22542656;Inhibition
bitopertin;GlyT1;f;;Human;30080045;Inhibition
bitopertin;GlyT1;f;;Human;20491477;Inhibition
GlyT1 inhibitor 27a;GlyT1;f;;Human;30080045;Inhibition
GSK931145;GlyT1;f;;Human;;Inhibition
LY2365109;GlyT1;f;;Human;18602930;Inhibition
N-methyl-SSR504734;GlyT1;f;;Human;;Inhibition
Org 24598;GlyT1;f;;Human;11454468;Inhibition
PF-03463275;GlyT1;f;;Human;19410451;Inhibition
(R)-NFPS;GlyT1;f;;Human;18602930;Inhibition
SSR-103800;GlyT1;f;;Human;18621075;Inhibition
[35S]ACPPB;GlyT1;f;;Human;18355687;Binding
[3H]GSK931145;GlyT1;f;;Human;20691713;Binding
[3H](R)-NPTS;GlyT1;f;;Human;12657266;Binding
[3H]SB-733993;GlyT1;f;;Human;20691713;Binding
[3H]NFPS;GlyT1;f;;Human;;None
[3H]N-methyl-SSR504734;GlyT1;f;;Human;;None
ALX 1393;GlyT2;f;;Human;23962079;Inhibition
ALX 1405;GlyT2;f;;Human;;Inhibition
bitopertin;GlyT2;f;;Human;20491477;Inhibition
GT-0198;GlyT2;f;;Human;25837937;Inhibition
opiranserin;GlyT2;f;;Human;28815639;Inhibition
Org 25543;GlyT2;f;;Human;11495577;Inhibition
GM-CSF;GM-CSF receptor, α subunit;t;Human;Human;;Agonist
mavrilimumab;GM-CSF receptor, α subunit;f;;Human;;Binding
alarelin;GnRH1 receptor;f;;Human;26398856;Full agonist
alarelin;GnRH1 receptor;f;;Human;26398856;Full agonist
buserelin;GnRH1 receptor;f;;Human;26398856;Full agonist
buserelin;GnRH1 receptor;f;;Mouse;26774084;Full agonist
buserelin;GnRH1 receptor;f;;Human;26774084;Full agonist
buserelin;GnRH1 receptor;f;;Human;26398856;Full agonist
[des-Gly10,D-Ala6]GnRH N-ethylamide;GnRH1 receptor;f;;Mouse;1328228;Full agonist
deslorelin;GnRH1 receptor;f;;Human;26398856;Full agonist
deslorelin;GnRH1 receptor;f;;Human;26398856;Full agonist
[D-Lys6]GnRH-II;GnRH1 receptor;f;;Human;19638591;Full agonist
fertirelin;GnRH1 receptor;f;;Human;26398856;Full agonist
fertirelin;GnRH1 receptor;f;;Human;26398856;Full agonist
[Gln8]GnRH;GnRH1 receptor;f;;Human;17452338;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Mouse;26774084;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Mouse;1328228;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Human;26398856;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Rat;8013367;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Human;26774084;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Human;17452338;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Human;26398856;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Human;11726197|17095587;Full agonist
GnRH I;GnRH1 receptor;t;Human|Mouse|Rat;Rat;11726197;Full agonist
GnRH II;GnRH1 receptor;t;Human;Human;17452338|17942747|19638591;Full agonist
GnRH III;GnRH1 receptor;f;;Human;17254668;Full agonist
goserelin;GnRH1 receptor;f;;Human;;Full agonist
[His5,D-Tyr6]GnRH;GnRH1 receptor;f;;Human;17095587;Full agonist
histerelin;GnRH1 receptor;f;;Human;26398856;Full agonist
histerelin;GnRH1 receptor;f;;Human;26398856;Full agonist
histrelin;GnRH1 receptor;f;;Human;;Full agonist
leuprolide;GnRH1 receptor;f;;Human;17095587;Full agonist
leuprolide;GnRH1 receptor;f;;Rat;8013367;Full agonist
nafarelin;GnRH1 receptor;f;;Human;;Full agonist
[Ser8]GnRH;GnRH1 receptor;f;;Human;17452338;Full agonist
[125I]buserelin;GnRH1 receptor;f;;Rat;8013367;Full agonist
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide;GnRH1 receptor;f;;Human;12606616;Full agonist
[125I]GnRH I (human, mouse, rat);GnRH1 receptor;f;;Human;;Full agonist
[125I]triptorelin;GnRH1 receptor;f;;Rat;9484907;Full agonist
[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH;GnRH1 receptor;f;;Human;6346049;Full agonist
triptorelin;GnRH1 receptor;f;;Human;11726197;Full agonist
triptorelin;GnRH1 receptor;f;;Rat;11726197;Full agonist
[Trp8]GnRH;GnRH1 receptor;f;;Human;17452338;Full agonist
[Tyr8]GnRH;GnRH1 receptor;f;;Human;17452338;Full agonist
5-(N,N-hexamethylene)-amiloride;GnRH1 receptor;f;;Human;18344315;Negative
CMPD-1;GnRH1 receptor;f;;Human;17176055;Negative
FD-1;GnRH1 receptor;f;;Human;18344315;Negative
abarelix;GnRH1 receptor;f;;Human;17095587;Antagonist
[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II;GnRH1 receptor;f;;Human;19638591;Antagonist
antarelix;GnRH1 receptor;f;;Human;9300077;Antagonist
cetrorelix;GnRH1 receptor;f;;Human;11861490;Antagonist
cetrorelix;GnRH1 receptor;f;;Human;17095587|9300077|7649152;Antagonist
CMPD-1;GnRH1 receptor;f;;Human;12606616;Antagonist
compound 4 [PMID: 32677155];GnRH1 receptor;f;;Rat;32677155;Antagonist
cyclorelix;GnRH1 receptor;f;;Human;9300077;Antagonist
D-23487;GnRH1 receptor;f;;Human;9300077;Antagonist
D-24710;GnRH1 receptor;f;;Human;9300077;Antagonist
degarelix;GnRH1 receptor;f;;Human;21188095;Antagonist
elagolix;GnRH1 receptor;f;;Human;19006286;Antagonist
FD-1;GnRH1 receptor;f;;Human;18344315;Antagonist
ganirelix;GnRH1 receptor;f;;Human;;Antagonist
IN-3;GnRH1 receptor;f;;Human;11551758|12107234;Antagonist
IN-3;GnRH1 receptor;f;;Rat;11551758;Antagonist
iturelix;GnRH1 receptor;f;;Human;11861490;Antagonist
iturelix;GnRH1 receptor;f;;Human;1850267;Antagonist
NBI-42902;GnRH1 receptor;f;;Human;17095587;Antagonist
NBI-42902;GnRH1 receptor;f;;Human;17095587;Antagonist
sufugolix;GnRH1 receptor;f;;Human;12502365;Antagonist
[125I]cetrorelix;GnRH1 receptor;f;;Human;10894158;Antagonist
[3H]NBI-49202;GnRH1 receptor;f;;Human;16930559;Antagonist
T-98475;GnRH1 receptor;f;;Human;9784092;Antagonist
TAK-385;GnRH1 receptor;f;;Human;21657270;Antagonist
TAK-385;GnRH1 receptor;f;;Rat;21657270;Antagonist
WAY-207024;GnRH1 receptor;f;;Human;19271735;Antagonist
WAY-207024;GnRH1 receptor;f;;Rat;19271735;Antagonist
GnRH I;GnRH2 receptor;t;Human|Mouse|Rat;Monkey;15082521|11493674;Full agonist
GnRH II;GnRH2 receptor;t;Human;Monkey;11493674;Full agonist
trptorelix-1;GnRH2 receptor;f;;Monkey;14651258;Antagonist
compound 15 [PMID: 25411721];GPBA receptor;f;;Human;25411721;Agonist
compound 15 [PMID: 25411721];GPBA receptor;f;;Mouse;25411721;Agonist
INT-767;GPBA receptor;f;;Human;20631053;Agonist
S-EMCA;GPBA receptor;f;;Mouse;20014870;Agonist
betulinic acid;GPBA receptor;f;;Human;19911773;Full agonist
chenodeoxycholic acid;GPBA receptor;t;;Human;12419312;Full agonist
cholic acid;GPBA receptor;t;;Human;12419312;Full agonist
deoxycholic acid;GPBA receptor;t;;Human;12419312;Full agonist
lithocholic acid;GPBA receptor;t;;Human;12419312;Full agonist
oleanolic acid;GPBA receptor;f;;Human;17825251;Full agonist
4-hydroxytamoxifen;GPER;f;;Human;15705806;Agonist
17β-estradiol;GPER;t;;Human;15705806|15539556;Full agonist
fulvestrant;GPER;f;;Human;15539556;Full agonist
G-1;GPER;f;;Human;16520733;Full agonist
raloxifene;GPER;f;;Human;24379833;Full agonist
[3H]17β-estradiol;GPER;f;;Human;15539556;Full agonist
tamoxifen;GPER;f;;Human;15539556;Full agonist
G15;GPER;f;;Human;19430488;Antagonist
G36;GPER;f;;Human;21782022;Antagonist
glycine;GPRC6 receptor;t;;Human;15576628;Full agonist
L-alanine;GPRC6 receptor;t;;Human;15576628;Full agonist
L-arginine;GPRC6 receptor;t;;Human;15576628;Full agonist
L-citrulline;GPRC6 receptor;t;;Human;15576628;Full agonist
L-glutamine;GPRC6 receptor;t;;Human;15576628;Full agonist
L-lysine;GPRC6 receptor;t;;Human;15576628;Full agonist
L-ornithine;GPRC6 receptor;t;;Human;15576628;Full agonist
L-serine;GPRC6 receptor;t;;Human;15576628;Full agonist
calindol;GPRC6 receptor;f;;Mouse;19836834;Negative
NPS 2143;GPRC6 receptor;f;;Mouse;19836834;Negative
balanol;G protein-coupled receptor kinase 1;f;;Human;20128603;Inhibition
balanol;G protein-coupled receptor kinase 4;f;;Human;20128603;Inhibition
compound 1o [PMID: 24210504];G protein-coupled receptor kinase 5;f;;Human;24210504;Inhibition
balanol;G protein-coupled receptor kinase 6;f;;Human;20128603;Inhibition
balanol;G protein-coupled receptor kinase 7;f;;Human;20128603;Inhibition
FR900359;G protein subunit alpha q;f;;Hamster;;Inhibition
YM-254890;G protein subunit alpha q;f;;Hamster;;Inhibition
G-CSF;Granulocyte colony-stimulating factor receptor;t;Human;Human;;Agonist
pegfilgrastim;Granulocyte colony-stimulating factor receptor;f;;Human;;Agonist
G-CSF;Granulocyte macrophage colony-stimulating factor receptor;t;Human;Human;;Agonist
GM-CSF;Granulocyte macrophage colony-stimulating factor receptor;t;Human;Human;;Agonist
compound 20 [PMID:12127536];granzyme B;f;;Human;12127536;Inhibition
growth/differentiation factor-1;Growth/differentiation factor receptors;t;Human;Human;;Agonist
growth/differentiation factor-10;Growth/differentiation factor receptors;t;Human;Human;;Agonist
growth/differentiation factor-3;Growth/differentiation factor receptors;t;Human;Human;;Agonist
growth/differentiation factor-7;Growth/differentiation factor receptors;t;Human;Human;;Agonist
growth/differentiation factor-9;Growth/differentiation factor receptors;t;Human;Human;;Agonist
growth hormone 1;Growth hormone receptor;t;Human;Human;;Agonist
growth hormone 2;Growth hormone receptor;t;Human;Human;;Agonist
pegvisomant;Growth hormone receptor;f;;Human;10770982;Antagonist
cenderitide;Guanylyl cyclase-A;f;;Human;23272242;Agonist
Dendroaspis natriuretic peptide;Guanylyl cyclase-A;f;;Human;16778132;Agonist
mutant ANP;Guanylyl cyclase-A;t;;Human;19729120;Agonist
PL-3994;Guanylyl cyclase-A;f;;Human;23154072;Agonist
PL-3994;Guanylyl cyclase-A;f;;Rat;23154072;Agonist
sANP;Guanylyl cyclase-A;f;;Human;8700153;Agonist
[125I]ANP (human);Guanylyl cyclase-A;f;;Human;;Agonist
atrial natriuretic peptide;Guanylyl cyclase-A;t;Human;Human;8700153;Binding
brain natriuretic peptide;Guanylyl cyclase-A;t;Human;Human;8700153;Binding
A-71915;Guanylyl cyclase-A;f;;Human;1680722;Antagonist
anantin;Guanylyl cyclase-A;f;;Human;1826288|1849131;Antagonist
[Asu7,23']β-ANP-(7-28);Guanylyl cyclase-A;f;;Human;2542088;Antagonist
HS-142-1;Guanylyl cyclase-A;f;;Human;1674870;Antagonist
ataciguat;Guanylyl cyclase, α1β1;f;;Human;16332991;Activation
BAY412272;Guanylyl cyclase, α1β1;f;;Human;11242081;Activation
cinaciguat;Guanylyl cyclase, α1β1;f;;Human;12086987;Activation
latanoprostene bunod;Guanylyl cyclase, α1β1;f;;Rat;21396362;Activation
latanoprostene bunod;Guanylyl cyclase, α1β1;f;;Human;21396362;Activation
NO;Guanylyl cyclase, α1β1;f;;Human;;Activation
olinciguat;Guanylyl cyclase, α1β1;f;;Human;29859918;Activation
praliciguat;Guanylyl cyclase, α1β1;f;;Human;29643251;Activation
riociguat;Guanylyl cyclase, α1β1;f;;Human;11242081|19089334;Activation
vericiguat;Guanylyl cyclase, α1β1;f;;Human;28557445;Activation
YC-1;Guanylyl cyclase, α1β1;f;;Human;9003762|9742221|7527671;Activation
NS 2028;Guanylyl cyclase, α1β1;f;;Bovine;9489619;Inhibition
ODQ;Guanylyl cyclase, α1β1;f;;Human;7544433;Inhibition
cinaciguat;Guanylyl cyclase, α2β1;f;;Human;12086987;Activation
olinciguat;Guanylyl cyclase, α2β1;f;;Human;29859918;Activation
riociguat;Guanylyl cyclase, α2β1;f;;Human;11242081|19089334;Activation
vericiguat;Guanylyl cyclase, α2β1;f;;Human;28557445;Activation
YC-1;Guanylyl cyclase, α2β1;f;;Human;9742221|7527671;Activation
ODQ;Guanylyl cyclase, α2β1;f;;Human;;Inhibition
cenderitide;Guanylyl cyclase-B;f;;Human;23272242;Agonist
vosoritide;Guanylyl cyclase-B;f;;Human;23200862;Agonist
C-type natriuretic peptide;Guanylyl cyclase-B;t;Human;Human;1309330;Binding
compound C10 [PMID: 24297249];Guanylyl cyclase-B;f;;Human;24297249;Antagonist
HS-142-1;Guanylyl cyclase-B;f;;Human;1674870;Antagonist
peptide P19 [PMID: 15652659];Guanylyl cyclase-B;f;;Human;15652659;Antagonist
[Ser11](N-CNP,C-ANP)pBNP2-15;Guanylyl cyclase-B;f;;Human;15652659;Antagonist
[125I]CNP (human);Guanylyl cyclase-B;f;;Human;;None
dolcanatide;Guanylyl cyclase-C;f;;Human;26558155;Agonist
E. coli heat-stable enterotoxin (STa);Guanylyl cyclase-C;f;;Human;20863829;Agonist
linaclotide;Guanylyl cyclase-C;f;;Human;17694454|20863829;Agonist
linaclotide;Guanylyl cyclase-C;f;;Rat;20863829;Agonist
plecanatide;Guanylyl cyclase-C;f;;Human;23625291;Agonist
[125I]Sta;Guanylyl cyclase-C;f;;Human;9122260;Agonist
guanylin;Guanylyl cyclase-C;t;Human;Human;;Binding
uroguanylin;Guanylyl cyclase-C;t;Human;Human;;Binding
indusatumab vedotin;Guanylyl cyclase-C;f;;Human;;Binding
PF-07062119;Guanylyl cyclase-C;f;;Mouse;31996389;Binding
PF-07062119;Guanylyl cyclase-C;f;;Monkey;31996389;Binding
PF-07062119;Guanylyl cyclase-C;f;;Human;31996389;Binding
uroguanylin;Guanylyl cyclase-D;f;Human;Human;;Binding
guanylyl cyclase-activating protein 1;Guanylyl cyclase-E;t;Human|Mouse|Rat;Human;;Activation
guanylyl cyclase-activating protein 2;Guanylyl cyclase-E;t;Human|Mouse|Rat;Human;;Activation
guanylyl cyclase-activating protein 1;Guanylyl cyclase-F;t;Human|Mouse|Rat;Human;;Activation
guanylyl cyclase-activating protein 2;Guanylyl cyclase-F;t;Human|Mouse|Rat;Human;;Activation
compound 1 [PMID: 16821802];Haem oxygenase 1;f;;Rat;16821802;Inhibition
compound 1 [PMID: 16821802];Haem oxygenase 1;f;;Human;16821802;Inhibition
compound 1 [PMID: 16821802];Haem oxygenase 2;f;;Rat;16821802;Inhibition
compound 2 [PMID: 24486398];HCA1 receptor;f;;Human;24486398;Agonist
compound 2 [PMID: 31932225];HCA1 receptor;f;;Human;31932225|28978803;Agonist
nicotinic acid;HCA1 receptor;f;;Human;12522134;Agonist
3,5-dihydroxybenzoic acid;HCA1 receptor;f;;Human;22434674;Full agonist
3,5-dihydroxybenzoic acid;HCA1 receptor;f;;Mouse;22434674;Full agonist
γ-hydroxybutyric acid;HCA1 receptor;f;;Human;19047060;Full agonist
L-lactic acid;HCA1 receptor;t;;Human;18952058|19047060|20374963|23396314;Full agonist
L-lactic acid;HCA1 receptor;t;;Mouse;19047060|20374963;Full agonist
D-lactic acid;HCA1 receptor;f;;Human;18952058;Partial agonist
butyric acid;HCA2 receptor;t;;Human;;Agonist
GSK256073;HCA2 receptor;f;;Human;25773497;Agonist
SCH 900271;HCA2 receptor;f;;Human;24900372;Agonist
3-pyridine-acetic acid;HCA2 receptor;f;;Human;12522134;Full agonist
(+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid;HCA2 receptor;f;;Human;17358052|15929991;Full agonist
5-methyl nicotinic acid;HCA2 receptor;f;;Human;12522134;Full agonist
acifran;HCA2 receptor;f;;Human;12522134|16389067|17358052|15929991;Full agonist
acipimox;HCA2 receptor;f;;Human;12522134|12646212;Full agonist
β-D-hydroxybutyric acid;HCA2 receptor;t;;Mouse;15929991;Full agonist
β-D-hydroxybutyric acid;HCA2 receptor;t;;Human;15929991;Full agonist
cinnamic acid;HCA2 receptor;f;;Human;19136666;Full agonist
compound (+)17a [PMID: 20363624];HCA2 receptor;f;;Human;20363624;Full agonist
compound 21 [PMID: 21185185];HCA2 receptor;f;;Human;21185185;Full agonist
compound 2g [PMID: 19309152];HCA2 receptor;f;;Human;19309152;Full agonist
compound 8f [PMID: 20615702];HCA2 receptor;f;;Human;20615702;Full agonist
MK 1903;HCA2 receptor;f;;Human;22435740;Full agonist
MK 6892;HCA2 receptor;f;;Human;20184326;Full agonist
MK 6892;HCA2 receptor;f;;Human;20184326;Full agonist
monomethyl fumarate;HCA2 receptor;f;;Human;21167710;Full agonist
monomethyl fumarate;HCA2 receptor;f;;Human;18722346;Full agonist
nicotinic acid;HCA2 receptor;f;;Human;12522134|12563315|12646212;Full agonist
para-coumaric acid;HCA2 receptor;f;;Human;19136666;Full agonist
[3H]nicotinic acid;HCA2 receptor;f;;Human;12522134|12563315|12646212;Full agonist
5-butyl-1H-pyrazole-3-carboxylic acid;HCA2 receptor;f;;Rat;12930155;Partial agonist
compound 1q  [PMID: 18029181];HCA2 receptor;f;;Human;18029181;Partial agonist
MK 0354;HCA2 receptor;f;;Human;18665582;Partial agonist
compound 42 [PMID: 22420767];HCA2 receptor;f;;Human;22420767;Positive
compound 9n [PMID: 18752940];HCA2 receptor;f;;Human;18752940;Positive
2-hydroxyoctanoic acid;HCA3 receptor;f;;Human;19561068;Full agonist
3-hydroxyoctanoic acid;HCA3 receptor;t;;Human;19561068;Full agonist
4-(n-propyl)amino-3-nitrobenzoic acid;HCA3 receptor;f;;Human;17931863;Full agonist
5-methyl-5-(5-methylthiophen-3-yl)-4-oxo-4,5-dihydrofuran-2-carboxylic acid;HCA3 receptor;f;;Human;17358052;Full agonist
acifran;HCA3 receptor;f;;Human;12522134|16389067|17358052|15929991;Full agonist
compound 5b [PMID: 17358052];HCA3 receptor;f;;Human;17358052;Full agonist
compound 6o [PMID: 19524438];HCA3 receptor;f;;Human;19524438;Full agonist
D-kynurenine;HCA3 receptor;f;;Human;19237584;Full agonist
D-phenylalanine;HCA3 receptor;f;;Human;19237584;Full agonist
D-tryptophan;HCA3 receptor;f;;Human;19237584;Full agonist
IBC 293;HCA3 receptor;f;;Human;16480258;Full agonist
nicotinic acid;HCA3 receptor;f;;Human;12522134;Full agonist
compound 2 [PMID: 15546730];HCK proto-oncogene, Src family tyrosine kinase;f;;Human;15546730;Inhibition
eCF506;HCK proto-oncogene, Src family tyrosine kinase;f;;Human;27115835;Inhibition
ibrutinib;HCK proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
pexmetinib;HCK proto-oncogene, Src family tyrosine kinase;f;;Human;27287719;Inhibition
PP121;HCK proto-oncogene, Src family tyrosine kinase;f;;Human;18849971;Inhibition
cyclic AMP;HCN1;t;;Mouse;11331358|11524455;Agonist
cilobradine;HCN1;f;;Human;16387796;Antagonist
clonidine;HCN1;f;;Mouse;17261653;Antagonist
Cs+;HCN1;f;;Human;16043489;Antagonist
ivabradine;HCN1;f;;Mouse;16484306;Antagonist
ivabradine;HCN1;f;;Human;16387796;Antagonist
zatebradine;HCN1;f;;Human;16387796;Antagonist
ZD7288;HCN1;f;;Human;16043489;Antagonist
MEL57A;HCN1;f;;Mouse;22091830;None
Mg2+;HCN1;f;;Mouse;18579800;None
propofol;HCN1;f;;Mouse;16033909|17569731;None
cyclic AMP;HCN2;t;;Mouse;9634236;Agonist
cyclic GMP;HCN2;t;;Mouse;9634236;Agonist
cyclic CMP;HCN2;f;;Mouse;22715094;None
PIP2;HCN2;f;;Mouse;17074978;None
cilobradine;HCN2;f;;Human;16387796;Antagonist
clonidine;HCN2;f;;Mouse;17261653;Antagonist
Cs+;HCN2;f;;Human;16043489;Antagonist
ivabradine;HCN2;f;;Mouse;16387796;Antagonist
zatebradine;HCN2;f;;Human;16387796;Antagonist
ZD7288;HCN2;f;;Human;16043489;Antagonist
Mg2+;HCN2;f;;Mouse;18579800;None
cilobradine;HCN3;f;;Human;16387796;Antagonist
Cs+;HCN3;f;;Human;16043489;Antagonist
ivabradine;HCN3;f;;Human;16387796;Antagonist
zatebradine;HCN3;f;;Human;16387796;Antagonist
ZD7288;HCN3;f;;Human;16043489;Antagonist
cilobradine;HCN4;f;;Human;16387796;Antagonist
clonidine;HCN4;f;;Mouse;17261653;Antagonist
Cs+;HCN4;f;;Human;16043489;Antagonist
ivabradine;HCN4;f;;Human;16387796;Antagonist
zatebradine;HCN4;f;;Human;16387796;Antagonist
ZD7288;HCN4;f;;Human;16043489;Antagonist
EC18;HCN4;f;;Human;22091830;None
alvespimycin;heat shock protein 90 alpha family class A member 1;f;;Human;18929486;Inhibition
BIIB021;heat shock protein 90 alpha family class A member 1;f;;Human;24332488;Inhibition
retaspimycin hydrochloride;heat shock protein 90 alpha family class A member 1;f;;Human;16854066;Inhibition
SNX0723;heat shock protein 90 alpha family class A member 1;f;;Human;24332488;Inhibition
geldanamycin;heat shock protein 90 alpha family class B member 1;f;;Human;24984936;Inhibition
luminespib;heat shock protein 90 alpha family class B member 1;f;;Human;;Inhibition
compound 18c [PMID: 25901531];heat shock protein 90 beta family member 1;f;;Human;25901531;Inhibition
Grp94 inhibitor 54;heat shock protein 90 beta family member 1;f;;Human;30351001;Inhibition
semapimod;heat shock protein 90 beta family member 1;f;;Human;27194788;Inhibition
pixatimod;heparanase;f;;Human;22458531;Inhibition
simeprevir;Hepatitis C virus genome polyprotein;f;;Hepatitis C virus;18678486;Inhibition
linoleic acid;Hepatocyte nuclear factor-4-α;t;;Human;19440305;Full agonist
BI6015;Hepatocyte nuclear factor-4-α;f;;Human;22840769;Antagonist
B and T lymphocyte attenuator;herpes virus entry mediator;t;Human;Human;;None
LIGHT;herpes virus entry mediator;t;Human;Human;;None
lymphotoxin-α;herpes virus entry mediator;t;Human;Human;;None
AMA;Histidine decarboxylase;f;;Human;;Inhibition
FMH;Histidine decarboxylase;f;;Human;7452304;Inhibition
abexinostat;histone deacetylase 1;f;;Human;16731764;Inhibition
ACY-738;histone deacetylase 1;f;;Human;23954848;Inhibition
apicidin;histone deacetylase 1;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 1;f;;Human;17868033;Inhibition
belinostat;histone deacetylase 1;f;;Human;20139990;Inhibition
BML-281;histone deacetylase 1;f;;Human;18642892;Inhibition
butyric acid;histone deacetylase 1;f;;Human;21874153;Inhibition
CHR-3996;histone deacetylase 1;f;;Human;21080647;Inhibition
citarinostat;histone deacetylase 1;f;;Human;27926524;Inhibition
CUDC-101;histone deacetylase 1;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 1;f;;Human;20139990;Inhibition
entinostat;histone deacetylase 1;f;;Human;17868033;Inhibition
entinostat;histone deacetylase 1;f;;Human;20139990;Inhibition
fimepinostat;histone deacetylase 1;f;;Human;22693356;Inhibition
givinostat;histone deacetylase 1;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 1;f;;Human;17868033;Inhibition
KA1010;histone deacetylase 1;f;;Human;27222932;Inhibition
martinostat;histone deacetylase 1;f;;Human;25203558;Inhibition
mocetinostat;histone deacetylase 1;f;;Human;20139990;Inhibition
nexturastat A;histone deacetylase 1;f;;Human;23009203;Inhibition
panobinostat;histone deacetylase 1;f;;Human;17868033;Inhibition
pracinostat;histone deacetylase 1;f;;Human;20197387;Inhibition
quisinostat;histone deacetylase 1;f;;Human;19861438;Inhibition
resminostat;histone deacetylase 1;f;;Human;20201941;Inhibition
RGFP109;histone deacetylase 1;f;;Human;20098685;Inhibition
ricolinostat;histone deacetylase 1;f;;Human;22262760;Inhibition
romidepsin;histone deacetylase 1;f;;Human;20139990;Inhibition
scriptaid;histone deacetylase 1;f;;Human;20139990;Inhibition
SS-208;histone deacetylase 1;f;;Human;31414801;Inhibition
suprastat;histone deacetylase 1;f;;Human;32815366;Inhibition
tacedinaline;histone deacetylase 1;f;;Human;18182289;Inhibition
tacedinaline;histone deacetylase 1;f;;Human;20139990;Inhibition
trichostatin A;histone deacetylase 1;f;;Human;20139990;Inhibition
tubastatin A;histone deacetylase 1;f;;Human;;Inhibition
tucidinostat;histone deacetylase 1;f;;Human;20060381;Inhibition
valproic acid;histone deacetylase 1;f;;Human;11473107;Inhibition
vorinostat;histone deacetylase 1;f;;Human;20139990;Inhibition
BML-281;histone deacetylase 10;f;;Human;18642892;Inhibition
bufexamac;histone deacetylase 10;f;;Human;21258344;Inhibition
CUDC-101;histone deacetylase 10;f;;Human;20143778;Inhibition
fimepinostat;histone deacetylase 10;f;;Human;22693356;Inhibition
KA1010;histone deacetylase 10;f;;Human;27222932;Inhibition
pracinostat;histone deacetylase 10;f;;Human;20197387;Inhibition
quisinostat;histone deacetylase 10;f;;Human;19861438;Inhibition
vorinostat;histone deacetylase 10;f;;Human;20451378;Inhibition
fimepinostat;histone deacetylase 11;f;;Human;22693356;Inhibition
KA1010;histone deacetylase 11;f;;Human;27222932;Inhibition
quisinostat;histone deacetylase 11;f;;Human;19861438;Inhibition
SS-208;histone deacetylase 11;f;;Human;31414801;Inhibition
vorinostat;histone deacetylase 11;f;;Human;20451378;Inhibition
ACY-738;histone deacetylase 2;f;;Human;23954848;Inhibition
apicidin;histone deacetylase 2;f;;Human;20139990;Inhibition
apicidin;histone deacetylase 2;f;;Human;17868033;Inhibition
belinostat;histone deacetylase 2;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 2;f;;Human;17868033;Inhibition
BML-281;histone deacetylase 2;f;;Human;18642892;Inhibition
butyric acid;histone deacetylase 2;f;;Human;21874153;Inhibition
CHR-3996;histone deacetylase 2;f;;Human;21080647;Inhibition
citarinostat;histone deacetylase 2;f;;Human;27926524;Inhibition
CUDC-101;histone deacetylase 2;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 2;f;;Human;20139990;Inhibition
entinostat;histone deacetylase 2;f;;Human;20139990;Inhibition
entinostat;histone deacetylase 2;f;;Human;17868033;Inhibition
fimepinostat;histone deacetylase 2;f;;Human;22693356;Inhibition
givinostat;histone deacetylase 2;f;;Human;17868033;Inhibition
givinostat;histone deacetylase 2;f;;Human;20139990;Inhibition
KA1010;histone deacetylase 2;f;;Human;27222932;Inhibition
marbostat-100;histone deacetylase 2;f;;Human;29589441;Inhibition
martinostat;histone deacetylase 2;f;;Human;25203558;Inhibition
mocetinostat;histone deacetylase 2;f;;Human;20139990;Inhibition
panobinostat;histone deacetylase 2;f;;Human;17868033;Inhibition
quisinostat;histone deacetylase 2;f;;Human;19861438;Inhibition
ricolinostat;histone deacetylase 2;f;;Human;22262760;Inhibition
romidepsin;histone deacetylase 2;f;;Human;20139990;Inhibition
santacruzamate A;histone deacetylase 2;f;;Human;24164245;Inhibition
scriptaid;histone deacetylase 2;f;;Human;20139990;Inhibition
suprastat;histone deacetylase 2;f;;Human;32815366;Inhibition
tacedinaline;histone deacetylase 2;f;;Human;20139990;Inhibition
trichostatin A;histone deacetylase 2;f;;Human;20139990;Inhibition
vorinostat;histone deacetylase 2;f;;Human;20139990;Inhibition
abexinostat;histone deacetylase 3;f;;Human;16731764;Inhibition
ACY-738;histone deacetylase 3;f;;Human;23954848;Inhibition
apicidin;histone deacetylase 3;f;;Human;17868033;Inhibition
apicidin;histone deacetylase 3;f;;Human;17868033;Inhibition
apicidin;histone deacetylase 3;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 3;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 3;f;;Human;17868033;Inhibition
BML-281;histone deacetylase 3;f;;Human;18642892;Inhibition
butyric acid;histone deacetylase 3;f;;Human;21874153;Inhibition
CHR-3996;histone deacetylase 3;f;;Human;21080647;Inhibition
citarinostat;histone deacetylase 3;f;;Human;27926524;Inhibition
CUDC-101;histone deacetylase 3;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 3;f;;Human;20139990;Inhibition
droxinostat;histone deacetylase 3;f;;Human;20053768;Inhibition
entinostat;histone deacetylase 3;f;;Human;20139990;Inhibition
entinostat;histone deacetylase 3;f;;Human;17868033;Inhibition
fimepinostat;histone deacetylase 3;f;;Human;22693356;Inhibition
givinostat;histone deacetylase 3;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 3;f;;Human;17868033;Inhibition
KA1010;histone deacetylase 3;f;;Human;27222932;Inhibition
martinostat;histone deacetylase 3;f;;Human;25203558;Inhibition
mocetinostat;histone deacetylase 3;f;;Human;20139990;Inhibition
panobinostat;histone deacetylase 3;f;;Human;17868033;Inhibition
pracinostat;histone deacetylase 3;f;;Human;20197387;Inhibition
quisinostat;histone deacetylase 3;f;;Human;19861438;Inhibition
resminostat;histone deacetylase 3;f;;Human;20201941;Inhibition
RGFP109;histone deacetylase 3;f;;Human;20098685;Inhibition
RGFP966;histone deacetylase 3;f;;Human;23297220;Inhibition
ricolinostat;histone deacetylase 3;f;;Human;22262760;Inhibition
romidepsin;histone deacetylase 3;f;;Human;20139990;Inhibition
scriptaid;histone deacetylase 3;f;;Human;20139990;Inhibition
suprastat;histone deacetylase 3;f;;Human;32815366;Inhibition
tacedinaline;histone deacetylase 3;f;;Human;20139990;Inhibition
trichostatin A;histone deacetylase 3;f;;Human;20139990;Inhibition
vorinostat;histone deacetylase 3;f;;Human;20139990;Inhibition
tasquinimod;histone deacetylase 4;f;;Human;23149916;Inhibition
belinostat;histone deacetylase 4;f;;Human;17868033;Inhibition
belinostat;histone deacetylase 4;f;;Human;20139990;Inhibition
CUDC-101;histone deacetylase 4;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 4;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 4;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 4;f;;Human;17868033;Inhibition
KA1010;histone deacetylase 4;f;;Human;27222932;Inhibition
martinostat;histone deacetylase 4;f;;Human;25203558;Inhibition
panobinostat;histone deacetylase 4;f;;Human;17868033;Inhibition
quisinostat;histone deacetylase 4;f;;Human;19861438;Inhibition
romidepsin;histone deacetylase 4;f;;Human;20139990;Inhibition
santacruzamate A;histone deacetylase 4;f;;Human;24164245;Inhibition
scriptaid;histone deacetylase 4;f;;Human;20139990;Inhibition
TMP269;histone deacetylase 4;f;;Human;23524983;Inhibition
trichostatin A;histone deacetylase 4;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 5;f;;Human;20139990;Inhibition
CHR-3996;histone deacetylase 5;f;;Human;21080647;Inhibition
CUDC-101;histone deacetylase 5;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 5;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 5;f;;Human;20139990;Inhibition
KA1010;histone deacetylase 5;f;;Human;27222932;Inhibition
martinostat;histone deacetylase 5;f;;Human;25203558;Inhibition
pracinostat;histone deacetylase 5;f;;Human;20197387;Inhibition
quisinostat;histone deacetylase 5;f;;Human;19861438;Inhibition
romidepsin;histone deacetylase 5;f;;Human;20139990;Inhibition
scriptaid;histone deacetylase 5;f;;Human;20139990;Inhibition
SS-208;histone deacetylase 5;f;;Human;31414801;Inhibition
TMP269;histone deacetylase 5;f;;Human;23524983;Inhibition
trichostatin A;histone deacetylase 5;f;;Human;20139990;Inhibition
vorinostat;histone deacetylase 5;f;;Human;20139990;Inhibition
ACY-738;histone deacetylase 6;f;;Human;23954848;Inhibition
bavarostat;histone deacetylase 6;f;;Human;30118224;Inhibition
belinostat;histone deacetylase 6;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 6;f;;Human;17868033;Inhibition
BML-281;histone deacetylase 6;f;;Human;18642892;Inhibition
bufexamac;histone deacetylase 6;f;;Human;21258344;Inhibition
CHR-3996;histone deacetylase 6;f;;Human;21080647;Inhibition
citarinostat;histone deacetylase 6;f;;Human;27926524;Inhibition
compound 16 [PMID: 20947351];histone deacetylase 6;f;;Human;20947351;Inhibition
compound 7d [PMID: 19111466];histone deacetylase 6;f;;Human;19111466;Inhibition
CUDC-101;histone deacetylase 6;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 6;f;;Human;20139990;Inhibition
droxinostat;histone deacetylase 6;f;;Human;20053768;Inhibition
fimepinostat;histone deacetylase 6;f;;Human;22693356;Inhibition
givinostat;histone deacetylase 6;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 6;f;;Human;17868033;Inhibition
KA1010;histone deacetylase 6;f;;Human;27222932;Inhibition
marbostat-100;histone deacetylase 6;f;;Human;29589441;Inhibition
martinostat;histone deacetylase 6;f;;Human;25203558;Inhibition
nexturastat A;histone deacetylase 6;f;;Human;23009203;Inhibition
nexturastat A;histone deacetylase 6;f;;Human;32815366;Inhibition
NQN-1;histone deacetylase 6;f;;Human;22047054;Inhibition
panobinostat;histone deacetylase 6;f;;Human;17868033;Inhibition
quisinostat;histone deacetylase 6;f;;Human;19861438;Inhibition
resminostat;histone deacetylase 6;f;;Human;20201941;Inhibition
ricolinostat;histone deacetylase 6;f;;Human;22262760;Inhibition
romidepsin;histone deacetylase 6;f;;Human;20139990;Inhibition
santacruzamate A;histone deacetylase 6;f;;Human;24164245;Inhibition
scriptaid;histone deacetylase 6;f;;Human;20139990;Inhibition
SS-208;histone deacetylase 6;f;;Human;31414801;Inhibition
suprastat;histone deacetylase 6;f;;Human;32815366;Inhibition
trichostatin A;histone deacetylase 6;f;;Human;20139990;Inhibition
tubacin;histone deacetylase 6;f;;Human;12677000;Inhibition
tubastatin A;histone deacetylase 6;f;;Human;;Inhibition
vorinostat;histone deacetylase 6;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 7;f;;Human;17868033;Inhibition
belinostat;histone deacetylase 7;f;;Human;20139990;Inhibition
CUDC-101;histone deacetylase 7;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 7;f;;Human;20139990;Inhibition
givinostat;histone deacetylase 7;f;;Human;17868033;Inhibition
givinostat;histone deacetylase 7;f;;Human;20139990;Inhibition
KA1010;histone deacetylase 7;f;;Human;27222932;Inhibition
panobinostat;histone deacetylase 7;f;;Human;17868033;Inhibition
quisinostat;histone deacetylase 7;f;;Human;19861438;Inhibition
romidepsin;histone deacetylase 7;f;;Human;20139990;Inhibition
scriptaid;histone deacetylase 7;f;;Human;20139990;Inhibition
SS-208;histone deacetylase 7;f;;Human;31414801;Inhibition
TMP269;histone deacetylase 7;f;;Human;23524983;Inhibition
trichostatin A;histone deacetylase 7;f;;Human;20139990;Inhibition
apicidin;histone deacetylase 8;f;;Human;17868033;Inhibition
apicidin;histone deacetylase 8;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 8;f;;Human;20139990;Inhibition
belinostat;histone deacetylase 8;f;;Human;17868033;Inhibition
BML-281;histone deacetylase 8;f;;Human;18642892;Inhibition
butyric acid;histone deacetylase 8;f;;Human;21874153;Inhibition
citarinostat;histone deacetylase 8;f;;Human;27926524;Inhibition
CUDC-101;histone deacetylase 8;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 8;f;;Human;20139990;Inhibition
droxinostat;histone deacetylase 8;f;;Human;20053768;Inhibition
givinostat;histone deacetylase 8;f;;Human;20139990;Inhibition
KA1010;histone deacetylase 8;f;;Human;27222932;Inhibition
marbostat-100;histone deacetylase 8;f;;Human;29589441;Inhibition
panobinostat;histone deacetylase 8;f;;Human;17868033;Inhibition
quisinostat;histone deacetylase 8;f;;Human;19861438;Inhibition
resminostat;histone deacetylase 8;f;;Human;20201941;Inhibition
ricolinostat;histone deacetylase 8;f;;Human;22262760;Inhibition
romidepsin;histone deacetylase 8;f;;Human;20139990;Inhibition
scriptaid;histone deacetylase 8;f;;Human;20139990;Inhibition
SS-208;histone deacetylase 8;f;;Human;31414801;Inhibition
suprastat;histone deacetylase 8;f;;Human;32815366;Inhibition
trichostatin A;histone deacetylase 8;f;;Human;20139990;Inhibition
tubastatin A;histone deacetylase 8;f;;Human;;Inhibition
vorinostat;histone deacetylase 8;f;;Human;20451378|20139990;Inhibition
belinostat;histone deacetylase 9;f;;Human;17868033;Inhibition
belinostat;histone deacetylase 9;f;;Human;20139990;Inhibition
CUDC-101;histone deacetylase 9;f;;Human;20143778;Inhibition
dacinostat;histone deacetylase 9;f;;Human;20139990;Inhibition
entinostat;histone deacetylase 9;f;;Human;17868033;Inhibition
givinostat;histone deacetylase 9;f;;Human;20139990;Inhibition
KA1010;histone deacetylase 9;f;;Human;27222932;Inhibition
panobinostat;histone deacetylase 9;f;;Human;17868033;Inhibition
quisinostat;histone deacetylase 9;f;;Human;19861438;Inhibition
romidepsin;histone deacetylase 9;f;;Human;20139990;Inhibition
scriptaid;histone deacetylase 9;f;;Human;20139990;Inhibition
TMP269;histone deacetylase 9;f;;Human;23524983;Inhibition
trichostatin A;histone deacetylase 9;f;;Human;20139990;Inhibition
vorinostat;histone deacetylase 9;f;;Human;20451378;Inhibition
SGI-1776;histone H3 associated protein kinase;f;;Human;22924342;Inhibition
staurosporine;homeodomain interacting protein kinase 1;f;;Human;19397322;Inhibition
compound 1a [PMID: 24900749];homeodomain interacting protein kinase 2;f;;Human;24900749;Inhibition
compound 5b [PMID: 24900464];homeodomain interacting protein kinase 2;f;;Human;24900464;Inhibition
silmitasertib;homeodomain interacting protein kinase 3;f;;Human;21174434;Inhibition
compound 3 [PMID: 21650226];HPGD;f;;Human;21650226;Inhibition
HQL-79;H-PGDS;f;;Human;16547010;Inhibition
lonafarnib;HRAS;f;;Human;9810004;Inhibition
ST-1006;H1 receptor;f;;Human;26084539;Agonist
vilazodone;H1 receptor;f;;Human;15341484;Agonist
2-(3-bromophenyl)histamine;H1 receptor;f;;Human;12626648;Full agonist
2-(3-chlorophenyl)histamine;H1 receptor;f;;Human;12626648;Full agonist
2-(3-iodophenyl)histamine;H1 receptor;f;;Human;12626648;Full agonist
2-pyridylethylamine;H1 receptor;f;;Human;15206929;Full agonist
dimethylhistaprodifen;H1 receptor;f;;Human;12626648;Full agonist
histamine;H1 receptor;t;;Human;7925364|12065734|16394198|12626648|15206929;Full agonist
histaprodifen;H1 receptor;f;;Human;15947036;Full agonist
methylhistaprodifen;H1 receptor;f;;Human;12626648;Full agonist
oxo-arpromidine;H1 receptor;f;;Human;16394198;Full agonist
UR-PG131A;H1 receptor;f;;Human;16394198;Full agonist
UR-PG146;H1 receptor;f;;Human;16394198;Full agonist
UR-PG153;H1 receptor;f;;Human;16394198;Full agonist
UR-PG55B;H1 receptor;f;;Human;16394198;Full agonist
2-(2-thiazolyl)ethanamine;H1 receptor;f;;Human;12626648;Partial agonist
9-OH-risperidone;H1 receptor;f;;Human;8935801;Antagonist
A-317920;H1 receptor;f;;Human;12606603|15294456;Antagonist
alimemazine;H1 receptor;f;;Bovine;2884340;Antagonist
amitriptyline;H1 receptor;f;;Human;16782354;Antagonist
aripiprazole;H1 receptor;f;;Human;12629531;Antagonist
arpromidine;H1 receptor;f;;Human;16394198|12626648;Antagonist
asenapine;H1 receptor;f;;Human;8935801;Antagonist
astemizole;H1 receptor;f;;Human;12747773;Antagonist
AZD3778;H1 receptor;f;;Human;23031591;Antagonist
azelastine;H1 receptor;f;;Human;21381763;Antagonist
BU-E 47;H1 receptor;f;;Human;12626648;Antagonist
chlorpheniramine;H1 receptor;f;;Human;21381763;Antagonist
(-)-chlorpheniramine;H1 receptor;f;;Human;12065734;Antagonist
(+)-chlorpheniramine;H1 receptor;f;;Human;7925364|12065734;Antagonist
chlorpromazine;H1 receptor;f;;Human;12629531;Antagonist
ciproxifan;H1 receptor;f;;Human;26084539;Antagonist
clemastine;H1 receptor;f;;Human;;Antagonist
clobenpropit;H1 receptor;f;;Human;12606603;Antagonist
clozapine;H1 receptor;f;;Human;8935801|12629531|12065734;Antagonist
conessine;H1 receptor;f;;Human;26084539;Antagonist
cyclizine;H1 receptor;f;;Human;;Antagonist
cyproheptadine;H1 receptor;f;;Human;7925364;Antagonist
desloratadine;H1 receptor;f;;Human;15482930;Antagonist
diphenhydramine;H1 receptor;f;;Human;12065734;Antagonist
dosulepin;H1 receptor;f;;Human;10379421;Antagonist
doxepin;H1 receptor;f;;Human;12065734;Antagonist
epinastine;H1 receptor;f;;Human;18446005;Antagonist
fexofenadine;H1 receptor;f;;Human;19660947;Antagonist
fluphenazine;H1 receptor;f;;Human;12629531;Antagonist
fluspirilene;H1 receptor;f;;Human;8935801;Antagonist
haloperidol;H1 receptor;f;;Human;8935801|12629531;Antagonist
hydroxyzine;H1 receptor;f;;Human;11809864;Antagonist
(+)-cis-H2-PAT;H1 receptor;f;;Human;12065734;Antagonist
impromidine;H1 receptor;f;;Human;16394198;Antagonist
INCB-38579;H1 receptor;f;;Human;26084539;Antagonist
(-)-trans-H2-PAT;H1 receptor;f;;Human;12065734;Antagonist
(+)-trans-H2-PAT;H1 receptor;f;;Human;12065734;Antagonist
JNJ-39758979;H1 receptor;f;;Human;26084539;Antagonist
ketotifen;H1 receptor;f;;Human;21470866;Antagonist
loratadine;H1 receptor;f;;Human;15771458;Antagonist
loxapine;H1 receptor;f;;Human;12629531;Antagonist
mizolastine;H1 receptor;f;;Human;19553115;Antagonist
mizolastine;H1 receptor;f;;Guinea pig;7612054;Antagonist
MK-0249;H1 receptor;f;;Human;26084539;Antagonist
molindone;H1 receptor;f;;Human;12629531;Antagonist
olanzapine;H1 receptor;f;;Human;8935801|12629531;Antagonist
perphenazine;H1 receptor;f;;Human;12629531;Antagonist
pimozide;H1 receptor;f;;Human;12629531;Antagonist
pipamperone;H1 receptor;f;;Human;8935801;Antagonist
pitolisant;H1 receptor;f;;Human;26084539;Antagonist
(±)-cis-H2-PAT;H1 receptor;f;;Human;12065734;Antagonist
(±)-cis-H2-PAT;H1 receptor;f;;Human;12065734;Antagonist
(±)-trans-H2-PAT;H1 receptor;f;;Human;12065734;Antagonist
promethazine;H1 receptor;f;;Human;16782354;Antagonist
quetiapine;H1 receptor;f;;Human;8935801|12629531;Antagonist
risperidone;H1 receptor;f;;Human;8935801|12629531;Antagonist
rupatadine;H1 receptor;f;;Human;16220969;Antagonist
rupatadine;H1 receptor;f;;Guinea pig;8996188;Antagonist
(S)-dimetindene;H1 receptor;f;;Human;12593665;Antagonist
sertindole;H1 receptor;f;;Human;8935801|12629531;Antagonist
[11C]doxepin;H1 receptor;f;;Human;15093820;Antagonist
terfenadine;H1 receptor;f;;Human;19660947;Antagonist
thioridazine;H1 receptor;f;;Human;12629531;Antagonist
thiothixene;H1 receptor;f;;Human;12629531;Antagonist
trifluoperazine;H1 receptor;f;;Human;12629531;Antagonist
tripelennamine;H1 receptor;f;;Human;14667234;Antagonist
tripelennamine;H1 receptor;f;;Human;14667234;Antagonist
triprolidine;H1 receptor;f;;Human;7925364|12065734;Antagonist
ziprasidone;H1 receptor;f;;Human;8935801|12629531;Antagonist
zotepine;H1 receptor;f;;Human;8935801;Antagonist
A-349821;H1 receptor;f;;Human;15294456;Inverse agonist
ABT-239;H1 receptor;f;;Human;15608078;Inverse agonist
cetirizine;H1 receptor;f;;Human;7925364;Inverse agonist
(R)-cetirizine;H1 receptor;f;;Human;15206929;Inverse agonist
(S)-cetirizine;H1 receptor;f;;Human;15206929;Inverse agonist
mepyramine;H1 receptor;f;;Human;12065734|15206929;Inverse agonist
[11C]pyrilamine;H1 receptor;f;;Human;;Inverse agonist
[3H]pyrilamine;H1 receptor;f;;Human;8935801|9794809|7925364|12626648;Inverse agonist
ST-1006;H2 receptor;f;;Human;26084539;Agonist
amthamine;H2 receptor;f;;Human;19072936;Full agonist
arpromidine;H2 receptor;f;;Human;16394198;Full agonist
burimamide;H2 receptor;f;;Human;9681472;Full agonist
histamine;H2 receptor;t;;Rat;9384502;Full agonist
impromidine;H2 receptor;f;;Human;16394198;Full agonist
oxo-arpromidine;H2 receptor;f;;Human;16394198;Full agonist
UR-PG146;H2 receptor;f;;Human;16394198;Full agonist
burimamide;H2 receptor;f;;Rat;8692899;Antagonist
cimetidine;H2 receptor;f;;Rat;9384502;Antagonist
cimetidine;H2 receptor;f;;Human;23466604;Antagonist
ciproxifan;H2 receptor;f;;Human;26084539;Antagonist
clobenpropit;H2 receptor;f;;Human;12606603;Antagonist
conessine;H2 receptor;f;;Human;26084539;Antagonist
famotidine;H2 receptor;f;;Human;;Antagonist
INCB-38579;H2 receptor;f;;Human;26084539;Antagonist
iodoaminopotentidine;H2 receptor;f;;Rat;9384502;Antagonist
JNJ-39758979;H2 receptor;f;;Human;26084539;Antagonist
metiamide;H2 receptor;f;;Rat;9384502;Antagonist
MK-0249;H2 receptor;f;;Human;26084539;Antagonist
pitolisant;H2 receptor;f;;Human;26084539;Antagonist
ranitidine;H2 receptor;f;;Rat;9384502;Antagonist
ranitidine;H2 receptor;f;;Human;7921611;Antagonist
[125I]iodoaminopotentidine;H2 receptor;f;;Rat;8961278;Antagonist
[3H]tiotidine;H2 receptor;f;;Human;12869657;Antagonist
tiotidine;H2 receptor;f;;Rat;9384502;Antagonist
ABT-239;H2 receptor;f;;Human;15608078;Inverse agonist
ST-1006;H3 receptor;f;;Human;26084539;Agonist
cipralisant;H3 receptor;f;;Rat;12393057;Full agonist
cipralisant;H3 receptor;f;;Human;12393057;Full agonist
dimaprit;H3 receptor;f;;Human;11179434;Full agonist
histamine;H3 receptor;t;;Rat;10869375|11162480|11090094;Full agonist
histamine;H3 receptor;t;;Mouse;12706455|15341517;Full agonist
histamine;H3 receptor;t;;Human;10869375|11284713|11090094|12393057|11179434|14640553;Full agonist
imbutamine;H3 receptor;f;;Human;14640553;Full agonist
imetit;H3 receptor;f;;Human;10869375|11284713|11714875|12393057|11179434;Full agonist
imetit;H3 receptor;f;;Rat;10869375|11162480|12393057;Full agonist
imetit;H3 receptor;f;;Mouse;12706455|15341517;Full agonist
immepip;H3 receptor;f;;Mouse;12706455;Full agonist
immepip;H3 receptor;f;;Human;10869375|11284713|12393057|11179434|14640553;Full agonist
immepip;H3 receptor;f;;Rat;10869375|12393057;Full agonist
immethridine;H3 receptor;f;;Human;15115383;Full agonist
impentamine;H3 receptor;f;;Human;14640553;Full agonist
N-α-methylhistamine;H3 receptor;f;;Mouse;12706455;Full agonist
N-methylhistamine;H3 receptor;f;;Human;10869375|11284713|11179434;Full agonist
N-methylhistamine;H3 receptor;f;;Rat;10869375;Full agonist
N-[3H]α-methylhistamine;H3 receptor;f;;Mouse;12706455;Full agonist
N-[3H]methylhistamine;H3 receptor;f;;Rat;10869375;Full agonist
N-[3H]methylhistamine;H3 receptor;f;;Human;11179434;Full agonist
iodoproxyfan;H3 receptor;f;;Human;12393057;Full agonist
iodoproxyfan;H3 receptor;f;;Rat;12393057;Full agonist
(R)-α-methylhistamine;H3 receptor;f;;Human;10869375|11284713|11714875|11090094|12393057|11179434;Full agonist
(R)-α-methylhistamine;H3 receptor;f;;Rat;10869375|11090094|12393057;Full agonist
(R)-α-methylhistamine;H3 receptor;f;;Mouse;12706455;Full agonist
(S)-α-methylhistamine;H3 receptor;f;;Human;12393057;Full agonist
(S)-α-methylhistamine;H3 receptor;f;;Rat;12393057;Full agonist
methimepip;H3 receptor;f;;Human;15771452;Full agonist
proxyfan;H3 receptor;f;;Rat;11162480|12393057;Full agonist
proxyfan;H3 receptor;f;;Human;12393057;Full agonist
proxyfan;H3 receptor;f;;Mouse;15341517;Full agonist
[3H]histamine;H3 receptor;f;;Human;11179434|11179435;Full agonist
[3H](R)-α-methylhistamine;H3 receptor;f;;Human;11179434;Full agonist
VUF 5207;H3 receptor;f;;Human;11714875;Full agonist
compound 3a [PMID: 18606542];H3 receptor;f;;Human;18606542;Inverse agonist
GSK-189254;H3 receptor;f;;Human;17327487;Inverse agonist
MK-0249;H3 receptor;f;;Human;18598020;Inverse agonist
SUVN-G3031;H3 receptor;f;;Human;30629436;Inverse agonist
GR 175737;H3 receptor;f;;Rat;12393057;Partial agonist
GR 175737;H3 receptor;f;;Human;12393057;Partial agonist
impromidine;H3 receptor;f;;Human;11179434;Partial agonist
VUF 8328;H3 receptor;f;;Human;11714875;Partial agonist
A-304121;H3 receptor;f;;Rat;12606603|15294456;Antagonist
A-304121;H3 receptor;f;;Human;12606603|15294456;Antagonist
A-317920;H3 receptor;f;;Rat;12606603|15294456;Antagonist
A-317920;H3 receptor;f;;Human;12606603|15294456;Antagonist
A331440;H3 receptor;f;;Human;15033391;Antagonist
adriforant;H3 receptor;f;;Human;26084539;Antagonist
burimamide;H3 receptor;f;;Human;11714875|11179434;Antagonist
burimamide;H3 receptor;f;;Rat;11714875;Antagonist
ciproxifan;H3 receptor;f;;Human;12606603|15294456|11284713|11090094|12393057|26084539;Antagonist
ciproxifan;H3 receptor;f;;Rat;12606603|15294456|11162480|11090094|12393057;Antagonist
ciproxifan;H3 receptor;f;;Mouse;15341517;Antagonist
clobenpropit;H3 receptor;f;;Mouse;12706455;Antagonist
clobenpropit;H3 receptor;f;;Human;12606603|10869375|11284713|11714875|11090094|12393057|11179434;Antagonist
clobenpropit;H3 receptor;f;;Rat;12606603|10869375|11714875|11162480|11090094|12393057;Antagonist
clozapine;H3 receptor;f;;Rat;10869375;Antagonist
conessine;H3 receptor;f;;Human;26084539;Antagonist
FUB 349;H3 receptor;f;;Mouse;15341517;Antagonist
FUB 349;H3 receptor;f;;Human;11090094;Antagonist
FUB 349;H3 receptor;f;;Rat;11090094;Antagonist
FUB 465;H3 receptor;f;;Rat;11162480;Antagonist
GSK334429;H3 receptor;f;;Human;21062081|25218907;Antagonist
GT2394;H3 receptor;f;;Rat;12393057;Antagonist
GT2394;H3 receptor;f;;Human;12393057;Antagonist
impentamine;H3 receptor;f;;Rat;11714875;Antagonist
impentamine;H3 receptor;f;;Human;11714875;Antagonist
INCB-38579;H3 receptor;f;;Human;26084539;Antagonist
iodophenpropit;H3 receptor;f;;Rat;11714875|12393057;Antagonist
iodophenpropit;H3 receptor;f;;Human;11714875|12393057;Antagonist
JB 98064;H3 receptor;f;;Rat;12393057;Antagonist
JB 98064;H3 receptor;f;;Human;12393057;Antagonist
JNJ-39758979;H3 receptor;f;;Human;26084539;Antagonist
JNJ-5207852;H3 receptor;f;;Human;12930154;Antagonist
MK-0249;H3 receptor;f;;Human;26084539;Antagonist
PF-03654746;H3 receptor;f;;Mouse;21928839;Antagonist
PF-03654746;H3 receptor;f;;Human;21928839;Antagonist
pitolisant;H3 receptor;f;;Human;26084539|19329325;Antagonist
proxyfan;H3 receptor;f;;Human;11090094;Antagonist
proxyfan;H3 receptor;f;;Rat;11090094;Antagonist
[123I]iodoproxyfan;H3 receptor;f;;Human;11090094;Antagonist
[123I]iodoproxyfan;H3 receptor;f;;Rat;11090094;Antagonist
[125I]iodophenpropit;H3 receptor;f;;Rat;7834183;Antagonist
thioperamide;H3 receptor;f;;Rat;12606603|15294456|10869375|11714875|11162480|11090094|12393057;Antagonist
thioperamide;H3 receptor;f;;Human;12606603|15294456|10869375|11284713|11714875|11090094|12393057;Antagonist
thioperamide;H3 receptor;f;;Mouse;15341517;Antagonist
UCL-2138;H3 receptor;f;;Human;11179434;Antagonist
VUF14738;H3 receptor;f;;Human;29470065;Antagonist
VUF14862;H3 receptor;f;;Human;29470065;Antagonist
VUF 4904;H3 receptor;f;;Human;11714875;Antagonist
A-349821;H3 receptor;f;;Human;15294456;Inverse agonist
A-349821;H3 receptor;f;;Rat;15294456;Inverse agonist
ABT-239;H3 receptor;f;;Human;15608078;Inverse agonist
ABT-239;H3 receptor;f;;Rat;15608078;Inverse agonist
enerisant;H3 receptor;f;;Rat;32862143;Inverse agonist
enerisant;H3 receptor;f;;Human;32862143;Inverse agonist
ST-1006;H4 receptor;f;;Human;26084539;Agonist
2-(3-bromophenyl)histamine;H4 receptor;f;;Human;15947036;Full agonist
2-methylhistamine;H4 receptor;f;;Human;15947036|16432504;Full agonist
4-methylhistamine;H4 receptor;f;;Human;15947036|16432504;Full agonist
CCL16;H4 receptor;t;Human;Human;15265943;Full agonist
dimaprit;H4 receptor;f;;Human;11179434|11181941|11179436|15947036;Full agonist
histamine;H4 receptor;t;;Human;11179434|11561071|11181941|11179436|15947036|16432504|15454206;Full agonist
histamine;H4 receptor;t;;Rat;11561071;Full agonist
histamine;H4 receptor;t;;Mouse;11561071;Full agonist
HTMT;H4 receptor;f;;Human;11179436;Full agonist
imetit;H4 receptor;f;;Mouse;11561071;Full agonist
imetit;H4 receptor;f;;Rat;11561071;Full agonist
imetit;H4 receptor;f;;Human;11179434|11561071|11181941|11179436;Full agonist
immepip;H4 receptor;f;;Human;11179434|14640553|11179436;Full agonist
improgan;H4 receptor;f;;Human;11179436;Full agonist
N-α-methylhistamine;H4 receptor;f;;Human;11181941|11179436;Full agonist
N-ethylhistamine;H4 receptor;f;;Human;16432504;Full agonist
N-methylhistamine;H4 receptor;f;;Rat;11561071;Full agonist
N-methylhistamine;H4 receptor;f;;Human;11179434|11561071|16432504;Full agonist
N-methylhistamine;H4 receptor;f;;Mouse;11561071;Full agonist
N-[3H]methylhistamine;H4 receptor;f;;Human;11179434;Full agonist
N,N-dimethylhistamine;H4 receptor;f;;Human;16432504;Full agonist
(R)-α-methylhistamine;H4 receptor;f;;Human;11179434|11561071|11181941|11179436;Full agonist
(R)-α-methylhistamine;H4 receptor;f;;Rat;11561071;Full agonist
(R)-α-methylhistamine;H4 receptor;f;;Mouse;11561071;Full agonist
(S)-α-methylhistamine;H4 receptor;f;;Human;11181941;Full agonist
methimepip;H4 receptor;f;;Human;15771452;Full agonist
[125I]CCL16 (human);H4 receptor;f;;Human;15265943;Full agonist
[3H]histamine;H4 receptor;f;;Mouse;11561071;Full agonist
[3H]histamine;H4 receptor;f;;Rat;11561071;Full agonist
[3H]histamine;H4 receptor;f;;Human;11179434|11179435|11561071|11181941|10973974|16432504;Full agonist
[3H](R)-α-methylhistamine;H4 receptor;f;;Human;11179434;Full agonist
VUF 8430;H4 receptor;f;;Human;17154494;Full agonist
clobenpropit;H4 receptor;f;;Human;12606603|11179434|11561071|11181941|15947036;Partial agonist
clobenpropit;H4 receptor;f;;Rat;11561071;Partial agonist
clobenpropit;H4 receptor;f;;Mouse;11561071;Partial agonist
impromidine;H4 receptor;f;;Human;11179434|15947036;Partial agonist
adriforant;H4 receptor;f;;Human;26084539;Antagonist
burimamide;H4 receptor;f;;Mouse;11561071;Antagonist
burimamide;H4 receptor;f;;Human;11179434|11561071|11181941|11179436|15947036;Antagonist
burimamide;H4 receptor;f;;Rat;11561071;Antagonist
ciproxifan;H4 receptor;f;;Human;12606603|15294456|26084539;Antagonist
clozapine;H4 receptor;f;;Human;11179434|11561071|11179436|15947036;Antagonist
clozapine;H4 receptor;f;;Rat;11561071;Antagonist
clozapine;H4 receptor;f;;Mouse;11561071;Antagonist
conessine;H4 receptor;f;;Human;26084539;Antagonist
H4 antagonist 48;H4 receptor;f;;Human;29579390;Antagonist
H4 antagonist 48;H4 receptor;f;;Mouse;29579390;Antagonist
INCB-38579;H4 receptor;f;;Human;26084539;Antagonist
iodophenpropit;H4 receptor;f;;Human;11179436;Antagonist
JNJ-10191584;H4 receptor;f;;Human;15454206;Antagonist
JNJ-39758979;H4 receptor;f;;Human;26084539|24495018;Antagonist
JNJ 7777120;H4 receptor;f;;Human;15947036|14722321|16854056;Antagonist
MK-0249;H4 receptor;f;;Human;26084539;Antagonist
pitolisant;H4 receptor;f;;Human;26084539;Antagonist
SENS-111;H4 receptor;f;;Human;31347148;Antagonist
[3H]JNJ 7777120;H4 receptor;f;;Human;14722321;Antagonist
[3H]pyrilamine;H4 receptor;f;;Human;11179435;Antagonist
thioperamide;H4 receptor;f;;Mouse;11561071;Antagonist
thioperamide;H4 receptor;f;;Human;12606603|15294456|11179434|11561071|11181941|11179436;Antagonist
thioperamide;H4 receptor;f;;Rat;11561071;Antagonist
toreforant;H4 receptor;f;;Human;;Antagonist
Cd2+;Hv1;f;;Human;;None
Zn2+;Hv1;f;;Human;;None
trilostane;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2;f;;None;6574022;Inhibition
atorvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;11349148;Competitive
atorvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;16128575;Competitive
atorvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11256847;Competitive
cerivastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11256847;Competitive
cerivastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;16128575;Competitive
cerivastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;15686906;Competitive
DFGYVAE;hydroxymethylglutaryl-CoA reductase;f;;Human;20494585;Competitive
DFGYVAE;hydroxymethylglutaryl-CoA reductase;f;;Human;20494585;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11256847;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;11349148;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;19502059;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;12773150;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;8246237;Competitive
fluvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;16128575;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;2153213;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;1992138;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Mouse;;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;1597859;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;8246234;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Competitive
lovastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;6933445;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3989819;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3989819;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3656359;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;1992137;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3981532;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;19502059;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;15686906;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;1992138;Competitive
mevastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3973903;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;18072721;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11392538;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11256847;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;8246234;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;1597859;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;11392538;Competitive
pravastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;16128575;Competitive
rosuvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;11349148;Competitive
rosuvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;17574412;Competitive
rosuvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;16128575;Competitive
rosuvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11256847;Competitive
rosuvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;11256847;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3634830;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;11349148;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Human;1433193;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;11256847;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;17574412;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;17574412;Competitive
simvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;17574412;Competitive
5-ketodihydromevinolin;hydroxymethylglutaryl-CoA reductase;f;;Rat;3656359;Inhibition
atorvastatin lactone;hydroxymethylglutaryl-CoA reductase;f;;Rat;1992137;Inhibition
BMY-21950;hydroxymethylglutaryl-CoA reductase;f;;Rat;1992149;Inhibition
BMY 22089;hydroxymethylglutaryl-CoA reductase;f;;Rat;2231596;Inhibition
compound 11dd [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Inhibition
compound 11ff [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Inhibition
compound 11jj [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Human;1656041;Inhibition
compound 11nn [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Human;1656041;Inhibition
compound 11nn [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Inhibition
compound 13b [PMID: 18412317];hydroxymethylglutaryl-CoA reductase;f;;Rat;18412317;Inhibition
compound 13b [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Rat;2153213;Inhibition
compound 13g [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Rat;2153213;Inhibition
compound 13 [PMID: 1992149];hydroxymethylglutaryl-CoA reductase;f;;Rat;1992149;Inhibition
compound 16f [PMID: 18155906];hydroxymethylglutaryl-CoA reductase;f;;Rat;18155906;Inhibition
compound 17 [PMID: 15686906];hydroxymethylglutaryl-CoA reductase;f;;Human;15686906;Inhibition
compound 17 [PMID: 3701793];hydroxymethylglutaryl-CoA reductase;f;;Rat;3701793;Inhibition
compound 18 [PMID: 1875346];hydroxymethylglutaryl-CoA reductase;f;;Rat;1875346;Inhibition
compound 18 [PMID: 8426367];hydroxymethylglutaryl-CoA reductase;f;;Human;8426367;Inhibition
compound 18t [PMID: 8246237];hydroxymethylglutaryl-CoA reductase;f;;Rat;8246237;Inhibition
compound 1a [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Inhibition
compound 1e [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Inhibition
compound 1f [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Inhibition
compound 1 [Patel et al., 1991];hydroxymethylglutaryl-CoA reductase;f;;Human;;Inhibition
compound 1 [PMID: 1895299];hydroxymethylglutaryl-CoA reductase;f;;Rat;1895299;Inhibition
compound 25d [PMID: 19502059];hydroxymethylglutaryl-CoA reductase;f;;Rat;19502059;Inhibition
compound 25 [PMID: 2296027];hydroxymethylglutaryl-CoA reductase;f;;Rat;2296027;Inhibition
compound 28 [PMID: 8246233];hydroxymethylglutaryl-CoA reductase;f;;Rat;8246233;Inhibition
compound 29f [PMID: 17560788];hydroxymethylglutaryl-CoA reductase;f;;Rat;17560788;Inhibition
compound 29 [PMID: 1527791];hydroxymethylglutaryl-CoA reductase;f;;Human;1527791;Inhibition
compound 29 [PMID: 15686906];hydroxymethylglutaryl-CoA reductase;f;;Human;15686906;Inhibition
compound 29 [PMID: 2296027];hydroxymethylglutaryl-CoA reductase;f;;Rat;2296027;Inhibition
compound 2c [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Inhibition
compound 2d [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Inhibition
compound 2 [Dreyer et al., 1991];hydroxymethylglutaryl-CoA reductase;f;;Human;;Inhibition
compound 2f [PMID: 2153213];hydroxymethylglutaryl-CoA reductase;f;;Human;2153213;Inhibition
compound 2g [PMID: 2296036];hydroxymethylglutaryl-CoA reductase;f;;Rat;2296036;Inhibition
compound 2t [PMID: 2296036];hydroxymethylglutaryl-CoA reductase;f;;Human;2296036;Inhibition
compound 33 [PMID: 17574412];hydroxymethylglutaryl-CoA reductase;f;;Human;17574412;Inhibition
compound 35 [PMID: 8246233];hydroxymethylglutaryl-CoA reductase;f;;Rat;8246233;Inhibition
compound 3 [Dreyer et al., 1991];hydroxymethylglutaryl-CoA reductase;f;;Human;;Inhibition
compound 3h [PMID: 8246234];hydroxymethylglutaryl-CoA reductase;f;;Rat;8246234;Inhibition
compound 3j [PMID: 2231594];hydroxymethylglutaryl-CoA reductase;f;;Rat;2231594;Inhibition
compound 3k [PMID: 2231594];hydroxymethylglutaryl-CoA reductase;f;;Rat;2231594;Inhibition
compound 3q [PMID: 2231594];hydroxymethylglutaryl-CoA reductase;f;;Rat;2231594;Inhibition
compound 3u [PMID: 2231594];hydroxymethylglutaryl-CoA reductase;f;;Rat;2231594;Inhibition
compound 41 [PMID: 17574411];hydroxymethylglutaryl-CoA reductase;f;;Human;17574411;Inhibition
compound 42 [PMID: 17574411];hydroxymethylglutaryl-CoA reductase;f;;Human;17574411;Inhibition
compound 4 [Balasubramanian et al., 1992];hydroxymethylglutaryl-CoA reductase;f;;Rat;;Inhibition
compound 4d [PMID: 2296036];hydroxymethylglutaryl-CoA reductase;f;;Rat;2296036;Inhibition
compound 4ff [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Human;1656041;Inhibition
compound 4i [PMID: 2296036];hydroxymethylglutaryl-CoA reductase;f;;Human;2296036;Inhibition
compound 4p [PMID: 1895299];hydroxymethylglutaryl-CoA reductase;f;;Rat;1895299;Inhibition
compound 4rr [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Inhibition
compound 50 [PMID: 18072721];hydroxymethylglutaryl-CoA reductase;f;;Rat;18072721;Inhibition
compound 5ab [PMID: 8246233];hydroxymethylglutaryl-CoA reductase;f;;Rat;8246233;Inhibition
compound 6a [Patil et al., 1989];hydroxymethylglutaryl-CoA reductase;f;;Human;;Inhibition
compound 6v [PMID: 1895299];hydroxymethylglutaryl-CoA reductase;f;;Rat;1895299;Inhibition
compound 74 [PMID: 1656041];hydroxymethylglutaryl-CoA reductase;f;;Rat;1656041;Inhibition
compound 7 [PMID: 2909732];hydroxymethylglutaryl-CoA reductase;f;;Rat;2909732;Inhibition
compound 8b [PMID: 1992138];hydroxymethylglutaryl-CoA reductase;f;;Rat;1992138;Inhibition
compound 9a [Patil et al., 1989];hydroxymethylglutaryl-CoA reductase;f;;Human;;Inhibition
compound 9 [PMID: 1992149];hydroxymethylglutaryl-CoA reductase;f;;Human;1597859;Inhibition
compound 9 [PMID: 1992149];hydroxymethylglutaryl-CoA reductase;f;;Rat;1992149;Inhibition
compound 9 [PMID: 7932551];hydroxymethylglutaryl-CoA reductase;f;;Rat;7932551;Inhibition
dalvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;8434028;Inhibition
FPYVAE peptide [PMID: 20494585];hydroxymethylglutaryl-CoA reductase;f;;Human;20494585;Inhibition
GLPDGG peptide [PMID: 20494585];hydroxymethylglutaryl-CoA reductase;f;;Human;20494585;Inhibition
o-hydroxyatorvastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;18540668;Inhibition
pitavastatin;hydroxymethylglutaryl-CoA reductase;f;;Rat;19879766;Inhibition
(S)-3-hydroxy-3-methylglutaryl-CoA;hydroxymethylglutaryl-CoA synthase 1;f;;Human;19706283;Feedback inhibition
L-659,699;hydroxymethylglutaryl-CoA synthase 1;f;;Rat;2890166|8094614;Unknown
ABT-384;hydroxysteroid 11-beta dehydrogenase 1;f;;Human;16996734;Inhibition
AZD4017;hydroxysteroid 11-beta dehydrogenase 1;f;;Human;22691057;Inhibition
AZD8329;hydroxysteroid 11-beta dehydrogenase 1;f;;Human;;Inhibition
BMS-823778;hydroxysteroid 11-beta dehydrogenase 1;f;;Human;30613321;Inhibition
enoxolone;hydroxysteroid 11-beta dehydrogenase 1;f;;Human;25590374;Inhibition
enoxolone;hydroxysteroid 11-beta dehydrogenase 1;f;;Rat;19914836;Inhibition
enoxolone;hydroxysteroid 11-beta dehydrogenase 1;f;;Human;18653260;Inhibition
enoxolone;hydroxysteroid 11-beta dehydrogenase 2;f;;Human;25590374;Inhibition
enoxolone;hydroxysteroid 11-beta dehydrogenase 2;f;;Rat;19914836;Inhibition
compound 24 [PMID: 31343176];hydroxysteroid 17-beta dehydrogenase 2;f;;Mouse;31343176;Inhibition
compound 24 [PMID: 31343176];hydroxysteroid 17-beta dehydrogenase 2;f;;Human;31343176;Inhibition
compound 24 [PMID: 31343176];hydroxysteroid 17-beta dehydrogenase 2;f;;Rat;31343176;Inhibition
1-oleoyl glycerol;GPR119;f;;Human;21778222;Agonist
1-palmitoyl-lysophosphatidylcholine;GPR119;f;;Human;15607732;Agonist
1-stearoyl-lysophosphatidylcholine;GPR119;f;;Human;15607732;Agonist
2-oleoyl glycerol;GPR119;f;;Human;21778222;Agonist
AR231453;GPR119;f;;Human;17289847;Agonist
AS1269574;GPR119;f;;Human;20804735;Agonist
AS1535907;GPR119;f;;Human;20937249|21114601|22365911;Agonist
AS1907417;GPR119;f;;Human;20816753;Agonist
compound 1 [PMID: 21273063];GPR119;f;;Human;21273063;Agonist
compound 1 [PMID: 21939274];GPR119;f;;Human;21939274;Agonist
compound 20f [PMID: 21536438];GPR119;f;;Human;21536438;Agonist
compound 23 [PMID: 21444206];GPR119;f;;Human;21444206;Agonist
compound 29a [PMID: 21444206];GPR119;f;;Human;21444206;Agonist
compound 2 [PMID: 21939274];GPR119;f;;Human;21939274;Agonist
compound 36j [PMID: 21536438];GPR119;f;;Human;21536438;Agonist
compound 36 [PMID: 21273063];GPR119;f;;Human;21273063;Agonist
compound 3a [PMID: 21444206];GPR119;f;;Human;21444206;Agonist
compound 3j [PMID: 21444206];GPR119;f;;Human;21444206;Agonist
compound 3 [PMID: 21310611];GPR119;f;;Human;21310611;Agonist
compound 42 [PMID: 22545772];GPR119;f;;Human;22545772;Agonist
compound 58 [PMID: 21273063];GPR119;f;;Human;21273063;Agonist
compound 8g [PMID: 21444206];GPR119;f;;Human;21444206;Agonist
DS-8500a;GPR119;f;;Human;30217957;Agonist
JNJ-38431055;GPR119;f;;Human;22264481;Agonist
lysophosphatidylethanolamine;GPR119;f;;Human;15607732;Agonist
lysophosphatidylinositol;GPR119;f;;Human;15607732;Agonist
MBX-2982;GPR119;f;;Human;24751443;Agonist
N-oleoyldopamine;GPR119;f;;Human;19901198;Agonist
N-oleoylethanolamide;GPR119;t;;Human;16517404|19901198|23396314;Agonist
oleoyl-lysophosphatidylcholine;GPR119;f;;Human;15607732;Agonist
olvanil;GPR119;f;;Human;19901198;Agonist
PSN375963;GPR119;f;;Human;16517404;Agonist
PSN632408;GPR119;f;;Human;16517404;Agonist
(R)-N-oleoyltyrosinol;GPR119;f;;Human;19901198;Agonist
(S)-N-oleoyltyrosinol;GPR119;f;;Human;19901198;Agonist
YH18968;GPR119;f;;Human;29495245;Agonist
N-palmitoylethanolamine;GPR119;t;;Human;;Full agonist
SEA;GPR119;t;;Human;;Full agonist
sphingosine 1-phosphate;GPR12;t;;Human;12220620;Full agonist
sphingosylphosphorylcholine;GPR12;f;;Human;12574419;Full agonist
9-hydroxyoctadecadienoic acid;GPR132;t;;Human;16236715;Full agonist
JNJ-63533054;GPR139;f;;Human;26349500;Agonist
LP-360924;GPR139;f;;Human;19525486;Agonist
L-phenylalanine;GPR139;t;;Human;24826842;Agonist
L-phenylalanine;GPR139;t;;Human;26349500;Agonist
L-phenylalanine;GPR139;t;;Human;26349500;Agonist
L-tryptophan;GPR139;t;;Human;26349500;Agonist
L-tryptophan;GPR139;t;;Human;26349500;Agonist
L-tryptophan;GPR139;t;;Human;24826842;Agonist
compound 1a [PMID: 24900311];GPR139;f;;Human;24900311;Full agonist
LP-471756;GPR139;f;;Human;19525486;Antagonist
NCRW0005-F05;GPR139;f;;Human;26027661;Antagonist
compound 33 [Toda et al., 2013];GPR142;f;;Human;24900747;Agonist
levodopa;GPR143;t;;Human;18828673;Agonist
GPR15L;GPR15;f;Human;Human;28900043;Agonist
GPR15L (71-81);GPR15;f;Human;Human;31675498;Agonist
lysophosphatidylserine;GPR174;t;;Human;22983457;Full agonist
ASN02563583;GPR17;f;;Human;21744154;Agonist
ASN04421891;GPR17;f;;Human;21744154;Agonist
ASN04450772;GPR17;f;;Human;21744154;Agonist
ASN04885796;GPR17;f;;Human;21744154;Agonist
ASN06917370;GPR17;f;;Human;21744154;Agonist
ATP;GPR17;t;;Human;21773766;Agonist
LTC4;GPR17;t;;Human;16990797;Agonist
LTC4;GPR17;t;;Mouse;18974869;Agonist
LTD4;GPR17;t;;Human;16990797;Agonist
LTD4;GPR17;t;;Mouse;18974869;Agonist
LTE4;GPR17;t;;Mouse;18974869;Agonist
UDP-galactose;GPR17;t;;Human;20148890|16990797;Agonist
UDP-galactose;GPR17;t;;Mouse;18974869;Agonist
UDP-glucose;GPR17;t;;Human;20148890|16990797;Agonist
UDP-glucose;GPR17;t;;Mouse;18974869;Agonist
uridine diphosphate;GPR17;t;;Human;20148890|16990797;Agonist
cangrelor;GPR17;f;;Mouse;18974869;Antagonist
montelukast;GPR17;f;;Mouse;18974869;Antagonist
adrenomedullin;GPR182;t;Rat;Rat;7592696;Partial agonist
25-hydroxycholesterol;GPR183;t;;Human;21796211;Agonist
27-hydroxycholesterol;GPR183;t;;Human;21796211;Agonist
7α,27-dihydroxycholesterol;GPR183;t;;Human;21796211;Agonist
7α-hydroxycholesterol;GPR183;t;;Human;21796211;Agonist
7β, 25-dihydroxycholesterol;GPR183;t;;Human;21796211;Agonist
7β, 27-dihydroxycholesterol;GPR183;t;;Human;21796211;Agonist
7β-hydroxycholesterol;GPR183;t;;Human;21796211;Agonist
7α,25-dihydroxycholesterol;GPR183;t;;Human;21796211|21796212;Full agonist
7α,25-dihydroxycholesterol;GPR183;t;;Human;21796211|21796212;Full agonist
abnormal cannabidiol;GPR18;f;;Human;21595653;Agonist
arachidonylcyclopropylamide;GPR18;f;;Human;21595653;Agonist
N-arachidonoylglycine;GPR18;t;;Human;16844083;Agonist
O-1602;GPR18;f;;Human;21595653;Agonist
PSB-KD107;GPR18;f;;Human;;Agonist
anandamide;GPR18;f;;Human;21595653;Full agonist
Δ9-tetrahydrocannabinol;GPR18;f;;Human;21595653|22014123;Full agonist
N-arachidonoylglycine;GPR18;t;;Human;21595653;Full agonist
AM251;GPR18;f;;Human;21595653;Partial agonist
cannabidiol;GPR18;f;;Human;21595653;Partial agonist
adropin;GPR19;f;Human;Human;28476646;Agonist
12S-[3H]HETE;GPR31;f;;Mouse;21712392;Agonist
12S-HETE;GPR31;t;;Mouse;21712392;Full agonist
[3H]resolvin D1;GPR32;f;;Human;20080636;Agonist
LXA4;GPR32;t;;Human;20080636;Full agonist
resolvin D1;GPR32;t;;Human;20080636;Full agonist
RvD1-ME;GPR32;f;;Human;22449948;Full agonist
lysophosphatidylserine;GPR34;t;;Mouse;16460680;Agonist
lysophosphatidylserine;GPR34;t;;Human;16460680|22343749;Full agonist
2-oleoyl-LPA;GPR35;t;;Human;20361937;Agonist
bumetanide;GPR35;f;;Human;22236570;Agonist
compound 83 [PMID: 23888932];GPR35;f;;Human;23888932;Agonist
CXCL17;GPR35;f;Human;Human;25411203;Agonist
furosemide;GPR35;f;;Human;22236570;Agonist
kynurenic acid;GPR35;t;;Mouse;16754668;Agonist
kynurenic acid;GPR35;t;;Human;16754668|23396314;Agonist
kynurenic acid;GPR35;t;;Rat;16754668;Agonist
lodoxamide;GPR35;f;;Human;29068046;Agonist
pamoic acid;GPR35;f;;Rat;20919992;Agonist
pamoic acid;GPR35;f;;Human;20919992;Agonist
zaprinast;GPR35;f;;Human;16934253;Agonist
zaprinast;GPR35;f;;Rat;16934253;Agonist
CID2745687;GPR35;f;;Human;23888932;Antagonist
CID2745687;GPR35;f;;Human;23888932;Antagonist
CID2745687;GPR35;f;;Human;23888932;Antagonist
CID2745687;GPR35;f;;Human;20826425;Antagonist
neuropeptide head activator;GPR37;f;;Human;16443751;Agonist
prosaptide;GPR37;t;Human;Human;23690594;Agonist
prosaptide;GPR37L1;t;Human;Human;23690594;Agonist
Zn2+;GPR39;t;;Human;16959833;Agonist
compound 15 [PMID: 25313322];GPR39;f;;Human;25313322;Full agonist
compound 1 [PMID: 24900608];GPR39;f;;Human;24900608;Full agonist
diphenyleneiodonium chloride;GPR3;f;;Human;24633425;Full agonist
sphingosine 1-phosphate;GPR3;t;;Human;12220620;Full agonist
GPR4 antagonist 3b;GPR4;f;;Human;27190599;Antagonist
NE 52-QQ57;GPR4;f;;Human;28445047;Antagonist
NE 52-QQ57;GPR4;f;;Rat;28445047;Antagonist
compound 7a [PMID: 24884590];GPR52;f;;Human;24884590;Agonist
derivative 17 [Nakahata et al., 2018];GPR52;f;;Human;29478803;Agonist
2-arachidonoylglycerol;GPR55;t;;Human;17876302;Agonist
2-arachidonyl glyceryl ether;GPR55;f;;Human;17876302;Agonist
abnormal cannabidiol;GPR55;f;;Human;17876302;Agonist
abnormal cannabidiol;GPR55;f;;Human;17704827;Agonist
AM251;GPR55;f;;Human;17876302|20136841|19723626;Agonist
anandamide;GPR55;t;;Human;17876302;Agonist
Chgb (511-532);GPR55;f;Rat;Human;;Agonist
CID1172084;GPR55;f;;Human;21534610;Agonist
CID1792197;GPR55;f;;Human;21534610;Agonist
CID2440433;GPR55;f;;Human;21534610;Agonist
CLUL1 (52-77);GPR55;f;Human;Human;31675498;Agonist
CP55940;GPR55;f;;Human;17876302|16318877;Agonist
Δ9-tetrahydrocannabinol;GPR55;f;;Human;17876302;Agonist
GSK494581A;GPR55;f;;Human;21233197;Agonist
GSK575594A;GPR55;f;;Human;21233197;Agonist
HU-210;GPR55;f;;Human;17876302;Agonist
JWH015;GPR55;f;;Human;17876302;Agonist
lysophosphatidylinositol;GPR55;t;;Human;17765871|20136841|23396314;Agonist
MANSC (415-431);GPR55;f;Human;Human;31675498;Agonist
MSMB (91-114);GPR55;f;Human;Human;31675498;Agonist
N-oleoylethanolamide;GPR55;f;;Human;17876302;Agonist
N-palmitoylethanolamine;GPR55;t;;Human;17876302;Agonist
O-1602;GPR55;f;;Human;10381763|17876302|21079038;Agonist
O-arachidonoyl ethanolamine;GPR55;f;;Human;17876302;Agonist
SPAG11B (61-103);GPR55;f;Human;Human;31675498;Agonist
[3H]CP55940;GPR55;f;;Human;17876302;Agonist
T1117;GPR55;f;;Human;20136833;Agonist
2-arachidonoylglycerolphosphoinositol;GPR55;t;;Human;18845565;Full agonist
compound 3a [Badolato et al., 2019];GPR55;f;;Human;30996770;Inverse agonist
CP55,244;GPR55;f;;Human;21233197;Inverse agonist
[3H]rimonabant;GPR55;f;;Human;17876302;Partial agonist
AM281;GPR55;f;;Human;17876302|20136841;Antagonist
cannabidiol;GPR55;f;;Human;17876302|21079038;Antagonist
CID16020046;GPR55;f;;Human;23639801;Antagonist
ML193;GPR55;f;;Human;22091481;Antagonist
rimonabant;GPR55;f;;Human;20136841|21233197;Antagonist
CP55,667;GPR55;f;;Human;21233197;Inverse agonist
dihydrosphingosine 1-phosphate;GPR63;t;;Human;12618218;Full agonist
dioleoylphosphatidic acid;GPR63;t;;Human;12618218;Full agonist
sphingosine 1-phosphate;GPR63;t;;Human;12618218;Full agonist
CARTPT (76-96);GPR68;f;;Human;31675498;Agonist
OSTN (115-133);GPR68;f;;Human;31675498;Agonist
Pomc (141-162);GPR68;f;;Human;31675498;Agonist
lorazepam;GPR68;f;;Human;26550826;Positive
MS48107;GPR68;f;;Human;31298539;Positive
ogerin;GPR68;f;;Human;26550826;Positive
sphingosine 1-phosphate;GPR6;t;;Mouse;12220620|14592418;Full agonist
CCL5;GPR75;t;Human;Human;17001303;Full agonist
PEN;GPR83;f;Mouse;Mouse;27117253;Agonist
PEN;GPR83;f;Mouse;Mouse;27117253;Agonist
PEN;GPR83;f;Rat;Mouse;27117253;Agonist
Zn2+;GPR83;f;;Mouse;23335960;Full agonist
6-nonylpyridine-2,4-diol;GPR84;f;;Human;32869860;Agonist
DL-175;GPR84;f;;Human;32869860;Agonist
Embelin;GPR84;f;;Human;32869860;Agonist
lauric acid;GPR84;f;;Human;16966319;Agonist
PSB-1584;GPR84;f;;Human;30023867;Agonist
PSB-1584;GPR84;f;;Human;30023867;Agonist
PSB-16434;GPR84;f;;Human;32869860;Agonist
PSB-17365;GPR84;f;;Human;30023867;Agonist
undecanoic acid;GPR84;f;;Human;16966319;Agonist
ZQ-16;GPR84;f;;Human;32869860;Agonist
2-hydroxy capric acid;GPR84;f;;Human;23449982;Full agonist
2-hydroxylauric acid;GPR84;f;;Human;23449982;Full agonist
3-hydroxy capric acid;GPR84;f;;Human;23449982;Full agonist
3-hydroxylauric acid;GPR84;f;;Human;23449982;Full agonist
6-n-octylaminouracil;GPR84;f;;Human;23449982;Full agonist
decanoic acid;GPR84;f;;Human;16966319|23396314;Full agonist
DIM;GPR84;f;;Human;32869860;Agonist
GLPG1205;GPR84;f;;Human;;Antagonist
setogepram;GPR84;f;;Human;29454750;Antagonist
LPA;GPR87;t;;Human;17905198|18466763;Agonist
dioctanoylglycerol pyrophosphate;GPR87;f;;Human;17905198;Antagonist
Ki16425;GPR87;f;;Human;17905198;Antagonist
RTI-13951-33;GPR88;f;;Human;30011199;Agonist
compound 2 [PMID: 24793972];GPR88;f;;Human;24793972;Full agonist
acalabrutinib;IL2 inducible T cell kinase;f;;Human;26641137;Inhibition
BMS-509744;IL2 inducible T cell kinase;f;;Human;16682193;Inhibition
compound 25 [PMID: 31260299];IL2 inducible T cell kinase;f;;Human;31260299;Inhibition
compound 4g [PMID: 21316219];IL2 inducible T cell kinase;f;;Human;21316219;Inhibition
compound 7 [PMID: 22464456];IL2 inducible T cell kinase;f;;Human;22464456;Inhibition
GNE-4997;IL2 inducible T cell kinase;f;;Human;25844760;Inhibition
ibrutinib;IL2 inducible T cell kinase;f;;Human;26641137;Inhibition
PRN694;IL2 inducible T cell kinase;f;;Human;25593320;Inhibition
WZ4002;IL2 inducible T cell kinase;f;;Human;20033049;Inhibition
R-spondin-1;LGR4;t;Human;Human;21693646;Full agonist
R-spondin-2;LGR4;t;Human;Human;21693646;Full agonist
R-spondin-3;LGR4;f;Human;Human;21909076;Full agonist
R-spondin-3;LGR4;t;Human;Human;21693646;Full agonist
R-spondin-4;LGR4;t;Human;Human;21693646;Full agonist
R-spondin-1;LGR5;t;Human;Human;21693646;Full agonist
R-spondin-2;LGR5;t;Human;Human;21693646;Full agonist
R-spondin-3;LGR5;t;Human;Human;21693646;Full agonist
R-spondin-4;LGR5;t;Human;Human;21693646;Full agonist
R-spondin-3;LGR6;t;Human;Human;21727895|21693646;Agonist
R-spondin-1;LGR6;f;Mouse;Human;22615920;Full agonist
R-spondin-1;LGR6;t;Human;Human;21727895|21693646;Full agonist
R-spondin-2;LGR6;f;Mouse;Human;22615920;Full agonist
R-spondin-2;LGR6;t;Human;Human;21727895|21693646;Full agonist
R-spondin-3;LGR6;f;Mouse;Human;22615920;Full agonist
R-spondin-4;LGR6;t;Human;Human;21727895|21693646;Full agonist
R-spondin-4;LGR6;f;Mouse;Human;22615920;Full agonist
angiotensin-(1-7);MAS1;f;Human|Mouse|Rat;Mouse;12829792;Agonist
angiotensin-(1-7);MAS1;f;Human|Mouse|Rat;Mouse;21670420;Agonist
AR234958;MAS1;f;;Human;29928987;Agonist
AR234960;MAS1;f;;Human;22003054;Full agonist
AR234960;MAS1;f;;Rat;22003054;Full agonist
AVE 0991;MAS1;f;;Mouse;15326087;Full agonist
CGEN-856;MAS1;f;;Human;18854305|20479330;Full agonist
CGEN-857;MAS1;f;;Human;18854305|20479330;Full agonist
MBP7;MAS1;f;;Rat;16336942;Full agonist
neuropeptide FF;MAS1;f;Human|Mouse|Rat;Mouse;11551509;Full agonist
[125I]angiotensin-(1-7) (human, mouse, rat);MAS1;f;;Mouse;12829792;Full agonist
[D-Ala7]-angiotensin(1-7);MAS1;f;;Mouse;12829792;Antagonist
[D-Ala7]-angiotensin(1-7);MAS1;f;;Mouse;21670420;Antagonist
AR244555;MAS1;f;;Rat;22003054;Inverse agonist
AR244555;MAS1;f;;Human;22003054;Inverse agonist
AR291903;MAS1;f;;Human;29928987;Inverse agonist
AR305352;MAS1;f;;Human;22003054;Inverse agonist
AR305352;MAS1;f;;Rat;22003054;Inverse agonist
ligelizumab;immunoglobulin heavy constant epsilon;f;;Human;25200415;Binding
omalizumab;immunoglobulin heavy constant epsilon;f;;Human;;Binding
omalizumab;immunoglobulin heavy constant epsilon;f;;Human;25200415;Binding
quilizumab;immunoglobulin heavy constant epsilon;f;;Human;;Binding
Li+;IMPase 1;f;;Human;1377913;Inhibition
β-alanine;MRGPRD;f;;Rat;15037633;Agonist
β-alanine;MRGPRD;f;;Mouse;15037633;Agonist
β-alanine;MRGPRD;t;;Human;15037633|23396314;Full agonist
chloroquine;MRGPRX1;f;;Human;20004959;Agonist
compound 16 [PMID: 31498617];MRGPRX1;f;;Human;31498617;Agonist
bovine adrenal medulla peptide 8-22;MRGPRX1;t;Human;Human;11850634;Full agonist
bovine adrenal medulla peptide 8-22;MRGPRX1;t;Human;Human;15163697|11850634|23396314;Full agonist
bovine adrenal medulla peptide 8-22;MRGPRX1;t;Human;Human;11850634;Full agonist
compound 48/80;MRGPRX2;f;;Human;28288109;Agonist
(R)-ZINC-3573;MRGPRX2;f;;Human;28288109;Agonist
SRIF-28;MRGPRX2;f;Human|Mouse|Rat;Human;23396314;Agonist
substance P;MRGPRX2;f;Human|Mouse|Rat;Human;28288109|25517090;Agonist
TAN-67;MRGPRX2;f;;Human;23396314|28288109|11765135;Agonist
compound 2 [PMID: 19230660];MRGPRX2;f;;Human;19230660;Full agonist
cortistatin-14;MRGPRX2;f;Mouse|Rat;Human;12915402|15823563|23396314|28288109;Full agonist
PAMP-12 (human);MRGPRX2;f;;Human;15823563;Full agonist
PAMP-20;MRGPRX2;t;Human;Human;15823563;Full agonist
QWF;MRGPRX2;f;;Human;27734033;Antagonist
1-methyl-L-tryptophan;indoleamine 2,3-dioxygenase 1;f;;Human;24099220;Inhibition
amg-1;indoleamine 2,3-dioxygenase 1;f;;Human;21835273;Inhibition
beta-carboline;indoleamine 2,3-dioxygenase 1;f;;Human;21269836;Inhibition
compound 8u [PMID: 31999451];indoleamine 2,3-dioxygenase 1;f;;Human;31999451;Inhibition
epacadostat;indoleamine 2,3-dioxygenase 1;f;;Human;19507862;Inhibition
linrodostat;indoleamine 2,3-dioxygenase 1;f;;Human;29531094;Inhibition
LW106;indoleamine 2,3-dioxygenase 1;f;;Human;29722898;Inhibition
navoximod;indoleamine 2,3-dioxygenase 1;f;;Human;31264862;Inhibition
necrostatin-1;indoleamine 2,3-dioxygenase 1;f;;Human;15711557;Inhibition
PF-06840003;indoleamine 2,3-dioxygenase 1;f;;Human;;Inhibition
tryptanthrin;indoleamine 2,3-dioxygenase 1;f;;Human;24099220;Inhibition
tryptanthrin 5i;indoleamine 2,3-dioxygenase 1;f;;Human;27475108;Inhibition
tryptanthrin 5i;indoleamine 2,3-dioxygenase 1;f;;Human;27475108;Inhibition
tryptanthrin 5i;indoleamine 2,3-dioxygenase 2;f;;Human;27475108;Inhibition
tryptanthrin 5i;indoleamine 2,3-dioxygenase 2;f;;Human;27475108;Inhibition
tryptanthrin 5i;indoleamine 2,3-dioxygenase 2;f;;Human;27475108;Inhibition
1400W;Inducible NOS;f;;Human;9030556;Inhibition
2-amino-4-methylpyridine;Inducible NOS;f;;Human;8937711;Inhibition
aminoguanidine;Inducible NOS;f;;Human;1378415;Inhibition
GW274150;Inducible NOS;f;;Human;15163211;Inhibition
L-NNA;Inducible NOS;f;;Human;9667974;Inhibition
NIL;Inducible NOS;f;;Human;7525961;Inhibition
PIBTU;Inducible NOS;f;;Human;7523409;Inhibition
BMS-345541;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;22037378;Negative
BMS-345541;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;12403772;Negative
BI605906;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;;Inhibition
compound 47 [PMID: 28737909];inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;28737909;Inhibition
IKK-2 inhibitor IV;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;15316093;Inhibition
IKK-beta inhibitor R-28;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;30613320;Inhibition
LASSBio-1524;inhibitor of nuclear factor kappa B kinase subunit beta;f;;None;32546529;Inhibition
MLN-120B;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;16525037;Inhibition
PHA-408;inhibitor of nuclear factor kappa B kinase subunit beta;f;;Human;19168710;Inhibition
amlexanox;inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;23396211;Inhibition
BAY-985;inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;31859507;Inhibition
compound 17d [PMID: 23099093];inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;23099093;Inhibition
compound II [PMID: 21329883];inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;21329883;Inhibition
GSK8612;inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;31097999;Inhibition
MPI-0485520;inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;;Inhibition
MRT67307;inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;21138416;Inhibition
SR8185;inhibitor of nuclear factor kappa B kinase subunit epsilon;f;;Human;24150799;Inhibition
ARN19702;N-Acylethanolamine acid amidase;f;;Human;27404798;Inhibition
CCP;N-Acylethanolamine acid amidase;f;;Human;14686878;Inhibition
F215;N-Acylethanolamine acid amidase;f;;Human;29572189|28802121;Inhibition
S-OOPP;N-Acylethanolamine acid amidase;f;;Rat;19926854;Inhibition
ARN726;N-Acylethanolamine acid amidase;f;;Rat;25874594;Irreversible inhibition
ARN726;N-Acylethanolamine acid amidase;f;;Human;25874594;Irreversible inhibition
ARN19874;N-Acylphosphatidylethanolamine-phospholipase D;f;;Human;29143042;Inhibition
bithionol;N-Acylphosphatidylethanolamine-phospholipase D;f;;Human;32284327;Inhibition
hexachlorophene;N-Acylphosphatidylethanolamine-phospholipase D;f;;Human;32284327;Inhibition
LEI-401;N-Acylphosphatidylethanolamine-phospholipase D;f;;Human;32393901;Inhibition
compound 2e [PMID: 19013076];NG,NG-Dimethylarginine dimethylaminohydrolase 1;f;;Human;19013076;Inhibition
mycophenolate mofetil;inosine monophosphate dehydrogenase 1;f;;Human;;Inhibition
mycophenolic acid;inosine monophosphate dehydrogenase 1;f;;Human;1967654;Inhibition
ribavirin;inosine monophosphate dehydrogenase 1;f;;Human;22555152;Inhibition
thioguanine;inosine monophosphate dehydrogenase 1;f;;Human;18609073|14529546;Inhibition
merimepodib;inosine monophosphate dehydrogenase 2;f;;Human;12014950;Inhibition
mycophenolate mofetil;inosine monophosphate dehydrogenase 2;f;;Human;;Inhibition
mycophenolic acid;inosine monophosphate dehydrogenase 2;f;;Human;1967654;Inhibition
ribavirin;inosine monophosphate dehydrogenase 2;f;;Human;22555152;Inhibition
thioguanine;inosine monophosphate dehydrogenase 2;f;;Human;18609073|14529546;Inhibition
compound 5 [Noble et al., 1992];INPP5A;f;;Human;;Inhibition
rosiptor;INPP5D;f;;Human;23121445;Activation
3 alpha-aminocholestane;INPP5D;f;;Human;20200281;Inhibition
AS1949490;INPPL1;f;;Human;19694723;Inhibition
NTE-1;insulin degrading enzyme;f;;Human;26085101;Inhibition
NTE-2;insulin degrading enzyme;f;;Human;26085101;Inhibition
quinoline 2;insulin degrading enzyme;f;;Human;26085101;Inhibition
insulin-like growth factor 1;Insulin-like growth factor I receptor;t;Human;Human;;Agonist
insulin-like growth factor 2;Insulin-like growth factor I receptor;t;Human;Human;;Agonist
teprotumumab;Insulin-like growth factor I receptor;f;;Human;;Antagonist
teprotumumab;Insulin-like growth factor I receptor;f;;Human;;Antagonist
istiratumab;Insulin-like growth factor I receptor;f;;Human;24282274;Binding
AG 1024;Insulin-like growth factor I receptor;f;;Human;9075698;Inhibition
AZD3463;Insulin-like growth factor I receptor;f;;Human;;Inhibition
AZD4547;Insulin-like growth factor I receptor;f;;Human;;Inhibition
BMS-536924;Insulin-like growth factor I receptor;f;;Human;16134929;Inhibition
BMS-754807;Insulin-like growth factor I receptor;f;;Human;19778024;Inhibition
brigatinib;Insulin-like growth factor I receptor;f;;Human;27144831;Inhibition
ceritinib;Insulin-like growth factor I receptor;f;;Human;23742252;Inhibition
compound 19a [PMID: 30503936];Insulin-like growth factor I receptor;f;;Human;30503936;Inhibition
GSK1511931;Insulin-like growth factor I receptor;f;;Human;19081716;Inhibition
GSK-1838705A;Insulin-like growth factor I receptor;f;;Human;19825801;Inhibition
GSK-1838705A;Insulin-like growth factor I receptor;f;;Human;22037378;Inhibition
linsitinib;Insulin-like growth factor I receptor;f;;Human;21425998;Inhibition
NVP-AEW541;Insulin-like growth factor I receptor;f;;Human;15050915;Inhibition
NVP-TAE 226;Insulin-like growth factor I receptor;f;;Human;17431114;Inhibition
picropodophyllin;Insulin-like growth factor I receptor;f;;Human;14729630;Inhibition
PQ401;Insulin-like growth factor I receptor;f;;Human;16648580;Inhibition
insulin;Insulin receptor;t;Human;Human;;Agonist
BMS-536924;Insulin receptor;f;;Human;16134929;Inhibition
brigatinib;Insulin receptor;f;;Human;27144831;Inhibition
ceritinib;Insulin receptor;f;;Human;23742252;Inhibition
compound 15 [PMID: 24900237];Insulin receptor;f;;Human;24900237;Inhibition
dovitinib;Insulin receptor;f;;Human;15598814;Inhibition
GSK-1838705A;Insulin receptor;f;;Human;19825801;Inhibition
linsitinib;Insulin receptor;f;;Human;21425998;Inhibition
NVP-TAE 226;Insulin receptor;f;;Human;17431114;Inhibition
linsitinib;Insulin receptor-related receptor;f;;Human;21425998;Inhibition
obtustatin;integrin α1β1;f;;Human;12727812;Inhibition
TCI15;integrin α2β1;f;;Human;19141632;Inhibition
peptide ligand 2 [PMID: 19055415];integrin, alpha 3 subunit (antigen CD49C, alpha 3 subunit of VLA-3 receptor);f;;Human;19055415;Binding
carotegrast;integrin α4β1;f;;Human;;Antagonist
natalizumab;integrin α4β1;f;;Human;15293871;Inhibition
BIO1211;integrin α4β1;f;;Human;10072689;Inhibition
TCS2314;integrin α4β1;f;;Human;;Inhibition
carotegrast;integrin α4β7;f;;Human;;Antagonist
vedolizumab;integrin α4β7;f;;Human;;Antagonist
etrolizumab;integrin α4β7;f;;Human;;Binding
natalizumab;integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor);f;;Human;15293871;Inhibition
volociximab;integrin α5β1;f;;Human;17786386|18042290;Binding
volociximab;integrin, alpha 5 subunit (fibronectin receptor, alpha polypeptide);f;;Human;17786386|18042290;Binding
abciximab;integrin αIIbβ3;f;;Human;;Binding
eptifibatide;integrin αIIbβ3;f;;Human;10999999;Inhibition
G4120;integrin αIIbβ3;f;;Human;7955174|8485125;Inhibition
GR 144053;integrin αIIbβ3;f;;Human;7966149;Inhibition
tirofiban;integrin αIIbβ3;f;;Human;23644213;Inhibition
A286982;integrin αLβ2;f;;Human;11052808;Inhibition
lifitegrast;"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)";f;;Human;24900456;Inhibition
efalizumab;"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)";f;;Human;;Binding
rovelizumab;"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)";f;;Human;9784282|11140880;Binding
BI-1950;"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)";f;;Human;;Binding
BIRT 377;"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)";f;;Human;10553036;Binding
TP508;integrin αVβ3;f;;Human;20508901;Activation
cilengitide;integrin αVβ3;f;;Human;11855984;Antagonist
CWHM12;integrin αVβ3;f;;Human;24216753;Antagonist
echistatin;integrin αVβ3;f;;Human;15634795;Antagonist
GSK2603566A;integrin αVβ3;f;;Human;31497959;Antagonist
P11;integrin αVβ3;f;;Human;15634795;Antagonist
etaracizumab;integrin αVβ3;f;;Human;;Binding
MK-0429;integrin, alpha V subunit;f;;Human;14561098;Antagonist
compound 7 [PMID: 31381331];integrin, beta 1 subunit (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12);f;;Human;31381331;Inhibition
rovelizumab;integrin, beta 2 subunit (complement component 3 receptor 3 and 4 subunit);f;;Human;9784282|11140880;Binding
compound 7 [PMID: 31381331];integrin, beta 3 subunit (platelet glycoprotein IIIa, antigen CD61);f;;Human;31381331;Inhibition
compound 7 [PMID: 31381331];integrin, beta 5 subunit;f;;Human;31381331;Inhibition
compound 7 [PMID: 31381331];integrin, beta 6 subunit;f;;Human;31381331;Inhibition
compound 7 [PMID: 31381331];integrin, beta 8 subunit;f;;Human;31381331;Inhibition
compound 22 [PMID: 21823616];integrin linked kinase;f;;Human;21823616;Inhibition
IFN-α10;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α1/13;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α14;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α16;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α17;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α2;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α21;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α4;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α5;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α6;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α7;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-α8;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-β;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-κ;Interferon-α/β receptor;t;Human;Human;;Agonist
IFN-ω;Interferon-α/β receptor;t;Human;Human;;Agonist
peginterferon alfa-2b;Interferon-α/β receptor;f;;Human;10607680;Agonist
IFN-β;interferon α/β  receptor 1;t;Human;Human;29311663;Agonist
peginterferon alfa-2b;interferon α/β  receptor 1;f;;Human;10607680;Agonist
anifrolumab;interferon α/β  receptor 1;f;;Human;;Binding
IFN-γ;Interferon-γ receptor;t;Human;Human;;Agonist
IFN-λ1;Interferon-λ receptor 1;t;Human;Human;;Agonist
IFN-λ2;Interferon-λ receptor 1;t;Human;Human;;Agonist
IFN-λ3;Interferon-λ receptor 1;t;Human;Human;;Agonist
IL-10;Interleukin-10 receptor;t;Human;Human;;Agonist
IL-10;Interleukin 10 receptor, α subunit;f;Human;Human;19161426;Agonist
IL-11;Interleukin-11 receptor;t;Human;Human;;Agonist
oprelvekin;Interleukin-11 receptor;f;;Human;18020592|11033834;Full agonist
IL-12;Interleukin-12 receptor;t;Human;Human;;Agonist
ALT-803;Interleukin-15 receptor;f;;Human;19710453;Agonist
IL-15;Interleukin-15 receptor;t;Human;Human;19710453;Agonist
IL-15;Interleukin-15 receptor subunit α;f;Human;Human;;Agonist
IL-17C;Interleukin-17C receptor;t;Human;Human;;Agonist
IL-17A;Interleukin-17 receptor;t;Human;Human;;Agonist
IL-17A/IL-17F;Interleukin-17 receptor;t;Human;Human;;Agonist
IL-17F;Interleukin-17 receptor;t;Human;Human;;Agonist
brodalumab;Interleukin 17 receptor A;f;;Human;;Binding
IL-18;Interleukin-18 receptor;t;Human;Human;;Agonist
IL-37;Interleukin-18 receptor;t;Human;Human;;Agonist
belizatinib;interleukin 1 receptor associated kinase 1;f;;Human;22734674;Inhibition
compound 1 [WO2012007375];interleukin 1 receptor associated kinase 1;f;;Human;;Inhibition
compound 7 [WO2012007375];interleukin 1 receptor associated kinase 1;f;;Human;;Inhibition
IRAK-1/4 inhibitor;interleukin 1 receptor associated kinase 1;f;;Human;16563752;Inhibition
Takinib;interleukin 1 receptor associated kinase 1;f;;Human;28820959;Inhibition
compound R-16 [PMID: 21967808];interleukin 1 receptor associated kinase 3;f;;Human;21967808;Inhibition
CA-4948;interleukin 1 receptor associated kinase 4;f;;Human;;Inhibition
compound 1 [WO2012007375];interleukin 1 receptor associated kinase 4;f;;Human;;Inhibition
compound 7 [WO2012007375];interleukin 1 receptor associated kinase 4;f;;Human;;Inhibition
IRAK-1/4 inhibitor;interleukin 1 receptor associated kinase 4;f;;Human;16563752;Inhibition
IRAK4 inhibitor 4b [PMID: 18474425];interleukin 1 receptor associated kinase 4;f;;Human;18474425;Inhibition
IRAK4 inhibitor rac-45 [PMID: 18501603];interleukin 1 receptor associated kinase 4;f;;Human;18501603;Inhibition
ND-2110;interleukin 1 receptor associated kinase 4;f;;Human;25479567;Inhibition
ND-2158;interleukin 1 receptor associated kinase 4;f;;Human;25479567;Inhibition
PF-06426779;interleukin 1 receptor associated kinase 4;f;;Human;;Inhibition
PF-06650833;interleukin 1 receptor associated kinase 4;f;;Human;28498658;Inhibition
Takinib;interleukin 1 receptor associated kinase 4;f;;Human;28820959;Inhibition
MAB92;Interleukin-1 receptor-like 2;f;;Human;28726542;Antagonist
IL-1α;Interleukin-1 receptor, type I;t;Human;Human;;Agonist
IL-1β;Interleukin-1 receptor, type I;t;Human;Human;;Agonist
AF12198;Interleukin-1 receptor, type I;f;;Human;8940020;Antagonist
IL-1 receptor antagonist;Interleukin-1 receptor, type I;t;Human;Human;;Antagonist
anakinra;Interleukin-1 receptor, type I;f;;Human;1834644;Inhibition
isunakinra;Interleukin-1 receptor, type I;f;;Human;28727604;Inhibition
IL-19;Interleukin-20 receptor;t;Human;Human;;Agonist
IL-20;Interleukin-20 receptor;t;Human;Human;;Agonist
IL-24;Interleukin-20 receptor;t;Human;Human;;Agonist
IL-21;Interleukin-21 receptor;t;Human;Human;;Agonist
IL-22;Interleukin-22α1/10β heteromer;t;Human;Human;;Agonist
IL-20;Interleukin-22α1/20β heteromer;t;Human;Human;;Agonist
IL-24;Interleukin-22α1/20β heteromer;t;Human;Human;;Agonist
IL-23;Interleukin-23 receptor;t;Human;Human;;Agonist
IL-17B;Interleukin-25 receptor;t;Human;Human;;Agonist
IL-25;Interleukin-25 receptor;t;Human;Human;;Agonist
IL-27;Interleukin-27 receptor;t;Human;Human;;Agonist
IL-2;Interleukin-2 receptor;t;Human;Human;;Agonist
AF12198;Interleukin-2 receptor;f;;Human;8940020;Antagonist
IL-1 receptor antagonist;Interleukin-2 receptor;t;Human;Human;;Antagonist
Ro26-4550;Interleukin-2 receptor;f;;Human;;Antagonist
basiliximab;Interleukin-2 receptor subunit α;f;;Human;;Binding
daclizumab;Interleukin-2 receptor subunit α;f;;Human;;Binding
bempegaldesleukin;Interleukin-2 receptor subunit β;f;;Human;28678791;Agonist
IL-31;Interleukin-31 receptor;t;Human;Human;;Agonist
nemolizumab;Interleukin-31 receptor, α subunit;f;;Human;;Binding
IL-33;Interleukin-33 receptor;t;Human;Human;;Agonist
IL-36α;Interleukin-36 receptor;t;Human;Human;;Agonist
IL-36β;Interleukin-36 receptor;t;Human;Human;;Agonist
IL-36γ;Interleukin-36 receptor;t;Human;Human;;Agonist
IL-36 receptor antagonist;Interleukin-36 receptor;t;Human;Human;;Antagonist
IL-3;Interleukin-3 receptor;t;Human;Human;;Agonist
IL-3;Interleukin 3 receptor, α subunit;t;Human;Human;;Agonist
dupilumab;Interleukin-4 receptor subunit α;f;;Human;;Binding
IL-4;Interleukin-4 receptor type I;t;Human;Human;;Agonist
IL-13;Interleukin-4 receptor type II;t;Human;Human;;Agonist
IL-4;Interleukin-4 receptor type II;t;Human;Human;;Agonist
IL-5;Interleukin-5 receptor;t;Human;Human;;Agonist
YM90709;Interleukin-5 receptor;f;;Human;12469943;Antagonist
IL-5;Interleukin 5 receptor, α subunit;t;Human;Human;;Agonist
benralizumab;Interleukin 5 receptor, α subunit;f;;Human;;Binding
IL-6;Interleukin-6 receptor;t;Human;Human;1995637;Agonist
satralizumab;Interleukin-6 receptor;f;;Human;;Binding
tocilizumab;Interleukin-6 receptor;f;;Human;;Binding
vobarilizumab;Interleukin-6 receptor;f;;Human;25994180;Binding
IL-6;Interleukin-6 receptor, α subunit;t;Human;Human;1995637;Agonist
sarilumab;Interleukin-6 receptor, α subunit;f;;Human;;Binding
IL-7;Interleukin-7 receptor;t;Human;Human;;Agonist
OSE-127;Interleukin-7 receptor subunit α;f;;Human;;Antagonist
IL-9;Interleukin-9 receptor;t;Human;Human;;Agonist
LPA;P2RY10;t;;Human;18466763;Agonist
sphingosine 1-phosphate;P2RY10;t;;Human;18466763;Agonist
dioctanoylglycerol pyrophosphate;P2RY10;f;;Human;18466763;Antagonist
JTE-013;P2RY10;f;;Human;18466763;Antagonist
beraprost;IP receptor;f;;Human;17545310;Agonist
beraprost;IP receptor;f;;Rat;17545310;Agonist
esuberaprost;IP receptor;f;;Human;2665758;Agonist
PGI2;IP receptor;t;;Human;372237;Agonist
selexipag;IP receptor;f;;Human;17545310;Agonist
selexipag;IP receptor;f;;Rat;17545310;Agonist
AFP-07;IP receptor;f;;Human;9112287;Full agonist
beraprost;IP receptor;f;;Mouse;9313928;Full agonist
BMY 45778;IP receptor;f;;Human;9156364;Full agonist
butaprost (free acid form);IP receptor;f;;Human;10634944;Full agonist
carbacyclin;IP receptor;f;;Human;10634944;Full agonist
carbacyclin;IP receptor;f;;Mouse;9313928;Full agonist
cicaprost;IP receptor;f;;Mouse;9313928;Full agonist
cicaprost;IP receptor;f;;Human;10634944;Full agonist
EP 157;IP receptor;f;;Human;3026540;Full agonist
FK-788;IP receptor;f;;Human;15914004;Full agonist
FR181157;IP receptor;f;;Human;16837197;Full agonist
iloprost;IP receptor;f;;Mouse;9313928;Full agonist
iloprost;IP receptor;f;;Human;16604093|10634944;Full agonist
isocarbacyclin;IP receptor;f;;Mouse;9313928;Full agonist
MRE-269;IP receptor;f;;Human;17545310|23850788;Full agonist
MRE-269;IP receptor;f;;Rat;17545310;Full agonist
ONO-1301;IP receptor;f;;Mouse;9313928;Full agonist
PGE1;IP receptor;t;;Human;11454473|17704830;Full agonist
PGE1;IP receptor;t;;Mouse;9313928;Full agonist
[3H]iloprost;IP receptor;f;;Human;16604093|10634944|7512962|22480736;Full agonist
[3H]iloprost;IP receptor;f;;Mouse;7511597;Full agonist
[3H]iloprost;IP receptor;f;;Rat;7803522;Full agonist
taprostene;IP receptor;f;;Human;9156364;Full agonist
TEI-9063;IP receptor;f;;Human;9156364;Full agonist
treprostinil;IP receptor;f;;Human;22480736;Full agonist
treprostinil;IP receptor;f;;Human;22480736;Full agonist
U46619;IP receptor;f;;Human;10634944;Full agonist
taprostene;IP receptor;f;;Human;22480736;Partial agonist
BAY-73-1449;IP receptor;f;;Human;18603238;Antagonist
RO1138452;IP receptor;f;;Human;16331286;Antagonist
RO1138452;IP receptor;f;;Human;16331286|21549696;Antagonist
RO3244794;IP receptor;f;;Human;16331286;Antagonist
RO3244794;IP receptor;f;;Human;16331286;Antagonist
RO3244794;IP receptor;f;;Human;19880449|21173040;Antagonist
TG6-129;IP receptor;f;;Human;23914286;Antagonist
GNF362;IP3 kinase A;f;;Human;26121493;Inhibition
GNF362;IP3 kinase B;f;;Human;26121493;Inhibition
GNF362;IP3 kinase C;f;;Human;26121493;Inhibition
adenophostin A;IP3R1;f;;Human;;None
ATP;IP3R1;t;;Human;;None
Ca2+;IP3R1;t;;Human;;None
inositol 2,4,5-trisphosphate;IP3R1;f;;Human;;None
IP3;IP3R1;t;;Human;;None
caffeine;IP3R1;f;;Human;;Antagonist
decavanadate;IP3R1;f;;Human;;Antagonist
PIP2;IP3R1;f;;Human;;Antagonist
xestospongin C;IP3R1;f;;Human;;Antagonist
adenophostin A;IP3R2;f;;Human;;None
Ca2+;IP3R2;t;;Human;;None
inositol 2,4,5-trisphosphate;IP3R2;f;;Human;;None
IP3;IP3R2;t;;Human;;None
decavanadate;IP3R2;f;;Human;;Antagonist
Ca2+;IP3R3;t;;Human;;None
IP3;IP3R3;t;;Human;;None
decavanadate;IP3R3;f;;Human;;Antagonist
AGI-5198;isocitrate dehydrogenase (NADP(+)) 1;f;;Human;;Inhibition
ivosidenib;isocitrate dehydrogenase (NADP(+)) 1;f;;Human;;Inhibition
olutasidenib;isocitrate dehydrogenase (NADP(+)) 1;f;;Human;;Inhibition
vorasidenib;isocitrate dehydrogenase (NADP(+)) 1;f;;Human;32071674;Inhibition
enasidenib;isocitrate dehydrogenase (NADP(+)) 2;f;;Human;;Binding
vorasidenib;isocitrate dehydrogenase (NADP(+)) 2;f;;Human;32071674;Inhibition
NE21650;isopentenyl-diphosphate Δ-isomerase 1;f;;Human;11785983;Inhibition
isoamylamine;TAAR3;t;;Mouse;16878137;Full agonist
β-phenylethylamine;TAAR4P ;f;;Mouse;16878137;Agonist
naphazoline;TAAR4P ;f;;Mouse;20559446;Agonist
xylometazoline;TAAR4P ;f;;Mouse;20559446;Full agonist
β-phenylethylamine;TAAR4P ;f;;Rat;20559446;Partial agonist
naphazoline;TAAR4P ;f;;Rat;20559446;Partial agonist
dimethylethylamine;TAAR5;f;;Mouse;17088868;Full agonist
trimethylamine;TAAR5;f;;Mouse;16878137;Full agonist
6-methoxysakuranetin;TAS2R31;f;;Human;21650152;Antagonist
GIV3727;TAS2R31;f;;Human;20537538;Antagonist
T5-8;TAS2R5;f;;Human;;Agonist
BMS-986165;Janus kinase 1;f;;Human;31318208;Inhibition
abrocitinib;Janus kinase 1;f;;Human;29298069;Inhibition
AZD1480;Janus kinase 1;f;;Human;21138246;Inhibition
AZD4205;Janus kinase 1;f;;Human;32297743;Inhibition
baricitinib;Janus kinase 1;f;;Human;24417533;Inhibition
baricitinib;Janus kinase 1;f;;Human;20363976;Inhibition
BMS-911543;Janus kinase 1;f;;Human;22015772;Inhibition
brepocitinib;Janus kinase 1;f;;Human;30113844;Inhibition
cerdulatinib;Janus kinase 1;f;;Human;25253883;Inhibition
compound 18e [PMID: 31670517];Janus kinase 1;f;;Human;31670517;Inhibition
compound 19a [PMID: 24359159];Janus kinase 1;f;;Human;24359159;Inhibition
compound 5e [PMID: 28580438];Janus kinase 1;f;;Human;28580438;Inhibition
decernotinib;Janus kinase 1;f;;Human;24417533;Inhibition
decernotinib;Janus kinase 1;f;;Human;24417533;Inhibition
delgocitinib;Janus kinase 1;f;;Human;32511913;Inhibition
delgocitinib;Janus kinase 1;f;;Human;25387665;Inhibition
example 1 [WO2018112379A1];Janus kinase 1;f;;Human;;Inhibition
example 1 [WO2020051105A1];Janus kinase 1;f;;Human;;Inhibition
fedratinib;Janus kinase 1;f;;Human;21106455;Inhibition
filgotinib;Janus kinase 1;f;;Human;24417533;Inhibition
filgotinib;Janus kinase 1;f;;Human;24006460;Inhibition
ilginatinib;Janus kinase 1;f;;Human;22829185;Inhibition
itacitinib;Janus kinase 1;f;;Human;;Inhibition
izencitinib;Janus kinase 1;f;;Human;;Inhibition
JAK3 inhibitor 32;Janus kinase 1;f;;Human;30423248;Inhibition
JAK3 inhibitor 34;Janus kinase 1;f;;Human;30423248;Inhibition
JAK3 inhibitor II;Janus kinase 1;f;;Human;18094329;Inhibition
JAK3 inhibitor IV;Janus kinase 1;f;;Human;10741557;Inhibition
JAK inhibitor 17b;Janus kinase 1;f;;Human;30460842;Inhibition
JAK inhibitor 20a;Janus kinase 1;f;;Human;30460842;Inhibition
LASW1393;Janus kinase 1;f;;Human;31609613;Inhibition
momelotinib;Janus kinase 1;f;;Human;19295546;Inhibition
NIK inhibitor 12f;Janus kinase 1;f;;Human;32479083;Inhibition
oclacitinib;Janus kinase 1;f;;Human;;Inhibition
pacritinib;Janus kinase 1;f;;Human;21604762;Inhibition
peficitinib;Janus kinase 1;f;;Human;28117214;Inhibition
PF-06263276;Janus kinase 1;f;;Human;27983835;Inhibition
PF-956980;Janus kinase 1;f;;Human;32352776;Inhibition
ritlecitinib;Janus kinase 1;f;;Human;28139931;Inhibition
ruxolitinib;Janus kinase 1;f;;Human;20130243|23061660;Inhibition
ruxolitinib;Janus kinase 1;f;;Human;24417533;Inhibition
SAR-20347;Janus kinase 1;f;;Human;25156366;Inhibition
SAR-20347;Janus kinase 1;f;;Human;25156366;Inhibition
solcitinib;Janus kinase 1;f;;Human;;Inhibition
TG02;Janus kinase 1;f;;Human;21860433;Inhibition
tofacitinib;Janus kinase 1;f;;Human;24417533;Inhibition
upadacitinib;Janus kinase 1;f;;Human;;Inhibition
upadacitinib;Janus kinase 1;f;;Human;;Inhibition
XL019;Janus kinase 1;f;;Human;23127890;Inhibition
JNJ-7706621;Janus kinase 2;f;;Human;28626521;Binding
abrocitinib;Janus kinase 2;f;;Human;29298069;Inhibition
AC430;Janus kinase 2;f;;Human;;Inhibition
AT-9283;Janus kinase 2;f;;Human;19143567;Inhibition
AZ960;Janus kinase 2;f;;Human;18775810;Inhibition
AZD1480;Janus kinase 2;f;;Human;18775810;Inhibition
AZD4205;Janus kinase 2;f;;Human;32297743;Inhibition
baricitinib;Janus kinase 2;f;;Human;24417533;Inhibition
baricitinib;Janus kinase 2;f;;Human;20363976;Inhibition
BIIB068;Janus kinase 2;f;;Human;32696648;Inhibition
BMS-911543;Janus kinase 2;f;;Human;22015772;Inhibition
brepocitinib;Janus kinase 2;f;;Human;30113844;Inhibition
CEP-33779;Janus kinase 2;f;;Human;22594690;Inhibition
cerdulatinib;Janus kinase 2;f;;Human;25253883;Inhibition
compound 18e [PMID: 31670517];Janus kinase 2;f;;Human;31670517;Inhibition
compound 19a [PMID: 24359159];Janus kinase 2;f;;Human;24359159;Inhibition
compound 1d [PMID: 21493067];Janus kinase 2;f;;Human;21493067;Inhibition
decernotinib;Janus kinase 2;f;;Human;24417533;Inhibition
decernotinib;Janus kinase 2;f;;Human;24417533;Inhibition
delgocitinib;Janus kinase 2;f;;Human;32511913;Inhibition
delgocitinib;Janus kinase 2;f;;Human;25387665;Inhibition
example 11 [WO2014151871A9];Janus kinase 2;f;;Human;;Inhibition
example 1 [WO2018112379A1];Janus kinase 2;f;;Human;;Inhibition
example 1 [WO2020051105A1];Janus kinase 2;f;;Human;;Inhibition
fedratinib;Janus kinase 2;f;;Human;21106455|18394554;Inhibition
filgotinib;Janus kinase 2;f;;Human;24417533;Inhibition
filgotinib;Janus kinase 2;f;;Human;24006460;Inhibition
gandotinib;Janus kinase 2;f;;Human;23584399;Inhibition
GSK2646264;Janus kinase 2;f;;Human;30249354;Inhibition
gusacitinib;Janus kinase 2;f;;Human;;Inhibition
HG-10-102-01;Janus kinase 2;f;;Human;22591441;Inhibition
ilginatinib;Janus kinase 2;f;;Human;22829185;Inhibition
itacitinib;Janus kinase 2;f;;Human;;Inhibition
izencitinib;Janus kinase 2;f;;Human;;Inhibition
JAK3 inhibitor 32;Janus kinase 2;f;;Human;30423248;Inhibition
JAK3 inhibitor 34;Janus kinase 2;f;;Human;30423248;Inhibition
JAK3 inhibitor II;Janus kinase 2;f;;Human;18094329;Inhibition
JAK inhibitor 17b;Janus kinase 2;f;;Human;30460842;Inhibition
JAK inhibitor 20a;Janus kinase 2;f;;Human;30460842;Inhibition
JAK inhibitor I;Janus kinase 2;f;;Human;11934592;Inhibition
LASW1393;Janus kinase 2;f;;Human;31609613;Inhibition
momelotinib;Janus kinase 2;f;;Human;19295546;Inhibition
oclacitinib;Janus kinase 2;f;;Human;;Inhibition
pacritinib;Janus kinase 2;f;;Human;21604762;Inhibition
peficitinib;Janus kinase 2;f;;Human;28117214;Inhibition
PF-06263276;Janus kinase 2;f;;Human;27983835;Inhibition
PF-956980;Janus kinase 2;f;;Human;32352776;Inhibition
repotrectinib;Janus kinase 2;f;;Human;30093503;Inhibition
RG-1530;Janus kinase 2;f;;Human;20814247;Inhibition
RGB-286638;Janus kinase 2;f;;Human;23807770;Inhibition
ruxolitinib;Janus kinase 2;f;;Human;20130243|23061660;Inhibition
ruxolitinib;Janus kinase 2;f;;Human;24417533;Inhibition
SAR-20347;Janus kinase 2;f;;Human;25156366;Inhibition
solcitinib;Janus kinase 2;f;;Human;;Inhibition
TG02;Janus kinase 2;f;;Human;22148278|21860433;Inhibition
tofacitinib;Janus kinase 2;f;;Human;24417533;Inhibition
upadacitinib;Janus kinase 2;f;;Human;;Inhibition
XL019;Janus kinase 2;f;;Human;23127890;Inhibition
abivertinib;Janus kinase 3;f;;Human;27573423;Inhibition
acalabrutinib;Janus kinase 3;f;;Human;26641137;Inhibition
AT-9283;Janus kinase 3;f;;Human;19143567;Inhibition
AZD1480;Janus kinase 3;f;;Human;18775810;Inhibition
baricitinib;Janus kinase 3;f;;Human;24417533;Inhibition
BMS-911543;Janus kinase 3;f;;Human;22015772;Inhibition
brepocitinib;Janus kinase 3;f;;Human;30113844;Inhibition
CEP-33779;Janus kinase 3;f;;Human;22594690;Inhibition
cerdulatinib;Janus kinase 3;f;;Human;25253883;Inhibition
compound 18e [PMID: 31670517];Janus kinase 3;f;;Human;31670517;Inhibition
compound 19a [PMID: 24359159];Janus kinase 3;f;;Human;24359159;Inhibition
compound 1d [PMID: 21493067];Janus kinase 3;f;;Human;21493067;Inhibition
compound 2 [PMID: 15546730];Janus kinase 3;f;;Human;15546730;Inhibition
decernotinib;Janus kinase 3;f;;Human;24417533;Inhibition
decernotinib;Janus kinase 3;f;;Human;24417533;Inhibition
delgocitinib;Janus kinase 3;f;;Human;32511913;Inhibition
delgocitinib;Janus kinase 3;f;;Human;25387665;Inhibition
example 1 [WO2018112379A1];Janus kinase 3;f;;Human;;Inhibition
example 1 [WO2020051105A1];Janus kinase 3;f;;Human;;Inhibition
fedratinib;Janus kinase 3;f;;Human;21106455;Inhibition
filgotinib;Janus kinase 3;f;;Human;24006460;Inhibition
gandotinib;Janus kinase 3;f;;Human;23584399;Inhibition
ibrutinib;Janus kinase 3;f;;Human;26641137;Inhibition
ilginatinib;Janus kinase 3;f;;Human;22829185;Inhibition
izencitinib;Janus kinase 3;f;;Human;;Inhibition
JAK3 inhibitor 32;Janus kinase 3;f;;Human;30423248;Inhibition
JAK3 inhibitor 34;Janus kinase 3;f;;Human;30423248;Inhibition
JAK3 inhibitor II;Janus kinase 3;f;;Human;18094329;Inhibition
JAK3 inhibitor IV;Janus kinase 3;f;;Human;10741557;Inhibition
JAK inhibitor 17b;Janus kinase 3;f;;Human;30460842;Inhibition
JAK inhibitor 20a;Janus kinase 3;f;;Human;30460842;Inhibition
JAK inhibitor I;Janus kinase 3;f;;Human;11934592;Inhibition
LASW1393;Janus kinase 3;f;;Human;31609613;Inhibition
lazertinib;Janus kinase 3;f;;Human;;Inhibition
mivavotinib;Janus kinase 3;f;;Human;27839918;Inhibition
momelotinib;Janus kinase 3;f;;Human;19295546;Inhibition
NIK inhibitor 12f;Janus kinase 3;f;;Human;32479083;Inhibition
oclacitinib;Janus kinase 3;f;;Human;;Inhibition
pacritinib;Janus kinase 3;f;;Human;21604762;Inhibition
peficitinib;Janus kinase 3;f;;Human;28117214;Inhibition
PF-06263276;Janus kinase 3;f;;Human;27983835;Inhibition
PF-956980;Janus kinase 3;f;;Human;32352776;Inhibition
poseltinib;Janus kinase 3;f;;Human;;Inhibition
PRN694;Janus kinase 3;f;;Human;25593320;Inhibition
ritlecitinib;Janus kinase 3;f;;Human;;Inhibition
ruxolitinib;Janus kinase 3;f;;Human;23061660;Inhibition
ruxolitinib;Janus kinase 3;f;;Human;24417533;Inhibition
SAR-20347;Janus kinase 3;f;;Human;25156366;Inhibition
solcitinib;Janus kinase 3;f;;Human;;Inhibition
tofacitinib;Janus kinase 3;f;;Human;27572962;Inhibition
tofacitinib;Janus kinase 3;f;;Human;24417533;Inhibition
tofacitinib;Janus kinase 3;f;;Human;21105711|14593182;Inhibition
upadacitinib;Janus kinase 3;f;;Human;;Inhibition
XL019;Janus kinase 3;f;;Human;23127890;Inhibition
example 131 [WO2009133348];kallikrein 1;f;;Human;;Inhibition
lanadelumab;kallikrein B1;f;;Human;;Binding
compound 11 [PMID: 16413183];kallikrein B1;f;;Human;16413183;Inhibition
compound 3 [PMID: 23849879];kallikrein related peptidase 14;f;;Human;23849879;Inhibition
compound 4d [PMID: 25489658];kallikrein related peptidase 14;f;;Human;25489658;Inhibition
hK2p01 derivative KLK2 inhibitor;kallikrein related peptidase 2;f;;Human;16527822;Inhibition
peptide KLK2b(c1);kallikrein related peptidase 2;f;;Human;17436344;Inhibition
compound 20 [PMID: 23692593];kallikrein related peptidase 3;f;;Human;23692593;Inhibition
compound 32 [PMID: 31675166];kallikrein related peptidase 4;f;;Human;31675166;Inhibition
compound 33 [PMID: 19908842];kallikrein related peptidase 4;f;;Human;19908842;Inhibition
compound 3 [PMID: 23849879];kallikrein related peptidase 5;f;;Human;23849879;Inhibition
compound 4d [PMID: 25489658];kallikrein related peptidase 5;f;;Human;25489658;Inhibition
compound 32 [PMID: 31675166];kallikrein related peptidase 6;f;;Human;31675166;Inhibition
compound 5 {PMID: 24900446];kallikrein related peptidase 6;f;;Human;24900446;Inhibition
DKFZ‐251;kallikrein related peptidase 6;f;;Human;30212625;Inhibition
compound 3 [PMID: 23849879];kallikrein related peptidase 7;f;;Human;23849879;Inhibition
compound 4d [PMID: 25489658];kallikrein related peptidase 7;f;;Human;25489658;Inhibition
compound 32 [PMID: 31675166];kallikrein related peptidase 8;f;;Human;31675166;Inhibition
ADL5747;κ receptor;f;;Human;19694468;Agonist
ADL5859;κ receptor;f;;Human;18788723;Agonist
AR-M1000390;κ receptor;f;;Human;;Agonist
asimadoline;κ receptor;f;;Guinea pig;;Agonist
bilorphin;κ receptor;f;;Human;31611414;Agonist
BU08028;κ receptor;f;;Human;21177476;Agonist
BW373U86;κ receptor;f;;Human;18788723;Agonist
BW373U86;κ receptor;f;;Rat;8246159;Agonist
carfentanil;κ receptor;f;;Guinea pig;1310142;Agonist
cebranopadol;κ receptor;f;;Human;24713140;Agonist
cebranopadol;κ receptor;f;;Rat;24713140;Agonist
difelikefalin;κ receptor;f;;Human;;Agonist
difelikefalin;κ receptor;f;;Mouse;;Agonist
hydrocodone;κ receptor;f;;Human;22439881;Agonist
hydromorphone;κ receptor;f;;Human;19282177;Agonist
MP1104;κ receptor;f;;Human;29307491;Agonist
pethidine;κ receptor;f;;Human;11585443;Agonist
probe 1.1 [PMID: 24187130];κ receptor;f;;Human;24187130;Agonist
probe 2.1 [PMID: 24187130];κ receptor;f;;Human;24187130;Agonist
SCH221510;κ receptor;f;;Human;18492950;Agonist
SR16835;κ receptor;f;;Human;19773529;Agonist
tramadol;κ receptor;f;;Human;19282177;Agonist
U50488;κ receptor;f;;Human;9686407|7869844|7624359|9262330|6129321|14718611;Agonist
UFP-512;κ receptor;f;;Human;18069089;Agonist
probe 1.1 [PMID: 24187130];κ receptor;f;;Human;24187130;Biased agonist
probe 1.1 [PMID: 24187130];κ receptor;f;;Human;24187130;Biased agonist
probe 2.1 [PMID: 24187130];κ receptor;f;;Human;24187130;Biased agonist
probe 2.1 [PMID: 24187130];κ receptor;f;;Human;24187130;Biased agonist
α-neoendorphin;κ receptor;t;Human|Mouse|Rat;Mouse;8393575;Full agonist
α-neoendorphin;κ receptor;t;Human|Mouse|Rat;Rat;8240268|8234341;Full agonist
α-neoendorphin;κ receptor;t;Human|Mouse|Rat;Human;7869844|7624359;Full agonist
β-endorphin;κ receptor;f;Human;Rat;8234341;Full agonist
β-neoendorphin;κ receptor;t;Human|Mouse|Rat;Human;7624359;Full agonist
β-neoendorphin;κ receptor;t;Human|Mouse|Rat;Rat;8234341;Full agonist
(-)-bremazocine;κ receptor;f;;Mouse;8393575;Full agonist
[D-Ala2,F5,Phe4]dynorphin-(1-13)-NH2;κ receptor;f;;Mouse;8393575;Full agonist
[D-Ala2,F5,Phe4]dynorphin-(1-17)-NH2;κ receptor;f;;Mouse;8393575;Full agonist
dynorphin-(1-11);κ receptor;f;;Human;9686407;Full agonist
dynorphin-(1-17)-NH2;κ receptor;f;;Mouse;8393575;Full agonist
dynorphin A;κ receptor;t;Human|Mouse|Rat;Mouse;8393575;Full agonist
dynorphin A;κ receptor;t;Human|Mouse|Rat;Rat;8240268|8234341;Full agonist
dynorphin A;κ receptor;t;Human|Mouse|Rat;Human;9686407|7869844|7624359|9262330;Full agonist
dynorphin A-(1-13);κ receptor;t;Human|Mouse|Rat;Rat;8234341;Full agonist
dynorphin A-(1-13);κ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
dynorphin A-(1-8);κ receptor;t;Human|Mouse|Rat;Human;9686407|7624359|1967312;Full agonist
dynorphin A-(1-8);κ receptor;t;Human|Mouse|Rat;Mouse;8393575;Full agonist
dynorphin B;κ receptor;t;Human|Mouse|Rat;Rat;8234341;Full agonist
dynorphin B;κ receptor;t;Human|Mouse|Rat;Mouse;8393575;Full agonist
E2078;κ receptor;f;;Rat;8234341;Full agonist
E2078;κ receptor;f;;Human;9918595;Full agonist
enadoline;κ receptor;f;;Human;14613319|2178014;Full agonist
enadoline;κ receptor;f;;Human;8863844;Full agonist
ethyketazocine;κ receptor;f;;Human;9262330;Full agonist
ethyketazocine;κ receptor;f;;Rat;8234341;Full agonist
ethyketazocine;κ receptor;f;;Mouse;8393575;Full agonist
ethylketocyclazocine;κ receptor;f;;Human;9686407;Full agonist
etorphine;κ receptor;f;;Human;9686407;Full agonist
GR 89696;κ receptor;f;;Human;11786275;Full agonist
HS665;κ receptor;f;;Human;23134120;Full agonist
HS665;κ receptor;f;;Human;23134120;Full agonist
ICI 204448;κ receptor;f;;Rat;8240267;Full agonist
ICI 204448;κ receptor;f;;Mouse;8393575;Full agonist
[Leu]enkephalin;κ receptor;t;Human|Mouse|Rat;Rat;8234341;Full agonist
[Met]enkephalin;κ receptor;t;Human|Mouse|Rat;Rat;8234341;Full agonist
[Met5]dynorphin-(1-17);κ receptor;f;;Mouse;8393575;Full agonist
nalbuphine;κ receptor;f;;Human;9262330;Full agonist
nalbuphine;κ receptor;f;;Mouse;8393575;Full agonist
nalfurafine;κ receptor;f;;Human;15383632;Full agonist
normorphine;κ receptor;f;;Human;9686407;Full agonist
salvinorin A;κ receptor;f;;Human;12192085|15869877;Full agonist
spiradoline;κ receptor;f;;Mouse;8393575;Full agonist
spiradoline;κ receptor;f;;Rat;8240267;Full agonist
[3H]enadoline;κ receptor;f;;Human;11239918;Full agonist
[3H]U69593;κ receptor;f;;Human;7624359|2986999;Full agonist
tifluadom;κ receptor;f;;Human;9262330;Full agonist
U69593;κ receptor;f;;Human;9686407|2986999;Full agonist
U69593;κ receptor;f;;Rat;8240267|8234341;Full agonist
U69593;κ receptor;f;;Mouse;8393575;Full agonist
β-endorphin;κ receptor;t;Human;Human;9686407|7624359;Partial agonist
β-endorphin;κ receptor;f;Human;Mouse;8393575;Partial agonist
(-)-bremazocine;κ receptor;f;;Human;9686407;Partial agonist
butorphanol;κ receptor;f;;Human;18674902;Partial agonist
compound 3 [PMID: 23134120];κ receptor;f;;Human;23134120;Partial agonist
compound 3 [PMID: 23134120];κ receptor;f;;Human;23134120;Partial agonist
(-)-cyclazocine;κ receptor;f;;Human;9686407;Partial agonist
DAMGO;κ receptor;f;;Rat;8234341;Partial agonist
DAMGO;κ receptor;f;;Human;9686407;Partial agonist
dihydromorphine;κ receptor;f;;Human;9686407;Partial agonist
dynorphin B;κ receptor;t;Human|Mouse|Rat;Human;9686407|7624359;Partial agonist
etonitazene;κ receptor;f;;Human;9686407;Partial agonist
fentanyl;κ receptor;f;;Human;9686407;Partial agonist
(-)-methadone;κ receptor;f;;Human;9686407;Partial agonist
morphine;κ receptor;f;;Human;9686407;Partial agonist
morphine;κ receptor;f;;Rat;8240267|8234341;Partial agonist
nalorphine;κ receptor;f;;Human;9686407|9262330;Partial agonist
naloxone benzoylhydrazone;κ receptor;f;;Human;9686407;Partial agonist
(-)-pentazocine;κ receptor;f;;Human;9686407|9262330;Partial agonist
U50488;κ receptor;f;;Rat;8240267|8240268|8234341;Partial agonist
U50488;κ receptor;f;;Mouse;8393575;Partial agonist
5'-guanidinonaltrindole;κ receptor;f;;Human;10822054|10893314;Antagonist
alvimopan;κ receptor;f;;Human;18313920;Antagonist
AT-076;κ receptor;f;;Human;9686407|25635572;Antagonist
β-FNA;κ receptor;f;;Human;9686407;Antagonist
BNTX;κ receptor;f;;Human;9686407;Antagonist
BTRX-335140;κ receptor;f;;Human;30707578;Antagonist
buprenorphine;κ receptor;f;;Human;9686407|9262330;Antagonist
diprenorphine;κ receptor;f;;Human;9686407|7869844|9262330;Antagonist
JDTic;κ receptor;f;;Human;11495579;Antagonist
JDTic;κ receptor;f;;Human;25635572|11495579|23976952;Antagonist
LY2456302;κ receptor;f;;Human;24071566;Antagonist
LY2456302;κ receptor;f;;Human;24071566;Antagonist
methylnaltrexone;κ receptor;f;;Human;19282177;Antagonist
nalmefene;κ receptor;f;;Human;9686407;Antagonist
naloxone;κ receptor;f;;Mouse;8393575;Antagonist
naloxone;κ receptor;f;;Human;9686407|7869844|7624359|9262330;Antagonist
naloxone;κ receptor;f;;Rat;8240267|8240268|8234341;Antagonist
(+)-naloxone;κ receptor;f;;Rat;8234341;Antagonist
naltrexone;κ receptor;f;;Human;9686407|7624359;Antagonist
naltrexone;κ receptor;f;;Mouse;8393575;Antagonist
naltriben;κ receptor;f;;Human;9686407;Antagonist
naltrindole;κ receptor;f;;Rat;8240268;Antagonist
naltrindole;κ receptor;f;;Mouse;8393575;Antagonist
naltrindole;κ receptor;f;;Human;9686407;Antagonist
NFP;κ receptor;f;;Human;30608693;Antagonist
nor-binaltorphimine;κ receptor;f;;Rat;8240267|8240268|8234341;Antagonist
nor-binaltorphimine;κ receptor;f;;Human;9686407|7869844|7624359|9262330|2444704;Antagonist
nor-binaltorphimine;κ receptor;f;;Mouse;8393575;Antagonist
quadazocine;κ receptor;f;;Human;9686407;Antagonist
samidorphan;κ receptor;f;;Human;15808478;Antagonist
[3H]diprenorphine;κ receptor;f;;Human;7624359|1313812;Antagonist
zyklophin;κ receptor;f;;Human;15999987;Antagonist
zyklophin;κ receptor;f;;Human;15999987;Antagonist
compound 16 [PMID: 31498617];κ receptor;f;;Human;31498617;Binding
DIOA;K-Cl cotransporter 1;f;;Human;;Inhibition
DIOA;K-Cl cotransporter 2;f;;Human;;Inhibition
VU0240551;K-Cl cotransporter 2;f;;Human;19279215;Inhibition
DIOA;K-Cl cotransporter 3;f;;Human;;Inhibition
DIOA;K-Cl cotransporter 4;f;;Human;;Inhibition
Nrf2 peptide [PMID: 23647822];kelch like ECH-associated protein 1;f;;Human;23647822;Binding
bardoxolone;kelch like ECH-associated protein 1;f;;Human;24896564;Binding
compound 10 [PMID: 31411465];kelch like ECH-associated protein 1;f;;Human;31411465;Binding
CPUY192018;kelch like ECH-associated protein 1;f;;Human;27215610;Binding
CPUY192018;kelch like ECH-associated protein 1;f;;Human;24512214;Binding
CPUY192018;kelch like ECH-associated protein 1;f;;Human;26258437;Binding
CPUY192018;kelch like ECH-associated protein 1;f;;Human;24512214;Binding
isoquinoline 17 [PMID: 30122040];kelch like ECH-associated protein 1;f;;Human;30122040;Binding
isoquinoline 17 [PMID: 30122040];kelch like ECH-associated protein 1;f;;Human;30122040;Binding
RA839;kelch like ECH-associated protein 1;f;;Human;26459563;Binding
RA839;kelch like ECH-associated protein 1;f;;Human;26459563;Binding
bumetanide;Kidney-specific Na-K-Cl symporter;f;;Human;11882915;Inhibition
furosemide;Kidney-specific Na-K-Cl symporter;f;;Human;11882915;Inhibition
piretanide;Kidney-specific Na-K-Cl symporter;f;;Human;11882915;Inhibition
compound 8ay [PMID: 29589443];Kidney urea transporter;f;;Rat;29589443;Inhibition
monalizumab;killer cell lectin like receptor C1 (CD159a);f;;Human;;Binding
VEGFA;kinase insert domain receptor;f;Human;Human;31023826;Agonist
VEGFA;kinase insert domain receptor;f;Human;Human;31023826;Agonist
ramucirumab;kinase insert domain receptor;f;;Human;12917408;Antagonist
ramucirumab;kinase insert domain receptor;f;;Human;12917408;Antagonist
AEE788;kinase insert domain receptor;f;;Human;15256466;Inhibition
altiratinib;kinase insert domain receptor;f;;Human;;Inhibition
AST-487;kinase insert domain receptor;f;;Human;17638907;Inhibition
axitinib;kinase insert domain receptor;f;;Human;20869793;Inhibition
axitinib;kinase insert domain receptor;f;;Human;22037378;Inhibition
AZD4547;kinase insert domain receptor;f;;Human;;Inhibition
BIBF-1202;kinase insert domain receptor;f;;Human;22037378;Inhibition
BMS-690514;kinase insert domain receptor;f;;Human;20166197;Inhibition
brivanib;kinase insert domain receptor;f;;Human;16570908;Inhibition
BX-795;kinase insert domain receptor;f;;Human;15772071;Inhibition
BX-912;kinase insert domain receptor;f;;Human;15772071;Inhibition
cabozantinib;kinase insert domain receptor;f;;Human;21926191;Inhibition
catequentinib;kinase insert domain receptor;f;;Human;;Inhibition
cediranib;kinase insert domain receptor;f;;Human;15899831;Inhibition
cediranib;kinase insert domain receptor;f;;Human;22037378;Inhibition
cenisertib;kinase insert domain receptor;f;;Human;22695126;Inhibition
CEP-11981;kinase insert domain receptor;f;;Human;22148921;Inhibition
compound 13a [PMID: 23639540];kinase insert domain receptor;f;;Human;23639540;Inhibition
compound 19a [PMID: 30503936];kinase insert domain receptor;f;;Human;30503936;Inhibition
compound 8h [PMID: 22765894];kinase insert domain receptor;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];kinase insert domain receptor;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];kinase insert domain receptor;f;;Human;21613405;Inhibition
compound T.14;kinase insert domain receptor;f;;Human;30878834;Inhibition
CP-547632;kinase insert domain receptor;f;;Human;14612527;Inhibition
CS2164;kinase insert domain receptor;f;;Human;28004478;Inhibition
DMBI;kinase insert domain receptor;f;;Mouse;10956210;Inhibition
dorsomorphin;kinase insert domain receptor;f;;Human;20932747;Inhibition
dovitinib;kinase insert domain receptor;f;;Human;19113866|15598814;Inhibition
ENMD-2076;kinase insert domain receptor;f;;Human;19320489;Inhibition
erdafitinib;kinase insert domain receptor;f;;Human;;Inhibition
famitinib;kinase insert domain receptor;f;;Human;21028894;Inhibition
foretinib;kinase insert domain receptor;f;;Human;23098265;Inhibition
fruquintinib;kinase insert domain receptor;f;;Human;25482937;Inhibition
fruquintinib;kinase insert domain receptor;f;;Human;25482937;Inhibition
glesatinib;kinase insert domain receptor;f;;Human;18434145;Inhibition
golvatinib;kinase insert domain receptor;f;;Human;19832844;Inhibition
henatinib;kinase insert domain receptor;f;;Human;21028894;Inhibition
ilorasertib;kinase insert domain receptor;f;;Human;22935731;Inhibition
infigratinib;kinase insert domain receptor;f;;Human;21936542;Inhibition
Ki-20227;kinase insert domain receptor;f;;Human;17121910;Inhibition
lazertinib;kinase insert domain receptor;f;;Human;;Inhibition
lenvatinib;kinase insert domain receptor;f;;Human;23098265;Inhibition
linifanib;kinase insert domain receptor;f;;Human;16648571;Inhibition
lucitanib;kinase insert domain receptor;f;;Human;22304225;Inhibition
LY2874455;kinase insert domain receptor;f;;Human;21900693;Inhibition
mivavotinib;kinase insert domain receptor;f;;Human;27839918;Inhibition
MK-2461;kinase insert domain receptor;f;;Human;20145145;Inhibition
MLKL compound 1;kinase insert domain receptor;f;;Human;15990302;Inhibition
motesanib;kinase insert domain receptor;f;;Human;23098265;Inhibition
motesanib;kinase insert domain receptor;f;;Human;22037378;Inhibition
nintedanib;kinase insert domain receptor;f;;Human;18559524;Inhibition
orantinib;kinase insert domain receptor;f;;Human;19110422;Inhibition
OSI-930;kinase insert domain receptor;f;;Human;16424037;Inhibition
pamufetinibT;kinase insert domain receptor;f;;Human;24140932;Inhibition
pazopanib;kinase insert domain receptor;f;;Human;18620382;Inhibition
pazopanib;kinase insert domain receptor;f;;Human;22037378;Inhibition
pegdinetanib;kinase insert domain receptor;f;;Human;16720276;Inhibition
pexidartinib;kinase insert domain receptor;f;;Human;26222558;Inhibition
PLX-4720;kinase insert domain receptor;f;;Human;12538485;Inhibition
PP121;kinase insert domain receptor;f;;Human;18849971;Inhibition
pralsetinib;kinase insert domain receptor;f;;Human;29657135;Inhibition
regorafenib;kinase insert domain receptor;f;;Human;21170960;Inhibition
RG-1530;kinase insert domain receptor;f;;Human;20814247;Inhibition
rivoceranib;kinase insert domain receptor;f;;Human;21443688;Inhibition
semaxanib;kinase insert domain receptor;f;;Human;10882357;Inhibition
sitravatinib;kinase insert domain receptor;f;;Human;26675259;Inhibition
sorafenib;kinase insert domain receptor;f;;Human;15466206;Inhibition
sorafenib;kinase insert domain receptor;f;;Human;21613405;Inhibition
sorafenib;kinase insert domain receptor;f;;Human;22037378;Inhibition
SU11652;kinase insert domain receptor;f;;Human;12646019;Inhibition
SU-14813;kinase insert domain receptor;f;;Human;16891463;Inhibition
SU-14813;kinase insert domain receptor;f;;Human;22037378;Inhibition
sunitinib;kinase insert domain receptor;f;;Human;20570526;Inhibition
surufatinib;kinase insert domain receptor;f;;Human;;Inhibition
tafetinib;kinase insert domain receptor;f;;Human;21638122;Inhibition
telatinib;kinase insert domain receptor;f;;Human;;Inhibition
tesevatinib;kinase insert domain receptor;f;;Human;17575237;Inhibition
tivozanib;kinase insert domain receptor;f;;Human;23098265;Inhibition
vandetanib;kinase insert domain receptor;f;;Human;15743202;Inhibition
vatalanib;kinase insert domain receptor;f;;Human;22037378;Inhibition
vatalanib;kinase insert domain receptor;f;;Human;16321531;Inhibition
VEGF receptor 2 kinase inhibitor I;kinase insert domain receptor;f;;Mouse;9651163;Inhibition
VEGF receptor 2 kinase inhibitor II;kinase insert domain receptor;f;;Human;10893303;Inhibition
VEGF receptor 2 kinase inhibitor IV;kinase insert domain receptor;f;;Human;12443771;Inhibition
VEGF receptor tyrosine kinase inhibitor II;kinase insert domain receptor;f;;Human;17869515;Inhibition
VEGF receptor tyrosine kinase inhibitor III;kinase insert domain receptor;f;;Human;18077363;Inhibition
ZM-306416;kinase insert domain receptor;f;;Human;10639280;Inhibition
GSK2646264;kinase insert domain receptor;f;;Human;30249354;Potentiation
VEGFA;kinase insert domain receptor;t;Human;Human;;None
VEGFC;kinase insert domain receptor;t;Human;Human;;None
VEGFE;kinase insert domain receptor;t;Human;Human;;None
AZD4877;kinesin-5;f;;Human;21899292;Inhibition
[d-Tyr-14C]TAK-448;kisspeptin receptor;f;;Human;30044673;Agonist
TAK-448;kisspeptin receptor;f;;Human;27589480;Agonist
4-fluorobenzoyl-FGLRW-NH2;kisspeptin receptor;f;;Human;18302161;Full agonist
[dY]1KP-10;kisspeptin receptor;f;;Mouse;19934405;Full agonist
kisspeptin-10;kisspeptin receptor;t;Human;Human;11385580|11457843;Full agonist
kisspeptin-10;kisspeptin receptor;f;Human;Rat;11457843;Full agonist
kisspeptin-13;kisspeptin receptor;t;Human;Human;11457843;Full agonist
kisspeptin-13;kisspeptin receptor;f;Human;Rat;11457843;Full agonist
kisspeptin-14;kisspeptin receptor;t;Human;Human;11457843;Full agonist
kisspeptin-14;kisspeptin receptor;f;Human;Rat;11457843;Full agonist
kisspeptin-15;kisspeptin receptor;f;;Human;11385580;Full agonist
kisspeptin-28;kisspeptin receptor;f;;Human;11457843;Full agonist
kisspeptin-54;kisspeptin receptor;t;Human;Human;11385580|11457843;Full agonist
kisspeptin-54;kisspeptin receptor;f;Human;Rat;11457843;Full agonist
kisspeptin-9;kisspeptin receptor;f;;Human;11385580;Full agonist
[125I]kisspeptin-10 (human);kisspeptin receptor;f;;Human;11457843;Full agonist
[125I]kisspeptin-13 (human);kisspeptin receptor;f;;Human;17023533;Full agonist
[125I]kisspeptin-14 (human);kisspeptin receptor;f;;Human;17023533;Full agonist
[125I]kisspeptin-54 (human);kisspeptin receptor;f;;Human;11385580;Full agonist
[125I]Tyr45-kisspeptin-15;kisspeptin receptor;f;;Human;11385580;Full agonist
peptide 234;kisspeptin receptor;f;;Human;19321788;Antagonist
stem cell factor;KIT proto-oncogene, receptor tyrosine kinase;t;Human;Human;7536489;Agonist
AC710;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;24900421;Inhibition
AKN-028;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22864397;Inhibition
AST-487;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;17638907;Inhibition
avapritinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;29093181;Inhibition
BLZ945;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;24498562;Inhibition
cediranib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;15899831;Inhibition
CHMFL-KIT-64;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;31250638;Inhibition
CHMFL-KIT-8140;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;27545040;Inhibition
compound 19a [PMID: 30503936];KIT proto-oncogene, receptor tyrosine kinase;f;;Human;30503936;Inhibition
compound 7k [PMID: 23521020];KIT proto-oncogene, receptor tyrosine kinase;f;;Human;23521020;Inhibition
compound 8h [PMID: 22765894];KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];KIT proto-oncogene, receptor tyrosine kinase;f;;Human;21613405;Inhibition
CP-673451;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;15705896;Inhibition
crenolanib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22745105;Inhibition
CS2164;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;28004478;Inhibition
DCC-3014;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;;Inhibition
dovitinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;19113866|15598814;Inhibition
edicotinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;26233509;Inhibition
famitinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;21028894;Inhibition
flumatinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;20703259;Inhibition
GTP-14564;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;12815052;Inhibition
henatinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;21028894;Inhibition
ilorasertib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22935731;Inhibition
JNJ-28312141;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;19887542;Inhibition
KBP-7018;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;29152045;Inhibition
Ki-20227;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;17121910;Inhibition
linifanib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;16648571;Inhibition
lucitanib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22304225;Inhibition
masitinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;19789626;Inhibition
masitinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22037378;Inhibition
OSI-930;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;16424037;Inhibition
pazopanib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;18620382;Inhibition
pexidartinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;26222558;Inhibition
quizartinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;19754199;Inhibition
RG-1530;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;20814247;Inhibition
ripretinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;;Inhibition
rivoceranib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;21443688;Inhibition
semaxanib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;10882357;Inhibition
sitravatinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;26675259;Inhibition
sorafenib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;15466206;Inhibition
sorafenib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;21613405;Inhibition
SU11652;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;18077363;Inhibition
SU-14813;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;16891463;Inhibition
sunitinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;22037378;Inhibition
sunitinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;20570526;Inhibition
tandutinib;KIT proto-oncogene, receptor tyrosine kinase;f;;Human;12124172;Inhibition
AMG510;KRAS;f;;Human;31820981;Inhibition
ARS-1620;KRAS;f;;Human;29373830;Inhibition
compound 25 [PMID: 32023060];KRAS;f;;Human;32023060;Inhibition
lonafarnib;KRAS;f;;Human;9810004;Inhibition
MRTX849;KRAS;f;;Human;32250617;Inhibition
arachidonic acid;K2P10.1;t;;Human;10880510;None
BL-1249;K2P10.1;f;;Human;30089357;None
docosahexaenoic acid;K2P10.1;f;;Human;10880510;None
GI‐530159;K2P10.1;f;;Human;29150838;None
halothane;K2P10.1;f;;Human;10880510;None
linoleic acid;K2P10.1;f;;Human;10880510;None
lysophosphatidylcholine;K2P10.1;f;;Human;10880510;None
quinidine;K2P10.1;f;;Rat;12122143;None
halothane;K2P12.1;f;;Human;25148687;None
arachidonic acid;K2P13.1;t;;None;25148687;None
Ba2+;K2P13.1;f;;None;;None
halothane;K2P13.1;f;;Human;25148687;None
isoflurane;K2P16.1;f;;Human;11263999;None
NO;K2P16.1;f;;Human;11263999;None
Ba2+;K2P16.1;f;;Human;11263999;None
chloroform;K2P16.1;f;;Human;11263999;None
quinidine;K2P16.1;f;;Human;11263999;None
NO;K2P17.1;f;;Human;15513946;None
chloroform;K2P17.1;f;;Human;11263999;None
Ba2+;K2P18.1;f;;None;;None
quinidine;K2P18.1;f;;None;;None
quinine;K2P18.1;f;;None;;None
arachidonic acid;K2P18.1;t;;Human;12754259;None
arachidonic acid;K2P2.1;t;;Human;9687497;Activation
BL-1249;K2P2.1;f;;Human;30089357;None
chloroform;K2P2.1;f;;Human;10321245;None
GI‐530159;K2P2.1;f;;Human;29150838;None
GI‐530159;K2P2.1;f;;Human;29150838;None
halothane;K2P2.1;f;;Human;10321245;None
isoflurane;K2P2.1;f;;Human;10321245;None
riluzole;K2P2.1;f;;Human;;None
norfluoxetine;K2P2.1;f;;Human;15685212;None
halothane;K2P3.1;f;;Human;20519544;None
halothane;K2P3.1;f;;Rat;11850453|9687497;Positive
isoflurane;K2P3.1;f;;Rat;11850453;Positive
anandamide;K2P3.1;f;;Human;11226154;Inhibition
anandamide;K2P3.1;f;;Human;11226154;None
angiotensin II;K2P3.1;f;Human|Mouse|Rat;Rat;10847588;None
arachidonic acid;K2P3.1;f;;Human;11226154;None
AVE1231;K2P3.1;f;;Human;31001961;None
Ba2+;K2P3.1;f;;Human;;None
R-(+)-methanandamide;K2P3.1;f;;Human;11226154;None
arachidonic acid;K2P4.1;t;;Human;9628867;None
riluzole;K2P4.1;f;;Human;10779373;None
arachidonic acid;K2P4.1;t;;Rat;7623282;Positive
riluzole;K2P4.1;f;;Human;10779373;Positive
Ba2+;K2P4.1;f;;Rat;7623282;None
halothane;K2P5.1;f;;Human;10839924;None
clofilium;K2P5.1;f;;Mouse;11560934;None
quinidine;K2P5.1;f;;Human;14985088;None
Ba2+;K2P6.1;f;;Rat;10887187;None
quinidine;K2P6.1;f;;Rat;10887187;None
halothane;K2P9.1;f;;Human;11886861;None
ruthenium red;K2P9.1;f;;None;;None
anandamide;K2P9.1;f;;Human;10747866;None
R-(+)-methanandamide;K2P9.1;f;;Human;10747866;None
ruthenium red;K2P9.1;f;;Human;;None
NS1643;KCa1.1;f;;Human;8938721;Agonist
17β-estradiol;KCa1.1;f;;Human;10489376;None
flindokalner;KCa1.1;f;;Human;11283675;None
NS004;KCa1.1;f;;Human;;None
NS1619;KCa1.1;f;;Human;;None
slotoxin;KCa1.1;f;;Human;11576530;Antagonist
charybdotoxin;KCa1.1;f;;Human;;None
iberiotoxin;KCa1.1;f;;Human;;None
tetraethylammonium;KCa1.1;f;;Human;;None
toxin BmP09;KCa1.1;f;;Rat;15695820;None
paxilline;KCa1.1;f;;Mouse;8938726;None
Ca2+;KCa2.1;t;;Human;8781233|9774106;Agonist
CM-TPMF;KCa2.1;f;;Human;22046005;Agonist
EBIO;KCa2.1;f;;Human;11134030|20359520;Agonist
GW542573X;KCa2.1;f;;Human;19515965;Agonist
NS309;KCa2.1;f;;Human;15471565|20359520;Agonist
riluzole;KCa2.1;f;;Human;18955585;Agonist
SKA-20;KCa2.1;f;;Human;18955585;Agonist
SKA-31;KCa2.1;f;;Human;18955585;Agonist
bicuculline;KCa2.1;f;;Human;10696100;Antagonist
dequalinium;KCa2.1;f;;Human;10683185|10696100;Antagonist
Lei-Dab7;KCa2.1;f;;Human;11527975;Antagonist
leiurotoxin I;KCa2.1;f;;Human;10696100|11527975;Antagonist
tamapin;KCa2.1;f;;Human;12239213;Antagonist
tubocurarine;KCa2.1;f;;Human;8781233|10683185|10696100;Antagonist
UCL1848;KCa2.1;f;;Human;10683185;Antagonist
tetraethylammonium;KCa2.1;f;;Human;20359520;None
B-TPMF;KCa2.1;f;;Human;22046005;Antagonist
NS8593;KCa2.1;f;;Human;16926279;Antagonist
apamin;KCa2.1;f;;Human;10683185|15208027|10696100;None
UCL1684;KCa2.1;f;;Human;10696100|20359520;None
Ca2+;KCa2.2;t;;Human;9774106|16239218|10991935;Agonist
Ca2+;KCa2.2;t;;Rat;8781233|9524139;Agonist
CyPPA;KCa2.2;f;;Human;17486140;Agonist
DC-EBIO;KCa2.2;f;;Human;16239218;Agonist
EBIO;KCa2.2;f;;Human;16239218|20359520;Agonist
EBIO;KCa2.2;f;;Rat;11134030|11181893;Agonist
NS13001;KCa2.2;f;;Mouse;23102227;Agonist
NS309;KCa2.2;f;;Human;15471565|16239218|20359520;Agonist
riluzole;KCa2.2;f;;Rat;18955585;Agonist
SKA-31;KCa2.2;f;;Human;18955585;Agonist
zoxazolamine;KCa2.2;f;;Rat;10712246|11181893;Agonist
chlorzoxazone;KCa2.2;f;;Rat;10712246|11181893;None
apamin;KCa2.2;f;;Rat;8781233|10696100;Antagonist
bicuculline;KCa2.2;f;;Rat;10696100;Antagonist
dequalinium;KCa2.2;f;;Rat;10696100|10915830;Antagonist
Lei-Dab7;KCa2.2;f;;Human;11527975;Antagonist
leiurotoxin I;KCa2.2;f;;Human;11527975|10713270;Antagonist
leiurotoxin I;KCa2.2;f;;Rat;10696100;Antagonist
P05;KCa2.2;f;;Human;11527975;Antagonist
tamapin;KCa2.2;f;;Rat;12239213;Antagonist
tubocurarine;KCa2.2;f;;Human;10713270;Antagonist
tubocurarine;KCa2.2;f;;Rat;8781233|10696100|9287325;Antagonist
UCL1684;KCa2.2;f;;Rat;10696100;Antagonist
UCL1848;KCa2.2;f;;Rat;14559917;Antagonist
UCL1848;KCa2.2;f;;Human;11278890;Antagonist
tetraethylammonium;KCa2.2;f;;Human;20359520;None
NS8593;KCa2.2;f;;Human;16926279;Antagonist
RA-2;KCa2.2;f;;Mouse;25468883;Antagonist
apamin;KCa2.2;f;;Human;10713270;None
UCL1684;KCa2.2;f;;Human;11278890|20359520;None
Ca2+;KCa2.3;t;;Rat;11245600;Agonist
Ca2+;KCa2.3;f;;Human;9774106|17486140|14978258;Agonist
CyPPA;KCa2.3;f;;Human;17486140;Agonist
DC-EBIO;KCa2.3;f;;Human;17584055;Agonist
EBIO;KCa2.3;f;;Rat;11378158;Agonist
EBIO;KCa2.3;f;;Human;14978258|20359520;Agonist
NS13001;KCa2.3;f;;Mouse;23102227;Agonist
NS309;KCa2.3;f;;Human;15471565|20359520;Agonist
riluzole;KCa2.3;f;;Human;18955585;Agonist
riluzole;KCa2.3;f;;Rat;11378158;Agonist
SKA-31;KCa2.3;f;;Human;18955585;Agonist
Lei-Dab7;KCa2.3;f;;Human;11527975;Agonist
P05;KCa2.3;f;;Human;11527975;Agonist
apamin;KCa2.3;f;;Rat;11245600|11533126;Antagonist
dequalinium;KCa2.3;f;;Human;11369031;Antagonist
leiurotoxin I;KCa2.3;f;;Human;11527975|14978258;Antagonist
leiurotoxin I;KCa2.3;f;;Rat;11533126;Antagonist
tamapin;KCa2.3;f;;Rat;12239213;Antagonist
tubocurarine;KCa2.3;f;;Human;11369031|14978258;Antagonist
UCL1684;KCa2.3;f;;Rat;11533126;Antagonist
UCL1848;KCa2.3;f;;Rat;11533126;Antagonist
tetraethylammonium;KCa2.3;f;;Human;20359520;None
NS8593;KCa2.3;f;;Human;16926279;Antagonist
RA-2;KCa2.3;f;;Human;25468883;Antagonist
NS11757;KCa2.3;f;;Rat;18998663;None
apamin;KCa2.3;f;;Human;11369031|14978258;None
UCL1684;KCa2.3;f;;Human;11278890|20359520;None
Ca2+;KCa3.1;f;;Human;9326665|9380751|10712246|9407042|7505804;Agonist
chlorzoxazone;KCa3.1;f;;Human;10712246;Agonist
DC-EBIO;KCa3.1;f;;Human;11160649;Agonist
EBIO;KCa3.1;f;;Human;11134030|10712246|20359520;Agonist
NS309;KCa3.1;f;;Human;15471565|20359520;Agonist
SKA-111;KCa3.1;f;;Human;24958817;Agonist
SKA-121;KCa3.1;f;;Human;24958817;Agonist
riluzole;KCa3.1;f;;Human;18955585;None
SKA-31;KCa3.1;f;;Human;18955585;None
charybdotoxin;KCa3.1;f;;Human;10961988;Inhibition
charybdotoxin-GLU32 analog;KCa3.1;f;;Human;10625664;Inhibition
clotrimazole;KCa3.1;f;;Human;9326665|9693050|9407042|10884437;Inhibition
compound rac-16 [PMID: 15603962];KCa3.1;f;;Human;15379997|15603962;Inhibition
maurotoxin;KCa3.1;f;;Human;12527813;Inhibition
nitrendipine;KCa3.1;f;;Human;10884437;Inhibition
nitrendipine;KCa3.1;f;;Human;9730970;Inhibition
NS6180;KCa3.1;f;;Human;22891655;Inhibition
senicapoc;KCa3.1;f;;Human;12433690;Inhibition
TRAM-34;KCa3.1;f;;Human;10884437|12939222;Inhibition
charybdotoxin;KCa3.1;f;;Human;9380751|9730970;None
NS004;KCa5.1;f;;Human;;None
NS1619;KCa5.1;f;;Human;;None
quinidine;KCa5.1;f;;Human;26381170;None
quinidine;KCa5.1;f;;Mouse;19934650|26045093;None
K+;Kir1.1;t;;Rat;8663367;Activation
Ba2+;Kir1.1;f;;Rat;7680431|8997197;Antagonist
Ba2+;Kir1.1;f;;Human;7929082;Antagonist
Cs+;Kir1.1;f;;Rat;8997197;Antagonist
[125I]tertiapin Y1/K12/Q13;Kir1.1;f;;Rat;16906771;Antagonist
tertiapin-Q;Kir1.1;f;;Rat;16906771|10572003;Antagonist
tertiapin-Q;Kir1.1;f;;Rat;10572003;Antagonist
MK-7145;Kir1.1;f;;Human;27437080;Inhibition
tertiapin-Q;Kir1.1;f;;Human;10572003;Inhibition
VU591;Kir1.1;f;;Rat;20926757;Inhibition
Mg2+;Kir1.1;f;;Rat;21030597|8057249;None
Mg2+;Kir1.1;f;;Rat;21030597;None
H+;Kir1.1;t;;Rat;8663367|7762610|12547773;Antagonist
PIP2;Kir2.1;t;;Mouse;15980413|9486652|11172809;Agonist
Ba2+;Kir2.1;f;;Mouse;11454958;Antagonist
Cs+;Kir2.1;f;;Mouse;8799888;Antagonist
Mg2+;Kir2.1;t;;Mouse;7748552;Antagonist
putrescine;Kir2.1;t;;Mouse;7748552|8866861;Antagonist
Rb+;Kir2.1;f;;Mouse;8799888;Antagonist
spermidine;Kir2.1;t;;Mouse;7748552;Antagonist
spermine;Kir2.1;t;;Mouse;7748552|8866861;Antagonist
oleoyl-CoA;Kir2.1;t;;Mouse;15980413|16777940;Antagonist
Ba2+;Kir2.2;f;;Mouse;8083233;Antagonist
Ba2+;Kir2.2;f;;Rat;9592090;Antagonist
Cs+;Kir2.2;f;;Mouse;8083233;Antagonist
Mg2+;Kir2.2;t;;Human;8735700;None
arachidonic acid;Kir2.3;t;;Human;11306688;Agonist
tenidap;Kir2.3;f;;Human;11821021;Agonist
Ba2+;Kir2.3;f;;Human;12032359|8051145|8034048;Antagonist
Ba2+;Kir2.3;f;;Mouse;8013643|7926018;Antagonist
Cs+;Kir2.3;f;;Mouse;8013643|7926018;Antagonist
Cs+;Kir2.3;f;;Human;8051145;Antagonist
Mg2+;Kir2.3;t;;Human;7969496;Antagonist
putrescine;Kir2.3;t;;Human;7969496;Antagonist
SCH-23390;Kir2.3;f;;Human;12065762;Antagonist
spermidine;Kir2.3;t;;Human;7969496;Antagonist
spermine;Kir2.3;t;;Human;7969496;Antagonist
tetraethylammonium;Kir2.3;f;;Human;8051145;Antagonist
Zn2+;Kir2.3;f;;Human;7576658;Antagonist
H+;Kir2.3;t;;Human;10200419|10896660;Antagonist
H+;Kir2.3;t;;Human;7576658|10200419;Antagonist
rose bengal (photoactivated);Kir2.3;f;;Mouse;8524851;Antagonist
Ba2+;Kir2.4;f;;Human;10942728;Antagonist
Ba2+;Kir2.4;f;;Rat;9592090|17347781;Antagonist
Cs+;Kir2.4;f;;Human;10942728;Antagonist
Cs+;Kir2.4;f;;Rat;9592090;Antagonist
H+;Kir2.4;t;;Human;10942728;Antagonist
Mg2+;Kir2.4;t;;Human;;None
VU0810464;Kir3.1;f;;Human;28697302;Activation
VU0810464;Kir3.1;f;;Human;28697302;Activation
ethanol;Kir3.1;f;;Mouse;10570485|10570486;Agonist
Na+;Kir3.1;t;;Human;10085101;Agonist
PIP2;Kir3.1;t;;Unknown;9486652;Agonist
ML297;Kir3.1;f;;Human;23730969;None
Ba2+;Kir3.1;f;;Rat;8234283;Antagonist
Ba2+;Kir3.1;f;;Rat;8234283;Antagonist
Ba2+;Kir3.1;f;;Human;8804710;Antagonist
tertiapin-Q;Kir3.1;f;;None;10572004;Antagonist
tertiapin-Q;Kir3.1;f;;Rat;9748337;Antagonist
AZD2927;Kir3.1;f;;Human;;None
ethanol;Kir3.2;f;;None;10570485|10570486|19561601;Agonist
Na+;Kir3.2;t;;Human;10085101;Agonist
PIP2;Kir3.2;t;;Unknown;9486652;Agonist
amitriptyline;Kir3.2;f;;Mouse;15150531;Antagonist
clomipramine;Kir3.2;f;;Mouse;15150531;Antagonist
desipramine;Kir3.2;f;;Mouse;15150531;Antagonist
imipramine;Kir3.2;f;;Mouse;15150531;Antagonist
maprotiline;Kir3.2;f;;Mouse;15150531;Antagonist
nortriptyline;Kir3.2;f;;Mouse;15150531;Antagonist
QX-314;Kir3.2;f;;Mouse;8630252;Antagonist
bupivacaine;Kir3.2;f;;None;11353868;Antagonist
clozapine;Kir3.2;f;;Mouse;10780978;Antagonist
dizocilpine;Kir3.2;f;;Mouse;8630252;Antagonist
F3;Kir3.2;f;;None;11465552;Antagonist
fluoxetine;Kir3.2;f;;Mouse;12684268;Antagonist
haloperidol;Kir3.2;f;;Mouse;10780978;Antagonist
halothane;Kir3.2;f;;None;11455015;Antagonist
pimozide;Kir3.2;f;;Mouse;10780978;Antagonist
SCH-23390;Kir3.2;f;;Human;12065762;Antagonist
thioridazine;Kir3.2;f;;Mouse;10780978;Antagonist
verapamil;Kir3.2;f;;Mouse;8630252;Antagonist
PIP2;Kir3.3;t;;Human;8688080;None
arachidonic acid;Kir3.4;f;;Rat;2492640;Agonist
fingolimod;Kir3.4;f;;Mouse;15707407;Agonist
Na+;Kir3.4;t;;Human;8923264;Agonist
ethanol;Kir3.4;f;;Mouse;10570485|10570486;None
PIP2;Kir3.4;t;;Human;8688080|9804555;None
amitriptyline;Kir3.4;f;;Mouse;15150531;Antagonist
Ba2+;Kir3.4;f;;Rat;7877685;Antagonist
clomipramine;Kir3.4;f;;Mouse;15150531;Antagonist
Cs+;Kir3.4;f;;Rat;7877685;Antagonist
desipramine;Kir3.4;f;;Mouse;15150531;Antagonist
imipramine;Kir3.4;f;;Mouse;15150531;Antagonist
maprotiline;Kir3.4;f;;Mouse;15150531;Antagonist
NIP-142;Kir3.4;f;;Human;15879679;Antagonist
nortriptyline;Kir3.4;f;;Mouse;15150531;Antagonist
tertiapin-Q;Kir3.4;f;;None;10572004;Antagonist
tertiapin-Q;Kir3.4;f;;Rat;9748337;Antagonist
AZD2927;Kir3.4;f;;Human;;None
phorbol 12-myristate 13-acetate;Kir3.4;f;;Rat;14732702;None
Ba2+;Kir4.1;f;;Rat;10856114|7608203|12456399;Antagonist
Cs+;Kir4.1;f;;Rat;7608203;Antagonist
nortriptyline;Kir4.1;f;;Human;17071817;Antagonist
H+;Kir4.1;t;;Rat;11306656|10764726;Antagonist
K+;Kir4.2;t;;Mouse;9882736|22025665;Activation
Ba2+;Kir4.2;f;;Mouse;9882736;Antagonist
Cs+;Kir4.2;f;;Mouse;9882736;Antagonist
H+;Kir4.2;f;;Rat;11306656;Antagonist
Ba2+;Kir5.1;f;;Rat;11988170;Antagonist
Cs+;Kir5.1;f;;Rat;7874445;Antagonist
ATP;Kir6.1;t;;Mouse;9130167;Agonist
diazoxide;Kir6.1;f;;Mouse;9130167;Agonist
guanosine 5'-diphosphate;Kir6.1;t;;Mouse;9130167;Agonist
guanosine-5'-triphosphate;Kir6.1;t;;Mouse;9130167;Agonist
nicorandil;Kir6.1;f;;Mouse;9130167;Agonist
pinacidil;Kir6.1;f;;Mouse;9130167;Agonist
uridine diphosphate;Kir6.1;f;;Mouse;9130167;Agonist
cromakalim;Kir6.1;f;;Human;;None
minoxidil;Kir6.1;f;;Human;;None
ATP;Kir6.1;t;;Mouse;9130167;Antagonist
guanosine-5'-triphosphate;Kir6.1;f;;Mouse;9130167;Antagonist
glibenclamide;Kir6.1;f;;Human;;None
tolbutamide;Kir6.1;f;;Human;;None
cromakalim;Kir6.2;f;;Mouse;8630239;Agonist
diazoxide;Kir6.2;f;;Mouse;7502040;Agonist
diazoxide;Kir6.2;f;;Rat;8798681;Agonist
pinacidil;Kir6.2;f;;Mouse;8630239;Agonist
pinacidil;Kir6.2;f;;Rat;8798681;Agonist
minoxidil;Kir6.2;f;;Human;;None
nicorandil;Kir6.2;f;;Human;;None
glibenclamide;Kir6.2;f;;Rat;8798681;Antagonist
glibenclamide;Kir6.2;f;;Mouse;7502040|8630239;Antagonist
tolbutamide;Kir6.2;f;;Rat;8798681;Antagonist
tolbutamide;Kir6.2;f;;Mouse;7502040;Antagonist
ATP;Kir6.2;f;;Mouse;7502040|8630239;Antagonist
glibenclamide;Kir6.2;f;;Human;;None
tolbutamide;Kir6.2;f;;Human;;None
Ba2+;Kir7.1;f;;Human;9620703|9786970|9738472|11179389;Antagonist
Cs+;Kir7.1;f;;Human;9620703|9786970|9738472;Antagonist
fampridine;Kir7.1;f;;Human;9620703;Antagonist
bithionol;KNa1.1;f;;Rat;16876206;Agonist
Cl-;KNa1.1;t;;Rat;12628167;Agonist
loxapine;KNa1.1;f;;Human;22171093;Agonist
Na+;KNa1.1;t;;Rat;12628167;Agonist
niclosamide;KNa1.1;f;;Human;22171093;Agonist
phorbol 12-myristate 13-acetate;KNa1.1;f;;Rat;16687497;Agonist
clofilium;KNa1.1;f;;Human;23271893;Antagonist
quinidine;KNa1.1;f;;Human;24591078;Antagonist
tetraethylammonium;KNa1.1;f;;Rat;15979166;Antagonist
quinidine;KNa1.1;f;;Rat;16876206|14684870;None
Ca2+;KNa1.1;t;;Rat;10196543;Antagonist
Ca2+;KNa1.1;f;;Mouse;16446508;Antagonist
bepridil;KNa1.1;f;;Rat;16876206;None
Cl-;KNa1.2;t;;Rat;14684870;Agonist
flufenamic acid;KNa1.2;f;;Human;20176855|22851714;Agonist
Na+;KNa1.2;t;;Rat;14684870;Agonist
niflumic acid;KNa1.2;f;;Human;20176855|22851714;Agonist
clofilium;KNa1.2;f;;Human;23271893;Antagonist
Ba2+;KNa1.2;f;;Human;14684870;Inhibition
quinidine;KNa1.2;f;;Rat;14684870;Inhibition
tetraethylammonium;KNa1.2;f;;Human;16687497;Inhibition
tetraethylammonium;KNa1.2;f;;Rat;16687497;Inhibition
phorbol 12-myristate 13-acetate;KNa1.2;f;;Human;16687497;Inhibition
ATP;KNa1.2;t;;Rat;14684870;None
astemizole;Kv10.1;f;;Human;15365094;None
calmodulin;Kv10.1;f;Human;Rat;8790430;None
clofilium;Kv10.1;f;;Human;12522086;None
dofetilide;Kv10.1;f;;Human;16949586;None
E4031;Kv10.1;f;;Human;12522086;None
haloperidol;Kv10.1;f;;Human;12522086;None
imipramine;Kv10.1;f;;Human;15365094;None
LY97241;Kv10.1;f;;Human;12522086;None
MK-499;Kv10.1;f;;Human;16949586|15102940;None
quinidine;Kv10.1;f;;Human;11943152;None
terfenadine;Kv10.1;f;;Human;15102940;None
ICA-105574;Kv10.1;f;;Human;23319419;Inhibition
LY97241;Kv10.2;f;;Human;9400421|15102940;Pore blocker
quinidine;Kv10.2;f;;Human;15102940;Pore blocker
margatoxin;Kv1.1;f;;Rat;9346893;Inhibition
margatoxin;Kv1.1;f;;Human;24878374;Inhibition
tetraethylammonium;Kv1.1;f;;Mouse;7517498;Inhibition
α-dendrotoxin;Kv1.1;f;;Rat;7517498|1921987;None
capsaicin;Kv1.1;f;;Mouse;7517498;None
dendrotoxin-I;Kv1.1;f;;Mouse;7517498|8612784;None
diltiazem;Kv1.1;f;;Mouse;7517498;None
flecainide;Kv1.1;f;;Mouse;7517498;None
hongotoxin-1;Kv1.1;f;;Rat;9446567;None
kaliotoxin;Kv1.1;f;;Mouse;7517498;None
mast cell degranulating peptide;Kv1.1;f;;Mouse;7517498;None
nifedipine;Kv1.1;f;;Mouse;7517498;None
resiniferatoxin;Kv1.1;f;;Mouse;7517498;None
ShK Toxin;Kv1.1;f;;Rat;7517498;None
dendrotoxin-k;Kv1.1;f;;Rat;8612784;Pore blocker
HelaTx1;Kv1.1;f;;Human;22305749;Pore blocker
ginsenoside Rg3;Kv11.1;f;;Human;21586280;Activation
ICA-105574;Kv11.1;f;;Human;19805508;Activation
KB-130015;Kv11.1;f;;Human;20097192;Activation
NS1643;Kv11.1;f;;Human;16284303|16219910;Activation
NS3623;Kv11.1;f;;Human;16825484;Activation
rottlerin;Kv11.1;f;;Human;16928897;Activation
VU0405601;Kv11.1;f;;Human;23033485;Activation
A-935142;Kv11.1;f;;Human;19426677;None
PD-118057;Kv11.1;f;;Human;15976038;None
PD-307243;Kv11.1;f;;Human;18042732;None
RPR260243;Kv11.1;f;;Human;15548764;None
LUF7244;Kv11.1;f;;Human;27071825;Negative
AZD3778;Kv11.1;f;;Human;23031591;Inhibition
disopyramide;Kv11.1;f;;Human;12873512;Inhibition
dofetilide;Kv11.1;f;;Human;17536794;Inhibition
halofantrine;Kv11.1;f;;Human;19222165;Inhibition
MK-7145;Kv11.1;f;;Human;27437080;Inhibition
riluzole;Kv11.1;f;;Human;18955585;Inhibition
astemizole;Kv11.1;f;;Human;10376921;None
BeKm-1;Kv11.1;f;;Human;15137031;None
BeKm-1;Kv11.1;f;;Rat;16497878;None
cisapride;Kv11.1;f;;Human;9395068;None
E4031;Kv11.1;f;;Rat;9390998;None
E4031;Kv11.1;f;;Human;9449325;None
ErgTx-1;Kv11.1;f;;Human;16497878;None
ErgTx-1;Kv11.1;f;;Rat;16497878;None
γ-KTx1.7;Kv11.1;f;;Human;18338253;None
ibutilide;Kv11.1;f;;Human;12873512|15266014;None
terfenadine;Kv11.1;f;;Human;9395068;None
APETx-1;Kv11.1;f;;Human;12815161;Inhibition
APETx-1;Kv11.1;f;;Human;17473056;None
nemiralisib;Kv11.1;f;;Human;26301626;Inhibition
zorifertinib;Kv11.1;f;;Human;26313252;Inhibition
NS1643;Kv11.2;f;;Human;17610913;None
E4031;Kv11.2;f;;Rat;9390998;None
ErgTx-1;Kv11.2;f;;Human;6497878;Inhibition
BeKm-1;Kv11.2;f;;Rat;9390998;None
ErgTx-1;Kv11.2;f;;Rat;9390998;None
γ-KTx1.7;Kv11.2;f;;Human;18338253;None
NS1643;Kv11.3;f;;Rat;23226420;None
E4031;Kv11.3;f;;Rat;9390998;None
BeKm-1;Kv11.3;f;;Rat;17097705;Pore blocker
ErgTx-1;Kv11.3;f;;Rat;17097705;Pore blocker
margatoxin;Kv1.2;f;;Human;24878374;Inhibition
α-dendrotoxin;Kv1.2;f;;Rat;7517498|1921987;None
α-KTx 13.2;Kv1.2;f;;Rat;11527374;None
BgK;Kv1.2;f;;Rat;9063464;None
charybdotoxin;Kv1.2;f;;Rat;7517498;None
dendrotoxin-I;Kv1.2;f;;Rat;7517498;None
hongotoxin-1;Kv1.2;f;;Rat;9446567;None
mast cell degranulating peptide;Kv1.2;f;;Rat;7517498;None
noxiustoxin;Kv1.2;f;;Rat;7517498;None
pandinotoxin-K α;Kv1.2;f;;Rat;11527374;None
anandamide;Kv1.2;f;;Human;8938728;Pore blocker
capsaicin;Kv1.2;f;;Rat;7517498;Pore blocker
diltiazem;Kv1.2;f;;Rat;7517498;Pore blocker
fampridine;Kv1.2;f;;Rat;7517498;Pore blocker
flecainide;Kv1.2;f;;Rat;7517498;Pore blocker
nifedipine;Kv1.2;f;;Rat;7517498;Pore blocker
resiniferatoxin;Kv1.2;f;;Rat;7517498;Pore blocker
Ba2+;Kv12.1;f;;Human;12890647;None
Cd2+;Kv12.1;f;;Mouse;19580749;None
Zn2+;Kv12.1;f;;Mouse;19580749;None
Cs+;Kv12.2;f;;Human;12193184;Pore blocker
CX4;Kv12.2;f;;Mouse;20676103;Inhibition
5-(4-phenoxybutoxy)psoralen;Kv1.3;f;;Mouse;16099841;None
charybdotoxin;Kv1.3;f;;Human;10961988|1373731|2475579;None
charybdotoxin;Kv1.3;f;;Rat;7517498;None
correolide;Kv1.3;f;;Human;10213593;None
HsTX1[R14A];Kv1.3;f;;Human;28389388;None
kaliotoxin;Kv1.3;f;;Rat;7517498;None
margatoxin;Kv1.3;f;;Human;10961988|8360176;None
maurotoxin;Kv1.3;f;;None;9792177;None
noxiustoxin;Kv1.3;f;;Mouse;7517498;None
OSK1-K16-D20;Kv1.3;f;;Mouse;15588251;None
psora-4;Kv1.3;f;;Human;20971642;None
ShK(L5);Kv1.3;f;;Rat;15665253;None
ShK Toxin;Kv1.3;f;;Rat;9830012|14622016|8567178;None
tetraethylammonium;Kv1.3;f;;Mouse;7517498;None
Vm24;Kv1.3;f;;Human;22540187;None
Vm24;Kv1.3;f;;Human;22540187;None
correolide;Kv1.3;f;;Human;10213593;Pore blocker
CP-339818;Kv1.4;f;;Mouse;8967992;None
fampridine;Kv1.4;f;;Rat;2555158;None
nicardipine;Kv1.4;f;;Rat;12788813;None
quinidine;Kv1.4;f;;Rat;7589202;None
bupivacaine;Kv1.5;f;;Human;9400387;None
clofilium;Kv1.5;f;;Human;7838129;None
DPO-1;Kv1.5;f;;Human;20304642;None
fampridine;Kv1.5;f;;None;8508531;None
flecainide;Kv1.5;f;;Human;7517498;None
nifedipine;Kv1.5;f;;Human;7517498;None
propafenone;Kv1.5;f;;Human;9846634;None
quinidine;Kv1.5;f;;Human;1538710;None
resiniferatoxin;Kv1.5;f;;Human;7517498;None
S9947;Kv1.5;f;;Human;12382079|11692231;None
diltiazem;Kv1.5;f;;Human;7517498;Pore blocker
fampridine;Kv1.5;f;;Human;7517498;Pore blocker
dronedarone;Kv1.5;f;;Human;24824064;Inhibition
α-dendrotoxin;Kv1.6;f;;Human;2347305;None
charybdotoxin;Kv1.6;f;;Human;2347305;None
hongotoxin-1;Kv1.6;f;;Rat;9446567;None
mast cell degranulating peptide;Kv1.6;f;;Human;2347305;None
ShK Toxin;Kv1.6;f;;Rat;9830012;None
[125I]α-DTX;Kv1.6;f;;Rat;11707459;None
[125I]BgK (W5Y / Y26F);Kv1.6;f;;Rat;11707459;None
tetraethylammonium;Kv1.6;f;;Human;2347305;None
conopeptide Y-PI1;Kv1.6;f;;Rat;18505731;Pore blocker
amiodarone;Kv1.7;f;;Human;11896454;None
capsaicin;Kv1.7;f;;Mouse;9488722;None
CP-339818;Kv1.7;f;;Mouse;9488722;None
cromakalim;Kv1.7;f;;Mouse;9488722;None
diltiazem;Kv1.7;f;;Mouse;9488722;None
fampridine;Kv1.7;f;;Mouse;9488722;None
flecainide;Kv1.7;f;;Human;11896454;None
margatoxin;Kv1.7;f;;Mouse;9488722;None
nifedipine;Kv1.7;f;;Mouse;9488722;None
noxiustoxin;Kv1.7;f;;Mouse;9488722;None
quinidine;Kv1.7;f;;Human;11896454;None
resiniferatoxin;Kv1.7;f;;Mouse;9488722;None
ShK Toxin;Kv1.7;f;;Mouse;9488722;None
tedisamil;Kv1.7;f;;Mouse;9488722;None
tetraethylammonium;Kv1.7;f;;Mouse;9488722;None
tetraethylammonium;Kv1.7;f;;Human;11896454;None
verapamil;Kv1.7;f;;Human;11896454;None
conkunitzin-S1 toxin;Kv1.7;f;;Mouse;22438204;Pore blocker
fampridine;Kv1.7;f;;Mouse;16801386;Pore blocker
Ba2+;Kv1.8;f;;Human;10836990;None
charybdotoxin;Kv1.8;f;;Human;10836990;None
fampridine;Kv1.8;f;;Human;10836990;None
ketoconazole;Kv1.8;f;;Human;10836990;None
pimozide;Kv1.8;f;;Human;10836990;None
tetraethylammonium;Kv1.8;f;;Human;10836990;None
verapamil;Kv1.8;f;;Human;10836990;None
linoleic acid;Kv2.1;f;;Human;11546665;None
3-bicyclo[2.2.1]hept-2-yl-benzene-1,2-diol;Kv2.1;f;;Human;14722253;None
Ba2+;Kv2.1;f;;Rat;8341271;None
Ba2+;Kv2.1;f;;Rat;8341271;None
DABCO-C16;Kv2.1;f;;Rat;16317109;None
halothane;Kv2.1;f;;Rat;8638845;None
linoleic acid;Kv2.1;f;;Human;11546665;None
fampridine;Kv2.1;f;;Rat;8301258;Pore blocker
Na+;Kv2.1;f;;Rat;8189205;Pore blocker
SsmTx-1;Kv2.1;f;;Rat;24464516;Pore blocker
tetraethylammonium;Kv2.1;f;;Rat;16478442;Pore blocker
GxTx-1E;Kv2.1;f;;Human;16567526;None
HaTx1;Kv2.1;f;;Rat;7576642;None
jingzhaotoxin-III;Kv2.1;f;;Rat;17481690;None
jingzhaotoxin-XI;Kv2.1;f;;Mouse;17176080;None
RY796;Kv2.1;f;;Human;21948463;None
ScTx1;Kv2.1;f;;Rat;12065754;None
SGTx1;Kv2.1;f;;Rat;14744131;None
fampridine;Kv2.2;f;;Human;9612272;None
quinine;Kv2.2;f;;Human;9612272;None
tetraethylammonium;Kv2.2;f;;Human;9612272;None
GxTx-1E;Kv2.2;f;;Human;16567526;None
RY796;Kv2.2;f;;Human;21948463;None
ScTx1;Kv2.2;f;;Rat;12065754;None
capsaicin;Kv3.1;f;;Mouse;7517498;None
cromakalim;Kv3.1;f;;Mouse;7517498;None
diltiazem;Kv3.1;f;;Mouse;7517498;None
fampridine;Kv3.1;f;;Mouse;7517498;None
flecainide;Kv3.1;f;;Mouse;7517498;None
nifedipine;Kv3.1;f;;Mouse;7517498;None
resiniferatoxin;Kv3.1;f;;Mouse;7517498;None
tetraethylammonium;Kv3.1;f;;Mouse;7517498;None
fluoxetine;Kv3.1;f;;Rat;11543764;None
norfluoxetine;Kv3.1;f;;Rat;11543764;None
fampridine;Kv3.2;f;;Rat;11790809;None
ShK Toxin;Kv3.2;f;;Human;15709110;None
tetraethylammonium;Kv3.2;f;;Rat;11790809;None
verapamil;Kv3.2;f;;Rat;10670415;None
fampridine;Kv3.3;f;;Rat;1381835;None
tetraethylammonium;Kv3.3;f;;Rat;1381835;None
DABCO;Kv3.4;f;;Rat;16317109;None
DABCO-C16;Kv3.4;f;;Rat;16317109;None
sea anemone toxin BDS-I;Kv3.4;f;;Rat;9506974;None
tetraethylammonium;Kv3.4;f;;Rat;1840526|1378392;None
thiopental;Kv3.4;f;;Rat;16217144;None
fampridine;Kv4.1;f;;Human;10729221;None
fampridine;Kv4.1;f;;Mouse;11805342;None
HmTx1;Kv4.1;f;;Mouse;12065754;None
tetraethylammonium;Kv4.1;f;;Human;12349911;None
arachidonic acid;Kv4.2;f;;Rat;10503950|8786428;None
fampridine;Kv4.2;f;;Mouse;16317109;None
heteropodatoxin-2;Kv4.2;f;;Rat;15208026|9058605|16987219;None
phrixotoxin 1;Kv4.2;f;;Mouse;15096626|22615428;None
phrixotoxin 2;Kv4.2;f;;Mouse;15096626|22615428;None
quinidine;Kv4.2;f;;Rat;12721103;None
riluzole;Kv4.2;f;;Rat;18955585;None
sBmTX 3;Kv4.2;f;;Rat;16987219;None
bupivacaine;Kv4.3;f;;Mouse;17016508;None
bupivacaine;Kv4.3;f;;Mouse;17220193;None
fampridine;Kv4.3;f;;Mouse;17016508;None
nicotine;Kv4.3;f;;Rat;10973847;None
phrixotoxin 1;Kv4.3;f;;Rat;10973847;None
phrixotoxin 2;Kv4.3;f;;Mouse;17016508|17220193;None
phrixotoxin 2;Kv4.3;f;;Rat;10973847;None
sibutramine;Kv4.3;f;;Rat;17312186;None
riluzole;Kv4.3;f;;Rat;16815868;None
ML277;Kv7.1;f;;Human;22910039;Activation
mefenamic acid;Kv7.1;f;;Human;11207363;None
R-L3;Kv7.1;f;;Human;9658209;None
zinc pyrithione;Kv7.1;f;;Human;17435769;None
niflumic acid;Kv7.1;f;;Human;7969055;Positive
(3R,4S)-293B;Kv7.1;f;;Human;16909339|11739240;Antagonist
3S,4R-293B;Kv7.1;f;;Human;11739240;Antagonist
HMR-1556;Kv7.1;f;;Human;16909339;Antagonist
azimilide;Kv7.1;f;;Mouse;9313924;None
IKs124;Kv7.1;f;;Human;15579540;None
L735821;Kv7.1;f;;Human;12815162|9397166;None
linopirdine;Kv7.1;f;;Mouse;12690036;None
XE991;Kv7.1;f;;Human;10825393;None
flindokalner;Kv7.2;f;;Human;11378159;None
flupirtine;Kv7.2;f;;Human;14736843;None
ICA-27243;Kv7.2;f;;Human;19733209;None
PIP2;Kv7.2;t;;Human;16251430;None
QO-58;Kv7.2;f;;Human;23013484;None
retigabine;Kv7.2;f;;Human;11466425;None
(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide;Kv7.2;f;;Human;12852750|16904708;None
zinc pyrithione;Kv7.2;f;;Human;17435769;None
ztz240;Kv7.2;f;;Unknown;20584905;None
L735821;Kv7.2;f;;Human;9827540;None
tetraethylammonium;Kv7.2;f;;Human;10711337|10953053;None
linopirdine;Kv7.2;f;;Human;9836639;None
XE991;Kv7.2;f;;Human;9836639;None
gabapentin;Kv7.3;f;;Human;30021858;Activation
retigabine;Kv7.3;f;;Human;11466425;None
tetraethylammonium;Kv7.3;f;;Human;10711337;None
linopirdine;Kv7.3;f;;Rat;9836639;None
ML213;Kv7.4;f;;Human;22125664;Activation
NC00075159;Kv7.4;f;;Human;21782781;Activation
flindokalner;Kv7.4;f;;Human;11245603;None
PIP2;Kv7.4;t;;Human;16251430;None
retigabine;Kv7.4;f;;Human;11466425;None
(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide;Kv7.4;f;;Human;16904708;None
zinc pyrithione;Kv7.4;f;;Human;17435769;None
bepridil;Kv7.4;f;;Human;11245603;None
tetraethylammonium;Kv7.4;f;;Human;18786918;None
linopirdine;Kv7.4;f;;Human;11245603;None
XE991;Kv7.4;f;;Human;11245603;None
gabapentin;Kv7.5;f;;Human;30021858;Activation
flindokalner;Kv7.5;f;;Human;11890900;None
retigabine;Kv7.5;f;;Human;11890900;None
(S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide;Kv7.5;f;;Human;16904708;None
zinc pyrithione;Kv7.5;f;;Human;17435769;None
tetraethylammonium;Kv7.5;f;;Human;10787416|10816588;None
linopirdine;Kv7.5;f;;Human;10787416;None
XE991;Kv7.5;f;;Human;10816588;None
GSK065;kynurenine 3-monooxygenase;f;;Human;28604669;Inhibition
GSK065;kynurenine 3-monooxygenase;f;;Human;28604669;Inhibition
GSK180;kynurenine 3-monooxygenase;f;;Human;26752518;Inhibition
UNC1215;L3MBTL histone methyl-lysine binding protein 3;f;;Human;23292653;Agonist
relatlimab;LAG3 (CD223);f;;Human;;Antagonist
abscisic acid;LanC like 2;f;;Human;17389374;Binding
BT-11;LanC like 2;f;;Human;27933891;Binding
NSC61610;LanC like 2;f;;Human;27933891|22509338;Binding
29-methylidene-2,3-oxidosqualene;lanosterol synthase;f;;Rat;9003518;Inhibition
compound 10 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 1 [Gotteland et al., 1997];lanosterol synthase;f;;Human;;Inhibition
compound 1 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 3 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 3 [PMID: 9003518];lanosterol synthase;f;;Rat;9003518;Inhibition
compound 4a [Marquart et al., 1994];lanosterol synthase;f;;Rat;;Inhibition
compound 4b [Marquart et al., 1994];lanosterol synthase;f;;Rat;;Inhibition
compound 4 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 4 [PMID: 9003518];lanosterol synthase;f;;Rat;9003518;Inhibition
compound 5 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 6 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 7 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 8 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
compound 9 [PMID: 22533316];lanosterol synthase;f;;Human;22533316;Inhibition
Ro 48-8071;lanosterol synthase;f;;Human;22533316;Inhibition
compound 35 [PMID: 20684608];large tumor suppressor kinase 2;f;;Human;20684608;Inhibition
3-hydroxybenzylhydrazine;L-Aromatic amino-acid decarboxylase ;f;;Human;;Inhibition
benserazide;L-Aromatic amino-acid decarboxylase ;f;;Human;22384042;Inhibition
carbidopa;L-Aromatic amino-acid decarboxylase ;f;;Human;;Inhibition
L-α-methyldopa;L-Aromatic amino-acid decarboxylase ;f;;Human;;Inhibition
7-hydroxystaurosporine;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;15486189;Inhibition
acalabrutinib;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;;Inhibition
belizatinib;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;22734674;Inhibition
CCT196969;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;25500121;Inhibition
CCT241161;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;25500121;Inhibition
compound 19a [PMID: 21855335];LCK proto-oncogene, Src family tyrosine kinase;f;;Human;21855335;Inhibition
compound 23 [PMID: 17600705];LCK proto-oncogene, Src family tyrosine kinase;f;;Human;17600705;Inhibition
compound 2 [PMID: 15546730];LCK proto-oncogene, Src family tyrosine kinase;f;;Human;15546730;Inhibition
compound 30 [PMID: 17280833];LCK proto-oncogene, Src family tyrosine kinase;f;;Human;17280833;Inhibition
compound 36 [PMID: 21958547];LCK proto-oncogene, Src family tyrosine kinase;f;;Human;21958547;Inhibition
compound 7 [PMID: 22464456];LCK proto-oncogene, Src family tyrosine kinase;f;;Human;22464456;Inhibition
DDR1/2 inhibitor 5n;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;30075624;Inhibition
dorsomorphin;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;20932747;Inhibition
eCF506;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;27115835;Inhibition
GSK2646264;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;30249354;Inhibition
ibrutinib;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
JNJ-28312141;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;19887542;Inhibition
Lck inhibitor;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;11012022;Inhibition
neolymphostin A;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;30380865;Inhibition
pexidartinib;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;26222558;Inhibition
PP1;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;8557675;Inhibition
PP2;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;8557675;Inhibition
saracatinib;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;17064066;Inhibition
SU6656;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;17850214;Inhibition
WH-4-023;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;16884310;Inhibition
xiliertinib;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;28881608;Inhibition
ZAK inhibitor 6p;LCK proto-oncogene, Src family tyrosine kinase;f;;Human;31244114;Inhibition
compound 7u [PMID: 24775305];legumain;f;;Human;24775305;Inhibition
leptin;Leptin receptor;t;Human;Mouse;24743494;Agonist
bestatin;Leucine aminopeptidase 3;f;;Bovine;8422382|12801228;Inhibition
opicinumab;leucine rich repeat and Ig domain containing 1;f;;Human;;Binding
GNE-7915;leucine rich repeat kinase 2;f;;Human;24354345;Binding
compound 20 [PMID: 30998356];leucine rich repeat kinase 2;f;;Human;30998356;Inhibition
DCLK1-IN-1;leucine rich repeat kinase 2;f;;Human;32251410;Inhibition
GNE-0877;leucine rich repeat kinase 2;f;;Human;24354345;Inhibition
GNE-7915;leucine rich repeat kinase 2;f;;Human;24354345;Inhibition
GNE-9605;leucine rich repeat kinase 2;f;;Human;24354345;Inhibition
GSK2646264;leucine rich repeat kinase 2;f;;Human;30249354;Inhibition
HG-10-102-01;leucine rich repeat kinase 2;f;;Human;22591441;Inhibition
JAK3 inhibitor VI;leucine rich repeat kinase 2;f;;Human;;Inhibition
LRRK2-IN-1;leucine rich repeat kinase 2;f;;Human;23721803;Inhibition
LRRK2-IN-1;leucine rich repeat kinase 2;f;;Human;21378983;Inhibition
NIK inhibitor 12f;leucine rich repeat kinase 2;f;;Human;32479083;Inhibition
NIK SMI1;leucine rich repeat kinase 2;f;;Human;29330524;Inhibition
PF-06447475;leucine rich repeat kinase 2;f;;Human;25353650;Inhibition
PF-06454589;leucine rich repeat kinase 2;f;;Human;25353650;Inhibition
TTT-3002;leucine rich repeat kinase 2;f;;Human;23065705;Inhibition
URMC-099;leucine rich repeat kinase 2;f;;Human;24044867;Inhibition
compound 17 [PMID: 23916253];Leucyl-cysteinyl aminopeptidase;f;;Human;23916253;Inhibition
inhibitor 19 [PMID: 21476495];Leucyl-cysteinyl aminopeptidase;f;;Human;21476495;Inhibition
cardiotrophin-1;Leukemia inhibitory factor receptor;t;Human;Human;;Agonist
LIF;Leukemia inhibitory factor receptor;t;Human;Human;;Agonist
oncostatin M;Leukemia inhibitory factor receptor;t;Human;Human;;Agonist
anti-ILT7 antibody;leukocyte immunoglobulin like receptor A4 (CD85g);f;;Human;;Binding
belizatinib;leukocyte receptor tyrosine kinase;f;;Human;22734674;Inhibition
compound 20 [PMID: 30998356];leukocyte receptor tyrosine kinase;f;;Human;30998356;Inhibition
compound 8e [PMID: 24432909];leukocyte receptor tyrosine kinase;f;;Human;24432909;Inhibition
gilteritinib;leukocyte receptor tyrosine kinase;f;;Human;27908881;Inhibition
4-OMe-ARM1;Leukotriene A4 hydrolase;f;;Human;31751136;Activation
bestatin;Leukotriene A4 hydrolase;f;;Human;1846352;Inhibition
compound 1a [PMID: 25692029];Leukotriene A4 hydrolase;f;;Human;25692029|18804029;Inhibition
DG-051;Leukotriene A4 hydrolase;f;;Human;19950900;Inhibition
LYS006;Leukotriene A4 hydrolase;f;;Human;;Inhibition
SC-22716;Leukotriene A4 hydrolase;f;;Human;10691697;Inhibition
AZD9898;Leukotriene C4 synthase;f;;Human;;Inhibition
compound 39 [PMID: 23623673];Leukotriene C4 synthase;f;;Human;23623673;Inhibition
example 36 [WO2016177845];Leukotriene C4 synthase;f;;Human;;Inhibition
TK05;Leukotriene C4 synthase;f;;Human;26283693;Inhibition
hCG;LH receptor;t;Human;Human;12727981|1922095;Full agonist
LH;LH receptor;t;Human;Human;12727981|1922095;Full agonist
[125I]chorionic gonadotropin (human);LH receptor;f;;Human;;Full agonist
[125I]LH;LH receptor;f;;Human;;Full agonist
compound 14 [PMID: 19831390];LIM domain kinase 1;f;;Human;19831390;Inhibition
compound 30 [PMID: 22902653];LIM domain kinase 1;f;;Human;22902653;Inhibition
compound 31 [PMID: 22902653];LIM domain kinase 1;f;;Human;22902653;Inhibition
compound 35 [PMID: 22902653];LIM domain kinase 1;f;;Human;22902653;Inhibition
LIMKi3;LIM domain kinase 1;f;;Human;29574791|19001433|20876278|22496574;Inhibition
RKI-1447;LIM domain kinase 1;f;;Human;23275831;Inhibition
SR7826;LIM domain kinase 1;f;;Human;25621531|29574791;Inhibition
voruciclib;LIM domain kinase 1;f;;Human;26606677;Inhibition
ZAK inhibitor 6p;LIM domain kinase 1;f;;Human;31244114;Inhibition
compound 14 [PMID: 19831390];LIM domain kinase 2;f;;Human;19831390;Inhibition
compound 22m [PMID: 19831390];LIM domain kinase 2;f;;Human;19831390;Inhibition
compound 30 [PMID: 22902653];LIM domain kinase 2;f;;Human;22902653;Inhibition
compound 31 [PMID: 22902653];LIM domain kinase 2;f;;Human;22902653;Inhibition
compound 35 [PMID: 22902653];LIM domain kinase 2;f;;Human;22902653;Inhibition
LIMKi3;LIM domain kinase 2;f;;Human;29574791|19001433|20876278|22496574;Inhibition
ZAK inhibitor 6p;LIM domain kinase 2;f;;Human;31244114;Inhibition
compound 41 [PMID: 15026062];lipase E, hormone sensitive type;f;;Human;15026062;Inhibition
compound 12 [PMID: 31990537];lipase G, endothelial type;f;;Human;31990537;Inhibition
GSK-264220A;lipase G, endothelial type;f;;Human;19058966;Irreversible inhibition
compound 6N [PMID: 31419141];Liver receptor homolog-1;f;;Human;31419141;Agonist
RJW100;Liver receptor homolog-1;f;;Human;21391689;Agonist
RJW100;Liver receptor homolog-1;f;;Human;31419141;Agonist
22R-hydroxycholesterol;Liver X receptor-α;t;;Human;8878485;Agonist
24(S), 25-epoxycholesterol;Liver X receptor-α;t;;Human;9874807|9013544|23292650;Agonist
24(S)-hydroxycholesterol;Liver X receptor-α;t;;Human;9013544;Agonist
27-hydroxycholesterol;Liver X receptor-α;t;;Human;11504730;Agonist
acetyl-podocarpic dimer;Liver X receptor-α;f;;Human;11790770;Agonist
AZ12260493;Liver X receptor-α;f;;Human;;Agonist
desmosterol;Liver X receptor-α;f;;Human;16857673;Agonist
GW3965;Liver X receptor-α;f;;Human;11985463;Agonist
L-783483;Liver X receptor-α;f;;Human;12072387;Agonist
paxilline;Liver X receptor-α;f;;Human;12893846;Agonist
T0901317;Liver X receptor-α;f;;Human;11090131;Agonist
IMB-808;Liver X receptor-α;f;;Human;28087808;Partial agonist
GSK2033;Liver X receptor-α;f;;Human;20345102;Antagonist
SR9238;Liver X receptor-α;f;;Mouse;23237488;Inverse agonist
DRL-17822;Liver X receptor-α;f;;Human;;Inhibition
22R-hydroxycholesterol;Liver X receptor-β;t;;Human;8878485;Agonist
24(S), 25-epoxycholesterol;Liver X receptor-β;t;;Human;9013544|23292650;Agonist
24(S)-hydroxycholesterol;Liver X receptor-β;t;;Human;9013544;Agonist
27-hydroxycholesterol;Liver X receptor-β;t;;Human;11504730;Agonist
acetyl-podocarpic dimer;Liver X receptor-β;f;;Human;11790770;Agonist
AZ12260493;Liver X receptor-β;f;;Human;;Agonist
desmosterol;Liver X receptor-β;f;;Human;16857673;Agonist
GW3965;Liver X receptor-β;f;;Human;11985463;Agonist
L-783483;Liver X receptor-β;f;;Human;12072387;Agonist
rovazolac;Liver X receptor-β;f;;Human;;Agonist
T0901317;Liver X receptor-β;f;;Human;11090131;Agonist
IMB-808;Liver X receptor-β;f;;Human;28087808;Partial agonist
GSK9772;Liver X receptor-β;f;;Human;18800767;Negative
compound 17l [PMID: 26288691];Liver X receptor-β;f;;Human;26288691;Antagonist
GSK2033;Liver X receptor-β;f;;Human;20345102;Antagonist
SR9238;Liver X receptor-β;f;;Mouse;23237488;Inverse agonist
2-oleoyl-LPA;LPA1 receptor;f;;Human;10922489;Agonist
alkyl OMPT;LPA1 receptor;f;;Human;16892372;Agonist
CpX;LPA1 receptor;f;;Human;32409422;Agonist
CpX;LPA1 receptor;f;;Human;32409422;Agonist
CpY;LPA1 receptor;f;;Human;32409422;Agonist
CpY;LPA1 receptor;f;;Human;32409422;Agonist
UCM-05194;LPA1 receptor;f;;Human;31790581;Agonist
LPA;LPA1 receptor;t;;Mouse;18781939|8922387|20505096;Full agonist
NAEPA;LPA1 receptor;f;;Mouse;18781939;Partial agonist
oleoyl-thiophosphate;LPA1 receptor;f;;Human;16033271;Partial agonist
oleoyl-thiophosphate;LPA1 receptor;f;;Mouse;20729877;Partial agonist
T13;LPA1 receptor;f;;Mouse;18781939|20729877;Partial agonist
AM095;LPA1 receptor;f;;Human;21159750;Antagonist
AM095;LPA1 receptor;f;;Mouse;21159750;Antagonist
AM966;LPA1 receptor;f;;Human;21159750;Antagonist
AM966;LPA1 receptor;f;;Mouse;20649573;Antagonist
amitriptyline;LPA1 receptor;f;;Human;32007501;Antagonist
anti-BrP-LPA;LPA1 receptor;f;;Human;19509223;Antagonist
anti-BrP-LPA;LPA1 receptor;f;;Human;19509223;Antagonist
BMS-986020;LPA1 receptor;f;;Human;;Antagonist
BrP-LPA;LPA1 receptor;f;;Human;19509223;Antagonist
BrP-LPA;LPA1 receptor;f;;Human;19509223;Antagonist
dioctanoylglycerol pyrophosphate;LPA1 receptor;f;;Human;18781939|11562440;Antagonist
Ki16425;LPA1 receptor;f;;Mouse;14500756;Antagonist
mianserin;LPA1 receptor;f;;Human;32007501;Antagonist
ONO-3080573;LPA1 receptor;f;;Human;26091040;Antagonist
ONO-7300243;LPA1 receptor;f;;Human;27774128;Antagonist
ONO-9780307;LPA1 receptor;f;;Human;26091040;Antagonist
ONO-9910539;LPA1 receptor;f;;Human;26091040;Antagonist
SAR100842;LPA1 receptor;f;;Human;32627178;Antagonist
syn-BrP-LPA;LPA1 receptor;f;;Human;19509223;Antagonist
syn-BrP-LPA;LPA1 receptor;f;;Human;19509223;Antagonist
VPC12249;LPA1 receptor;f;;Mouse;11723223;Antagonist
VPC32179;LPA1 receptor;f;;Human;15125924;Antagonist
VPC32183;LPA1 receptor;f;;Human;15125924;Antagonist
VPC32183;LPA1 receptor;f;;Mouse;15125924;Antagonist
2-oleoyl-LPA;LPA2 receptor;f;;Human;10922489;Agonist
CpX;LPA2 receptor;f;;Human;32409422;Agonist
CpX;LPA2 receptor;f;;Human;32409422;Agonist
CpY;LPA2 receptor;f;;Human;32409422;Agonist
CpY;LPA2 receptor;f;;Human;32409422;Agonist
farnesyl diphosphate;LPA2 receptor;t;;Human;19366702;Agonist
GRI977143;LPA2 receptor;f;;Human;22968304;Agonist
LPA;LPA2 receptor;t;;Human;10727522|15177455;Agonist
Radioprotectin-1;LPA2 receptor;f;;Human;30063964;Agonist
Radioprotectin-1;LPA2 receptor;f;;Mouse;30063964;Agonist
decyl dihydrogen phosphate;LPA2 receptor;f;;Human;12695531;Full agonist
dodecylphosphate;LPA2 receptor;f;;Human;12695531;Full agonist
LPA;LPA2 receptor;t;;Mouse;18781939|9525886;Full agonist
NAEPA;LPA2 receptor;f;;Mouse;18781939;Full agonist
dodecyl-thiophosphate;LPA2 receptor;f;;Mouse;16033271;Partial agonist
oleoyl-thiophosphate;LPA2 receptor;f;;Mouse;16033271;Partial agonist
AM966;LPA2 receptor;f;;Mouse;20649573;Antagonist
AM966;LPA2 receptor;f;;Human;20649573;Antagonist
BrP-LPA;LPA2 receptor;f;;Mouse;19509223;Antagonist
BrP-LPA;LPA2 receptor;f;;Mouse;19509223;Antagonist
compound 15 [PMID: 18178086];LPA2 receptor;f;;Mouse;18178086;Antagonist
farnesyl monophosphate;LPA2 receptor;t;;None;19366702;Antagonist
H2L5186303;LPA2 receptor;f;;Human;19800804;Antagonist
Ki16425;LPA2 receptor;f;;Human;14500756;Antagonist
2-oleoyl-LPA;LPA3 receptor;f;;Human;10922489;Agonist
alkyl OMPT;LPA3 receptor;f;;Human;16892372;Agonist
α-fluoromethylenephosphonate;LPA3 receptor;f;;Human;15857137;Agonist
CpX;LPA3 receptor;f;;Human;32409422;Agonist
CpY;LPA3 receptor;f;;Human;32409422;Agonist
dioctanoylglycerol pyrophosphate;LPA3 receptor;f;;Human;11562440;Agonist
LPA;LPA3 receptor;t;;Mouse;18781939;Agonist
LPA;LPA3 receptor;t;;Human;10488122;Agonist
NAEPA;LPA3 receptor;f;;Mouse;18781939;Agonist
OMPT;LPA3 receptor;f;;Human;12554733;Agonist
T13;LPA3 receptor;f;;Mouse;18781939;Agonist
oleoyl-thiophosphate;LPA3 receptor;f;;Mouse;16033271;Partial agonist
AM966;LPA3 receptor;f;;Human;20649573;Antagonist
AM966;LPA3 receptor;f;;Mouse;20649573;Antagonist
compound 12 [PMID: 19800804];LPA3 receptor;f;;Mouse;19800804;Antagonist
dioctanoylglycerol pyrophosphate;LPA3 receptor;f;;Human;14500756|11562440;Antagonist
dodecylphosphate;LPA3 receptor;f;;Human;12695531;Antagonist
dodecyl-thiophosphate;LPA3 receptor;f;;Mouse;16033271;Antagonist
farnesyl diphosphate;LPA3 receptor;t;;Human;19366702;Antagonist
farnesyl diphosphate;LPA3 receptor;t;;Human;17092771;Antagonist
farnesyl monophosphate;LPA3 receptor;t;;Human;17092771;Antagonist
farnesyl monophosphate;LPA3 receptor;t;;Human;19366702;Antagonist
H2L5186303;LPA3 receptor;f;;Human;19800804;Antagonist
Ki16425;LPA3 receptor;f;;Human;14500756;Antagonist
VPC12249;LPA3 receptor;f;;Human;18781939|11723223;Antagonist
VPC12249;LPA3 receptor;f;;Human;11723223;Antagonist
VPC32179;LPA3 receptor;f;;Human;15125924;Antagonist
VPC32183;LPA3 receptor;f;;Human;15125924;Antagonist
VPC32183;LPA3 receptor;f;;Human;15125924;Antagonist
LPA;LPA4 receptor;t;;Mouse;12724320;Agonist
LPA;LPA4 receptor;t;;Human;12724320;Agonist
[1-bromo-(3S)-hydrox-4-(palmitoyloxy)butyl]phosphate;LPA4 receptor;f;;Human;18781939;Antagonist
AM966;LPA4 receptor;f;;Human;20649573;Antagonist
farnesyl diphosphate;LPA4 receptor;t;;Human;19366702;Antagonist
farnesyl monophosphate;LPA4 receptor;f;;Human;19366702;Antagonist
farnesyl monophosphate;LPA5 receptor;t;;Human;19366702;Agonist
LPA;LPA5 receptor;t;;Human;18499677|20056548|23396314;Agonist
alkyl glycerol phosphate 18:1;LPA5 receptor;f;;Rat;19366702;Full agonist
LPA;LPA5 receptor;t;;Human;16651401;Full agonist
farnesyl diphosphate;LPA5 receptor;t;;Human;19366702|18499677;Partial agonist
N-arachidonoylglycine;LPA5 receptor;t;;Human;19366702|18499677;Partial agonist
octyl thiophosphatidic acid;LPA5 receptor;f;;Rat;19366702;Partial agonist
AS2717638;LPA5 receptor;f;;Human;28859883;Antagonist
TCLPA5;LPA5 receptor;f;;Human;22801643;Antagonist
LPA;LPA6 receptor;t;;Human;19386608|18297070;Agonist
LPA;LPA6 receptor;t;;Mouse;19386608;Partial agonist
AT-56;L-PGDS;f;;Human;19131342;Inhibition
sapropterin;L-Phenylalanine hydroxylase ;f;;Human;15537351;Activation
α-methylphenylalanine;L-Phenylalanine hydroxylase ;f;;Rat;944951;Inhibition
fenclonine;L-Phenylalanine hydroxylase ;f;;Human;;Inhibition
6-fluorotryptophan;L-Tryptophan hydroxylase 1;f;;Human;6457252;Inhibition
α-propyldopacetamide;L-Tryptophan hydroxylase 1;f;;Human;;Inhibition
fenclonine;L-Tryptophan hydroxylase 1;f;;Human;;Inhibition
fenfluramine;L-Tryptophan hydroxylase 1;f;;Human;;Inhibition
rodatristat;L-Tryptophan hydroxylase 1;f;;Human;28041831;Inhibition
telotristat ethyl;L-Tryptophan hydroxylase 1;f;;Human;26206858;Inhibition
6-fluorotryptophan;L-Tryptophan hydroxylase 2;f;;Human;6457252;Inhibition
α-propyldopacetamide;L-Tryptophan hydroxylase 2;f;;Human;;Inhibition
fenclonine;L-Tryptophan hydroxylase 2;f;;Human;;Inhibition
fenfluramine;L-Tryptophan hydroxylase 2;f;;Human;;Inhibition
rodatristat;L-Tryptophan hydroxylase 2;f;;Human;28041831;Inhibition
KYT-0353;L-type amino acid transporter 1;f;;Human;19900191;Inhibition
3-chlorotyrosine;L-Tyrosine hydroxylase ;f;;Human;;Inhibition
3-iodotyrosine;L-Tyrosine hydroxylase ;f;;Human;;Inhibition
alpha-methyltyrosine;L-Tyrosine hydroxylase ;f;;Human;;Inhibition
α-propyldopacetamide;L-Tyrosine hydroxylase ;f;;Human;;Inhibition
methyltyrosine;L-Tyrosine hydroxylase ;f;;Human;;Inhibition
neoceptin-3;lymphocyte antigen 96;f;;Human;26831104;Binding
L6H21;lymphocyte antigen 96;f;;Human;26076332;Inhibition
LIGHT;lymphotoxin β receptor;t;Human;Human;;None
lymphotoxin β2α1 heterotrimer;lymphotoxin β receptor;t;Human;None;;None
tolimidone;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;22473614;Activation
acalabrutinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
acalabrutinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;;Inhibition
bafetinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;17376680;Inhibition
bosutinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;19039322;Inhibition
compound 23 [PMID: 17600705];LYN proto-oncogene, Src family tyrosine kinase;f;;Human;17600705;Inhibition
compound 36 [PMID: 21958547];LYN proto-oncogene, Src family tyrosine kinase;f;;Human;21958547;Inhibition
eCF506;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;27115835;Inhibition
ibrutinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;26641137;Inhibition
NG-25;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;25075558;Inhibition
pexmetinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;27287719;Inhibition
SU6656;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;18077363;Inhibition
xiliertinib;LYN proto-oncogene, Src family tyrosine kinase;f;;Human;28881608;Inhibition
anacardic acid;lysine acetyltransferase 2B;f;;Human;;Inhibition
compound 1 [PMID: 15724976];lysine acetyltransferase 2B;f;;Human;15724976;Inhibition
epigallocatechin-3-gallate;lysine acetyltransferase 2B;f;;Human;19147572;Inhibition
garcinol;lysine acetyltransferase 2B;f;;Human;15155757;Inhibition
H3-CoA-20;lysine acetyltransferase 2B;f;;Human;10882143;Inhibition
LTK-14;lysine acetyltransferase 2B;f;;Human;17584612;Inhibition
Lys-CoA;lysine acetyltransferase 2B;f;;Human;10882143;Inhibition
MB-3;lysine acetyltransferase 2B;f;;Unknown;15274229;Inhibition
plumbagin;lysine acetyltransferase 2B;f;;Human;19570987;Inhibition
MG149;lysine acetyltransferase 5;f;;Human;22100137;Inhibition
MG149;lysine acetyltransferase 8;f;;Human;22100137;Inhibition
ORY-1001;lysine demethylase 1A;f;;Human;26111032;Activation
CC-90011;lysine demethylase 1A;f;;Human;33034194;Inhibition
GSK2879552;lysine demethylase 1A;f;;Human;;Inhibition
GSK-LSD1;lysine demethylase 1A;f;;Human;;Inhibition
NCL-1;lysine demethylase 1A;f;;Human;21227703;Inhibition
OG-L002;lysine demethylase 1A;f;;Human;23386436;Inhibition
RN-1;lysine demethylase 1A;f;;Human;22754608;Inhibition
tranylcypromine;lysine demethylase 1A;f;;Human;23386436;Inhibition
daminozide;lysine demethylase 2A;f;;Human;22724510;Inhibition
IOX2;lysine demethylase 2A;f;;Human;23683440;Inhibition
IOX1;lysine demethylase 3A;f;;Human;24504543;Inhibition
compound 6a [PMID: 18942826];lysine demethylase 4A;f;;Human;18942826;Inhibition
KDM5 inhibitor N71;lysine demethylase 4A;f;;Human;30392349;Inhibition
ML324;lysine demethylase 4A;f;;Human;24260783;Inhibition
IOX1;lysine demethylase 4C;f;;Human;24504543;Inhibition
compound 6a [PMID: 18942826];lysine demethylase 4E;f;;Human;18942826;Inhibition
ML324;lysine demethylase 4E;f;;Human;24260783;Inhibition
GSK-J1;lysine demethylase 5A;f;;Human;25279926;Inhibition
PBIT;lysine demethylase 5A;f;;Human;23408432;Inhibition
KDM5 inhibitor N71;lysine demethylase 5A;f;;Human;30392349;Irreversible inhibition
Compound 9  [doi:10.26434/chemrxiv.7072592.v1];lysine demethylase 5B;f;;Human;30431220;Inhibition
GSK-J1;lysine demethylase 5B;f;;Human;25279926;Inhibition
GSK-J4;lysine demethylase 5B;f;;Human;25279926;Inhibition
PBIT;lysine demethylase 5B;f;;Human;23408432;Inhibition
KDM5 inhibitor N71;lysine demethylase 5B;f;;Human;30392349;Irreversible inhibition
GSK-J1;lysine demethylase 5C;f;;Human;25279926;Inhibition
GSK-J4;lysine demethylase 5C;f;;Human;25279926;Inhibition
IOX2;lysine demethylase 5C;f;;Human;23683440;Inhibition
PBIT;lysine demethylase 5C;f;;Human;23408432;Inhibition
GSK-J1;lysine demethylase 6A;f;;Human;25279926;Inhibition
GSK-J4;lysine demethylase 6A;f;;Human;25279926;Inhibition
KDM5 inhibitor N71;lysine demethylase 6A;f;;Human;30392349;Inhibition
compound 3 [PMID: 29633584];lysine demethylase 6B;f;;Human;29633584;Inhibition
GSK-J1;lysine demethylase 6B;f;;Human;22842901|25279926;Inhibition
GSK-J4;lysine demethylase 6B;f;;Human;25279926;Inhibition
IOX1;lysine demethylase 6B;f;;Human;24504543;Inhibition
daminozide;lysine demethylase 7A;f;;Human;22724510;Inhibition
Cdk4 inhibitor III;lysine methyltransferase 5A;f;;Human;25137013;Inhibition
nahuoic acid A;lysine methyltransferase 5A;f;;Human;23272941;Inhibition
A-196;lysine methyltransferase 5B;f;;Human;;Inhibition
A-196;lysine methyltransferase 5C;f;;Human;;Inhibition
CCT365623;lysyl oxidase;f;;Human;31070916;Inhibition
compound 21b [PMID: 31430136];lysyl oxidase;f;;Human;31430136;Inhibition
CCT365623;lysyl oxidase like 2;f;;Human;31070916;Inhibition
compound 21b [PMID: 31430136];lysyl oxidase like 2;f;;Human;31430136;Inhibition
simtuzumab;lysyl oxidase like 2;f;;Human;;Inhibition
BMS-777607;macrophage stimulating 1 receptor;f;;Human;19260711;Inhibition
compound 19a [PMID: 30503936];macrophage stimulating 1 receptor;f;;Human;30503936;Inhibition
compound 8i [PMID: 22765894];macrophage stimulating 1 receptor;f;;Human;21613405;Inhibition
merestinib;macrophage stimulating 1 receptor;f;;Human;23275061;Inhibition
MK-2461;macrophage stimulating 1 receptor;f;;Human;20145145;Inhibition
macrophage stimulating protein 1;macrophage stimulating 1 receptor;t;Human;Human;;None
phloretin;major facilitator superfamily domain containing 4B;f;;Rat;12590146;Inhibition
phlorizin;major facilitator superfamily domain containing 4B;f;;Rat;12590146;Inhibition
urea;major facilitator superfamily domain containing 4B;f;;Rat;26423860;Inhibition
compound 10h [PMID: 20832306];Malonyl-CoA decarboxylase;f;;Human;20832306;Inhibition
pecazine;MALT1 paracaspase;f;;Human;23946259;Inhibition
acarbose;maltase-glucoamylase;f;;Mouse;21669536;Inhibition
miglitol;maltase-glucoamylase;f;;Human;20970346;Inhibition
miglitol;maltase-glucoamylase;f;;Mouse;21669536;Inhibition
compound 16 [PMID: 17480064];MAPK activated protein kinase 2;f;;Human;17480064;Inhibition
compound 16 [PMID: 18945615];MAPK activated protein kinase 2;f;;Human;18945615;Inhibition
compound 33 [PMID: 19364658];MAPK activated protein kinase 2;f;;Human;19364658;Inhibition
compound 8 [PMID: 17480064];MAPK activated protein kinase 2;f;;Human;17480064;Inhibition
MK2a inhibitor;MAPK activated protein kinase 2;f;;Human;17964780;Inhibition
PF-3644022;MAPK activated protein kinase 2;f;;Human;20237073;Inhibition
PF-3644022;MAPK activated protein kinase 2;f;;Human;20237073;Inhibition
compound 16 [PMID: 17480064];MAPK activated protein kinase 3;f;;Human;17480064;Inhibition
compound 16 [PMID: 17480064];MAPK activated protein kinase 5;f;;Human;17480064;Inhibition
compound 16 [PMID: 18945615];MAPK activated protein kinase 5;f;;Human;18945615;Inhibition
Galapagos MAPKAPK5 inhibitor D;MAPK activated protein kinase 5;f;;Human;;Inhibition
Galapagos MAPKAPK5 inhibitor D;MAPK activated protein kinase 5;f;;Human;;Inhibition
dorsomorphin;MAPK interacting serine/threonine kinase 1;f;;Human;20932747;Inhibition
MNK1 inhibitor;MAPK interacting serine/threonine kinase 1;f;;Human;20722422;Inhibition
tomivosertib;MAPK interacting serine/threonine kinase 1;f;;Human;29526098;Inhibition
MELK-TI;MAPK interacting serine/threonine kinase 2;f;;Human;25589925;Inhibition
MNK1 inhibitor;MAPK interacting serine/threonine kinase 2;f;;Human;20722422;Inhibition
tomivosertib;MAPK interacting serine/threonine kinase 2;f;;Human;29526098;Inhibition
cimetidine;MATE2;f;;Human;19164462;Inhibition
pyrimethamine;MATE2;f;;Mouse;20065018;Inhibition
[14C]metformin;MATE2;f;;Human;17509534;None
[14C]TEA;MATE2;f;;Human;17509534;None
MELK-TI;maternal embryonic leucine zipper kinase;f;;Human;25589925;Inhibition
OTSSP167;maternal embryonic leucine zipper kinase;f;;Human;23283305;Inhibition
chlorpromazine;Maxi Cl-;f;;Human;;None
GTPγS;Maxi Cl-;f;;Human;;None
tamoxifen;Maxi Cl-;f;;Human;;None
toremifene;Maxi Cl-;f;;Human;;None
triflupromazine;Maxi Cl-;f;;Human;;None
arachidonic acid;Maxi Cl-;t;;Human;;None
DIDS;Maxi Cl-;f;;Human;20830208;None
diphenylamine-2-carboxylic acid;Maxi Cl-;f;;Human;;None
Gd3+;Maxi Cl-;f;;Human;;None
NPPB;Maxi Cl-;f;;Human;20830208;None
SITS;Maxi Cl-;f;;Human;;None
Zn2+;Maxi Cl-;f;;Human;18658230;None
Ac-hMCH-(6-16)-NH2;MCH1 receptor;f;;Human;12009900;Full agonist
C3;MCH1 receptor;f;;Human;11561073;Full agonist
compound 2 [PMID: 11375253];MCH1 receptor;f;;Human;11375253;Full agonist
MCH (salmon);MCH1 receptor;f;;Rat;11561073;Full agonist
MCH (salmon);MCH1 receptor;f;;Human;10421367|11375253;Full agonist
MCH6-17;MCH1 receptor;f;;Human;11375253;Full agonist
MCH6-17;MCH1 receptor;f;;Rat;11561073;Full agonist
melanin-concentrating hormone;MCH1 receptor;t;Human|Mouse|Rat;Rat;11561073;Full agonist
melanin-concentrating hormone;MCH1 receptor;t;Human|Mouse|Rat;Human;10421367|11375253;Full agonist
p-guanidinobenzoyl-MCH-(7-17);MCH1 receptor;f;;Human;19619599;Full agonist
[Phe13,Tyr19]MCH;MCH1 receptor;f;;Human;11159839|10421367|11404457;Full agonist
[Phe13,Tyr19]MCH;MCH1 receptor;f;;Rat;11561073;Full agonist
S36057;MCH1 receptor;f;;Rat;11561073;Full agonist
S36057;MCH1 receptor;f;;Human;11375253;Full agonist
S36077;MCH1 receptor;f;;Rat;11561073;Full agonist
S36077;MCH1 receptor;f;;Human;11375253;Full agonist
[125I]MCH (human, mouse, rat);MCH1 receptor;f;;Human;10421367;Full agonist
[125I][Phe13,Tyr19]MCH;MCH1 receptor;f;;Human;9434758;Full agonist
[3H]MCH (human, mouse, rat);MCH1 receptor;f;;Human;9434758;Full agonist
variant MCH;MCH1 receptor;f;;Human;10421367;Full agonist
MQ1;MCH1 receptor;f;;Human;22490048|24670150;Negative
4-arylphthalazin-1(2H)-3,4-Di-F;MCH1 receptor;f;;Human;22137790;Antagonist
7-fluorochromone-2-carboxamide;MCH1 receptor;f;;Human;17064075;Antagonist
ATC0065;MCH1 receptor;f;;Human;15677346;Antagonist
ATC0175;MCH1 receptor;f;;Human;15677346;Antagonist
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2;MCH1 receptor;f;;Human;12009900;Antagonist
AZ13483342;MCH1 receptor;f;;Human;17532215;Antagonist
compound 17 [PMID: 17125263];MCH1 receptor;f;;Human;17125263;Antagonist
compound 4b [PMID: 19683441];MCH1 receptor;f;;Human;19683441;Antagonist
compound (R)-10h [PMID: 22490048];MCH1 receptor;f;;Human;22490048;Antagonist
GW803430;MCH1 receptor;f;;Human;16870432;Antagonist
pyrrolidine MCHR1 antagonist 1;MCH1 receptor;f;;Human;21414780;Antagonist
S36539;MCH1 receptor;f;;Human;11375253;Antagonist
S36540;MCH1 receptor;f;;Human;11375253;Antagonist
S36541;MCH1 receptor;f;;Human;11375253;Antagonist
S38151;MCH1 receptor;f;;Human;19619599;Antagonist
SB-568849;MCH1 receptor;f;;Human;16839763;Antagonist
SNAP-7941;MCH1 receptor;f;;Human;12118247;Antagonist
SNAP-7941;MCH1 receptor;f;;Human;12118247;Antagonist
[125I](3-iodo-Tyr13)-MCH;MCH1 receptor;f;;Human;11375253;Antagonist
[125I]S36057;MCH1 receptor;f;;Human;11375253;Antagonist
[3H]SNAP-7941;MCH1 receptor;f;;Human;12118247;Antagonist
T-226296;MCH1 receptor;f;;Human;11909603;Antagonist
tetralin_urea analogue (7o);MCH1 receptor;f;;Human;17251014;Antagonist
TPI 1361-17;MCH1 receptor;f;;Human;19041642;Antagonist
Ac-hMCH-(6-16)-NH2;MCH2 receptor;f;;Human;12009900;Full agonist
MCH (salmon);MCH2 receptor;f;;Human;11459838|11404457;Full agonist
melanin-concentrating hormone;MCH2 receptor;t;Human|Mouse|Rat;Human;11404457;Full agonist
[Phe13,Tyr19]MCH;MCH2 receptor;f;;Human;11459838|11404457;Full agonist
ATC0065;MCH2 receptor;f;;Human;15677346;Antagonist
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2;MCH2 receptor;f;;Human;12009900;Antagonist
compound 38 [PMID: 22123324];MCH2 receptor;f;;Human;22123324;Antagonist
obatoclax;MCL1 apoptosis regulator, BCL2 family member;f;;Human;29407973;Antagonist
venetoclax;MCL1 apoptosis regulator, BCL2 family member;f;;Human;23291630;Antagonist
ACTH;MC1 receptor;f;Human;Human;7774675;Agonist
bremelanotide;MC1 receptor;f;;Human;22335602;Agonist
setmelanotide;MC1 receptor;f;;Human;19646498;Agonist
afamelanotide;MC1 receptor;f;;Human;12007532|3286233;Full agonist
α-MSH;MC1 receptor;t;Human|Mouse|Rat;Human;12007532;Full agonist
MS05;MC1 receptor;f;;Human;10764951;Full agonist
MT-II;MC1 receptor;f;;Human;12007532|2535874;Full agonist
[125I]NDP-MSH;MC1 receptor;f;;Human;15840392;Full agonist
HS014;MC1 receptor;f;;Human;10657491;Partial agonist
SHU9119;MC1 receptor;f;;Human;10657491|7658432;Partial agonist
HS024;MC1 receptor;f;;Human;9832440;Antagonist
agouti;MC1 receptor;t;Mouse;Mouse;7935841|9454589;Inverse agonist
ASIP [90-132 (L89Y)];MC1 receptor;f;;Human;11705773|9058374;Inverse agonist
corticotrophin-releasing hormone;MC2 receptor;f;Human|Mouse|Rat;Human;;Agonist
corticotropin zinc hydroxide;MC2 receptor;f;;Human;;Agonist
cosyntropin;MC2 receptor;f;;Human;;Agonist
ACTH;MC2 receptor;t;Mouse|Rat;Mouse;8754753;Full agonist
ACTH-(1-24);MC2 receptor;f;;Mouse;8754753;Full agonist
[125I]ACTH-(1-24);MC2 receptor;f;;Human;;Full agonist
ACTH-(11-24);MC2 receptor;f;;Human;8754753;Antagonist
ASIP [90-132 (L89Y)];MC2 receptor;f;;Human;11705773;Inverse agonist
ACTH;MC3 receptor;f;Human;Human;7774675;Agonist
bremelanotide;MC3 receptor;f;;Human;22335602;Agonist
setmelanotide;MC3 receptor;f;;Human;19646498;Agonist
AP1189;MC3 receptor;f;;Human;;Biased agonist
afamelanotide;MC3 receptor;f;;Human;10493100;Full agonist
α-MSH;MC3 receptor;t;Human|Mouse|Rat;Human;10358030|10493100;Full agonist
[D-Trp8]γ-MSH;MC3 receptor;f;;Human;11150170;Full agonist
γ-MSH;MC3 receptor;t;Human|Mouse|Rat;Human;10358030;Full agonist
MT-II;MC3 receptor;f;;Human;10493100;Full agonist
[125I]NDP-MSH;MC3 receptor;f;;Human;15840392;Full agonist
HS014;MC3 receptor;f;;Human;10657491;Antagonist
HS024;MC3 receptor;f;;Human;9832440;Antagonist
PG-106;MC3 receptor;f;;Human;17482720;Antagonist
PG-901;MC3 receptor;f;;Human;12431055;Antagonist
SHU9119;MC3 receptor;f;;Rat;10493100;Antagonist
SHU9119;MC3 receptor;f;;Human;12007532|10657491|7658432;Antagonist
[125I]SHU9119;MC3 receptor;f;;Human;12604699;Antagonist
agouti;MC3 receptor;t;Mouse;Mouse;9454589;Inverse agonist
agouti-related protein;MC3 receptor;t;Human;Human;9819197;Inverse agonist
ACTH;MC4 receptor;f;Human;Human;8884876;Agonist
bremelanotide;MC4 receptor;f;;Human;22335602;Agonist
setmelanotide;MC4 receptor;f;;Rat;19646498;Agonist
setmelanotide;MC4 receptor;f;;Human;19646498;Agonist
afamelanotide;MC4 receptor;f;;Human;10493100|11101306|6777774;Full agonist
α-MSH;MC4 receptor;t;Human|Mouse|Rat;Human;10493100|11101306;Full agonist
MT-II;MC4 receptor;f;;Human;2535874|10493100|11101306;Full agonist
RY764;MC4 receptor;f;;Human;15982875;Full agonist
[125I]NDP-MSH;MC4 receptor;f;;Human;15840392|7774675;Full agonist
THIQ;MC4 receptor;f;;Human;12361385;Full agonist
HS014;MC4 receptor;f;;Human;10051117;Antagonist
HS014;MC4 receptor;f;;Human;9630346;Antagonist
HS024;MC4 receptor;f;;Human;9832440;Antagonist
MBP10;MC4 receptor;f;;Human;11606131;Antagonist
MCL0129;MC4 receptor;f;;Human;12538838;Antagonist
PG-901;MC4 receptor;f;;Human;12431055;Antagonist
SHU9119;MC4 receptor;f;;Human;10657491|10493100;Antagonist
[125I]SHU9119;MC4 receptor;f;;Human;12604699;Antagonist
agouti;MC4 receptor;t;Mouse;Mouse;9454589;Inverse agonist
agouti-related protein;MC4 receptor;t;Human;Human;9299416;Inverse agonist
ACTH;MC5 receptor;f;Human;Human;7774675;Agonist
bremelanotide;MC5 receptor;f;;Human;22335602;Agonist
setmelanotide;MC5 receptor;f;;Human;19646498;Agonist
afamelanotide;MC5 receptor;f;;Human;12007532;Full agonist
α-MSH;MC5 receptor;t;Human|Mouse|Rat;Human;12007532;Full agonist
MT-II;MC5 receptor;f;;Human;12007532;Full agonist
PG-901;MC5 receptor;f;;Human;12431055;Full agonist
[125I]NDP-MSH;MC5 receptor;f;;Human;15840392;Full agonist
SHU9119;MC5 receptor;f;;Human;10657491;Partial agonist
Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2;MC5 receptor;f;;Human;12904077;Antagonist
HS024;MC5 receptor;f;;Human;9832440;Antagonist
agouti;MC5 receptor;t;Mouse;Mouse;9454589;Inverse agonist
agouti-related protein;MC5 receptor;t;Human;Human;9892020;Inverse agonist
RG7112;MDM2 proto-oncogene;f;;Human;24900694;Binding
AMG-232;MDM2 proto-oncogene;f;;Human;24456472;Inhibition
apitolisib;mechanistic target of rapamycin kinase;f;;Human;21981714;Inhibition
AZD8055;mechanistic target of rapamycin kinase;f;;Human;23375793;Inhibition
berzosertib;mechanistic target of rapamycin kinase;f;;Human;23222511;Inhibition
bimiralisib;mechanistic target of rapamycin kinase;f;;Human;;Inhibition
CC-223;mechanistic target of rapamycin kinase;f;;Human;26083478;Inhibition
compound 11j [PMID: 23021994];mechanistic target of rapamycin kinase;f;;Human;23021994;Inhibition
compound 12b [PMID: 31465220];mechanistic target of rapamycin kinase;f;;Human;31465220;Inhibition
compound 15a [PMID: 32069401];mechanistic target of rapamycin kinase;f;;Human;32069401;Inhibition
compound 7 [PMID: 31955578];mechanistic target of rapamycin kinase;f;;Human;31955578;Inhibition
compound 82 [PMID: 21332118];mechanistic target of rapamycin kinase;f;;Human;21332118;Inhibition
copanlisib;mechanistic target of rapamycin kinase;f;;Human;24170767;Inhibition
CZ415;mechanistic target of rapamycin kinase;f;;Human;27563401;Inhibition
dactolisib;mechanistic target of rapamycin kinase;f;;Human;18606717;Inhibition
eCF309;mechanistic target of rapamycin kinase;f;;Human;;Inhibition
eCF309;mechanistic target of rapamycin kinase;f;;Human;;Inhibition
everolimus;mechanistic target of rapamycin kinase;f;;Human;9723437;Inhibition
Example 51 [WO2012135160A1];mechanistic target of rapamycin kinase;f;;Human;;Inhibition
gedatolisib;mechanistic target of rapamycin kinase;f;;Human;20166697;Inhibition
KU-0063794;mechanistic target of rapamycin kinase;f;;Human;19402821;Inhibition
MEN1611;mechanistic target of rapamycin kinase;f;;Human;21316229;Inhibition
neolymphostin A;mechanistic target of rapamycin kinase;f;;Human;30380865;Inhibition
omipalisib;mechanistic target of rapamycin kinase;f;;Human;24900173;Inhibition
panulisib;mechanistic target of rapamycin kinase;f;;Human;25700704;Inhibition
paxalisib;mechanistic target of rapamycin kinase;f;;Human;27096040;Inhibition
PF-04691502;mechanistic target of rapamycin kinase;f;;Human;24900269;Inhibition
PI-103;mechanistic target of rapamycin kinase;f;;Human;19584227;Inhibition
PP121;mechanistic target of rapamycin kinase;f;;Human;18849971;Inhibition
PP-242;mechanistic target of rapamycin kinase;f;;Human;18849971;Inhibition
PQR620;mechanistic target of rapamycin kinase;f;;Human;30359003;Inhibition
PQR620;mechanistic target of rapamycin kinase;f;;Human;30359003;Inhibition
RapaLink-1;mechanistic target of rapamycin kinase;f;;Human;27279227;Inhibition
ridaforolimus;mechanistic target of rapamycin kinase;f;;Human;21482695;Inhibition
samotolisib;mechanistic target of rapamycin kinase;f;;Human;;Inhibition
sapanisertib;mechanistic target of rapamycin kinase;f;;Human;22367541;Inhibition
sapanisertib;mechanistic target of rapamycin kinase;f;;Human;22367541;Inhibition
serabelisib;mechanistic target of rapamycin kinase;f;;Human;;Inhibition
STK16-IN-1;mechanistic target of rapamycin kinase;f;;Human;27082499;Inhibition
temsirolimus;mechanistic target of rapamycin kinase;f;;Human;21438579;Inhibition
torin 1;mechanistic target of rapamycin kinase;f;;Human;20860370;Inhibition
torin 2;mechanistic target of rapamycin kinase;f;;Human;21322566;Inhibition
vistusertib;mechanistic target of rapamycin kinase;f;;Human;23375793;Inhibition
VS-5584;mechanistic target of rapamycin kinase;f;;Human;23270925;Inhibition
wortmannin;mechanistic target of rapamycin kinase;f;;Human;30380865;Inhibition
WYE-354;mechanistic target of rapamycin kinase;f;;Human;19584280;Inhibition
XL388;mechanistic target of rapamycin kinase;f;;Human;23394126;Inhibition
imaprelimab;melanoma cell adhesion molecule;f;;Human;;Binding
compound 7b [PMID: 17583500];membrane bound transcription factor peptidase, site 1;f;;Human;17583500;Inhibition
belizatinib;MER proto-oncogene, tyrosine kinase;f;;Human;22734674;Inhibition
BMS-777607;MER proto-oncogene, tyrosine kinase;f;;Human;19260711;Inhibition
G749;MER proto-oncogene, tyrosine kinase;f;;Human;24532805;Inhibition
gilteritinib;MER proto-oncogene, tyrosine kinase;f;;Human;27908881;Inhibition
LDC1267;MER proto-oncogene, tyrosine kinase;f;;Human;24553136;Inhibition
merestinib;MER proto-oncogene, tyrosine kinase;f;;Human;23275061;Inhibition
MK-2461;MER proto-oncogene, tyrosine kinase;f;;Human;20145145;Inhibition
RIPK1 inhibitor 22b;MER proto-oncogene, tyrosine kinase;f;;Human;30480444;Inhibition
RIPK1 inhibitor 22b;MER proto-oncogene, tyrosine kinase;f;;Human;30480444;Inhibition
sitravatinib;MER proto-oncogene, tyrosine kinase;f;;Human;26675259;Inhibition
UNC4203;MER proto-oncogene, tyrosine kinase;f;;Human;30347155;Inhibition
growth arrest specific protein 6;MER proto-oncogene, tyrosine kinase;t;Human;Human;8939948;None
compound 14 [PMID: 23634668];Methionyl aminopeptidase 1;f;;Human;23634668;Inhibition
beloranib;Methionyl aminopeptidase 2;f;;Human;17446235;Inhibition
XMT-1191;Methionyl aminopeptidase 2;f;;Human;;Inhibition
amivantamab;MET proto-oncogene, receptor tyrosine kinase;f;;Human;26260789;Binding
emibetuzumab;MET proto-oncogene, receptor tyrosine kinase;f;;Human;;Binding
onartuzumab;MET proto-oncogene, receptor tyrosine kinase;f;;Human;;Binding
alectinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;22225917;Inhibition
altiratinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;;Inhibition
AM7;MET proto-oncogene, receptor tyrosine kinase;f;;Human;18055465;Inhibition
AMG-337;MET proto-oncogene, receptor tyrosine kinase;f;;Human;19819693;Inhibition
BMS-777607;MET proto-oncogene, receptor tyrosine kinase;f;;Human;19260711;Inhibition
cabozantinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;21926191;Inhibition
capmatinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;21918175;Inhibition
compound 16 [PMID: 18945615];MET proto-oncogene, receptor tyrosine kinase;f;;Human;18945615;Inhibition
compound 19a [PMID: 30503936];MET proto-oncogene, receptor tyrosine kinase;f;;Human;30503936;Inhibition
compound 1o [PMID: 24210504];MET proto-oncogene, receptor tyrosine kinase;f;;Human;24210504;Inhibition
compound 27 [PMID: 21123062];MET proto-oncogene, receptor tyrosine kinase;f;;Human;21123062;Inhibition
compound 8i [PMID: 22765894];MET proto-oncogene, receptor tyrosine kinase;f;;Human;21613405;Inhibition
compound R-16 [PMID: 21967808];MET proto-oncogene, receptor tyrosine kinase;f;;Human;21967808;Inhibition
crizotinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;21812414;Inhibition
crizotinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;21708465;Inhibition
ensartinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;21613408;Inhibition
foretinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;23098265|23644189;Inhibition
foretinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;22037378;Inhibition
glesatinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;18434145;Inhibition
golvatinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;19832844;Inhibition
merestinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;23275061;Inhibition
merestinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;23275061;Inhibition
MK-2461;MET proto-oncogene, receptor tyrosine kinase;f;;Human;20145145;Inhibition
OMO-1;MET proto-oncogene, receptor tyrosine kinase;f;;Human;;Inhibition
OMO-1;MET proto-oncogene, receptor tyrosine kinase;f;;Human;;Inhibition
pamufetinibT;MET proto-oncogene, receptor tyrosine kinase;f;;Human;24140932;Inhibition
PHA-665752;MET proto-oncogene, receptor tyrosine kinase;f;;Human;14612533;Inhibition
PHA-665752;MET proto-oncogene, receptor tyrosine kinase;f;;Human;22037378;Inhibition
RIPK3 inhibitor 18;MET proto-oncogene, receptor tyrosine kinase;f;;Human;;Inhibition
savolitinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;25148209;Inhibition
SGX-523;MET proto-oncogene, receptor tyrosine kinase;f;;Human;19934279;Inhibition
SGX-523;MET proto-oncogene, receptor tyrosine kinase;f;;Human;22037378;Inhibition
sitravatinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;26675259;Inhibition
SU11274;MET proto-oncogene, receptor tyrosine kinase;f;;Human;14617781;Inhibition
tanespimycin;MET proto-oncogene, receptor tyrosine kinase;f;;Human;15978816;Inhibition
tepotinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;23553846;Inhibition
tivantinib;MET proto-oncogene, receptor tyrosine kinase;f;;Human;20484018;Inhibition
GE-137;MET proto-oncogene, receptor tyrosine kinase;f;;Human;26168295;Binding
hepatocyte growth factor;MET proto-oncogene, receptor tyrosine kinase;t;Human;Human;;None
dimethylallyl diphosphate;mevalonate kinase;t;;Human;9392419;Competitive
dolichol phosphate;mevalonate kinase;f;;Human;9392419;Competitive
farnesol;mevalonate kinase;f;;Human;9392419;Competitive
geranyl diphosphate;mevalonate kinase;t;;Rat;16524256;Feedback inhibition
geranyl diphosphate;mevalonate kinase;t;;Human;9392419;Feedback inhibition
geranylgeranyl diphosphate;mevalonate kinase;t;;Human;9392419;Feedback inhibition
isopentenyl diphosphate;mevalonate kinase;t;;Human;9392419;Feedback inhibition
(RS)-5-diphosphomevalonate;mevalonate kinase;f;;Rat;16524256;Feedback inhibition
trans,trans-farnesyl diphosphate;mevalonate kinase;t;;Human;9392419;Feedback inhibition
trans,trans-farnesyl diphosphate;mevalonate kinase;t;;Rat;14679225;Feedback inhibition
trans,trans-farnesyl diphosphate;mevalonate kinase;t;;Rat;2153681;Feedback inhibition
trans,trans-farnesyl diphosphate;mevalonate kinase;t;;Human;18302342;Feedback inhibition
farnesyl thiodiphosphate;mevalonate kinase;f;;Human;14679225;Inhibition
farnesyl thiodiphosphate;mevalonate kinase;f;;Rat;14679225;Inhibition
L-glutamic acid;mGlu1 receptor;t;;Human;10443583;Agonist
(1S,3R)-ACPD;mGlu1 receptor;f;;Rat;12695537|7690672|11080213;Full agonist
3,5-DHPG;mGlu1 receptor;f;;Rat;12695537;Full agonist
ibotenic acid;mGlu1 receptor;f;;Rat;7690672|11080213;Full agonist
L-CCG-I;mGlu1 receptor;f;;Rat;11080213;Full agonist
L-glutamic acid;mGlu1 receptor;t;;Rat;12695537|11080213;Full agonist
quisqualate;mGlu1 receptor;f;;Rat;12695537|11080213;Full agonist
[3H]quisqualate;mGlu1 receptor;f;;Rat;12695537|12509432;Full agonist
(S)-3HPG;mGlu1 receptor;f;;Rat;11080213;Partial agonist
3,5-dimethyl PPP;mGlu1 receptor;f;;Rat;12470711;Negative
A-794278;mGlu1 receptor;f;;Rat;18054908;Negative
A-794278;mGlu1 receptor;f;;Human;16279797;Negative
A-794282;mGlu1 receptor;f;;Rat;18054908;Negative
A-794282;mGlu1 receptor;f;;Human;16279797;Negative
A-841720;mGlu1 receptor;f;;Rat;18054908|16809035;Negative
A-841720;mGlu1 receptor;f;;Human;16279797;Negative
A-850002;mGlu1 receptor;f;;Human;16279797;Negative
A-850002;mGlu1 receptor;f;;Rat;18054908;Negative
BAY 367620;mGlu1 receptor;f;;Rat;12695537|11306677;Negative
BAY 367620;mGlu1 receptor;f;;Rat;11306677;Negative
CFMMC;mGlu1 receptor;f;;Human;19559036;Negative
CFMTI;mGlu1 receptor;f;;Human;19359526;Negative
compound 10i [PMID: 23084894];mGlu1 receptor;f;;Human;23084894;Negative
compound 11c [PMID: 17929793];mGlu1 receptor;f;;Rat;17929793;Negative
compound 11c [PMID: 17929793];mGlu1 receptor;f;;Human;17929793;Negative
compound 11q [PMID: 19433355];mGlu1 receptor;f;;Human;19433355;Negative
compound 11q [PMID: 19433355];mGlu1 receptor;f;;Rat;19433355;Negative
compound 11s [PMID: 19433355];mGlu1 receptor;f;;Human;19433355;Negative
compound 11s [PMID: 19433355];mGlu1 receptor;f;;Rat;19433355;Negative
compound 12e [PMID: 22266036];mGlu1 receptor;f;;Rat;22266036;Negative
compound 12e [PMID: 22266036];mGlu1 receptor;f;;Human;22266036;Negative
compound 22 [PMID: 17276684];mGlu1 receptor;f;;Human;17276684;Negative
compound 22 [PMID: 17276684];mGlu1 receptor;f;;Rat;17276684;Negative
compound 22 [PMID: 19289283];mGlu1 receptor;f;;Rat;19289283;Negative
compound 23c [PMID: 17929793];mGlu1 receptor;f;;Rat;17929793;Negative
compound 23c [PMID: 17929793];mGlu1 receptor;f;;Human;17929793;Negative
compound 23e [PMID: 17929793];mGlu1 receptor;f;;Human;17929793;Negative
compound 23e [PMID: 17929793];mGlu1 receptor;f;;Rat;17929793;Negative
compound 23h [PMID: 17929793];mGlu1 receptor;f;;Human;17929793;Negative
compound 23h [PMID: 17929793];mGlu1 receptor;f;;Rat;17929793;Negative
compound 23i [PMID: 17929793];mGlu1 receptor;f;;Human;17929793;Negative
compound 24 [PMID: 20346665];mGlu1 receptor;f;;Human;20346665;Negative
compound 24 [PMID: 20346665];mGlu1 receptor;f;;Human;20346665;Negative
compound 24 [PMID: 20346665];mGlu1 receptor;f;;Rat;20346665;Negative
compound 27 [PMID: 20346665];mGlu1 receptor;f;;Rat;20346665;Negative
compound 27 [PMID: 20346665];mGlu1 receptor;f;;Human;20346665;Negative
compound 29 [PMID: 17064898];mGlu1 receptor;f;;Rat;17064898;Negative
compound 29 [PMID: 17064898];mGlu1 receptor;f;;Rat;17064898;Negative
compound 2f [PMID: 17532216];mGlu1 receptor;f;;Human;17532216;Negative
compound 32 [PMID: 19289283];mGlu1 receptor;f;;Rat;19289283;Negative
compound 3 [PMID: 12470711];mGlu1 receptor;f;;Rat;12470711;Negative
compound 9a [PMID: 22266036];mGlu1 receptor;f;;Human;22266036;Negative
compound 9a [PMID: 22266036];mGlu1 receptor;f;;Human;22266036;Negative
compound 9n [PMID: 23084894];mGlu1 receptor;f;;Human;23084894;Negative
CPCCOEt;mGlu1 receptor;f;;Rat;12695537;Negative
CPCCOEt;mGlu1 receptor;f;;Rat;11961143;Negative
CPCCOEt;mGlu1 receptor;f;;Human;10051528;Negative
DM-PPP;mGlu1 receptor;f;;Rat;12470711;Negative
EM-TBPC;mGlu1 receptor;f;;Rat;12509432;Negative
EM-TBPC;mGlu1 receptor;f;;Rat;12509432;Negative
FITM;mGlu1 receptor;f;;Rat;22316010;Negative
FPTQ;mGlu1 receptor;f;;Rat;21172734;Negative
FTIDC;mGlu1 receptor;f;;Human;17360958;Negative
FTIDC;mGlu1 receptor;f;;Rat;17360958;Negative
cis-10 [PMID: 15771457];mGlu1 receptor;f;;Human;15771457;Negative
JNJ16259685;mGlu1 receptor;f;;Human;15555631;Negative
JNJ-16567083;mGlu1 receptor;f;;Rat;16078827;Negative
LY456066;mGlu1 receptor;f;;Human;19559036;Negative
LY456066;mGlu1 receptor;f;;Rat;19559036;Negative
LY456236;mGlu1 receptor;f;;Human;;Negative
MK-5435;mGlu1 receptor;f;;Human;20524178;Negative
NPS2390;mGlu1 receptor;f;;Rat;12695537;Negative
R214127;mGlu1 receptor;f;;Human;12695537;Negative
R214127;mGlu1 receptor;f;;Rat;12695537;Negative
[11C]MMTP;mGlu1 receptor;f;;Rat;20494576;Negative
[11C]MMTP;mGlu1 receptor;f;;Human;20494576;Negative
[18F]FITM;mGlu1 receptor;f;;Human;21470858;Negative
[18F]FITM;mGlu1 receptor;f;;Rat;21470858;Negative
[18F]FPIT;mGlu1 receptor;f;;Rat;21668889;Negative
[18F]MK-1312;mGlu1 receptor;f;;Human;20524178;Negative
[3H]R214127;mGlu1 receptor;f;;Human;12695537;Negative
[3H]YM298198;mGlu1 receptor;f;;Rat;15976016;Negative
VU0469650;mGlu1 receptor;f;;Human;23727046;Negative
YM-202074;mGlu1 receptor;f;;Rat;18164695;Negative
YM-202074;mGlu1 receptor;f;;Rat;18164695;Negative
YM298198;mGlu1 receptor;f;;Human;19559036;Negative
YM298198;mGlu1 receptor;f;;Rat;15976016;Negative
compound 3a [PMID: 16099654];mGlu1 receptor;f;;Rat;16099654;Positive
compound 4b [PMID: 16099654];mGlu1 receptor;f;;Rat;16099654;Positive
PHCCC;mGlu1 receptor;f;;Human;;Positive
Ro01-6128;mGlu1 receptor;f;;Rat;11606768;Positive
Ro0711401;mGlu1 receptor;f;;Rat;19233648;Positive
Ro67-4853;mGlu1 receptor;f;;Rat;11606768;Positive
Ro67-7476;mGlu1 receptor;f;;Rat;11606768;Positive
[3H]EM-TBPC;mGlu1 receptor;f;;Rat;12509432;Positive
VU0483605;mGlu1 receptor;f;;None;29514854;Positive
VU0483605;mGlu1 receptor;f;;Human;25137254;Positive
VU-71;mGlu1 receptor;f;;Rat;16099654;Positive
3-MATIDA;mGlu1 receptor;f;;Rat;12015200;Antagonist
AIDA;mGlu1 receptor;f;;Rat;12695537;Antagonist
AIDA;mGlu1 receptor;f;;Human;9152378;Antagonist
DCG-IV;mGlu1 receptor;f;;Rat;11080213;Antagonist
(S)-4C3HPG;mGlu1 receptor;f;;Human;12695537|11080213;Antagonist
LY341495;mGlu1 receptor;f;;Human;9680254;Antagonist
LY367385;mGlu1 receptor;f;;Human;;Antagonist
LY367385;mGlu1 receptor;f;;Rat;12695537;Antagonist
(+)-MCPG;mGlu1 receptor;f;;Rat;12695537;Antagonist
(S)-4CPG;mGlu1 receptor;f;;Rat;12695537;Antagonist
(S)-(+)-CBPG;mGlu1 receptor;f;;Rat;10428410;Antagonist
(S)-TBPG;mGlu1 receptor;f;;Rat;11249114;Antagonist
[11C]JNJ-16567083;mGlu1 receptor;f;;Rat;16078827;Antagonist
L-glutamic acid;mGlu2 receptor;t;;Human;10443583;Agonist
(1S,3R)-ACPD;mGlu2 receptor;f;;Human;10530814;Full agonist
(1S,3R)-ACPD;mGlu2 receptor;f;;Rat;9504391|10884552;Full agonist
(2R,3R)-APDC;mGlu2 receptor;f;;Human;10530814;Full agonist
DCG-IV;mGlu2 receptor;f;;Rat;9504391|10884552;Full agonist
DCG-IV;mGlu2 receptor;f;;Human;10530814;Full agonist
eglumegad;mGlu2 receptor;f;;Rat;9504391|10884552;Full agonist
eglumegad;mGlu2 receptor;f;;Human;10530814;Full agonist
(S)-4C3HPG;mGlu2 receptor;f;;Rat;9504391;Full agonist
L-CCG-I;mGlu2 receptor;f;;Rat;9504391|10884552;Full agonist
L-CCG-I;mGlu2 receptor;f;;Human;10530814;Full agonist
L-glutamic acid;mGlu2 receptor;t;;Rat;8022410|10652549;Full agonist
L-glutamic acid;mGlu2 receptor;t;;Human;10530814;Full agonist
LY379268;mGlu2 receptor;f;;Human;10090786;Full agonist
MGS0028;mGlu2 receptor;f;;Rat;11123999;Full agonist
[3H]eglumegad;mGlu2 receptor;f;;Rat;10884552;Full agonist
compound 2 [PMID: 21105727];mGlu2 receptor;f;;Human;21105727;Negative
compound 2 [PMID: 21105727];mGlu2 receptor;f;;Human;21105727;Negative
compound 3 [PMID: 21105727];mGlu2 receptor;f;;Human;21105727;Negative
compound 3 [PMID: 21105727];mGlu2 receptor;f;;Human;21105727;Negative
compound 4 [PMID: 21105727];mGlu2 receptor;f;;Human;21105727;Negative
compound 4 [PMID: 21105727];mGlu2 receptor;f;;Human;21105727;Negative
MNI-135;mGlu2 receptor;f;;Rat;17416742;Negative
MNI-135;mGlu2 receptor;f;;Human;17416742;Negative
MNI-136;mGlu2 receptor;f;;Human;17416742;Negative
MNI-136;mGlu2 receptor;f;;Rat;17416742;Negative
MNI-137;mGlu2 receptor;f;;Human;17416742;Negative
MNI-137;mGlu2 receptor;f;;Rat;17416742;Negative
Ro4491533;mGlu2 receptor;f;;Rat;22091727;Negative
Ro4491533;mGlu2 receptor;f;;Human;20971004;Negative
Ro4491533;mGlu2 receptor;f;;Human;22091727;Negative
Ro4491533;mGlu2 receptor;f;;Rat;20971004|22091727;Negative
RO4988546;mGlu2 receptor;f;;Rat;21470207;Negative
RO4988546;mGlu2 receptor;f;;Rat;21470207;Negative
RO5488608;mGlu2 receptor;f;;Rat;21470207;Negative
Ro64-5229;mGlu2 receptor;f;;Rat;10465539;Negative
2,2,2-TEMPS;mGlu2 receptor;f;;Human;15149652;Positive
3-MPPTS;mGlu2 receptor;f;;Human;12852748|14500736|15717213;Positive
4-APPES;mGlu2 receptor;f;;Human;15717213;Positive
4-MPPTS;mGlu2 receptor;f;;Human;12852748|14500736|15717213|15149652;Positive
AZD8529;mGlu2 receptor;f;;Human;;Positive
biphenylindanone A;mGlu2 receptor;f;;Human;16046122;Positive
CBiPES;mGlu2 receptor;f;;Human;15717213;Positive
compound 14a [PMID: 18812259];mGlu2 receptor;f;;Rat;18812259;Positive
compound 14c [PMID: 18812259];mGlu2 receptor;f;;Rat;18812259;Positive
compound 14 [PMID: 21155570];mGlu2 receptor;f;;Rat;21155570;Positive
compound 19 [PMID: 18812259];mGlu2 receptor;f;;Rat;18812259;Positive
compound 34 [PMID: 20409708];mGlu2 receptor;f;;Human;20409708;Positive
compound 48 [PMID: 22364337];mGlu2 receptor;f;;Human;22364337;Positive
cyPPTS;mGlu2 receptor;f;;Human;15717213;Positive
GSK1331258;mGlu2 receptor;f;;Human;20005096;Positive
GSK1331268;mGlu2 receptor;f;;Human;20005096;Positive
JNJ-40068782;mGlu2 receptor;f;;Rat;23766542;Positive
JNJ-40068782;mGlu2 receptor;f;;Human;23766542;Positive
JNJ-40411813;mGlu2 receptor;f;;Human;25692015;Positive
JNJ-42153605;mGlu2 receptor;f;;Human;23072213;Positive
JNJ-42153605;mGlu2 receptor;f;;Human;23072213;Positive
JNJ-46281222;mGlu2 receptor;f;;Human;26589404;Positive
JNJ-46281222;mGlu2 receptor;f;;Human;26589404;Positive
PTBE;mGlu2 receptor;f;;Human;15317469;Positive
[3H]2,2,2-TEMPS;mGlu2 receptor;f;;Rat;21470207;Positive
[3H]JNJ-40068782;mGlu2 receptor;f;;Rat;23766542;Positive
[3H]JNJ-40068782;mGlu2 receptor;f;;Human;23766542;Positive
THIIC;mGlu2 receptor;f;;Human;20947638;Positive
THIIC;mGlu2 receptor;f;;Rat;20947638;Positive
α-methylserine-O-phosphate;mGlu2 receptor;f;;Rat;9504391;Antagonist
eGlu;mGlu2 receptor;f;;Rat;9504391|10884552;Antagonist
LY341495;mGlu2 receptor;f;;Human;10530814;Antagonist
LY341495;mGlu2 receptor;f;;Rat;9504391|10884552;Antagonist
(+)-MCPG;mGlu2 receptor;f;;Rat;9504391;Antagonist
(+)-MCPG;mGlu2 receptor;f;;Human;10530814;Antagonist
MGS0039;mGlu2 receptor;f;;Rat;14975669|15317467;Antagonist
PCCG-4;mGlu2 receptor;f;;Rat;8667369;Antagonist
[3H]LY341495;mGlu2 receptor;f;;Human;10530814;Antagonist
L-glutamic acid;mGlu3 receptor;t;;Human;10443583;Agonist
(1S,3R)-ACPD;mGlu3 receptor;f;;Human;10530814;Full agonist
(1S,3R)-ACPD;mGlu3 receptor;f;;Rat;10884552;Full agonist
(2R,3R)-APDC;mGlu3 receptor;f;;Human;10530814;Full agonist
DCG-IV;mGlu3 receptor;f;;Rat;10884552;Full agonist
DCG-IV;mGlu3 receptor;f;;Human;10530814;Full agonist
eglumegad;mGlu3 receptor;f;;Rat;10884552;Full agonist
eglumegad;mGlu3 receptor;f;;Human;10530814;Full agonist
L-CCG-I;mGlu3 receptor;f;;Rat;10884552;Full agonist
L-CCG-I;mGlu3 receptor;f;;Human;10530814;Full agonist
L-glutamic acid;mGlu3 receptor;t;;Rat;10884552;Full agonist
L-glutamic acid;mGlu3 receptor;t;;Human;10530814;Full agonist
LY379268;mGlu3 receptor;f;;Human;10090786;Full agonist
NAAG;mGlu3 receptor;t;;Human;10884552;Full agonist
[3H]LY341495;mGlu3 receptor;f;;Rat;10884552;Full agonist
LY2389575;mGlu3 receptor;f;;Human;22607673;Negative
ML337;mGlu3 receptor;f;;Rat;23718281;Negative
MNI-135;mGlu3 receptor;f;;Rat;17416742;Negative
MNI-136;mGlu3 receptor;f;;Rat;17416742;Negative
MNI-137;mGlu3 receptor;f;;Rat;17416742;Negative
Ro4491533;mGlu3 receptor;f;;Human;22091727;Negative
Ro4491533;mGlu3 receptor;f;;Rat;20971004;Negative
VU0463597;mGlu3 receptor;f;;Rat;22607673;Negative
VU0650786;mGlu3 receptor;f;;Human;26335039;Negative
compound 2 [PMID: 21105727];mGlu3 receptor;f;;Human;21105727;Positive
compound 3 [PMID: 21105727];mGlu3 receptor;f;;Human;21105727;Positive
compound 4 [PMID: 21105727];mGlu3 receptor;f;;Human;21105727;Positive
eGlu;mGlu3 receptor;f;;Rat;10884552;Antagonist
LY341495;mGlu3 receptor;f;;Rat;10884552;Antagonist
LY341495;mGlu3 receptor;f;;Human;10530814;Antagonist
(+)-MCPG;mGlu3 receptor;f;;Human;10530814;Antagonist
MGS0039;mGlu3 receptor;f;;Rat;14975669|15317467;Antagonist
[3H]LY341495;mGlu3 receptor;f;;Human;10530814;Antagonist
L-AP4;mGlu4 receptor;f;;Human;9473604;Agonist
L-glutamic acid;mGlu4 receptor;t;;Human;10443583;Agonist
L-serine-O-phosphate;mGlu4 receptor;f;;Human;9473604;Agonist
LSP1-2111;mGlu4 receptor;f;;Rat;19525404;Agonist
LSP4-2022;mGlu4 receptor;f;;Human;22223752;Agonist
ACPT-I;mGlu4 receptor;f;;Rat;9301676;Full agonist
FP0429;mGlu4 receptor;f;;Human;17167031;Full agonist
(R,S)-4-PPG;mGlu4 receptor;f;;Human;10336568|10866390;Full agonist
(S)-3,4-DCPG;mGlu4 receptor;f;;Human;11166323;Full agonist
L-AP4;mGlu4 receptor;f;;Rat;8463825|9144638|8719808|10187777;Full agonist
L-CCG-I;mGlu4 receptor;f;;Rat;1330184;Full agonist
L-glutamic acid;mGlu4 receptor;t;;Rat;9144638|10187777|1361913|9357538;Full agonist
L-serine-O-phosphate;mGlu4 receptor;t;;Rat;8463825|9144638|8719808|10187777|8106006;Full agonist
[3H]AP4;mGlu4 receptor;f;;Rat;10187777;Full agonist
ADX88178;mGlu4 receptor;f;;Human;22787118;Positive
ADX88178;mGlu4 receptor;f;;Human;22787118;Positive
ADX88178;mGlu4 receptor;f;;Rat;22787118;Positive
compound 11 [PMID: 20638279];mGlu4 receptor;f;;Human;20638279;Positive
compound 1 [PMID: 22465637];mGlu4 receptor;f;;Human;22465637;Positive
compound 22a [PMID: 21688779];mGlu4 receptor;f;;Human;21688779;Positive
compound 7 [PMID: 20638279];mGlu4 receptor;f;;Human;20638279;Positive
foliglurax;mGlu4 receptor;f;;Human;;Positive
Lu AF21934;mGlu4 receptor;f;;Human;22491024;Positive
MPEP;mGlu4 receptor;f;;Human;12684257;Positive
PHCCC;mGlu4 receptor;f;;Human;14573382;Positive
SIB-1893;mGlu4 receptor;f;;Human;12684257;Positive
VU0001171;mGlu4 receptor;f;;Human;19097893;Positive
VU0080241;mGlu4 receptor;f;;Human;18793851;Positive
VU0092145;mGlu4 receptor;f;;Human;19097893;Positive
VU0155041;mGlu4 receptor;f;;Human;18664603;Positive
VU0359516;mGlu4 receptor;f;;Human;20582156;Positive
VU0361737;mGlu4 receptor;f;;Human;19469556;Positive
VU0364770;mGlu4 receptor;f;;Rat;22088953;Positive
VU0364770;mGlu4 receptor;f;;Human;22088953;Positive
VU0400195;mGlu4 receptor;f;;Rat;21966889;Positive
VU0400195;mGlu4 receptor;f;;Human;21966889;Positive
VU2957;mGlu4 receptor;f;;Human;30891122;Positive
CPPG;mGlu4 receptor;f;;Rat;10187777;Antagonist
LY341495;mGlu4 receptor;f;;Human;8532170;Antagonist
MAP4;mGlu4 receptor;f;;Rat;10187777;Antagonist
MPPG;mGlu4 receptor;f;;Rat;10187777;Antagonist
L-glutamic acid;mGlu5 receptor;t;;Human;10443583;Agonist
VU0092273;mGlu5 receptor;f;;Rat;22021324;Agonist
VU0424465;mGlu5 receptor;f;;Rat;23140665;Agonist
(1S,3R)-ACPD;mGlu5 receptor;f;;Rat;11080213;Full agonist
CHPG;mGlu5 receptor;f;;Human;11080213;Full agonist
ibotenic acid;mGlu5 receptor;f;;Rat;11080213;Full agonist
L-CCG-I;mGlu5 receptor;f;;Rat;11080213;Full agonist
L-glutamic acid;mGlu5 receptor;t;;Rat;11080213;Full agonist
quisqualate;mGlu5 receptor;f;;Rat;11080213;Full agonist
3,5-DHPG;mGlu5 receptor;f;;Rat;11080213;Partial agonist
(S)-3HPG;mGlu5 receptor;f;;Rat;11080213;Partial agonist
(S)-(+)-CBPG;mGlu5 receptor;f;;Rat;10428410;Partial agonist
alloswitch-1;mGlu5 receptor;f;;Rat;25173999;Negative
AZD6538;mGlu5 receptor;f;;Human;23046966;Negative
AZD6538;mGlu5 receptor;f;;Human;23046966;Negative
AZD9272;mGlu5 receptor;f;;Human;23046966;Negative
AZD9272;mGlu5 receptor;f;;Human;23046966;Negative
basimglurant;mGlu5 receptor;f;;Human;25565255;Negative
BOMA;mGlu5 receptor;f;;Human;14697765;Negative
Br-5MPEPy;mGlu5 receptor;f;;Rat;16155210;Negative
compound 10 [PMID: 15482906];mGlu5 receptor;f;;Human;15482906;Negative
compound 10 [PMID: 15482906];mGlu5 receptor;f;;Human;15482906;Negative
compound 10 [PMID: 15482908];mGlu5 receptor;f;;Rat;15482908;Negative
compound 10 [PMID: 15482908];mGlu5 receptor;f;;Human;15482908;Negative
compound 11a [PMID: 14697765];mGlu5 receptor;f;;Rat;14697765;Negative
compound 11a [PMID: 14697765];mGlu5 receptor;f;;Human;14697765;Negative
compound 13 [PMID: 15686941];mGlu5 receptor;f;;Human;15686941;Negative
compound 16a [PMID: 14697765];mGlu5 receptor;f;;Human;14697765;Negative
compound 16a [PMID: 14697765];mGlu5 receptor;f;;Rat;14697765;Negative
compound 16m [PMID: 19931453];mGlu5 receptor;f;;Human;19931453;Negative
compound 16m [PMID: 19931453];mGlu5 receptor;f;;Human;19931453;Negative
compound 18 [PMID: 17723296];mGlu5 receptor;f;;Rat;17723296;Negative
compound 18 [PMID: 21927650];mGlu5 receptor;f;;Human;21927650;Negative
compound 18 [PMID: 21927650];mGlu5 receptor;f;;Rat;21927650;Negative
compound 20 [PMID: 16439120];mGlu5 receptor;f;;Rat;16439120;Negative
compound 23 [PMID: 17590335];mGlu5 receptor;f;;Rat;17590335;Negative
compound 23 [PMID: 17590335];mGlu5 receptor;f;;Rat;17590335;Negative
compound 24d [PMID: 23357634];mGlu5 receptor;f;;Rat;23357634;Negative
compound 24d [PMID: 23357634];mGlu5 receptor;f;;Human;23357634;Negative
compound 24 [PMID: 23374867];mGlu5 receptor;f;;Human;23374867;Negative
compound 26 [PMID: 16439120];mGlu5 receptor;f;;Rat;16439120;Negative
compound 27 [PMID: 20598884];mGlu5 receptor;f;;Rat;20598884;Negative
compound 27 [PMID: 20598884];mGlu5 receptor;f;;Rat;20598884;Negative
compound 29b [PMID: 20809633];mGlu5 receptor;f;;Human;20809633;Negative
compound 29b [PMID: 20809633];mGlu5 receptor;f;;Rat;20809633;Negative
compound 30 [PMID: 21757343];mGlu5 receptor;f;;Human;21757343;Negative
compound 30 [PMID: 21757343];mGlu5 receptor;f;;Rat;21757343;Negative
compound 30 [PMID: 21757343];mGlu5 receptor;f;;Human;21757343;Negative
compound 36 [PMID: 17936624];mGlu5 receptor;f;;Rat;17936624;Negative
compound 41 [PMID: 23434029];mGlu5 receptor;f;;Human;23434029;Negative
compound 42 [PMID: 17189691];mGlu5 receptor;f;;Rat;17189691;Negative
compound 42 [PMID: 17189691];mGlu5 receptor;f;;Rat;17189691;Negative
compound 53 [PMID: 23434029];mGlu5 receptor;f;;Human;23434029;Negative
compound 8 [PMID: 15482908];mGlu5 receptor;f;;Human;15482908;Negative
compound 8 [PMID: 15482908];mGlu5 receptor;f;;Rat;15482908;Negative
compound 8 [PMID: 20598884];mGlu5 receptor;f;;Rat;20598884;Negative
compound 8 [PMID: 20598884];mGlu5 receptor;f;;Rat;20598884;Negative
CTEP;mGlu5 receptor;f;;Human;21849627|25565255;Negative
CTEP;mGlu5 receptor;f;;Rat;21849627;Negative
CTEP;mGlu5 receptor;f;;Human;21849627;Negative
CTEP;mGlu5 receptor;f;;Mouse;21849627;Negative
dipraglurant;mGlu5 receptor;f;;Human;23434029;Negative
fenobam;mGlu5 receptor;f;;Human;16040814;Negative
GRN-529;mGlu5 receptor;f;;Human;22551786;Negative
GRN-529;mGlu5 receptor;f;;Rat;22551786;Negative
GSK2210875;mGlu5 receptor;f;;Human;21051228;Negative
M-5MPEP;mGlu5 receptor;f;;Rat;16155210;Negative
methoxymethyl-MTEP;mGlu5 receptor;f;;Rat;12438526;Negative
MPEP;mGlu5 receptor;f;;Human;11814808|10530811;Negative
MTEB;mGlu5 receptor;f;;Human;14697765;Negative
MTEP;mGlu5 receptor;f;;Human;12473093;Negative
PTeB;mGlu5 receptor;f;;Human;15341479;Negative
SIB-1757;mGlu5 receptor;f;;Human;11814808|10381773;Negative
SIB-1893;mGlu5 receptor;f;;Human;11814808|10381773;Negative
SP203;mGlu5 receptor;f;;Rat;17571866;Negative
[14C]MTEP;mGlu5 receptor;f;;Rat;12438526;Negative
[3H]CTEP;mGlu5 receptor;f;;Mouse;21849627;Negative
[3H]CTEP;mGlu5 receptor;f;;Human;21849627;Negative
[3H]CTEP;mGlu5 receptor;f;;Rat;21849627;Negative
[3H]fenobam;mGlu5 receptor;f;;Rat;16040814;Negative
[3H]fenobam;mGlu5 receptor;f;;Human;16040814;Negative
[3H]methoxymethyl-MTEP;mGlu5 receptor;f;;Rat;12565928;Negative
[3H]methoxy-PEPy;mGlu5 receptor;f;;Rat;12565928;Negative
[3H]M-MPEP;mGlu5 receptor;f;;Human;12920211;Negative
[3H]M-MPEP;mGlu5 receptor;f;;Human;11814808;Negative
VU0285683;mGlu5 receptor;f;;Rat;20923853;Negative
VU0285683;mGlu5 receptor;f;;Rat;20923853;Negative
VU0366058;mGlu5 receptor;f;;Rat;22267125;Negative
VU0366058;mGlu5 receptor;f;;Rat;22267125;Negative
VU0463841;mGlu5 receptor;f;;Rat;23682684;Negative
VU0463841;mGlu5 receptor;f;;Rat;23682684;Negative
5-MPEP;mGlu5 receptor;f;;Rat;16155210;Neutral
CPCCOEt;mGlu5 receptor;f;;Rat;29514854;Neutral
GS39783;mGlu5 receptor;f;;Rat;29514854;Neutral
PHCCC;mGlu5 receptor;f;;Rat;29514854;Neutral
3,3'-difluorobenzaldazine;mGlu5 receptor;f;;Human;14747613|12920211;Positive
5PAM523;mGlu5 receptor;f;;Rat;23291536;Positive
5PAM523;mGlu5 receptor;f;;Rat;23291536;Positive
5PAM523;mGlu5 receptor;f;;Human;23291536;Positive
ADX-47273;mGlu5 receptor;f;;Rat;;Positive
ADX-47273;mGlu5 receptor;f;;Rat;22884720;Positive
ADX-47273;mGlu5 receptor;f;;Rat;22884720;Positive
ADX-47273;mGlu5 receptor;f;;Human;22884720;Positive
AZ12216052;mGlu5 receptor;f;;Rat;29514854;Positive
CDPPB;mGlu5 receptor;f;;Human;15608073|15537338;Positive
CDPPB;mGlu5 receptor;f;;Rat;15537338;Positive
CGP7930;mGlu5 receptor;f;;Rat;29514854;Positive
cinacalcet;mGlu5 receptor;f;;Rat;29514854;Positive
compound 47 [PMID: 21295468];mGlu5 receptor;f;;Human;21295468;Positive
CPPHA;mGlu5 receptor;f;;Human;14747613;Positive
CPPZ;mGlu5 receptor;f;;Rat;21335002;Positive
CPPZ;mGlu5 receptor;f;;Human;21335002;Positive
LSN2463359;mGlu5 receptor;f;;Rat;22884720;Positive
LSN2463359;mGlu5 receptor;f;;Human;22884720;Positive
LSN2463359;mGlu5 receptor;f;;Rat;22884720;Positive
LSN2814617;mGlu5 receptor;f;;Rat;22884720;Positive
LSN2814617;mGlu5 receptor;f;;Human;22884720;Positive
LSN2814617;mGlu5 receptor;f;;Rat;22884720;Positive
NCFP;mGlu5 receptor;f;;Rat;23348500;Positive
NCFP;mGlu5 receptor;f;;Rat;23348500;Positive
NCFP;mGlu5 receptor;f;;Rat;23348500;Positive
NPS 2143;mGlu5 receptor;f;;Rat;29514854;Positive
VU0092273;mGlu5 receptor;f;;Rat;22021324;Positive
VU0240382;mGlu5 receptor;f;;Rat;22021324;Positive
VU0357121;mGlu5 receptor;f;;Rat;20981342;Positive
VU0360172;mGlu5 receptor;f;;Rat;20923853;Positive
VU0360172;mGlu5 receptor;f;;Rat;20923853;Positive
VU0361747;mGlu5 receptor;f;;Rat;22021324;Positive
VU0364289;mGlu5 receptor;f;;Rat;23308336;Positive
VU0404251;mGlu5 receptor;f;;Human;22981332;Positive
VU0404251;mGlu5 receptor;f;;Rat;22981332;Positive
VU0424465;mGlu5 receptor;f;;Rat;23140665;Positive
VU0483605;mGlu5 receptor;f;;Rat;29514854;Positive
VU-1545;mGlu5 receptor;f;;Human;16722652;Positive
VU-1545;mGlu5 receptor;f;;Rat;16722652;Positive
VU-29;mGlu5 receptor;f;;Rat;17303702;Positive
VU-29;mGlu5 receptor;f;;Rat;17303702;Positive
ACDPP;mGlu5 receptor;f;;Human;15686941;Antagonist
DCG-IV;mGlu5 receptor;f;;Rat;11080213;Antagonist
(S)-4C3HPG;mGlu5 receptor;f;;Rat;11080213;Antagonist
LY341495;mGlu5 receptor;f;;Human;9680254;Antagonist
(+)-MCPG;mGlu5 receptor;f;;Rat;11080213;Antagonist
methoxy-MPEP;mGlu5 receptor;f;;Human;11814808;Antagonist
(S)-4CPG;mGlu5 receptor;f;;Rat;11080213;Antagonist
[11C]JNJ-16567083;mGlu5 receptor;f;;Rat;16078827;Antagonist
homo-AMPA;mGlu6 receptor;f;;Human;8759641;Agonist
L-glutamic acid;mGlu6 receptor;t;;Human;10443583;Agonist
LSP1-2111;mGlu6 receptor;f;;Rat;19525404;Agonist
LSP4-2022;mGlu6 receptor;f;;Human;22223752;Agonist
1-benzyl-APDC;mGlu6 receptor;f;;Rat;;Full agonist
(1S,3R)-ACPD;mGlu6 receptor;f;;Rat;;Full agonist
(1S,3R)-ACPD;mGlu6 receptor;f;;Human;9144651;Full agonist
ACPT-I;mGlu6 receptor;f;;Rat;;Full agonist
eglumegad;mGlu6 receptor;f;;Human;10090786;Full agonist
(R,S)-4-PPG;mGlu6 receptor;f;;Human;10336568|11166323;Full agonist
(S)-3,4-DCPG;mGlu6 receptor;f;;Human;11166323;Full agonist
L-AP4;mGlu6 receptor;f;;Human;11166323|9144651;Full agonist
L-CCG-I;mGlu6 receptor;f;;Rat;9833633;Full agonist
L-CCG-I;mGlu6 receptor;f;;Human;9144651;Full agonist
L-glutamic acid;mGlu6 receptor;t;;Rat;9833633;Full agonist
L-glutamic acid;mGlu6 receptor;t;;Human;9144651;Full agonist
L-serine-O-phosphate;mGlu6 receptor;t;;Human;9144651;Full agonist
LY379268;mGlu6 receptor;f;;Human;10090786;Full agonist
PHCCC;mGlu6 receptor;f;;Rat;18593581;Positive
α-methylserine-O-phosphate;mGlu6 receptor;f;;Rat;12769621;Antagonist
DCG-IV;mGlu6 receptor;f;;Rat;9833633;Antagonist
MAP4;mGlu6 receptor;f;;Rat;12769621;Antagonist
MPPG;mGlu6 receptor;f;;Human;;Antagonist
[3H]LY341495;mGlu6 receptor;f;;Human;11138847;Antagonist
THPG;mGlu6 receptor;f;;Unknown;9144637;Antagonist
L-AP4;mGlu7 receptor;f;;Human;9473604;Agonist
L-glutamic acid;mGlu7 receptor;t;;Human;10443583;Agonist
L-serine-O-phosphate;mGlu7 receptor;f;;Human;9473604;Agonist
LSP1-2111;mGlu7 receptor;f;;Rat;19525404;Agonist
LSP4-2022;mGlu7 receptor;f;;Human;22223752;Agonist
(1S,3R)-ACPD;mGlu7 receptor;f;;Human;11138847;Full agonist
(1S,3R)-ACPD;mGlu7 receptor;f;;Human;11138847;Full agonist
(R,S)-4-PPG;mGlu7 receptor;f;;Human;10336568|10866390;Full agonist
L-AP4;mGlu7 receptor;f;;Human;11138847;Full agonist
L-CCG-I;mGlu7 receptor;f;;Human;11138847;Full agonist
L-glutamic acid;mGlu7 receptor;t;;Human;11138847;Full agonist
L-serine-O-phosphate;mGlu7 receptor;t;;Human;11138847;Full agonist
PPG;mGlu7 receptor;f;;Human;11138847;Full agonist
ADX71743;mGlu7 receptor;f;;Human;23257312;Negative
ADX71743;mGlu7 receptor;f;;Rat;23257312;Negative
MDIP;mGlu7 receptor;f;;Rat;17609420;Negative
MMPIP;mGlu7 receptor;f;;Rat;17609420|20026717;Negative
VU6010608;mGlu7 receptor;f;;Rat;29259756;Negative
VU6012962;mGlu7 receptor;f;;Human;30608678;Negative
XAP044;mGlu7 receptor;f;;Human;24596089;Negative
AMN082;mGlu7 receptor;f;;Human;16339898;Positive
α-methylserine-O-phosphate;mGlu7 receptor;f;;Human;11138847;Antagonist
DCG-IV;mGlu7 receptor;f;;Human;11138847;Antagonist
LY341495;mGlu7 receptor;f;;Human;11138847;Antagonist
MAP4;mGlu7 receptor;f;;Human;11138847;Antagonist
MCCG;mGlu7 receptor;f;;Human;11138847;Antagonist
(+)-MCPG;mGlu7 receptor;f;;Human;11138847;Antagonist
MPPG;mGlu7 receptor;f;;Human;11138847;Antagonist
MSOPPE;mGlu7 receptor;f;;Human;11138847;Antagonist
[3H]LY341495;mGlu7 receptor;f;;Human;11138847;Antagonist
L-glutamic acid;mGlu8 receptor;t;;Human;10443583;Agonist
(1S,3R)-ACPD;mGlu8 receptor;f;;Rat;9016353;Full agonist
(1S,3R)-ACPD;mGlu8 receptor;f;;Human;9473604;Full agonist
D-AP4;mGlu8 receptor;f;;Human;9473604;Full agonist
eglumegad;mGlu8 receptor;f;;Human;10216218;Full agonist
(R,S)-4-PPG;mGlu8 receptor;f;;Human;10336568|10866390|11166323;Full agonist
(S)-3,4-DCPG;mGlu8 receptor;f;;Human;11166323;Full agonist
L-AP4;mGlu8 receptor;f;;Rat;9016353;Full agonist
L-AP4;mGlu8 receptor;f;;Human;10216218;Full agonist
L-CCG-I;mGlu8 receptor;f;;Human;10216218;Full agonist
L-CCG-I;mGlu8 receptor;f;;Rat;9016353;Full agonist
L-glutamic acid;mGlu8 receptor;t;;Human;9473604|10216218;Full agonist
L-serine-O-phosphate;mGlu8 receptor;t;;Human;9473604|10216218;Full agonist
[3H]AP4;mGlu8 receptor;f;;Human;10216218;Full agonist
ACPT-I;mGlu8 receptor;f;;Rat;10771029;Partial agonist
AZ12216052;mGlu8 receptor;f;;None;29514854;Positive
AZ12216052;mGlu8 receptor;f;;Human;20385173;Positive
VU0155094;mGlu8 receptor;f;;Human;25225882;Positive
VU0422288;mGlu8 receptor;f;;Human;25225882;Positive
α-methylserine-O-phosphate;mGlu8 receptor;f;;Rat;12769621;Antagonist
CPPG;mGlu8 receptor;f;;Rat;10719229;Antagonist
DCG-IV;mGlu8 receptor;f;;Human;10216218;Antagonist
LY341495;mGlu8 receptor;f;;Human;9680254;Antagonist
MAP4;mGlu8 receptor;f;;Rat;9016353|10719229;Antagonist
MPPG;mGlu8 receptor;f;;Human;9473604;Antagonist
7-hydroxystaurosporine;microtubule affinity regulating kinase 1;f;;Human;10786669;Inhibition
compound 17d [PMID: 23099093];microtubule affinity regulating kinase 3;f;;Human;23099093;Inhibition
compound 35 [PMID: 23916259];Microtubule associated serine/threonine kinase 3;f;;Human;23916259;Inhibition
aldosterone;Mineralocorticoid receptor;t;;Human;8282004|10611474;Agonist
AZD9567;Mineralocorticoid receptor;f;;Human;29424542;Agonist
benzodrocortisone;Mineralocorticoid receptor;f;;Human;;Agonist
budesonide;Mineralocorticoid receptor;f;;Human;28937774;Agonist
cortisol;Mineralocorticoid receptor;t;;Human;8282004|10611474;Agonist
deoxycorticosterone;Mineralocorticoid receptor;t;;Human;8282004;Agonist
dexamethasone;Mineralocorticoid receptor;f;;Human;8282004|10611474;Agonist
fludrocortisone;Mineralocorticoid receptor;f;;Human;8282004;Agonist
fluticasone propionate;Mineralocorticoid receptor;f;;Human;28937774;Agonist
prednisolone;Mineralocorticoid receptor;f;;Human;11520196;Agonist
prednisolone;Mineralocorticoid receptor;f;;Human;29424542;Agonist
[3H]aldosterone;Mineralocorticoid receptor;f;;Rat;6320679|16188378;Agonist
AZD9977;Mineralocorticoid receptor;f;;Human;30596500;Antagonist
drospirenone;Mineralocorticoid receptor;f;;Human;1493716;Antagonist
eplerenone;Mineralocorticoid receptor;f;;Human;18038968;Antagonist
esaxerenone;Mineralocorticoid receptor;f;;Human;22866979|29688582;Antagonist
finerenone;Mineralocorticoid receptor;f;;Human;22791416;Antagonist
nimodipine;Mineralocorticoid receptor;f;;Human;18250364;Antagonist
onapristone;Mineralocorticoid receptor;f;;Human;12781198;Antagonist
PF-03882845;Mineralocorticoid receptor;f;;Human;24738581;Antagonist
progesterone;Mineralocorticoid receptor;t;;Human;8282004;Antagonist
RU28318;Mineralocorticoid receptor;f;;Human;;Antagonist
spironolactone;Mineralocorticoid receptor;f;;Human;18038968;Antagonist
ZK112993;Mineralocorticoid receptor;f;;Human;;Antagonist
pexmetinib;misshapen like kinase 1;f;;Human;27287719;Inhibition
PF-03715455;misshapen like kinase 1;f;;Human;21888439;Inhibition
bongkrek acid;Mitochondrial adenine nucleotide translocator 1;f;;Human;;Inhibition
carboxyatractyloside;Mitochondrial adenine nucleotide translocator 1;f;;Human;;Inhibition
1,2,3-benzenetricarboxylic acid;Mitochondrial citrate transporter;f;;Human;;Inhibition
α-cyano-4-hydroxycinnamate;mitochondrial pyruvate carrier 1;f;;Rat;1156402;Antagonist
α-Cyano-5-phenyl-2,4-pentadienic acid;mitochondrial pyruvate carrier 1;f;;Rat;1156402;Antagonist
α-cyanocinnamate;mitochondrial pyruvate carrier 1;f;;Rat;1156402;Antagonist
mitoglitazone;mitochondrial pyruvate carrier 1;f;;Mouse;23513224;Antagonist
UK-5099;mitochondrial pyruvate carrier 1;f;;Rat;22628558|1156402|23690925;Antagonist
α-cyano-4-hydroxycinnamate;mitochondrial pyruvate carrier 2;f;;Rat;1156402;Antagonist
α-Cyano-5-phenyl-2,4-pentadienic acid;mitochondrial pyruvate carrier 2;f;;Rat;1156402;Antagonist
α-cyanocinnamate;mitochondrial pyruvate carrier 2;f;;Rat;1156402;Antagonist
mitoglitazone;mitochondrial pyruvate carrier 2;f;;Mouse;23513224;Antagonist
UK-5099;mitochondrial pyruvate carrier 2;f;;Rat;22628558|1156402|23690925;Antagonist
compound 13B [PMID: 32506913];mitofusin 2;f;;Mouse;32506913;Activation
ERK inhibitor III;mitogen-activated protein kinase 1;f;;Human;17000106;Binding
CHIR-99021;mitogen-activated protein kinase 1;f;;Human;12606497;Inhibition
compound 27 [PMID: 29775310];mitogen-activated protein kinase 1;f;;Human;29775310;Inhibition
ERK inhibitor II;mitogen-activated protein kinase 1;f;;Human;16139248;Inhibition
example 184 [WO2015066188A1];mitogen-activated protein kinase 1;f;;Human;;Inhibition
MK-8353;mitogen-activated protein kinase 1;f;;Human;29467321;Inhibition
ravoxertinib;mitogen-activated protein kinase 1;f;;Human;27227380;Inhibition
SCH772984;mitogen-activated protein kinase 1;f;;Human;23614898;Inhibition
SCH772984;mitogen-activated protein kinase 1;f;;Human;23614898;Inhibition
ulixertinib;mitogen-activated protein kinase 1;f;;Human;25977981;Inhibition
VTX-11e;mitogen-activated protein kinase 1;f;;Human;19827834;Inhibition
brimapitide;mitogen-activated protein kinase 10;f;;Human;;Inhibition
compound 11 [PMID: 26431428];mitogen-activated protein kinase 10;f;;Human;26431428;Inhibition
compound 20 [PMID: 30998356];mitogen-activated protein kinase 10;f;;Human;30998356;Inhibition
GNE-3511;mitogen-activated protein kinase 10;f;;Human;25341110;Inhibition
J30-8;mitogen-activated protein kinase 10;f;;Human;31268308;Inhibition
JNK-IN-8;mitogen-activated protein kinase 10;f;;Human;22284361;Inhibition
JNK inhibitor 9l;mitogen-activated protein kinase 10;f;;Human;19947601;Inhibition
JNK inhibitor IX;mitogen-activated protein kinase 10;f;;Human;;Inhibition
JNK inhibitor V;mitogen-activated protein kinase 10;f;;Human;;Inhibition
JNK inhibitor VIII;mitogen-activated protein kinase 10;f;;Human;16759099;Inhibition
pamapimod;mitogen-activated protein kinase 10;f;;Human;21375264;Inhibition
SP600125;mitogen-activated protein kinase 10;f;;Human;11717429;Inhibition
tanzisertib;mitogen-activated protein kinase 10;f;;Human;22244937;Inhibition
doramapimod;mitogen-activated protein kinase 11;f;;Human;22014550;Inhibition
neflamapimod;mitogen-activated protein kinase 11;f;;Human;18183025;Inhibition
pamapimod;mitogen-activated protein kinase 11;f;;Human;21375264;Inhibition
pexmetinib;mitogen-activated protein kinase 11;f;;Human;27287719;Inhibition
PH-797804;mitogen-activated protein kinase 11;f;;Human;21620699;Inhibition
SB203580;mitogen-activated protein kinase 11;f;;Human;9653550;Inhibition
TAK-715;mitogen-activated protein kinase 11;f;;Human;16162000;Inhibition
talmapimod;mitogen-activated protein kinase 11;f;;Human;20071169;Inhibition
VX-702;mitogen-activated protein kinase 11;f;;Human;19950901;Inhibition
doramapimod;mitogen-activated protein kinase 12;f;;Human;22014550;Inhibition
doramapimod;mitogen-activated protein kinase 13;f;;Human;22014550;Inhibition
MAPK13-IN-1;mitogen-activated protein kinase 13;f;;Human;23187130;Inhibition
MAPK13-IN-1;mitogen-activated protein kinase 13;f;;Human;;Inhibition
PF-03715455;mitogen-activated protein kinase 13;f;;Human;21888439;Inhibition
PF-03715455;mitogen-activated protein kinase 14;f;;Human;21888439;Binding
7-hydroxystaurosporine;mitogen-activated protein kinase 14;f;;Human;17292828;Inhibition
acumapimod;mitogen-activated protein kinase 14;f;;Human;;Inhibition
ARRY-371797;mitogen-activated protein kinase 14;f;;Human;19950901;Inhibition
AZD6703;mitogen-activated protein kinase 14;f;;Human;22608965;Inhibition
BMS-582949;mitogen-activated protein kinase 14;f;;Human;20804198;Inhibition
CBS-3595;mitogen-activated protein kinase 14;f;;Human;28613871;Inhibition
compound 12 [PMID: 22521646];mitogen-activated protein kinase 14;f;;Human;22521646;Inhibition
dilmapimod;mitogen-activated protein kinase 14;f;;Human;;Inhibition
doramapimod;mitogen-activated protein kinase 14;f;;Human;22014550;Inhibition
doramapimod;mitogen-activated protein kinase 14;f;;Human;22037378;Inhibition
losmapimod;mitogen-activated protein kinase 14;f;;Human;19772287;Inhibition
MAPK13-IN-1;mitogen-activated protein kinase 14;f;;Human;23187130;Inhibition
MW150;mitogen-activated protein kinase 14;f;;Human;25676389;Inhibition
neflamapimod;mitogen-activated protein kinase 14;f;;Human;18183025;Inhibition
pamapimod;mitogen-activated protein kinase 14;f;;Human;21375264;Inhibition
pexmetinib;mitogen-activated protein kinase 14;f;;Human;27287719;Inhibition
PF-03715455;mitogen-activated protein kinase 14;f;;Human;21888439;Inhibition
PF-670462;mitogen-activated protein kinase 14;f;;Human;17502429;Inhibition
PH-797804;mitogen-activated protein kinase 14;f;;Human;;Inhibition
PP1;mitogen-activated protein kinase 14;f;;Human;12534346;Inhibition
ralimetinib;mitogen-activated protein kinase 14;f;;Human;18039577;Inhibition
SB202190;mitogen-activated protein kinase 14;f;;Human;16509574;Inhibition
SB203580;mitogen-activated protein kinase 14;f;;Human;9653550;Inhibition
SB220025;mitogen-activated protein kinase 14;f;;Human;11597418;Inhibition
SKF-86002;mitogen-activated protein kinase 14;f;;Human;19928858;Inhibition
TAK-715;mitogen-activated protein kinase 14;f;;Human;16162000;Inhibition
talmapimod;mitogen-activated protein kinase 14;f;;Human;20071169;Inhibition
VX-702;mitogen-activated protein kinase 14;f;;Human;19950901;Inhibition
BS-194;mitogen-activated protein kinase 15;f;;Human;21080703;Inhibition
ERK inhibitor II;mitogen-activated protein kinase 3;f;;Human;16139248;Inhibition
MK-8353;mitogen-activated protein kinase 3;f;;Human;29467321;Inhibition
ravoxertinib;mitogen-activated protein kinase 3;f;;Human;27227380;Inhibition
ulixertinib;mitogen-activated protein kinase 3;f;;Human;25977981;Inhibition
BAY-885;mitogen-activated protein kinase 7;f;;Human;30563338;Inhibition
BIX02188;mitogen-activated protein kinase 7;f;;Human;18834865;Inhibition
BIX02189;mitogen-activated protein kinase 7;f;;Human;18834865;Inhibition
DCLK1-IN-1;mitogen-activated protein kinase 7;f;;Human;32251410;Inhibition
XMD17-109;mitogen-activated protein kinase 7;f;;Human;24239623;Inhibition
XMD8-92;mitogen-activated protein kinase 7;f;;Human;20832753;Inhibition
compound 11 [PMID: 26431428];mitogen-activated protein kinase 8;f;;Human;26431428;Inhibition
compound 20 [PMID: 30998356];mitogen-activated protein kinase 8;f;;Human;30998356;Inhibition
compound 35 [PMID: 23916259];mitogen-activated protein kinase 8;f;;Human;23916259;Inhibition
GNE-3511;mitogen-activated protein kinase 8;f;;Human;25341110;Inhibition
JNK-IN-8;mitogen-activated protein kinase 8;f;;Human;22284361;Inhibition
JNK inhibitor 9l;mitogen-activated protein kinase 8;f;;Human;19947601;Inhibition
JNK inhibitor VIII;mitogen-activated protein kinase 8;f;;Human;16759099;Inhibition
pamapimod;mitogen-activated protein kinase 8;f;;Human;21375264;Inhibition
SP600125;mitogen-activated protein kinase 8;f;;Human;11717429;Inhibition
SU-3327;mitogen-activated protein kinase 8;f;;Human;19271755;Inhibition
tanzisertib;mitogen-activated protein kinase 8;f;;Human;22244937;Inhibition
compound 20 [PMID: 30998356];mitogen-activated protein kinase 9;f;;Human;30998356;Inhibition
JNK-IN-8;mitogen-activated protein kinase 9;f;;Human;22284361;Inhibition
JNK inhibitor IX;mitogen-activated protein kinase 9;f;;Human;17194588;Inhibition
JNK inhibitor VIII;mitogen-activated protein kinase 9;f;;Human;16759099;Inhibition
pamapimod;mitogen-activated protein kinase 9;f;;Human;21375264;Inhibition
RGB-286638;mitogen-activated protein kinase 9;f;;Human;23807770;Inhibition
SP600125;mitogen-activated protein kinase 9;f;;Human;11717429;Inhibition
tanzisertib;mitogen-activated protein kinase 9;f;;Human;22244937;Inhibition
TAK-733;mitogen-activated protein kinase kinase 1;f;;Human;21310613;Inhibition
binimetinib;mitogen-activated protein kinase kinase 1;f;;Human;;Negative
CI-1040;mitogen-activated protein kinase kinase 1;f;;Human;22037378;Negative
CI-1040;mitogen-activated protein kinase kinase 1;f;;Rabbit;10998351;Negative
cobimetinib;mitogen-activated protein kinase kinase 1;f;;Human;24900486;Negative
compound 3 [PMID: 31804822];mitogen-activated protein kinase kinase 1;f;;Human;31804822;Negative
refametinib;mitogen-activated protein kinase kinase 1;f;;Human;19706763;Negative
selumetinib;mitogen-activated protein kinase kinase 1;f;;Human;17332304|17237274;Negative
CH4987655;mitogen-activated protein kinase kinase 1;f;;Human;21316218;Inhibition
E6201;mitogen-activated protein kinase kinase 1;f;;Human;19684251;Inhibition
GDC-0623;mitogen-activated protein kinase kinase 1;f;;Human;23934108;Inhibition
MEK inhibitor I;mitogen-activated protein kinase kinase 1;f;;Human;15006386;Inhibition
MEK inhibitor II;mitogen-activated protein kinase kinase 1;f;;Human;18077363;Inhibition
MS432;mitogen-activated protein kinase kinase 1;f;;Human;31730343;Inhibition
PD 0325901;mitogen-activated protein kinase kinase 1;f;;Human;23474388;Inhibition
trametinib;mitogen-activated protein kinase kinase 1;f;;Human;21245089|21523318;Inhibition
binimetinib;mitogen-activated protein kinase kinase 2;f;;Human;;Negative
cobimetinib;mitogen-activated protein kinase kinase 2;f;;Human;24900486;Negative
refametinib;mitogen-activated protein kinase kinase 2;f;;Human;19706763;Negative
MEK1/2 inhibitor;mitogen-activated protein kinase kinase 2;f;;Human;18077363;Inhibition
MS432;mitogen-activated protein kinase kinase 2;f;;Human;31730343;Inhibition
trametinib;mitogen-activated protein kinase kinase 2;f;;Human;21523318;Inhibition
voruciclib;mitogen-activated protein kinase kinase 2;f;;Human;26606677;Inhibition
MEK inhibitor I;mitogen-activated protein kinase kinase 3;f;;Human;15006386;Inhibition
compound 11 [PMID: 26431428];mitogen-activated protein kinase kinase 4;f;;Human;9353380;Inhibition
MEK inhibitor I;mitogen-activated protein kinase kinase 4;f;;Human;15006386;Inhibition
staurosporine;mitogen-activated protein kinase kinase 4;f;;Human;12166950;Inhibition
BIX02188;mitogen-activated protein kinase kinase 5;f;;Human;18834865;Inhibition
BIX02189;mitogen-activated protein kinase kinase 5;f;;Human;18834865;Inhibition
staurosporine;mitogen-activated protein kinase kinase 6;f;;Human;12166950;Inhibition
cobimetinib;mitogen-activated protein kinase kinase 7;f;;Human;24900486;Negative
compound 11 [PMID: 26431428];mitogen-activated protein kinase kinase 7;f;;Human;26431428;Inhibition
E6201;mitogen-activated protein kinase kinase kinase 1;f;;Human;19684251;Inhibition
CEP-1347;mitogen-activated protein kinase kinase kinase 10;f;;Human;24044867|11325962;Inhibition
URMC-099;mitogen-activated protein kinase kinase kinase 10;f;;Human;24044867;Inhibition
CEP-1347;mitogen-activated protein kinase kinase kinase 11;f;;Human;24044867|11325962;Inhibition
compound 8 [PMID: 24044867];mitogen-activated protein kinase kinase kinase 11;f;;Human;24044867;Inhibition
URMC-099;mitogen-activated protein kinase kinase kinase 11;f;;Human;24044867;Inhibition
CEP-1347;mitogen-activated protein kinase kinase kinase 12;f;;Human;29863360;Inhibition
compound 11 [PMID: 26431428];mitogen-activated protein kinase kinase kinase 12;f;;Human;26431428;Inhibition
compound 16d [Tao et al., 2009];mitogen-activated protein kinase kinase kinase 12;f;;Human;;Inhibition
GNE-3511;mitogen-activated protein kinase kinase kinase 12;f;;Human;26431428;Inhibition
GNE-8505;mitogen-activated protein kinase kinase kinase 12;f;;Human;;Inhibition
GNE-3511;mitogen-activated protein kinase kinase kinase 13;f;;Human;25341110;Inhibition
compound 31 [PMID: 23374866];mitogen-activated protein kinase kinase kinase 14;f;;Human;23374866;Inhibition
compound 3a [Pipionne et al, 2018];mitogen-activated protein kinase kinase kinase 14;f;;Human;30108985;Inhibition
NIK inhibitor 12f;mitogen-activated protein kinase kinase kinase 14;f;;Human;32479083;Inhibition
NIK SMI1;mitogen-activated protein kinase kinase kinase 14;f;;Mouse;29330524;Inhibition
NIK SMI1;mitogen-activated protein kinase kinase kinase 14;f;;Human;29330524;Inhibition
BIIB068;mitogen-activated protein kinase kinase kinase 19;f;;Human;32696648;Inhibition
compound 1 [PMID: 24793884];mitogen-activated protein kinase kinase kinase 19;f;;Human;24793884;Inhibition
URMC-099;mitogen-activated protein kinase kinase kinase 2;f;;Human;24044867;Inhibition
compound 5n [PMID: 20483621];mitogen-activated protein kinase kinase kinase 3;f;;Human;20483621;Inhibition
compound 10 [PMID: 23147077];mitogen-activated protein kinase kinase kinase 5;f;;Human;23147077;Inhibition
compound 26 [PMID: 31710475];mitogen-activated protein kinase kinase kinase 5;f;;Human;31710475;Inhibition
compound 26 [PMID: 31710475];mitogen-activated protein kinase kinase kinase 5;f;;Human;31710475;Inhibition
GS-444217;mitogen-activated protein kinase kinase kinase 5;f;;Human;26180085;Inhibition
MSC2032964A;mitogen-activated protein kinase kinase kinase 5;f;;Human;21064192;Inhibition
selonsertib;mitogen-activated protein kinase kinase kinase 5;f;;Human;;Inhibition
compound 10 [PMID: 23147077];mitogen-activated protein kinase kinase kinase 6;f;;Human;23147077;Inhibition
5Z-7-oxozeaenol;mitogen-activated protein kinase kinase kinase 7;f;;Human;23272696|22621397;Inhibition
CEP-11981;mitogen-activated protein kinase kinase kinase 7;f;;Human;22148921;Inhibition
compound 12 [PMID: 27448772];mitogen-activated protein kinase kinase kinase 7;f;;Human;27448772;Inhibition
compound 17d [PMID: 23099093];mitogen-activated protein kinase kinase kinase 7;f;;Human;23099093;Inhibition
compound 25 [PMID: 28038940];mitogen-activated protein kinase kinase kinase 7;f;;Human;28038940;Inhibition
compound 5 [PMID: 28038940];mitogen-activated protein kinase kinase kinase 7;f;;Human;28038940;Inhibition
NG-25;mitogen-activated protein kinase kinase kinase 7;f;;Human;25075558;Inhibition
RGB-286638;mitogen-activated protein kinase kinase kinase 7;f;;Human;23807770;Inhibition
Takinib;mitogen-activated protein kinase kinase kinase 7;f;;Human;28820959;Inhibition
MEK inhibitor II;mitogen-activated protein kinase kinase kinase 8;f;;Human;18077363;Inhibition
Tpl2 kinase inhibitor;mitogen-activated protein kinase kinase kinase 8;f;;Human;16165349;Inhibition
apitolisib;mitogen-activated protein kinase kinase kinase 9;f;;Human;21981714;Inhibition
CEP-1347;mitogen-activated protein kinase kinase kinase 9;f;;Human;24044867|11325962|29863360;Inhibition
cerdulatinib;mitogen-activated protein kinase kinase kinase 9;f;;Human;25253883;Inhibition
compound 8e [PMID: 24432909];mitogen-activated protein kinase kinase kinase 9;f;;Human;29863360;Inhibition
GNE-3511;mitogen-activated protein kinase kinase kinase 9;f;;Human;25341110;Inhibition
P505-15;mitogen-activated protein kinase kinase kinase 9;f;;Human;22040680;Inhibition
URMC-099;mitogen-activated protein kinase kinase kinase 9;f;;Human;24044867;Inhibition
BAY 61-3606;mitogen-activated protein kinase kinase kinase kinase 2;f;;Human;22815993;Inhibition
belizatinib;mitogen-activated protein kinase kinase kinase kinase 2;f;;Human;22734674;Inhibition
NG-25;mitogen-activated protein kinase kinase kinase kinase 2;f;;Human;25075558;Inhibition
compound 8h [PMID: 22765894];mitogen-activated protein kinase kinase kinase kinase 3;f;;Human;22765894;Inhibition
RIPK3 inhibitor 18;mitogen-activated protein kinase kinase kinase kinase 3;f;;Human;;Inhibition
compound 21 [PMID: 23312943];mitogen-activated protein kinase kinase kinase kinase 4;f;;Human;23312943;Inhibition
compound 26 [PMID: 24673130];mitogen-activated protein kinase kinase kinase kinase 4;f;;Human;24673130;Inhibition
bosutinib;mitogen-activated protein kinase kinase kinase kinase 5;f;;Human;19039322;Inhibition
NIK SMI1;mitogen-activated protein kinase kinase kinase kinase 5;f;;Human;29330524;Inhibition
RIPK1 inhibitor 22b;mitogen-activated protein kinase kinase kinase kinase 5;f;;Human;30480444;Inhibition
MLKL compound 1;mixed lineage kinase domain like pseudokinase;f;;Human;25288762;Inhibition
MLKL compound 1;mixed lineage kinase domain like pseudokinase;f;;Human;25288762;Binding
apratastat;MMP1;f;;Human;16426848;Inhibition
batimastat;MMP1;f;;Human;;Inhibition
batimastat;MMP1;f;;Human;12877590;Inhibition
CGS-27023A;MMP1;f;;Human;21514700;Inhibition
cipemastat;MMP1;f;;Human;11890658;Inhibition
ilomastat;MMP1;f;;Human;14684295;Inhibition
marimastat;MMP1;f;;Human;9364582;Inhibition
CM-352;MMP10;f;;Human;25686022;Inhibition
compound 10 [PMID: 18790648];MMP11;f;;Human;18790648;Inhibition
AZD1236;MMP12;f;;Human;;Inhibition
AZD6605;MMP12;f;;Human;;Inhibition
compound 1 [PMID: 24900526];MMP12;f;;Human;24900526;Inhibition
compound 20 [PMID: 22153340];MMP12;f;;Human;22153340;Inhibition
compound 5  [PMID: 24900526];MMP12;f;;Human;24900526;Inhibition
ilomastat;MMP12;f;;Human;14684295;Inhibition
RXP470.1;MMP12;f;;Human;23343195;Inhibition
apratastat;MMP13;f;;Human;16426848;Inhibition
AZD6605;MMP13;f;;Human;;Inhibition
batimastat;MMP13;f;;Human;12877590;Inhibition
CL82198;MMP13;f;;Human;;Inhibition
compound 15 [PMID: 22017539];MMP13;f;;Human;22017539;Inhibition
compound 1 [PMID: 17935984];MMP13;f;;Human;17935984;Inhibition
PF-152;MMP13;f;;Human;26653735;Inhibition
prinomastat;MMP13;f;;Human;16789888;Inhibition
SL422;MMP13;f;;Human;11472217;Inhibition
WAY170523;MMP13;f;;Human;;Inhibition
CGS-27023A;MMP14;f;;Human;21514700;Inhibition
compound 29e [PMID: 23631440];MMP14;f;;Human;23631440;Inhibition
ilomastat;MMP14;f;;Human;14684295;Inhibition
(R)-ND-336;MMP14;f;;Human;30212201;Inhibition
ilomastat;MMP15;f;;Human;14684295;Inhibition
SL422;MMP15;f;;Human;11472217;Inhibition
ilomastat;MMP16;f;;Human;14684295;Inhibition
SL422;MMP16;f;;Human;11472217;Inhibition
ilomastat;MMP17;f;;Human;17623656;Inhibition
ARP100;MMP2;f;;Human;16483784;Inhibition
AZD6605;MMP2;f;;Human;;Inhibition
CGS-27023A;MMP2;f;;Human;21514700;Inhibition
ilomastat;MMP2;f;;Human;14684295;Inhibition
marimastat;MMP2;f;;Human;9364582;Inhibition
(R)-ND-336;MMP2;f;;Human;30212201;Inhibition
SB-3CT;MMP2;f;;Human;;Inhibition
tanomastat;MMP2;f;;Human;16680577;Inhibition
tiludronic acid;MMP2;f;;Human;24071448;Inhibition
CGS-27023A;MMP25;f;;Human;21514700;Inhibition
ilomastat;MMP26;f;;Human;14684295;Inhibition
batimastat;MMP3;f;;Human;9548812;Inhibition
CGS-27023A;MMP3;f;;Human;21514700;Inhibition
CM-352;MMP3;f;;Human;25686022;Inhibition
marimastat;MMP3;f;;Human;9364582;Inhibition
UK-356618;MMP3;f;;Human;11229774;Inhibition
doxycycline;MMP7;f;;Human;15665254;Inhibition
marimastat;MMP7;f;;Human;9364582;Inhibition
RS 39066;MMP7;f;;Human;;Inhibition
SL422;MMP7;f;;Human;11472217;Inhibition
CGS-27023A;MMP8;f;;Human;21514700;Inhibition
doxycycline;MMP8;f;;Human;7781360;Inhibition
ONO-4817;MMP8;f;;Human;10858013;Inhibition
SL422;MMP8;f;;Human;11472217;Inhibition
andecaliximab;MMP9;f;;Human;25961845;Binding
AZD1236;MMP9;f;;Human;;Inhibition
AZD6605;MMP9;f;;Human;;Inhibition
CGS-27023A;MMP9;f;;Human;21514700;Inhibition
compound 1a [PMID: 15055993];MMP9;f;;Human;15055993;Inhibition
compound 29e [PMID: 23631440];MMP9;f;;Human;23631440;Inhibition
ilomastat;MMP9;f;;Human;14684295;Inhibition
marimastat;MMP9;f;;Human;9364582;Inhibition
(R)-ND-336;MMP9;f;;Human;30212201;Inhibition
SB-3CT;MMP9;f;;Human;;Inhibition
SL422;MMP9;f;;Human;11472217;Inhibition
compound 36 [PMID: 32429662];Monoacylglycerol lipase;f;;Human;32429662;Inhibition
JJKK 048;Monoacylglycerol lipase;f;;Human;23521796;Inhibition
JNJ-42226314;Monoacylglycerol lipase;f;;Human;31818916;Inhibition
JZL184;Monoacylglycerol lipase;f;;Human;19029917;Inhibition
JZL195;Monoacylglycerol lipase;f;;Human;19918051;Inhibition
KML29;Monoacylglycerol lipase;f;;Human;22542104;Inhibition
MJN110;Monoacylglycerol lipase;f;;Human;23731016;Inhibition
ABX-1431;Monoacylglycerol lipase;f;;Human;30067909;Irreversible inhibition
ABX-1431;Monoacylglycerol lipase;f;;Mouse;30067909;Irreversible inhibition
JZL184;Monoacylglycerol lipase;f;;Human;22542104;Irreversible inhibition
befloxatone;Monoamine oxidase A;f;;Human;10333983;Inhibition
clorgiline;Monoamine oxidase A;f;;Human;;Inhibition
CR4056;Monoamine oxidase A;f;;Human;21647215;Inhibition
linezolid;Monoamine oxidase A;f;;Human;26536532;Inhibition
moclobemide;Monoamine oxidase A;f;;Human;21680183;Inhibition
pirlindole;Monoamine oxidase A;f;;Human;9564636;Inhibition
selegiline;Monoamine oxidase A;f;;Human;21377879;Inhibition
tranylcypromine;Monoamine oxidase A;f;;Human;15110846;Inhibition
phenelzine;Monoamine oxidase A;f;;Human;18426226;Irreversible inhibition
lazabemide;Monoamine oxidase B;f;;Human;2122653|16137882;Inhibition
linezolid;Monoamine oxidase B;f;;Human;19321235;Inhibition
linezolid;Monoamine oxidase B;f;;Human;26536532;Inhibition
moclobemide;Monoamine oxidase B;f;;Human;21680183;Inhibition
pargyline;Monoamine oxidase B;f;;Rat;6817759;Inhibition
rasagiline;Monoamine oxidase B;f;;Human;11159700;Inhibition
safinamide;Monoamine oxidase B;f;;Human;24139167;Inhibition
safinamide;Monoamine oxidase B;f;;Human;15027868;Inhibition
selegiline;Monoamine oxidase B;f;;Human;15974574|21377879;Inhibition
tranylcypromine;Monoamine oxidase B;f;;Human;15110846;Inhibition
mofegiline;Monoamine oxidase B;f;;Rat;2597310;Irreversible inhibition
phenelzine;Monoamine oxidase B;f;;Human;18426226;Irreversible inhibition
AZD3965;Monocarboxylate transporter 1;f;;Human;29050199;Inhibition
compound 30 [PMID: 16455256];Monocarboxylate transporter 1;f;;Human;16455256;Inhibition
BAY-8002;Monocarboxylate transporter 1;f;;Human;30115664;None
BAY-8002;Monocarboxylate transporter 1;f;;Human;30115664;None
7ACC2;Monocarboxylate transporter 2;f;;Human;24095010;Inhibition
AZD3965;Monocarboxylate transporter 2;f;;Human;29050199;Inhibition
BAY-8002;Monocarboxylate transporter 2;f;;Human;30115664;None
alemcinal;motilin receptor;f;;Human;15764739;Full agonist
azithromycin;motilin receptor;f;;Human;23190027;Full agonist
[Bpa1,Ile13]motilin (human);motilin receptor;f;;Human;11461914;Full agonist
camicinal;motilin receptor;f;;Human;19374732|25341626;Full agonist
EM-523;motilin receptor;f;;Human;15764739;Full agonist
erythromycin;motilin receptor;f;;Human;10381885|15764739;Full agonist
KOS1326;motilin receptor;f;;Human;15764739;Full agonist
[Leu13]motilin (human);motilin receptor;f;;Human;10381885;Full agonist
ME36;motilin receptor;f;;Human;15764739;Full agonist
ME4;motilin receptor;f;;Human;15764739;Full agonist
ME67;motilin receptor;f;;Human;15764739;Full agonist
mitemcinal;motilin receptor;f;;Rabbit;10081621;Full agonist
mitemcinal;motilin receptor;f;;Rabbit;17183187;Full agonist
motilin;motilin receptor;t;Human|Pig;Human;15677347|11461914|11781320|16531413;Full agonist
motilin;motilin receptor;f;Rabbit;Human;10381885;Full agonist
motilin;motilin receptor;f;Dog;Human;10381885;Full agonist
motilin-(1-11) (human);motilin receptor;f;;Human;10381885;Full agonist
motilin-(1-12) (human);motilin receptor;f;;Human;10381885;Full agonist
motilin-(1-13) (human);motilin receptor;f;;Human;10381885;Full agonist
motilin-(1-19) (human);motilin receptor;f;;Human;10381885;Full agonist
motilin-(2-22) (human);motilin receptor;f;;Human;10381885;Full agonist
[nLeu13,Glu14]motilin (human);motilin receptor;f;;Human;10381885;Full agonist
[Phe3,Leu13]motilin (human);motilin receptor;f;;Human;10381885;Full agonist
roxithromycin;motilin receptor;f;;Human;10381885;Full agonist
[D-Bpa5,Ile13]motilin (human);motilin receptor;f;;Human;15677347;Full agonist
[L-Bpa5,Ile13]motilin (human);motilin receptor;f;;Human;15677347;Full agonist
[125I]motilin (human);motilin receptor;f;;Human;10381885;Full agonist
GM-109;motilin receptor;f;;Rabbit;11806718;Antagonist
GM-109;motilin receptor;f;;Rabbit;10081621|7752063;Antagonist
MA-2029;motilin receptor;f;;Human;18164286;Antagonist
OHM-11526;motilin receptor;f;;Human;9277420;Antagonist
compound 30 [PMID: 15953724];mPGES1;f;;Human;15953724;Inhibition
compound 39 [PMID: 23623673];mPGES1;f;;Human;23623673;Inhibition
compound 44 [PMID: 19748780];mPGES1;f;;Human;19748780;Inhibition
compound III [PMID: 24045148];mPGES1;f;;Human;24045148;Inhibition
compound III [PMID: 24045148];mPGES1;f;;Rat;24045148;Inhibition
compound III [PMID: 24045148];mPGES1;f;;Rat;;Inhibition
compound III [PMID: 24045148];mPGES1;f;;Human;;Inhibition
compound 30 [PMID: 15953724];mPGES2;f;;Human;15953724;Inhibition
cevimeline;M1 receptor;f;;Human;9399977;Agonist
methacholine;M1 receptor;f;;Rat;9622546;Agonist
SPP1;M1 receptor;f;;None;30276808;Agonist
AC-42;M1 receptor;f;;Human;16207821;Full agonist
(+)-aceclidine;M1 receptor;f;;Human;8968358;Full agonist
acetylcholine;M1 receptor;t;;Rat;12235229;Full agonist
acetylcholine;M1 receptor;t;;Human;7651370|9224827;Full agonist
arecaidine propargyl ester;M1 receptor;f;;Human;9224827;Full agonist
arecoline;M1 receptor;f;;Human;9224827;Full agonist
bethanechol;M1 receptor;f;;Human;9224827;Full agonist
bethanechol;M1 receptor;f;;Rat;2537406;Full agonist
carbachol;M1 receptor;f;;Human;9224827|9614217|10323594;Full agonist
carbachol;M1 receptor;f;;Rat;12235229;Full agonist
furtrethonium;M1 receptor;f;;Human;9224827;Full agonist
methylfurmethide;M1 receptor;f;;Human;9224827;Full agonist
NNC 11-1314;M1 receptor;f;;Human;11504829;Full agonist
NNC 11-1585;M1 receptor;f;;Human;11504829;Full agonist
NNC 11-1607;M1 receptor;f;;Human;11504829;Full agonist
oxotremorine-M;M1 receptor;f;;Rat;2537406;Full agonist
oxotremorine-M;M1 receptor;f;;Human;9224827;Full agonist
pentylthio-TZTP;M1 receptor;f;;Human;9224827;Full agonist
[11C]butylthio-TZTP;M1 receptor;f;;Human;8835881;Full agonist
[11C]xanomeline;M1 receptor;f;;Human;8835881;Full agonist
(-)-aceclidine;M1 receptor;f;;Human;8968358;Partial agonist
arecoline;M1 receptor;f;;Rat;2537406;Partial agonist
AZD6088;M1 receptor;f;;Human;;Partial agonist
LY593093;M1 receptor;f;;Human;21558436;Partial agonist
McN-A-343;M1 receptor;f;;Rat;2537406;Partial agonist
McN-A-343;M1 receptor;f;;Human;7620715;Partial agonist
milameline;M1 receptor;f;;Human;10323594;Partial agonist
oxotremorine;M1 receptor;f;;Human;9224827;Partial agonist
oxotremorine;M1 receptor;f;;Rat;2537406;Partial agonist
pilocarpine;M1 receptor;f;;Human;9224827;Partial agonist
pilocarpine;M1 receptor;f;;Rat;2537406;Partial agonist
(±)YM796;M1 receptor;f;;Human;1310135;Partial agonist
sabcomeline;M1 receptor;f;;Human;10323594;Partial agonist
xanomeline;M1 receptor;f;;Human;9884068|9614217|10323594|16675658;Partial agonist
(-)-YM796;M1 receptor;f;;Human;1310135;Partial agonist
AC-42;M1 receptor;f;;Human;16207821;Negative
alcuronium;M1 receptor;f;;Human;9224827;Negative
Gö 7874;M1 receptor;f;;Human;10860942;Negative
N-benzyl brucine;M1 receptor;f;;Human;9495826;Negative
muscarinic toxin 7;M1 receptor;f;;Human;10799315;Negative
N-chloromethyl-brucine;M1 receptor;f;;Human;9495826;Negative
strychnine;M1 receptor;f;;Human;7651370;Negative
tacrine;M1 receptor;f;;Mouse;1552502;Negative
WIN 51,708;M1 receptor;f;;Human;12435818;Negative
WIN 62,577;M1 receptor;f;;Human;12435818;Negative
brucine;M1 receptor;f;;Human;9495826;Neutral
brucine N-oxide;M1 receptor;f;;Human;9495826;Neutral
strychnine;M1 receptor;f;;Human;7651370|9224827;Neutral
thiochrome;M1 receptor;f;;Human;14722259;Neutral
vinburnine;M1 receptor;f;;Human;9224827;Neutral
vincamine;M1 receptor;f;;Human;9224827;Neutral
AC-260584;M1 receptor;f;;Rat;16959945;Positive
benzoquinazolinone 12;M1 receptor;f;;Human;25326383;Positive
BQCA;M1 receptor;f;;Human;19717450|22086918|24443568|25326383;Positive
brucine;M1 receptor;f;;Human;9224827|9495826;Positive
brucine N-oxide;M1 receptor;f;;Human;9495826;Positive
clozapine;M1 receptor;f;;Human;14595031;Positive
clozapine;M1 receptor;f;;Rat;16959945;Positive
N-desmethylclozapine;M1 receptor;f;;Rat;16959945;Positive
N-desmethylclozapine;M1 receptor;f;;Human;14595031;Positive
K-252a;M1 receptor;f;;Human;10860942;Positive
KT 5720;M1 receptor;f;;Human;10860942;Positive
KT 5823;M1 receptor;f;;Human;10860942;Positive
MK-7622;M1 receptor;f;;Human;30034595;Positive
ML169;M1 receptor;f;;Human;23173069;Positive
PF-06767832;M1 receptor;f;;Human;27275946;Positive
staurosporine;M1 receptor;f;;Human;10860942;Positive
T‐495;M1 receptor;f;;Human;31990455;Positive
VU0029767;M1 receptor;f;;Human;19047481;Positive
VU0090157;M1 receptor;f;;Human;19047481;Positive
VU0119498;M1 receptor;f;;Human;19438238;Positive
4-DAMP;M1 receptor;f;;Rat;1325587;Antagonist
4-DAMP;M1 receptor;f;;Human;1994002;Antagonist
aclidinium;M1 receptor;f;;Human;19653626;Antagonist
AE9C90CB;M1 receptor;f;;Human;20590605;Antagonist
AFDX384;M1 receptor;f;;Human;1994002;Antagonist
Alexa-488-telenzepine;M1 receptor;f;;Human;20133736;Antagonist
amitriptyline;M1 receptor;f;;Human;8100134;Antagonist
AQ-RA 741;M1 receptor;f;;Human;1994002|9671109;Antagonist
atropine;M1 receptor;f;;Human;3443095|9614217|12049493|16439611|11303071|9029489;Antagonist
atropine;M1 receptor;f;;Rat;12235229|1325587|2704370;Antagonist
benzatropine;M1 receptor;f;;Rat;7562926;Antagonist
biperiden;M1 receptor;f;;Human;1346637;Antagonist
BODIPY-pirenzepine;M1 receptor;f;;Human;19451648;Antagonist
Cy3B-telenzepine;M1 receptor;f;;Human;20133736;Antagonist
darifenacin;M1 receptor;f;;Human;11303071|9113359|12122494|20590605|9671109;Antagonist
dicyclomine;M1 receptor;f;;Human;;Antagonist
dosulepin;M1 receptor;f;;Human;8100134;Antagonist
ethopropazine;M1 receptor;f;;Rat;2904117;Antagonist
glycopyrrolate;M1 receptor;f;;Human;21036043;Antagonist
guanylpirenzepine;M1 receptor;f;;Rat;8813552|10323493;Antagonist
hexahydrodifenidol;M1 receptor;f;;Rat;2704370;Antagonist
hexahydrosiladifenidol;M1 receptor;f;;Human;8759038;Antagonist
hexahydrosiladifenidol;M1 receptor;f;;Rat;1325587|2704370;Antagonist
hexocyclium;M1 receptor;f;;Rat;2704370;Antagonist
himbacine;M1 receptor;f;;Human;7925952|1331410|1994002;Antagonist
p-F-HHSiD;M1 receptor;f;;Human;12049493|8759038;Antagonist
ipratropium;M1 receptor;f;;Human;11303071;Antagonist
lithocholylcholine;M1 receptor;f;;Rat;12235229;Antagonist
methoctramine;M1 receptor;f;;Human;8759038|9029489|1994002|9113359;Antagonist
methoctramine;M1 receptor;f;;Rat;2704370;Antagonist
ML381;M1 receptor;f;;Human;24692176;Antagonist
muscarinic toxin 1;M1 receptor;f;;Human;12512959|16439611;Antagonist
muscarinic toxin 2;M1 receptor;f;;Human;12512959;Antagonist
muscarinic toxin 3;M1 receptor;f;;Human;7925952;Antagonist
N-methyl scopolamine;M1 receptor;f;;Human;16439611;Antagonist
otenzepad;M1 receptor;f;;Rat;1325587|2704370;Antagonist
otenzepad;M1 receptor;f;;Human;8759038;Antagonist
oxybutynin;M1 receptor;f;;Rat;16220976;Antagonist
oxybutynin;M1 receptor;f;;Human;22243489|12122494|20590605;Antagonist
pirenzepine;M1 receptor;f;;Rat;1325587|2704370;Antagonist
pirenzepine;M1 receptor;f;;Human;12049493|2704370|7925952|1994002|9113359|2043926;Antagonist
propantheline;M1 receptor;f;;Human;12049493;Antagonist
revefenacin;M1 receptor;f;;Human;29736245;Antagonist
scopolamine;M1 receptor;f;;Human;12049493;Antagonist
(S)-dimetindene;M1 receptor;f;;Human;12593665;Antagonist
silahexocyclium;M1 receptor;f;;Rat;2704370;Antagonist
solifenacin;M1 receptor;f;;Human;21524581;Antagonist
solifenacin;M1 receptor;f;;Human;12122494|20590605;Antagonist
solifenacin;M1 receptor;f;;Rat;16220976;Antagonist
[18F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate;M1 receptor;f;;Rat;9313861;Antagonist
[3H]darifenacin;M1 receptor;f;;Human;9029489;Antagonist
[3H]N-methyl scopolamine;M1 receptor;f;;Human;7651370|9224827|9614217|16675658|7925952|11303071|16369696|9846649|11578621;Antagonist
[3H]N-methyl scopolamine;M1 receptor;f;;Rat;7687290|12235229;Antagonist
[3H]pirenzepine;M1 receptor;f;;Human;6546354;Antagonist
[3H]pirenzepine;M1 receptor;f;;Rat;2704371|7350532;Antagonist
[3H]QNB;M1 receptor;f;;Human;3443095|11578621;Antagonist
[3H](+)telenzepine;M1 receptor;f;;Rat;2704371;Antagonist
tiotropium;M1 receptor;f;;Human;8441333;Antagonist
tolterodine;M1 receptor;f;;Human;20590605|9671109;Antagonist
trihexyphenidyl;M1 receptor;f;;Human;;Antagonist
tripitramine;M1 receptor;f;;Human;7805774;Antagonist
UH-AH 37;M1 receptor;f;;Human;2043926|9671109;Antagonist
umeclidinium;M1 receptor;f;;Human;19317446|23435542;Antagonist
VU0255035;M1 receptor;f;;Human;19407080;Antagonist
cevimeline;M2 receptor;f;;Human;9399977;Agonist
methacholine;M2 receptor;f;;Rat;9622546;Agonist
[3H]acetylcholine;M2 receptor;f;;Human;14722259;Agonist
(+)-aceclidine;M2 receptor;f;;Human;8968358|17392404;Full agonist
acetylcholine;M2 receptor;t;;Rat;9454790;Full agonist
acetylcholine;M2 receptor;t;;Human;7651370|12235229|9224827|9454790;Full agonist
arecaidine propargyl ester;M2 receptor;f;;Human;9224827;Full agonist
arecoline;M2 receptor;f;;Human;9224827;Full agonist
bethanechol;M2 receptor;f;;Human;9224827;Full agonist
carbachol;M2 receptor;f;;Human;12235229|9224827|9454790;Full agonist
carbachol;M2 receptor;f;;Rat;9454790;Full agonist
furtrethonium;M2 receptor;f;;Human;9224827;Full agonist
iperoxo;M2 receptor;f;;Human;23062057;Full agonist
methylfurmethide;M2 receptor;f;;Human;9224827;Full agonist
NNC 11-1314;M2 receptor;f;;Human;11504829;Full agonist
NNC 11-1585;M2 receptor;f;;Human;11504829;Full agonist
NNC 11-1607;M2 receptor;f;;Human;11504829;Full agonist
oxotremorine;M2 receptor;f;;Rat;9454790;Full agonist
oxotremorine;M2 receptor;f;;Human;9224827|9454790;Full agonist
oxotremorine-M;M2 receptor;f;;Human;9224827;Full agonist
pentylthio-TZTP;M2 receptor;f;;Human;9224827;Full agonist
[18F]FP-TZTP;M2 receptor;f;;Mouse;12668051;Full agonist
[3H]oxotremorine-M;M2 receptor;f;;Human;6478115;Full agonist
xanomeline;M2 receptor;f;;Human;9884068|10323594;Full agonist
(-)-aceclidine;M2 receptor;f;;Human;8968358|17392404;Partial agonist
McN-A-343;M2 receptor;f;;Rat;7680092;Partial agonist
pilocarpine;M2 receptor;f;;Human;9224827;Partial agonist
alcuronium;M2 receptor;f;;Human;9224827|12815174;Negative
brucine;M2 receptor;f;;Human;9495826;Negative
brucine N-oxide;M2 receptor;f;;Human;9495826;Negative
C7/3-phth;M2 receptor;f;;Human;9890565;Negative
gallamine;M2 receptor;f;;Rat;9454790;Negative
gallamine;M2 receptor;f;;Human;7651370|990587;Negative
gallamine;M2 receptor;f;;Human;9454790|12815174;Negative
Gö 7874;M2 receptor;f;;Human;10860942;Negative
N-benzyl brucine;M2 receptor;f;;Human;9495826;Negative
N-chloromethyl-brucine;M2 receptor;f;;Human;9495826;Negative
tacrine;M2 receptor;f;;Mouse;1552502;Negative
W-84;M2 receptor;f;;Human;12815174|15163212;Negative
WIN 51,708;M2 receptor;f;;Human;12435818;Negative
WIN 62,577;M2 receptor;f;;Human;12435818;Negative
thiochrome;M2 receptor;f;;Human;14722259;Neutral
vinburnine;M2 receptor;f;;Human;9224827;Neutral
vincamine;M2 receptor;f;;Human;9224827;Neutral
brucine;M2 receptor;f;;Human;9224827|9495826;Positive
brucine N-oxide;M2 receptor;f;;Human;9495826;Positive
dimethyl-W84;M2 receptor;f;;Human;12815174;Positive
Duo3;M2 receptor;f;;Human;16157694;Positive
N-benzyl brucine;M2 receptor;f;;Human;9495826;Positive
KT 5823;M2 receptor;f;;Human;10860942;Positive
LY2033298;M2 receptor;f;;Human;21989256;Positive
LY2119620;M2 receptor;f;;Human;24256733|24807965;Positive
N-chloromethyl-brucine;M2 receptor;f;;Human;9495826;Positive
staurosporine;M2 receptor;f;;Human;10860942;Positive
strychnine;M2 receptor;f;;Human;7651370|9224827|12815174;Positive
[3H]dimethyl-W84;M2 receptor;f;;Human;12815174;Positive
W-84;M2 receptor;f;;Human;12815174;Positive
WDuo3;M2 receptor;f;;Human;12815174;Positive
4-DAMP;M2 receptor;f;;Human;9454790;Antagonist
4-DAMP;M2 receptor;f;;Rat;1325587|9454790;Antagonist
aclidinium;M2 receptor;f;;Human;19653626;Antagonist
AE9C90CB;M2 receptor;f;;Human;20590605;Antagonist
AFDX384;M2 receptor;f;;Human;1994002;Antagonist
Alexa-488-telenzepine;M2 receptor;f;;Human;23357106;Antagonist
amitriptyline;M2 receptor;f;;Human;8100134;Antagonist
AQ-RA 741;M2 receptor;f;;Human;1994002|9671109;Antagonist
atropine;M2 receptor;f;;Human;3443095|12235229|12049493|2704370|11303071|9454790|16188951;Antagonist
atropine;M2 receptor;f;;Rat;1325587|9454790;Antagonist
benzatropine;M2 receptor;f;;Rat;7562926;Antagonist
biperiden;M2 receptor;f;;Human;1346637;Antagonist
Cy3B-telenzepine;M2 receptor;f;;Human;23357106;Antagonist
dexetimide;M2 receptor;f;;Human;9454790;Antagonist
dexetimide;M2 receptor;f;;Rat;9454790;Antagonist
dicyclomine;M2 receptor;f;;Human;2704370;Antagonist
dosulepin;M2 receptor;f;;Human;8100134;Antagonist
ethopropazine;M2 receptor;f;;Rat;2904117;Antagonist
glycopyrrolate;M2 receptor;f;;Human;21036043;Antagonist
guanylpirenzepine;M2 receptor;f;;Rat;8813552;Antagonist
hexahydrodifenidol;M2 receptor;f;;Human;2704370;Antagonist
hexahydrosiladifenidol;M2 receptor;f;;Human;8759038|2704370|9454790;Antagonist
hexahydrosiladifenidol;M2 receptor;f;;Rat;1325587|9454790;Antagonist
hexocyclium;M2 receptor;f;;Human;2704370;Antagonist
himbacine;M2 receptor;f;;Human;7925952|1331410|9454790|1994002;Antagonist
himbacine;M2 receptor;f;;Rat;9454790;Antagonist
imipramine;M2 receptor;f;;Human;9454790;Antagonist
p-F-HHSiD;M2 receptor;f;;Human;12049493|8759038;Antagonist
ipratropium;M2 receptor;f;;Human;11303071;Antagonist
levetimide;M2 receptor;f;;Human;9454790;Antagonist
levetimide;M2 receptor;f;;Rat;9454790;Antagonist
lithocholylcholine;M2 receptor;f;;Human;12235229;Antagonist
mepenzolic acid;M2 receptor;f;;Human;24844758;Antagonist
methoctramine;M2 receptor;f;;Rat;9454790;Antagonist
methoctramine;M2 receptor;f;;Human;8759038|2704370|9454790|16188951|1994002|9113359;Antagonist
ML381;M2 receptor;f;;Human;24692176;Antagonist
muscarinic toxin 3;M2 receptor;f;;Human;7925952;Antagonist
muscarinic toxin 3;M2 receptor;f;;Human;9862767;Antagonist
muscarinic toxin 7;M2 receptor;f;;Human;10799315;Antagonist
otenzepad;M2 receptor;f;;Human;2704370|9454790;Antagonist
otenzepad;M2 receptor;f;;Rat;2846274|1325587|9454790;Antagonist
oxybutynin;M2 receptor;f;;Human;12122494|20590605;Antagonist
pirenzepine;M2 receptor;f;;Rat;2846274|1325587|9454790;Antagonist
pirenzepine;M2 receptor;f;;Human;12049493|2704370|7925952|9454790|16188951|1994002|9113359|2043926;Antagonist
propantheline;M2 receptor;f;;Human;12049493;Antagonist
revefenacin;M2 receptor;f;;Human;29736245;Antagonist
SCH 57790;M2 receptor;f;;Human;10069520;Antagonist
scopolamine;M2 receptor;f;;Human;12049493;Antagonist
(S)-dimetindene;M2 receptor;f;;Human;12593665;Antagonist
silahexocyclium;M2 receptor;f;;Human;2704370;Antagonist
solifenacin;M2 receptor;f;;Human;21524581;Antagonist
solifenacin;M2 receptor;f;;Human;12122494|20590605;Antagonist
[3H]4NMPB;M2 receptor;f;;Rat;2846274;Antagonist
[3H]AF DX-384;M2 receptor;f;;Human;1941609;Antagonist
[3H]clidinium;M2 receptor;f;;Human;9454790;Antagonist
[3H]clidinium;M2 receptor;f;;Rat;9454790;Antagonist
[3H]N-methyl scopolamine;M2 receptor;f;;Human;7687290|7651370|12235229|9224827|16675658|7925952|11303071|16369696|9846649;Antagonist
[3H]N-methyl scopolamine;M2 receptor;f;;Rat;2846274;Antagonist
[3H]QNB;M2 receptor;f;;Human;3443095;Antagonist
[3H]tiotropium;M2 receptor;f;;Human;23435542;Antagonist
THRX160209;M2 receptor;f;;Human;17478612;Antagonist
tiotropium;M2 receptor;f;;Human;8441333;Antagonist
tripitramine;M2 receptor;f;;Human;7805774;Antagonist
UH-AH 37;M2 receptor;f;;Human;2043926|9671109;Antagonist
umeclidinium;M2 receptor;f;;Human;19317446|23435542;Antagonist
VU0255035;M2 receptor;f;;Human;19407080;Antagonist
darifenacin;M2 receptor;f;;Human;11303071|16188951|9113359|12122494|20590605|9671109;Inverse agonist
oxybutynin;M2 receptor;f;;Human;22243489;Inverse agonist
tolterodine;M2 receptor;f;;Human;16188951|20590605|9671109;Inverse agonist
cevimeline;M3 receptor;f;;Human;9399977;Agonist
methacholine;M3 receptor;f;;Rat;9622546;Agonist
methacholine;M3 receptor;f;;Rat;9622546;Agonist
(+)-aceclidine;M3 receptor;f;;Human;8968358;Full agonist
acetylcholine;M3 receptor;t;;Human;7651370|12235229|9224827;Full agonist
acetylcholine;M3 receptor;t;;Rat;12235229;Full agonist
arecaidine propargyl ester;M3 receptor;f;;Human;9224827;Full agonist
arecoline;M3 receptor;f;;Human;9224827;Full agonist
bethanechol;M3 receptor;f;;Human;9224827;Full agonist
carbachol;M3 receptor;f;;Rat;12235229;Full agonist
carbachol;M3 receptor;f;;Human;12235229|9224827|10323594;Full agonist
furtrethonium;M3 receptor;f;;Human;9224827;Full agonist
methylfurmethide;M3 receptor;f;;Human;9224827;Full agonist
NNC 11-1314;M3 receptor;f;;Human;11504829;Full agonist
NNC 11-1585;M3 receptor;f;;Human;11504829;Full agonist
NNC 11-1607;M3 receptor;f;;Human;11504829;Full agonist
oxotremorine;M3 receptor;f;;Human;9224827;Full agonist
oxotremorine-M;M3 receptor;f;;Human;9224827;Full agonist
pentylthio-TZTP;M3 receptor;f;;Human;9224827;Full agonist
(-)-aceclidine;M3 receptor;f;;Human;8968358;Partial agonist
McN-A-343;M3 receptor;f;;Human;7620715;Partial agonist
milameline;M3 receptor;f;;Human;10323594;Partial agonist
pilocarpine;M3 receptor;f;;Human;9224827;Partial agonist
sabcomeline;M3 receptor;f;;Human;10323594;Partial agonist
xanomeline;M3 receptor;f;;Human;9884068|10323594;Partial agonist
alcuronium;M3 receptor;f;;Human;9224827;Negative
brucine;M3 receptor;f;;Human;9224827|9495826;Negative
Gö 7874;M3 receptor;f;;Human;10860942;Negative
N-benzyl brucine;M3 receptor;f;;Human;9495826;Negative
strychnine;M3 receptor;f;;Human;7651370|9224827;Negative
WIN 51,708;M3 receptor;f;;Human;12435818;Negative
brucine N-oxide;M3 receptor;f;;Human;9495826;Neutral
thiochrome;M3 receptor;f;;Human;14722259;Neutral
vinburnine;M3 receptor;f;;Human;9224827;Neutral
vincamine;M3 receptor;f;;Human;9224827;Neutral
brucine N-oxide;M3 receptor;f;;Human;9495826;Positive
N-benzyl brucine;M3 receptor;f;;Human;9495826;Positive
N-chloromethyl-brucine;M3 receptor;f;;Human;9495826;Positive
VU0119498;M3 receptor;f;;Human;19438238;Positive
WIN 62,577;M3 receptor;f;;Human;12435818;Positive
4-DAMP;M3 receptor;f;;Rat;1325587;Antagonist
4-DAMP;M3 receptor;f;;Human;1994002;Antagonist
aclidinium;M3 receptor;f;;Human;19653626;Antagonist
AE9C90CB;M3 receptor;f;;Human;20590605;Antagonist
AFDX384;M3 receptor;f;;Human;1994002;Antagonist
amitriptyline;M3 receptor;f;;Human;8100134;Antagonist
AQ-RA 741;M3 receptor;f;;Human;1994002|9671109;Antagonist
atropine;M3 receptor;f;;Human;3443095|12049493|2704370|11303071|9029489|16847442;Antagonist
atropine;M3 receptor;f;;Rat;12235229|1325587;Antagonist
biperiden;M3 receptor;f;;Human;1346637;Antagonist
clidinium;M3 receptor;f;;Human;16847442;Antagonist
darifenacin;M3 receptor;f;;Human;11303071|9113359|12122494|20590605|9671109;Antagonist
dicyclomine;M3 receptor;f;;Human;;Antagonist
dosulepin;M3 receptor;f;;Human;8100134;Antagonist
glycopyrrolate;M3 receptor;f;;Human;21036043;Antagonist
guanylpirenzepine;M3 receptor;f;;Rat;8813552;Antagonist
hexahydrodifenidol;M3 receptor;f;;Human;2704370;Antagonist
hexahydrosiladifenidol;M3 receptor;f;;Human;8759038|2704370;Antagonist
hexocyclium;M3 receptor;f;;Human;2704370;Antagonist
himbacine;M3 receptor;f;;Human;7925952|1331410|1994002;Antagonist
p-F-HHSiD;M3 receptor;f;;Human;12049493|8759038;Antagonist
p-F-HHSiD;M3 receptor;f;;Rat;1325587;Antagonist
ipratropium;M3 receptor;f;;Human;11303071|16847442;Antagonist
lithocholylcholine;M3 receptor;f;;Human;12235229;Antagonist
lithocholylcholine;M3 receptor;f;;Rat;12235229;Antagonist
mepenzolic acid;M3 receptor;f;;Human;24844758;Antagonist
methoctramine;M3 receptor;f;;Human;8759038|2704370|9029489|1994002|9113359;Antagonist
ML381;M3 receptor;f;;Human;24692176;Antagonist
muscarinic toxin 3;M3 receptor;f;;Human;7925952;Antagonist
muscarinic toxin 7;M3 receptor;f;;Human;10799315;Antagonist
N-methyl scopolamine;M3 receptor;f;;Human;16847442;Antagonist
otenzepad;M3 receptor;f;;Rat;1325587;Antagonist
otenzepad;M3 receptor;f;;Human;2704370;Antagonist
oxybutynin;M3 receptor;f;;Human;22243489|12122494|20590605;Antagonist
pirenzepine;M3 receptor;f;;Rat;1325587;Antagonist
pirenzepine;M3 receptor;f;;Human;12049493|2704370|7925952|1994002|9113359|2043926;Antagonist
propantheline;M3 receptor;f;;Human;12049493;Antagonist
revefenacin;M3 receptor;f;;Human;29736245;Antagonist
scopolamine;M3 receptor;f;;Human;12049493;Antagonist
(S)-dimetindene;M3 receptor;f;;Human;12593665;Antagonist
silahexocyclium;M3 receptor;f;;Human;2704370;Antagonist
solifenacin;M3 receptor;f;;Human;21524581;Antagonist
solifenacin;M3 receptor;f;;Human;12122494|20590605;Antagonist
[3H]darifenacin;M3 receptor;f;;Human;9029489;Antagonist
[3H]N-methyl scopolamine;M3 receptor;f;;Rat;7687290|12235229;Antagonist
[3H]N-methyl scopolamine;M3 receptor;f;;Human;7651370|12235229|9224827|12049493|7925952|11303071|16369696|9846649;Antagonist
[3H]QNB;M3 receptor;f;;Human;3443095;Antagonist
[3H]tiotropium;M3 receptor;f;;Human;23435542;Antagonist
tiotropium;M3 receptor;f;;Human;16847442|8441333;Antagonist
tolterodine;M3 receptor;f;;Human;20590605|9671109;Antagonist
tripitramine;M3 receptor;f;;Human;18595721;Antagonist
tropicamide;M3 receptor;f;;Human;;Antagonist
UH-AH 37;M3 receptor;f;;Human;2043926|9671109;Antagonist
umeclidinium;M3 receptor;f;;Human;19317446|23435542;Antagonist
VU0255035;M3 receptor;f;;Human;19407080;Antagonist
cevimeline;M4 receptor;f;;Human;9399977;Agonist
methacholine;M4 receptor;f;;Rat;9622546;Agonist
[3H]acetylcholine;M4 receptor;f;;Human;14722259;Agonist
(+)-aceclidine;M4 receptor;f;;Human;8968358;Full agonist
acetylcholine;M4 receptor;t;;Human;7651370|12235229|9224827;Full agonist
arecaidine propargyl ester;M4 receptor;f;;Human;9224827;Full agonist
arecoline;M4 receptor;f;;Human;9224827;Full agonist
bethanechol;M4 receptor;f;;Human;9224827;Full agonist
carbachol;M4 receptor;f;;Human;9224827|10323594;Full agonist
furtrethonium;M4 receptor;f;;Human;9224827;Full agonist
methylfurmethide;M4 receptor;f;;Human;9224827;Full agonist
NNC 11-1314;M4 receptor;f;;Human;11504829;Full agonist
NNC 11-1585;M4 receptor;f;;Human;11504829;Full agonist
NNC 11-1607;M4 receptor;f;;Human;11504829;Full agonist
oxotremorine;M4 receptor;f;;Human;9224827;Full agonist
oxotremorine-M;M4 receptor;f;;Human;9224827;Full agonist
pentylthio-TZTP;M4 receptor;f;;Human;9224827;Full agonist
(-)-aceclidine;M4 receptor;f;;Human;8968358;Partial agonist
McN-A-343;M4 receptor;f;;Human;7680092;Partial agonist
milameline;M4 receptor;f;;Human;10323594;Partial agonist
pilocarpine;M4 receptor;f;;Human;9224827;Partial agonist
sabcomeline;M4 receptor;f;;Human;10323594;Partial agonist
xanomeline;M4 receptor;f;;Human;9884068|10323594;Partial agonist
alcuronium;M4 receptor;f;;Human;9224827;Negative
brucine;M4 receptor;f;;Human;9224827|9495826;Negative
N-benzyl brucine;M4 receptor;f;;Human;9495826;Negative
muscarinic toxin 3;M4 receptor;f;;Human;7925952|9862767;Negative
WIN 51,708;M4 receptor;f;;Human;12435818;Negative
WIN 62,577;M4 receptor;f;;Human;12435818;Negative
brucine N-oxide;M4 receptor;f;;Human;9495826;Neutral
Gö 7874;M4 receptor;f;;Human;10860942;Neutral
N-benzyl brucine;M4 receptor;f;;Human;9495826;Neutral
KT 5720;M4 receptor;f;;Human;10860942;Neutral
N-chloromethyl-brucine;M4 receptor;f;;Human;9495826;Neutral
staurosporine;M4 receptor;f;;Human;10860942;Neutral
brucine N-oxide;M4 receptor;f;;Human;9495826;Positive
LY2033298;M4 receptor;f;;Human;18678919;Positive
LY2119620;M4 receptor;f;;Human;24807965;Positive
strychnine;M4 receptor;f;;Human;7651370|9224827;Positive
thiochrome;M4 receptor;f;;Human;14722259;Positive
vinburnine;M4 receptor;f;;Human;9224827;Positive
vincamine;M4 receptor;f;;Human;9224827;Positive
VU0010010;M4 receptor;f;;Human;19201489;Positive
VU0152099;M4 receptor;f;;Rat;18772318;Positive
VU0152100;M4 receptor;f;;Rat;18772318;Positive
3-quinuclidinyl-benzilate;M4 receptor;f;;Human;29860464;Antagonist
4-DAMP;M4 receptor;f;;Human;1994002;Antagonist
4-DAMP;M4 receptor;f;;Rat;1325587;Antagonist
AE9C90CB;M4 receptor;f;;Human;20590605;Antagonist
AFDX384;M4 receptor;f;;Human;1994002;Antagonist
amitriptyline;M4 receptor;f;;Human;8100134;Antagonist
AQ-RA 741;M4 receptor;f;;Human;1994002|9671109;Antagonist
atropine;M4 receptor;f;;Rat;1325587;Antagonist
atropine;M4 receptor;f;;Human;29860464;Antagonist
atropine;M4 receptor;f;;Human;3443095|12049493|2704370|11303071;Antagonist
biperiden;M4 receptor;f;;Human;1346637;Antagonist
darifenacin;M4 receptor;f;;Human;11303071|9113359|20590605|9671109;Antagonist
dicyclomine;M4 receptor;f;;Human;29860464;Antagonist
dosulepin;M4 receptor;f;;Human;8100134;Antagonist
glycopyrrolate;M4 receptor;f;;Human;21036043;Antagonist
guanylpirenzepine;M4 receptor;f;;Rat;8813552;Antagonist
hexahydrodifenidol;M4 receptor;f;;Human;2704370;Antagonist
hexahydrosiladifenidol;M4 receptor;f;;Human;8759038|2704370;Antagonist
hexahydrosiladifenidol;M4 receptor;f;;Rat;1325587;Antagonist
hexocyclium;M4 receptor;f;;Human;2704370;Antagonist
himbacine;M4 receptor;f;;Human;29860464;Antagonist
himbacine;M4 receptor;f;;Human;7925952|1331410|1994002;Antagonist
p-F-HHSiD;M4 receptor;f;;Human;12049493|8759038;Antagonist
ipratropium;M4 receptor;f;;Human;11303071;Antagonist
lithocholylcholine;M4 receptor;f;;Human;12235229;Antagonist
mepenzolic acid;M4 receptor;f;;Human;29860464;Antagonist
methoctramine;M4 receptor;f;;Human;8759038|2704370|1994002|9113359;Antagonist
ML381;M4 receptor;f;;Human;24692176;Antagonist
muscarinic toxin 1;M4 receptor;f;;Human;12512959;Antagonist
muscarinic toxin 2;M4 receptor;f;;Human;12512959;Antagonist
muscarinic toxin 3;M4 receptor;f;;Human;29860464;Antagonist
muscarinic toxin 7;M4 receptor;f;;Human;10799315;Antagonist
otenzepad;M4 receptor;f;;Human;8759038;Antagonist
otenzepad;M4 receptor;f;;Rat;1325587;Antagonist
oxybutynin;M4 receptor;f;;Human;20590605;Antagonist
oxyphenonium;M4 receptor;f;;Human;29860464;Antagonist
pirenzepine;M4 receptor;f;;Human;12049493|7925952|1994002|9113359|2043926;Antagonist
pirenzepine;M4 receptor;f;;Human;29860464;Antagonist
pirenzepine;M4 receptor;f;;Rat;1325587;Antagonist
propantheline;M4 receptor;f;;Human;12049493;Antagonist
revefenacin;M4 receptor;f;;Human;29736245;Antagonist
scopolamine;M4 receptor;f;;Human;12049493;Antagonist
(S)-dimetindene;M4 receptor;f;;Human;12593665;Antagonist
silahexocyclium;M4 receptor;f;;Human;2704370;Antagonist
solifenacin;M4 receptor;f;;Human;20590605;Antagonist
[3H]AF DX-384;M4 receptor;f;;Human;1941609;Antagonist
[3H]N-methyl scopolamine;M4 receptor;f;;Human;7687290|7651370|12235229|9224827|7925952|11303071|16369696|9846649|11578621|9862767;Antagonist
[3H]QNB;M4 receptor;f;;Human;3443095|11578621;Antagonist
tolterodine;M4 receptor;f;;Human;20590605|9671109;Antagonist
tripitramine;M4 receptor;f;;Human;18595721;Antagonist
tropicamide;M4 receptor;f;;Human;29860464;Antagonist
UH-AH 37;M4 receptor;f;;Human;2043926|9671109;Antagonist
umeclidinium;M4 receptor;f;;Human;23435542;Antagonist
VU0255035;M4 receptor;f;;Human;19407080;Antagonist
(+)-aceclidine;M5 receptor;f;;Human;8968358;Full agonist
acetylcholine;M5 receptor;t;;Human;12235229;Full agonist
carbachol;M5 receptor;f;;Human;10323594;Full agonist
NNC 11-1314;M5 receptor;f;;Human;11504829;Full agonist
NNC 11-1585;M5 receptor;f;;Human;11504829;Full agonist
NNC 11-1607;M5 receptor;f;;Human;11504829;Full agonist
(-)-aceclidine;M5 receptor;f;;Human;8968358;Partial agonist
McN-A-343;M5 receptor;f;;Human;7620715;Partial agonist
milameline;M5 receptor;f;;Human;10323594;Partial agonist
pilocarpine;M5 receptor;f;;Human;16002459;Partial agonist
sabcomeline;M5 receptor;f;;Human;10323594;Partial agonist
xanomeline;M5 receptor;f;;Human;9884068|10323594|16002459;Partial agonist
brucine;M5 receptor;f;;Human;9495826;Negative
brucine N-oxide;M5 receptor;f;;Human;9495826;Negative
N-benzyl brucine;M5 receptor;f;;Human;9495826;Negative
ML375;M5 receptor;f;;Human;24164599;Negative
N-chloromethyl-brucine;M5 receptor;f;;Human;9495826;Negative
strychnine;M5 receptor;f;;Human;7651370;Negative
N-benzyl brucine;M5 receptor;f;;Human;9495826;Neutral
brucine N-oxide;M5 receptor;f;;Human;9495826;Positive
ML380;M5 receptor;f;;Human;25147929|27461343;Positive
VU0119498;M5 receptor;f;;Human;19438238;Positive
VU0238429;M5 receptor;f;;Human;19438238;Positive
4-DAMP;M5 receptor;f;;Rat;1325587;Antagonist
4-DAMP;M5 receptor;f;;Human;1994002;Antagonist
AE9C90CB;M5 receptor;f;;Human;20590605;Antagonist
AFDX384;M5 receptor;f;;Human;1994002;Antagonist
amitriptyline;M5 receptor;f;;Human;8100134;Antagonist
AQ-RA 741;M5 receptor;f;;Human;1994002|9671109;Antagonist
atropine;M5 receptor;f;;Rat;1325587;Antagonist
atropine;M5 receptor;f;;Human;2704370|11303071;Antagonist
biperiden;M5 receptor;f;;Human;1346637;Antagonist
darifenacin;M5 receptor;f;;Human;11303071|9113359|20590605|9671109;Antagonist
dosulepin;M5 receptor;f;;Human;8100134;Antagonist
glycopyrrolate;M5 receptor;f;;Human;21036043;Antagonist
guanylpirenzepine;M5 receptor;f;;Unknown;7808421;Antagonist
hexahydrodifenidol;M5 receptor;f;;Human;2704370;Antagonist
hexahydrosiladifenidol;M5 receptor;f;;Rat;1325587;Antagonist
hexahydrosiladifenidol;M5 receptor;f;;Human;8759038|2704370;Antagonist
hexocyclium;M5 receptor;f;;Human;2704370;Antagonist
himbacine;M5 receptor;f;;Human;7925952|1331410|1994002;Antagonist
p-F-HHSiD;M5 receptor;f;;Human;8759038;Antagonist
ipratropium;M5 receptor;f;;Human;11303071;Antagonist
lithocholylcholine;M5 receptor;f;;Human;12235229;Antagonist
methoctramine;M5 receptor;f;;Human;8759038|2704370|1994002|9113359;Antagonist
ML381;M5 receptor;f;;Human;24692176;Antagonist
muscarinic toxin 3;M5 receptor;f;;Human;7925952;Antagonist
muscarinic toxin 7;M5 receptor;f;;Human;10799315;Antagonist
otenzepad;M5 receptor;f;;Human;2704370;Antagonist
otenzepad;M5 receptor;f;;Rat;1325587;Antagonist
oxybutynin;M5 receptor;f;;Human;20590605;Antagonist
pirenzepine;M5 receptor;f;;Rat;1325587;Antagonist
pirenzepine;M5 receptor;f;;Human;7925952|9113359|2043926;Antagonist
revefenacin;M5 receptor;f;;Human;29736245;Antagonist
(S)-dimetindene;M5 receptor;f;;Human;12593665;Antagonist
silahexocyclium;M5 receptor;f;;Human;2704370;Antagonist
solifenacin;M5 receptor;f;;Human;20590605;Antagonist
[3H]N-methyl scopolamine;M5 receptor;f;;Human;7687290|12235229|7925952|11303071|16369696|9846649;Antagonist
[3H]QNB;M5 receptor;f;;Human;;Antagonist
tolterodine;M5 receptor;f;;Human;20590605|9671109;Antagonist
tripitramine;M5 receptor;f;;Human;7805774;Antagonist
UH-AH 37;M5 receptor;f;;Human;2043926|9671109;Antagonist
umeclidinium;M5 receptor;f;;Human;23435542;Antagonist
VU0255035;M5 receptor;f;;Human;19407080;Antagonist
TAM16;MTB polyketide synthase Pks13;f;;Mycobacterium tuberculosis;28669536;Inhibition
UCSF4226;MT1 receptor;f;;Human;32040955;Agonist
2-iodo-melatonin;MT1 receptor;f;;Human;12764576|2991499;Full agonist
2-methoxy-α,β-didehydro-agomelatine;MT1 receptor;f;;Human;23265885;Full agonist
2-[125I]melatonin;MT1 receptor;f;;Human;12764576|9089668;Full agonist
5-HEAT;MT1 receptor;f;;Human;11068946;Full agonist
6-Cl-MLT;MT1 receptor;f;;Human;12764576|9089668|9618428|2991499;Full agonist
6-hydroxymelatonin;MT1 receptor;f;;Human;10696085|9089668|9618428|2991499;Full agonist
agomelatine;MT1 receptor;f;;Human;12764576|9618428;Full agonist
difluoroagomelatine;MT1 receptor;f;;Human;22301214;Full agonist
EFPPEA;MT1 receptor;f;;Human;21568291;Full agonist
GR 196429;MT1 receptor;f;;Human;10696085|9618428;Full agonist
IIK7;MT1 receptor;f;;Human;10737738;Full agonist
LY 156735;MT1 receptor;f;;Human;15302228;Full agonist
melatonin;MT1 receptor;t;;Human;12764576|9089668|2991499;Full agonist
ramelteon;MT1 receptor;f;;Human;15695169;Full agonist
S24773;MT1 receptor;f;;Human;12764576;Full agonist
[125I]SD6;MT1 receptor;f;;Human;23698757;Full agonist
[125I]SD6;MT1 receptor;f;;Human;23698757|26759496;Full agonist
[3H]melatonin;MT1 receptor;f;;Human;10696085;Full agonist
tasimelteon;MT1 receptor;f;;Human;19054552;Full agonist
UCM 793;MT1 receptor;f;;Human;18052314;Full agonist
UCSF3384;MT1 receptor;f;;Human;32040955;Inverse agonist
UCSF7447;MT1 receptor;f;;Human;32040955;Inverse agonist
AAE-M-PBP-amine;MT1 receptor;f;;Human;22927210;Partial agonist
CBOBNEA;MT1 receptor;f;;Human;20444610;Partial agonist
GR 128107;MT1 receptor;f;;Human;9089668|10205014;Partial agonist
ICOA-13;MT1 receptor;f;;Human;28493341;Partial agonist
S24014;MT1 receptor;f;;Human;12764576;Partial agonist
S26284;MT1 receptor;f;;Human;12764576;Partial agonist
4P-PDOT;MT1 receptor;f;;Human;12764576|9089668|9737724;Antagonist
AZD7325;MT1 receptor;f;;Human;;Antagonist
K185;MT1 receptor;f;;Human;10737738;Antagonist
luzindole;MT1 receptor;f;;Human;10696085|12764576|9089668|2843633;Antagonist
S20928;MT1 receptor;f;;Human;12764576;Antagonist
S22153;MT1 receptor;f;;Human;12764576;Antagonist
S26131;MT1 receptor;f;;Human;12764576;Antagonist
UCM 549;MT1 receptor;f;;Human;15293992|17907131;Antagonist
UCM 724;MT1 receptor;f;;Human;17907131;Antagonist
UCSF4226;MT2 receptor;f;;Human;32040955;Agonist
2-iodo-melatonin;MT2 receptor;f;;Human;12764576|9089668|9618428|2991499;Full agonist
2-[125I]melatonin;MT2 receptor;f;;Human;12764576|9089668;Full agonist
6-Cl-MLT;MT2 receptor;f;;Human;12764576|9089668|9618428|2991499;Full agonist
6-hydroxymelatonin;MT2 receptor;f;;Human;10696085|9089668|2991499;Full agonist
agomelatine;MT2 receptor;f;;Human;12764576|9618428;Full agonist
BOMPPA;MT2 receptor;f;;Human;23228808;Full agonist
CIFEA;MT2 receptor;f;;Human;21473625;Full agonist
EFPPEA;MT2 receptor;f;;Human;21568291;Full agonist
GR 196429;MT2 receptor;f;;Human;10696085|9618428;Full agonist
ICOA-13;MT2 receptor;f;;Human;28493341;Full agonist
IIK7;MT2 receptor;f;;Mouse;24106342;Full agonist
IIK7;MT2 receptor;f;;Human;10737738|10420436;Full agonist
LY 156735;MT2 receptor;f;;Human;15302228;Full agonist
melatonin;MT2 receptor;t;;Human;12764576|9089668|2991499;Full agonist
ramelteon;MT2 receptor;f;;Human;15695169|21182402;Full agonist
[125I]SD6;MT2 receptor;f;;Human;23698757;Full agonist
[125I]SD6;MT2 receptor;f;;Human;23698757|26759496;Full agonist
[3H]melatonin;MT2 receptor;f;;Human;10696085;Full agonist
tasimelteon;MT2 receptor;f;;Human;19054552;Full agonist
UCM1014;MT2 receptor;f;;Human;26334942;Full agonist
UCM 765;MT2 receptor;f;;Human;18052314;Full agonist
UCM 793;MT2 receptor;f;;Human;18052314;Full agonist
UCSF3384;MT2 receptor;f;;Human;32040955;Inverse agonist
UCSF7447;MT2 receptor;f;;Human;32040955;Inverse agonist
5-methoxy-luzindole;MT2 receptor;f;;Human;9089668;Partial agonist
GR 128107;MT2 receptor;f;;Human;9089668|10205014;Partial agonist
isoamyl-agomelatine;MT2 receptor;f;;Human;22301214;Partial agonist
S22153;MT2 receptor;f;;Human;12764576;Partial agonist
S24014;MT2 receptor;f;;Human;12764576;Partial agonist
S24773;MT2 receptor;f;;Human;12764576;Partial agonist
S26284;MT2 receptor;f;;Human;12764576;Partial agonist
[125I]DIV880;MT2 receptor;f;;Human;23698757;Partial agonist
[125I]DIV880;MT2 receptor;f;;Human;23698757|26759496;Partial agonist
[125I]S70254;MT2 receptor;f;;Human;23698757;Partial agonist
[125I]S70254;MT2 receptor;f;;Human;23698757|26759496;Partial agonist
2-(indolin-1yl)-melatonin;MT2 receptor;f;;Human;19193160;Antagonist
4P-PDOT;MT2 receptor;f;;Human;12764576|9089668|9737724;Antagonist
5-HEAT;MT2 receptor;f;;Human;11068946;Antagonist
DH97;MT2 receptor;f;;Human;9840420;Antagonist
(hydroxymethylphenyl)agomelatine;MT2 receptor;f;;Human;18778943;Antagonist
K185;MT2 receptor;f;;Human;10737738|10420436;Antagonist
luzindole;MT2 receptor;f;;Human;10696085|12764576|9089668|9737724|2843633;Antagonist
S20928;MT2 receptor;f;;Human;12764576;Antagonist
S26131;MT2 receptor;f;;Human;12764576;Antagonist
UCM 454;MT2 receptor;f;;Human;15943478;Antagonist
UCM 549;MT2 receptor;f;;Human;15293992|17907131;Antagonist
UCM 724;MT2 receptor;f;;Human;15293992;Antagonist
cimetidine;Multidrug and toxin extrusion;f;;Human;19164462;Inhibition
pyrimethamine;Multidrug and toxin extrusion;f;;Human;20065018;Inhibition
[14C]metformin;Multidrug and toxin extrusion;f;;Human;17509534|16850272;None
[14C]TEA;Multidrug and toxin extrusion;f;;Human;16330770|16850272;None
2F-MT-45;μ receptor;f;;Human;32246840;Agonist
3F-MT-45;μ receptor;f;;Human;32246840;Agonist
4F-MT-45;μ receptor;f;;Human;32246840;Agonist
ADL5747;μ receptor;f;;Human;19694468;Agonist
ADL5859;μ receptor;f;;Human;18788723;Agonist
AR-M1000390;μ receptor;f;;Human;;Agonist
bilorphin;μ receptor;f;;Human;31611414;Agonist
BU72;μ receptor;f;;Guinea pig;;Agonist
BW373U86;μ receptor;f;;Rat;8246159;Agonist
BW373U86;μ receptor;f;;Human;18788723;Agonist
carfentanil;μ receptor;f;;Guinea pig;1310142;Agonist
cebranopadol;μ receptor;f;;Human;24713140;Agonist
cebranopadol;μ receptor;f;;Rat;24713140;Agonist
compound 3 [PMID: 23134120];μ receptor;f;;Human;23134120;Agonist
eluxadoline;μ receptor;f;;Rat;22695132;Agonist
eluxadoline;μ receptor;f;;Human;22695132;Agonist
HS665;μ receptor;f;;Human;23134120;Agonist
hydrocodone;μ receptor;f;;Human;22439881;Agonist
hydromorphone;μ receptor;f;;Human;19282177;Agonist
levorphanol;μ receptor;f;;Human;12502358;Agonist
loperamide;μ receptor;f;;Human;15454210;Agonist
methadone;μ receptor;f;;Human;11585443;Agonist
MT-45;μ receptor;f;;Human;32246840;Agonist
nalbuphine;μ receptor;f;;Human;19282177;Agonist
oxycodegol;μ receptor;f;;Human;28778859;Agonist
pethidine;μ receptor;f;;Human;11585443;Agonist
SCH221510;μ receptor;f;;Human;18492950;Agonist
SR16835;μ receptor;f;;Human;19773529;Agonist
[3H]PL017;μ receptor;f;;Rat;3030778;Agonist
tapentadol;μ receptor;f;;Human;17656655;Agonist
tramadol;μ receptor;f;;Human;19282177;Agonist
U-47700;μ receptor;f;;Rat;2999404;Agonist
UFP-505;μ receptor;f;;Human;22194444|29524334;Agonist
UFP-512;μ receptor;f;;Human;18069089;Agonist
PZM21;μ receptor;f;;Human;27533032;Biased agonist
PZM21;μ receptor;f;;Human;27533032;Biased agonist
β-endorphin;μ receptor;f;Human;Rat;8114680;Full agonist
codeine;μ receptor;f;;Human;9686407;Full agonist
DADLE;μ receptor;f;;Human;9686407;Full agonist
DAMGO;μ receptor;f;;Rat;8114680;Full agonist
DAMGO;μ receptor;f;;Human;9686407|6263640;Full agonist
dihydromorphine;μ receptor;f;;Human;9686407;Full agonist
DSLET;μ receptor;f;;Human;9686407;Full agonist
dynorphin-(1-11);μ receptor;f;;Human;9686407;Full agonist
dynorphin A;μ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
dynorphin A-(1-13);μ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
dynorphin A-(1-8);μ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
dynorphin B;μ receptor;t;Human|Mouse|Rat;Human;9686407;Full agonist
endomorphin-1;μ receptor;t;Human;Human;9849897|9087409;Full agonist
endomorphin-2;μ receptor;t;Human;Rat;9087409;Full agonist
ethylketocyclazocine;μ receptor;f;;Human;9686407;Full agonist
etonitazene;μ receptor;f;;Human;9686407;Full agonist
etorphine;μ receptor;f;;Human;9686407;Full agonist
fentanyl;μ receptor;f;;Human;9686407;Full agonist
fentanyl;μ receptor;f;;Rat;8114680;Full agonist
[Met]enkephalin;μ receptor;t;Human|Mouse|Rat;Rat;8114680;Full agonist
(-)-methadone;μ receptor;f;;Human;9686407;Full agonist
morphine;μ receptor;f;;Human;9686407|2549383;Full agonist
normorphine;μ receptor;f;;Human;9686407;Full agonist
PL017;μ receptor;f;;Human;9686407|6313901;Full agonist
sufentanil;μ receptor;f;;Rat;2843777;Full agonist
sufentanil;μ receptor;f;;Human;21215785;Full agonist
[3H]DAMGO;μ receptor;f;;Rat;8114680;Full agonist
BU08028;μ receptor;f;;Human;21177476;Partial agonist
buprenorphine;μ receptor;f;;Human;9686407;Partial agonist
butorphanol;μ receptor;f;;Human;18674902;Partial agonist
(-)-cyclazocine;μ receptor;f;;Human;9686407;Partial agonist
[Leu]enkephalin;μ receptor;t;Human|Mouse|Rat;Human;9686407;Partial agonist
morphine;μ receptor;f;;Rat;8114680;Partial agonist
(-)-pentazocine;μ receptor;f;;Human;9686407;Partial agonist
BMS-986123;μ receptor;f;;Human;23754417;Neutral
BMS-986124;μ receptor;f;;Human;23754417;Neutral
BMS-986121;μ receptor;f;;Human;23754417;Positive
BMS-986121;μ receptor;f;;Human;23754417;Positive
BMS-986122;μ receptor;f;;Human;23754417;Positive
BMS-986122;μ receptor;f;;Human;23754417;Positive
BMS-986187;μ receptor;f;;Rat;29233847;Positive
alvimopan;μ receptor;f;;Human;18313920;Antagonist
AT-076;μ receptor;f;;Human;9686407|25635572;Antagonist
β-FNA;μ receptor;f;;Mouse;8114680;Antagonist
β-FNA;μ receptor;f;;Human;9686407;Antagonist
BNTX;μ receptor;f;;Human;9686407;Antagonist
(-)-bremazocine;μ receptor;f;;Human;9686407;Antagonist
BTRX-335140;μ receptor;f;;Human;30707578;Antagonist
CTAP;μ receptor;f;;Human;9686407|6313901;Antagonist
CTOP;μ receptor;f;;Human;8114680;Antagonist
diprenorphine;μ receptor;f;;Human;9686407;Antagonist
diprenorphine;μ receptor;f;;Mouse;8114680;Antagonist
GSK1521498;μ receptor;f;;Human;24973897;Antagonist
levallorphan;μ receptor;f;;Human;21621410;Antagonist
LY2456302;μ receptor;f;;Human;24071566;Antagonist
methylnaltrexone;μ receptor;f;;Human;19282177;Antagonist
naldemedine;μ receptor;f;;Human;30446313;Antagonist
nalmefene;μ receptor;f;;Human;9686407;Antagonist
nalorphine;μ receptor;f;;Human;9686407;Antagonist
naloxonazine;μ receptor;f;;Mouse;8114680;Antagonist
naloxone;μ receptor;f;;Human;9686407;Antagonist
naloxone;μ receptor;f;;Mouse;8114680;Antagonist
naloxone benzoylhydrazone;μ receptor;f;;Human;9686407;Antagonist
naloxone benzoylhydrazone;μ receptor;f;;Human;9686407;Antagonist
naltrexone;μ receptor;f;;Human;9686407|24973897;Antagonist
naltriben;μ receptor;f;;Human;9686407;Antagonist
naltrindole;μ receptor;f;;Human;9686407;Antagonist
NFP;μ receptor;f;;Human;30608693;Antagonist
nor-binaltorphimine;μ receptor;f;;Human;9686407;Antagonist
quadazocine;μ receptor;f;;Human;9686407;Antagonist
samidorphan;μ receptor;f;;Human;15808478;Antagonist
[3H]diprenorphine;μ receptor;f;;Mouse;8114680;Antagonist
[3H]naloxone;μ receptor;f;;Rat;8913353;Antagonist
zyklophin;μ receptor;f;;Human;15999987;Antagonist
compound 16 [PMID: 31498617];μ receptor;f;;Human;31498617;Binding
compound 1d [PMID: 21493067];muscle associated receptor tyrosine kinase;f;;Human;21493067;Inhibition
compound 25 [PMID: 17935989];muscle associated receptor tyrosine kinase;f;;Human;17935989;Inhibition
aminopyridine 2;myeloperoxidase;f;;Human;30076263;Inhibition
AZD5904;myeloperoxidase;f;;Human;21880720;Inhibition
compound 28 [PMID: 28671460];myeloperoxidase;f;;Human;28671460;Inhibition
PF-06282999;myeloperoxidase;f;;Human;26509551;Inhibition
verdiperstat;myeloperoxidase;f;;Human;;Inhibition
calmodulin;myosin light chain kinase;t;Human;Human;156362;Activation
MLCK inhibitor peptide 18;myosin light chain kinase;f;;Chicken;10072688;Inhibition
RKI-1447;myosin light chain kinase;f;;Human;23275831;Inhibition
calmodulin;myosin light chain kinase 2;t;Human;Human;156362;Activation
GSK2606414;myosin light chain kinase 2;f;;Human;22827572;Inhibition
compound 5 [Stecula et al., 2020];N-acetyltransferase 8 like;f;;Human;;Inhibition
chlorothiazide;Na-Cl symporter;f;;Human;;Inhibition
cyclothiazide;Na-Cl symporter;f;;Human;;Inhibition
hydrochlorothiazide;Na-Cl symporter;f;;Human;;Inhibition
metolazone;Na-Cl symporter;f;;Human;;Inhibition
compound 7c [PMID: 22041175];NADPH oxidase 1;f;;Human;22041175;Inhibition
GKT136901;NADPH oxidase 1;f;;Human;20942471;Inhibition
NSC 780521;NADPH oxidase 1;f;;Human;28709950;Inhibition
setanaxib;NADPH oxidase 1;f;;Human;22806357;Inhibition
compound 7c [PMID: 22041175];NADPH oxidase 4;f;;Human;22041175;Inhibition
compound 87 [PMID: 20942471];NADPH oxidase 4;f;;Human;20942471;Inhibition
GKT136901;NADPH oxidase 4;f;;Human;20942471;Inhibition
setanaxib;NADPH oxidase 4;f;;Human;22806357;Inhibition
compound 7c [PMID: 22041175];NADPH oxidase 5;f;;Human;22041175;Inhibition
NSC 780521;NADPH oxidase 5;f;;Human;28709950;Inhibition
setanaxib;NADPH oxidase 5;f;;Human;22806357;Inhibition
Cd2+;Navi2.1;f;;Human;;None
Co2+;Navi2.1;f;;Human;;None
Gd3+;Navi2.1;f;;Human;;None
verapamil;Navi2.1;f;;Human;;None
batrachotoxin;Nav1.1;f;;Human;;Activation
veratridine;Nav1.1;f;;Human;;Activation
GNE-616;Nav1.1;f;;Human;30943032;Inhibition
Hm1a;Nav1.1;f;;Rat;27281198;None
μ-conotoxin SmIIIA;Nav1.1;f;;Rat;21652775;Pore blocker
saxitoxin;Nav1.1;f;;Human;;Pore blocker
tetrodotoxin;Nav1.1;f;;Rat;9437003;Pore blocker
tetrodotoxin;Nav1.1;f;;Human;;Pore blocker
AFT-II;Nav1.1;f;;Human;15169781;Slows inactivation
ATX-II;Nav1.1;f;;Human;15169781;Slows inactivation
Bc-III;Nav1.1;f;;Human;15169781;Slows inactivation
cangitoxin II;Nav1.1;f;;Human;21802465;Slows inactivation
GNE-131;Nav1.1;f;;Human;29737846;Inhibition
batrachotoxin;Nav1.2;f;;Rat;9811906;Agonist
aconitine;Nav1.2;f;;Rat;6114956;Partial agonist
β-scorpion toxin Css IV;Nav1.2;f;;Rat;9808476;Partial agonist
veratridine;Nav1.2;f;;Rat;6114956;Partial agonist
lacosamide;Nav1.2;f;;Rat;24065921;Antagonist
GNE-616;Nav1.2;f;;Human;30943032;Inhibition
etidocaine;Nav1.2;f;;Rat;8085162;Pore blocker
lamotrigine;Nav1.2;f;;Rat;12604088|7491269;Pore blocker
lidocaine;Nav1.2;f;;Rat;8799190;Pore blocker
μ-conotoxin SmIIIA;Nav1.2;f;;Rat;21652775;Pore blocker
phenytoin;Nav1.2;f;;Rat;8799190;Pore blocker
phenytoin;Nav1.2;f;;Human;1658608;Pore blocker
saxitoxin;Nav1.2;f;;Rat;15815630;Pore blocker
tetrodotoxin;Nav1.2;f;;Rat;15815630;Pore blocker
AFT-II;Nav1.2;f;;Human;15169781;Slows inactivation
α-scorpion toxin 2;Nav1.2;f;;Rat;8663157;Slows inactivation
α-scorpion toxin 2;Nav1.2;f;;Rat;14978247;Slows inactivation
ATX-II;Nav1.2;f;;Human;15169781;Slows inactivation
Bc-III;Nav1.2;f;;Human;15169781;Slows inactivation
δ-hexatoxin-Mg1a;Nav1.2;f;;Rat;19592486;Slows inactivation
huwentoxin IV;Nav1.2;f;;Human;23760503;Voltage-dependent inhibition
protoxin II;Nav1.2;f;;Human;18728100;Voltage-dependent inhibition
GNE-131;Nav1.2;f;;Human;29737846;Inhibition
batrachotoxin;Nav1.3;f;;Human;;None
veratridine;Nav1.3;f;;Human;;None
lacosamide;Nav1.3;f;;Rat;18378801;Antagonist
GNE-616;Nav1.3;f;;Human;30943032;Inhibition
saxitoxin;Nav1.3;f;;Human;;Pore blocker
tetrodotoxin;Nav1.3;f;;Human;11122339;Pore blocker
PF‐06526290;Nav1.3;f;;Human;29791744;Inhibition
AFT-II;Nav1.3;f;;Human;15169781;Slows inactivation
ATX-II;Nav1.3;f;;Human;15169781;Slows inactivation
Bc-III;Nav1.3;f;;Human;15169781;Slows inactivation
β-scorpion toxin TiTXγ;Nav1.4;f;;Rat;9048656;Agonist
grayanotoxin III;Nav1.4;f;;Rat;11562450;Agonist
batrachotoxin;Nav1.4;f;;Rat;9482942;Full agonist
veratridine;Nav1.4;f;;Rat;9482942;Partial agonist
mexiletine;Nav1.4;f;;Human;14608007;Antagonist
μ-conotoxin GIIIA;Nav1.4;f;;Rat;10627583|1325372;Antagonist
μ-conotoxin PIIIA;Nav1.4;f;;Rat;10627583;Antagonist
GNE-616;Nav1.4;f;;Human;30943032;Inhibition
lidocaine;Nav1.4;f;;Rat;10533585;Pore blocker
μ-conotoxin GIIIA;Nav1.4;f;;Human;8058462;Pore blocker
saxitoxin;Nav1.4;f;;Rat;11159437;Pore blocker
tetrodotoxin;Nav1.4;f;;Rat;2559760;Pore blocker
tetrodotoxin;Nav1.4;f;;Human;8058462;Pore blocker
AFT-II;Nav1.4;f;;Human;15169781;Slows inactivation
ATX-II;Nav1.4;f;;Human;15169781|8660409;Slows inactivation
Bc-III;Nav1.4;f;;Human;15169781;Slows inactivation
AM-6120;Nav1.4;f;;Human;30346167;Inhibition
batrachotoxin;Nav1.5;f;;Rat;2431264;Full agonist
aconitine;Nav1.5;f;;Human;11826163|2433183;Partial agonist
veratridine;Nav1.5;f;;Rat;2154667;Partial agonist
GNE-616;Nav1.5;f;;Human;30943032;Inhibition
amiodarone;Nav1.5;f;;Rat;2546697;Pore blocker
bupivacaine;Nav1.5;f;;Human;25692452;Pore blocker
bupivacaine;Nav1.5;f;;Human;25692452;Pore blocker
lidocaine;Nav1.5;f;;Rat;2546048;Pore blocker
lidocaine;Nav1.5;f;;Human;8786356;Pore blocker
μ-conotoxin SmIIIA;Nav1.5;f;;Rat;21652775;Pore blocker
quinidine;Nav1.5;f;;Rat;2546048|8301556;Pore blocker
ropivacaine;Nav1.5;f;;Human;25692452;Pore blocker
ropivacaine;Nav1.5;f;;Human;25692452;Pore blocker
saxitoxin;Nav1.5;f;;Rat;8967455|2175715;Pore blocker
tetrodotoxin;Nav1.5;f;;Rat;8967455|2175715;Pore blocker
AFT-II;Nav1.5;f;;Human;15169781;Slows inactivation
α-scorpion toxin 2;Nav1.5;f;;Rat;8663157;Slows inactivation
ATX-II;Nav1.5;f;;Human;15169781;Slows inactivation
Bc-III;Nav1.5;f;;Human;15169781;Slows inactivation
jingzhaotoxin-III;Nav1.5;f;;Human;21665957;Voltage-dependent inhibition
protoxin II;Nav1.5;f;;Human;12475222;Voltage-dependent inhibition
AM-6120;Nav1.5;f;;Human;30346167;Inhibition
eleclazine;Nav1.5;f;;Human;;Inhibition
GNE-131;Nav1.5;f;;Human;29737846;Inhibition
GS-458967;Nav1.5;f;;Human;27080178|29582428;Inhibition
batrachotoxin;Nav1.6;f;;Human;;None
β-scorpion toxin Cn2;Nav1.6;f;;Human;16702217;None
veratridine;Nav1.6;f;;Human;;None
4,9-anhydro-tetrodotoxin;Nav1.6;f;;Mouse;17522141;Inhibition
GNE-616;Nav1.6;f;;Human;30943032;Inhibition
saxitoxin;Nav1.6;f;;Human;;Pore blocker
tetrodotoxin;Nav1.6;f;;Mouse;9698304;Pore blocker
tetrodotoxin;Nav1.6;f;;Rat;9603190;Pore blocker
AFT-II;Nav1.6;f;;Human;15169781;Slows inactivation
ATX-II;Nav1.6;f;;Human;15169781;Slows inactivation
Bc-III;Nav1.6;f;;Human;15169781;Slows inactivation
AM-6120;Nav1.6;f;;Human;30346167;Inhibition
GNE-131;Nav1.6;f;;Human;29737846;Inhibition
batrachotoxin;Nav1.7;f;;Human;;None
veratridine;Nav1.7;f;;Human;;None
lacosamide;Nav1.7;f;;Human;18378801;Antagonist
GNE-616;Nav1.7;f;;Human;30943032;Inhibition
GNE-616;Nav1.7;f;;Human;30943032;Inhibition
GNE-616;Nav1.7;f;;Rat;30943032;Inhibition
PF-05089771;Nav1.7;f;;None;32193331;Inhibition
pyrrolopyrimidine 48 [PMID: 22318156];Nav1.7;f;;Human;22318156;Inhibition
XEN907;Nav1.7;f;;Human;21570288;Inhibition
Cd2+;Nav1.7;f;;Human;7720699;Pore blocker
lidocaine;Nav1.7;f;;Rat;15148257;Pore blocker
saxitoxin;Nav1.7;f;;Human;23077250;Pore blocker
tetrodotoxin;Nav1.7;f;;Rat;9169448;Pore blocker
tetrodotoxin;Nav1.7;f;;Human;7720699;Pore blocker
N-Me-aminopyrimidinone 9;Nav1.7;f;;Human;22209205;Inhibition
PF‐06526290;Nav1.7;f;;Human;29791744;Inhibition
GNE-131;Nav1.7;f;;Human;29737846;Binding
AM-6120;Nav1.7;f;;Human;30346167;Inhibition
AM-6120;Nav1.7;f;;Mouse;30346167;Inhibition
DS-1971a;Nav1.7;f;;Human;32392056;Inhibition
DS-1971a;Nav1.7;f;;Mouse;32392056;Inhibition
GNE-131;Nav1.7;f;;Human;29737846;Inhibition
batrachotoxin;Nav1.8;f;;Human;15527793;None
veratridine;Nav1.8;f;;Rat;17962978;None
lacosamide;Nav1.8;f;;Rat;18378801;Antagonist
A-803467;Nav1.8;f;;Rat;17483457;None
lidocaine;Nav1.8;f;;Rat;1514825;Pore blocker
PF-01247324;Nav1.8;f;;Human;25625641;Pore blocker
tetrodotoxin;Nav1.8;f;;Rat;8538791;Pore blocker
AM-6120;Nav1.8;f;;Human;30346167;Inhibition
tetrodotoxin;Nav1.9;f;;Rat;10594087;Pore blocker
BI01383298;Na+/citrate cotransporter;f;;Human;;Inhibition
cANF4-23;natriuretic peptide receptor 3;f;;Human;2823385;Agonist
PL-3994;natriuretic peptide receptor 3;f;;Human;23154072;Agonist
M372049;natriuretic peptide receptor 3;f;;Human;15337698;Antagonist
osteocrin;natriuretic peptide receptor 3;t;Human;Human;17951249;Antagonist
AP811;natriuretic peptide receptor 3;f;;Human;10987424;Binding
[125I]ANP (human);natriuretic peptide receptor 3;f;;Human;;None
Large proline-rich protein BAG6;Natural cytotoxicity triggering receptor 3 (CD337);f;;Human;;Activation
Natural cytotoxicity triggering receptor 3 ligand 1;Natural cytotoxicity triggering receptor 3 (CD337);f;Human;Human;;Activation
enfortumab vedotin;nectin cell adhesion molecule 4;f;;Human;31526130;Binding
compound 25 [PMID: 17935989];nemo like kinase;f;;Human;17935989;Inhibition
BDNF;nerve growth factor receptor;t;Human;Human;;None
neurotrophin-3;nerve growth factor receptor;t;Human;Human;;None
neurotrophin-4;nerve growth factor receptor;t;Human;Human;;None
NGF;nerve growth factor receptor;t;Human;Human;22227462;None
amitriptyline;NET;f;;Human;23602445;Inhibition
amoxapine;NET;f;;Human;;Inhibition
atomoxetine;NET;f;;Human;9871604;Inhibition
bupropion;NET;f;;Human;19442525;Inhibition
citalopram;NET;f;;Human;23168018;Inhibition
clomipramine;NET;f;;Human;9537821;Inhibition
desipramine;NET;f;;Human;20462211;Inhibition
desvenlafaxine;NET;f;;Human;24900709;Inhibition
dexamfetamine;NET;f;;Human;23602445;Inhibition
dexmethylphenidate;NET;f;;Rat;17489581;Inhibition
dosulepin;NET;f;;Human;9537821;Inhibition
doxepin;NET;f;;Human;;Inhibition
duloxetine;NET;f;;Human;23084899;Inhibition
H05;NET;f;;Rat;29615471;Inhibition
imipramine;NET;f;;Human;;Inhibition
N-desalkylquetiapine;NET;f;;Human;18059438;Inhibition
levomilnacipran;NET;f;;Human;18468895;Inhibition
lofepramine;NET;f;;Human;9537821;Inhibition
maprotiline;NET;f;;Human;19836247;Inhibition
mazindol;NET;f;;Human;;Inhibition
methylphenidate;NET;f;;Human;;Inhibition
mianserin;NET;f;;Rat;6747993;Inhibition
milnacipran;NET;f;;Human;23347683;Inhibition
nefazodone;NET;f;;Human;9871604;Inhibition
nisoxetine;NET;f;;Human;;Inhibition
nomifensine;NET;f;;Human;;Inhibition
nortriptyline;NET;f;;Human;10715164;Inhibition
norzotepine;NET;f;;Human;20223878;Inhibition
phenelzine;NET;f;;Human;9537821;Inhibition
protriptyline;NET;f;;Human;9537821;Inhibition
protriptyline;NET;f;;Human;18983139;Inhibition
protriptyline;NET;f;;Human;22420844;Inhibition
quetiapine;NET;f;;Human;18059438;Inhibition
reboxetine;NET;f;;Human;10812041;Inhibition
sibutramine;NET;f;;Human;;Inhibition
solriamfetol;NET;f;;Human;29891587;Inhibition
solriamfetol;NET;f;;Human;29891587;Inhibition
[3H]mazindol;NET;f;;Rat;15300361;Inhibition
[3H]nisoxetine;NET;f;;Human;;Inhibition
tapentadol;NET;f;;Human;17656655;Inhibition
trimipramine;NET;f;;Human;9537821;Inhibition
venlafaxine;NET;f;;Human;20378347;Inhibition
ziprasidone;NET;f;;Rat;18595716;Inhibition
zotepine;NET;f;;Human;20223878;Inhibition
3-bromo-7NI;Neuronal NOS;f;;Human;7544863;Inhibition
7NI;Neuronal NOS;f;;Human;7693279;Inhibition
compound 14j [PMID: 27050842];Neuronal NOS;f;;Rat;27050842;Inhibition
compound 14j [PMID: 27050842];Neuronal NOS;f;;Human;27050842;Inhibition
GW274150;Neuronal NOS;f;;Human;15163211;Inhibition
L-NNA;Neuronal NOS;f;;Human;9667974;Inhibition
NANT;Neuronal NOS;f;;None;;Inhibition
Nωpropyl-L-arginine;Neuronal NOS;f;;Rat;9397167;Inhibition
EG01377;neuropilin 1;f;;Human;29648813;Antagonist
EG01377;neuropilin 1;f;;Human;29648813;Antagonist
AZD1332;neurotrophic receptor tyrosine kinase 1;f;;Human;;Inhibition
AZD7451;neurotrophic receptor tyrosine kinase 1;f;;Human;;Inhibition
CEP-11981;neurotrophic receptor tyrosine kinase 1;f;;Human;22148921;Inhibition
compound 1d [PMID: 21493067];neurotrophic receptor tyrosine kinase 1;f;;Human;21493067;Inhibition
compound 2c [PMID: 24900538];neurotrophic receptor tyrosine kinase 1;f;;Human;24900538;Inhibition
DDR1/2 inhibitor 5n;neurotrophic receptor tyrosine kinase 1;f;;Human;30075624;Inhibition
DS-6051b;neurotrophic receptor tyrosine kinase 1;f;;Human;31399568;Inhibition
gilteritinib;neurotrophic receptor tyrosine kinase 1;f;;Human;27908881;Inhibition
GNF-5837;neurotrophic receptor tyrosine kinase 1;f;;Human;24900443;Inhibition
GR-389988;neurotrophic receptor tyrosine kinase 1;f;;Human;;Inhibition
GW-2580;neurotrophic receptor tyrosine kinase 1;f;;Human;22037378;Inhibition
JNJ-28312141;neurotrophic receptor tyrosine kinase 1;f;;Human;19887542;Inhibition
larotrectinib;neurotrophic receptor tyrosine kinase 1;f;;Human;;Inhibition
milciclib;neurotrophic receptor tyrosine kinase 1;f;;Human;19603809;Inhibition
MK-2461;neurotrophic receptor tyrosine kinase 1;f;;Human;20145145;Inhibition
ONO-7579;neurotrophic receptor tyrosine kinase 1;f;;None;32217770;Inhibition
repotrectinib;neurotrophic receptor tyrosine kinase 1;f;;Human;30093503;Inhibition
RIPK1 inhibitor 22b;neurotrophic receptor tyrosine kinase 1;f;;Human;30480444;Inhibition
selitrectinib;neurotrophic receptor tyrosine kinase 1;f;;Human;;Inhibition
sitravatinib;neurotrophic receptor tyrosine kinase 1;f;;Human;26675259;Inhibition
AZD1332;neurotrophic receptor tyrosine kinase 2;f;;Human;;Inhibition
CEP-11981;neurotrophic receptor tyrosine kinase 2;f;;Human;22148921;Inhibition
compound 8e [PMID: 24432909];neurotrophic receptor tyrosine kinase 2;f;;Human;24432909;Inhibition
DDR1/2 inhibitor 5n;neurotrophic receptor tyrosine kinase 2;f;;Human;30075624;Inhibition
DS-6051b;neurotrophic receptor tyrosine kinase 2;f;;Human;31399568;Inhibition
GNF-5837;neurotrophic receptor tyrosine kinase 2;f;;Human;24900443;Inhibition
GR-389988;neurotrophic receptor tyrosine kinase 2;f;;Human;;Inhibition
GW-2580;neurotrophic receptor tyrosine kinase 2;f;;Human;22037378;Inhibition
MK-2461;neurotrophic receptor tyrosine kinase 2;f;;Human;20145145;Inhibition
ONO-7579;neurotrophic receptor tyrosine kinase 2;f;;None;32217770;Inhibition
repotrectinib;neurotrophic receptor tyrosine kinase 2;f;;Human;30093503;Inhibition
RIPK1 inhibitor 22b;neurotrophic receptor tyrosine kinase 2;f;;Human;30480444;Inhibition
selitrectinib;neurotrophic receptor tyrosine kinase 2;f;;Human;;Inhibition
AZD1332;neurotrophic receptor tyrosine kinase 3;f;;Human;;Inhibition
DDR1/2 inhibitor 5n;neurotrophic receptor tyrosine kinase 3;f;;Human;30075624;Inhibition
DS-6051b;neurotrophic receptor tyrosine kinase 3;f;;Human;31399568;Inhibition
GNF-5837;neurotrophic receptor tyrosine kinase 3;f;;Human;24900443;Inhibition
GR-389988;neurotrophic receptor tyrosine kinase 3;f;;Human;;Inhibition
GW-2580;neurotrophic receptor tyrosine kinase 3;f;;Human;22037378;Inhibition
NIK inhibitor 12f;neurotrophic receptor tyrosine kinase 3;f;;Human;32479083;Inhibition
ONO-7579;neurotrophic receptor tyrosine kinase 3;f;;None;32217770;Inhibition
pexidartinib;neurotrophic receptor tyrosine kinase 3;f;;Human;26222558;Inhibition
repotrectinib;neurotrophic receptor tyrosine kinase 3;f;;Human;30093503;Inhibition
RIPK1 inhibitor 22b;neurotrophic receptor tyrosine kinase 3;f;;Human;30480444;Inhibition
selitrectinib;neurotrophic receptor tyrosine kinase 3;f;;Human;;Inhibition
neurotrophin-3;neurotrophic receptor tyrosine kinase 3;t;Human;Human;;None
candoxatril;Neutral endopeptidase;f;;Human;;Inhibition
candoxatrilat;Neutral endopeptidase;f;;Human;10669559;Inhibition
compound 1a [PMID: 25692029];Neutral endopeptidase;f;;Human;25692029|11585456;Inhibition
compound 1b [PMID: 18078750];Neutral endopeptidase;f;;Human;18078750;Inhibition
daglutril;Neutral endopeptidase;f;;Human;;Inhibition
fasidotril;Neutral endopeptidase;f;;Human;;Inhibition
fasidotrilat;Neutral endopeptidase;f;;Human;16789889;Inhibition
KC-12615;Neutral endopeptidase;f;;Human;22480516;Inhibition
sacubitrilat;Neutral endopeptidase;f;;Human;;Inhibition
thiorphan;Neutral endopeptidase;f;;Human;;Inhibition
α-bungarotoxin;nicotinic acetylcholine receptor α10 subunit;f;;Human;;Antagonist
α-conotoxin RgIA;nicotinic acetylcholine receptor α10 subunit;f;;Human;;Antagonist
muscarine;nicotinic acetylcholine receptor α10 subunit;f;;Human;;Antagonist
nicotine;nicotinic acetylcholine receptor α10 subunit;f;;Human;;Antagonist
RgIA4;nicotinic acetylcholine receptor α10 subunit;f;;Human;28223528;Antagonist
RgIA4;nicotinic acetylcholine receptor α10 subunit;f;;Rat;28223528;Antagonist
strychnine;nicotinic acetylcholine receptor α10 subunit;f;;Human;;Antagonist
[3H]methyllycaconitine;nicotinic acetylcholine receptor α10 subunit;f;;Human;;Antagonist
succinylcholine;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Full agonist
α-bungarotoxin;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
α-conotoxin GI;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
α-conotoxin MI;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
atracurium;nicotinic acetylcholine receptor α1 subunit;f;;Human;16931985;Antagonist
pancuronium;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
[125I]α-bungarotoxin;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
[3H]α-bungarotoxin;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
waglerin-1;nicotinic acetylcholine receptor α1 subunit;f;;Human;;Antagonist
gallamine;nicotinic acetylcholine receptor α1 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α1 subunit;f;;Human;;None
[125I]epibatidine;nicotinic acetylcholine receptor α2 subunit;f;;Rat;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α2 subunit;f;;Rat;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α2 subunit;f;;Human;;Full agonist
[3H]cytisine;nicotinic acetylcholine receptor α2 subunit;f;;Human;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α2 subunit;f;;Rat;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α2 subunit;f;;Human;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α2 subunit;f;;Rat;;Full agonist
CP-601927;nicotinic acetylcholine receptor α2 subunit;f;;Human;21566524;Partial agonist
LY2087101;nicotinic acetylcholine receptor α2 subunit;f;;Human;16738207;Positive
hexamethonium;nicotinic acetylcholine receptor α2 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α2 subunit;f;;Human;;None
nicotine;nicotinic acetylcholine receptor α3 subunit;f;;Human;32026697;Agonist
varenicline;nicotinic acetylcholine receptor α3 subunit;f;;Human;32026697;Agonist
[125I]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Rat;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Rat;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Full agonist
[3H]cytisine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Rat;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Rat;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Full agonist
α-conotoxin AuIB;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Antagonist
α-conotoxin-GIC;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Antagonist
α-conotoxin MII;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Antagonist
α-conotoxin PnIA;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Antagonist
α-conotoxin TxIA;nicotinic acetylcholine receptor α3 subunit;f;;Human;;Antagonist
atracurium;nicotinic acetylcholine receptor α3 subunit;f;;Human;16931985;Antagonist
A-867744;nicotinic acetylcholine receptor α3 subunit;f;;Human;19389923;None
hexamethonium;nicotinic acetylcholine receptor α3 subunit;f;;Human;;None
hexamethonium;nicotinic acetylcholine receptor α3 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α3 subunit;f;;Human;;None
NS1738;nicotinic acetylcholine receptor α3 subunit;f;;Human;17625074;None
nicotine;nicotinic acetylcholine receptor α4 subunit;f;;Human;32026697;Agonist
rivanicline;nicotinic acetylcholine receptor α4 subunit;f;;Rat;8968366;Agonist
rivanicline;nicotinic acetylcholine receptor α4 subunit;f;;Human;14698195;Agonist
varenicline;nicotinic acetylcholine receptor α4 subunit;f;;Human;32026697;Agonist
varenicline;nicotinic acetylcholine receptor α4 subunit;f;;Human;16171993;Agonist
[125I]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Rat;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Rat;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;Full agonist
[125I]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;Full agonist
[3H]cytisine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;Full agonist
[3H]cytisine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;Full agonist
[3H]cytisine;nicotinic acetylcholine receptor α4 subunit;f;;Rat;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Rat;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α4 subunit;f;;Rat;;Full agonist
[3H]nicotine;nicotinic acetylcholine receptor α4 subunit;f;;Rat;;Full agonist
TC-2559;nicotinic acetylcholine receptor α4 subunit;f;;Human;12871651;Full agonist
tebanicline;nicotinic acetylcholine receptor α4 subunit;f;;Rat;9580626;Partial agonist
LY2087101;nicotinic acetylcholine receptor α4 subunit;f;;Human;16738207;Positive
NS9283;nicotinic acetylcholine receptor α4 subunit;f;;Human;21763685;Positive
atracurium;nicotinic acetylcholine receptor α4 subunit;f;;Human;16931985;Antagonist
SUVN-911;nicotinic acetylcholine receptor α4 subunit;f;;Human;32026697;Antagonist
A-867744;nicotinic acetylcholine receptor α4 subunit;f;;Human;19389923;None
hexamethonium;nicotinic acetylcholine receptor α4 subunit;f;;Human;;None
hexamethonium;nicotinic acetylcholine receptor α4 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α4 subunit;f;;Human;;None
NS1738;nicotinic acetylcholine receptor α4 subunit;f;;Human;17625074;None
α-conotoxin-GIC;nicotinic acetylcholine receptor α5 subunit;f;;Human;;Antagonist
α-conotoxin MII;nicotinic acetylcholine receptor α5 subunit;f;;Human;;Antagonist
α-conotoxin PnIA;nicotinic acetylcholine receptor α5 subunit;f;;Human;;Antagonist
α-conotoxin TxIA;nicotinic acetylcholine receptor α5 subunit;f;;Human;;Antagonist
[3H]epibatidine;nicotinic acetylcholine receptor α6 subunit;f;;Chicken;;Full agonist
α-conotoxin MII;nicotinic acetylcholine receptor α6 subunit;f;;Human;;Antagonist
α-conotoxin MII [H9A, L15A];nicotinic acetylcholine receptor α6 subunit;f;;Human;;Antagonist
α-conotoxin PIA;nicotinic acetylcholine receptor α6 subunit;f;;Human;;Antagonist
[125I]α-conotoxin MII;nicotinic acetylcholine receptor α6 subunit;f;;Human;;Antagonist
hexamethonium;nicotinic acetylcholine receptor α6 subunit;f;;Human;;None
mecamylamine;nicotinic acetylcholine receptor α6 subunit;f;;Human;;None
AQW051;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Agonist
4BP-TQS;nicotinic acetylcholine receptor α7 subunit;f;;Human;21436053;Full agonist
A-582941;nicotinic acetylcholine receptor α7 subunit;f;;Human;17898229;Full agonist
AZD0328;nicotinic acetylcholine receptor α7 subunit;f;;Human;21919481;Full agonist
bradanicline;nicotinic acetylcholine receptor α7 subunit;f;;Human;19482012;Full agonist
PHA-543613;nicotinic acetylcholine receptor α7 subunit;f;;Human;16821801;Full agonist
PHA-709829;nicotinic acetylcholine receptor α7 subunit;f;;Human;18490160;Full agonist
PNU-282987;nicotinic acetylcholine receptor α7 subunit;f;;Human;15715459;Full agonist
PSAB-OFP;nicotinic acetylcholine receptor α7 subunit;f;;Human;12354563;Full agonist
[3H]A-585539;nicotinic acetylcholine receptor α7 subunit;f;;Human;17959745;Full agonist
[3H]AZ11637326;nicotinic acetylcholine receptor α7 subunit;f;;Human;20674564;Full agonist
[3H]epibatidine;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Full agonist
encenicline;nicotinic acetylcholine receptor α7 subunit;f;;Human;15293871|21919481;Partial agonist
A-867744;nicotinic acetylcholine receptor α7 subunit;f;;Human;19389923;Positive
BNC375;nicotinic acetylcholine receptor α7 subunit;f;;Human;32094294;Positive
BNC375;nicotinic acetylcholine receptor α7 subunit;f;;Rat;31097995;Positive
ivermectin;nicotinic acetylcholine receptor α7 subunit;f;;Human;9463487;Positive
JNJ1930942;nicotinic acetylcholine receptor α7 subunit;f;;Human;21084390;Positive
LY2087101;nicotinic acetylcholine receptor α7 subunit;f;;Human;16738207;Positive
NS1738;nicotinic acetylcholine receptor α7 subunit;f;;Human;17625074;Positive
PNU-120596;nicotinic acetylcholine receptor α7 subunit;f;;Human;15858066;Positive
α-bungarotoxin;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Antagonist
α-conotoxin ArIB;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Antagonist
α-conotoxin ImI;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Antagonist
atracurium;nicotinic acetylcholine receptor α7 subunit;f;;Human;16931985;Antagonist
methyllycaconitine;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Antagonist
[125I]α-bungarotoxin;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Antagonist
[3H]α-bungarotoxin;nicotinic acetylcholine receptor α7 subunit;f;;Human;;Antagonist
[3H]methyllycaconitine;nicotinic acetylcholine receptor α7 subunit;f;;Rat;;Antagonist
mecamylamine;nicotinic acetylcholine receptor α7 subunit;f;;Human;;None
[125I]α-bungarotoxin;nicotinic acetylcholine receptor α8 subunit (avian);f;;Human;;None
[3H]α-bungarotoxin;nicotinic acetylcholine receptor α8 subunit (avian);f;;Human;;None
[3H]epibatidine;nicotinic acetylcholine receptor α8 subunit (avian);f;;Human;;None
α-bungarotoxin;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
α-bungarotoxin;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
α-conotoxin RgIA;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
muscarine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
muscarine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
nicotine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
nicotine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
RgIA4;nicotinic acetylcholine receptor α9 subunit;f;;Human;28223528;Antagonist
RgIA4;nicotinic acetylcholine receptor α9 subunit;f;;Rat;28223528;Antagonist
strychnine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
strychnine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
[125I]α-bungarotoxin;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
[3H]α-bungarotoxin;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
[3H]methyllycaconitine;nicotinic acetylcholine receptor α9 subunit;f;;Human;;Antagonist
PhTX-11;nicotinic acetylcholine receptor δ subunit;f;;Human;11934578;Antagonist
compound 31 [PMID: 20936789];NIMA related kinase 1;f;;Human;20936789;Inhibition
compound 25 [PMID: 17935989];NIMA related kinase 11;f;;Human;17935989;Inhibition
compound 2 [PMID: 21627121];NIMA related kinase 2;f;;Human;21627121;Inhibition
compound 31 [PMID: 20936789];NIMA related kinase 2;f;;Human;20936789;Inhibition
GSK579289A;NIMA related kinase 2;f;;Human;19237286;Inhibition
compound 25 [PMID: 17935989];NIMA related kinase 3;f;;Human;17935989;Inhibition
compound 22 [PMID: 20462760];NIMA related kinase 6;f;;Human;20462760;Inhibition
compound 22 [PMID: 20462760];NIMA related kinase 7;f;;Human;20462760;Inhibition
eledoisin;NK1 receptor;f;;Human;8702757;Full agonist
hemokinin 1;NK1 receptor;f;Mouse;Human;11786503;Full agonist
kassinin;NK1 receptor;f;;Human;8702757;Full agonist
neurokinin A;NK1 receptor;t;Human|Mouse|Rat;Human;11786503|8985159|1311270|9190866;Full agonist
neurokinin B;NK1 receptor;t;Human|Mouse|Pig|Rat;Human;9190866;Full agonist
neuropeptide-γ;NK1 receptor;t;;Human;8702757;Full agonist
neuropeptide K;NK1 receptor;t;Human|Rat;Human;8702757;Full agonist
phyllomedusin;NK1 receptor;f;;Human;8702757;Full agonist
physalaemin;NK1 receptor;f;;Human;8702757;Full agonist
[Pro9]SP;NK1 receptor;f;;Rat;9243521;Full agonist
[Sar9,Met(O2)11]SP;NK1 receptor;f;;Human;8702757;Full agonist
septide;NK1 receptor;f;;Human;11786503|8985159;Full agonist
substance P;NK1 receptor;t;Human|Mouse|Rat;Human;11786503|15265501;Full agonist
substance P-(4-11);NK1 receptor;f;;Human;8702757;Full agonist
substance P-(6-11);NK1 receptor;f;;Human;8702757;Full agonist
substance P-OMe;NK1 receptor;f;;Human;8702757;Full agonist
[125I]BH-[Sar9,Met(O2)11]SP;NK1 receptor;f;;Rat;1705465;Full agonist
[125I]SP (human, mouse, rat);NK1 receptor;f;;Human;;Full agonist
[3H]BH-[Sar9,Met(O2)11]SP;NK1 receptor;f;;Rat;1722129;Full agonist
[3H]SP (human, mouse, rat);NK1 receptor;f;;Human;2410593;Full agonist
aprepitant;NK1 receptor;f;;Human;9804700|10737756;Antagonist
befetupitant;NK1 receptor;f;;Human;16332435;Antagonist
casopitant;NK1 receptor;f;;Human;20533894|24106886;Antagonist
CP 99994;NK1 receptor;f;;Human;9190866|12206858;Antagonist
ezlopitant;NK1 receptor;f;;Human;12372904;Antagonist
FK 224;NK1 receptor;f;;Human;1378096;Antagonist
FK-888;NK1 receptor;f;;Human;8630576;Antagonist
fosaprepitant;NK1 receptor;f;;Human;10737756;Antagonist
imnopitant;NK1 receptor;f;;Human;16332435;Antagonist
L-703,606;NK1 receptor;f;;Human;8702757;Antagonist
L-732,138;NK1 receptor;f;;Rat;7509807;Antagonist
L-732,138;NK1 receptor;f;;Human;7509807;Antagonist
L760735;NK1 receptor;f;;Human;11708932;Antagonist
lanepitant;NK1 receptor;f;;Human;20533894;Antagonist
lanepitant;NK1 receptor;f;;Human;7473161;Antagonist
netupitant;NK1 receptor;f;;Human;16332435;Antagonist
nolpitantium;NK1 receptor;f;;Human;8702757;Antagonist
osanetant;NK1 receptor;f;;Human;12206858;Antagonist
osanetant;NK1 receptor;f;;Human;9042606;Antagonist
R116031;NK1 receptor;f;;Human;12130734;Antagonist
R-486;NK1 receptor;f;;Human;12206858;Antagonist
rolapitant;NK1 receptor;f;;Human;22497992;Antagonist
RP67580;NK1 receptor;f;;Human;1281470;Antagonist
saredutant;NK1 receptor;f;;Human;9190866|12206858;Antagonist
SCH 206272;NK1 receptor;f;;Human;12206858;Antagonist
serlopitant;NK1 receptor;f;;Human;19354254;Antagonist
spantide I;NK1 receptor;f;;Rabbit;1693780;Antagonist
spantide I;NK1 receptor;f;;Rat;6208451;Antagonist
spantide I;NK1 receptor;f;;Rat;1702895;Antagonist
spantide I;NK1 receptor;f;;Guinea pig;1693780|1702895;Antagonist
spantide II;NK1 receptor;f;;Rabbit;1693780;Antagonist
spantide II;NK1 receptor;f;;Guinea pig;1693780|1702895;Antagonist
spantide II;NK1 receptor;f;;Rat;1702895;Antagonist
[125I]L703,606;NK1 receptor;f;;Human;8287060;Antagonist
[18F]SPA-RQ;NK1 receptor;f;;Human;;Antagonist
T2328;NK1 receptor;f;;Human;18187929;Antagonist
TAK-637;NK1 receptor;f;;Human;10508446;Antagonist
tradipitant;NK1 receptor;f;;Human;;Antagonist
vestipitant;NK1 receptor;f;;Human;18657401|19388677;Antagonist
vofopitant;NK1 receptor;f;;Human;8876035;Antagonist
ZD6021;NK1 receptor;f;;Human;11408556;Antagonist
neurokinin A;NK2 receptor;f;Human|Mouse|Rat;Guinea pig;2426129;Agonist
neuropeptide γ;NK2 receptor;t;Human|Mouse|Rat;Guinea pig;1311427;Agonist
neuropeptide K;NK2 receptor;t;Human|Rat;Guinea pig;1311427;Agonist
[βAla8]neurokinin A-(4-10);NK2 receptor;f;;Human;7682062;Full agonist
GR64349;NK2 receptor;f;;Rat;1331460;Full agonist
hemokinin 1;NK2 receptor;f;Mouse;Human;11786503;Full agonist
[Lys5,Me-Leu9,Nle10]NKA-(4-10);NK2 receptor;f;;Rat;9718274;Full agonist
neurokinin A;NK2 receptor;t;Human|Mouse|Rat;Human;11786503|9190866|7682062|11137709;Full agonist
neurokinin B;NK2 receptor;t;Human|Mouse|Pig|Rat;Human;9190866|7682062;Full agonist
[Phe(Me)7]neurokinin B;NK2 receptor;f;;Human;9190866;Full agonist
substance P;NK2 receptor;t;Human|Mouse|Rat;Human;11786503|9190866|7682062;Full agonist
[125I]NKA (human, mouse, rat);NK2 receptor;f;;Human;10455255;Full agonist
FK-888;NK2 receptor;f;;Human;11937780;Antagonist
GR100679;NK2 receptor;f;;Human;8210508;Antagonist
GR 159897;NK2 receptor;f;;Human;7682062|7562907|7713168;Antagonist
GR94800;NK2 receptor;f;;Human;8027981;Antagonist
ibodutant;NK2 receptor;f;;Human;16979621;Antagonist
MEN 10376;NK2 receptor;f;;Human;7682062;Antagonist
MEN10627;NK2 receptor;f;;Human;11063600;Antagonist
nepadutant;NK2 receptor;f;;Human;16979621|9484857;Antagonist
osanetant;NK2 receptor;f;;Human;9190866|12206858;Antagonist
R396;NK2 receptor;f;;Human;7682062;Antagonist
saredutant;NK2 receptor;f;;Human;9190866|12206858|7682062;Antagonist
saredutant;NK2 receptor;f;;Rat;1313515;Antagonist
saredutant;NK2 receptor;f;;Guinea pig;1334836;Antagonist
SB 414240;NK2 receptor;f;;Human;11356103;Antagonist
SCH 206272;NK2 receptor;f;;Human;12206858;Antagonist
[3H]GR100679;NK2 receptor;f;;Human;8210508;Antagonist
[3H]saredutant;NK2 receptor;f;;Rat;7719707;Antagonist
talnetant;NK2 receptor;f;;Human;9190866;Antagonist
YM44778;NK2 receptor;f;;Human;11937780;Antagonist
YM44781;NK2 receptor;f;;Human;11937780;Antagonist
YM49598;NK2 receptor;f;;Human;11937780;Antagonist
ZM 253270;NK2 receptor;f;;Guinea pig;7562491;Antagonist
ZM 253270;NK2 receptor;f;;Human;7562491;Antagonist
ZM-274773;NK2 receptor;f;;Human;22149761;Antagonist
senktide;NK3 receptor;f;;Guinea pig;2431898;Agonist
eledoisin;NK3 receptor;f;;Human;8702757|1312036;Full agonist
hemokinin 1;NK3 receptor;f;Mouse;Human;11226387;Full agonist
hemokinin 1;NK3 receptor;t;Mouse;Mouse;11226387;Full agonist
kassinin;NK3 receptor;f;;Human;8702757;Full agonist
neurokinin A;NK3 receptor;t;Human|Mouse|Rat;Mouse;11226387;Full agonist
neurokinin A;NK3 receptor;t;Human|Mouse|Rat;Human;1312036;Full agonist
neurokinin A;NK3 receptor;t;Human|Mouse|Rat;Human;9190866|11226387;Full agonist
neurokinin B;NK3 receptor;t;Human|Mouse|Pig|Rat;Human;1312036|2176308;Full agonist
neurokinin B;NK3 receptor;t;Human|Mouse|Pig|Rat;Mouse;11226387;Full agonist
neurokinin B;NK3 receptor;t;Human|Mouse|Pig|Rat;Human;9190866|11226387;Full agonist
[Phe(Me)7]neurokinin B;NK3 receptor;f;;Mouse;11226387;Full agonist
[Phe(Me)7]neurokinin B;NK3 receptor;f;;Human;9190866|11226387;Full agonist
[Phe(Me)7]neurokinin B;NK3 receptor;f;;Human;2176308|7476898;Full agonist
[Pro7]neurokinin B;NK3 receptor;f;;Human;8702757;Full agonist
senktide;NK3 receptor;f;;Rat;2426259;Full agonist
senktide;NK3 receptor;f;;Mouse;11226387;Full agonist
senktide;NK3 receptor;f;;Rat;2426259|1312036;Full agonist
senktide;NK3 receptor;f;;Human;8702757|9190866|11226387;Full agonist
substance P;NK3 receptor;t;Human|Mouse|Rat;Mouse;11226387;Full agonist
substance P;NK3 receptor;t;Human|Mouse|Rat;Human;9190866|11226387;Full agonist
[125I][MePhe7]NKB;NK3 receptor;f;;Human;;Full agonist
[3H]senktide;NK3 receptor;f;;Guinea pig;1694464;Full agonist
fezolinetant;NK3 receptor;f;;Human;26191358;Antagonist
FK 224;NK3 receptor;f;;Human;1378096;Antagonist
GR138676;NK3 receptor;f;;Human;7534879;Antagonist
GSK 172981;NK3 receptor;f;;Guinea pig;19879867;Antagonist
GSK 172981;NK3 receptor;f;;Human;19117759;Antagonist
GSK 256471;NK3 receptor;f;;Guinea pig;19879867;Antagonist
GSK 256471;NK3 receptor;f;;Human;19117759;Antagonist
N',2-diphenylquinoline-4-carbohydrazide 8m;NK3 receptor;f;;Human;16950617;Antagonist
N′,2-diphenylquinoline-4-carbohydrazide;NK3 receptor;f;;Human;16950620;Antagonist
osanetant;NK3 receptor;f;;Guinea pig;7830490;Antagonist
osanetant;NK3 receptor;f;;Human;8702757|9190866|12206858|9042606|11226387|11757797|7616392|7476898|7830490;Antagonist
osanetant;NK3 receptor;f;;Human;7476898;Antagonist
pavinetant;NK3 receptor;f;;Human;;Antagonist
PD 154740;NK3 receptor;f;;Human;7476898;Antagonist
PD 154740;NK3 receptor;f;;Human;7476898;Antagonist
PD157672;NK3 receptor;f;;Human;7476898;Antagonist
PD157672;NK3 receptor;f;;Human;8702757|8648606;Antagonist
PD 161182;NK3 receptor;f;;Human;8648606;Antagonist
saredutant;NK3 receptor;f;;Human;9190866|12206858;Antagonist
saredutant;NK3 receptor;f;;Human;8117304;Antagonist
SB 218795;NK3 receptor;f;;Human;8691422;Antagonist
SB 222200;NK3 receptor;f;;Human;11226387|10992004;Antagonist
SB 222200;NK3 receptor;f;;Human;10992004;Antagonist
SB 235375;NK3 receptor;f;;Human;11752131;Antagonist
SCH 206272;NK3 receptor;f;;Human;12206858;Antagonist
SSR 146977;NK3 receptor;f;;Human;12056557;Antagonist
[3H]osanetant;NK3 receptor;f;;Human;;Antagonist
talnetant;NK3 receptor;f;;Rat;11226387;Antagonist
talnetant;NK3 receptor;f;;Human;9190866|15265501|11226387|8691422;Antagonist
[Trp7, β-Ala8] neurokinin A-(4-10);NK3 receptor;f;;Rat;2176308;Antagonist
muramyl dipeptide;NLRP1;f;;Human;;Agonist
CY-09;NLRP3;f;;Human;29021150;Inhibition
dapansutrile;NLRP3;f;;Human;29378952;Inhibition
MCC950;NLRP3;f;;Human;25686105;Inhibition
CPN-267;NMU1 receptor;f;;Human;28548497;Agonist
neuromedin S-33;NMU1 receptor;t;Human;Human;15635449;Agonist
neuromedin U-23;NMU1 receptor;f;Rat;Human;15292653;Agonist
neuromedin U-25;NMU1 receptor;f;Pig;Human;15292653;Agonist
neuromedin U-25;NMU1 receptor;t;Human;Human;15292653;Agonist
neuromedin U-8;NMU1 receptor;f;Dog;Human;15292653;Agonist
neuromedin U-8;NMU1 receptor;f;Pig;Human;15292653;Agonist
[125I]neuromedin U-23 (rat);NMU1 receptor;f;;Human;10894543|10899166;Agonist
[125I]neuromedin U-25 (human);NMU1 receptor;f;;Human;15292653|15331768;Agonist
[125I]neuromedin U-8 (pig);NMU1 receptor;f;;Human;10899166;Agonist
compound 5d [PMID: 25815150];NMU1 receptor;f;;Human;25815150;Full agonist
compound 8d [PMID: 24999562];NMU1 receptor;f;;Human;24999562;Full agonist
HAS-NMU;NMU1 receptor;f;;Human;24222478;Full agonist
neuromedin S-33;NMU1 receptor;t;Human;Human;15635449;Full agonist
neuromedin U-23;NMU1 receptor;f;Rat;Human;10894543|10899166|15292653;Full agonist
neuromedin U-25;NMU1 receptor;t;Human;Human;10894543|10899166|15292653|15331768;Full agonist
neuromedin U-25;NMU1 receptor;f;Pig;Human;10894543|10899166|15292653;Full agonist
neuromedin U-8;NMU1 receptor;f;Pig;Human;10894543|10899166|15292653;Full agonist
NM4-C16;NMU1 receptor;f;;Human;26204509;Full agonist
PEG40-NMU;NMU1 receptor;f;;Human;22771182;Full agonist
neuromedin S-33;NMU2 receptor;t;Human;Human;15635449;Agonist
neuromedin U-23;NMU2 receptor;f;Rat;Human;15292653;Agonist
neuromedin U-25;NMU2 receptor;f;Pig;Human;15292653;Agonist
neuromedin U-25;NMU2 receptor;t;Human;Human;15292653;Agonist
neuromedin U-8;NMU2 receptor;f;Pig;Human;15292653;Agonist
neuromedin U-8;NMU2 receptor;f;Dog;Human;15292653;Agonist
NY0116;NMU2 receptor;f;;Human;30151213;Agonist
[125I]neuromedin U-23 (rat);NMU2 receptor;f;;Human;10899166;Agonist
[125I]neuromedin U-25 (human);NMU2 receptor;f;;Human;15292653|15331768;Agonist
[125I]neuromedin U-8 (pig);NMU2 receptor;f;;Human;10899166;Agonist
compound 6b [PMID: 24999562];NMU2 receptor;f;;Human;24999562;Full agonist
compound NRA 4 [PMID: 25262941];NMU2 receptor;f;;Human;25262941;Full agonist
HAS-NMU;NMU2 receptor;f;;Human;24222478;Full agonist
neuromedin S-33;NMU2 receptor;t;Human;Human;15635449;Full agonist
neuromedin U-23;NMU2 receptor;f;Rat;Human;10894543|10899166|15292653;Full agonist
neuromedin U-25;NMU2 receptor;f;Pig;Human;10894543|10899166|15292653;Full agonist
neuromedin U-25;NMU2 receptor;t;Human;Human;10894543|10899166|15292653|15331768;Full agonist
neuromedin U-8;NMU2 receptor;f;Pig;Human;10894543|10899166|15292653;Full agonist
NM4-C16;NMU2 receptor;f;;Human;26204509;Full agonist
PEG40-NMU;NMU2 receptor;f;;Human;22771182;Full agonist
R-PSOP;NMU2 receptor;f;;Human;19369576;Antagonist
Ac-RYYRIK-NH2;NOP receptor;f;;Human;9353393;Agonist
Ac-RYYRWK-NH2;NOP receptor;f;;Human;9353393;Agonist
AT-403;NOP receptor;f;;Human;29232769;Agonist
cebranopadol;NOP receptor;f;;Rat;24713140;Agonist
cebranopadol;NOP receptor;f;;Human;24713140;Agonist
cebranopadol;NOP receptor;f;;Human;24713140;Agonist
nociceptin/orphanin FQ;NOP receptor;f;Human|Mouse|Rat;Human;9353393;Agonist
[(pF)Phe4]N/OFQ-(1-13)-NH2;NOP receptor;f;;Human;15743186;Agonist
PWT2-N/OFQ;NOP receptor;f;;Human;24903280;Agonist
PWT2-N/OFQ;NOP receptor;f;;Human;24903280;Agonist
Ro64-6198;NOP receptor;f;;Human;11006485;Agonist
(R)-Ro65-6570;NOP receptor;f;;Human;10476866;Agonist
(R)-Ro65-6570;NOP receptor;f;;Human;10476866;Agonist
SCH221510;NOP receptor;f;;Human;18492950;Agonist
SCH221510;NOP receptor;f;;Human;18492950;Agonist
SCH221510;NOP receptor;f;;Rat;18492950;Agonist
SCH221510;NOP receptor;f;;Mouse;18492950;Agonist
SCH486757;NOP receptor;f;;Human;20006596;Agonist
SCH486757;NOP receptor;f;;Human;20006596;Agonist
SR16835;NOP receptor;f;;Human;19773529;Agonist
SR16835;NOP receptor;f;;Human;19773529;Agonist
[Arg14Lys15]N/OFQ;NOP receptor;f;;Human;11097863;Full agonist
nociceptin/orphanin FQ;NOP receptor;t;Human|Mouse|Rat;Human;10369464|12070757|9413015;Full agonist
nociceptin/orphanin FQ;NOP receptor;t;Human|Mouse|Rat;Mouse;9353393;Full agonist
N/OFQ-(1-13)-NH2;NOP receptor;f;;Human;12967935|10369464|12070757|9191955;Full agonist
N/OFQ-NH2;NOP receptor;f;;Human;12967935;Full agonist
[(pF)Phe4]N/OFQ-(1-13)-NH2;NOP receptor;f;;Human;12070757|15743186;Full agonist
Ro64-6198;NOP receptor;f;;Human;10758169|11006485;Full agonist
[3H]Leu-N/OFQ;NOP receptor;f;;Human;12967935;Full agonist
[3H]N/OFQ;NOP receptor;f;;Human;9353393|8849681;Full agonist
[3H]Tyr14-N/OFQ;NOP receptor;f;;Mouse;9413015;Full agonist
UFP-102;NOP receptor;f;;Human;15509719;Full agonist
UFP-112;NOP receptor;f;;Human;17532097|19183962;Full agonist
Ac-RYYRIK-NH2;NOP receptor;f;;Mouse;9353393;Partial agonist
Ac-RYYRIK-NH2;NOP receptor;f;;Human;9353393|12967935;Partial agonist
Ac-RYYRWK-NH2;NOP receptor;f;;Mouse;9353393;Partial agonist
Ac-RYYRWK-NH2;NOP receptor;f;;Human;9353393|12967935;Partial agonist
BU08028;NOP receptor;f;;Human;21177476;Partial agonist
[F/G]N/OFQ-(1-13)-NH2;NOP receptor;f;;Human;12967935;Partial agonist
AT-076;NOP receptor;f;;Human;25635572;Antagonist
compound 24 [PMID: 16451050];NOP receptor;f;;Human;19445927;Antagonist
compound 24 [PMID: 16451050];NOP receptor;f;;Human;19445927|16451050;Antagonist
J-113397;NOP receptor;f;;Human;10940356;Antagonist
J-113397;NOP receptor;f;;Human;10602690;Antagonist
JTC-801;NOP receptor;f;;Human;11101358;Antagonist
LY2940094;NOP receptor;f;;Human;24678969;Antagonist
NiK-21273;NOP receptor;f;;Human;22994368;Antagonist
[Nphe1]N/OFQ-(1-13)-NH2;NOP receptor;f;;Human;12010780;Antagonist
peptide III-BTD;NOP receptor;f;;Human;10488086;Antagonist
SB 612111;NOP receptor;f;;Human;14593080|17329552;Antagonist
SB 612111;NOP receptor;f;;Human;14593080|17329552;Antagonist
TRAP-101;NOP receptor;f;;Mouse;16202610;Antagonist
UFP-101;NOP receptor;f;;Human;12010780;Antagonist
tarextumab;notch receptor 2;f;;Human;;Binding
tarextumab;notch receptor 3;f;;Human;;Binding
[125I]NPW-23 (human);NPBW1 receptor;f;;Human;15261118;Agonist
Ava3;NPBW1 receptor;f;;Human;17486669;Full agonist
Ava5;NPBW1 receptor;f;;Human;17486669;Full agonist
des-Br-neuropeptide B-23;NPBW1 receptor;t;Human;Human;12401809|12118011;Full agonist
des-Br-neuropeptide B-29;NPBW1 receptor;t;Human;Human;12401809|12118011;Full agonist
neuropeptide B-29;NPBW1 receptor;t;Human;Human;12118011;Full agonist
neuropeptide W-23;NPBW1 receptor;t;Human;Human;12130646;Full agonist
neuropeptide W-30;NPBW1 receptor;t;Human;Human;12130646;Full agonist
[125I]NPW-23 (human);NPBW1 receptor;f;;Rat;15261118;Full agonist
[125I][Tyr11]des-Br-NPB-23;NPBW1 receptor;f;;Human;12118011;Full agonist
[125I]NPW-23 (human);NPBW2 receptor;f;;Human;12130646;Agonist
neuropeptide B-23;NPBW2 receptor;t;Human;Human;12401809;Full agonist
neuropeptide B-29;NPBW2 receptor;t;Human;Human;12401809;Full agonist
neuropeptide W-23;NPBW2 receptor;t;Human;Human;12401809;Full agonist
neuropeptide W-30;NPBW2 receptor;t;Human;Human;12401809;Full agonist
ezetimibe;NPC1 like intracellular cholesterol transporter 1;f;;Human;15928087;Inhibition
1DMe;NPFF1 receptor;f;;Human;11024015|17011599|12421602;Full agonist
EFWSLAAPQRF-NH2;NPFF1 receptor;f;;Human;12242085|12421602;Full agonist
neuropeptide FF;NPFF1 receptor;t;Human|Mouse|Rat;Human;12242085|17011599|12421602;Full agonist
RFRP-3;NPFF1 receptor;t;Human;Human;12242085|12421602|17337079;Full agonist
[125I]1DMe;NPFF1 receptor;f;;Human;11024015;Full agonist
[125I]NPFF;NPFF1 receptor;f;;Human;17011599;Full agonist
[125I]Y-RFRP-3;NPFF1 receptor;f;;Human;12421602;Full agonist
[3H]NPVF;NPFF1 receptor;f;;Human;19682524;Full agonist
Y-RFRP-3;NPFF1 receptor;f;;Human;12242085|12421602;Full agonist
pancreatic polypeptide;NPFF1 receptor;f;European common frog;Human;11024015|12421602;Partial agonist
AC262620;NPFF1 receptor;f;;Human;20354177;Antagonist
AC262970;NPFF1 receptor;f;;Human;20354177;Antagonist
BIBP3226;NPFF1 receptor;f;;Human;11024015|12242085|12421602;Antagonist
compound 46 [PMID: 25268943];NPFF1 receptor;f;;Human;25268943;Antagonist
RF9;NPFF1 receptor;f;;Human;16407169;Antagonist
1DMe;NPFF2 receptor;f;;Human;11024015|12242085|12421602;Full agonist
AC263093;NPFF2 receptor;f;;Human;20354177;Full agonist
dNPA;NPFF2 receptor;f;;Human;16129413;Full agonist
EFWSLAAPQRF-NH2;NPFF2 receptor;f;;Human;12242085;Full agonist
neuropeptide FF;NPFF2 receptor;t;Human|Mouse|Rat;Human;12421602|11325787;Full agonist
pancreatic polypeptide;NPFF2 receptor;f;European common frog;Human;11024015|11325787;Full agonist
RFRP-3;NPFF2 receptor;f;Human;Human;12242085|12421602;Full agonist
[125I]EYF;NPFF2 receptor;f;;Human;12242085;Full agonist
[125I]NPFF;NPFF2 receptor;f;;Human;17011599;Full agonist
[3H]EYF;NPFF2 receptor;f;;Human;19682524;Full agonist
Y-RFRP-3;NPFF2 receptor;f;;Human;12242085|12421602;Full agonist
BIBP3226;NPFF2 receptor;f;;Human;11024015|11325787;Antagonist
compound 46 [PMID: 25268943];NPFF2 receptor;f;;Human;25268943;Antagonist
RF9;NPFF2 receptor;f;;Human;16407169;Antagonist
[Cy5-Lys19]NPS;NPS receptor;f;;Human;26865629;Full agonist
neuropeptide S;NPS receptor;t;Mouse;Human;15312648;Full agonist
neuropeptide S;NPS receptor;t;Human;Human;15312648;Full agonist
neuropeptide S;NPS receptor;t;Rat;Human;15312648;Full agonist
NPS(1-4)NH2;NPS receptor;f;;Mouse;28267583;Full agonist
NPS(1-4)NH2;NPS receptor;f;;Human;28267583;Full agonist
PWT1-NPS;NPS receptor;f;;Mouse;25692025;Full agonist
[125I]Tyr10NPS (human);NPS receptor;f;;Human;15312648;Full agonist
[D-Cys(tBu)5]NPS;NPS receptor;f;;Mouse;18971372;Antagonist
[D-Cys(tBu)5]NPS;NPS receptor;f;;Rat;22342393;Antagonist
[D-Val5]NPS;NPS receptor;f;;Mouse;19473027;Antagonist
[tBu-D-Gly5]NPS;NPS receptor;f;;Rat;22342393;Antagonist
[tBu-D-Gly5]NPS;NPS receptor;f;;Mouse;19473027;Antagonist
NCGC 84;NPS receptor;f;;Human;23761908;Antagonist
PI1;NPS receptor;f;;Human;20615693;Antagonist
QA1;NPS receptor;f;;Human;20510609;Antagonist
RTI-118;NPS receptor;f;;Human;18555684;Antagonist
SHA 68;NPS receptor;f;;Mouse;20172007;Antagonist
SHA 68;NPS receptor;f;;Rat;22342393;Antagonist
lonafarnib;NRAS;f;;Human;9810004;Inhibition
ABS-201;NTS1 receptor;f;;Mouse;22459147;Full agonist
ABS-212;NTS1 receptor;f;;Rat;20481538;Full agonist
contulakin-G;NTS1 receptor;f;;Human;10318778;Full agonist
contulakin-G;NTS1 receptor;f;;Rat;10318778;Full agonist
EISAI-1;NTS1 receptor;f;;Rat;12869647;Full agonist
EISAI-2;NTS1 receptor;f;;Rat;12869647;Full agonist
JMV2004;NTS1 receptor;f;;Human;11723247;Full agonist
JMV431;NTS1 receptor;f;;Human;11723247;Full agonist
JMV449;NTS1 receptor;f;;Rat;12869647;Full agonist
JMV457;NTS1 receptor;f;;Human;11723247;Full agonist
JMV458;NTS1 receptor;f;;Human;11723247;Full agonist
KH28;NTS1 receptor;f;;Human;16095636;Full agonist
large neuromedin N;NTS1 receptor;t;Human;Human;11811984;Full agonist
large neurotensin;NTS1 receptor;t;Human;Human;11811984;Full agonist
neuromedin N;NTS1 receptor;t;Mouse|Rat;Rat;12869647;Full agonist
neurotensin;NTS1 receptor;t;Bovine|Human|Mouse|Rat;Human;11723247|10930533;Full agonist
neurotensin;NTS1 receptor;t;Bovine|Human|Mouse|Rat;Rat;12869647|10930533|9632698;Full agonist
[125I]neurotensin (human, mouse, rat);NTS1 receptor;f;;Rat;7746272|12869647;Full agonist
Thr10contulakin-G;NTS1 receptor;f;;Human;10318778;Full agonist
Thr10contulakin-G;NTS1 receptor;f;;Rat;10318778;Full agonist
meclinertant;NTS1 receptor;f;;Human;9023294;Antagonist
meclinertant;NTS1 receptor;f;;Rat;7746272|9632698;Antagonist
meclinertant;NTS1 receptor;f;;Human;11723247;Antagonist
SR142948A;NTS1 receptor;f;;Human;9023294;Antagonist
SR48527;NTS1 receptor;f;;Rat;7746272;Antagonist
[3H]meclinertant;NTS1 receptor;f;;Rat;7746272;Antagonist
contulakin-G;NTS2 receptor;f;;Rat;10318778;Full agonist
[D-Trp11]neurotensin;NTS2 receptor;f;;Mouse;9480852;Full agonist
JMV2004;NTS2 receptor;f;;Human;11723247;Full agonist
JMV431;NTS2 receptor;f;;Human;11723247;Full agonist
JMV457;NTS2 receptor;f;;Human;11723247;Full agonist
JMV458;NTS2 receptor;f;;Human;11723247;Full agonist
levocabastine;NTS2 receptor;f;;Human;11723247|8795617;Full agonist
levocabastine;NTS2 receptor;f;;Mouse;9480852;Full agonist
meclinertant;NTS2 receptor;f;;Mouse;9480852;Full agonist
meclinertant;NTS2 receptor;f;;Human;11723247;Full agonist
neuromedin N;NTS2 receptor;t;Mouse|Rat;Mouse;9480852;Full agonist
neuromedin N;NTS2 receptor;t;Mouse|Rat;Rat;8647296;Full agonist
neurotensin;NTS2 receptor;t;Bovine|Human|Mouse|Rat;Mouse;9480852;Full agonist
neurotensin;NTS2 receptor;t;Bovine|Human|Mouse|Rat;Human;11723247;Full agonist
neurotensin;NTS2 receptor;t;Bovine|Human|Mouse|Rat;Rat;10318778;Full agonist
[125I]neurotensin (human, mouse, rat);NTS2 receptor;f;;Rat;8647296;Full agonist
[125I]neurotensin (human, mouse, rat);NTS2 receptor;f;;Mouse;8795617|9480852;Full agonist
Thr10contulakin-G;NTS2 receptor;f;;Rat;10318778;Full agonist
Trp11-neurotensin;NTS2 receptor;f;;Mouse;9480852;Full agonist
xenin;NTS2 receptor;t;Human|Mouse|Rat;Mouse;9480852;Full agonist
levocabastine;NTS2 receptor;f;;Rat;8647296;Partial agonist
cerdulatinib;NUAK family kinase 1;f;;Human;25253883;Inhibition
compound 25b [PMID: 22564207];NUAK family kinase 1;f;;Human;22564207;Inhibition
HTH-01-015;NUAK family kinase 1;f;;Human;24171924;Inhibition
HTH-02-006;NUAK family kinase 1;f;;Human;30446657;Inhibition
WZ4002;NUAK family kinase 1;f;;Human;20033049;Inhibition
WZ4003;NUAK family kinase 1;f;;Human;24171924;Inhibition
HTH-02-006;NUAK family, SNF1-like kinase, 2;f;;Human;30446657;Inhibition
WZ4003;NUAK family, SNF1-like kinase, 2;f;;Human;24171924;Inhibition
ML385;nuclear factor, erythroid 2 like 2;f;;Human;27552339;Binding
compound 26 [PMID: 21733693];nuclear receptor coactivator 1;f;;Human;21733693;Inhibition
KML110;nucleobindin 1;f;;Human;26091042;Antagonist
MJN228;nucleobindin 1;f;;Human;26091042;Antagonist
meso-DAP;nucleotide binding oligomerization domain containing 1;f;;Human;;Agonist
ML130;nucleotide binding oligomerization domain containing 1;f;;Human;22003428;Inhibition
muramyl dipeptide;nucleotide binding oligomerization domain containing 2;f;;Human;;Agonist
ML130;nucleotide binding oligomerization domain containing 2;f;;Human;22003428;Inhibition
NUDT7-COV-1;nudix hydrolase 7;f;;Human;;Inhibition
naringin;OATP1A2;f;;Human;17301733;Inhibition
rifampicin;OATP1A2;f;;Human;12085361;Inhibition
rifamycin SV;OATP1A2;f;;Human;12085361;Inhibition
[3H]BSP;OATP1A2;f;;Human;;None
[3H]DPDPE;OATP1A2;f;;Human;;None
[3H]estrone-3-sulphate;OATP1A2;f;;Human;;None
cyclosporin A;OATP1B1;f;;Human;14530907|22541068;Inhibition
estrone-3-sulphate;OATP1B1;f;;Human;20448812;Inhibition
gemfibrozil;OATP1B1;f;;Human;17470528;Inhibition
glycyrrhizin;OATP1B1;f;;Human;;Inhibition
indocyanine green;OATP1B1;f;;Human;;Inhibition
rifampicin;OATP1B1;f;;Human;22541068;Inhibition
rifamycin SV;OATP1B1;f;;Human;12085361;Inhibition
pravastatin;OATP1B1;f;;Human;;Binding
[3H]estradiol-17β-glucuronide;OATP1B1;f;;Human;;None
[3H]estrone-3-sulphate;OATP1B1;f;;Human;;None
cyclosporin A;OATP1B3;f;;Human;17496208|22541068;Inhibition
gemfibrozil;OATP1B3;f;;Human;;Inhibition
glycyrrhizin;OATP1B3;f;;Human;;Inhibition
rifampicin;OATP1B3;f;;Human;17496208|22541068;Inhibition
rifamycin SV;OATP1B3;f;;Human;;Inhibition
sildenafil;OATP1B3;f;;Human;17496208;Inhibition
[3H]BSP;OATP1B3;f;;Human;;None
[3H]CCK-8 (human, mouse, rat);OATP1B3;f;;Human;;None
[3H]estradiol-17β-glucuronide;OATP1B3;f;;Human;;None
DPDPE;OATP1C1;f;;Human;;Inhibition
probenecid;OATP1C1;f;;Human;;Inhibition
taurocholic acid;OATP1C1;f;;Human;;Inhibition
[125I]thyroxine;OATP1C1;f;;Human;;None
[3H]BSP;OATP1C1;f;;Human;;None
[3H]estrone-3-sulphate;OATP1C1;f;;Human;;None
bromocresol green;OATP2A1;f;;Rat;7754369;Inhibition
bromsulphthalein;OATP2A1;f;;Rat;7754369;Inhibition
[3H]PGE2;OATP2A1;f;;Human;9506966;Binding
erlotinib;OATP2B1;f;;Human;22541068;Inhibition
gemfibrozil;OATP2B1;f;;Human;;Inhibition
glibenclamide;OATP2B1;f;;Human;;Inhibition
rifamycin SV;OATP2B1;f;;Human;;Inhibition
sildenafil;OATP2B1;f;;Human;17496208;Inhibition
verlukast;OATP2B1;f;;Human;22541068;Inhibition
[3H]BSP;OATP2B1;f;;Human;;None
[3H]estrone-3-sulphate;OATP2B1;f;;Human;;None
[3H]estrone-3-sulphate;OATP3A1;f;;Human;;None
[3H]PGE2;OATP3A1;f;;Human;;None
[3H]estrone-3-sulphate;OATP4A1;f;;Human;;None
[3H]digoxin;OATP4C1;f;;Human;;None
MK-8719;O-GlcNAcase;f;;Human;31487175;Inhibition
MK-8719;O-GlcNAcase;f;;Rat;31487175;Inhibition
thiamet-G;O-GlcNAcase;f;;Human;18587388;Inhibition
oncostatin M;Oncostatin-M receptor;t;Human;Human;;Agonist
CM4620;Orai1;f;;Human;;Inhibition
GSK-7975A;Orai1;f;;Human;;Inhibition
CRAC channel inhibitor 1 [PMID: 26256403];Orai1;f;;Human;26256403;None
CRAC channel inhibitor 5b [PMID: 26256403];Orai1;f;;Human;26256403;None
CM4620;Orai2;f;;Human;;Inhibition
GSK-7975A;Orai2;f;;Human;;Inhibition
probenecid;Organic anion transporter 1;f;;Human;12472777;Inhibition
cephalothin;Organic anion transporter 3;f;;Human;11909604;Inhibition
cephalothin;Organic anion transporter 4;f;;Human;11909604;Inhibition
clonidine;Organic cation transporter 1;f;;Human;9655880;Inhibition
decynium 22;Organic cation transporter 2;f;;Human;9260930;Inhibition
disprocynium24;Organic cation transporter 3;f;;Human;10196521;Inhibition
APA;Ornithine decarboxylase;f;;Human;1573631;Inhibition
eflornithine;Ornithine decarboxylase;f;;Human;12859253;Inhibition
carbetocin;OT receptor;f;;Mouse;30199637;Agonist
carbetocin;OT receptor;f;;Human;30199637;Agonist
LIT-001;OT receptor;f;;Human;30199637;Agonist
arginine vasotocin;OT receptor;f;;Human;7774575|8955347;Full agonist
dAVP;OT receptor;f;;Human;15084136;Full agonist
d[Cha4]AVP;OT receptor;f;;Human;12446593|16158071;Full agonist
d[Cha4,Dab8]VP;OT receptor;f;;Rat;17300166;Full agonist
d[Cha4]LVP;OT receptor;f;;Rat;17300166;Full agonist
desmopressin;OT receptor;f;;Human;7774575|7475979;Full agonist
d[Leu4]AVP;OT receptor;f;;Human;15084136;Full agonist
d[Leu4,Dap8]VP;OT receptor;f;;Rat;17300166;Full agonist
d[Leu4]LVP;OT receptor;f;;Rat;17300166;Full agonist
oxytocin;OT receptor;t;Human|Mouse|Rat;Human;10519430|7774575|12660315|16158071|7475979|8955347;Full agonist
oxytocin;OT receptor;t;Human|Mouse|Rat;Rat;12660315;Full agonist
[Phe3]OT;OT receptor;f;;Human;7774575|8955347;Full agonist
[3H]OT (human, mouse, rat);OT receptor;f;;Human;7774575|7921228|7475979|6278592;Full agonist
[Thr4,Gly7]OT;OT receptor;f;;Human;7475979|8955347|2827511;Full agonist
[3H]AVP (human, mouse, rat);OT receptor;f;;Human;7774575|11337500;Partial agonist
vasopressin;OT receptor;t;Human|Mouse|Rat;Human;12446593|15084136|10519430|7774575|11337500|16158071|7475979|8955347;Partial agonist
atosiban;OT receptor;f;;Rat;12660315;Antagonist
atosiban;OT receptor;f;;Human;10519430|12660315|14722330|15880385|7475979;Antagonist
balovaptan;OT receptor;f;;Human;31951127;Antagonist
compound 37 [PMID: 16250654];OT receptor;f;;Human;16250654;Antagonist
d(CH2)5[Tyr(Me)2]AVP;OT receptor;f;;Human;7475979;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT;OT receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT;OT receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT;OT receptor;f;;Human;7774575|11337500|8955347;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT;OT receptor;f;;Human;15880385|16158071;Antagonist
desGlyNH2-d(CH2)5[Tyr(Me)2,Thr4,Orn8]OT;OT receptor;f;;Human;;Antagonist
L023103;OT receptor;f;;Rat;16302826;Antagonist
L023103;OT receptor;f;;Human;16302826;Antagonist
L-365,209;OT receptor;f;;Human;7475979;Antagonist
L-366,509;OT receptor;f;;Human;7475979;Antagonist
L-366,682;OT receptor;f;;Human;7475979;Antagonist
L-366,875;OT receptor;f;;Human;7475979;Antagonist
L-366,948;OT receptor;f;;Human;7475979;Antagonist
L-367,773;OT receptor;f;;Human;7475979;Antagonist
L-367,938;OT receptor;f;;Human;7475979;Antagonist
L-368,228;OT receptor;f;;Human;7475979;Antagonist
L-368,899;OT receptor;f;;Human;7475979;Antagonist
L-368,930;OT receptor;f;;Human;7475979;Antagonist
L-369,020;OT receptor;f;;Human;7475979;Antagonist
L-371,257;OT receptor;f;;Human;16158071;Antagonist
L-372662;OT receptor;f;;Human;9622556;Antagonist
LS-192629;OT receptor;f;;Rat;12660315;Antagonist
LS-192629;OT receptor;f;;Human;12660315;Antagonist
[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT;OT receptor;f;;Human;17316912;Antagonist
[Mpa1,D-Tyr(Et)2,D-Tic7]OT;OT receptor;f;;Human;17316912;Antagonist
[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT;OT receptor;f;;Human;17316912;Antagonist
nelivaptan;OT receptor;f;;Human;11861823|16158071;Antagonist
OPC-21268;OT receptor;f;;Human;7475979;Antagonist
relcovaptan;OT receptor;f;;Human;10519430|16158071;Antagonist
retosiban;OT receptor;f;;Human;17395790;Antagonist
Ro5028442;OT receptor;f;;Human;25654260;Antagonist
SSR126768A;OT receptor;f;;Human;14722330;Antagonist
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT;OT receptor;f;;Human;;Antagonist
[35S]non-peptide OT antagonist;OT receptor;f;;Human;12176104;Antagonist
[111In]DOTA-dLVT;OT receptor;f;;Human;12942128;None
MOXR0916;OX40;f;;Human;;Agonist
compound 1 [PMID: 24930776];OX40;f;;Human;24930776;Binding
OX-40 ligand;OX40;t;Human;Human;;None
[3H]5-oxo-ETE;OXE receptor;f;;Human;9829988;Agonist
5-oxo-15-HETE;OXE receptor;t;;Human;7803484|8387490|7797484|8598482;Full agonist
5-oxo-20-HETE;OXE receptor;t;;Human;8598482;Full agonist
5-oxo-C20:3;OXE receptor;t;;Human;18292294;Full agonist
5-oxo-ETE;OXE receptor;t;;Human;7797484|19450703|18292294|9829988|1326548;Full agonist
5-oxo-ODE;OXE receptor;t;;Human;18287092;Full agonist
5S-HETE;OXE receptor;t;;Human;7803484|8387490|16039985;Full agonist
5S-HPETE;OXE receptor;t;;Human;16039985;Full agonist
Gue1654;OXE receptor;f;;Human;22634634;Negative
5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid;OXE receptor;f;;Human;23581530;Antagonist
5-oxo-12-HETE;OXE receptor;t;;Human;9920859;Antagonist
S‐Y048;OXE receptor;f;;Human;31655025;Antagonist
compound 74 [PMID: 24793884];oxidative stress responsive kinase 1;f;;Human;24793884;Inhibition
[3H]LTE4;oxoglutarate receptor;f;;Mouse;23504326;Agonist
α-ketoglutaric acid;oxoglutarate receptor;t;;Human;15141213|23396314;Full agonist
Nag 26;OX1 receptor;f;;Human;26267383;Agonist
[125I]-orexin-A;OX1 receptor;f;;Human;9491897|26582739|25132134;Agonist
[Ala11, D-Leu15]orexin-B;OX1 receptor;f;;Human;12467628|21362456;Full agonist
orexin-A;OX1 receptor;t;Human|Mouse|Rat;Human;9491897|15271651|10498827|14691055|11403934|12606634|12702704|11205421|11266181|20002100|11162621|12208495|17115071|18488139|21718304|22550093|26582739;Full agonist
orexin-B;OX1 receptor;t;Human;Human;9491897|15271651|10498827|14691055|11403934|12606634|11205421|20002100|11162621|12208495|21362456|18488139;Full agonist
ACT-335827;OX1 receptor;f;;Human;23589487;Antagonist
ACT-335827;OX1 receptor;f;;Rat;23589487;Antagonist
ACT-462206;OX1 receptor;f;;Human;25147058;Antagonist
almorexant;OX1 receptor;f;;Human;19751316|19542319|20404073|24376396|22796453;Antagonist
almorexant;OX1 receptor;f;;Human;17259994;Antagonist
compound 11 [PMID: 15261275];OX1 receptor;f;;Human;15261275;Antagonist
compound 1 [PMID: 15261275];OX1 receptor;f;;Human;15261275;Antagonist
Cp-1;OX1 receptor;f;;Human;19751316|19542319;Antagonist
filorexant;OX1 receptor;f;;Human;20565075|22019562|24376396;Antagonist
JNJ-10397049;OX1 receptor;f;;Human;15261275;Antagonist
lemborexant;OX1 receptor;f;;Human;25953512;Antagonist
LSN2424100;OX1 receptor;f;;Human;24478625;Antagonist
MK-1064;OX1 receptor;f;;Human;24376006;Antagonist
MK-3697;OX1 receptor;f;;Human;25248679;Antagonist
SB-334867;OX1 receptor;f;;Human;14691055|11250867|11459658|19751316|19542319|22079339;Antagonist
SB-408124;OX1 receptor;f;;Human;14691055|19542319|23692283;Antagonist
SB-410220;OX1 receptor;f;;Human;14691055;Antagonist
SB-649868;OX1 receptor;f;;Human;20565075|24376396;Antagonist
SB-649868;OX1 receptor;f;;Human;21831639;Antagonist
SB-674042;OX1 receptor;f;;Human;14691055|19751316|19542319|20404073;Antagonist
seltorexant;OX1 receptor;f;;Rat;26177655;Antagonist
seltorexant;OX1 receptor;f;;Human;26177655;Antagonist
[3H]-almorexant;OX1 receptor;f;;Human;19542319|20404073;Antagonist
[3H]SB-674042;OX1 receptor;f;;Human;14691055|19542319|20404073;Antagonist
suvorexant;OX1 receptor;f;;Human;20565075|24376396|23692283;Antagonist
TCS 1102;OX1 receptor;f;;Human;18207395;Antagonist
Nag 26;OX2 receptor;f;;Human;26267383|30194937;Agonist
[125I]-orexin-A;OX2 receptor;f;;Human;9491897|26582739|25132134;Agonist
YNT-185;OX2 receptor;f;;Human;26267383|28507129;Agonist
[Ala11, D-Leu15]orexin-B;OX2 receptor;f;;Human;12467628|21362456;Full agonist
orexin-A;OX2 receptor;t;Human|Mouse|Rat;Human;9491897|10498827|12890892|12606634|12702704|11162621|12208495|18599270|26582739|27237973;Full agonist
orexin-B;OX2 receptor;t;Human;Human;9491897|10498827|12890892|12606634|12702704|11162621|12208495|18599270;Full agonist
ACT-335827;OX2 receptor;f;;Human;23589487;Antagonist
ACT-335827;OX2 receptor;f;;Rat;23589487;Antagonist
ACT-462206;OX2 receptor;f;;Human;25147058;Antagonist
almorexant;OX2 receptor;f;;Human;17259994;Antagonist
compound 11 [PMID: 15261275];OX2 receptor;f;;Human;15261275;Antagonist
compound 1 [PMID: 15261275];OX2 receptor;f;;Human;15261275;Antagonist
Cp-1;OX2 receptor;f;;Human;19751316|19542319;Antagonist
EMPA;OX2 receptor;f;;Human;19751316|19542319|20404073|23692283|21679703;Antagonist
filorexant;OX2 receptor;f;;Human;20565075|22019562|24376396;Antagonist
JNJ-10397049;OX2 receptor;f;;Human;15261275|20565075|21679703;Antagonist
lemborexant;OX2 receptor;f;;Human;25953512;Antagonist
LSN2424100;OX2 receptor;f;;Human;24478625;Antagonist
MK-1064;OX2 receptor;f;;Human;24376006;Antagonist
MK-3697;OX2 receptor;f;;Human;25248679;Antagonist
SB-334867;OX2 receptor;f;;Human;11459658|19542319;Antagonist
SB-408124;OX2 receptor;f;;Human;14691055|19542319;Antagonist
SB-649868;OX2 receptor;f;;Human;20565075|24376396;Antagonist
SB-674042;OX2 receptor;f;;Human;23891187;Antagonist
seltorexant;OX2 receptor;f;;Human;26177655;Antagonist
seltorexant;OX2 receptor;f;;Rat;26177655;Antagonist
[3H]-almorexant;OX2 receptor;f;;Human;19542319|20404073;Antagonist
[3H]Cp-1;OX2 receptor;f;;Human;19542319;Antagonist
[3H]EMPA;OX2 receptor;f;;Human;19751316|20404073;Antagonist
[3H]SB-674042;OX2 receptor;f;;Human;14691055|19542319;Antagonist
suvorexant;OX2 receptor;f;;Human;20565075|24376396|23692283;Antagonist
TCS 1102;OX2 receptor;f;;Human;18207395;Antagonist
TCS-OX2-29;OX2 receptor;f;;Human;14643355|18207395;Antagonist
compound 3 [PMID: 26191365];p21 (RAC1) activated kinase 1;f;;Human;26191365;Negative
compound 1 [PMID: 20005102];p21 (RAC1) activated kinase 1;f;;Human;20005102;Inhibition
compound 4 [PMID: 24432870];p21 (RAC1) activated kinase 1;f;;Human;26191365|24432870;Inhibition
FRAX486;p21 (RAC1) activated kinase 1;f;;Human;23509247;Inhibition
FRAX597;p21 (RAC1) activated kinase 1;f;;Human;23960073;Inhibition
Il-94;p21 (RAC1) activated kinase 1;f;;Human;24900689;Inhibition
IPA-3;p21 (RAC1) activated kinase 1;f;;Human;18420139;Inhibition
PF-3758309;p21 (RAC1) activated kinase 1;f;;Human;24432870;Inhibition
RKI-1447;p21 (RAC1) activated kinase 1;f;;Human;23275831;Inhibition
compound 3 [PMID: 26191365];p21 (RAC1) activated kinase 2;f;;Human;26191365;Negative
compound 4 [PMID: 24432870];p21 (RAC1) activated kinase 2;f;;Human;26191365;Inhibition
FRAX486;p21 (RAC1) activated kinase 2;f;;Human;23509247;Inhibition
FRAX597;p21 (RAC1) activated kinase 2;f;;Human;23960073;Inhibition
Il-94;p21 (RAC1) activated kinase 2;f;;Human;24900689;Inhibition
PF-3758309;p21 (RAC1) activated kinase 2;f;;Human;26191365;Inhibition
PQA-18;p21 (RAC1) activated kinase 2;f;;Human;26827943;Inhibition
staurosporine;p21 (RAC1) activated kinase 2;f;;Human;19397322;Inhibition
compound 4 [PMID: 24432870];p21 (RAC1) activated kinase 3;f;;Human;26191365;Inhibition
FRAX486;p21 (RAC1) activated kinase 3;f;;Human;23509247;Inhibition
FRAX597;p21 (RAC1) activated kinase 3;f;;Human;23960073;Inhibition
PF-3758309;p21 (RAC1) activated kinase 3;f;;Human;26191365;Inhibition
compound 4 [PMID: 24432870];p21 (RAC1) activated kinase 4;f;;Human;26191365;Inhibition
FRAX486;p21 (RAC1) activated kinase 4;f;;Human;23509247;Inhibition
FRAX597;p21 (RAC1) activated kinase 4;f;;Human;23960073;Inhibition
GSK690693;p21 (RAC1) activated kinase 4;f;;Human;18800763;Inhibition
PF-3758309;p21 (RAC1) activated kinase 4;f;;Human;24432870;Inhibition
compound 4 [PMID: 24432870];p21 (RAC1) activated kinase 5;f;;Human;26191365;Inhibition
GSK690693;p21 (RAC1) activated kinase 5;f;;Human;18800763;Inhibition
PF-3758309;p21 (RAC1) activated kinase 5;f;;Human;26191365;Inhibition
compound 4 [PMID: 24432870];p21 (RAC1) activated kinase 6;f;;Human;26191365;Inhibition
GSK690693;p21 (RAC1) activated kinase 6;f;;Human;18800763;Inhibition
PF-3758309;p21 (RAC1) activated kinase 6;f;;Human;26191365;Inhibition
ATP;P2X1;t;;Human;12213051;Agonist
αβ-meATP;P2X1;f;;Human;;Full agonist
BzATP;P2X1;f;;Human;;Full agonist
L-βγ-meATP;P2X1;f;;Human;;Full agonist
MRS 2219;P2X1;f;;Human;9632352;Positive
Ip5I;P2X1;f;;Human;10556935;Antagonist
MRS2159;P2X1;f;;Rat;11462975;Antagonist
NF023;P2X1;f;;Human;10193905;Antagonist
NF279;P2X1;f;;Human;10963748;Antagonist
NF279;P2X1;f;;Human;10650169;Antagonist
NF449;P2X1;f;;Human;15072843;Antagonist
suramin;P2X1;f;;Rat;12213051;Antagonist
TNP-ATP;P2X1;f;;Human;9614197;Antagonist
ATP;P2X2;t;;Rat;18600475;Agonist
NF770;P2X2;f;;Human;23253448;Antagonist
NF778;P2X2;f;;Human;23253448;Antagonist
PSB-10211;P2X2;f;;Human;23253448;Antagonist
suramin;P2X2;f;;Rat;12213051;Antagonist
ATP;P2X3;t;;Human;12213051;Agonist
αβ-meATP;P2X3;f;;Human;;Full agonist
BzATP;P2X3;f;;Human;;Full agonist
spinorphin;P2X3;f;;Human;;Negative
A317491;P2X3;f;;Human;12482951;Antagonist
AF353;P2X3;f;;Human;20590629;Antagonist
AF-906;P2X3;f;;Human;26686393;Antagonist
gefapixant;P2X3;f;;Human;26686393;Antagonist
RO3;P2X3;f;;Human;16465177;Antagonist
suramin;P2X3;f;;Human;12213051;Antagonist
suramin;P2X3;f;;Rat;12213051;Antagonist
TNP-ATP;P2X3;f;;Human;9614197;Antagonist
BLU-5937;P2X3;f;;Human;30902655;Non-competitive
ATP;P2X4;t;;Mouse;12213051;Agonist
ATP;P2X4;f;;Human;10694247;Agonist
ATP;P2X4;f;;Rat;10694247;Agonist
ATP;P2X4;f;;Mouse;10694247;Agonist
ATP;P2X4;t;;Human;12213051;Agonist
αβ-meATP;P2X4;f;;Human;10694247;Partial agonist
αβ-meATP;P2X4;f;;Mouse;10694247;Partial agonist
ivermectin;P2X4;f;;Rat;10460235;Positive
5-BDBD;P2X4;f;;Human;23253448|26686393;Antagonist
BX-430;P2X4;f;;Human;23253448|26686393;Antagonist
NP-1815-PX;P2X4;f;;Human;27576299;Antagonist
paroxetine;P2X4;f;;Human;23253448|26686393;Antagonist
PPADS;P2X4;f;;Human;10694247;Antagonist
PPADS;P2X4;f;;Mouse;10694247;Antagonist
PSB-12062;P2X4;f;;Human;23253448|26686393;Antagonist
ATP;P2X5;t;;Rat;12213051;Agonist
suramin;P2X5;f;;Rat;12213051;Antagonist
ATP;P2X6;t;;Rat;12213051;Agonist
ATP;P2X7;t;;Human;12213051;Agonist
BzATP;P2X7;f;;Human;19558545;Agonist
BzATP;P2X7;f;;Rat;19558545;Agonist
BzATP;P2X7;f;;Mouse;19558545;Agonist
GSK1482160;P2X7;f;;Human;27765863;Binding
AZ10606120;P2X7;f;;Human;18071294;Negative
AZ10606120;P2X7;f;;Human;18071294;Negative
AZ11645373;P2X7;f;;Human;17031385|19309360;Negative
chelerythrine;P2X7;f;;Human;15210579;Negative
GSK1482160;P2X7;f;;Rat;20673717;Negative
GSK1482160;P2X7;f;;Human;20673717;Negative
GW791343;P2X7;f;;Human;18071294|18660826;Negative
KN62;P2X7;f;;Human;15210579|9113369;Negative
clemastine;P2X7;f;;Human;21262970;Positive
GW791343;P2X7;f;;Rat;18071294|18660826;Positive
ivermectin;P2X7;f;;Human;22506590;Positive
LL-37;P2X7;f;Human;Human;18765670;Positive
polymyxin B;P2X7;f;;Human;15383600;Positive
A438079;P2X7;f;;Human;17471177;Antagonist
A740003;P2X7;f;;Human;16982702;Antagonist
A804598;P2X7;f;;Human;;Antagonist
A839977;P2X7;f;;Human;17471177|19558545|19464323;Antagonist
AZ10606120;P2X7;f;;Rat;18071294;Antagonist
AZ10606120;P2X7;f;;Human;18071294;Antagonist
AZ11657312 (salt free);P2X7;f;;Human;;Antagonist
AZ11657312 (salt free);P2X7;f;;Rat;;Antagonist
brilliant blue G;P2X7;f;;Human;10860929;Antagonist
compound 16i [PMID: 31525963];P2X7;f;;Human;31525963;Antagonist
decavanadate;P2X7;f;;Human;16487507;Antagonist
GSK1370319A;P2X7;f;;Human;31525963;Antagonist
GSK1482160;P2X7;f;;Human;31525963;Antagonist
JNJ-47965567;P2X7;f;;Human;23889535;Antagonist
JNJ-47965567;P2X7;f;;Human;23889535;Antagonist
PF-04905428;P2X7;f;;Human;21565499;Antagonist
oxidised ATP;P2X7;f;;Mouse;8463330;Irreversible inhibition
2MeSATP;P2Y11 receptor;f;;Human;10578132;Full agonist
ADPβS;P2Y11 receptor;f;;Human;10578132;Full agonist
AR-C67085;P2Y11 receptor;f;;Human;10578132|15893764;Full agonist
ATP;P2Y11 receptor;t;;Human;10578132|12761346|12213051;Full agonist
ATPγS;P2Y11 receptor;f;;Human;10578132;Full agonist
BzATP;P2Y11 receptor;f;;Human;10578132;Full agonist
dATP;P2Y11 receptor;f;;Human;10578132;Full agonist
NAADP;P2Y11 receptor;f;;Human;17707504;Full agonist
NAD;P2Y11 receptor;f;;Human;16926152;Full agonist
NF546;P2Y11 receptor;f;;Human;19815812;Full agonist
uridine triphosphate;P2Y11 receptor;t;;Human;12761346;Full agonist
NF157;P2Y11 receptor;f;;Human;16250663;Antagonist
NF340;P2Y11 receptor;f;;Human;19815812;Antagonist
NF340;P2Y11 receptor;f;;Human;18404494;Antagonist
reactive blue-2;P2Y11 receptor;f;;Human;10578132;Antagonist
suramin;P2Y11 receptor;f;;Human;10578132;Antagonist
2MeSADP;P2Y12 receptor;f;;Human;15199474;Full agonist
ADP;P2Y12 receptor;t;;Human;15199474;Full agonist
ADPβS;P2Y12 receptor;f;;Human;11502873;Full agonist
[3H]2MeSADP;P2Y12 receptor;f;;Human;11502873;Full agonist
2MeSAMP;P2Y12 receptor;f;;Human;11502873;Antagonist
Ap4A;P2Y12 receptor;f;;Human;12815166;Antagonist
AR-C67085;P2Y12 receptor;f;;Human;23495690;Antagonist
ARL66096;P2Y12 receptor;f;;Human;7582510|7858849;Antagonist
AZD1283;P2Y12 receptor;f;;Human;24670650|24215345;Antagonist
BX 048;P2Y12 receptor;f;;Human;18539312;Antagonist
BX 667;P2Y12 receptor;f;;Human;18539312;Antagonist
cangrelor;P2Y12 receptor;f;;Human;11502873;Antagonist
cangrelor;P2Y12 receptor;f;;Human;12213051;Antagonist
clopidogrel (active metabolite);P2Y12 receptor;f;;Human;15199474;Antagonist
compound 20o [PMID: 22984835];P2Y12 receptor;f;;Human;22984835;Antagonist
compound 4 [PMID: 22984835];P2Y12 receptor;f;;Human;22984835;Antagonist
compound 4 [PMID: 23083103];P2Y12 receptor;f;;Human;23083103;Antagonist
compound 58l [PMID: 30843696];P2Y12 receptor;f;;Human;30843696;Antagonist
INS49266;P2Y12 receptor;f;;Human;18232657;Antagonist
pCMBS;P2Y12 receptor;f;;Human;15199474;Antagonist
PSB-0739;P2Y12 receptor;f;;Human;19690189;Antagonist
PSB-0739;P2Y12 receptor;f;;Human;19463000;Antagonist
R-138727;P2Y12 receptor;f;;Human;16268477;Antagonist
regrelor;P2Y12 receptor;f;;Human;18232657;Antagonist
[3H]PSB-0413;P2Y12 receptor;f;;Human;22892887|16213725;Antagonist
ticagrelor;P2Y12 receptor;f;;Human;22984835;Antagonist
ticagrelor;P2Y12 receptor;f;;Human;17827008;Antagonist
ticagrelor;P2Y12 receptor;f;;Human;25186974;Antagonist
2MeSADP;P2Y13 receptor;f;;Human;12815166;Full agonist
2MeSATP;P2Y13 receptor;f;;Human;12815166;Full agonist
ADP;P2Y13 receptor;t;;Human;12815166;Full agonist
ADPβS;P2Y13 receptor;f;;Human;12815166;Full agonist
ATP;P2Y13 receptor;t;;Human;12815166;Full agonist
ATPγS;P2Y13 receptor;f;;Human;12815166;Full agonist
[33P]2MeSADP;P2Y13 receptor;f;;Human;12815166;Full agonist
2MeSAMP;P2Y13 receptor;f;;Human;12815166;Antagonist
Ap4A;P2Y13 receptor;f;;Human;12815166;Antagonist
cangrelor;P2Y13 receptor;f;;Human;12815166;Antagonist
MRS2211;P2Y13 receptor;f;;Human;15913566;Antagonist
MRS2603;P2Y13 receptor;f;;Human;15913566;Antagonist
PPADS;P2Y13 receptor;f;;Human;12815166;Antagonist
reactive blue-2;P2Y13 receptor;f;;Human;12815166;Antagonist
suramin;P2Y13 receptor;f;;Human;12815166;Antagonist
MRS2690;P2Y14 receptor;f;;Human;17407275|22825617;Agonist
MRS2802;P2Y14 receptor;f;;Human;19902968;Agonist
MRS2905;P2Y14 receptor;f;;Human;21484092;Agonist
MRS4183;P2Y14 receptor;f;;Human;26303895;Agonist
2-thio-UDP;P2Y14 receptor;f;;Human;19902968;Full agonist
α.β-methylene-2-thio-UDP;P2Y14 receptor;f;;Human;19902968;Full agonist
UDP-galactose;P2Y14 receptor;t;;Human;19339661;Full agonist
UDP-galactose;P2Y14 receptor;t;;Mouse;11735218;Full agonist
UDP-galactose;P2Y14 receptor;t;;Rat;11735218;Full agonist
UDP-glucose;P2Y14 receptor;t;;Mouse;11735218;Full agonist
UDP-glucose;P2Y14 receptor;t;;Rat;11735218;Full agonist
UDP-glucose;P2Y14 receptor;f;;Human;19339661;Full agonist
UDP-glucuronic acid;P2Y14 receptor;f;;Human;19339661;Full agonist
UDP-glucuronic acid;P2Y14 receptor;t;;Mouse;11735218;Full agonist
UDP-glucuronic acid;P2Y14 receptor;t;;Rat;11735218;Full agonist
UDP N-acetyl-glucosamine;P2Y14 receptor;t;;Rat;11735218;Full agonist
UDP N-acetyl-glucosamine;P2Y14 receptor;f;;Human;19339661;Full agonist
UDP N-acetyl-glucosamine;P2Y14 receptor;t;;Mouse;11735218;Full agonist
uridine diphosphate;P2Y14 receptor;t;;Rat;18252808;Full agonist
uridine diphosphate;P2Y14 receptor;t;;Human;19759354;Full agonist
MRS4174;P2Y14 receptor;f;;Human;25299434;Antagonist
MRS4458;P2Y14 receptor;f;;Human;29767967;Antagonist
MRS4478;P2Y14 receptor;f;;Human;29767967;Antagonist
PPTN;P2Y14 receptor;f;;Human;23592514;Antagonist
2-Cl-ADP(α-BH3);P2Y1 receptor;f;;Human;23751098;Agonist
ADPβS;P2Y1 receptor;f;;Human;11502873;Agonist
Ap3a;P2Y1 receptor;f;;Rat;16539385;Agonist
Ap5a;P2Y1 receptor;f;;Human;16539385;Agonist
MRS2365;P2Y1 receptor;f;;Human;15345752;Agonist
[35S]ADPβS;P2Y1 receptor;f;;Unknown;;Agonist
[3H]2MeSADP;P2Y1 receptor;f;;Human;11502873;Agonist
2MeSADP;P2Y1 receptor;f;;Human;9154346|12391289;Full agonist
ADP;P2Y1 receptor;t;;Human;9154346|12391289;Full agonist
compound 3a [PMID: 22873688];P2Y1 receptor;f;;Turkey;22873688;Full agonist
2',3'-ddATP;P2Y1 receptor;f;;Human;9154346;Partial agonist
2MeSATP;P2Y1 receptor;f;;Human;9154346|12391289;Partial agonist
ATP;P2Y1 receptor;t;;Human;9154346|12391289;Partial agonist
ATPγS;P2Y1 receptor;f;;Human;9154346;Partial agonist
dATPαS;P2Y1 receptor;f;;Human;9154346;Partial agonist
2,2'-pyridylisatogen tosylate;P2Y1 receptor;f;;Human;15193995;Negative
BMS compound 16 [PMID:23368907];P2Y1 receptor;f;;Human;25822790;Negative
2-chloroadenosine-5-triphosphate;P2Y1 receptor;f;;Human;9547364;Antagonist
2MeSATP;P2Y1 receptor;f;;Human;9547364;Antagonist
A2P5P;P2Y1 receptor;f;;Human;8913364;Antagonist
adenosine-3'-5'-bisphosphate;P2Y1 receptor;f;;Human;8913364;Antagonist
ATP;P2Y1 receptor;t;;Human;9547364;Antagonist
BMS compound 4c;P2Y1 receptor;f;;Human;23668989;Antagonist
GlaxoSmithKline compound 5h [PMID:20542694];P2Y1 receptor;f;;Human;20542694;Antagonist
GlaxoSmithKline compound 6i [PMID:18926700];P2Y1 receptor;f;;Human;18926700;Antagonist
MRS2179;P2Y1 receptor;f;;Human;12391289|8913364;Antagonist
MRS2279;P2Y1 receptor;f;;Human;12391289;Antagonist
MRS2298;P2Y1 receptor;f;;Human;15476670;Antagonist
MRS2496;P2Y1 receptor;f;;Human;15476670;Antagonist
MRS2500;P2Y1 receptor;f;;Human;15476670|14584948;Antagonist
MRS2950;P2Y1 receptor;f;;Human;22831801;Antagonist
Pfizer compound 11 [PMID:18445527];P2Y1 receptor;f;;Human;18445527;Antagonist
Pfizer compound 67 [PMID:18445527];P2Y1 receptor;f;;Human;18445527;Antagonist
PPADS;P2Y1 receptor;f;;Human;12391289;Antagonist
[32P]MRS2500;P2Y1 receptor;f;;Human;16299552;Antagonist
[3H]MRS2279;P2Y1 receptor;f;;Human;12391289;Antagonist
suramin;P2Y1 receptor;f;;Human;12391289;Antagonist
2-thioUTP;P2Y2 receptor;f;;Human;17125260;Agonist
4-thio-UTP;P2Y2 receptor;f;;Human;16475938;Full agonist
5BrUTP;P2Y2 receptor;f;;Human;8564228;Full agonist
Ap4A;P2Y2 receptor;f;;Human;11711032|1393282;Full agonist
ATP;P2Y2 receptor;t;;Human;8564228|11754592|12213051;Full agonist
denufosol;P2Y2 receptor;f;;Human;11206448|12183642|8825364;Full agonist
diquafosol;P2Y2 receptor;f;;Human;11206448;Full agonist
MRS2698;P2Y2 receptor;f;;Human;17302398;Full agonist
MRS2768;P2Y2 receptor;f;;Human;18514530;Full agonist
PSB1114;P2Y2 receptor;f;;Human;17125260|17088057|21417463;Full agonist
uridine triphosphate;P2Y2 receptor;t;;Human;8564228|11754592;Full agonist
UTPγS;P2Y2 receptor;f;;Human;8564228;Full agonist
AR-C118925XX;P2Y2 receptor;f;;Human;15231488;Antagonist
AR-C126313;P2Y2 receptor;f;;Human;17302398;Antagonist
PSB-416;P2Y2 receptor;f;;Human;19419204;Antagonist
reactive blue-2;P2Y2 receptor;f;;Human;10401562;Antagonist
suramin;P2Y2 receptor;f;;Human;9154346|10401562;Antagonist
ATP;P2Y4 receptor;t;;Human;21193033;Agonist
UTPγS;P2Y4 receptor;f;;Unknown;8825364;Agonist
denufosol;P2Y4 receptor;f;;Human;12183642;Full agonist
diquafosol;P2Y4 receptor;f;;Human;16475938;Full agonist
MRS2927;P2Y4 receptor;f;;Human;21528910;Full agonist
MRS4062;P2Y4 receptor;f;;Human;21528910;Full agonist
(N)methanocarba-UTP;P2Y4 receptor;f;;Human;11754592;Full agonist
N4-phenylethoxycytidine-5'-triphosphate;P2Y4 receptor;f;;Human;21528910;Full agonist
uridine triphosphate;P2Y4 receptor;t;;Human;10779375;Full agonist
2-amino-uridine-5'-monophosphate;P2Y4 receptor;f;;Human;21417463;Partial agonist
Ap4A;P2Y4 receptor;f;;Rat;10779375;Partial agonist
ATP;P2Y4 receptor;t;;Rat;9647463|10779375|12213051;Partial agonist
CTP;P2Y4 receptor;f;;Rat;10779375;Partial agonist
guanosine-5'-triphosphate;P2Y4 receptor;f;;Rat;10779375;Partial agonist
guanosine-5'-triphosphate;P2Y4 receptor;f;;Human;10779375;Partial agonist
ITP;P2Y4 receptor;f;;Human;10779375;Partial agonist
ITP;P2Y4 receptor;f;;Rat;9647463|10779375;Partial agonist
uridine triphosphate;P2Y4 receptor;t;;Rat;9647463;Partial agonist
ATP;P2Y4 receptor;f;;Human;10779375;Antagonist
PPADS;P2Y4 receptor;f;;Human;18600475;Antagonist
reactive blue-2;P2Y4 receptor;f;;Rat;9647463;Antagonist
MRS2957;P2Y6 receptor;f;;Human;20446735;Agonist
Rp-5-OMe-UDPαB;P2Y6 receptor;f;;Human;22901672|24970757;Agonist
3-phenacyl-UDP;P2Y6 receptor;f;;Human;17125260;Full agonist
INS48823;P2Y6 receptor;f;;Human;16475938;Full agonist
MRS2693;P2Y6 receptor;f;;Human;16942026;Full agonist
MRS2782;P2Y6 receptor;f;;Human;18514530;Full agonist
UDP-β-S;P2Y6 receptor;f;;Human;16475938;Full agonist
Up3U;P2Y6 receptor;f;;Human;16475938;Full agonist
uridine diphosphate;P2Y6 receptor;t;;Human;8670200;Full agonist
2MeSATP;P2Y6 receptor;f;;Human;8670200;Partial agonist
5BrUTP;P2Y6 receptor;f;;Human;8670200;Partial agonist
ADP;P2Y6 receptor;f;;Human;8670200;Partial agonist
uridine triphosphate;P2Y6 receptor;f;;Human;8670200;Partial agonist
MRS2567;P2Y6 receptor;f;;Human;15081875;Antagonist
MRS2567;P2Y6 receptor;f;;Rat;15081875;Antagonist
MRS2578;P2Y6 receptor;f;;Human;15081875;Antagonist
MRS2578;P2Y6 receptor;f;;Rat;15081875;Antagonist
MRS4162;P2Y6 receptor;f;;Human;24712832;Antagonist
PPADS;P2Y6 receptor;f;;Human;26519900;Antagonist
reactive blue-2;P2Y6 receptor;f;;Human;16475938;Antagonist
reactive blue-2;P2Y6 receptor;f;;Human;26519900;Antagonist
suramin;P2Y6 receptor;f;;Human;26519900;Antagonist
[Ac-His1]PACAP-27;PAC1 receptor;f;;Rat;7774670;Agonist
[Ac-His1]PACAP-27;PAC1 receptor;f;;Rat;7774670;Agonist
[Ala11,22,28]VIP;PAC1 receptor;f;;Human;16930633;Agonist
[Ala11,22,28]VIP;PAC1 receptor;f;;Human;16930633;Agonist
[Arg16]chicken secretin;PAC1 receptor;f;;Rat;9437714;Agonist
BAY 55-9837;PAC1 receptor;f;;Human;11978642;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;PAC1 receptor;f;;Human;11931347;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;PAC1 receptor;f;;Human;11931347;Agonist
maxadilan;PAC1 receptor;f;;Human;16930633;Agonist
maxadilan;PAC1 receptor;f;;Human;16930633;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;10583729;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;11931347;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Rat;7774670;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;10583729;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;11931347;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;16930633;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;10583729;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;10583729;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;10583729;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Rat;7774670;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;16930633;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Rat;7774670;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;10583729;Agonist
PACAP-27;PAC1 receptor;t;Human|Mouse|Rat|Sheep;Rat;7774670;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Rat;8995389;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
PACAP-38;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
PG 99-465;PAC1 receptor;f;;Human;16930633;Agonist
Ro 25-1553;PAC1 receptor;f;;Rat;9145428;Agonist
Ro 25-1553;PAC1 receptor;f;;Human;11931347;Agonist
Ro 25-1553;PAC1 receptor;f;;Human;11931347;Agonist
secretin;PAC1 receptor;f;Pig;Rat;9437714;Agonist
[125I][Ac-His1]PACAP-27;PAC1 receptor;f;;Human;1321043;Agonist
[125I]PACAP-27;PAC1 receptor;f;;Human;11193823;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;11931347;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;11931347;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Rat;9437714;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Rat;7774670;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
VIP;PAC1 receptor;t;Human|Mouse|Rat;Human;10583729;Agonist
[Arg16]chicken secretin;PAC1 receptor;f;;Human;;Full agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;PAC1 receptor;f;;Human;;Full agonist
[125I]VIP (human, mouse, rat);PAC1 receptor;f;;Human;;Full agonist
M65;PAC1 receptor;f;;Human;16930633;Antagonist
M65;PAC1 receptor;f;;Human;16930633;Antagonist
MK-0893;PAC1 receptor;f;;Human;22708876;Antagonist
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28);PAC1 receptor;f;;Human;11931347;Antagonist
PACAP-(6-38);PAC1 receptor;f;;Rat;7774670;Antagonist
PACAP-(6-38);PAC1 receptor;f;;Rat;7774670;Antagonist
PACAP-(6-38);PAC1 receptor;f;;Rat;7774670;Antagonist
PACAP-(6-38);PAC1 receptor;f;;Rat;7774670;Antagonist
PG 97-269;PAC1 receptor;f;;Rat;9437716;Antagonist
PG 97-269;PAC1 receptor;f;;Human;9437714;Antagonist
methylcarbamyl PAF;PAF receptor;f;;Unknown;;Agonist
2-O-ethyl-PAF C-16;PAF receptor;f;;Human;7594622;Full agonist
2-O-methyl-PAF C-18;PAF receptor;f;;Human;7594622;Full agonist
enantio PAF C-16;PAF receptor;f;;Human;7594622;Full agonist
PAF;PAF receptor;t;;Human;7594622;Full agonist
PAF;PAF receptor;t;;Human;1657923|8798529;Full agonist
[3H]PAF;PAF receptor;f;;Human;1657923|11560941;Full agonist
10-OBn-7α-F-gingkolide B;PAF receptor;f;;Mouse;12570381;Antagonist
10-OBn-epi-ginkgolide C;PAF receptor;f;;Mouse;12570381;Antagonist
10-OBn-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
10-OBn-ginkgolide C;PAF receptor;f;;Mouse;12570381;Antagonist
7α-Cl-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-F-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-NHEt-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-NHMe-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-NH2-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-N3-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-OAc-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7α-OCOCH2Ph-ginkgolide B;PAF receptor;f;;Mouse;12570381;Antagonist
7-epi-ginkgolide C;PAF receptor;f;;Mouse;12570381;Antagonist
ABT-299;PAF receptor;f;;Human;8667228;Antagonist
ABT-491;PAF receptor;f;;Human;9151941;Antagonist
apafant;PAF receptor;f;;Human;8798529|8380690;Antagonist
bepafant;PAF receptor;f;;Human;2262914;Antagonist
bepafant;PAF receptor;f;;Human;2170626;Antagonist
BN 50739;PAF receptor;f;;Human;8380690;Antagonist
CV-3988;PAF receptor;f;;Human;2986648;Antagonist
CV-6209;PAF receptor;f;;Human;1657923|15922596;Antagonist
foropafant;PAF receptor;f;;Human;8395255;Antagonist
ginkgolide A;PAF receptor;f;;Mouse;12190325;Antagonist
ginkgolide B;PAF receptor;f;;Mouse;12570381|12190325;Antagonist
ginkgolide C;PAF receptor;f;;Mouse;12190325;Antagonist
ginkgolide J;PAF receptor;f;;Mouse;12190325;Antagonist
israpafant;PAF receptor;f;;Human;1657923;Antagonist
L659989;PAF receptor;f;;Human;2841449;Antagonist
PCA 4248;PAF receptor;f;;Human;2170626;Antagonist
PCA 4248;PAF receptor;f;;Human;2170626;Antagonist
RP-52770;PAF receptor;f;;Human;2831350;Antagonist
rupatadine;PAF receptor;f;;Human;16220969;Antagonist
SCH 37370;PAF receptor;f;;Human;10465415;Antagonist
SCH 40338;PAF receptor;f;;Human;10465415;Antagonist
SDZ 64-412;PAF receptor;f;;Human;3183958;Antagonist
[3H]52770 RP;PAF receptor;f;;Human;2831350;Antagonist
[3H]apafant;PAF receptor;f;;Human;1657923|11560941|7594622;Antagonist
orlistat;pancreatic lipase;f;;Human;;Inhibition
F16357;PAR1;f;;Human;;Agonist
[3H]haTRAP;PAR1;f;;Human;9203642;Agonist
TFLLR-NH2;PAR1;f;;Human;11877318;Full agonist
atopaxar;PAR1;f;;Human;21300059;Antagonist
RWJ-56110;PAR1;f;;Human;10535908;Antagonist
SCH-79797;PAR1;f;;Human;11020444;Antagonist
vorapaxar;PAR1;f;;Human;18447380;Antagonist
2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 ;PAR2;f;;Human;18477767;Agonist
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2;PAR2;f;;Human;18477767;Agonist
AC264613;PAR2;f;;Human;18720984;Agonist
AC-55541;PAR2;f;;Human;18720984;Agonist
AC-98170;PAR2;f;;Human;18720984;Agonist
AY77;PAR2;f;;Human;26819675;Agonist
GB110;PAR2;f;;Human;20873792;Agonist
SLIGKV-NH2;PAR2;f;;Human;18179608;Agonist
SLIGRL-NH2;PAR2;f;;Human;18179608;Agonist
[3H]2-furoyl-LIGRL-NH2;PAR2;f;;Human;15765104;Agonist
trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2;PAR2;f;;Human;10411588;Agonist
2-furoyl-LIGRLO-amide;PAR2;f;;Human;14976230;Full agonist
AZ3451;PAR2;f;;Human;28445455;Negative
AZ3451;PAR2;f;;Human;28445455;Negative
AZ3451;PAR2;f;;Human;28445455;Negative
AZ7188;PAR2;f;;Human;28445455;Antagonist
AZ8838;PAR2;f;;Human;28445455;Antagonist
AZ8838;PAR2;f;;Human;28445455;Antagonist
AZ8838;PAR2;f;;Human;28445455;Antagonist
C391;PAR2;f;;Human;26140338;Antagonist
C391;PAR2;f;;Human;26140338;Antagonist
GB88;PAR2;f;;Human;21806599;Antagonist
I-191;PAR2;f;;Human;29263243;Antagonist
P2pal18s;PAR2;f;;Human;21536878;Antagonist
AYPGKF-NH2;PAR4;f;;Human;;Full agonist
GYPGKF-NH2;PAR4;f;;Human;;Full agonist
GYPGQV-NH2;PAR4;f;;Human;;Full agonist
RAG8;PAR4;f;;Human;28126849;Agonist
BMS-986120;PAR4;f;;Human;28053157;Antagonist
ML354;PAR4;f;;Human;25176330;Antagonist
P4pal-10;PAR4;f;;Human;12357249;Antagonist
UDM-001651;PAR4;f;;Human;31246024;Antagonist
YD-3;PAR4;f;;Human;25176330;Antagonist
PP-242;PAS domain containing serine/threonine kinase;f;;Human;18849971;Inhibition
OTS964;PDZ binding kinase;f;;Human;25338756;Inhibition
compound 3 [PMID: 8410973];pepsinogen A5;f;;Human;8410973;Inhibition
phosphoenolpyruvic acid;peptidase D;f;;Pig;;Inhibition
4-AMBA;Peptide transporter 1;f;;Human;15930458|9882198;Inhibition
Lys[Z(NO2)]-Pro;Peptide transporter 1;f;;Human;11284702;Inhibition
Lys[Z(NO2)]-Val;Peptide transporter 1;f;;Human;14706812;Inhibition
[11C]GlySar;Peptide transporter 1;f;;Human;18344442;None
[14C]GlySar;Peptide transporter 1;f;;Human;11284702|7592745|9610386|27543355|11454935|9374833|15567297|18713951|9379359|9753615|18824524|9092716|10578127|10748266|15974593|8843163|30135242;None
[3H]GlySar;Peptide transporter 1;f;;Human;9706043|22950754|16627568|8956326|20660104|11714740|12538834|16434549|11602669|27903454;None
Lys[Z(NO2)]-Lys[Z(NO2)];Peptide transporter 2;f;;Human;16868651|11752223;Inhibition
Lys[Z(NO2)]-Pro;Peptide transporter 2;f;;Human;;Inhibition
[11C]GlySar;Peptide transporter 2;f;;Human;15781409;None
[14C]GlySar;Peptide transporter 2;f;;Human;7592745|9610386|11454935|9374833|15567297|18713951|18824524|9092716|10578127|10748266|24548120|14715149|7756356;None
[3H]GlySar;Peptide transporter 2;f;;Human;22950754|16434549|27903454|18367661|27836942|26494147;None
[14C]histidine;Peptide transporter 3;f;;Human;11336635;None
[3H]histidine;Peptide transporter 3;f;;Human;11336635;None
[14C]histidine;Peptide transporter 4;f;;Human;9092568|27845049|29305823;Binding
[3H]histidine;Peptide transporter 4;f;;Human;16289537|27543355|22950754|27845049;None
o-F-amidine;peptidyl arginine deiminase 1;f;;Human;21882827;Irreversible inhibition
Cl-amidine;peptidyl arginine deiminase 3;f;;Human;25742366;Inhibition
streptonigrin;peptidyl arginine deiminase 3;f;;None;;Inhibition
compound 14b [PMID: 25742366];peptidyl arginine deiminase 3;f;;Human;25742366;Irreversible inhibition
compound 3 [PMID: 24440480];peptidyl arginine deiminase 3;f;;None;24440480;Irreversible inhibition
Cl-amidine;peptidyl arginine deiminase 4;f;;Human;25742366;Inhibition
streptonigrin;peptidyl arginine deiminase 4;f;;None;20740228;Inhibition
compound 14b [PMID: 25742366];peptidyl arginine deiminase 4;f;;Human;25742366;Irreversible inhibition
compound 3 [PMID: 24440480];peptidyl arginine deiminase 4;f;;None;24440480;Irreversible inhibition
o-F-amidine;peptidyl arginine deiminase 4;f;;Human;21882827;Irreversible inhibition
cyclosporin A;peptidylprolyl isomerase A;f;;Human;1373887;Inhibition
compound 16 [PMID: 31525966];perforin 1;f;;Human;31525966;Inhibition
8S-HETE;Peroxisome proliferator-activated receptor-α;t;;Human;9113986|7592593;Agonist
AD-5061;Peroxisome proliferator-activated receptor-α;f;;Human;11095972|15219816;Agonist
AZD4619;Peroxisome proliferator-activated receptor-α;f;;Human;;Agonist
bezafibrate;Peroxisome proliferator-activated receptor-α;f;;Human;15293980|11779144;Agonist
ciprofibrate;Peroxisome proliferator-activated receptor-α;f;;Human;22381047;Agonist
clofibrate;Peroxisome proliferator-activated receptor-α;f;;Human;9836620|15293980|10691680;Agonist
CP-775146;Peroxisome proliferator-activated receptor-α;f;;Human;18971326;Agonist
DRF 2519;Peroxisome proliferator-activated receptor-α;f;;Human;15140637;Agonist
edaglitazone;Peroxisome proliferator-activated receptor-α;f;;Human;22489042;Agonist
eicosatetranoic acid;Peroxisome proliferator-activated receptor-α;f;;Unknown;8384714|9278144;Agonist
elafibranor;Peroxisome proliferator-activated receptor-α;f;;Human;24428677;Agonist
farglitazar;Peroxisome proliferator-activated receptor-α;f;;Human;15452359|10691680;Agonist
fenofibrate;Peroxisome proliferator-activated receptor-α;f;;Human;15293980;Agonist
gemfibrozil;Peroxisome proliferator-activated receptor-α;f;;Human;21889235;Agonist
GW2331;Peroxisome proliferator-activated receptor-α;f;;Unknown;1324435;Agonist
GW409544;Peroxisome proliferator-activated receptor-α;f;;Human;15293980|11698662;Agonist
GW7647;Peroxisome proliferator-activated receptor-α;f;;Human;10389847|11354382;Agonist
GW9578;Peroxisome proliferator-activated receptor-α;f;;Human;10389847|10508427|11354382;Agonist
imiglitazar;Peroxisome proliferator-activated receptor-α;f;;Human;11095972;Agonist
LTB4;Peroxisome proliferator-activated receptor-α;t;;Unknown;8900274|9171241;Agonist
LY-465608;Peroxisome proliferator-activated receptor-α;f;;Human;11405642|15115385;Agonist
LY-510929;Peroxisome proliferator-activated receptor-α;f;;Human;15115385;Agonist
LY-518674;Peroxisome proliferator-activated receptor-α;f;;Human;14613314;Agonist
MK-0767;Peroxisome proliferator-activated receptor-α;f;;Human;15120604|9836514|10403814;Agonist
N-oleoylethanolamide;Peroxisome proliferator-activated receptor-α;f;;Human;12955147|15910890;Agonist
NS-220;Peroxisome proliferator-activated receptor-α;f;;Human;14982965;Agonist
pirinixic acid;Peroxisome proliferator-activated receptor-α;f;;Human;10691680;Agonist
pristanic acid;Peroxisome proliferator-activated receptor-α;t;;Human;11060349;Agonist
pterostilbene;Peroxisome proliferator-activated receptor-α;f;;None;;Agonist
(R)-16 [PMID: 32267688];Peroxisome proliferator-activated receptor-α;f;;Human;32267688;Agonist
ragaglitazar;Peroxisome proliferator-activated receptor-α;f;;Human;12672231;Agonist
reglitazar;Peroxisome proliferator-activated receptor-α;f;;Human;9932726;Agonist
seladelpar;Peroxisome proliferator-activated receptor-α;f;;Human;17524639;Agonist
TZD18;Peroxisome proliferator-activated receptor-α;f;;Human;14701675;Agonist
GW6471;Peroxisome proliferator-activated receptor-α;f;;Human;11845213;Antagonist
MK-886;Peroxisome proliferator-activated receptor-α;f;;Mouse;11139388;Antagonist
compound 25 [PMID: 32687365];Peroxisome proliferator-activated receptor-β/δ;f;;Human;32687365;Agonist
(R)-16 [PMID: 32267688];Peroxisome proliferator-activated receptor-β/δ;f;;Human;32267688;Agonist
seladelpar;Peroxisome proliferator-activated receptor-β/δ;f;;Human;17524639;Agonist
GW0742X;Peroxisome proliferator-activated receptor-β/δ;f;;Human;15939051|12699745;Full agonist
GW2433;Peroxisome proliferator-activated receptor-β/δ;f;;Human;10691680|9427656;Full agonist
GW501516;Peroxisome proliferator-activated receptor-β/δ;f;;Human;11309497;Full agonist
GW9578;Peroxisome proliferator-activated receptor-β/δ;f;;Human;11354382;Full agonist
L-165041;Peroxisome proliferator-activated receptor-β/δ;f;;Human;10691680|10037770;Full agonist
L-783483;Peroxisome proliferator-activated receptor-β/δ;f;;Human;10037770;Full agonist
L-796449;Peroxisome proliferator-activated receptor-β/δ;f;;Human;15293980|10037770;Full agonist
tretinoin;Peroxisome proliferator-activated receptor-β/δ;t;;Human;12963727;Full agonist
GSK0660;Peroxisome proliferator-activated receptor-β/δ;f;;Human;17975020;Antagonist
edaglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;22489042;Agonist
elafibranor;Peroxisome proliferator-activated receptor-γ;f;;Human;24428677;Agonist
MDG 548;Peroxisome proliferator-activated receptor-γ;f;;Human;22582973;Agonist
(R)-16 [PMID: 32267688];Peroxisome proliferator-activated receptor-γ;f;;Human;32267688;Agonist
rosiglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;11720854;Agonist
seladelpar;Peroxisome proliferator-activated receptor-γ;f;;Human;17524639;Agonist
tagitinin A;Peroxisome proliferator-activated receptor-γ;f;;Human;22424975;Agonist
tirotundin;Peroxisome proliferator-activated receptor-γ;f;;Human;22424975;Agonist
VCE-004.3;Peroxisome proliferator-activated receptor-γ;f;;Human;30033591;Agonist
zafirlukast;Peroxisome proliferator-activated receptor-γ;f;;Human;29878767;Agonist
15-deoxy-Δ-12,14-prostaglandin J2;Peroxisome proliferator-activated receptor-γ;t;;Human;9113987|8521498|9514791|11955950|16198309;Full agonist
AD-5061;Peroxisome proliferator-activated receptor-γ;f;;Human;11095972|15219816;Full agonist
AD5075;Peroxisome proliferator-activated receptor-γ;f;;Human;10037770|12554792;Full agonist
BADGE;Peroxisome proliferator-activated receptor-γ;f;;Human;11030710|10636887;Full agonist
ciglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;9836620;Full agonist
COOH;Peroxisome proliferator-activated receptor-γ;f;;Unknown;14600074|12540599;Full agonist
DRF 2519;Peroxisome proliferator-activated receptor-γ;f;;Unknown;15140637;Full agonist
GW1929;Peroxisome proliferator-activated receptor-γ;f;;Human;10389847;Full agonist
GW2331;Peroxisome proliferator-activated receptor-γ;f;;Unknown;9113987;Full agonist
GW409544;Peroxisome proliferator-activated receptor-γ;f;;Human;15293980|11698662;Full agonist
GW7845;Peroxisome proliferator-activated receptor-γ;f;;Human;9836620|9836622;Full agonist
GW9578;Peroxisome proliferator-activated receptor-γ;f;;Human;11354382;Full agonist
ibuprofen;Peroxisome proliferator-activated receptor-γ;f;;Unknown;11755111|14646253;Full agonist
L-165461;Peroxisome proliferator-activated receptor-γ;f;;Human;10037770;Full agonist
L-783483;Peroxisome proliferator-activated receptor-γ;f;;Human;10037770;Full agonist
L-796449;Peroxisome proliferator-activated receptor-γ;f;;Human;10037770;Full agonist
LG100754;Peroxisome proliferator-activated receptor-γ;f;;Human;11463859|11877384;Full agonist
linoleic acid;Peroxisome proliferator-activated receptor-γ;t;;Human;11301062|14717706;Full agonist
LY-465608;Peroxisome proliferator-activated receptor-γ;f;;Human;11405642;Full agonist
LY-510929;Peroxisome proliferator-activated receptor-γ;f;;Human;3071214|15115385;Full agonist
mesalazine;Peroxisome proliferator-activated receptor-γ;f;;Human;15824083;Full agonist
MK-0767;Peroxisome proliferator-activated receptor-γ;f;;Human;9836514|10403814;Full agonist
MK-0767;Peroxisome proliferator-activated receptor-γ;f;;Human;15120604;Full agonist
netoglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;9830009;Full agonist
pioglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;9836620|11095972|9454824;Full agonist
ragaglitazar;Peroxisome proliferator-activated receptor-γ;f;;Human;12672231|12970088|15655531;Full agonist
reglitazar;Peroxisome proliferator-activated receptor-γ;f;;Human;9932726;Full agonist
rosiglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;9836620|9013583|9454824;Full agonist
SB-219993;Peroxisome proliferator-activated receptor-γ;f;;Human;9454824;Full agonist
SB-219994;Peroxisome proliferator-activated receptor-γ;f;;Human;9454824;Full agonist
[125I]SB-236636;Peroxisome proliferator-activated receptor-γ;f;;Human;9454824;Full agonist
[3H]AD5075;Peroxisome proliferator-activated receptor-γ;f;;Human;8828476;Full agonist
[3H]GW2331;Peroxisome proliferator-activated receptor-γ;f;;Unknown;9113987;Full agonist
troglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;9836620|9454824;Full agonist
troglitazone;Peroxisome proliferator-activated receptor-γ;f;;Human;8828476;Full agonist
TZD18;Peroxisome proliferator-activated receptor-γ;f;;Human;14701675;Full agonist
bardoxolone;Peroxisome proliferator-activated receptor-γ;f;;Human;11043571;Partial agonist
diclofenac;Peroxisome proliferator-activated receptor-γ;f;;Unknown;14646253;Partial agonist
farglitazar;Peroxisome proliferator-activated receptor-γ;f;;Human;9836620|14717706;Partial agonist
FMOC-L-Leucine;Peroxisome proliferator-activated receptor-γ;f;;Human;11684010;Partial agonist
GW0072;Peroxisome proliferator-activated receptor-γ;f;;Human;10339548;Partial agonist
indomethacin;Peroxisome proliferator-activated receptor-γ;f;;Human;11301062|9013583;Partial agonist
L-764406;Peroxisome proliferator-activated receptor-γ;f;;Human;10075686;Partial agonist
MRL20;Peroxisome proliferator-activated receptor-γ;f;;Human;15603954;Partial agonist
MRL24;Peroxisome proliferator-activated receptor-γ;f;;Human;15603954;Partial agonist
nTzDpa;Peroxisome proliferator-activated receptor-γ;f;;Human;12554792;Partial agonist
PAT5A;Peroxisome proliferator-activated receptor-γ;f;;Human;12730351|11092504;Partial agonist
triple modulator 10 [PMID: 29878767];Peroxisome proliferator-activated receptor-γ;f;;Human;29878767;Partial agonist
BADGE;Peroxisome proliferator-activated receptor-γ;f;;Human;10636887;Antagonist
bexarotene;Peroxisome proliferator-activated receptor-γ;f;;Human;26451138;Antagonist
CDDO-Me;Peroxisome proliferator-activated receptor-γ;f;;Human;11043571;Antagonist
diclofenac;Peroxisome proliferator-activated receptor-γ;f;;Human;11752200;Antagonist
resveratrol;Peroxisome proliferator-activated receptor-γ;f;;Human;24796862;Antagonist
T0070907;Peroxisome proliferator-activated receptor-γ;f;;Human;11877444;Antagonist
GW9662;Peroxisome proliferator-activated receptor-γ;f;;Human;12022867;Irreversible inhibition
daminozide;PHD finger protein 8;f;;Human;22724510;Inhibition
LY134046;Phenylethanolamine N-methyltransferase;f;;Human;6268095;Inhibition
P6949;phosphatase and tensin homolog;f;;Human;22705189;Inhibition
compound 12b [PMID: 31465220];phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;31465220;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;31855425;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;31855425;Inhibition
compound 82 [PMID: 21332118];phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;21332118;Inhibition
PIK-III;phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;25327288;Inhibition
PQR620;phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;30359003;Inhibition
SAR260301;phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;24387221;Inhibition
SAR405;phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;25326666;Inhibition
torin 2;phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;21322566;Inhibition
VPS34-IN-1;phosphatidylinositol 3-kinase catalytic subunit type 3;f;;Human;;Inhibition
PIK-108;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;22524426;Negative
acalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24133210;Inhibition
alpelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;23726034;Inhibition
AMG319;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;25469863;Inhibition
apitolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;21981714;Inhibition
AS-252424;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;16789742;Inhibition
AZ2;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;30718815;Inhibition
AZD6482;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;22906130;Inhibition
AZD7648;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;31851518;Inhibition
AZD8154;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
AZD8186;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;25398829;Inhibition
AZD8835;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;26475521;Inhibition
BGT-226;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;22357447;Inhibition
bimiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
buparlisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24900266;Inhibition
compound 11j [PMID: 23021994];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;23021994;Inhibition
compound 12b [PMID: 31465220];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;31465220;Inhibition
compound 15a [PMID: 32069401];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;32069401;Inhibition
compound 15 [PMID: 29852070];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;29852070;Inhibition
compound 22 [PMID: 24754609];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24754609;Inhibition
compound 2q [PMID: 30986068];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;30986068;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;31855425;Inhibition
compound 52 [PMID: 28541707];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;28541707;Inhibition
compound 5d [PMID: 31335136];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;31335136;Inhibition
compound 7 [PMID: 31955578];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;31955578;Inhibition
compound 82 [PMID: 21332118];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;21332118;Inhibition
copanlisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24170767;Inhibition
dactolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;18606717;Inhibition
dezapelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
duvelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24211136;Inhibition
eCF309;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
Example 51 [WO2012135160A1];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
fimepinostat;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;22693356;Inhibition
GDC-0077;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
gedatolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;20166697;Inhibition
GSK1059615;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24900173;Inhibition
HS-173;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;21388141;Inhibition
idelalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;20959606;Inhibition
IPI549;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;27660692;Inhibition
KU-0060648;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;23855836;Inhibition
leniolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
LY 294002;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;19297156|23855836;Inhibition
MEN1611;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;21316229;Inhibition
nemiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;26301626;Inhibition
neolymphostin A;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;30380865;Inhibition
omipalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24900173;Inhibition
panulisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;25700704;Inhibition
paxalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;27096040;Inhibition
PF-04691502;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24900269;Inhibition
PI-103;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;19584227;Inhibition
PI 3-Kg inhibitor;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;16127437;Inhibition
PI 3-Kg inhibitor II;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;16127437;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;18754654;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;17601739;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;16647110;Inhibition
pilaralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
PP121;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;18849971;Inhibition
PQR620;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;30359003;Inhibition
PQR620;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;30359003;Inhibition
puquitinib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;28418085;Inhibition
quinostatin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;17462572;Inhibition
quinostatin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;17462572;Inhibition
RV1729;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
RV6153;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
samotolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
sapanisertib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;22367541;Inhibition
SAR260301;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;24387221;Inhibition
seletalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;28442583;Inhibition
serabelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;23662903;Inhibition
tenalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
TG-100-115;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;17685602;Inhibition
VS-5584;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;23270925;Inhibition
wortmannin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;15658870;Inhibition
wortmannin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;30380865;Inhibition
ZSTK474;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha;f;;Human;;Inhibition
PIK-108;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;22524426;Negative
acalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24133210;Inhibition
alpelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;23726034;Inhibition
AMG319;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;25469863;Inhibition
apitolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;21981714;Inhibition
AZ2;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;30718815;Inhibition
AZD6482;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;22906130;Inhibition
AZD8154;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
AZD8186;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;25398829;Inhibition
AZD8835;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;26475521;Inhibition
BGT-226;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;22357447;Inhibition
bimiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
compound 12b [PMID: 31465220];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;31465220;Inhibition
compound 15a [PMID: 32069401];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;32069401;Inhibition
compound 15 [PMID: 29852070];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;29852070;Inhibition
compound 20f [PMID: 28520415];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;28520415;Inhibition
compound 2q [PMID: 30986068];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;30986068;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;31855425;Inhibition
compound 5d [PMID: 31335136];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;31335136;Inhibition
compound 82 [PMID: 21332118];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;21332118;Inhibition
copanlisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24170767;Inhibition
dezapelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
duvelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24211136;Inhibition
Example 51 [WO2012135160A1];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
fimepinostat;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;22693356;Inhibition
GDC-0077;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
idelalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;20959606;Inhibition
IPI549;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;27660692;Inhibition
KU-0060648;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;23855836;Inhibition
LY 294002;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24533473;Inhibition
LY 294002;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;23855836;Inhibition
MEN1611;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;21316229;Inhibition
nemiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;26301626;Inhibition
neolymphostin A;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;30380865;Inhibition
omipalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24900173;Inhibition
panulisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;25700704;Inhibition
PI-103;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;19584227;Inhibition
PI-3065;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24919154;Inhibition
PI 3-Kg inhibitor;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;16127437;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;18754654;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;17601739;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;16647110;Inhibition
pilaralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
PP121;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;18849971;Inhibition
puquitinib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;28418085;Inhibition
RV6153;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
samotolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
SAR260301;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;24387221;Inhibition
seletalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;28442583;Inhibition
serabelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;23662903;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
tenalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;;Inhibition
TG-100-115;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;17685602;Inhibition
TGX-221;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;15834429;Inhibition
VS-5584;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;23270925;Inhibition
wortmannin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;30380865;Inhibition
ZSTK474;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta;f;;Human;16622124;Inhibition
compound 20f [PMID: 28520415];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;28520415;Inhibition
PIK-108;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;22524426;Negative
acalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24133210;Inhibition
alpelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;23726034;Inhibition
AMG319;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;25469863;Inhibition
apitolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;21981714;Inhibition
AZ2;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;30718815;Inhibition
AZD6482;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;22906130;Inhibition
AZD8154;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
AZD8186;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;25398829;Inhibition
AZD8835;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;26475521;Inhibition
bimiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
compound 15a [PMID: 32069401];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;32069401;Inhibition
compound 15 [PMID: 29852070];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;29852070;Inhibition
compound 2q [PMID: 30986068];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;30986068;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;31855425;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;31855425;Inhibition
compound 52 [PMID: 28541707];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;28541707;Inhibition
compound 5d [PMID: 31335136];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;31335136;Inhibition
compound 7 [PMID: 31955578];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;31955578;Inhibition
compound 82 [PMID: 21332118];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;21332118;Inhibition
copanlisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24170767;Inhibition
dactolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;18606717;Inhibition
dezapelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
duvelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24211136;Inhibition
eCF309;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
Example 51 [WO2012135160A1];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
fimepinostat;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;22693356;Inhibition
GDC-0077;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
IC-87114;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;15975507;Inhibition
IC-87114;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;12594293;Inhibition
idelalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;20959606;Inhibition
IPI549;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;27660692;Inhibition
KU-0060648;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;23855836;Inhibition
leniolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
linperlisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
LY 294002;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;23855836;Inhibition
LY 294002;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24533473;Inhibition
MEN1611;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;21316229;Inhibition
nemiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;26301626;Inhibition
neolymphostin A;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;30380865;Inhibition
omipalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24900173;Inhibition
panulisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;25700704;Inhibition
parsaclisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
PI-103;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;19584227;Inhibition
PI-3065;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24919154;Inhibition
PI 3-Kg inhibitor;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;16127437;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;18754654;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;16647110;Inhibition
pilaralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
PP121;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;18849971;Inhibition
puquitinib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;28418085;Inhibition
RV1729;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
RV6153;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
samotolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
sapanisertib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;22367541;Inhibition
SAR260301;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;24387221;Inhibition
seletalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;28442583;Inhibition
serabelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
STK16-IN-1;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;27082499;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;23662903;Inhibition
tenalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
TG-100-115;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;17685602;Inhibition
TGX-221;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;15834429;Inhibition
torin 2;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;21322566;Inhibition
umbralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;;Inhibition
VS-5584;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;23270925;Inhibition
wortmannin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;30380865;Inhibition
ZSTK474;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta;f;;Human;16622124;Inhibition
acalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;24133210;Inhibition
alpelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;23726034;Inhibition
AMG319;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;25469863;Inhibition
apitolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;21981714;Inhibition
AS-252424;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;16789742;Inhibition
AZ2;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;30718815;Inhibition
AZ2;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;30718815;Inhibition
AZD6482;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;22906130;Inhibition
AZD7648;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;31851518;Inhibition
AZD8154;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
AZD8186;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;25398829;Inhibition
AZD8835;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;26475521;Inhibition
berzosertib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;23222511;Inhibition
BGT-226;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;22357447;Inhibition
bimiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
compound 11j [PMID: 23021994];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;23021994;Inhibition
compound 15a [PMID: 32069401];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;32069401;Inhibition
compound 15 [PMID: 29852070];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;29852070;Inhibition
compound 22 [PMID: 24754609];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;24754609;Inhibition
compound 2q [PMID: 30986068];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;30986068;Inhibition
compound 41 [PMID: 31855425];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;31855425;Inhibition
compound 52 [PMID: 28541707];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;28541707;Inhibition
compound 5d [PMID: 31335136];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;31335136;Inhibition
compound 82 [PMID: 21332118];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;21332118;Inhibition
copanlisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;24170767;Inhibition
CZC 24832;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;22544264;Inhibition
CZC 24832;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;22544264;Inhibition
dactolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;18606717;Inhibition
dezapelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
duvelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;24211136;Inhibition
eCF309;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
Example 51 [WO2012135160A1];phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
fimepinostat;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;22693356;Inhibition
GDC-0077;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
idelalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;20959606;Inhibition
IPI549;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;27660692;Inhibition
KU-0060648;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;23855836;Inhibition
LY 294002;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;19297156|23855836;Inhibition
MEN1611;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;21316229;Inhibition
nemiralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;26301626;Inhibition
neolymphostin A;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;30380865;Inhibition
omipalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;24900173;Inhibition
panulisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;25700704;Inhibition
PI-103;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;19584227;Inhibition
PI 3-Kg inhibitor;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;16127437;Inhibition
PI 3-Kg inhibitor II;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;16127437;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
pictilisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;18754654;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;16647110;Inhibition
PIK-75;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;17601739;Inhibition
pilaralisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
PP121;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;18849971;Inhibition
puquitinib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;28418085;Inhibition
quinostatin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;17462572;Inhibition
RV1729;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
RV6153;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
samotolisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
sapanisertib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;22367541;Inhibition
seletalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;28442583;Inhibition
serabelisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
STK16-IN-1;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;27082499;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
taselisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;23662903;Inhibition
tenalisib;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;;Inhibition
TG-100-115;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;17685602;Inhibition
VS-5584;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;23270925;Inhibition
wortmannin;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;30380865;Inhibition
ZSTK474;phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma;f;;Human;16622124;Inhibition
phenylarsine oxide;phosphatidylinositol 4-kinase alpha;f;;Human;11923287;Inhibition
wortmannin;phosphatidylinositol 4-kinase alpha;f;;Human;9020160|10101268;Inhibition
PIK-93;phosphatidylinositol 4-kinase beta;f;;Human;16647110|18077555;Inhibition
torin 2;phosphatidylinositol 4-kinase beta;f;;Human;21322566;Inhibition
wortmannin;phosphatidylinositol 4-kinase beta;f;;Human;9020160|10101268;Inhibition
adenosine;phosphatidylinositol 4-kinase type 2 alpha;f;;Human;21704602;Inhibition
adenosine;phosphatidylinositol 4-kinase type 2 beta;f;;Human;21704602;Inhibition
torin 2;phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha;f;;Human;21322566;Inhibition
PI-103;phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta;f;;Human;17601739;Inhibition
torin 2;phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta;f;;Human;21322566;Inhibition
SAR260301;phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma;f;;Human;24387221;Inhibition
ISA-2011B;phosphatidylinositol-4-phosphate 5-kinase type 1 alpha;f;;Human;25071204;Inhibition
compound 19 [PMID: 22142545];phosphodiesterase 10A;f;;Human;22142545;Inhibition
compound 27 [PMID: 22142545];phosphodiesterase 10A;f;;Human;22142545;Inhibition
mardepodect;phosphodiesterase 10A;f;;Human;19630403;Inhibition
PDE4 inhibitor 16;phosphodiesterase 10A;f;;Human;31099559;Inhibition
BC11-38;phosphodiesterase 11A;f;;Human;22284362;Inhibition
tadalafil;phosphodiesterase 11A;f;;Human;21189023;Inhibition
calmodulin;phosphodiesterase 1A;t;Human;Human;;Activation
crisaborole;phosphodiesterase 1A;f;;Human;19303290;Inhibition
SCH51866;phosphodiesterase 1A;f;;Human;8961086;Inhibition
vinpocetine;phosphodiesterase 1A;f;;Human;8557689;Inhibition
calmodulin;phosphodiesterase 1B;t;Human;Human;;Activation
SCH51866;phosphodiesterase 1B;f;;Human;8961086;Inhibition
calmodulin;phosphodiesterase 1C;t;Human;Human;;Activation
compound 3m [PMID: 32603117];phosphodiesterase 1C;f;;Human;32603117;Inhibition
SCH51866;phosphodiesterase 1C;f;;Human;8961086;Inhibition
vinpocetine;phosphodiesterase 1C;f;;Human;8557689;Inhibition
cyclic GMP;phosphodiesterase 2A;t;;Human;;Activation
BAY607550;phosphodiesterase 2A;f;;Human;15555642;Inhibition
EHNA;phosphodiesterase 2A;f;;Human;8730511;Inhibition
milrinone;phosphodiesterase 2A;f;;Human;10644042;Inhibition
anagrelide;phosphodiesterase 3A;f;;Human;1321910|3027338|1311763;Inhibition
cilostamide;phosphodiesterase 3A;f;;Human;10644042;Inhibition
cilostazol;phosphodiesterase 3A;f;;Human;10644042;Inhibition
cyclic GMP;phosphodiesterase 3A;t;;Human;;Inhibition
enoximone;phosphodiesterase 3A;f;;Human;3027339;Inhibition
ibudilast;phosphodiesterase 3A;f;;Human;21530250;Inhibition
inamrinone;phosphodiesterase 3A;f;;Human;2536438;Inhibition
milrinone;phosphodiesterase 3A;f;;Human;10644042|14592490;Inhibition
cilostamide;phosphodiesterase 3B;f;;Human;10644042;Inhibition
cilostazol;phosphodiesterase 3B;f;;Human;10644042;Inhibition
cyclic GMP;phosphodiesterase 3B;t;;Human;;Inhibition
inamrinone;phosphodiesterase 3B;f;;Human;10644042;Inhibition
milrinone;phosphodiesterase 3B;f;;Human;10644042;Inhibition
apremilast;phosphodiesterase 4A;f;;Human;24882690;Inhibition
CDP840;phosphodiesterase 4A;f;;Human;9631241;Inhibition
ibudilast;phosphodiesterase 4A;f;;Human;18686943;Inhibition
MK-0359;phosphodiesterase 4A;f;;Human;17428447;Inhibition
MK-0873;phosphodiesterase 4A;f;;Human;18835163;Inhibition
revamilast;phosphodiesterase 4A;f;;Human;;Inhibition
Ro20-1724;phosphodiesterase 4A;f;;Human;9177268;Inhibition
rolipram;phosphodiesterase 4A;f;;Human;9177268;Inhibition
RS-25344;phosphodiesterase 4A;f;;Human;9720765;Inhibition
UFM24;phosphodiesterase 4A;f;;Human;28263828;Inhibition
YM976;phosphodiesterase 4A;f;;Human;10991987;Inhibition
apremilast;phosphodiesterase 4B;f;;Human;24882690;Inhibition
CBS-3595;phosphodiesterase 4B;f;;Human;28613871;Inhibition
CDP840;phosphodiesterase 4B;f;;Human;9631241;Inhibition
crisaborole;phosphodiesterase 4B;f;;Human;19303290;Inhibition
ibudilast;phosphodiesterase 4B;f;;Human;18686943;Inhibition
MK-0359;phosphodiesterase 4B;f;;Human;17428447;Inhibition
Ro20-1724;phosphodiesterase 4B;f;;Human;9177268;Inhibition
roflumilast;phosphodiesterase 4B;f;;Human;19195882;Inhibition
roflupram;phosphodiesterase 4B;f;;None;28605578;Inhibition
rolipram;phosphodiesterase 4B;f;;Human;9177268;Inhibition
RS-25344;phosphodiesterase 4B;f;;Human;9720765;Inhibition
UFM24;phosphodiesterase 4B;f;;Human;28263828;Inhibition
apremilast;phosphodiesterase 4C;f;;Human;24882690;Inhibition
CDP840;phosphodiesterase 4C;f;;Human;9631241;Inhibition
ibudilast;phosphodiesterase 4C;f;;Human;18686943;Inhibition
MK-0359;phosphodiesterase 4C;f;;Human;17428447;Inhibition
Ro20-1724;phosphodiesterase 4C;f;;Human;9177268;Inhibition
rolipram;phosphodiesterase 4C;f;;Human;9177268;Inhibition
RS-25344;phosphodiesterase 4C;f;;Human;9720765;Inhibition
UFM24;phosphodiesterase 4C;f;;Human;28263828;Inhibition
BPN14770;phosphodiesterase 4D;f;;Human;31013090;Negative
BPN14770;phosphodiesterase 4D;f;;Human;31013090;Negative
BPN14770;phosphodiesterase 4D;f;;Human;31013090;Negative
BPN14770;phosphodiesterase 4D;f;;Human;31013090;Negative
apremilast;phosphodiesterase 4D;f;;Human;24882690;Inhibition
CBS-3595;phosphodiesterase 4D;f;;Human;28613871;Inhibition
CDP840;phosphodiesterase 4D;f;;Human;9631241;Inhibition
compound 29 [Moslin et al., 2017];phosphodiesterase 4D;f;;Human;30108788;Inhibition
compound 3m [PMID: 32603117];phosphodiesterase 4D;f;;Human;32603117;Inhibition
difamilast;phosphodiesterase 4D;f;;Human;;Inhibition
MK-0359;phosphodiesterase 4D;f;;Human;17428447;Inhibition
PDE4 inhibitor 16;phosphodiesterase 4D;f;;Human;31099559;Inhibition
Ro20-1724;phosphodiesterase 4D;f;;Human;9177268;Inhibition
rolipram;phosphodiesterase 4D;f;;Human;9177268;Inhibition
RS-25344;phosphodiesterase 4D;f;;Human;9720765;Inhibition
UFM24;phosphodiesterase 4D;f;;Human;28263828;Inhibition
compound 3m [PMID: 32603117];phosphodiesterase 5A;f;;Human;32603117;Inhibition
compound 53 [PMID: 19631533];phosphodiesterase 5A;f;;Human;19631533;Inhibition
gisadenafil;phosphodiesterase 5A;f;;Human;22100260;Inhibition
ibudilast;phosphodiesterase 5A;f;;Human;21530250;Inhibition
icariside II;phosphodiesterase 5A;f;;None;31658364;Inhibition
milrinone;phosphodiesterase 5A;f;;Human;;Inhibition
nitrosoprodenafil;phosphodiesterase 5A;f;;Human;21145686;Inhibition
PF-00489791;phosphodiesterase 5A;f;;Human;;Inhibition
SCH51866;phosphodiesterase 5A;f;;Human;8961086;Inhibition
sildenafil;phosphodiesterase 5A;f;;Human;10385692|23137303;Inhibition
T0156;phosphodiesterase 5A;f;;Human;12450574;Inhibition
tadalafil;phosphodiesterase 5A;f;;Human;21189023;Inhibition
vardenafil;phosphodiesterase 5A;f;;Human;15837326;Inhibition
zaprinast;phosphodiesterase 5A;f;;Human;10385692;Inhibition
compound 53 [PMID: 19631533];phosphodiesterase 6A;f;;Human;19631533;Inhibition
PDE4 inhibitor 16;phosphodiesterase 6C;f;;Human;31099559;Inhibition
sildenafil;phosphodiesterase 6C;f;;Human;23137303;Inhibition
BRL50481;phosphodiesterase 7A;f;;Human;15371556|20228279;Inhibition
crisaborole;phosphodiesterase 7A;f;;Human;19303290;Inhibition
BRL50481;phosphodiesterase 7B;f;;Human;20228279;Inhibition
dipyridamole;phosphodiesterase 7B;f;;Human;10872825|10814504;Inhibition
SCH51866;phosphodiesterase 7B;f;;Human;10814504;Inhibition
dipyridamole;phosphodiesterase 8A;f;;Human;9618252;Inhibition
PF-04957325;phosphodiesterase 8A;f;;Human;24687066;Inhibition
dipyridamole;phosphodiesterase 8B;f;;Human;9784418;Inhibition
SCH51866;phosphodiesterase 9A;f;;Human;9624146;Inhibition
zaprinast;phosphodiesterase 9A;f;;Human;9624146;Inhibition
apilimod;phosphoinositide kinase, FYVE-type zinc finger containing;f;;Human;23890009;Inhibition
apilimod;phosphoinositide kinase, FYVE-type zinc finger containing;f;;Human;23890009;Inhibition
cinnamic acid;phosphomevalonate kinase;f;;Rat;226078;Competitive
isoferulic acid;phosphomevalonate kinase;f;;Rat;226078;Competitive
(R)-5-diphosphomevalonate;phosphomevalonate kinase;t;;Human;17902708;Competitive
3-hydroxy-3-methyl-6-phosphohexanoic acid;phosphomevalonate kinase;f;;Rat;;Inhibition
pemetrexed;phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase;f;;Mouse;9762351;Inhibition
A-443654;phosphorylase kinase catalytic subunit gamma 1;f;;Human;19465931;Inhibition
compound 2c [PMID: 24900538];phosphorylase kinase catalytic subunit gamma 2;f;;Human;24900538;Inhibition
staurosporine;phosphorylase kinase catalytic subunit gamma 2;f;;Human;19397322;Inhibition
Jedi1;Piezo1;f;;Mouse;29610524;Activation
Jedi2;Piezo1;f;;Mouse;29610524;Activation
Yoda1;Piezo1;f;;Human;26001275;Activation
Yoda1;Piezo1;f;;Mouse;26001275;Activation
Dooku1;Piezo1;f;;Human;29498036;Inhibition
Dooku1;Piezo1;f;;Human;29498036;Inhibition
Akt inhibitor X;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;;Inhibition
AZD1208;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;24900629;Inhibition
compound 14k [PMID: 21982499];Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;21982499;Inhibition
compound 20 [PMID: 22136433];Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;22136433;Inhibition
compound 28 [PMID: 30624936];Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;30624936;Inhibition
compound 2 [PMID: 22560567];Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;22560567;Inhibition
CX-5011;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;21870818;Inhibition
CX-5279;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;21870818;Inhibition
CX-6258;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;24900437;Inhibition
INCB053914;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;29927999;Inhibition
leucettine L41;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;21615147;Inhibition
LGB321;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;24474669;Inhibition
PIM447;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;26505898;Inhibition
ruboxistaurin;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;18077363;Inhibition
SGI-1776;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;22924342;Inhibition
silmitasertib;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;21870818;Inhibition
voruciclib;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;26606677;Inhibition
XL413;Pim-1 proto-oncogene, serine/threonine kinase;f;;Human;22560567;Inhibition
AZD1208;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;24900629;Inhibition
compound 14k [PMID: 21982499];Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;21982499;Inhibition
compound 28 [PMID: 30624936];Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;30624936;Inhibition
CX-6258;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;24900437;Inhibition
INCB053914;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;29927999;Inhibition
LGB321;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;24474669;Inhibition
PIM447;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;26505898;Inhibition
ruboxistaurin;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;18077363;Inhibition
SGI-1776;Pim-2 proto-oncogene, serine/threonine kinase;f;;Human;22924342;Inhibition
AZD1208;Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;24900629;Inhibition
compound 14k [PMID: 21982499];Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;21982499;Inhibition
compound 1a [PMID: 24900749];Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;24900749;Inhibition
compound 20 [PMID: 22136433];Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;22136433;Inhibition
CX-6258;Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;24900437;Inhibition
INCB053914;Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;29927999;Inhibition
LGB321;Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;24474669;Inhibition
PIM447;Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;26505898;Inhibition
SGI-1776;Pim-3 proto-oncogene, serine/threonine kinase;f;;Human;22924342;Inhibition
IS1;PKR1;f;;Human;25831128;Agonist
IS20;PKR1;f;;Human;25831128;Agonist
[125I]BH-MIT1;PKR1;f;;Human;12054613;Agonist
MIT1;PKR1;f;;Human;12054613;Full agonist
prokineticin-1;PKR1;t;Human;Human;12054613|15772293;Full agonist
prokineticin-2;PKR1;t;Human;Human;12054613|15772293;Full agonist
prokineticin-2β;PKR1;t;Human;Human;15772293;Full agonist
triazine compound PC1;PKR1;f;;Human;19006379;Antagonist
triazine compound PC10;PKR1;f;;Human;21421710;Antagonist
triazine compound PC7;PKR1;f;;Human;19375913|21421710;Antagonist
[125I]BH-MIT1;PKR2;f;;Human;12054613;Agonist
MIT1;PKR2;f;;Human;12054613;Full agonist
prokineticin-1;PKR2;t;Human;Human;12054613|15772293;Full agonist
prokineticin-2;PKR2;t;Human;Human;12054613|15772293;Full agonist
prokineticin-2β;PKR2;t;Human;Human;15772293;Full agonist
PKR-A;PKR2;f;;Human;22431614;Antagonist
triazine compound PC1;PKR2;f;;Human;19006379;Antagonist
triazine compound PC10;PKR2;f;;Human;21421710;Antagonist
cimetidine;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
decynium 22;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
desipramine;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
dipyridamole;Plasma membrane monoamine transporter;f;;Human;24021350;Inhibition
fluoxetine;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
quinidine;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
quinine;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
rhodamine123;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
verapamil;Plasma membrane monoamine transporter;f;;Human;16099839|27506881;Inhibition
6-aminocaproic acid;plasminogen;f;;Human;24900876;Binding
aprotinin;plasminogen;f;Bovine;Human;17666018;Binding
tranexamic acid;plasminogen;f;;Human;17666018;Binding
bis-triazole derivative 10;plasminogen;f;;Human;22276953;Inhibition
Dup-714;plasminogen activator, tissue type;f;;Human;;Inhibition
compound 4 [PMID: 18163548];plasminogen activator, urokinase;f;;Human;18163548;Inhibition
UK-356202;plasminogen activator, urokinase;f;;Human;15149680;Inhibition
upamostat;plasminogen activator, urokinase;f;;Human;;Inhibition
WX-UK1;plasminogen activator, urokinase;f;;Human;10560742;Inhibition
fosmidomycin;Plasmodium falciparum 1-deoxy-D-xylulose 5-phosphate reductoisomerase;f;;Plasmodium falciparum A2;10477522;None
fosmidomycin;Plasmodium falciparum 1-deoxy-D-xylulose 5-phosphate reductoisomerase;f;;Plasmodium falciparum Dd2;10477522;None
fosmidomycin;Plasmodium falciparum 1-deoxy-D-xylulose 5-phosphate reductoisomerase;f;;Plasmodium falciparum HB3;10477522;None
MMV008138;Plasmodium falciparum 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase;f;;Plasmodium falciparum;25367906;Inhibition
MMV008138;Plasmodium falciparum 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase;f;;Plasmodium falciparum Dd2;25754494;None
MMV008138;Plasmodium falciparum 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase;f;;Plasmodium falciparum W2;25367906;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum TM90C2A;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum 7G8;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum NF54;22508309;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum D6;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum W2;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum NF54;22508309;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum TM91C235;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum K1;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum V1/S;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum NF54;20813948;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum NF54;22508309;None
cipargamin;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum 3D7;20813948;None
GSK030;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum;;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum FCR3;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum NF54;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum 3D7;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum HB3;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum Dd2;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum TM90C2A;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum NF54;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum TM90C2B;25422853;None
PA21A092;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum V1/S;25422853;None
(+)-SJ733;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum Dd2;25453091;None
(+)-SJ733;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum K1;25453091;None
(+)-SJ733;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum V1/S;25453091;None
(+)-SJ733;Plasmodium falciparum ATPase4;f;;Plasmodium falciparum 3D7;25453091;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum TM90C2A;22363211;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum K1;22363211;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum W2;22363211;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum V1/S;22363211;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum NF54;22363211;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum 7G8;22363211;None
cycloguanil;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum D6;22363211;None
P218;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum TM4;23035243;None
P218;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum V1/S;23035243;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum 7G8;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum TM90C2A;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum D6;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum W2;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum V1/S;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum V1/S;23035243;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum K1;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum NF54;22363211;None
pyrimethamine;Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase;f;;Plasmodium falciparum TM4;23035243;None
ML10;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium falciparum 3D7;28874661;Inhibition
MMV030084;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium falciparum;32359426;Inhibition
ML10;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium falciparum 3D7;28874661;None
MMV030084;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium berghei;32359426;None
MMV030084;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium falciparum 3D7;32359426;None
MMV030084;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium falciparum Dd2;32359426;None
MMV030084;Plasmodium falciparum cGMP-dependent protein kinase;f;;Plasmodium falciparum NF54;32359426;None
AN3661;Plasmodium falciparum cleavage and polyadenylation specificity factor subunit 3;f;;Plasmodium falciparum Dd2;28262680;None
AN3661;Plasmodium falciparum cleavage and polyadenylation specificity factor subunit 3;f;;Plasmodium falciparum 3D7;28262680;None
AN3661;Plasmodium falciparum cleavage and polyadenylation specificity factor subunit 3;f;;Plasmodium falciparum K1;28262680;None
AN3661;Plasmodium falciparum cleavage and polyadenylation specificity factor subunit 3;f;;Plasmodium falciparum HB3;28262680;None
AN3661;Plasmodium falciparum cleavage and polyadenylation specificity factor subunit 3;f;;Plasmodium falciparum FCR3;28262680;None
TCMDC-135051;Plasmodium falciparum cyclin-dependent-like kinase CLK3;f;;Plasmodium falciparum 3D7;31467193;None
TCMDC-135051;Plasmodium falciparum cyclin-dependent-like kinase CLK3;f;;Plasmodium berghei;31467193;None
TCMDC-135051;Plasmodium falciparum cyclin-dependent-like kinase CLK3;f;;Plasmodium falciparum Dd2;31467193;None
compound 11c  [PMID: 30613327];Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum;30613327;Inhibition
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum D6;22363211;None
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum V1/S;22363211;None
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum TM90C2A;22363211;None
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum K1;22363211;None
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum NF54;22363211;None
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum 7G8;22363211;None
atovaquone;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum W2;22363211;None
compound 11c  [PMID: 30613327];Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum W2;30613327;None
compound 11c  [PMID: 30613327];Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum 3D7;30613327;None
compound 11c  [PMID: 30613327];Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum TM90C2B;30613327;None
compound 27 [PMID: 32945666];Plasmodium falciparum cytochrome b;f;;Plasmodium berghei;32945666;None
compound 27 [PMID: 32945666];Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum 3D7;32945666;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum W2;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum D6;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum W2;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum NF54;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum Dd2;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium cynomolgi;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum TM90C2B;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum D6;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum TM90C2B;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum TM91C235;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium berghei;23515079;None
ELQ-300;Plasmodium falciparum cytochrome b;f;;Plasmodium falciparum NF54;23515079;None
DSM265;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium vivax;32248693;Inhibition
DSM265;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum;32248693;Inhibition
DSM421;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium vivax;27641613;Inhibition
DSM421;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum;27641613;Inhibition
DSM502;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium vivax;32248693;Inhibition
DSM502;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum;32248693;Inhibition
DSM265;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum NF54;26180101;None
DSM421;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum 3D7;27641613;None
DSM421;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum 3D7;27641613;None
DSM421;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium vivax;27641613;None
DSM502;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum Dd2;32248693;None
DSM502;Plasmodium falciparum dihydroorotate dehydrogenase;f;;Plasmodium falciparum 3D7;32248693;None
M5717;Plasmodium falciparum elongation factor 2;f;;Plasmodium berghei;26085270;None
M5717;Plasmodium falciparum elongation factor 2;f;;Plasmodium falciparum NF54;26085270;None
M5717;Plasmodium falciparum elongation factor 2;f;;Plasmodium falciparum 3D7;26085270;None
M5717;Plasmodium falciparum elongation factor 2;f;;Plasmodium falciparum NF54;26085270;None
M5717;Plasmodium falciparum elongation factor 2;f;;Plasmodium falciparum NF54;26085270;None
M5717;Plasmodium falciparum elongation factor 2;f;;Plasmodium falciparum NF54;26085270;None
compound 3a [PMID: 30344903];Plasmodium falciparum heme detoxification protein;f;;Plasmodium falciparum FCR3;30344903;None
compound 3a [PMID: 30344903];Plasmodium falciparum heme detoxification protein;f;;Plasmodium falciparum K1;30344903;None
HTI-1;Plasmodium falciparum hexose transporter;f;;Plasmodium falciparum Dd2;32860739;None
HTI-1;Plasmodium falciparum hexose transporter;f;;Plasmodium falciparum 3D7;32860739;None
TCMDC-125163;Plasmodium falciparum hexose transporter;f;;Plasmodium falciparum 3D7;25894322;None
TCMDC-125163;Plasmodium falciparum hexose transporter;f;;Plasmodium falciparum K1;25894322;None
compound 1u [PMID: 30245402];Plasmodium falciparum histone deacetylase 1;f;;Plasmodium berghei;30245402;None
compound 1u [PMID: 30245402];Plasmodium falciparum histone deacetylase 1;f;;Plasmodium falciparum Dd2;30245402;None
compound 1u [PMID: 30245402];Plasmodium falciparum histone deacetylase 1;f;;Plasmodium falciparum 3D7;30245402;None
compound 2h [PMID: 30664827];Plasmodium falciparum histone deacetylase 1;f;;Plasmodium falciparum 3D7;30664827;None
dapsone;Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase;f;;Plasmodium falciparum;2024960;Inhibition
sulfadoxine;Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase;f;;Plasmodium falciparum 3D7;9076734;None
sulfadoxine;Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase;f;;Plasmodium falciparum HB3;9076734;None
sulfadoxine;Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase;f;;Plasmodium falciparum Dd2;9076734;None
sulfadoxine;Plasmodium falciparum hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase;f;;Plasmodium falciparum K1;9076734;None
cladosporin;Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum K1;22704625;None
cladosporin;Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium yoelii;22704625;None
cladosporin;Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum NF54;22704625;None
cladosporin;Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum D6;22704625;None
cladosporin;Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum 3D7;22704625;None
compound 5 [PMID: 30894487];Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum 3D7;30894487;None
compound 5 [PMID: 30894487];Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum NF54;30894487;None
compound 5 [PMID: 30894487];Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium vivax;30894487;None
compound 5 [PMID: 30894487];Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum NF54;30894487;None
compound 5 [PMID: 30894487];Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum K1;30894487;None
compound 5 [PMID: 30894487];Plasmodium falciparum lysine--tRNA ligase;f;;Plasmodium falciparum NF54;30894487;None
compound 34c [PMID: 24641010];Plasmodium falciparum N-Myristoyltransferase;f;;Plasmodium falciparum 3D7;24641010;Inhibition
compound 34c [PMID: 24641010];Plasmodium falciparum N-Myristoyltransferase;f;;Plasmodium berghei;24641010;None
compound 34c [PMID: 24641010];Plasmodium falciparum N-Myristoyltransferase;f;;Plasmodium falciparum K1;24641010;None
compound 34c [PMID: 24641010];Plasmodium falciparum N-Myristoyltransferase;f;;Plasmodium falciparum NF54;24641010;None
compound 34c [PMID: 24641010];Plasmodium falciparum N-Myristoyltransferase;f;;Plasmodium falciparum Dd2;24641010;None
compound 34c [PMID: 24641010];Plasmodium falciparum N-Myristoyltransferase;f;;Plasmodium falciparum 3D7;24641010;None
BRD3444;Plasmodium falciparum phenylalanine--tRNA ligase alpha subunit;f;;Plasmodium falciparum 3D7;27602946;Inhibition
CHMFL-PI4K-127;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;31911293;Inhibition
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;28446690;Binding
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;28446690;Binding
CHMFL-PI4K-127;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum 3D7;31911293;None
CHMFL-PI4K-127;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum Dd2;31911293;None
compound 55 [PMID: 29889526];Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;29889526;None
compound 55 [PMID: 29889526];Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum K1;29889526;None
MMV024101;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;29889526;None
MMV024101;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum 3D7;29889526;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium cynomolgi;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium cynomolgi;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium cynomolgi;28446690;None
MMV048;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;28446690;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum NF54;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium berghei;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum D6;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum V1/S;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium cynomolgi;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum K1;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum Dd2;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum HB3;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum 7G8;29941635;None
UCT943;Plasmodium falciparum phosphatidylinositol 4-kinase;f;;Plasmodium falciparum;29941635;None
WEHI-842;Plasmodium falciparum plasmepsin V;f;;Plasmodium falciparum NF54;31851913;None
WEHI-842;Plasmodium falciparum plasmepsin V;f;;Plasmodium falciparum 3D7;26214367;None
WM382;Plasmodium falciparum plasmepsin X;f;;Plasmodium falciparum;32109369;Inhibition
WM382;Plasmodium falciparum plasmepsin X;f;;Plasmodium falciparum Dd2;32109369;None
WM382;Plasmodium falciparum plasmepsin X;f;;Plasmodium falciparum;32109369;None
WM382;Plasmodium falciparum plasmepsin X;f;;Plasmodium knowlesi;32109369;None
WM382;Plasmodium falciparum plasmepsin X;f;;Plasmodium falciparum K1;32109369;None
WM382;Plasmodium falciparum plasmepsin X;f;;Plasmodium falciparum 3D7;32109369;None
halofuginone;Plasmodium falciparum proline--tRNA ligase;f;;Plasmodium falciparum 3D7;25995223;None
halofuginone;Plasmodium falciparum proline--tRNA ligase;f;;Plasmodium falciparum Dd2;25995223;None
bortezomib;Plasmodium falciparum proteasome subunit beta type-5;f;;Plasmodium falciparum;30373366;Inhibition
bortezomib;Plasmodium falciparum proteasome subunit beta type-5;f;;Plasmodium falciparum Dd2;17956613;None
bortezomib;Plasmodium falciparum proteasome subunit beta type-5;f;;Plasmodium falciparum 3D7;17956613;None
bortezomib;Plasmodium falciparum proteasome subunit beta type-5;f;;Plasmodium falciparum HB3;17956613;None
bortezomib;Plasmodium falciparum proteasome subunit beta type-5;f;;Plasmodium falciparum W2;17956613;None
WLL-vs;Plasmodium falciparum proteasome subunit beta type-5;f;;Plasmodium falciparum;30107725;None
forodesine;Plasmodium falciparum purine nucleoside phosphorylase;f;;Plasmodium falciparum;11707439;None
mefloquine;Plasmodium falciparum purine nucleoside phosphorylase;f;;Plasmodium falciparum;30602534;None
quinine;Plasmodium falciparum purine nucleoside phosphorylase;f;;Plasmodium falciparum;30602534;None
forodesine;Plasmodium falciparum purine nucleoside phosphorylase;f;;Plasmodium falciparum;11706018;None
borrelidin;Plasmodium falciparum threonine--tRNA ligase;f;;Plasmodium falciparum 3D7;25489076;None
borrelidin;Plasmodium falciparum threonine--tRNA ligase;f;;Plasmodium falciparum FCR3;14563165;None
borrelidin;Plasmodium falciparum threonine--tRNA ligase;f;;Plasmodium falciparum 3D7;25489076;None
borrelidin;Plasmodium falciparum threonine--tRNA ligase;f;;Plasmodium falciparum K1;14563165;None
MMV253;Plasmodium falciparum V-type proton ATPase;f;;Plasmodium falciparum NF54;25823686;None
MMV253;Plasmodium falciparum V-type proton ATPase;f;;Plasmodium falciparum K1;25823686;None
compound 12e [PMID: 18605714];PLA2-G5;f;;Human;18605714;Inhibition
rilapladib;PLA2-G7;f;;Human;19667981;Competitive
ABX-1431;PLA2-G7;f;;Human;30067909;Inhibition
compound 37 [PMID: 29193967];PLA2-G7;f;;Human;29193967;Inhibition
darapladib;PLA2-G7;f;;Human;12643913;Inhibition
darapladib;PLA2-G7;f;;Human;27933945;Inhibition
darapladib;PLA2-G7;f;;Human;27933945;Inhibition
(S)-23 [PMID: 27933945];PLA2-G7;f;;Human;27933945;Inhibition
(S)-23 [PMID: 27933945];PLA2-G7;f;;Human;27933945;Inhibition
olaratumab;platelet derived growth factor receptor alpha;f;;Human;;Binding
olaratumab;platelet derived growth factor receptor alpha;f;;Human;;Binding
AC710;platelet derived growth factor receptor alpha;f;;Human;24900421;Inhibition
cediranib;platelet derived growth factor receptor alpha;f;;Human;15899831;Inhibition
CHMFL-KIT-64;platelet derived growth factor receptor alpha;f;;Human;31250638;Inhibition
compound 8h [PMID: 21561767];platelet derived growth factor receptor alpha;f;;Human;21561767;Inhibition
compound 8h [PMID: 22765894];platelet derived growth factor receptor alpha;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];platelet derived growth factor receptor alpha;f;;Human;22765894;Inhibition
CP-673451;platelet derived growth factor receptor alpha;f;;Human;15705896;Inhibition
crenolanib;platelet derived growth factor receptor alpha;f;;Human;22745105;Inhibition
CS2164;platelet derived growth factor receptor alpha;f;;Human;28004478;Inhibition
DCC-3014;platelet derived growth factor receptor alpha;f;;Human;;Inhibition
dovitinib;platelet derived growth factor receptor alpha;f;;Human;15598814;Inhibition
ENMD-2076;platelet derived growth factor receptor alpha;f;;Human;19320489;Inhibition
ilorasertib;platelet derived growth factor receptor alpha;f;;Human;22935731;Inhibition
lucitanib;platelet derived growth factor receptor alpha;f;;Human;22304225;Inhibition
masitinib;platelet derived growth factor receptor alpha;f;;Human;19789626;Inhibition
nintedanib;platelet derived growth factor receptor alpha;f;;Human;18559524;Inhibition
PDGF receptor tyrosine kinase inhibitor II;platelet derived growth factor receptor alpha;f;;Mouse;11855980;Inhibition
PK10571;platelet derived growth factor receptor alpha;f;;Human;;Inhibition
PP121;platelet derived growth factor receptor alpha;f;;Human;18849971;Inhibition
quizartinib;platelet derived growth factor receptor alpha;f;;Human;19754199;Inhibition
sitravatinib;platelet derived growth factor receptor alpha;f;;Human;26675259;Inhibition
CHMFL-KIT-64;platelet derived growth factor receptor beta;f;;Human;31250638;Inhibition
AC710;platelet derived growth factor receptor beta;f;;Human;24900421;Inhibition
AGL 2043;platelet derived growth factor receptor beta;f;;Human;12670652;Inhibition
BLZ945;platelet derived growth factor receptor beta;f;;Human;24498562;Inhibition
cediranib;platelet derived growth factor receptor beta;f;;Human;15899831;Inhibition
compound 5e [PMID: 28580438];platelet derived growth factor receptor beta;f;;Human;28580438;Inhibition
compound 8h [PMID: 22765894];platelet derived growth factor receptor beta;f;;Human;22765894;Inhibition
compound 8i [PMID: 22765894];platelet derived growth factor receptor beta;f;;Human;21613405;Inhibition
CP-673451;platelet derived growth factor receptor beta;f;;Human;15705896;Inhibition
crenolanib;platelet derived growth factor receptor beta;f;;Human;22745105;Inhibition
CS2164;platelet derived growth factor receptor beta;f;;Human;28004478;Inhibition
DEBIO1347;platelet derived growth factor receptor beta;f;;Human;25169980;Inhibition
dovitinib;platelet derived growth factor receptor beta;f;;Human;19113866|15598814;Inhibition
famitinib;platelet derived growth factor receptor beta;f;;Human;21028894;Inhibition
Flt-3 inhibitor II;platelet derived growth factor receptor beta;f;;Human;16722630;Inhibition
flumatinib;platelet derived growth factor receptor beta;f;;Human;20703259;Inhibition
GTP-14564;platelet derived growth factor receptor beta;f;;Human;12815052;Inhibition
henatinib;platelet derived growth factor receptor beta;f;;Human;21028894;Inhibition
IACS-9439;platelet derived growth factor receptor beta;f;;Human;32787110;Inhibition
ilorasertib;platelet derived growth factor receptor beta;f;;Human;22935731;Inhibition
KBP-7018;platelet derived growth factor receptor beta;f;;Human;29152045;Inhibition
Ki-20227;platelet derived growth factor receptor beta;f;;Human;17121910;Inhibition
linifanib;platelet derived growth factor receptor beta;f;;Human;16648571;Inhibition
lucitanib;platelet derived growth factor receptor beta;f;;Human;22304225;Inhibition
LXH254;platelet derived growth factor receptor beta;f;;Human;31059256;Inhibition
masitinib;platelet derived growth factor receptor beta;f;;Human;19789626;Inhibition
MK-2461;platelet derived growth factor receptor beta;f;;Human;20145145;Inhibition
nintedanib;platelet derived growth factor receptor beta;f;;Human;18559524;Inhibition
orantinib;platelet derived growth factor receptor beta;f;;Human;19110422;Inhibition
pazopanib;platelet derived growth factor receptor beta;f;;Human;18620382;Inhibition
PD166285;platelet derived growth factor receptor beta;f;;Human;9400019;Inhibition
PDGF receptor tyrosine kinase inhibitor III;platelet derived growth factor receptor beta;f;;Human;14584942;Inhibition
PDGF receptor tyrosine kinase inhibitor IV;platelet derived growth factor receptor beta;f;;Human;16366598;Inhibition
PDGF RTK inhibitor;platelet derived growth factor receptor beta;f;;Human;16570914;Inhibition
PK10571;platelet derived growth factor receptor beta;f;;Human;;Inhibition
quizartinib;platelet derived growth factor receptor beta;f;;Human;19754199;Inhibition
semaxanib;platelet derived growth factor receptor beta;f;;Human;10882357;Inhibition
sorafenib;platelet derived growth factor receptor beta;f;;Mouse;15466206;Inhibition
sorafenib;platelet derived growth factor receptor beta;f;;Human;21613405;Inhibition
SU11652;platelet derived growth factor receptor beta;f;;Human;12646019;Inhibition
SU-14813;platelet derived growth factor receptor beta;f;;Human;16891463;Inhibition
sunitinib;platelet derived growth factor receptor beta;f;;Human;23279183;Inhibition
sunitinib;platelet derived growth factor receptor beta;f;;Human;12538485;Inhibition
tafetinib;platelet derived growth factor receptor beta;f;;Human;21638122;Inhibition
TAK-632;platelet derived growth factor receptor beta;f;;Human;23906342;Inhibition
tandutinib;platelet derived growth factor receptor beta;f;;Human;12124172;Inhibition
vatalanib;platelet derived growth factor receptor beta;f;;Human;10882357;Inhibition
compound 5 [PMID: 10869194];PLCγ1;f;;Bovine;10869194;Inhibition
CCT129957;PLCγ2;f;;Human;19303309;Inhibition
compound 69 [PMID: 19136975];PLD1;f;;Human;19136975;Inhibition
FIPI;PLD1;f;;Human;19136975;Inhibition
ADP-ribosylation factor 1;PLD2;t;Human;Human;;Activation
oleic acid;PLD2;t;;Human;12374567;Activation
PIP2;PLD2;t;;Human;9582313;Activation
compound 69 [PMID: 19136975];PLD2;f;;Human;19136975;Inhibition
FIPI;PLD2;f;;Human;19136975;Inhibition
VU0364739;PLD2;f;;Human;20735042;Inhibition
BI-2536;polo like kinase 1;f;;Human;17291758;Inhibition
BI-2536;polo like kinase 1;f;;Human;23103095;Inhibition
compound 2 [PMID: 19097784];polo like kinase 1;f;;Human;19097784;Inhibition
compound 6 [PMID: 30125504];polo like kinase 1;f;;Human;30125504;Inhibition
dual BRD4/PLK1 inhibitor 23;polo like kinase 1;f;;Human;30125504;Inhibition
GSK-461364A;polo like kinase 1;f;;Human;19690138;Inhibition
GSK579289A;polo like kinase 1;f;;Human;19237286;Inhibition
GW853606;polo like kinase 1;f;;Human;19097784;Inhibition
MLN0905;polo like kinase 1;f;;Human;22070629;Inhibition
NMS-P937;polo like kinase 1;f;;Human;21470862;Inhibition
Ro3280;polo like kinase 1;f;;Human;22172702;Inhibition
Ro3280;polo like kinase 1;f;;Human;22172702;Inhibition
volasertib;polo like kinase 1;f;;Human;23103095;Inhibition
BI-2536;polo like kinase 2;f;;Human;17291758;Inhibition
NMS-P937;polo like kinase 2;f;;Human;21470862;Inhibition
BI-2536;polo like kinase 3;f;;Human;17291758;Inhibition
NMS-P937;polo like kinase 3;f;;Human;21470862;Inhibition
axitinib;polo like kinase 4;f;;Human;23829549;Inhibition
CFI-400945;polo like kinase 4;f;;Human;25043604;Inhibition
RG-1530;polo like kinase 4;f;;Human;20814247;Inhibition
XMD8-92;polo like kinase 4;f;;Human;20832753;Inhibition
niraparib;poly(ADP-ribose) polymerase 1;f;;Human;19873981;Binding
AG14361;poly(ADP-ribose) polymerase 1;f;;Human;12519059;Inhibition
AZ1366;poly(ADP-ribose) polymerase 1;f;;Human;25815142;Inhibition
compound 10b [PMID: 26222319];poly(ADP-ribose) polymerase 1;f;;Human;26222319;Inhibition
compound 5 [Tomassi et al., 2020];poly(ADP-ribose) polymerase 1;f;;Human;;Inhibition
example 26 [WO2015037939A1];poly(ADP-ribose) polymerase 1;f;;Human;;Inhibition
MC2050;poly(ADP-ribose) polymerase 1;f;;Human;21365766;Inhibition
MC2050;poly(ADP-ribose) polymerase 1;f;;Human;;Inhibition
ME0328;poly(ADP-ribose) polymerase 1;f;;Human;24188023;Inhibition
olaparib;poly(ADP-ribose) polymerase 1;f;;Human;18800822|12857389;Inhibition
rucaparib;poly(ADP-ribose) polymerase 1;f;;Human;17363489;Inhibition
talazoparib;poly(ADP-ribose) polymerase 1;f;;Human;25195882;Inhibition
niraparib;poly(ADP-ribose) polymerase 2;f;;Human;19873981;Binding
AZ1366;poly(ADP-ribose) polymerase 2;f;;Human;25815142;Inhibition
compound 10b [PMID: 26222319];poly(ADP-ribose) polymerase 2;f;;Human;26222319;Inhibition
compound 5 [Tomassi et al., 2020];poly(ADP-ribose) polymerase 2;f;;Human;;Inhibition
MC2050;poly(ADP-ribose) polymerase 2;f;;Human;21365766;Inhibition
MC2050;poly(ADP-ribose) polymerase 2;f;;Human;;Inhibition
olaparib;poly(ADP-ribose) polymerase 2;f;;Human;18800822|12857389;Inhibition
talazoparib;poly(ADP-ribose) polymerase 2;f;;Human;25195882;Inhibition
ME0328;poly (ADP-ribose) polymerase 3;f;;Human;24188023;Inhibition
PFI-3;polybromo 1;f;;Human;;Binding
ETC-1922159;porcupine O-acyltransferase;f;;Human;26522946;Inhibition
GNF6231;porcupine O-acyltransferase;f;;Human;27437076;Inhibition
LGK974;porcupine O-acyltransferase;f;;Human;24277854;Inhibition
17β-estradiol;Pregnane X receptor;t;;Human;10628745;Agonist
3-keto-lithocholic acid;Pregnane X receptor;t;;Human;11248085;Agonist
5β-cholestane-3α,7α,12α-triol;Pregnane X receptor;f;;Human;12509506;Agonist
5β-cholestane-3α,7α,12α-triol;Pregnane X receptor;f;;Mouse;12569201;Agonist
5β-pregnane-3,20-dione;Pregnane X receptor;f;;Human;10628745;Agonist
clotrimazole;Pregnane X receptor;f;;Human;9770465;Agonist
dexamethasone;Pregnane X receptor;f;;Mouse;9489701;Agonist
garcinoic acid;Pregnane X receptor;f;;Human;32160459;Agonist
garcinoic acid;Pregnane X receptor;f;;Human;32160459;Agonist
hyperforin;Pregnane X receptor;f;;Human;10852961|10974665;Agonist
lithocholic acid;Pregnane X receptor;t;;Human;11248085;Agonist
mifepristone;Pregnane X receptor;f;;Human;9727070;Agonist
nifedipine;Pregnane X receptor;f;;Human;9770465;Agonist
paclitaxel;Pregnane X receptor;f;;Human;11329060;Agonist
phenobarbital;Pregnane X receptor;f;;Human;9727070;Agonist
pregnenolone-16α-carbonitrile;Pregnane X receptor;f;;Mouse;9489701;Agonist
rifampicin;Pregnane X receptor;f;;Human;9784494|9727070;Agonist
S20;Pregnane X receptor;f;;Human;15872116;Agonist
(+)-S20;Pregnane X receptor;f;;Human;15872116;Agonist
schisandrin A;Pregnane X receptor;f;;Human;16267138;Agonist
schisandrin A;Pregnane X receptor;f;;Mouse;16267138;Agonist
SR12813;Pregnane X receptor;f;;Human;10628745;Agonist
vitamin K2;Pregnane X receptor;f;;Mouse;12920130;Agonist
lovastatin;Pregnane X receptor;f;;Human;9727070;Full agonist
trabectedin;Pregnane X receptor;f;;Mouse;11329060;Antagonist
CHF-5074;presenilin 1;f;;Human;22061640;Binding
avagacestat;presenilin 1;f;;Human;;Inhibition
AZ4800;presenilin 1;f;;Human;22334705;Inhibition
begacestat;presenilin 1;f;;Human;19671883;Inhibition
ELND006;presenilin 1;f;;Human;23713656;Inhibition
RO4929097;presenilin 1;f;;Human;19773430;Inhibition
SCH-900229;presenilin 1;f;;Human;24900404;Inhibition
semagacestat;presenilin 1;f;;Human;19694467;Inhibition
compound 3 [PMID: 8410973];progastricsin;f;;Human;8410973;Inhibition
AZD9567;Progesterone receptor;f;;Human;29424542;Agonist
budesonide;Progesterone receptor;f;;Human;28937774;Agonist
budesonide;Progesterone receptor;f;;Human;28937774;Agonist
dydrogesterone;Progesterone receptor;f;;Human;14670641|21376746;Agonist
fluticasone propionate;Progesterone receptor;f;;Human;28937774;Agonist
levonorgestrel;Progesterone receptor;f;;Human;14670641|6645495;Agonist
medroxyprogesterone;Progesterone receptor;f;;Human;9464360;Agonist
norethisterone;Progesterone receptor;f;;Human;9464361;Agonist
ORG2058;Progesterone receptor;f;;Human;;Agonist
progesterone;Progesterone receptor;f;;Human;9464360;Agonist
progesterone;Progesterone receptor;t;;Human;9667968;Agonist
promegestone;Progesterone receptor;f;;Human;14670641;Agonist
[3H]ORG2058;Progesterone receptor;f;;Human;;Agonist
tanaproget;Progesterone receptor;f;;Human;18318463;Agonist
mifepristone;Progesterone receptor;f;;Human;12781197;Mixed
ulipristal acetate;Progesterone receptor;f;;Human;18243712;Partial agonist
APR19;Progesterone receptor;f;;Human;23579486;Antagonist
asoprisnil;Progesterone receptor;f;;Human;21854761;Antagonist
onapristone;Progesterone receptor;f;;Human;8627601;Antagonist
PF-03882845;Progesterone receptor;f;;Human;24738581;Antagonist
ulipristal acetate;Progesterone receptor;f;;Human;18243712;Antagonist
WAY-255348;Progesterone receptor;f;;Human;18318463|21854761;Antagonist
ZK112993;Progesterone receptor;f;;Human;;Antagonist
mifepristone;Progesterone receptor;f;;Human;12781197;Mixed
cemiplimab;programmed cell death 1 (CD279);f;;Monkey;28265006;Binding
cemiplimab;programmed cell death 1 (CD279);f;;Human;28265006;Binding
cemiplimab;programmed cell death 1 (CD279);f;;Monkey;28265006;Binding
cemiplimab;programmed cell death 1 (CD279);f;;Human;28265006;Binding
nivolumab;programmed cell death 1 (CD279);f;;Human;21154117|23302904;Binding
pembrolizumab;programmed cell death 1 (CD279);f;;Human;;Binding
spartalizumab;programmed cell death 1 (CD279);f;;Human;;Binding
tislelizumab;programmed cell death 1 (CD279);f;;Human;;Binding
AUNP-12;programmed cell death 1 (CD279);f;;Human;;Binding
programmed cell death 1 ligand 1;programmed cell death 1 (CD279);t;Human;Human;;Binding
choriomammotropin;Prolactin receptor;t;Human;Human;;Agonist
chorionic somatomammotropin hormone-like 1 ;Prolactin receptor;t;Human;Human;;Agonist
prolactin;Prolactin receptor;t;Human;Mouse;4362846;Agonist
compound 35 [PMID: 24157366];Prolylcarboxypeptidase;f;;Human;24157366;Inhibition
ARI-3531;prolyl endopeptidase;f;;Human;23594271;Inhibition
poststatin;prolyl endopeptidase;f;;Human;8931723;Inhibition
S 17092;prolyl endopeptidase;f;;Human;20058865;Inhibition
compound 8 [PMID: 21692504];prolyl endopeptidase like;f;;Mouse;21692504;Inhibition
phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide;proprotein convertase subtilisin/kexin type 1;f;;Human;20038105;Inhibition
peptide 18 [PMID: 24350995];proprotein convertase subtilisin/kexin type 2;f;;Human;24350995;Inhibition
furin inhibitor peptide;proprotein convertase subtilisin/kexin type 4;f;;Human;17537721;Inhibition
furin inhibitor peptide;proprotein convertase subtilisin/kexin type 5;f;;Human;17537721;Inhibition
phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide;proprotein convertase subtilisin/kexin type 5;f;;Human;20038105;Inhibition
furin inhibitor peptide;proprotein convertase subtilisin/kexin type 6;f;;Human;17537721;Inhibition
multi-Leu (ML)-peptide;proprotein convertase subtilisin/kexin type 6;f;;Human;23126600;Inhibition
peptide 18 [PMID: 24350995];proprotein convertase subtilisin/kexin type 6;f;;Human;24350995;Inhibition
phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide;proprotein convertase subtilisin/kexin type 6;f;;Human;20038105;Inhibition
furin inhibitor peptide;proprotein convertase subtilisin/kexin type 7;f;;Human;17537721;Inhibition
peptide 18 [PMID: 24350995];proprotein convertase subtilisin/kexin type 7;f;;Human;24350995;Inhibition
alirocumab;proprotein convertase subtilisin/kexin type 9;f;;Human;;Inhibition
bococizumab;proprotein convertase subtilisin/kexin type 9;f;;Human;;Inhibition
evolocumab;proprotein convertase subtilisin/kexin type 9;f;;Human;;Inhibition
compound 16 [PMID: 31653597];proprotein convertase subtilisin/kexin type 9;f;;Human;31653597;Binding
compound 58 [PMID: 25037917];PROT;f;;Human;25037917;Inhibition
LP-403812;PROT;f;;Human;19159658;Inhibition
compound 3b [PMID: 24946214];proteasome 20S subunit beta 1;f;;Human;24946214;Inhibition
compound 5b [PMID: 16686537];proteasome 20S subunit beta 2;f;;None;16686537;Inhibition
KZR-616;proteasome 20S subunit beta 2;f;;Human;30380863;Inhibition
bortezomib;proteasome 20S subunit beta 5;f;;Human;19428245;Inhibition
carfilzomib;proteasome 20S subunit beta 5;f;;Human;19348473;Inhibition
compound 3b [PMID: 24946214];proteasome 20S subunit beta 5;f;;Bovine;24946214;Inhibition
compound 5b [PMID: 16686537];proteasome 20S subunit beta 5;f;;Human;16686537;Inhibition
ixazomib;proteasome 20S subunit beta 5;f;;Human;20160034;Inhibition
KZR-616;proteasome 20S subunit beta 5;f;;Human;30380863;Inhibition
oprozomib;proteasome 20S subunit beta 5;f;;Human;22978849|19348473;Inhibition
HT1042;proteasome 20S subunit beta 8;f;;Human;24900849;Inhibition
KZR-616;proteasome 20S subunit beta 8;f;;Human;30380863;Inhibition
KZR-616;proteasome 20S subunit beta 8;f;;Mouse;30380863;Inhibition
ONX-0914;proteasome 20S subunit beta 8;f;;Human;19525961;Inhibition
KZR-616;proteasome 20S subunit beta 9;f;;Mouse;30380863;Inhibition
KZR-616;proteasome 20S subunit beta 9;f;;Human;30380863;Inhibition
AMI-1;protein arginine methyltransferase 1 ;f;;Human;15056663;Inhibition
C21;protein arginine methyltransferase 1 ;f;;Human;21838253;Inhibition
MS023;protein arginine methyltransferase 1 ;f;;Human;;Inhibition
RM65;protein arginine methyltransferase 1 ;f;;Human;17570663;Inhibition
SGC707;protein arginine methyltransferase 3;f;;Human;25728001;Negative
compound 1 [PMID: 22795084];protein arginine methyltransferase 3;f;;Human;22795084;Inhibition
MS023;protein arginine methyltransferase 3;f;;Human;;Inhibition
cmp5 [PMID: 25742700];protein arginine methyltransferase 5 ;f;;Human;25742700;Inhibition
DS-437;protein arginine methyltransferase 5 ;f;;Human;25893041;Inhibition
EPZ015666;protein arginine methyltransferase 5 ;f;;Human;;Inhibition
GSK591;protein arginine methyltransferase 5 ;f;;Human;;Inhibition
LLY-283;protein arginine methyltransferase 5 ;f;;Human;;Inhibition
C21;protein arginine methyltransferase 6;f;;Human;21838253;Inhibition
EPZ020411;protein arginine methyltransferase 6;f;;Human;26101569;Inhibition
MS023;protein arginine methyltransferase 6;f;;Human;;Inhibition
MS023;protein arginine methyltransferase 6;f;;Human;;Inhibition
MS049;protein arginine methyltransferase 6;f;;Human;27584694;Inhibition
MS049;protein arginine methyltransferase 6;f;;Human;27584694;Inhibition
DS-437;protein arginine methyltransferase 7 ;f;;Human;25893041;Inhibition
MS023;protein arginine methyltransferase 8;f;;Human;;Inhibition
MS049;protein arginine methyltransferase 8;f;;Human;27584694;Inhibition
azapro-3;proteinase 3;f;;Human;22209715;Inhibition
compound 11 [PMID: 29442501];proteinase 3;f;;Human;29442501;Inhibition
compound 4g [PMID: 22595175];proteinase 3;f;;Human;22595175;Inhibition
compound 37 [PMID: 24418773];protein C, inactivator of coagulation factors Va and VIIIa;f;;Human;24418773;Inhibition
N6 benzyl-cAMP;protein kinase A;f;;Human;12819211;Activation
Sp-cAMPS;protein kinase A;f;;None;;Activation
[3H]cAMP;protein kinase A;f;;Human;;Activation
7-hydroxystaurosporine;protein kinase A;f;;Rat;15486189;Inhibition
balanol;protein kinase A;f;;Rat;8978850;Inhibition
BX-795;protein kinase A;f;;Human;15772071;Inhibition
BX-912;protein kinase A;f;;Human;15772071;Inhibition
chelerythrine;protein kinase A;f;;Human;18077363;Inhibition
compound 1 [PMID: 20005102];protein kinase A;f;;Human;20005102;Inhibition
compound 1 [PMID: 21742770];protein kinase A;f;;Human;23256033;Inhibition
compound 33 [PMID: 19364658];protein kinase A;f;;Human;19364658;Inhibition
compound E22 [PMID: 31298542];protein kinase A;f;;Human;31298542;Inhibition
myr-PKI;protein kinase A;f;;None;;Inhibition
Rp-cAMPS;protein kinase A;f;;Human;;Inhibition
MT47-100;protein kinase AMP-activated non-catalytic subunit beta 1;f;;Human;26091167;Activation
MT47-100;protein kinase AMP-activated non-catalytic subunit beta 2;f;;Human;26091167;Negative
ingenol mebutate;protein kinase C alpha;f;;Human;15126366;Activation
RasGRP activator 1;protein kinase C alpha;f;;Human;24794745;Binding
7-hydroxystaurosporine;protein kinase C alpha;f;;Human;8022414;Inhibition
balanol;protein kinase C alpha;f;;Human;8978850;Inhibition
enzastaurin;protein kinase C alpha;f;;Human;12749884;Inhibition
GF109203X;protein kinase C alpha;f;;Bovine;1874734;Inhibition
Gö 6976;protein kinase C alpha;f;;Human;8486620;Inhibition
Gö 6983;protein kinase C alpha;f;;Human;8772178;Inhibition
LXS196;protein kinase C alpha;f;;Human;;Inhibition
Ro-32-0432;protein kinase C alpha;f;;Bovine;8114006|8373348;Inhibition
ruboxistaurin;protein kinase C alpha;f;;Human;15380221;Inhibition
sotrastaurin;protein kinase C alpha;f;;Human;19827831;Inhibition
GSK690693;protein kinase, cAMP-dependent, catalytic, alpha subunit;f;;Human;22037378;Inhibition
H-89;protein kinase, cAMP-dependent, catalytic, alpha subunit;f;;Human;2156866;Inhibition
ripasudil;protein kinase, cAMP-dependent, catalytic, alpha subunit;f;;Human;24502505;Inhibition
GSK690693;protein kinase, cAMP-dependent, catalytic, beta subunit;f;;Human;22037378;Inhibition
staurosporine;protein kinase, cAMP-dependent, catalytic, beta subunit;f;;Human;21435888;Inhibition
ingenol mebutate;protein kinase C beta;f;;Human;15126366;Activation
7-hydroxystaurosporine;protein kinase C beta;f;;Human;8022414;Inhibition
balanol;protein kinase C beta;f;;Human;8978850;Inhibition
bisindolylmaleimide IV;protein kinase C beta;f;;Human;15380221;Inhibition
CGP53353;protein kinase C beta;f;;Human;9121494;Inhibition
enzastaurin;protein kinase C beta;f;;Human;12749884;Inhibition
GF109203X;protein kinase C beta;f;;Bovine;1874734;Inhibition
Gö 6983;protein kinase C beta;f;;Human;8772178;Inhibition
PKCbeta inhibitor;protein kinase C beta;f;;Human;15380221;Inhibition
Ro-32-0432;protein kinase C beta;f;;Bovine;8114006|8373348;Inhibition
ruboxistaurin;protein kinase C beta;f;;Human;8709095;Inhibition
sotrastaurin;protein kinase C beta;f;;Human;19827831;Inhibition
ingenol mebutate;protein kinase C delta;f;;Human;15126366;Activation
7-hydroxystaurosporine;protein kinase C delta;f;;Human;8022414;Inhibition
balanol;protein kinase C delta;f;;Human;8978850;Inhibition
enzastaurin;protein kinase C delta;f;;Human;12749884;Inhibition
Gö 6983;protein kinase C delta;f;;Human;8772178;Inhibition
rottlerin;protein kinase C delta;f;;Human;8123051;Inhibition
ruboxistaurin;protein kinase C delta;f;;Human;8709095;Inhibition
sotrastaurin;protein kinase C delta;f;;Human;19827831;Inhibition
ingenol mebutate;protein kinase C epsilon;f;;Human;15126366;Activation
RasGRP activator 1;protein kinase C epsilon;f;;Human;24794745;Binding
7-hydroxystaurosporine;protein kinase C epsilon;f;;Human;8022414;Inhibition
balanol;protein kinase C epsilon;f;;Human;8978850;Inhibition
chelerythrine;protein kinase C epsilon;f;;Human;18077363;Inhibition
Ro-32-0432;protein kinase C epsilon;f;;Mouse;8114006|8373348;Inhibition
sotrastaurin;protein kinase C epsilon;f;;Human;19827831;Inhibition
Y27632;protein kinase C epsilon;f;;Human;20462760;Inhibition
balanol;protein kinase C eta;f;;Human;8978850;Inhibition
sotrastaurin;protein kinase C eta;f;;Human;19827831;Inhibition
ingenol mebutate;protein kinase C gamma;f;;Human;15126366;Activation
7-hydroxystaurosporine;protein kinase C gamma;f;;Human;8022414;Inhibition
balanol;protein kinase C gamma;f;;Human;8978850;Inhibition
enzastaurin;protein kinase C gamma;f;;Human;12749884;Inhibition
GF109203X;protein kinase C gamma;f;;Bovine;1874734;Inhibition
Gö 6983;protein kinase C gamma;f;;Human;8772178;Inhibition
Ro-32-0432;protein kinase C gamma;f;;Bovine;8114006|8373348;Inhibition
ruboxistaurin;protein kinase C gamma;f;;Human;8709095;Inhibition
staurosporine;protein kinase C iota;f;;Human;17875639;Inhibition
compound 41 [PMID: 25000588];protein kinase C theta;f;;Human;25000588;Inhibition
GSK690693;protein kinase C theta;f;;Human;18800763;Inhibition
LXS196;protein kinase C theta;f;;Human;;Inhibition
PKCθ inhibitor 14;protein kinase C theta;f;;Human;27117263;Inhibition
sotrastaurin;protein kinase C theta;f;;Human;19827831;Inhibition
arachidonic acid;protein kinase C zeta;t;;Human;7744003;Activation
balanol;protein kinase C zeta;f;;Human;8978850;Inhibition
compound 3 [PMID: 19097791];protein kinase C zeta;f;;Human;19097791;Inhibition
Gö 6983;protein kinase C zeta;f;;Human;8772178;Inhibition
BPKDi;protein kinase D1;f;;Human;20018189;Inhibition
compound 13c [PMID: 20684591];protein kinase D1;f;;Human;20684591;Inhibition
CRT 0066101;protein kinase D1;f;;Human;20442301;Inhibition
Gö 6976;protein kinase D1;f;;Human;8772178;Inhibition
kb-NB142-70;protein kinase D1;f;;Human;21617763;Inhibition
NIK SMI1;protein kinase D1;f;;Human;29330524;Inhibition
BPKDi;protein kinase D2;f;;Human;20018189;Inhibition
CRT 0066101;protein kinase D2;f;;Human;20442301;Inhibition
BPKDi;protein kinase D3;f;;Human;20018189;Inhibition
CRT 0066101;protein kinase D3;f;;Human;20442301;Inhibition
AZD7648;protein kinase, DNA-activated, catalytic subunit;f;;Human;31851518;Inhibition
AZD7648;protein kinase, DNA-activated, catalytic subunit;f;;Human;31851518;Inhibition
compound 82 [PMID: 21332118];protein kinase, DNA-activated, catalytic subunit;f;;Human;21332118;Inhibition
DNA-PK inhibitor III;protein kinase, DNA-activated, catalytic subunit;f;;Mouse;22835870;Inhibition
DNA-PK inhibitor V;protein kinase, DNA-activated, catalytic subunit;f;;Human;17562705;Inhibition
KU-0060648;protein kinase, DNA-activated, catalytic subunit;f;;Human;23855836;Inhibition
NU-7026;protein kinase, DNA-activated, catalytic subunit;f;;Human;12941339;Inhibition
NU-7441;protein kinase, DNA-activated, catalytic subunit;f;;Human;15546735;Inhibition
peposertib;protein kinase, DNA-activated, catalytic subunit;f;;Human;;Inhibition
PI-103;protein kinase, DNA-activated, catalytic subunit;f;;Human;19584227;Inhibition
PIK-75;protein kinase, DNA-activated, catalytic subunit;f;;Human;16647110;Inhibition
PP121;protein kinase, DNA-activated, catalytic subunit;f;;Human;18849971;Inhibition
torin 2;protein kinase, DNA-activated, catalytic subunit;f;;Human;21322566;Inhibition
wortmannin;protein kinase, DNA-activated, catalytic subunit;f;;Human;22835870;Inhibition
GSK690693;Protein kinase G (PKG) 1;f;;Human;18800763;Inhibition
ipatasertib;Protein kinase G (PKG) 1;f;;Human;22934575;Inhibition
Rp-8-CPT-cGMPS;Protein kinase G (PKG) 1;f;;Human;7851503;Inhibition
compound 32 [PMID: 20471253];Protein kinase G (PKG) 2;f;;Human;20471253;Inhibition
PD166285;protein kinase, membrane associated tyrosine/threonine 1;f;;Human;11719452|22189141;Inhibition
compound 20 [PMID: 22136433];protein kinase N1;f;;Human;22136433;Inhibition
RKI-1447;protein kinase N1;f;;Human;23275831;Inhibition
staurosporine;protein kinase N1;f;;Human;19397322;Inhibition
tofacitinib;protein kinase N1;f;;Human;27572962;Inhibition
compound 32 [PMID: 20471253];protein kinase N2;f;;Human;20471253;Inhibition
Y27632;protein kinase N2;f;;Human;20462760;Inhibition
GSK690693;protein kinase X-linked;f;;Human;18800763;Inhibition
ABL127;protein phosphatase methylesterase 1;f;;Human;24997602;Inhibition
GSK2830371;protein phosphatase, Mg2+/Mn2+ dependent 1D;f;;Human;26358280;Inhibition
GSK2830371;protein phosphatase, Mg2+/Mn2+ dependent 1D;f;;Human;24390428;Inhibition
SL-176;protein phosphatase, Mg2+/Mn2+ dependent 1D;f;;Human;26358280;Inhibition
CEP-37440;protein tyrosine kinase 2;f;;Human;27527804;Inhibition
compound 30 [PMID: 23414845];protein tyrosine kinase 2;f;;Human;23414845;Inhibition
conteltinib;protein tyrosine kinase 2;f;;Human;;Inhibition
ENMD-2076;protein tyrosine kinase 2;f;;Human;19320489;Inhibition
NVP-TAE 226;protein tyrosine kinase 2;f;;Human;17219439|17431114;Inhibition
PF-562271;protein tyrosine kinase 2;f;;Human;18339875;Inhibition
VS-4718;protein tyrosine kinase 2;f;;Human;20234191;Inhibition
aloisine;protein tyrosine kinase 2 beta;f;;Human;22289061;Inhibition
conteltinib;protein tyrosine kinase 2 beta;f;;Human;;Inhibition
NVP-TAE 226;protein tyrosine kinase 2 beta;f;;Human;17431114;Inhibition
PF-562271;protein tyrosine kinase 2 beta;f;;Human;18339875;Inhibition
compound 19a [PMID: 21855335];protein tyrosine kinase 6;f;;Human;21855335;Inhibition
tilfrinib;protein tyrosine kinase 6;f;;Human;24650640;Inhibition
compound 7b [Haftchenary et al., 2013];protein tyrosine phosphatase non-receptor type 1;f;;Human;;Inhibition
HPN;protein tyrosine phosphatase non-receptor type 1;f;;Human;23364683;Inhibition
I-C11;protein tyrosine phosphatase non-receptor type 1;f;;Human;18056643;Inhibition
NC1;protein tyrosine phosphatase non-receptor type 1;f;;Human;30979725;Inhibition
trodusquemine;protein tyrosine phosphatase non-receptor type 1;f;;Human;20075852;Inhibition
compound 8a [PMID: 23713581];protein tyrosine phosphatase non-receptor type 22;f;;Human;23713581;Inhibition
I-C11;protein tyrosine phosphatase non-receptor type 22;f;;Human;18056643;Inhibition
I-C11;protein tyrosine phosphatase non-receptor type 22;f;;Human;18056643;Inhibition
NC1;protein tyrosine phosphatase non-receptor type 22;f;;Human;30979725;Inhibition
5-hydroxy-L-tryptophan;Proton-coupled Amino acid Transporter 1;f;;Human;16126914;Inhibition
5-hydroxytryptamine;Proton-coupled Amino acid Transporter 1;f;;Human;16126914;Inhibition
indole-3-propionic acid;Proton-coupled Amino acid Transporter 1;f;;Human;16126914;Inhibition
L-tryptophan;Proton-coupled Amino acid Transporter 1;f;;Human;16126914;Inhibition
5-hydroxy-L-tryptophan;Proton-coupled Amino acid Transporter 2;f;;Human;20691150;Inhibition
α-methyl-D,L-tryptophan;Proton-coupled Amino acid Transporter 2;f;;Human;20691150;Inhibition
indomethacin;Proton-coupled folate transporter;f;;Human;17129779;Inhibition
sulfasalazine;Proton-coupled folate transporter;f;;Human;17129779;Inhibition
[3H]folinic acid;Proton-coupled folate transporter;f;;Human;;Binding
[3H]N5-methylfolate;Proton-coupled folate transporter;f;;Human;;Binding
[3H]pemetrexed;Proton-coupled folate transporter;f;;Human;;Binding
[3H]folic acid;Proton-coupled folate transporter;f;;Human;;None
[3H]methotrexate;Proton-coupled folate transporter;f;;Human;;None
PrRP-20;PrRP receptor;t;Human;Human;11030716|12606605;Full agonist
PrRP-20;PrRP receptor;f;Rat;Human;11030716;Full agonist
PrRP-(24-31) (human);PrRP receptor;f;;Human;12606605;Full agonist
PrRP-31;PrRP receptor;f;Rat;Human;11030716;Full agonist
PrRP-31;PrRP receptor;t;Human;Human;11030716|12606605;Full agonist
PTHrP;PrRP receptor;t;Human;Human;;Full agonist
[125I]PrRP-20 (human);PrRP receptor;f;;Human;11030716;Full agonist
[125I]PrRP31;PrRP receptor;f;;Human;15752583;Full agonist
NPY-(18-36) (human, pig);PrRP receptor;f;;Human;12606605;Partial agonist
neuropeptide Y;PrRP receptor;t;Human|Mouse|Rat;Human;15885496;Antagonist
crizanlizumab;P-selectin (CD62);f;;Human;;Binding
bimosiamose;P-selectin (CD62);f;;Human;9544210;Binding
rivipansel;P-selectin (CD62);f;;Human;20508165;Binding
selectin P ligand;P-selectin (CD62);t;Human;Human;9829984;Binding
abaloparatide;PTH1 receptor;f;;Human;24078470;Agonist
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human);PTH1 receptor;f;;Human;18946036;Full agonist
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human);PTH1 receptor;f;;Human;18946036;Full agonist
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2;PTH1 receptor;f;;Human;18946036;Full agonist
[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2;PTH1 receptor;f;;Human;18946036;Full agonist
[Arg19]PTH-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[His5,Arg19]PTH-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[His5]PTH-(1-34) (human);PTH1 receptor;f;;Human;8702701;Full agonist
[His5]PTH-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[Ile5,Glu19]PTHrP-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[Ile5,Glu19,Val21]PTHrP-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[Ile5]PTHrP-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[Ile5]PTHrP-(1-36) (human);PTH1 receptor;f;;Human;8702701;Full agonist
[Ile5,Trp23]PTHrP-(1-36) (human);PTH1 receptor;f;;Human;8702701|10537121;Full agonist
[Ile5,Trp23]PTHrP-(2-36) (human);PTH1 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23]PTHrP-(3-36) (human);PTH1 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23]PTHrP-(4-36) (human);PTH1 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human);PTH1 receptor;f;;Human;9360953;Full agonist
[Ile5,Val21]PTHrP-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
[Nle8,18,Tyr34]PTH-(1-34)-NH2 (bovine);PTH1 receptor;f;;Rat;8662729;Full agonist
[Nle8,18,Tyr34]PTH-(3-34)-NH2 (bovine);PTH1 receptor;f;;Rat;8662729;Full agonist
[Phe23]PTH-(1-34) (human);PTH1 receptor;f;;Human;8702701;Full agonist
PTH-(1-34) (rat);PTH1 receptor;f;;Human;10537121;Full agonist
PTHrP-(1-20)/TIP-(23-39) (human);PTH1 receptor;f;;Human;11159842;Full agonist
PTHrP-(1-21)/PTH-(22-34) (human);PTH1 receptor;f;;Human;8702701;Full agonist
PTHrP-(1-34) (human);PTH1 receptor;f;;Rat;7896796;Full agonist
PTHrP-(1-36);PTH1 receptor;t;Human;Human;8702701;Full agonist
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat);PTH1 receptor;f;;Human;9360953;Full agonist
teriparatide;PTH1 receptor;f;;Human;8702701;Full agonist
teriparatide;PTH1 receptor;f;;Rat;7896796;Full agonist
[Trp23]PTHrP-(1-36) (human);PTH1 receptor;f;;Human;8702701;Full agonist
[Trp23,Tyr36]PTHrP-(1-36)-NH2 (human);PTH1 receptor;f;;Human;9360953;Full agonist
[Tyr34]PTH-(1-34) (human);PTH1 receptor;f;;Human;11159842;Full agonist
[Tyr34]PTH-(1-34)-NH2 (human);PTH1 receptor;f;;Rat;8662729;Full agonist
[Tyr34]PTH-(3-34)-NH2 (human);PTH1 receptor;f;;Rat;8662729;Full agonist
[Tyr36]-PTHrP-(1-36) amide (human);PTH1 receptor;f;;Human;11159842;Full agonist
[D-Trp12,Tyr34]PTH-(7-34) (bovine);PTH1 receptor;f;;Human;11046116;Antagonist
[Ile5,Trp23]PTHrP-(5-36);PTH1 receptor;f;;Human;10537121;Antagonist
PTHrP-(7-34) (human, rat, mouse);PTH1 receptor;f;;Human;11046116;Antagonist
TIP39;PTH1 receptor;t;Bovine|Human;Human;11159842|10854439;Antagonist
TIP39-(3-39) (human/bovine);PTH1 receptor;f;;Human;11159842;Antagonist
TIP39-(7-39) (human/bovine);PTH1 receptor;f;;Human;11046116;Antagonist
TIP39-(9-39) (human/bovine);PTH1 receptor;f;;Human;11159842;Antagonist
[His5]PTH-(1-34) (human);PTH2 receptor;f;;Human;8702701;Full agonist
[Ile5]PTHrP-(1-36);PTH2 receptor;f;;Human;11602681;Full agonist
[Ile5,Trp23]PTHrP-(1-36) (human);PTH2 receptor;f;;Human;8702701|10537121;Full agonist
[Ile5,Trp23]PTHrP-(2-36) (human);PTH2 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23]PTHrP-(3-36) (human);PTH2 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23]PTHrP-(4-36) (human);PTH2 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23]PTHrP-(5-36) (human);PTH2 receptor;f;;Human;10537121;Full agonist
[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human);PTH2 receptor;f;;Human;9360953;Full agonist
[Phe23]PTH-(1-34) (human);PTH2 receptor;f;;Human;8702701;Full agonist
PTH-(1-34) (rat);PTH2 receptor;f;;Rat;11602681;Full agonist
PTH-(1-34) (rat);PTH2 receptor;f;;Human;10537121|10854439|11602681;Full agonist
PTHrP-(1-34) (human);PTH2 receptor;t;;Rat;11602681;Full agonist
PTHrP-(1-34) (human);PTH2 receptor;t;;Human;11602681;Full agonist
PTHrP-(1-36);PTH2 receptor;t;Human;Human;8702701;Full agonist
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat);PTH2 receptor;f;;Human;9360953;Full agonist
teriparatide;PTH2 receptor;f;;Human;8702701|11602681;Full agonist
teriparatide;PTH2 receptor;f;;Rat;11602681;Full agonist
TIP39;PTH2 receptor;f;Mouse|Rat;Human;11602681;Full agonist
TIP39;PTH2 receptor;f;Bovine|Human;Rat;11602681;Full agonist
TIP39;PTH2 receptor;f;Bovine|Human;Human;10854439|11602681;Full agonist
TIP39;PTH2 receptor;t;Mouse|Rat;Rat;11602681;Full agonist
[Trp23]PTHrP-(1-36) (human);PTH2 receptor;f;;Human;8702701;Full agonist
[Trp23,Tyr36]PTHrP-(1-36)-NH2 (human);PTH2 receptor;f;;Human;9360953;Full agonist
[D-Trp12]PTH-(7-34) (bovine);PTH2 receptor;f;;Rat;11602681;Antagonist
[D-Trp12]PTH-(7-34) (bovine);PTH2 receptor;f;;Human;11602681;Antagonist
[D-Trp12,Tyr34]PTH-(7-34) (bovine);PTH2 receptor;f;;Human;11046116;Antagonist
[His4, Tyr5, Trp6, His7]TIP39 (human);PTH2 receptor;f;;Rat;;Antagonist
[Ile5,Trp23]PTHrP-(5-36);PTH2 receptor;f;;Human;10537121;Antagonist
PTHrP-(1-21)/PTH-(22-34) (human);PTH2 receptor;f;;Human;8702701|11602681;Antagonist
PTHrP-(1-21)/PTH-(22-34) (human);PTH2 receptor;f;;Rat;11602681;Antagonist
PTHrP-(7-34) (human, rat, mouse);PTH2 receptor;f;;Human;11046116;Antagonist
TIP39-(7-39) (human/bovine);PTH2 receptor;f;;Rat;11602681;Antagonist
TIP39-(7-39) (human/bovine);PTH2 receptor;f;;Human;11046116|11602681;Antagonist
TIP39-(7-39) (mouse);PTH2 receptor;f;;Rat;11602681;Antagonist
TIP39-(7-39) (mouse);PTH2 receptor;f;;Human;11602681;Antagonist
forodesine;purine nucleoside phosphorylase;f;;Human;9628722;Inhibition
ANTAQ;Puromycin-sensitive aminopeptidase;f;;Human;12467622;Inhibition
carbenoxolone;Px1;f;;Human;;None
flufenamic acid;Px1;f;;Human;;None
carbenoxolone;Px2;f;;Human;;None
flufenamic acid;Px2;f;;Human;;None
carbenoxolone;Px3;f;;Human;;None
flufenamic acid;Px3;f;;Human;;None
AZD7545;pyruvate dehydrogenase kinase 1;f;;Human;14641019;Inhibition
VER-246608;pyruvate dehydrogenase kinase 1;f;;Human;25404640;Inhibition
AZD7545;pyruvate dehydrogenase kinase 2;f;;Human;14641019;Inhibition
VER-246608;pyruvate dehydrogenase kinase 2;f;;Human;25404640;Inhibition
VER-246608;pyruvate dehydrogenase kinase 3;f;;Human;25404640;Inhibition
VER-246608;pyruvate dehydrogenase kinase 4;f;;Human;25404640;Inhibition
compound 16 [PMID: 31977207];pyruvate kinase M1/2;f;;Human;31977207;Activation
DASA-58;pyruvate kinase M1/2;f;;Human;21958545;Activation
DMAMCL;pyruvate kinase M1/2;f;;Human;29641204;Activation
TEPP-46;pyruvate kinase M1/2;f;;Human;20451379;Activation
mitapivat;pyruvate kinase M1/2;f;;Human;;Activation
compound 1 [PMID: 31465224];pyruvate kinase M1/2;f;;Human;31465224;Inhibition
LV-2172;QRFP receptor;f;;Human;22800498;Agonist
LV-2186;QRFP receptor;f;;Human;30358997;Agonist
[125I]26RFa (human);QRFP receptor;f;;Human;17534937;Agonist
QRFP26;QRFP receptor;t;Mouse;Mouse;12714592;Full agonist
QRFP26;QRFP receptor;t;Rat;Rat;14657341;Full agonist
QRFP26;QRFP receptor;t;Human;Human;12714592|14657341;Full agonist
QRFP43;QRFP receptor;t;Human;Human;16500002|23396314;Full agonist
QRFP43;QRFP receptor;f;Rat;Human;16648250;Full agonist
QRFP43;QRFP receptor;f;Rat;Mouse;16648250;Full agonist
QRFP43;QRFP receptor;f;Human;Mouse;16648250;Full agonist
QRFP43;QRFP receptor;t;Mouse;Mouse;16648250;Full agonist
QRFP43;QRFP receptor;f;Human;Rat;16648250|12960173|14657341;Full agonist
[125I]QRFP43 (human);QRFP receptor;f;;Human;16648250|12960173;Full agonist
[125I]QRFP43 (human);QRFP receptor;f;;Mouse;16648250;Full agonist
compound 25e [PMID: 25875054];QRFP receptor;f;;Human;24937104|25875054;Antagonist
Nexinhib20;RAB27A, member RAS oncogene family;f;;Human;27702998;Inhibition
agerafenib;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;22168626;Inhibition
balamapimod;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;;Inhibition
CCT196969;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;25500121;Inhibition
CCT241161;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;25500121;Inhibition
GW5074;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;15255937;Inhibition
L779450;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;18346893;Inhibition
LXH254;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;31059256;Inhibition
LY3009120;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;26343583;Inhibition
OSI-930;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;16424037;Inhibition
PLX8394;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;26466569;Inhibition
RIPK3 inhibitor 18;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;;Inhibition
SB590885;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;17145850;Inhibition
sorafenib;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;15466206;Inhibition
TAK-632;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;23906342;Inhibition
TAK-632;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;23906342;Inhibition
vemurafenib;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;22808911|26343583;Inhibition
ZM336372;Raf-1 proto-oncogene, serine/threonine kinase;f;;Human;18077363|12534346;Inhibition
CE3F4;Rap guanine nucleotide exchange factor 3;f;;None;;Inhibition
ESI-09;Rap guanine nucleotide exchange factor 3;f;;Human;23066090;Inhibition
ESI-09;Rap guanine nucleotide exchange factor 4;f;;Human;23066090|24256330;Inhibition
HJC 0350;Rap guanine nucleotide exchange factor 4;f;;Human;23286832;Inhibition
7-hydroxycholesterol;RAR-related orphan receptor-α;f;;Human;14622968;Agonist
CD2314;RAR-related orphan receptor-α;f;;Human;19470764;Agonist
cholesterol;RAR-related orphan receptor-α;t;;Human;8858107|12467577;Agonist
cholesterol sulphate;RAR-related orphan receptor-α;f;;Human;12467577|14622968;Agonist
SR1001;RAR-related orphan receptor-α;f;;Human;21499262;Inverse agonist
T0901317;RAR-related orphan receptor-α;f;;Human;19887649;Inverse agonist
CD2314;RAR-related orphan receptor-β;f;;Human;19470764;Agonist
tretinoin;RAR-related orphan receptor-β;t;;Human;12958591;Agonist
all-trans-4-oxo-retinoic acid;RAR-related orphan receptor-β;f;;Human;12958591;Antagonist
all-trans-4-oxo-retinoic acid;RAR-related orphan receptor-β;f;;Human;12958591;Antagonist
ALRT 1550;RAR-related orphan receptor-β;f;;Human;12958591;Antagonist
ALRT 1550;RAR-related orphan receptor-β;f;;Human;12958591;Antagonist
tretinoin;RAR-related orphan receptor-β;t;;Human;12958591;Antagonist
tretinoin;RAR-related orphan receptor-β;t;;Human;12958591;Antagonist
25-hydroxycholesterol;RAR-related orphan receptor-γ;t;;Human;20203100;Agonist
cintirorgon;RAR-related orphan receptor-γ;f;;Human;;Agonist
cintirorgon;RAR-related orphan receptor-γ;f;;Human;;Agonist
compound 32 [PMID: 31638797];RAR-related orphan receptor-γ;f;;Human;;Inverse agonist
compound 32 [PMID: 31638797];RAR-related orphan receptor-γ;f;;Human;31638797;Inverse agonist
GNE-3500;RAR-related orphan receptor-γ;f;;Human;26061388;Inverse agonist
GSK2981278;RAR-related orphan receptor-γ;f;;Human;26870941;Inverse agonist
MRL-871;RAR-related orphan receptor-γ;f;;Human;26048793;Inverse agonist
RORC2 inverse agonist 66 [PMID: 30130103];RAR-related orphan receptor-γ;f;;Human;;Inverse agonist
RORC2 inverse agonist 66 [PMID: 30130103];RAR-related orphan receptor-γ;f;;Human;30130103;Inverse agonist
SR1001;RAR-related orphan receptor-γ;f;;Human;21499262;Inverse agonist
SR1555;RAR-related orphan receptor-γ;f;;Human;22769242;Inverse agonist
SR2211;RAR-related orphan receptor-γ;f;;Human;22292739;Inverse agonist
T0901317;RAR-related orphan receptor-γ;f;;Human;19887649;Inverse agonist
TAK-828F;RAR-related orphan receptor-γ;f;;Human;29510038;Inverse agonist
XY101;RAR-related orphan receptor-γ;f;;Human;30964293;Inverse agonist
XY101;RAR-related orphan receptor-γ;f;;Human;30964293;Inverse agonist
XY101;RAR-related orphan receptor-γ;f;;Human;30964293;Inverse agonist
compound 25 [Zhang et al., 2020];RAR-related orphan receptor-γ;f;;Human;32071676;Negative
ALRT 1550;RAR-related orphan receptor-γ;f;;Human;12958591;Antagonist
CID16197121;Ras converting CAAX endopeptidase 1;f;;Human;;Inhibition
compound 3 [PMID: 17942791];Ras converting CAAX endopeptidase 1;f;;Human;17942791;Inhibition
RasGRP activator 1;RAS guanyl releasing protein 1;f;;Human;24794745;Binding
Ala(1-naph)-Pro-CN;RB binding protein 9, serine hydrolase;f;;Human;24997602;Inhibition
RANK ligand;receptor activator of NF-kappa B;t;Human;Human;;None
6E11;receptor interacting serine/threonine kinase 1;f;;Human;29018243;Inhibition
compound 21 [PMID: 24900635];receptor interacting serine/threonine kinase 1;f;;Human;24900635;Inhibition
compound 27 [PMID: 24900635];receptor interacting serine/threonine kinase 1;f;;Human;24900635;Inhibition
example 42 [WO2017136727A2];receptor interacting serine/threonine kinase 1;f;;Human;;Inhibition
GSK2982772;receptor interacting serine/threonine kinase 1;f;;Human;28151659;Inhibition
GSK'547;receptor interacting serine/threonine kinase 1;f;;Human;;Inhibition
GSK963;receptor interacting serine/threonine kinase 1;f;;Human;27551444;Inhibition
necrostatin-1;receptor interacting serine/threonine kinase 1;f;;Human;18408713;Inhibition
necrostatin-1s;receptor interacting serine/threonine kinase 1;f;;Human;9736715;Inhibition
PN10;receptor interacting serine/threonine kinase 1;f;;Human;25801024;Inhibition
ponatinib;receptor interacting serine/threonine kinase 1;f;;Human;25801024;Inhibition
RIPA-56;receptor interacting serine/threonine kinase 1;f;;Human;27992216;Inhibition
RIPK1 inhibitor 22b;receptor interacting serine/threonine kinase 1;f;;Human;30480444;Inhibition
RIPK1 inhibitor 22b;receptor interacting serine/threonine kinase 1;f;;Human;30480444;Inhibition
RIPK3 inhibitor 18;receptor interacting serine/threonine kinase 1;f;;Human;;Inhibition
RIPK3 inhibitor 42;receptor interacting serine/threonine kinase 1;f;;Human;31095385;Inhibition
SZM594;receptor interacting serine/threonine kinase 1;f;;Human;30825190;Inhibition
TAK-632;receptor interacting serine/threonine kinase 1;f;;Human;30825190;Inhibition
AS3334034;receptor interacting serine/threonine kinase 2;f;;Rat;32561685;Inhibition
GSK583;receptor interacting serine/threonine kinase 2;f;;Human;27109867;Inhibition
GSK583;receptor interacting serine/threonine kinase 2;f;;Rat;27109867;Inhibition
OD36;receptor interacting serine/threonine kinase 2;f;;Human;25213858;Inhibition
PN10;receptor interacting serine/threonine kinase 2;f;;Human;25801024;Inhibition
ponatinib;receptor interacting serine/threonine kinase 2;f;;Human;25801024;Inhibition
RIPK2 inhibitor 5;receptor interacting serine/threonine kinase 2;f;;Rat;31265286;Inhibition
RIPK2 inhibitor 5;receptor interacting serine/threonine kinase 2;f;;Human;31265286;Inhibition
RIPK2 inhibitor 8;receptor interacting serine/threonine kinase 2;f;;Human;29057049;Inhibition
Src kinase inhibitor I;receptor interacting serine/threonine kinase 2;f;;Human;17850214;Inhibition
ZAK inhibitor 6p;receptor interacting serine/threonine kinase 2;f;;Human;31244114;Inhibition
ponatinib;receptor interacting serine/threonine kinase 3;f;;Human;25801024;Inhibition
RIPK1 inhibitor 22b;receptor interacting serine/threonine kinase 3;f;;Human;30480444;Inhibition
RIPK3 inhibitor 18;receptor interacting serine/threonine kinase 3;f;;Human;;Inhibition
RIPK3 inhibitor 42;receptor interacting serine/threonine kinase 3;f;;Human;31095385;Inhibition
SZM594;receptor interacting serine/threonine kinase 3;f;;Human;30825190;Inhibition
TAK-632;receptor interacting serine/threonine kinase 3;f;;Human;30825190;Inhibition
compound 9 [PMID: 15615544];Reduced folate transporter 1;f;;Human;15615544;Inhibition
methotrexate;Reduced folate transporter 1;f;;Human;15615544;Inhibition
[3H]folic acid;Reduced folate transporter 1;f;;Human;9525913;None
[3H]methotrexate;Reduced folate transporter 1;f;;Human;9525913;None
(4Z)-1-(3-fluorophenyl)-4-(2-oxo-1H-indol-3-ylidene)pyrazolidine-3,5-dione;regulator of G-protein signaling 4;f;;Human;24041654;Inhibition
(5E)-1-(4-fluorophenyl)-5-[(5-methylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione;regulator of G-protein signaling 4;f;;Human;24041654;Inhibition
5nd;regulator of G-protein signaling 4;f;;Rat;19463173;Inhibition
(5Z)-1-(2-fluorophenyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-diazinane-4,6-dione;regulator of G-protein signaling 4;f;;Human;24041654;Inhibition
(5Z)-5-[(5-bromothiophen-2-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione;regulator of G-protein signaling 4;f;;Human;24041654;Inhibition
CCG-4986;regulator of G-protein signaling 4;f;;Human;17012620|20530129|17660054;Inhibition
CCG-50014;regulator of G-protein signaling 4;f;;Human;21329361|22368763;Inhibition
CCG-63802;regulator of G-protein signaling 4;f;;Human;20571077;Inhibition
CCG-63808;regulator of G-protein signaling 4;f;;Human;20571077;Inhibition
RGS4 inhibitor 11b;regulator of G-protein signaling 4;f;;Human;22368763;Inhibition
RGS4 inhibitor 13;regulator of G-protein signaling 4;f;;Human;22368763;Inhibition
YJ34;regulator of G-protein signaling 4;f;;Rat;15009535|16629824;Inhibition
CCG-50014;regulator of G-protein signaling 8;f;;Human;21329361|22368763;Inhibition
RGS4 inhibitor 11b;regulator of G-protein signaling 8;f;;Human;22368763;Inhibition
RGS4 inhibitor 13;regulator of G-protein signaling 8;f;;Human;22368763;Inhibition
aliskiren;renin;f;;Human;18307734;Inhibition
elezanumab;repulsive guidance molecule BMP co-receptor a;f;;Human;;Binding
ozanezumab;reticulon 4;f;;Human;;Binding
adapalene;Retinoic acid receptor-α;f;;Human;8544175;Agonist
AGN193836;Retinoic acid receptor-α;f;;Human;12372520;Agonist
alitretinoin;Retinoic acid receptor-α;f;;Human;3184125|7791761;Agonist
BMS753;Retinoic acid receptor-α;f;;Human;10421757;Agonist
CD666;Retinoic acid receptor-α;f;;Human;1323296;Agonist
Ro 40-6055;Retinoic acid receptor-α;f;;Human;19058965;Agonist
Ro 40-6055;Retinoic acid receptor-α;f;;Human;1656191;Agonist
tamibarotene;Retinoic acid receptor-α;f;;Human;3184125|7791761|10637371;Agonist
tamibarotene;Retinoic acid receptor-α;f;;Human;20925433;Agonist
tazarotene;Retinoic acid receptor-α;f;;Human;19058965;Agonist
tretinoin;Retinoic acid receptor-α;f;;Human;19058965;Agonist
tretinoin;Retinoic acid receptor-α;t;;Human;8380496|8264595|10964567|7791761|10637371;Agonist
trifarotene;Retinoic acid receptor-α;f;;Human;29706423;Agonist
TTNPB;Retinoic acid receptor-α;f;;Human;8264595|10964567|7791761|10637371;Agonist
[3H]9-cis-retinoic acid;Retinoic acid receptor-α;f;;Mouse;8380496;Full agonist
BMS614;Retinoic acid receptor-α;f;;Human;10882070|10421757|11805839;Antagonist
Ro 41-5253;Retinoic acid receptor-α;f;;Human;8264595|1323127;Antagonist
AGN193109;Retinoic acid receptor-α;f;;Human;8798442|10777502|10637371;Inverse agonist
BMS493;Retinoic acid receptor-α;f;;Human;11805839;Inverse agonist
adapalene;Retinoic acid receptor-β;f;;Human;8544175;Agonist
alitretinoin;Retinoic acid receptor-β;f;;Human;10964567|7791761;Agonist
BMS641;Retinoic acid receptor-β;f;;Human;15319780;Agonist
CD666;Retinoic acid receptor-β;f;;Human;1323296;Agonist
Ro 40-6055;Retinoic acid receptor-β;f;;Human;19058965;Agonist
tamibarotene;Retinoic acid receptor-β;f;;Human;20925433;Agonist
tazarotene;Retinoic acid receptor-β;f;;Human;19058965;Agonist
tretinoin;Retinoic acid receptor-β;t;;Human;8264595|10964567|7791761|10637371;Agonist
tretinoin;Retinoic acid receptor-β;f;;Human;19058965;Agonist
trifarotene;Retinoic acid receptor-β;f;;Human;29706423;Agonist
TTNPB;Retinoic acid receptor-β;f;;Human;8264595|10964567|7791761|10637371;Agonist
AC261066;Retinoic acid receptor-β;f;;Human;16302793;Full agonist
AC55649;Retinoic acid receptor-β;f;;Human;16302793|19239230;Full agonist
[3H]9-cis-retinoic acid;Retinoic acid receptor-β;f;;Mouse;8380496;Full agonist
AGN193109;Retinoic acid receptor-β;f;;Human;8798442|10777502|10637371;Inverse agonist
BMS493;Retinoic acid receptor-β;f;;Human;11805839;Inverse agonist
adapalene;Retinoic acid receptor-γ;f;;Human;8544175;Agonist
AHPN;Retinoic acid receptor-γ;f;;Human;8544175;Agonist
alitretinoin;Retinoic acid receptor-γ;f;;Human;10964567|7791761;Agonist
BMS270394;Retinoic acid receptor-γ;f;;Human;10964567|10841540;Agonist
CD666;Retinoic acid receptor-γ;f;;Human;1323296;Agonist
palovarotene;Retinoic acid receptor-γ;f;;Human;;Agonist
Ro 40-6055;Retinoic acid receptor-γ;f;;Human;19058965;Agonist
tamibarotene;Retinoic acid receptor-γ;f;;Human;20925433;Agonist
tazarotene;Retinoic acid receptor-γ;f;;Human;19058965;Agonist
tretinoin;Retinoic acid receptor-γ;f;;Human;19058965;Agonist
tretinoin;Retinoic acid receptor-γ;t;;Human;8380496|8264595|10964567|7791761|10637371;Agonist
trifarotene;Retinoic acid receptor-γ;f;;Human;29706423;Agonist
TTNPB;Retinoic acid receptor-γ;f;;Human;8264595|10964567;Agonist
[3H]9-cis-retinoic acid;Retinoic acid receptor-γ;f;;Mouse;8380496;Full agonist
AGN193109;Retinoic acid receptor-γ;f;;Human;8798442|10777502|10637371;Antagonist
BMS493;Retinoic acid receptor-γ;f;;Human;11805839;Antagonist
CD2665;Retinoic acid receptor-γ;f;;Human;9187263;Antagonist
MM 11253;Retinoic acid receptor-γ;f;;Human;10723137;Antagonist
AGN194204;Retinoid X receptor-α;f;;Human;11428923;Agonist
alitretinoin;Retinoid X receptor-α;t;;Human;8380496|7791761|1310260|8837780|1309942|1312497;Agonist
bexarotene;Retinoid X receptor-α;f;;Human;10637371|10052980|8071941;Agonist
CD3254;Retinoid X receptor-α;f;;None;11805839;Agonist
compound 28 [Heitel et al., 2019];Retinoid X receptor-α;f;;Human;30783504;Agonist
compound 28 [Heitel et al., 2019];Retinoid X receptor-α;f;;Human;30783504;Agonist
docosahexaenoic acid;Retinoid X receptor-α;t;;Mouse;10529898|11690641;Agonist
fluorobexarotene;Retinoid X receptor-α;f;;Human;19791803;Agonist
fluorobexarotene;Retinoid X receptor-α;f;;Human;19791803;Agonist
LG100268;Retinoid X receptor-α;f;;Human;10637371|8837780|8308867;Agonist
methoprene acid;Retinoid X receptor-α;f;;Human;7597096;Agonist
phytanic acid;Retinoid X receptor-α;f;;Mouse;11690641|8617282;Agonist
SR11237;Retinoid X receptor-α;f;;Unknown;1335166;Agonist
[3H]9-cis-retinoic acid;Retinoid X receptor-α;f;;Mouse;8380496;Full agonist
HX 531;Retinoid X receptor-α;f;;Human;17651969;Antagonist
K-80003;Retinoid X receptor-α;f;;Human;20541701;Antagonist
LG100754;Retinoid X receptor-α;f;;Human;11463859;Antagonist
PA451;Retinoid X receptor-α;f;;Human;12139443;Antagonist
PA452;Retinoid X receptor-α;f;;Human;24900278;Antagonist
sulindac;Retinoid X receptor-α;f;;Human;20541701;Antagonist
UVI3003;Retinoid X receptor-α;f;;Mouse;15528208;Antagonist
AGN194204;Retinoid X receptor-β;f;;Mouse;11428923;Agonist
alitretinoin;Retinoid X receptor-β;t;;None;8380496|7791761|1310260|8837780|1309942|1312497;Agonist
bexarotene;Retinoid X receptor-β;f;;Human;10637371|10052980|8071941;Agonist
compound 28 [Heitel et al., 2019];Retinoid X receptor-β;f;;Human;30783504;Agonist
LG100268;Retinoid X receptor-β;f;;None;10637371|8837780|8308867;Agonist
[3H]9-cis-retinoic acid;Retinoid X receptor-β;f;;Mouse;8380496;Full agonist
LG100754;Retinoid X receptor-β;f;;Human;11463859|11877384|8837780;Antagonist
UVI3003;Retinoid X receptor-β;f;;Human;19408900;Antagonist
AGN194204;Retinoid X receptor-γ;f;;None;11428923;Agonist
alitretinoin;Retinoid X receptor-γ;t;;Human;8380496|7791761|1310260|8837780|1309942|1312497;Agonist
bexarotene;Retinoid X receptor-γ;f;;Human;10637371|10052980|8071941;Agonist
compound 28 [Heitel et al., 2019];Retinoid X receptor-γ;f;;Human;30783504;Agonist
LG100268;Retinoid X receptor-γ;f;;None;10637371|8837780|8308867;Agonist
[3H]9-cis-retinoic acid;Retinoid X receptor-γ;f;;Mouse;8380496;Full agonist
LG100754;Retinoid X receptor-γ;f;;None;8837780;Antagonist
A1120;retinol binding protein 4;f;;Human;24835984;Inhibition
AST-487;ret proto-oncogene;f;;Human;17638907;Inhibition
cabozantinib;ret proto-oncogene;f;;Human;29657135;Inhibition
CEP-11981;ret proto-oncogene;f;;Human;22148921;Inhibition
compound 1d [PMID: 21493067];ret proto-oncogene;f;;Human;21493067;Inhibition
compound 8h [PMID: 21561767];ret proto-oncogene;f;;Human;21561767;Inhibition
gilteritinib;ret proto-oncogene;f;;Human;27908881;Inhibition
KBP-7018;ret proto-oncogene;f;;Human;29152045;Inhibition
linifanib;ret proto-oncogene;f;;Human;16648571;Inhibition
lucitanib;ret proto-oncogene;f;;Human;22304225;Inhibition
ponatinib;ret proto-oncogene;f;;Human;23811235;Inhibition
pralsetinib;ret proto-oncogene;f;;Human;29657135;Inhibition
quizartinib;ret proto-oncogene;f;;Human;19754199;Inhibition
RG-1530;ret proto-oncogene;f;;Human;20814247;Inhibition
rivoceranib;ret proto-oncogene;f;;Human;21443688;Inhibition
selpercatinib;ret proto-oncogene;f;;Human;;Inhibition
sorafenib;ret proto-oncogene;f;;Human;23279183;Inhibition
sunitinib;ret proto-oncogene;f;;Human;23279183;Inhibition
tafetinib;ret proto-oncogene;f;;Human;21638122;Inhibition
tamatinib;ret proto-oncogene;f;;Human;19107952;Inhibition
vandetanib;ret proto-oncogene;f;;Human;29657135;Inhibition
vandetanib;ret proto-oncogene;f;;Human;12499271;Inhibition
vandetanib;ret proto-oncogene;f;;Human;22037378;Inhibition
WF-47-JS03;ret proto-oncogene;f;;Human;;Inhibition
WF-47-JS03;ret proto-oncogene;f;;Human;;Inhibition
GSK4112;Rev-Erb-α;f;;Human;20677822;Agonist
GSK4112;Rev-Erb-α;f;;Human;21043485;Agonist
heme;Rev-Erb-α;t;;Human;18037887|18006707;Agonist
SR9009;Rev-Erb-α;f;;Human;22460951;Agonist
SR9011;Rev-Erb-α;f;;Human;22460951;Agonist
SR8278;Rev-Erb-α;f;;Human;21043485;Antagonist
SR8278;Rev-Erb-α;f;;Human;21043485;Antagonist
heme;Rev-Erb-β;t;;Human;18037887|18006707|24872411;Agonist
SR9009;Rev-Erb-β;f;;Human;22460951;Agonist
SR9011;Rev-Erb-β;f;;Human;22460951;Agonist
cobalt protoporphyrin IX;Rev-Erb-β;f;;Human;24872411;Antagonist
zinc protoporphyrin IX;Rev-Erb-β;f;;Human;24872411;Antagonist
belumosudil;Rho associated coiled-coil containing protein kinase 1;f;;Human;18832915;Inhibition
compound 22 [PMID: 20462760];Rho associated coiled-coil containing protein kinase 1;f;;Human;20462760;Inhibition
compound 33 [PMID: 19364658];Rho associated coiled-coil containing protein kinase 1;f;;Human;19364658;Inhibition
compound 35 [PMID: 20684608];Rho associated coiled-coil containing protein kinase 1;f;;Human;20684608;Inhibition
compound 8 [PMID: 25898023];Rho associated coiled-coil containing protein kinase 1;f;;Human;25898023;Inhibition
compound E22 [PMID: 31298542];Rho associated coiled-coil containing protein kinase 1;f;;Human;31298542;Inhibition
cortistatin A;Rho associated coiled-coil containing protein kinase 1;f;;Human;19844931;Inhibition
fasudil;Rho associated coiled-coil containing protein kinase 1;f;;Human;21145740;Inhibition
fasudil;Rho associated coiled-coil containing protein kinase 1;f;;Human;21145740|19597037;Inhibition
GSK269962A;Rho associated coiled-coil containing protein kinase 1;f;;Human;17018693;Inhibition
GSK429286A;Rho associated coiled-coil containing protein kinase 1;f;;Human;17201405;Inhibition
HSD1590;Rho associated coiled-coil containing protein kinase 1;f;;Human;31330446;Inhibition
HSD1590;Rho associated coiled-coil containing protein kinase 1;f;;Human;31330446;Inhibition
netarsudil;Rho associated coiled-coil containing protein kinase 1;f;;Human;31330446;Inhibition
ripasudil;Rho associated coiled-coil containing protein kinase 1;f;;Human;24502505;Inhibition
RKI-1447;Rho associated coiled-coil containing protein kinase 1;f;;Human;23275831;Inhibition
ROCK inhibitor 3;Rho associated coiled-coil containing protein kinase 1;f;;Human;30753868;Inhibition
SAR407899;Rho associated coiled-coil containing protein kinase 1;f;;Human;19597037;Inhibition
verosudil;Rho associated coiled-coil containing protein kinase 1;f;;Human;21794845;Inhibition
Y27632;Rho associated coiled-coil containing protein kinase 1;f;;Human;9353125;Inhibition
Y27632;Rho associated coiled-coil containing protein kinase 1;f;;Human;20462760|19597037;Inhibition
belumosudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;18832915;Inhibition
compound 11d [DOI: 10.1039/c0md00194e];Rho associated coiled-coil containing protein kinase 2;f;;Human;;Inhibition
compound 18 [PMID: 24119557];Rho associated coiled-coil containing protein kinase 2;f;;Human;24119557;Inhibition
compound 22 [PMID: 20462760];Rho associated coiled-coil containing protein kinase 2;f;;Human;20462760;Inhibition
compound 32 [PMID: 20471253];Rho associated coiled-coil containing protein kinase 2;f;;Human;20471253;Inhibition
compound 35 [PMID: 20684608];Rho associated coiled-coil containing protein kinase 2;f;;Human;20684608;Inhibition
compound 8 [PMID: 25898023];Rho associated coiled-coil containing protein kinase 2;f;;Human;25898023;Inhibition
cortistatin A;Rho associated coiled-coil containing protein kinase 2;f;;Human;19844931;Inhibition
fasudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;21145740|19597037;Inhibition
fasudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;19597037;Inhibition
GSK269962A;Rho associated coiled-coil containing protein kinase 2;f;;Human;17018693;Inhibition
HSD1590;Rho associated coiled-coil containing protein kinase 2;f;;Human;31330446;Inhibition
HSD1590;Rho associated coiled-coil containing protein kinase 2;f;;Human;31330446;Inhibition
netarsudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;27072905;Inhibition
netarsudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;31330446;Inhibition
Rho kinase inhibitor IV;Rho associated coiled-coil containing protein kinase 2;f;;Human;16213195;Inhibition
ripasudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;24502505;Inhibition
RKI-1447;Rho associated coiled-coil containing protein kinase 2;f;;Human;23275831;Inhibition
ROCK inhibitor 3;Rho associated coiled-coil containing protein kinase 2;f;;Human;30753868;Inhibition
SAR407899;Rho associated coiled-coil containing protein kinase 2;f;;Human;19597037;Inhibition
SAR407899;Rho associated coiled-coil containing protein kinase 2;f;;Rat;19597037;Inhibition
SAR407899;Rho associated coiled-coil containing protein kinase 2;f;;Human;19597037;Inhibition
verosudil;Rho associated coiled-coil containing protein kinase 2;f;;Human;21794845;Inhibition
Y27632;Rho associated coiled-coil containing protein kinase 2;f;;Human;9353125|19597037;Inhibition
Y27632;Rho associated coiled-coil containing protein kinase 2;f;;Human;20462760|19597037;Inhibition
clofarabine;ribonucleotide reductase catalytic subunit M1;f;;Human;1707752;Inhibition
fludarabine;ribonucleotide reductase catalytic subunit M1;f;;Human;7048062;Inhibition
gemcitabine;ribonucleotide reductase catalytic subunit M1;f;;Human;2233693;Inhibition
hydroxyurea;ribonucleotide reductase catalytic subunit M1;f;;Human;15670581;Inhibition
clofarabine;ribonucleotide reductase regulatory subunit M2;f;;Human;1707752;Inhibition
fludarabine;ribonucleotide reductase regulatory subunit M2;f;;Human;7048062;Inhibition
gemcitabine;ribonucleotide reductase regulatory subunit M2;f;;Human;2233693;Inhibition
hydroxyurea;ribonucleotide reductase regulatory subunit M2;f;;Human;15670581;Inhibition
BI-D1870;ribosomal protein S6 kinase A1;f;;Human;17040210;Inhibition
compound 33 [PMID: 19364658];ribosomal protein S6 kinase A1;f;;Human;19364658;Inhibition
compound E22 [PMID: 31298542];ribosomal protein S6 kinase A1;f;;Human;31298542;Inhibition
dorsomorphin;ribosomal protein S6 kinase A1;f;;Human;20932747;Inhibition
GSK-1838705A;ribosomal protein S6 kinase A1;f;;Human;19825801;Inhibition
GSK429286A;ribosomal protein S6 kinase A1;f;;Human;17201405;Inhibition
prexasertib;ribosomal protein S6 kinase A1;f;;Human;26141948;Inhibition
BI-D1870;ribosomal protein S6 kinase A2;f;;Human;17040210;Inhibition
compound 25b [PMID: 22564207];ribosomal protein S6 kinase A2;f;;Human;22564207;Inhibition
BI-D1870;ribosomal protein S6 kinase A3;f;;Human;17040210;Inhibition
BIX 02565;ribosomal protein S6 kinase A3;f;;Human;22056746;Inhibition
compound 25b [PMID: 22564207];ribosomal protein S6 kinase A3;f;;Human;22564207;Inhibition
compound 8h [PMID: 22765894];ribosomal protein S6 kinase A3;f;;Human;22765894;Inhibition
FMK;ribosomal protein S6 kinase A3;f;;Human;17259979;Inhibition
compound 8 [PMID: 17480064];ribosomal protein S6 kinase A4;f;;Human;17480064;Inhibition
compound 24 [PMID: 15955699];ribosomal protein S6 kinase A5;f;;Human;15955699;Inhibition
SB-747651A;ribosomal protein S6 kinase A5;f;;Human;15955699;Inhibition
AT-9283;ribosomal protein S6 kinase A6;f;;Human;19143567;Inhibition
BAY-985;ribosomal protein S6 kinase A6;f;;Human;31859507;Inhibition
BI-D1870;ribosomal protein S6 kinase A6;f;;Human;17040210;Inhibition
compound 25b [PMID: 22564207];ribosomal protein S6 kinase A6;f;;Human;22564207;Inhibition
compound 1 [PMID: 20005102];ribosomal protein S6 kinase B1;f;;Human;20005102;Inhibition
compound E22 [PMID: 31298542];ribosomal protein S6 kinase B1;f;;Human;31298542;Inhibition
GNE-3511;ribosomal protein S6 kinase B1;f;;Human;17201405;Inhibition
LY2584702;ribosomal protein S6 kinase B1;f;;Human;24440085;Inhibition
PF-4708671;ribosomal protein S6 kinase B1;f;;Human;20704563;Inhibition
compound 13e [PMID: 16759857];RTP Type B;f;;Human;16759857;Inhibition
7-BIA;RTP Type D;f;;Human;30348770;Inhibition
illudalic acid;RTP Type F;f;;Human;18579388;Inhibition
compound 1 [PMID: 21882820];RTP Type G;f;;Human;21882820;Inhibition
compound 8a [PMID: 23713581];RTP Type M;f;;Human;23713581;Inhibition
7-BIA;RTP Type S;f;;Human;9276730;Inhibition
compound 7b [Haftchenary et al., 2013];RTP Type S;f;;Human;;Inhibition
europium-labelled relaxin;RXFP1;f;;Human;22425984;Agonist
A(4-24)(B7-24)H2;RXFP1;f;;Human;21878627;Full agonist
A(4-24)(B7-24)H2;RXFP1;f;;Human;21878627;Full agonist
A(4-24)(F23A)H2;RXFP1;f;;Human;23024363;Full agonist
A(4-24)(F23A)H2;RXFP1;f;;Human;23024363;Full agonist
(B7-33)H2;RXFP1;f;;Human;30155023;Full agonist
europium-labelled relaxin;RXFP1;f;;Human;19343240;Full agonist
INSL3;RXFP1;f;Human;Human;23303914;Full agonist
relaxin;RXFP1;t;Human;Human;12506116|15649866|18434306;Full agonist
relaxin;RXFP1;f;Human;Human;18434306;Full agonist
relaxin;RXFP1;f;Pig;Human;15649866;Full agonist
relaxin;RXFP1;f;Rat;Human;15649866;Full agonist
relaxin;RXFP1;f;Rhesus macaque;Human;15649866;Full agonist
relaxin-1;RXFP1;t;Human;Human;16411781;Full agonist
relaxin-3;RXFP1;t;Human;Human;12506116|15649866;Full agonist
[125I]relaxin (human);RXFP1;f;;Human;;Full agonist
[33P]relaxin (human);RXFP1;f;;Human;12506116|15649866;Full agonist
ML290;RXFP1;f;;Human;23764525|23905199;Agonist
B-R13/17K H2 relaxin;RXFP1;f;;Human;20043231|24812057;Antagonist
B-R13/17K H2 relaxin;RXFP1;f;;Human;20043231|24812057;Antagonist
europium-labelled INSL3;RXFP2;f;;Human;18529069;Full agonist
INSL3;RXFP2;t;Human;Human;15649866|18434306;Full agonist
INSL3;RXFP2;f;Human;Human;18434306;Full agonist
relaxin;RXFP2;t;Human;Human;15649866|18434306;Full agonist
relaxin;RXFP2;f;Human;Human;18434306;Full agonist
relaxin;RXFP2;f;Pig;Human;15649866;Full agonist
relaxin;RXFP2;f;Rhesus macaque;Human;15649866;Full agonist
relaxin-1;RXFP2;t;Human;Human;16411781;Full agonist
relaxin-3;RXFP2;t;Human;Human;16411781;Full agonist
[125I]INSL3 (human);RXFP2;f;;Human;16051677;Full agonist
[125I]INSL3 (human);RXFP2;f;;Human;16051677;Full agonist
[33P]relaxin (human);RXFP2;f;;Human;12506116|15649866;Full agonist
A(10-24)INSL3;RXFP2;f;;Human;18434306;Antagonist
A(4-24)(B7-24)H2;RXFP2;f;;Human;21878627;Antagonist
A(4-24)(B7-24)H2;RXFP2;f;;Human;21878627;Antagonist
A(9-26)INSL3;RXFP2;f;;Human;18434306;Antagonist
A(C10/15S)INSL3;RXFP2;f;;Human;20570702;Antagonist
A(Δ10/15C)INSL3;RXFP2;f;;Human;20570702;Antagonist
cyclic INSL3 B-chain analogue 6;RXFP2;f;;Human;17120268;Antagonist
(des 1-8) A-chain INSL3 analogue;RXFP2;f;;Human;15708846;Antagonist
INSL3 B-chain analogue;RXFP2;f;;Human;16547350;Antagonist
INSL3 B chain dimer analogue 8;RXFP2;f;;Human;20560146;Antagonist
europium-labelled relaxin-3-B/INSL5 A chimera;RXFP3;f;;Human;21384867;Agonist
[125I]relaxin-3-B/INSL5 A chimera;RXFP3;f;;Human;15465925;Agonist
europium-labelled relaxin-3-B/INSL5 A chimera;RXFP3;f;;Human;21384867|22257012;Full agonist
minimised relaxin-3 analogue 2;RXFP3;f;;Human;22257012;Full agonist
minimised relaxin-3 analogue 2;RXFP3;f;;Human;22257012;Full agonist
R3/I5;RXFP3;f;;Human;15465925;Full agonist
relaxin;RXFP3;f;Human;Human;20159943|24641548;Full agonist
relaxin;RXFP3;f;Human;Human;20159943;Full agonist
relaxin-3;RXFP3;t;Human;Human;15367576|14522968;Full agonist
relaxin-3;RXFP3;t;Human;Human;22257012|18434306|17351017;Full agonist
relaxin-3;RXFP3;f;Human;Human;20159943|22257012|24641548|18434306|17351017;Full agonist
relaxin-3 (B chain);RXFP3;t;Human;Human;14522968;Full agonist
relaxin-3 B chain dimer;RXFP3;f;;Human;17351017;Full agonist
[125I]relaxin-3 (human);RXFP3;f;;Human;14522968;Full agonist
[125I]relaxin-3 (human);RXFP3;f;;Human;14522968;Full agonist
135PAM1;RXFP3;f;;Human;22347403;Positive
europium-labelled R3(B1-22R);RXFP3;f;;Human;25792111;Antagonist
INSL5;RXFP3;t;Human;Human;18582868;Antagonist
minimised relaxin-3 analogue 3;RXFP3;f;;Human;22257012;Antagonist
R3-B1-22R;RXFP3;f;;Human;21384867;Antagonist
R3(BΔ23-27)R/I5 chimeric peptide;RXFP3;f;;Human;21384867;Antagonist
R3(BΔ23-27)R/I5 chimeric peptide;RXFP3;f;;Human;17606621;Antagonist
R3(BΔ23-27)R/I5 chimeric peptide;RXFP3;f;;Human;24641548;Antagonist
europium-labelled mouse INSL5;RXFP4;f;;Human;21866895;Agonist
europium-labelled relaxin-3-B/INSL5 A chimera;RXFP4;f;;Human;21384867;Agonist
[125I]relaxin-3-B/INSL5 A chimera;RXFP4;f;;Human;15465925;Agonist
europium-labelled mouse INSL5;RXFP4;f;;Mouse;24188028;Full agonist
hINSL5: A8-21 (T9R);RXFP4;f;;Human;;Full agonist
hINSL5: A8-21 (T9R);RXFP4;f;;Human;26824523;Full agonist
INSL5;RXFP4;t;Human;Human;15525639|22257012|18582868|24188028|26824523;Full agonist
INSL5;RXFP4;t;Mouse;Mouse;24188028|26824523;Full agonist
INSL5;RXFP4;f;Mouse;Mouse;27243554;Full agonist
INSL5;RXFP4;t;Mouse;Mouse;24188028|26824523;Full agonist
INSL5;RXFP4;t;Human;Human;15525639|18682868;Full agonist
INSL5;RXFP4;f;Human;Human;27243554;Full agonist
INSL5;RXFP4;t;Human;Human;15525639|22257012|24188028|26824523;Full agonist
INSL5 amide (human);RXFP4;f;;Human;21866895;Full agonist
INSL5 amide (human);RXFP4;f;;Human;21866895;Full agonist
INSL5 amide (mouse);RXFP4;f;;Mouse;21866895;Full agonist
INSL5 amide (mouse);RXFP4;f;;Mouse;21866895;Full agonist
minimised relaxin-3 analogue 2;RXFP4;f;;Human;22257012;Full agonist
minimised relaxin-3 analogue 2;RXFP4;f;;Human;22257012;Full agonist
R3/I5;RXFP4;f;;Human;17606621;Full agonist
R3/I5;RXFP4;f;;Human;17606621;Full agonist
relaxin-3;RXFP4;t;Human;Human;14522967;Full agonist
relaxin-3;RXFP4;f;Human;Human;18582868;Full agonist
relaxin-3;RXFP4;t;Human;Human;17606621;Full agonist
relaxin-3;RXFP4;t;Human;Human;17606621|18582868;Full agonist
[125I]INSL5 (human);RXFP4;f;;Human;15525639;Full agonist
[125I]relaxin-3 (human);RXFP4;f;;Human;14522967;Full agonist
minimised INSL5 analogue 7;RXFP4;f;;Human;24188028;Partial agonist
minimised INSL5 analogue 7;RXFP4;f;;Human;24188028;Partial agonist
relaxin-3 (B chain);RXFP4;f;Human;Human;14522967;Partial agonist
relaxin-3 (B chain);RXFP4;f;Human;Human;15525639|14522967;Partial agonist
minimised relaxin-3 analogue 3;RXFP4;f;;Human;22257012;Antagonist
R3(BΔ23-27)R/I5 chimeric peptide;RXFP4;f;;Human;17606621|21384867;Antagonist
europium-labelled INSL5;RXFP4;f;;Human;21384867;None
ATP;RyR1;t;;Human;;None
caffeine;RyR1;f;;Human;;None
Ca2+;RyR1;t;;Human;;None
Ca2+;RyR1;t;;Human;;None
ryanodine;RyR1;f;;Human;;None
suramin;RyR1;f;;Human;;None
Ca2+;RyR1;t;;Human;;Antagonist
dantrolene;RyR1;f;;Human;;Antagonist
Mg2+;RyR1;t;;Human;;Antagonist
procaine;RyR1;f;;Human;;None
ruthenium red;RyR1;f;;Human;;None
ryanodine;RyR1;f;;Human;;None
ATP;RyR2;t;;Human;;None
caffeine;RyR2;f;;Human;;None
Ca2+;RyR2;t;;Human;;None
Ca2+;RyR2;t;;Human;;None
ryanodine;RyR2;f;;Human;;None
suramin;RyR2;f;;Human;;None
Ca2+;RyR2;t;;Human;;Antagonist
Mg2+;RyR2;t;;Human;;Antagonist
procaine;RyR2;f;;Human;;None
ruthenium red;RyR2;f;;Human;;None
ryanodine;RyR2;f;;Human;;None
carvedilol;RyR2;f;;Human;24124794;Inhibition
VK-II-86;RyR2;f;;Human;24124794;Inhibition
ATP;RyR3;t;;Human;;None
caffeine;RyR3;f;;Human;;None
Ca2+;RyR3;t;;Human;;None
ryanodine;RyR3;f;;Human;;None
Ca2+;RyR3;t;;Human;;Antagonist
dantrolene;RyR3;f;;Human;;Antagonist
Mg2+;RyR3;t;;Human;;Antagonist
ruthenium red;RyR3;f;;Human;;None
A-971432;S1P1 receptor;f;;Human;26509640;Agonist
AFD(R);S1P1 receptor;f;;Human;11967257;Agonist
amiselimod phosphate;S1P1 receptor;f;;Human;31805144;Agonist
amiselimod phosphate;S1P1 receptor;f;;Human;27714763;Agonist
ASP4058;S1P1 receptor;f;;Human;25347187;Agonist
AUY954;S1P1 receptor;f;;Mouse;17114004;Agonist
AUY954;S1P1 receptor;f;;Human;17114004;Agonist
cenerimod;S1P1 receptor;f;;Human;29226621;Agonist
compound 26 [PMID: 16190743];S1P1 receptor;f;;Human;16190743;Agonist
compound 43 [PMID: 26751273];S1P1 receptor;f;;Human;26751273;Agonist
CYM5181;S1P1 receptor;f;;Human;18708635;Agonist
CYM5442;S1P1 receptor;f;;Human;18708635;Agonist
etrasimod;S1P1 receptor;f;;Human;31805144;Agonist
etrasimod;S1P1 receptor;f;;Human;25516790;Agonist
fingolimod;S1P1 receptor;f;;Human;15615513;Agonist
fingolimod-phosphate;S1P1 receptor;f;;Mouse;17898319|11967257;Agonist
fingolimod-phosphate;S1P1 receptor;f;;Human;14747617;Agonist
fingolimod-phosphate;S1P1 receptor;f;;Human;14747617;Agonist
fingolimod-phosphate;S1P1 receptor;f;;Human;11967257|14747617;Agonist
GSK2018682;S1P1 receptor;f;;Human;27128606;Agonist
KRP 203-phosphate;S1P1 receptor;f;;Mouse;17898319;Agonist
ozanimod;S1P1 receptor;f;;Human;31805144;Agonist
ozanimod;S1P1 receptor;f;;Human;18708635|26990079;Agonist
ozanimod;S1P1 receptor;f;;Human;26990079;Agonist
ponesimod;S1P1 receptor;f;;Human;20446681;Agonist
RP-001;S1P1 receptor;f;;Human;21445057;Agonist
RP-101075;S1P1 receptor;f;;Human;29608575;Agonist
SEW2871;S1P1 receptor;f;;Human;14732717;Agonist
SEW2871;S1P1 receptor;f;;Human;18708635|14732717;Agonist
SEW2871;S1P1 receptor;f;;Mouse;14732717;Agonist
siponimod;S1P1 receptor;f;;Human;24900670|29735753;Agonist
siponimod;S1P1 receptor;f;;Human;31805144;Agonist
sphingosine 1-phosphate;S1P1 receptor;t;;Human;31805144;Agonist
sphingosine 1-phosphate;S1P1 receptor;f;;Mouse;17114004|14732717;Agonist
sphingosine 1-phosphate;S1P1 receptor;t;;Human;11705398|17114004|9765227|11967257|14732717;Agonist
sphingosine 1-phosphate;S1P1 receptor;f;;Human;10446161|17170199;Agonist
SAR247799;S1P1 receptor;f;;Human;32487716;Biased agonist
NIBR-0213;S1P1 receptor;f;;Human;22999882;Antagonist
NIBR-0213;S1P1 receptor;f;;Human;22999882;Antagonist
SPM-354;S1P1 receptor;f;;Human;26494861;Antagonist
VPC03090-P;S1P1 receptor;f;;Mouse;21632869;Antagonist
VPC03090-P;S1P1 receptor;f;;Human;21632869;Antagonist
VPC23019;S1P1 receptor;f;;Human;15590668;Antagonist
VPC44116;S1P1 receptor;f;;Human;17113298;Antagonist
VPC44116;S1P1 receptor;f;;Human;17113298;Antagonist
W146;S1P1 receptor;f;;Human;16829954;Antagonist
AUY954;S1P2 receptor;f;;Mouse;17114004;Agonist
compound 43 [PMID: 26751273];S1P2 receptor;f;;Human;26751273;Agonist
CYM5520;S1P2 receptor;f;;Human;23849205;Agonist
fingolimod-phosphate;S1P2 receptor;f;;Human;25762025;Agonist
ozanimod;S1P2 receptor;f;;Human;26990079;Agonist
sphingosine 1-phosphate;S1P2 receptor;t;;Human;11705398|17114004;Agonist
sphingosine 1-phosphate;S1P2 receptor;t;;Human;10446161|9988698;Agonist
sphingosine 1-phosphate;S1P2 receptor;t;;Mouse;14732717;Agonist
compound 16 [PMID: 26794040];S1P2 receptor;f;;Human;26794040;Antagonist
JTE-013;S1P2 receptor;f;;Rat;12557151|12445827;Antagonist
JTE-013;S1P2 receptor;f;;Human;12445827;Antagonist
AFD(R);S1P3 receptor;f;;Human;11967257;Agonist
ASP4058;S1P3 receptor;f;;Human;25347187;Agonist
AUY954;S1P3 receptor;f;;Mouse;17114004|17113298;Agonist
compound 26 [PMID: 16190743];S1P3 receptor;f;;Human;16190743;Agonist
compound 43 [PMID: 26751273];S1P3 receptor;f;;Human;26751273;Agonist
CYM-5541;S1P3 receptor;f;;Human;22971058;Agonist
fingolimod-phosphate;S1P3 receptor;f;;Human;11967257|14747617;Agonist
fingolimod-phosphate;S1P3 receptor;f;;Human;11967257|14747617;Agonist
ozanimod;S1P3 receptor;f;;Human;26990079;Agonist
ponesimod;S1P3 receptor;f;;Human;20446681;Agonist
(S)-FTY720-phosphate;S1P3 receptor;f;;Human;17114004;Agonist
siponimod;S1P3 receptor;f;;Human;24900670;Agonist
sphingosine 1-phosphate;S1P3 receptor;t;;Human;10446161|9988698|17170199;Agonist
sphingosine 1-phosphate;S1P3 receptor;t;;Human;11705398|17114004|11967257;Agonist
sphingosine 1-phosphate;S1P3 receptor;t;;Mouse;14732717;Agonist
VPC12249;S1P3 receptor;f;;Human;17113298;Agonist
CYM-5541;S1P3 receptor;f;;Human;26494861;Positive
SPM-354;S1P3 receptor;f;;Human;26494861;Antagonist
TY-52156;S1P3 receptor;f;;Human;20097776;Antagonist
VPC03090-P;S1P3 receptor;f;;Human;21632869;Antagonist
VPC23019;S1P3 receptor;f;;Human;15590668;Antagonist
VPC44116;S1P3 receptor;f;;Human;17113298;Antagonist
AFD(R);S1P4 receptor;f;;Human;11967257|14732717;Agonist
ASP4058;S1P4 receptor;f;;Human;25347187;Agonist
AUY954;S1P4 receptor;f;;Mouse;17114004;Agonist
compound 26 [PMID: 16190743];S1P4 receptor;f;;Human;16190743;Agonist
compound 43 [PMID: 26751273];S1P4 receptor;f;;Human;26751273;Agonist
compound 5c [PMID: 27894870];S1P4 receptor;f;;Human;27894870;Agonist
compound 5c [PMID: 27894870];S1P4 receptor;f;;Human;27894870;Agonist
CYM-50308;S1P4 receptor;f;;Human;21982495;Agonist
dihydrosphingosine 1-phosphate;S1P4 receptor;f;;Human;12270137;Agonist
etrasimod;S1P4 receptor;f;;Human;12110609|25516790;Agonist
fingolimod-phosphate;S1P4 receptor;f;;Mouse;17898319|11967257;Agonist
fingolimod-phosphate;S1P4 receptor;f;;Human;17114004|11967257|14732717|14747617|25347187;Agonist
KRP 203-phosphate;S1P4 receptor;f;;Mouse;17898319;Agonist
ozanimod;S1P4 receptor;f;;Human;26990079;Agonist
phytosphingosine 1-phosphate;S1P4 receptor;f;;Human;12270137;Agonist
siponimod;S1P4 receptor;f;;Human;24125884;Agonist
sphingosine 1-phosphate;S1P4 receptor;t;;Mouse;14732717;Agonist
sphingosine 1-phosphate;S1P4 receptor;t;;Human;12270137|17114004|14732717;Agonist
sphingosine 1-phosphate;S1P4 receptor;t;;Human;12270137|11967257;Agonist
VPC03090-P;S1P4 receptor;f;;Human;21632869;Full agonist
VPC03090-P;S1P4 receptor;f;;Human;21632869;Full agonist
ponesimod;S1P4 receptor;f;;Human;20446681;Partial agonist
CYM-50358;S1P4 receptor;f;;Human;21570287|23913862;Antagonist
A-971432;S1P5 receptor;f;;Human;26509640|29688337;Agonist
A-971432;S1P5 receptor;f;;Human;26509640;Agonist
AFD(R);S1P5 receptor;f;;Human;11967257|14732717;Agonist
ASP4058;S1P5 receptor;f;;Human;25347187;Agonist
AUY954;S1P5 receptor;f;;Human;17114004;Agonist
AUY954;S1P5 receptor;f;;Mouse;17114004;Agonist
compound 26 [PMID: 16190743];S1P5 receptor;f;;Human;16190743;Agonist
compound 43 [PMID: 26751273];S1P5 receptor;f;;Human;26751273;Agonist
etrasimod;S1P5 receptor;f;;Human;25516790;Agonist
fingolimod;S1P5 receptor;f;;Human;15615513;Agonist
fingolimod-phosphate;S1P5 receptor;f;;Human;17114004|11967257|14747617;Agonist
fingolimod-phosphate;S1P5 receptor;f;;Human;14747617;Agonist
GSK2018682;S1P5 receptor;f;;Human;27128606;Agonist
ozanimod;S1P5 receptor;f;;Human;26990079;Agonist
ozanimod;S1P5 receptor;f;;Human;;Agonist
RP-101075;S1P5 receptor;f;;Human;29608575;Agonist
siponimod;S1P5 receptor;f;;Human;24125884|22646698|9735753;Agonist
sphingosine 1-phosphate;S1P5 receptor;t;;Mouse;11705398|14732717;Agonist
sphingosine 1-phosphate;S1P5 receptor;t;;Rat;10799507;Agonist
sphingosine 1-phosphate;S1P5 receptor;t;;Human;11705398|17114004|11967257|14732717;Agonist
ponesimod;S1P5 receptor;f;;Human;20446681;Partial agonist
VPC03090-P;S1P5 receptor;f;;Human;21632869;Partial agonist
VPC03090-P;S1P5 receptor;f;;Human;21632869;Partial agonist
VPC44116;S1P5 receptor;f;;Human;17113298;Partial agonist
3-deazaadenosine;S-Adenosylhomocysteine hydrolase;f;;Human;7470463;Inhibition
DZNep;S-Adenosylhomocysteine hydrolase;f;;Hamster;3457563;Inhibition
sardomozide;S-Adenosylmethionine decarboxylase ;f;;None;8340919;Inhibition
ARN-3236;salt inducible kinase 1;f;;Human;26590148;Inhibition
bosutinib;salt inducible kinase 1;f;;Human;25351958;Inhibition
compound 2c [PMID: 24900538];salt inducible kinase 1;f;;Human;24900538;Inhibition
dasatinib;salt inducible kinase 1;f;;Human;25351958;Inhibition
HG-9-91-01;salt inducible kinase 1;f;;Human;23033494;Inhibition
ARN-3236;salt inducible kinase 2;f;;Human;26590148;Inhibition
bosutinib;salt inducible kinase 2;f;;Human;25351958;Inhibition
dasatinib;salt inducible kinase 2;f;;Human;25351958;Inhibition
HG-9-91-01;salt inducible kinase 2;f;;Human;23033494;Inhibition
remdesivir;SARS-CoV RNA-dependent RNA polymerase;f;;SARS-CoV;32284326;Inhibition
[Arg16]chicken secretin;secretin receptor;f;;Rat;9437714;Agonist
secretin;secretin receptor;f;Pig;Rat;9437714;Agonist
VIP;secretin receptor;t;Human|Mouse|Rat;Rat;9437714;Agonist
[Bpa6,Tyr10]secretin-27 (rat);secretin receptor;f;;Rat;10383421;Full agonist
secretin;secretin receptor;t;Rat;Rat;10383421|9694908;Full agonist
secretin;secretin receptor;f;Pig;Rat;1646711;Full agonist
secretin;secretin receptor;t;Human;Human;7612008;Full agonist
secretin-(5-27) (pig);secretin receptor;f;;Rat;1646711;Full agonist
[125I]secretin (pig);secretin receptor;f;;Rat;1646711;Full agonist
[125I](Tyr10)secretin-27 (rat);secretin receptor;f;;Rat;9843782;Full agonist
VIP;secretin receptor;t;Human|Mouse|Rat;Human;1646711;Partial agonist
[(CH2NH)4,5]secretin;secretin receptor;f;;Human;1702423;Antagonist
pepinemab;semaphorin 4D (CD100);f;;Human;26431358;Binding
SPRi3;sepiapterin reductase;f;;Human;;Inhibition
TGN4;SERCA1;f;;Human;15828839;Negative
myriocin;serine palmitoyltransferase long chain base subunit 1;f;;Mouse;7794249;Inhibition
myriocin;serine palmitoyltransferase long chain base subunit 2;f;;Human;7794249;Inhibition
myriocin;serine palmitoyltransferase long chain base subunit 3;f;;Human;7794249;Inhibition
compound 18 [PMID: 32330443];serine palmitoyltransferase small subunit B;f;;Human;32330443;Inhibition
camostat;serine protease 1;f;;Human;7629790;Inhibition
compound 9 [PMID: 3514912];serine protease 1;f;;Human;3514912;Inhibition
nafamostat;serine protease 1;f;;Human;9544206;Inhibition
RWJ-56423;serine protease 1;f;;Bovine;12930148;Inhibition
BPTI-K15R/R17G;serine protease 3;f;;Human;21806544;Inhibition
B3C;serine protease 8;f;;Human;18752942;Inhibition
DDR1/2 inhibitor 5n;serine/threonine kinase 10;f;;Human;30075624;Inhibition
bosutinib;serine/threonine kinase 10;f;;Human;19039322;None
compound 27 [PMID: 21123062];serine/threonine kinase 16;f;;Human;21123062;Inhibition
STK16-IN-1;serine/threonine kinase 16;f;;Human;27082499;Inhibition
AT-9283;serine/threonine kinase 17a;f;;Human;19143567;Inhibition
BAY-985;serine/threonine kinase 17a;f;;Human;31859507;Inhibition
tomivosertib;serine/threonine kinase 17a;f;;Human;29526098;Inhibition
bosutinib;serine/threonine kinase 24;f;;Human;19039322;Inhibition
CEP-11981;serine/threonine kinase 3;f;;Human;22148921;Inhibition
staurosporine;serine/threonine kinase 3;f;;Human;19397322;Inhibition
compound 25 [PMID: 17935989];serine/threonine kinase 31;f;;Human;17935989;Inhibition
compound 74 [PMID: 24793884];serine/threonine kinase 32B;f;;Human;24793884;Inhibition
compound 1 [PMID: 21742770];serine/threonine kinase 33;f;;Human;21742770;Inhibition
Ro-0505124;serine/threonine kinase 36;f;;Human;16476733;Inhibition
compound 35 [PMID: 20684608];Serine/threonine kinase 38;f;;Human;20684608;Inhibition
compound 27 [PMID: 21123062];Serine/threonine kinase 38 like;f;;Human;21123062;Inhibition
bosutinib;serine/threonine kinase 4;f;;Human;19039322;Inhibition
cerdulatinib;serine/threonine kinase 4;f;;Human;25253883;Inhibition
compound 38 [PMID: 20817473];serine/threonine kinase 4;f;;Human;20817473;Inhibition
compound 89S [PMID: 19115845];serine/threonine-protein kinase NIM1;f;;Human;19115845;Inhibition
dalteparin;serpin family C member 1;f;;Human;3744129;Activation
danaparoid;serpin family C member 1;f;;Human;8137606|19398784;Activation
enoxaparin;serpin family C member 1;f;;Human;7667822;Activation
fondaparinux;serpin family C member 1;f;;Human;12383040;Activation
heparin;serpin family C member 1;f;;Human;23598032;Activation
tinzaparin;serpin family C member 1;f;;Human;7528134;Activation
amitriptyline;SERT;f;;Human;23602445;Inhibition
amoxapine;SERT;f;;Human;;Inhibition
atomoxetine;SERT;f;;Human;9871604;Inhibition
citalopram;SERT;f;;Human;18487050;Inhibition
clomipramine;SERT;f;;Human;9537821;Inhibition
clomipramine;SERT;f;;Human;9537821;Inhibition
dapoxetine;SERT;f;;Human;;Inhibition
desipramine;SERT;f;;Rat;20945906;Inhibition
desipramine;SERT;f;;Human;9400006;Inhibition
desvenlafaxine;SERT;f;;Human;24900709;Inhibition
dosulepin;SERT;f;;Human;9537821;Inhibition
doxepin;SERT;f;;Human;9537821;Inhibition
duloxetine;SERT;f;;Human;18387300;Inhibition
escitalopram;SERT;f;;Human;27049939;Inhibition
escitalopram;SERT;f;;Human;19720528;Inhibition
fluoxetine;SERT;f;;Human;9537821;Inhibition
fluvoxamine;SERT;f;;Rat;11311448;Inhibition
fluvoxamine;SERT;f;;Human;9537821;Inhibition
H05;SERT;f;;Rat;29615471;Inhibition
imipramine;SERT;f;;Human;8496700;Inhibition
levomilnacipran;SERT;f;;Human;18468895;Inhibition
lofepramine;SERT;f;;Human;9537821;Inhibition
lumateperone;SERT;f;;Human;25120104|24559051;Inhibition
milnacipran;SERT;f;;Human;23347683;Inhibition
nefazodone;SERT;f;;Human;9871604;Inhibition
nortriptyline;SERT;f;;Human;;Inhibition
norzotepine;SERT;f;;Human;20223878;Inhibition
paroxetine;SERT;f;;Human;9537821;Inhibition
paroxetine;SERT;f;;Human;27049939;Inhibition
phenelzine;SERT;f;;Human;9537821;Inhibition
protriptyline;SERT;f;;Human;9537821;Inhibition
sertraline;SERT;f;;Human;;Inhibition
sibutramine;SERT;f;;Human;;Inhibition
[3H]citalopram;SERT;f;;Human;;Inhibition
[3H]paroxetine;SERT;f;;Human;;Inhibition
trimipramine;SERT;f;;Human;9537821;Inhibition
venlafaxine;SERT;f;;Human;20378347;Inhibition
vilazodone;SERT;f;;Human;19499624|15341484;Inhibition
vortioxetine;SERT;f;;Human;21486038;Inhibition
ziprasidone;SERT;f;;Human;;Inhibition
zotepine;SERT;f;;Human;20223878;Inhibition
compound 14n [PMID: 25589934];serum/glucocorticoid regulated kinase 1;f;;Human;25589934;Inhibition
EMD638683;serum/glucocorticoid regulated kinase 1;f;;Human;21865856;Inhibition
GSK650394;serum/glucocorticoid regulated kinase 1;f;;Human;18794135;Inhibition
PO-322;serum/glucocorticoid regulated kinase 1;f;;Human;31724152;Inhibition
compound 14n [PMID: 25589934];serum/glucocorticoid regulated kinase 2;f;;Human;25589934;Inhibition
GSK650394;serum/glucocorticoid regulated kinase 2;f;;Human;18794135;Inhibition
compound 14n [PMID: 25589934];serum/glucocorticoid regulated kinase family member 3;f;;Human;25589934;Inhibition
AZ505;SET and MYND domain containing 2;f;;Human;21782458;Inhibition
BAY-598;SET and MYND domain containing 2;f;;Human;;Inhibition
LLY-507;SET and MYND domain containing 2;f;;Human;;Inhibition
(R)-PFI-2;SET domain containing 7, histone lysine methyltransferase;f;;Human;25136132;Inhibition
phlorizin;SGLT6;f;;Human;12133831;Inhibition
compound 10 [PMID: 18759424];SHP;f;;Human;18759424;Binding
PB-28;σ2;f;;Human;8568804;Agonist
[3H]-di-o-tolylguanidine;σ2;f;;Human;;Agonist
1,3-ditolylguanidine;σ2;f;;Guinea pig;16463398;Full agonist
PD-144418;σ2;f;;Mouse;9144641;Antagonist
SM 21;σ2;f;;Human;10096443;Antagonist
vanoxerine;σ2;f;;Rat;1980329;Binding
dextromethorphan;sigma non-opioid intracellular receptor 1;f;;Human;10087012;Agonist
opipramol;sigma non-opioid intracellular receptor 1;f;;Guinea pig;16033255;Agonist
PRE-084;sigma non-opioid intracellular receptor 1;f;;Human;1658302;Agonist
(RS)-PPCC;sigma non-opioid intracellular receptor 1;f;;Human;17328523;Agonist
(+)-SKF 10.047;sigma non-opioid intracellular receptor 1;f;;Human;;Agonist
[3H]pentazocine;sigma non-opioid intracellular receptor 1;f;;Human;;Agonist
1,3-ditolylguanidine;sigma non-opioid intracellular receptor 1;f;;Guinea pig;16463398;Full agonist
BD-1047;sigma non-opioid intracellular receptor 1;f;;Human;8566098;Antagonist
E-52862;sigma non-opioid intracellular receptor 1;f;;Human;22784008;Antagonist
fluvoxamine;sigma non-opioid intracellular receptor 1;f;;Human;23641311;Antagonist
NE-100;sigma non-opioid intracellular receptor 1;f;;Human;7901723;Antagonist
PD-144418;sigma non-opioid intracellular receptor 1;f;;Mouse;9144641;Antagonist
(-)-pentazocine;sigma non-opioid intracellular receptor 1;f;;Human;;Antagonist
vanoxerine;sigma non-opioid intracellular receptor 1;f;;Rat;1980329;Binding
compound 8u [PMID: 31999451];signal transducer and activator of transcription 3;f;;Human;31999451;Inhibition
STAT3 inhibitor 8q;signal transducer and activator of transcription 3;f;;Human;30472602;Inhibition
compound 19a [PMID: 26506089];signal transducer and activator of transcription 6;f;;Human;26506089;Inhibition
ARN-3236;SIK family kinase 3;f;;Human;26590148;Inhibition
bosutinib;SIK family kinase 3;f;;Human;25351958;Inhibition
dasatinib;SIK family kinase 3;f;;Human;25351958;Inhibition
HG-9-91-01;SIK family kinase 3;f;;Human;23033494;Inhibition
IL-37;single Ig and TIR domain containing;f;Human;Human;25729923;Agonist
SIRT1 activator 3;sirtuin 1;f;;Human;17099246;Activation
SRT1720;sirtuin 1;f;;Human;18046409;Activation
SRT2104;sirtuin 1;f;;Human;;Activation
compound 17 [PMID: 23570514];sirtuin 1;f;;Human;23570514;Inhibition
selisistat;sirtuin 1;f;;Human;16354677;Inhibition
splitomicin;sirtuin 1;f;;Human;20041717;Inhibition
AGK2;sirtuin 2;f;;Human;17588900|25275824;Inhibition
compound 17 [PMID: 23570514];sirtuin 2;f;;Human;23570514;Inhibition
compound 86 [PMID: 26982234];sirtuin 2;f;;Human;26982234;Inhibition
compound 17 [PMID: 23570514];sirtuin 3;f;;Human;23570514;Inhibition
compound 2 [Maurer et al., 2012];sirtuin 5;f;;Human;24900427;Inhibition
MDL-800;sirtuin 6;f;;Human;30374165;Activation
MDL-800;sirtuin 6;f;;Human;30374165;Binding
AKK(thioAc)LM21;sirtuin 6;f;;Human;24900419;Inhibition
fenoprofen;SMCT1;f;;Human;16729224;Inhibition
ibuprofen;SMCT1;f;;Human;16729224;Inhibition
ketoprofen;SMCT1;f;;Human;16729224;Inhibition
compound 11j [PMID: 23021994];SMG1 nonsense mediated mRNA decay associated PI3K related kinase;f;;Human;23021994;Inhibition
phlorizin;SMIT;f;;Human;12133831;Inhibition
purmorphamine;SMO;f;;Human;16408088;Agonist
SAG1.3;SMO;f;;Mouse;12391318;Agonist
GSA-10;SMO;f;;Human;23448715;Positive
ANTA XV;SMO;f;;Mouse;27180012;Antagonist
AZD8542;SMO;f;;Human;;Antagonist
AZD8542;SMO;f;;Mouse;;Antagonist
cyclopamine;SMO;f;;Mouse;27338657;Antagonist
cyclopamine-KAAD;SMO;f;;Mouse;10984056;Antagonist
glasdegib;SMO;f;;Human;24900436;Antagonist
MRT-92;SMO;f;;Human;25636740;Antagonist
SANT-1;SMO;f;;Mouse;12391318;Antagonist
SANT-2;SMO;f;;Mouse;12391318;Antagonist
saridegib;SMO;f;;Human;19522463;Antagonist
sonidegib;SMO;f;;Human;23063522;Antagonist
TAK-441;SMO;f;;Mouse;22898254;Antagonist
taladegib;SMO;f;;Human;28688278;Antagonist
vismodegib;SMO;f;;Human;23063522;Antagonist
cyclosporin A;Sodium/bile acid and sulphated solute cotransporter 1;f;;Human;23339484;Inhibition
cyclosporin A;Sodium/bile acid and sulphated solute cotransporter 1;f;;Human;10565843;Inhibition
irbesartan;Sodium/bile acid and sulphated solute cotransporter 1;f;;Human;23339484;Inhibition
(-)-propranolol;Sodium/bile acid and sulphated solute cotransporter 1;f;;Human;10565843;Inhibition
(+)-propranolol;Sodium/bile acid and sulphated solute cotransporter 1;f;;Human;10565843;Inhibition
264W94;Sodium/bile acid and sulphated solute cotransporter 2;f;;Human;14552767|23678871;Inhibition
elobixibat;Sodium/bile acid and sulphated solute cotransporter 2;f;;Human;;Inhibition
odevixibat;Sodium/bile acid and sulphated solute cotransporter 2;f;;Human;;Inhibition
SC-435;Sodium/bile acid and sulphated solute cotransporter 2;f;;Human;12810816;Inhibition
[3H]taurocholic acid;Sodium/bile acid and sulphated solute cotransporter 2;f;;Human;9458785;None
neurounina-1;Sodium/calcium exchanger 1;f;;Dog;23066092;Activation
neurounina-1;Sodium/calcium exchanger 2;f;;Rat;23066092;Activation
YM-244769;Sodium/calcium exchanger 3;f;;Human;16973719;Inhibition
[14C]alanine;sodium-coupled neutral amino acid transporter 1;f;;Human;;None
[3H]alanine;sodium-coupled neutral amino acid transporter 1;f;;Human;;None
[14C]alanine;sodium-coupled neutral amino acid transporter 2;f;;Human;;None
[3H]alanine;sodium-coupled neutral amino acid transporter 2;f;;Human;;None
[14C]glutamine;Sodium-coupled neutral amino acid transporter 3;f;;Human;;None
[3H]glutamine;Sodium-coupled neutral amino acid transporter 3;f;;Human;;None
[14C]alanine;sodium-coupled neutral amino acid transporter 4;f;;Human;;None
[14C]glycine;sodium-coupled neutral amino acid transporter 4;f;;Human;;None
[3H]alanine;sodium-coupled neutral amino acid transporter 4;f;;Human;;None
[3H]glycine;sodium-coupled neutral amino acid transporter 4;f;;Human;;None
[14C]histidine;Sodium-coupled neutral amino acid transporter 5;f;;Human;;None
[3H]histidine;Sodium-coupled neutral amino acid transporter 5;f;;Human;;None
phloretin;Sodium-dependent vitamin C transporter 1;f;;Human;10331392;Inhibition
[14C]ascorbic acid;Sodium-dependent vitamin C transporter 1;f;;Human;11895172;Binding
[14C]ascorbic acid;Sodium-dependent vitamin C transporter 2;f;;Human;;None
canagliflozin;Sodium/glucose cotransporter 1;f;;Human;22355316;Inhibition
dapagliflozin;Sodium/glucose cotransporter 1;f;;Human;21398124;Inhibition
empagliflozin;Sodium/glucose cotransporter 1;f;;Human;21985634;Inhibition
ertugliflozin;Sodium/glucose cotransporter 1;f;;Human;21449606;Inhibition
ipragliflozin;Sodium/glucose cotransporter 1;f;;Mouse;22139434;Inhibition
ipragliflozin;Sodium/glucose cotransporter 1;f;;Human;22139434;Inhibition
ipragliflozin;Sodium/glucose cotransporter 1;f;;Rat;22139434;Inhibition
licogliflozin;Sodium/glucose cotransporter 1;f;;Human;;Inhibition
mizagliflozin;Sodium/glucose cotransporter 1;f;;Human;28410751;Inhibition
remogliflozin;Sodium/glucose cotransporter 1;f;;Human;18583547;Inhibition
sergliflozin;Sodium/glucose cotransporter 1;f;;Human;17050778;Inhibition
sotagliflozin;Sodium/glucose cotransporter 1;f;;Human;22739142;Inhibition
tofogliflozin;Sodium/glucose cotransporter 1;f;;Human;22889351;Inhibition
canagliflozin;Sodium/glucose cotransporter 2;f;;Human;22355316;Inhibition
dapagliflozin;Sodium/glucose cotransporter 2;f;;Human;20637636;Inhibition
empagliflozin;Sodium/glucose cotransporter 2;f;;Human;21985634;Inhibition
ertugliflozin;Sodium/glucose cotransporter 2;f;;Human;21449606;Inhibition
ipragliflozin;Sodium/glucose cotransporter 2;f;;Human;22139434;Inhibition
ipragliflozin;Sodium/glucose cotransporter 2;f;;Mouse;22139434;Inhibition
ipragliflozin;Sodium/glucose cotransporter 2;f;;Rat;22139434;Inhibition
licogliflozin;Sodium/glucose cotransporter 2;f;;Human;;Inhibition
remogliflozin;Sodium/glucose cotransporter 2;f;;Human;18583547;Inhibition
sergliflozin;Sodium/glucose cotransporter 2;f;;Human;17050778;Inhibition
sotagliflozin;Sodium/glucose cotransporter 2;f;;Human;22739142;Inhibition
tofogliflozin;Sodium/glucose cotransporter 2;f;;Human;22889351;Inhibition
amiloride;Sodium/hydrogen exchanger 1;f;;Rat;12832126;Inhibition
amiloride;Sodium/hydrogen exchanger 2;f;;Rabbit;12832126;Inhibition
amiloride;Sodium/hydrogen exchanger 3;f;;Rat;12832126;Inhibition
tenapanor;Sodium/hydrogen exchanger 3;f;;Rat;;Inhibition
amiloride;Sodium/hydrogen exchanger 5;f;;Human;12832126;Inhibition
compound 48 [PMID: 25815140];Sodium/nucleoside cotransporter 2;f;;Human;25815140;Inhibition
lifastuzumab vedotin;Sodium phosphate 2;f;;Human;;Binding
acetyldigitoxin;sodium/potassium-transporting ATPase subunit α-1;f;;Human;;Inhibition
deslanoside;sodium/potassium-transporting ATPase subunit α-1;f;;Human;;Inhibition
digitoxin;sodium/potassium-transporting ATPase subunit α-1;f;;Dog;8421289;Inhibition
digitoxin;sodium/potassium-transporting ATPase subunit α-1;f;;Human;;Inhibition
digoxin;sodium/potassium-transporting ATPase subunit α-1;f;;Human;;Inhibition
digoxin;sodium/potassium-transporting ATPase subunit α-1;f;;Dog;12904068;Inhibition
compound 16 [PMID: 19097778];Solute carrier family 28 member 3;f;;Human;19097778;Inhibition
BAY-293;SOS Ras/Rac guanine nucleotide exchange factor 1;f;;Human;30683722;Binding
compound 21b [PMID: 31944697];sphingomyelin phosphodiesterase 1;f;;Human;31944697;Inhibition
WJYK50;sphingomyelin phosphodiesterase 1;f;;Human;29649738;Inhibition
WJYK50;sphingomyelin phosphodiesterase 1;f;;Human;31944697;Inhibition
inhibitor A [PMID: 12482429];sphingomyelin phosphodiesterase 2;f;;Bovine;12482429;Inhibition
compound 1j [PMID: 26314925];sphingomyelin synthase 1;f;;Human;26314925;Inhibition
sphingomyelin synthase 2 inhibitor 15w;sphingomyelin synthase 1;f;;Human;30074791;Inhibition
compound D24 [PMID: 24374347];sphingomyelin synthase 2;f;;Human;24374347;Inhibition
sphingomyelin synthase 2 inhibitor 15w;sphingomyelin synthase 2;f;;Human;30074791;Inhibition
compound 31 [PMID: 24809814];sphingosine-1-phosphate lyase 1;f;;Human;24809814|23499842|27519818|25630683;Inhibition
LX2931;sphingosine-1-phosphate lyase 1;f;;Human;24809814;Inhibition
compound 27d [PMID: 28231433];sphingosine kinase 1;f;;Human;28231433;Inhibition
compound 49 [PMID: 30889352];sphingosine kinase 1;f;;Human;30889352;Inhibition
compound 55 [PMID: 30889352];sphingosine kinase 1;f;;Human;30889352;Inhibition
compound 59 [PMID: 30889352];sphingosine kinase 1;f;;Human;30889352;Inhibition
compound 60 [PMID: 30889352];sphingosine kinase 1;f;;Human;30889352;Inhibition
MP-A08;sphingosine kinase 1;f;;Human;25788259;Inhibition
PF-543;sphingosine kinase 1;f;;Human;22397330;Inhibition
PF-543;sphingosine kinase 1;f;;Human;28231433;Inhibition
PF-543;sphingosine kinase 1;f;;Human;22397330;Inhibition
SK1-I;sphingosine kinase 1;f;;Human;18511810;Inhibition
SKI II;sphingosine kinase 1;f;;Human;14522923;Inhibition
SKI II;sphingosine kinase 1;f;;Human;20061445;Inhibition
SLC4101431;sphingosine kinase 1;f;;Human;28406646;Inhibition
SLM6071469;sphingosine kinase 1;f;;Human;31895563;Inhibition
compound 27d [PMID: 28231433];sphingosine kinase 2;f;;Human;28231433;Inhibition
compound 49 [PMID: 30889352];sphingosine kinase 2;f;;Human;30889352;Inhibition
compound 55 [PMID: 30889352];sphingosine kinase 2;f;;Human;30889352;Inhibition
compound 59 [PMID: 30889352];sphingosine kinase 2;f;;Human;30889352;Inhibition
compound 60 [PMID: 30889352];sphingosine kinase 2;f;;Human;30889352;Inhibition
MP-A08;sphingosine kinase 2;f;;Human;25788259;Inhibition
opaganib;sphingosine kinase 2;f;;Human;20061445;Inhibition
PF-543;sphingosine kinase 2;f;;Human;28231433;Inhibition
ROMe;sphingosine kinase 2;f;;Human;21620961;Inhibition
ROMe;sphingosine kinase 2;f;;Human;21620961;Inhibition
SKI II;sphingosine kinase 2;f;;Human;22970244;Inhibition
SLC4101431;sphingosine kinase 2;f;;Human;28406646;Inhibition
SLM6071469;sphingosine kinase 2;f;;Human;31895563;Inhibition
compound 12e [PMID: 18605714];sPLA2-10;f;;Human;18605714;Inhibition
compound 12e [PMID: 18605714];sPLA2-1B;f;;Human;18605714;Inhibition
compound 28xvii [PMID: 8809154];sPLA2-1B;f;;Human;8809154;Inhibition
compound 12e [PMID: 18605714];sPLA2-2A;f;;Human;18605714;Inhibition
KH064;sPLA2-2A;f;;Human;12616631;Inhibition
varespladib;sPLA2-2A;f;;Human;8978844;Inhibition
varespladib;sPLA2-2A;f;;Human;8978844|10027849;Inhibition
compound 12e [PMID: 18605714];sPLA2-2D;f;;Human;18605714;Inhibition
compound 12e [PMID: 18605714];sPLA2-2E;f;;Human;18605714;Inhibition
compound 12e [PMID: 18605714];sPLA2-2F;f;;Human;18605714;Inhibition
apitolisib;spleen associated tyrosine kinase;f;;Human;21981714;Inhibition
BAY 61-3606;spleen associated tyrosine kinase;f;;Human;22815993;Inhibition
cerdulatinib;spleen associated tyrosine kinase;f;;Human;25253883;Inhibition
compound 23 [PMID: 17600705];spleen associated tyrosine kinase;f;;Human;17600705;Inhibition
compound 7 [PMID: 22464456];spleen associated tyrosine kinase;f;;Human;22464456;Inhibition
entospletinib;spleen associated tyrosine kinase;f;;Human;24779514;Inhibition
ER-27319;spleen associated tyrosine kinase;f;;Human;22257213;Inhibition
GSK143;spleen associated tyrosine kinase;f;;Human;21903390;Inhibition
GSK2646264;spleen associated tyrosine kinase;f;;Human;30249354;Inhibition
gusacitinib;spleen associated tyrosine kinase;f;;Human;;Inhibition
lanraplenib;spleen associated tyrosine kinase;f;;Human;;Inhibition
lazertinib;spleen associated tyrosine kinase;f;;Human;;Inhibition
mivavotinib;spleen associated tyrosine kinase;f;;Human;27839918;Inhibition
mivavotinib;spleen associated tyrosine kinase;f;;Human;27839918;Inhibition
P505-15;spleen associated tyrosine kinase;f;;Human;22040680;Inhibition
Syk inhibitor;spleen associated tyrosine kinase;f;;Human;12941345;Inhibition
Syk inhibitor II;spleen associated tyrosine kinase;f;;Human;15990316;Inhibition
Syk inhibitor III;spleen associated tyrosine kinase;f;;Human;17601492;Inhibition
tamatinib;spleen associated tyrosine kinase;f;;Human;16946104|19254842;Inhibition
tamatinib;spleen associated tyrosine kinase;f;;Human;22037378;Inhibition
tamatinib;spleen associated tyrosine kinase;f;;Human;23151054;Inhibition
TAS05567;spleen associated tyrosine kinase;f;;Human;29728446;Inhibition
compound 1b [PMID: 9871762];squalene monooxygenase;f;;Human;9871762;Inhibition
1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole;squalene synthase ;f;;Human;15498666;Inhibition
1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole;squalene synthase ;f;;Rat;15498666;Inhibition
1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one;squalene synthase ;f;;Rat;15498666;Inhibition
1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one;squalene synthase ;f;;Human;15498666;Inhibition
BPH-830;squalene synthase ;f;;Human;19456099;Inhibition
compound 10 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 11 [PMID: 7473541];squalene synthase ;f;;Rat;7473541;Inhibition
compound 12 [PMID: 20299227];squalene synthase ;f;;Rat;20299227;Inhibition
compound 12 [Wattanasin et al.,1997];squalene synthase ;f;;Rat;;Inhibition
compound 12 [Wattanasin et al.,1997];squalene synthase ;f;;Rat;;Inhibition
compound 13 [PMID: 19456099];squalene synthase ;f;;Human;19456099;Inhibition
compound 14 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 14 [PMID: 9871507];squalene synthase ;f;;Rat;9871507;Inhibition
compound 15a [PMID: 22464687];squalene synthase ;f;;Human;22464687;Inhibition
compound 15 [Biller et al., 1993];squalene synthase ;f;;Rat;;Inhibition
compound 15 [PMID: 19456099];squalene synthase ;f;;Human;19456099;Inhibition
compound 15 [PMID: 8709131];squalene synthase ;f;;Rat;8709131;Inhibition
compound 16a [Sharratt et al., 1994];squalene synthase ;f;;Rat;;Inhibition
compound 17 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 17 [PMID: 8709131];squalene synthase ;f;;Rat;8709131;Inhibition
compound 17 [Shechter et al., 1996];squalene synthase ;f;;Rat;;Inhibition
compound 18 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 19 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 19 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 19 [PMID: 7473541];squalene synthase ;f;;Rat;7473541;Inhibition
compound 1c [Brown et al., 1997];squalene synthase ;f;;Human;;Inhibition
compound 1e [Brown et al., 1997];squalene synthase ;f;;Rat;;Inhibition
compound 1 [Overhand et al., 1997];squalene synthase ;f;;Human;;Inhibition
compound 1 [PMID: 8496942];squalene synthase ;f;;Rat;8496942;Inhibition
compound 1 [PMID: 8496942];squalene synthase ;f;;Rat;8496942;Inhibition
compound 20 [PMID: 20299227];squalene synthase ;f;;Rat;20299227;Inhibition
compound 20 [PMID: 7473541];squalene synthase ;f;;Rat;7473541;Inhibition
compound 20 [Shechter et al., 1996];squalene synthase ;f;;Rat;;Inhibition
compound 21 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 21 [PMID: 7473541];squalene synthase ;f;;Rat;7473541;Inhibition
compound 23 [PMID: 8709131];squalene synthase ;f;;Rat;8709131;Inhibition
compound 28 [PMID: 7473541];squalene synthase ;f;;Rat;7473541;Inhibition
compound 2a (+) [PMID: 8709131];squalene synthase ;f;;Rat;8709131;Inhibition
compound 2d [PMID: 7629799];squalene synthase ;f;;Rat;7629799;Inhibition
compound 2e [PMID: 7629799];squalene synthase ;f;;Rat;7629799;Inhibition
compound 32 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 35 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 3a [PMID: 12238936];squalene synthase ;f;;Human;12238936;Inhibition
compound 3f [PMID: 12238936];squalene synthase ;f;;Human;12238936;Inhibition
compound 3f [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 3 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 4 [Brinkman et al., 1996];squalene synthase ;f;;Rat;;Inhibition
compound 4e [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 4g [PMID: 17709461];squalene synthase ;f;;Human;17709461;Inhibition
compound 4 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 4 [PMID: 8576905];squalene synthase ;f;;Rat;8576905;Inhibition
compound 4 [PMID: 8709131];squalene synthase ;f;;Rat;8709131;Inhibition
compound 4q [PMID: 7650673];squalene synthase ;f;;Human;7650673;Inhibition
compound 5d [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 5d [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 5j [PMID: 9216829];squalene synthase ;f;;Rat;9216829;Inhibition
compound 5m [PMID: 9216829];squalene synthase ;f;;Rat;9216829;Inhibition
compound 5 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 6 [Biller et al., 1991];squalene synthase ;f;;Rat;;Inhibition
compound 6c [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 6d [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 6g [PMID: 7966163];squalene synthase ;f;;Rat;7966163;Inhibition
compound 6 [PMID: 7629799];squalene synthase ;f;;Rat;7629799;Inhibition
compound 6 [PMID: 7629799];squalene synthase ;f;;Human;19191557;Inhibition
compound 6 [PMID: 7629799];squalene synthase ;f;;Rat;8576905;Inhibition
compound 7 [Brinkman et al., 1996];squalene synthase ;f;;Rat;;Inhibition
compound 7 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 7 [PMID: 8496919];squalene synthase ;f;;Rat;8496919;Inhibition
compound 8 [Brinkman et al., 1996];squalene synthase ;f;;Rat;;Inhibition
compound 8 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
compound 8 [PMID: 19191557];squalene synthase ;f;;Human;19191557;Inhibition
compound 9 [PMID: 18754614];squalene synthase ;f;;Rat;18754614;Inhibition
CP-294838;squalene synthase ;f;;Rat;9473303;Inhibition
E5700;squalene synthase ;f;;Human;17371809;Inhibition
ibandronic acid;squalene synthase ;f;;Rat;20299227;Inhibition
J-104118;squalene synthase ;f;;Human;;Inhibition
J-104118;squalene synthase ;f;;Human;;Inhibition
J-104123;squalene synthase ;f;;Human;;Inhibition
L-731120;squalene synthase ;f;;Rat;;Inhibition
L-731128;squalene synthase ;f;;Rat;;Inhibition
L-735021;squalene synthase ;f;;Rat;7966163;Inhibition
NB-598;squalene synthase ;f;;Human;7650673;Inhibition
SQ-109;squalene synthase ;f;;Human;22486710;Inhibition
SQ-34919;squalene synthase ;f;;Rat;7629799;Inhibition
SQ-34919;squalene synthase ;f;;Rat;8576905;Inhibition
YM-75440;squalene synthase ;f;;Human;15498666;Inhibition
zaragozic acid A;squalene synthase ;f;;Rat;8419946;Inhibition
zaragozic acid A;squalene synthase ;f;;Human;9473303;Inhibition
zaragozic acid A;squalene synthase ;f;;Human;7864626;Inhibition
zaragozic acid B;squalene synthase ;f;;Rat;8419946;Inhibition
zaragozic acid C;squalene synthase ;f;;Rat;8419946;Inhibition
acalabrutinib;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;;Inhibition
balamapimod;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;;Inhibition
bosutinib;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;17721511;Inhibition
CCT196969;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;25500121;Inhibition
CCT241161;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;25500121;Inhibition
compound 19a [PMID: 30503936];SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;30503936;Inhibition
compound 25 [PMID: 31260299];SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;31260299;Inhibition
compound 2 [PMID: 15546730];SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;15546730;Inhibition
compound 36 [PMID: 21958547];SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;21958547;Inhibition
compound 8h [PMID: 22765894];SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;22765894;Inhibition
dasatinib;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;15930265;Inhibition
dorsomorphin;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;20932747;Inhibition
eCF506;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;27115835;Inhibition
ENMD-2076;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;19320489;Inhibition
GSK-3 inhibitor XIII;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;19447622;Inhibition
ibrutinib;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;26641137;Inhibition
KX2-361;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;29617135;Inhibition
KX2-391;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;29617135;Inhibition
NG-25;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;25075558;Inhibition
PD166285;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;9400019;Inhibition
PP121;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;18849971;Inhibition
saracatinib;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;17064066;Inhibition
SI306;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;;Inhibition
SU6656;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;22818848;Inhibition
Syk inhibitor III;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;17601492;Inhibition
WH-4-023;SRC proto-oncogene, non-receptor tyrosine kinase;f;;Human;16884310;Inhibition
compound 66 [PMID: 21802293];src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites;f;;Human;21802293;Inhibition
compound 13 [PMID: 15925511];SRSF protein kinase 1;f;;Human;15925511;Inhibition
URMC-099;SRSF protein kinase 2;f;;Human;24044867;Inhibition
compound 25 [PMID: 17935989];SRSF protein kinase 3;f;;Human;17935989;Inhibition
BIM 23050;SST1 receptor;f;;Human;8100350;Full agonist
BIM 23052;SST1 receptor;f;;Human;8769372|9650799|10598788;Full agonist
CGP 23996;SST1 receptor;f;;Human;8769372|9650799|10598788;Full agonist
CH 275;SST1 receptor;f;;Human;9600011;Full agonist
CH 275;SST1 receptor;f;;Rat;9166718;Full agonist
cortistatin-14;SST1 receptor;t;Mouse|Rat;Human;9650799|10598788;Full agonist
CST-17;SST1 receptor;t;Human;Human;9650799|10598788|15333679;Full agonist
cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,IAmp9,m-I-Tyr11,hhLys12]SRIF;SST1 receptor;f;;Human;15658865;Full agonist
Des-AA1,2,5,12,13-[D-Trp8]SRIF;SST1 receptor;f;;Human;15658865;Full agonist
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF;SST1 receptor;f;;Human;15658865;Full agonist
Des-AA5-[D-Trp8]SRIF;SST1 receptor;f;;Human;15658864;Full agonist
Des-Ala1,2,5-[D-Trp8,IAmp9]SRIF;SST1 receptor;f;;Human;15658864;Full agonist
KE 108;SST1 receptor;f;;Human;12450568;Full agonist
L-362,855;SST1 receptor;f;;Human;9650799|10598788;Full agonist
L-797,591;SST1 receptor;f;;Human;9784130;Full agonist
L-817,818;SST1 receptor;f;;Human;9784130;Full agonist
NC 4-28B;SST1 receptor;f;;Human;7988476;Full agonist
pasireotide;SST1 receptor;f;;Human;15477717;Full agonist
SRIF-14;SST1 receptor;t;Human|Mouse|Rat;Rat;9166718;Full agonist
SRIF-14;SST1 receptor;t;Human|Mouse|Rat;Human;9784130|8769372|9650799|10598788|9600011|15333679|7988476|11520208|9724791;Full agonist
SRIF-28;SST1 receptor;t;Human|Mouse|Rat;Human;8769372|9650799|10598788|9600011|15333679|7988476;Full agonist
[125I]CGP 23996;SST1 receptor;f;;Human;8100350|10598788;Full agonist
[125I]LTT-SRIF-28;SST1 receptor;f;;Human;9650799|10598788;Full agonist
[125I]LTT-SRIF-28;SST1 receptor;f;;Human;9784130;Full agonist
[125I]Tyr10-CST14;SST1 receptor;f;;Human;9650799|10598788;Full agonist
[125I]Tyr11-SRIF-14;SST1 receptor;f;;Mouse;8769370;Full agonist
BIM 23454;SST1 receptor;f;;Human;11897676;Antagonist
BIM 23627;SST1 receptor;f;;Human;11897676;Antagonist
[D-Tyr8]CYN 154806;SST1 receptor;f;;Human;12616335;Antagonist
[L-Tyr8]CYN 154806;SST1 receptor;f;;Human;12616335;Antagonist
SRA880;SST1 receptor;f;;Human;15135911;Antagonist
BIM 23027;SST2 receptor;f;;Rat;9121614;Agonist
BIM 23027;SST2 receptor;f;;Human;8646408;Agonist
KE 108;SST2 receptor;f;;Rat;19910453|21493671;Agonist
L-779,976;SST2 receptor;f;;Rat;15855408;Agonist
pasireotide;SST2 receptor;f;;Rat;19910453|21493671;Agonist
SRIF-14;SST2 receptor;f;Human|Mouse|Rat;Rat;15855408;Agonist
Tyr3-octreotide;SST2 receptor;f;;Human;;Agonist
veldoreotide;SST2 receptor;f;;Human;11145612;Agonist
AM3;SST2 receptor;f;;Human;20956465;Full agonist
BIM 23023;SST2 receptor;f;;Rat;9600011;Full agonist
BIM 23023;SST2 receptor;f;;Human;7988476;Full agonist
BIM 23023;SST2 receptor;f;;Mouse;9600011;Full agonist
BIM 23027;SST2 receptor;f;;Mouse;8100350|8769370;Full agonist
BIM 23030;SST2 receptor;f;;Human;9650799|10598788|9652348;Full agonist
BIM 23030;SST2 receptor;f;;Mouse;8100350;Full agonist
BIM 23034;SST2 receptor;f;;Human;7988476;Full agonist
BIM 23034;SST2 receptor;f;;Mouse;8100350;Full agonist
BIM 23052;SST2 receptor;f;;Human;8769372|9650799|10598788|9652348;Full agonist
BIM 23056;SST2 receptor;f;;Human;8769372|9650799|10598788|9652348;Full agonist
BIM 23059;SST2 receptor;f;;Mouse;8100350;Full agonist
BIM 23059;SST2 receptor;f;;Human;7988476;Full agonist
BIM 23060;SST2 receptor;f;;Mouse;8100350;Full agonist
BIM 23060;SST2 receptor;f;;Human;7988476;Full agonist
BIM 23066;SST2 receptor;f;;Mouse;8100350;Full agonist
BIM 23068;SST2 receptor;f;;Human;7988476;Full agonist
BIM 23068;SST2 receptor;f;;Mouse;8100350;Full agonist
BIM 23197;SST2 receptor;f;;Human;9045884;Full agonist
BOC-ATE;SST2 receptor;f;;Human;15709181;Full agonist
CGP 23996;SST2 receptor;f;;Human;8769372|9650799|10598788|9652348;Full agonist
cortistatin-14;SST2 receptor;t;Mouse|Rat;Human;9650799|10598788|9652348;Full agonist
CST-17;SST2 receptor;t;Human;Human;9650799|10598788|15333679;Full agonist
DC 23-60;SST2 receptor;f;;Mouse;8100350;Full agonist
DC 23-60;SST2 receptor;f;;Human;7988476;Full agonist
demotate 2;SST2 receptor;f;;Human;16568203;Full agonist
EC 5-21;SST2 receptor;f;;Mouse;8100350;Full agonist
EC 5-21;SST2 receptor;f;;Human;7988476;Full agonist
edotreotide;SST2 receptor;f;;Human;10774879;Full agonist
Ga-DOTA-NOC;SST2 receptor;f;;Human;17225119;Full agonist
[Ga-DOTA,Tyr3,Thr8]octreotide;SST2 receptor;f;;Human;17225119|10774879;Full agonist
Ga-KE88;SST2 receptor;f;;Human;18381940;Full agonist
In-NODAGATOC;SST2 receptor;f;;Human;12009943;Full agonist
KE 108;SST2 receptor;f;;Human;12450568;Full agonist
L-054,522;SST2 receptor;f;;Human;9724791;Full agonist
L-362,855;SST2 receptor;f;;Rat;9600011;Full agonist
L-362,855;SST2 receptor;f;;Mouse;9600011;Full agonist
L-362,855;SST2 receptor;f;;Human;9650799|10598788|9652348;Full agonist
L-363,301;SST2 receptor;f;;Human;9650799|10598788;Full agonist
L-363,301;SST2 receptor;f;;Mouse;8100350|8769370;Full agonist
L-363,377;SST2 receptor;f;;Human;9784130|9724791;Full agonist
L-363,377;SST2 receptor;f;;Mouse;8769370;Full agonist
L-363,409;SST2 receptor;f;;Mouse;8769370;Full agonist
L-779,976;SST2 receptor;f;;Human;9784130;Full agonist
lanreotide;SST2 receptor;f;;Human;8769372|9650799|10598788|7988476|9652348;Full agonist
lanreotide;SST2 receptor;f;;Mouse;9600011;Full agonist
lanreotide;SST2 receptor;f;;Rat;9600011;Full agonist
maltotriose-[125I][Tyr3,Thr8]octreotide;SST2 receptor;f;;Human;11807604;Full agonist
NC 4-28B;SST2 receptor;f;;Human;7988476;Full agonist
NC 4-28B;SST2 receptor;f;;Mouse;8100350|8769370;Full agonist
NC 8-12;SST2 receptor;f;;Mouse;8769370;Full agonist
NC 8-12;SST2 receptor;f;;Human;7988476;Full agonist
NOC-ATE;SST2 receptor;f;;Human;15709181;Full agonist
NODAGA-[Tyr3]-octreotide;SST2 receptor;f;;Human;12009943;Full agonist
octreotide;SST2 receptor;f;;Mouse;9600011;Full agonist
octreotide;SST2 receptor;f;;Human;8769372|9650799|10598788|7988476|9724791|9652348;Full agonist
octreotide;SST2 receptor;f;;Rat;9600011;Full agonist
pasireotide;SST2 receptor;f;;Human;15477717;Full agonist
seglitide;SST2 receptor;f;;Human;8769372|9650799|10598788|7988476|9724791|9652348;Full agonist
seglitide;SST2 receptor;f;;Mouse;9600011;Full agonist
seglitide;SST2 receptor;f;;Rat;9600011;Full agonist
SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate;SST2 receptor;f;;Human;21082773;Full agonist
SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate;SST2 receptor;f;;Human;21082773;Full agonist
SRIF-14;SST2 receptor;t;Human|Mouse|Rat;Human;9784130|8769372|9650799|10598788|15333679|7988476|11520208|9724791|9652348;Full agonist
SRIF-14;SST2 receptor;t;Human|Mouse|Rat;Mouse;9600011;Full agonist
SRIF-14;SST2 receptor;t;Human|Mouse|Rat;Rat;9600011;Full agonist
SRIF-28;SST2 receptor;t;Human|Mouse|Rat;Human;8769372|9650799|10598788|15333679|7988476|9652348;Full agonist
SRIF-28;SST2 receptor;t;Human|Mouse|Rat;Mouse;9600011;Full agonist
SRIF-28;SST2 receptor;t;Human|Mouse|Rat;Rat;9600011;Full agonist
[111In]DOTA-BOC-ATE;SST2 receptor;f;;Human;15709181;Full agonist
[111In]DOTA-NOC;SST2 receptor;f;;Human;12937948;Full agonist
[111In]DOTA-NOC-ATE;SST2 receptor;f;;Human;15709181;Full agonist
[111In,90Y]DOTA-LAN;SST2 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-NOC;SST2 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-OC;SST2 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-TOC;SST2 receptor;f;;Human;12937948;Full agonist
[125I]BIM23027;SST2 receptor;f;;Rat;9121614;Full agonist
[125I]CGP 23996;SST2 receptor;f;;Human;10598788|9652348;Full agonist
[125I]LTT-SRIF-28;SST2 receptor;f;;Rat;6114372|6125148;Full agonist
[125I]LTT-SRIF-28;SST2 receptor;f;;Human;9784130|9650799|9652348;Full agonist
[125I]MK-678;SST2 receptor;f;;Mouse;8100350;Full agonist
[125I]Tyr10-CST14;SST2 receptor;f;;Human;9650799|10598788;Full agonist
[125I]Tyr11-SRIF-14;SST2 receptor;f;;Mouse;8769370;Full agonist
[125I]Tyr11-SRIF-14;SST2 receptor;f;;Rat;6125148;Full agonist
[125I]Tyr3 SMS 201-995;SST2 receptor;f;;Human;10598788|9652348;Full agonist
[125I]Tyr3 SMS 201-995;SST2 receptor;f;;Human;11807604;Full agonist
[125I]Tyr3 SMS 201-995;SST2 receptor;f;;Rat;2859510;Full agonist
[125I][Tyr3,Thr8]octreotide;SST2 receptor;f;;Human;11807604;Full agonist
[67Ga]NODAGA-[Tyr3]octreotide;SST2 receptor;f;;Human;12009943;Full agonist
vapreotide;SST2 receptor;f;;Mouse;9600011;Full agonist
vapreotide;SST2 receptor;f;;Human;8769372|7988476;Full agonist
vapreotide;SST2 receptor;f;;Rat;9600011;Full agonist
Y-KE88;SST2 receptor;f;;Human;18381940;Full agonist
KE 108;SST2 receptor;f;;Rat;21493671;Partial agonist
L-779,976;SST2 receptor;f;;Rat;15855408;Partial agonist
pasireotide;SST2 receptor;f;;Rat;21493671;Partial agonist
AC-178,335;SST2 receptor;f;;Rat;9804621;Antagonist
analog 30 [PMID:18543899];SST2 receptor;f;;Human;18543899;Antagonist
analog 31 [PMID:18543899];SST2 receptor;f;;Human;18543899;Antagonist
analog 32 [PMID:18543899];SST2 receptor;f;;Human;18543899;Antagonist
analog 3 [PMID:18543899];SST2 receptor;f;;Human;18543899;Antagonist
BASS antagonist;SST2 receptor;f;;Human;8863814;Antagonist
BIM 23454;SST2 receptor;f;;Human;11897676;Antagonist
BIM 23627;SST2 receptor;f;;Human;11897676;Antagonist
DOTA-BASS;SST2 receptor;f;;Human;18543899;Antagonist
DOTA-JR11;SST2 receptor;f;;Human;18543899;Antagonist
[D-Tyr8]CYN 154806;SST2 receptor;f;;Human;12616335;Antagonist
Ga-NODAGA-LM3;SST2 receptor;f;;Human;21680701;Antagonist
KE 108;SST2 receptor;f;;Rat;19910453;Antagonist
[L-Tyr8]CYN 154806;SST2 receptor;f;;Human;12616335;Antagonist
pasireotide;SST2 receptor;f;;Rat;19910453;Antagonist
PRL-2915;SST2 receptor;f;;Rat;9544214;Antagonist
PRL-2970;SST2 receptor;f;;Rat;9544214;Antagonist
BIM 23023;SST3 receptor;f;;Rat;9600011;Full agonist
BIM 23023;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23023;SST3 receptor;f;;Human;7988476;Full agonist
BIM 23030;SST3 receptor;f;;Human;9650799|10598788;Full agonist
BIM 23034;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23034;SST3 receptor;f;;Human;7988476;Full agonist
BIM 23050;SST3 receptor;f;;Human;7988476;Full agonist
BIM 23050;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23052;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23052;SST3 receptor;f;;Human;8769372|9650799|10598788;Full agonist
BIM 23052;SST3 receptor;f;;Rat;9600011;Full agonist
BIM 23056;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23056;SST3 receptor;f;;Human;9650799|10598788;Full agonist
BIM 23056;SST3 receptor;f;;Rat;9166718;Full agonist
BIM 23058;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23058;SST3 receptor;f;;Human;7988476;Full agonist
BIM 23059;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23066;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23068;SST3 receptor;f;;Mouse;8100350;Full agonist
BIM 23068;SST3 receptor;f;;Human;7988476;Full agonist
BIM 23068;SST3 receptor;f;;Rat;9600011;Full agonist
BIM 23197;SST3 receptor;f;;Human;9045884;Full agonist
BIM 23295;SST3 receptor;f;;Rat;9600011;Full agonist
BN-81,644;SST3 receptor;f;;Human;11520208;Full agonist
BN-81,674;SST3 receptor;f;;Human;11520208;Full agonist
BOC-ATE;SST3 receptor;f;;Human;15709181;Full agonist
CGP 23996;SST3 receptor;f;;Human;9650799|10598788;Full agonist
cortistatin-14;SST3 receptor;t;Mouse|Rat;Human;9650799|10598788;Full agonist
CST-17;SST3 receptor;t;Human;Human;9650799|10598788|15333679;Full agonist
Des-AA5-[D-Trp8]SRIF;SST3 receptor;f;;Human;15658864;Full agonist
KE 108;SST3 receptor;f;;Human;12450568;Full agonist
L-362,823;SST3 receptor;f;;Mouse;8100350;Full agonist
L-362,855;SST3 receptor;f;;Human;9650799|10598788;Full agonist
L-363,301;SST3 receptor;f;;Human;9650799|10598788;Full agonist
L-796,778;SST3 receptor;f;;Human;9784130;Full agonist
lanreotide;SST3 receptor;f;;Mouse;8100350;Full agonist
lanreotide;SST3 receptor;f;;Human;8769372|9650799|10598788|7988476;Full agonist
lanreotide;SST3 receptor;f;;Rat;9600011;Full agonist
NC 4-28B;SST3 receptor;f;;Mouse;8100350;Full agonist
NC 4-28B;SST3 receptor;f;;Human;7988476;Full agonist
NC 8-12;SST3 receptor;f;;Human;7988476;Full agonist
NOC-ATE;SST3 receptor;f;;Human;15709181;Full agonist
octreotide;SST3 receptor;f;;Rat;9600011;Full agonist
octreotide;SST3 receptor;f;;Mouse;8100350;Full agonist
octreotide;SST3 receptor;f;;Human;8769372|9650799|10598788|7988476|9724791|8097479;Full agonist
pasireotide;SST3 receptor;f;;Human;15477717;Full agonist
seglitide;SST3 receptor;f;;Human;8769372|9650799|10598788|7988476|9724791;Full agonist
seglitide;SST3 receptor;f;;Mouse;8100350;Full agonist
seglitide;SST3 receptor;f;;Rat;9600011;Full agonist
SRIF-14;SST3 receptor;t;Human|Mouse|Rat;Mouse;8100350;Full agonist
SRIF-14;SST3 receptor;t;Human|Mouse|Rat;Rat;9600011;Full agonist
SRIF-14;SST3 receptor;t;Human|Mouse|Rat;Human;9784130|8769372|9650799|10598788|15333679|7988476|11520208|9724791|8097479;Full agonist
SRIF-28;SST3 receptor;t;Human|Mouse|Rat;Rat;9600011;Full agonist
SRIF-28;SST3 receptor;t;Human|Mouse|Rat;Human;8769372|9650799|10598788|9600011|15333679|7988476|8097479;Full agonist
SRIF-28;SST3 receptor;t;Human|Mouse|Rat;Mouse;8100350;Full agonist
[111In]DOTA-BOC-ATE;SST3 receptor;f;;Human;15709181;Full agonist
[111In]DOTA-NOC;SST3 receptor;f;;Human;12937948;Full agonist
[111In]DOTA-NOC-ATE;SST3 receptor;f;;Human;15709181;Full agonist
[111In,90Y]DOTA-LAN;SST3 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-NOC;SST3 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-OC;SST3 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-TOC;SST3 receptor;f;;Human;12937948;Full agonist
[125I]CGP 23996;SST3 receptor;f;;Human;10598788;Full agonist
[125I]CGP 23996;SST3 receptor;f;;Mouse;8100350;Full agonist
[125I]LTT-SRIF-28;SST3 receptor;f;;Human;9784130;Full agonist
[125I]LTT-SRIF-28;SST3 receptor;f;;Human;9650799|10598788|8097479;Full agonist
[125I]Tyr10-CST14;SST3 receptor;f;;Human;9650799|10598788;Full agonist
[125I]Tyr7-Sst3-ODN-8;SST3 receptor;f;;Human;11095748;Full agonist
vapreotide;SST3 receptor;f;;Human;8769372|9650799|7988476;Full agonist
vapreotide;SST3 receptor;f;;Rat;9600011;Full agonist
ACQ090;SST3 receptor;f;;Human;;Antagonist
BIM 23454;SST3 receptor;f;;Human;11897676;Antagonist
BIM 23627;SST3 receptor;f;;Human;11897676;Antagonist
[D-Tyr8]CYN 154806;SST3 receptor;f;;Human;10818261;Antagonist
[L-Tyr8]CYN 154806;SST3 receptor;f;;Human;10818261;Antagonist
MK-4256;SST3 receptor;f;;Human;24900499;Antagonist
PRL-2915;SST3 receptor;f;;Human;9544214;Antagonist
PRL-2970;SST3 receptor;f;;Human;9544214;Antagonist
sst3-ODN-8;SST3 receptor;f;;Human;11095748;Antagonist
J-2156;SST4 receptor;f;;Human;15333679;Agonist
veldoreotide;SST4 receptor;f;;Human;11145612;Agonist
β3-tetrapeptide;SST4 receptor;f;;Human;12595949;Full agonist
β3-tetrapeptide;SST4 receptor;f;;Mouse;12595949;Full agonist
BIM 23052;SST4 receptor;f;;Human;9650799;Full agonist
BIM 23052;SST4 receptor;f;;Rat;9166718;Full agonist
BIM 23068;SST4 receptor;f;;Human;7988476;Full agonist
BIM 23295;SST4 receptor;f;;Human;9600011;Full agonist
CGP 23996;SST4 receptor;f;;Human;9650799|10598788;Full agonist
cortistatin-14;SST4 receptor;t;Mouse|Rat;Human;9650799|10598788;Full agonist
CST-17;SST4 receptor;t;Human;Human;9650799|10598788;Full agonist
Des-AA5-[D-Trp8]SRIF;SST4 receptor;f;;Human;15658864;Full agonist
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH;SST4 receptor;f;;Human;14667212;Full agonist
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH;SST4 receptor;f;;Human;14667212;Full agonist
H-c[DCys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH;SST4 receptor;f;;Human;14667212;Full agonist
KE 108;SST4 receptor;f;;Human;12450568;Full agonist
L-362,855;SST4 receptor;f;;Human;9650799|10598788;Full agonist
L-803,087;SST4 receptor;f;;Human;9784130;Full agonist
NNC269100;SST4 receptor;f;;Human;9822540;Full agonist
SRIF-14;SST4 receptor;t;Human|Mouse|Rat;Rat;9166718;Full agonist
SRIF-14;SST4 receptor;t;Human|Mouse|Rat;Human;9784130|8769372|9650799|10598788|9600011|15333679|7988476|11520208|9724791;Full agonist
SRIF-28;SST4 receptor;t;Human|Mouse|Rat;Human;8769372|9650799|10598788|9600011|15333679|7988476;Full agonist
[125I]CGP 23996;SST4 receptor;f;;Human;10598788;Full agonist
[125I]LTT-SRIF-28;SST4 receptor;f;;Human;9650799;Full agonist
[125I]LTT-SRIF-28;SST4 receptor;f;;Human;9784130;Full agonist
[125I]Tyr10-CST14;SST4 receptor;f;;Human;10598788;Full agonist
[125I]Tyr11-SRIF-14;SST4 receptor;f;;Human;8483934;Full agonist
analog 32 [PMID:18543899];SST4 receptor;f;;Human;18543899;Antagonist
BIM 23454;SST4 receptor;f;;Human;11897676;Antagonist
BIM 23627;SST4 receptor;f;;Human;11897676;Antagonist
[D-Tyr8]CYN 154806;SST4 receptor;f;;Human;12616335;Antagonist
[L-Tyr8]CYN 154806;SST4 receptor;f;;Human;12616335;Antagonist
PRL-2915;SST4 receptor;f;;Human;10354394;Antagonist
veldoreotide;SST5 receptor;f;;Human;11145612;Agonist
BIM 23023;SST5 receptor;f;;Human;9600011|7988476;Full agonist
BIM 23023;SST5 receptor;f;;Rat;9600011;Full agonist
BIM 23030;SST5 receptor;f;;Mouse;10818261;Full agonist
BIM 23030;SST5 receptor;f;;Human;10598788;Full agonist
BIM 23050;SST5 receptor;f;;Human;7988476;Full agonist
BIM 23052;SST5 receptor;f;;Rat;9600011;Full agonist
BIM 23052;SST5 receptor;f;;Human;9650799|10598788|9600011|9652348;Full agonist
BIM 23056;SST5 receptor;f;;Rat;9600011;Full agonist
BIM 23056;SST5 receptor;f;;Mouse;10818261;Full agonist
BIM 23056;SST5 receptor;f;;Human;9650799|10598788|9600011|7988476|9652348;Full agonist
BIM 23059;SST5 receptor;f;;Human;7988476;Full agonist
BIM 23060;SST5 receptor;f;;Human;7988476;Full agonist
BIM 23197;SST5 receptor;f;;Human;9045884;Full agonist
BIM 23268;SST5 receptor;f;;Human;9600011;Full agonist
BIM 23268;SST5 receptor;f;;Rat;9600011;Full agonist
BIM 23313;SST5 receptor;f;;Human;9600011;Full agonist
BIM 23313;SST5 receptor;f;;Rat;9600011;Full agonist
BOC-ATE;SST5 receptor;f;;Human;15709181;Full agonist
CGP 23996;SST5 receptor;f;;Human;9650799|10598788|9652348;Full agonist
CGP 23996;SST5 receptor;f;;Mouse;10818261;Full agonist
cortistatin-14;SST5 receptor;t;Mouse|Rat;Human;9650799|10598788|9652348;Full agonist
cortistatin-14;SST5 receptor;t;Mouse|Rat;Mouse;10818261;Full agonist
CST-17;SST5 receptor;t;Human;Human;9650799|10598788|15333679;Full agonist
CST-17;SST5 receptor;t;Human;Mouse;10818261;Full agonist
Des-AA5-[D-Trp8]SRIF;SST5 receptor;f;;Human;15658864;Full agonist
KE 108;SST5 receptor;f;;Human;12450568;Full agonist
L-362,855;SST5 receptor;f;;Rat;9600011;Full agonist
L-362,855;SST5 receptor;f;;Human;9650799|10598788|9600011|9652348;Full agonist
L-362,855;SST5 receptor;f;;Mouse;10818261;Full agonist
L-363,301;SST5 receptor;f;;Human;9650799|10598788;Full agonist
L-363,301;SST5 receptor;f;;Rat;10818261;Full agonist
L-817,818;SST5 receptor;f;;Human;9784130;Full agonist
lanreotide;SST5 receptor;f;;Human;8769372|9650799|10598788|9600011|7988476|9652348;Full agonist
lanreotide;SST5 receptor;f;;Rat;9600011;Full agonist
NOC-ATE;SST5 receptor;f;;Human;15709181;Full agonist
octreotide;SST5 receptor;f;;Human;8769372|9650799|10598788|9600011|7988476|9724791|9652348;Full agonist
octreotide;SST5 receptor;f;;Mouse;10818261;Full agonist
octreotide;SST5 receptor;f;;Rat;9600011;Full agonist
pasireotide;SST5 receptor;f;;Human;15477717;Full agonist
seglitide;SST5 receptor;f;;Human;8769372|9650799|10598788|9600011|7988476|9724791|9652348;Full agonist
seglitide;SST5 receptor;f;;Mouse;10818261;Full agonist
seglitide;SST5 receptor;f;;Rat;9600011;Full agonist
SRIF-14;SST5 receptor;t;Human|Mouse|Rat;Rat;9600011;Full agonist
SRIF-14;SST5 receptor;t;Human|Mouse|Rat;Human;9784130|8769372|9650799|10598788|9600011|15333679|7988476|11520208|9724791|9652348;Full agonist
SRIF-14;SST5 receptor;t;Human|Mouse|Rat;Mouse;10818261;Full agonist
SRIF-28;SST5 receptor;t;Human|Mouse|Rat;Human;8769372|9650799|10598788|9600011|15333679|7988476|9652348;Full agonist
SRIF-28;SST5 receptor;t;Human|Mouse|Rat;Rat;9600011;Full agonist
SRIF-28;SST5 receptor;t;Human|Mouse|Rat;Mouse;10818261;Full agonist
[111In]DOTA-BOC-ATE;SST5 receptor;f;;Human;15709181;Full agonist
[111In]DOTA-NOC;SST5 receptor;f;;Human;12937948;Full agonist
[111In]DOTA-NOC-ATE;SST5 receptor;f;;Human;15709181;Full agonist
[111In,90Y]DOTA-LAN;SST5 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-NOC;SST5 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-OC;SST5 receptor;f;;Human;12937948;Full agonist
[111In,90Y]DOTA-TOC;SST5 receptor;f;;Human;12937948;Full agonist
[125I]CGP 23996;SST5 receptor;f;;Human;10598788|9652348;Full agonist
[125I]CGP 23996;SST5 receptor;f;;Mouse;10818261;Full agonist
[125I]LTT-SRIF-28;SST5 receptor;f;;Human;9784130;Full agonist
[125I]LTT-SRIF-28;SST5 receptor;f;;Human;9650799|10598788;Full agonist
[125I]LTT-SRIF-28;SST5 receptor;f;;Mouse;10818261;Full agonist
[125I]Tyr10-CST14;SST5 receptor;f;;Human;9650799|10598788;Full agonist
[125I]Tyr10-CST14;SST5 receptor;f;;Mouse;10818261;Full agonist
[125I]Tyr11-SRIF-14;SST5 receptor;f;;Rat;8078491;Full agonist
[125I]Tyr11-SRIF-14;SST5 receptor;f;;Human;8078491;Full agonist
[125I]Tyr3 SMS 201-995;SST5 receptor;f;;Human;10598788|9652348;Full agonist
[125I]Tyr3 SMS 201-995;SST5 receptor;f;;Mouse;10818261;Full agonist
vapreotide;SST5 receptor;f;;Human;8769372|9650799|10598788|9600011|7988476|9652348;Full agonist
vapreotide;SST5 receptor;f;;Rat;9600011;Full agonist
AC-178,335;SST5 receptor;f;;Rat;9804621;Antagonist
BIM 23056;SST5 receptor;f;;Human;;Antagonist
BIM 23454;SST5 receptor;f;;Human;11897676;Antagonist
BIM 23627;SST5 receptor;f;;Human;11897676;Antagonist
[D-Tyr8]CYN 154806;SST5 receptor;f;;Human;12616335;Antagonist
[D-Tyr8]CYN 154806;SST5 receptor;f;;Mouse;10818261;Antagonist
[L-Tyr8]CYN 154806;SST5 receptor;f;;Human;12616335;Antagonist
[L-Tyr8]CYN 154806;SST5 receptor;f;;Mouse;10818261;Antagonist
PRL-2915;SST5 receptor;f;;Human;10354394;Antagonist
PRL-2970;SST5 receptor;f;;Human;10354394;Antagonist
S5A1;SST5 receptor;f;;Human;28938487;Antagonist
compound 3 [PMID: 23849879];ST14 transmembrane serine protease matriptase ;f;;Human;23849879;Inhibition
compound 4d [PMID: 25489658];ST14 transmembrane serine protease matriptase ;f;;Human;25489658;Inhibition
I-432;ST14 transmembrane serine protease matriptase ;f;;Human;27277342;Inhibition
inhibitor 1 [Colombo et al., 2012];ST14 transmembrane serine protease matriptase ;f;;Human;24900505;Inhibition
danusertib;STE20 like kinase;f;;Human;17125279;Inhibition
RN486;STE20 like kinase;f;;Human;22228807;Inhibition
finasteride;steroid 5 alpha-reductase 2;f;;Human;3783591;Inhibition
RJW100;Steroidogenic factor 1;f;;Human;21391689;Agonist
2'3'-cGAMP;stimulator of interferon response cGAMP interactor 1;f;;Human;23747010;Agonist
ADU-S100;stimulator of interferon response cGAMP interactor 1;f;;Human;25959818;Agonist
STING agonist 2;stimulator of interferon response cGAMP interactor 1;f;;Human;30405246;Agonist
STING agonist 3;stimulator of interferon response cGAMP interactor 1;f;;Human;30405246;Agonist
H-151;stimulator of interferon response cGAMP interactor 1;f;;Human;29973723;Inhibition
cis-1,2-cyclopropanedicarboxylic acid;succinate receptor;f;;Human;28160606;Full agonist
cis-epoxysuccinic acid;succinate receptor;f;;Human;29157600;Full agonist
cis-epoxysuccinic acid;succinate receptor;f;;Human;28160606;Full agonist
maleic acid;succinate receptor;f;;Human;26386312;Full agonist
maleic acid;succinate receptor;t;;Human;28160606;Full agonist
maleic acid;succinate receptor;f;;Human;15141213;Full agonist
methylmalonic acid;succinate receptor;f;;Human;15141213;Full agonist
methylmalonic acid;succinate receptor;f;;Human;28160606;Full agonist
(S)-chlorosuccinic acid;succinate receptor;f;;Human;28160606;Full agonist
succinic acid;succinate receptor;t;;Human;15141213|23396314;Full agonist
compound 130 [PMID: 29157600];succinate receptor;f;;Human;29157600;Partial agonist
compound 31 [PMID: 29968758];succinate receptor;f;;Human;29968758;Partial agonist
compound 5g [PMID: 21571530];succinate receptor;f;;Rat;21571530;Antagonist
compound 5g [PMID: 21571530];succinate receptor;f;;Human;21571530;Antagonist
compound 7e [PMID: 21571530];succinate receptor;f;;Human;21571530;Antagonist
NF-56-EJ40;succinate receptor;f;;Human;31645725;Antagonist
NF-56-EJ40;succinate receptor;f;;Human;31645725;Antagonist
compound R-16 [PMID: 21967808];sugen kinase 110;f;;Human;21967808;Inhibition
ST074946;SUMO peptidase family member, NEDD8 specific;f;;Human;;Inhibition
compound 8e [PMID: 23044371];SUMO specific peptidase 1;f;;Human;23044371;Inhibition
chaetocin;suppressor of variegation 3-9 homolog 1;f;;Human;16408017|23416387;Inhibition
PFI-3;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4;f;;Human;;Binding
brivaracetam;synaptic vesicle glycoprotein 2A;f;;Rat;14736235;Inhibition
levetiracetam;synaptic vesicle glycoprotein 2A;f;;Rat;8605950;Inhibition
levetiracetam;synaptic vesicle glycoprotein 2A;f;;Rat;14736235;Inhibition
APRIL;TACI;t;Human;None;;None
BAFF;TACI;t;Human;Human;;None
amlexanox;TANK binding kinase 1;f;;Human;23396211;Inhibition
AZ13102909;TANK binding kinase 1;f;;Human;24962318;Inhibition
BAY-985;TANK binding kinase 1;f;;Human;31859507;Inhibition
compound 17d [PMID: 23099093];TANK binding kinase 1;f;;Human;23099093;Inhibition
compound II [PMID: 21329883];TANK binding kinase 1;f;;Human;21329883;Inhibition
GSK8612;TANK binding kinase 1;f;;Human;31097999;Inhibition
MPI-0485520;TANK binding kinase 1;f;;Human;;Inhibition
MRT67307;TANK binding kinase 1;f;;Human;21138416;Inhibition
SR8185;TANK binding kinase 1;f;;Human;24150799;Inhibition
AZ1366;tankyrase;f;;Human;25815142;Inhibition
compound 5 [Tomassi et al., 2020];tankyrase;f;;Human;;Inhibition
MC2050;tankyrase;f;;Human;;Inhibition
NVP‐TNKS656;tankyrase;f;;Human;;Inhibition
RK-287107;tankyrase;f;;Human;30238564;Inhibition
AZ1366;tankyrase 2;f;;Human;25815142;Inhibition
compound 5 [Tomassi et al., 2020];tankyrase 2;f;;Human;;Inhibition
MC2050;tankyrase 2;f;;Human;;Inhibition
NVP‐TNKS656;tankyrase 2;f;;Human;23844574;Inhibition
OM-1700;tankyrase 2;f;;Human;32511917;Inhibition
RK-287107;tankyrase 2;f;;Human;30238564;Inhibition
compound 18 [PMID: 20873740];TAO kinase 1;f;;Human;20873740;Inhibition
compound 1 [PMID: 24793884];TAO kinase 3;f;;Human;24793884;Inhibition
compound 89S [PMID: 19115845];TAO kinase 3;f;;Human;19115845;Inhibition
yzm18;taspase 1;f;;Human;19631530;Inhibition
2-phenyl-propylamine;TA1 receptor;f;;Human;17038507;Agonist
ractopamine;TA1 receptor;f;;Mouse;24799633;Agonist
SEP-363856;TA1 receptor;f;;Human;31371483;Agonist
tyramine;TA1 receptor;t;;Mouse;19892733;Agonist
3-iodothyronamine;TA1 receptor;t;;Rat;15146179|16451074|17497842;Full agonist
3-iodothyronamine;TA1 receptor;t;;Mouse;15146179|16451074|17497842;Full agonist
β-phenylethylamine;TA1 receptor;t;;Rat;17218486|11723224;Full agonist
β-phenylethylamine;TA1 receptor;t;;Human;11459929|18524885|17038507|18602830|19725810|22073124;Full agonist
β-phenylethylamine;TA1 receptor;t;;Mouse;17218486|17212650|19725810;Full agonist
dexamfetamine;TA1 receptor;f;;Mouse;17218486|17212650;Full agonist
dexamfetamine;TA1 receptor;f;;Human;18524885|22037049;Full agonist
dexamfetamine;TA1 receptor;f;;Rat;17218486|11723224;Full agonist
octopamine;TA1 receptor;f;;Human;11459929|18524885|17038507|19725810|22073124;Full agonist
octopamine;TA1 receptor;f;;Rat;11723224;Full agonist
octopamine;TA1 receptor;f;;Mouse;17212650|19725810;Full agonist
R(-)amphetamine;TA1 receptor;f;;Mouse;17218486|17212650;Full agonist
R(-)amphetamine;TA1 receptor;f;;Human;22037049;Full agonist
R(-)amphetamine;TA1 receptor;f;;Human;18524885;Full agonist
RO5166017;TA1 receptor;f;;Human;21525407;Full agonist
RO5166017;TA1 receptor;f;;Human;21525407;Full agonist
RO5166017;TA1 receptor;f;;Rat;21525407;Full agonist
RO5166017;TA1 receptor;f;;Rat;21525407;Full agonist
[3H]tyramine;TA1 receptor;f;;Human;11459929;Full agonist
tyramine;TA1 receptor;t;;Rat;19892733;Full agonist
tyramine;TA1 receptor;t;;Human;11459929|18524885|17038507|19892733|19725810|22073124;Full agonist
tyramine;TA1 receptor;t;;Rat;17218486|11723224|19892733;Full agonist
tyramine;TA1 receptor;t;;Mouse;17218486|17212650|19892733|19725810;Full agonist
R(-)amphetamine;TA1 receptor;f;;Rat;17218486|11723224;Partial agonist
RO5166017;TA1 receptor;f;;Mouse;21525407;Partial agonist
RO5166017;TA1 receptor;f;;Mouse;21525407;Partial agonist
RO5256390;TA1 receptor;f;;None;32246467;Partial agonist
EPPTB;TA1 receptor;f;;Human;19892733;Inverse agonist
EPPTB;TA1 receptor;f;;Rat;19892733;Inverse agonist
EPPTB;TA1 receptor;f;;Rat;19892733;Inverse agonist
EPPTB;TA1 receptor;f;;Mouse;19892733;Inverse agonist
EPPTB;TA1 receptor;f;;Mouse;21237643|19892733;Inverse agonist
BAY-299;TATA-box binding protein associated factor 1;f;;Human;;Inhibition
acalabrutinib;tec protein tyrosine kinase;f;;Human;26641137;Inhibition
compound 25 [PMID: 31260299];tec protein tyrosine kinase;f;;Human;31260299;Inhibition
compound 31 [PMID: 24915291];tec protein tyrosine kinase;f;;Human;24915291;Inhibition
compound 38 [PMID: 24915291];tec protein tyrosine kinase;f;;Human;24915291;Inhibition
compound 9 [PMID: 26006010];tec protein tyrosine kinase;f;;Human;26006010;Inhibition
ibrutinib;tec protein tyrosine kinase;f;;Human;26641137;Inhibition
PRN694;tec protein tyrosine kinase;f;;Human;25593320;Inhibition
ZYBT1;tec protein tyrosine kinase;f;;Human;32790160;Inhibition
altiratinib;TEK receptor tyrosine kinase;f;;Human;;Inhibition
CEP-11981;TEK receptor tyrosine kinase;f;;Human;22148921;Inhibition
compound 5 [PMID: 17618114];TEK receptor tyrosine kinase;f;;Human;17618114;Inhibition
compound 8h [PMID: 21561767];TEK receptor tyrosine kinase;f;;Human;21561767;Inhibition
compound 8i [PMID: 22765894];TEK receptor tyrosine kinase;f;;Human;21613405;Inhibition
DDR1/2 inhibitor 5n;TEK receptor tyrosine kinase;f;;Human;30075624;Inhibition
linifanib;TEK receptor tyrosine kinase;f;;Human;16648571;Inhibition
merestinib;TEK receptor tyrosine kinase;f;;Human;23275061;Inhibition
pexmetinib;TEK receptor tyrosine kinase;f;;Human;27287719;Inhibition
angiopoietin-1;TEK receptor tyrosine kinase;t;Human;Human;;None
angiopoietin-4;TEK receptor tyrosine kinase;t;Human;Human;;None
retinol;Testicular receptor 4;t;;Human;21068381;Full agonist
tretinoin;Testicular receptor 4;t;;Human;21068381;Full agonist
compound 30 [PMID: 22902653];testis associated actin remodelling kinase 1;f;;Human;22902653;Inhibition
compound 31 [PMID: 22902653];testis associated actin remodelling kinase 1;f;;Human;22902653;Inhibition
compound 35 [PMID: 22902653];testis associated actin remodelling kinase 1;f;;Human;22902653;Inhibition
compound 30 [PMID: 22902653];testis associated actin remodelling kinase 2;f;;Human;22902653;Inhibition
compound 31 [PMID: 22902653];testis associated actin remodelling kinase 2;f;;Human;22902653;Inhibition
compound 35 [PMID: 22902653];testis associated actin remodelling kinase 2;f;;Human;22902653;Inhibition
ceritinib;testis specific serine kinase 1B;f;;Human;23742252;Inhibition
compound 20 [PMID: 30998356];testis specific serine kinase 1B;f;;Human;30998356;Inhibition
compound 2c [PMID: 24900538];testis specific serine kinase 2;f;;Human;24900538;Inhibition
[3H]thiamine;Thiamine transporter 1;f;;Human;10542220;None
[3H]thiamine;Thiamine transporter 2;f;;Human;11731220;None
avatrombopag;Thrombopoietin receptor;f;;Human;19183407;Agonist
eltrombopag;Thrombopoietin receptor;f;;Human;18783949;Agonist
hetrombopag;Thrombopoietin receptor;f;;Human;;Agonist
lusutrombopag;Thrombopoietin receptor;f;;Human;29274361;Agonist
romiplostim;Thrombopoietin receptor;f;;Human;;Agonist
thrombopoietin;Thrombopoietin receptor;t;Human;Human;;Agonist
thymic stromal lymphopoietin;Thymic stromal lymphopoietin receptor;t;Human;Human;;Agonist
capecitabine;thymidylate synthetase;f;;Human;10631692|15709193;Inhibition
ONX-0801;thymidylate synthetase;f;;Mouse;16357184;Inhibition
pemetrexed;thymidylate synthetase;f;;Human;9762351;Inhibition
plevitrexed;thymidylate synthetase;f;;Mouse;10508430;Inhibition
raltitrexed;thymidylate synthetase;f;;Mouse;1372358;Inhibition
raltitrexed;thymidylate synthetase;f;;Human;22739090;Inhibition
dextrothyroxine;Thyroid hormone receptor-α;f;;Human;6777394;Agonist
KB-141;Thyroid hormone receptor-α;f;;Human;12699376;Agonist
rT3;Thyroid hormone receptor-α;f;;Human;2158622;Agonist
sobetirome;Thyroid hormone receptor-α;f;;Human;2158622;Agonist
tiratricol;Thyroid hormone receptor-α;f;;Human;2158622;Agonist
triiodothyronine;Thyroid hormone receptor-α;t;;Human;12109914;Agonist
T4;Thyroid hormone receptor-α;t;;Human;2158622;Agonist
NH-3;Thyroid hormone receptor-α;f;;Human;12109914;Antagonist
dextrothyroxine;Thyroid hormone receptor-β;f;;Human;6777394;Agonist
KB-141;Thyroid hormone receptor-β;f;;Human;12888625;Agonist
rT3;Thyroid hormone receptor-β;f;;Human;2158622;Agonist
sobetirome;Thyroid hormone receptor-β;f;;Human;269396|9653548;Agonist
tiratricol;Thyroid hormone receptor-β;f;;Human;2158622;Agonist
triiodothyronine;Thyroid hormone receptor-β;t;;Human;12109914;Agonist
T4;Thyroid hormone receptor-β;t;;Human;2158622;Agonist
NH-3;Thyroid hormone receptor-β;f;;Human;12109914;Antagonist
methimazole;thyroid peroxidase;f;;Human;748042;Inhibition
propylthiouracil;thyroid peroxidase;f;;Human;748042;Inhibition
compound 13 [PMID: 23098072];TLR2;f;;Human;23098072;Agonist
defoslimod;TLR2;f;;Mouse;17383632;Agonist
diprovocim-1;TLR2;f;;Human;30272974;Agonist
peptidoglycan;TLR2;f;;Human;10364168|10384090;Agonist
tomaralimab;TLR2;f;;Human;;Binding
tomaralimab;TLR2;f;;Mouse;;Binding
poly(I:C);TLR3;f;;Human;11607032;Agonist
defoslimod;TLR4;f;;Mouse;17383632;Agonist
GSK1795091;TLR4;f;;Human;18835160;Agonist
LPS;TLR4;f;;Human;9851930;Agonist
neoceptin-3;TLR4;f;;Human;26831104;Agonist
paclitaxel;TLR4;f;;Mouse;10644670;Agonist
CRX-555;TLR4;f;;Human;14570885;Partial agonist
resatorvid;TLR4;f;;Human;16373689;Antagonist
flagellin;TLR5;f;;Human;11323673;Agonist
852A;TLR7;f;;Human;23265901;Agonist
852A;TLR7;f;;Mouse;23265901;Agonist
GSK2245035;TLR7;f;;Human;26861551;Agonist
imiquimod;TLR7;f;;Human;29152046;Agonist
loxoribine;TLR7;f;;Human;14579267;Agonist
resiquimod;TLR7;f;;Human;11812998|12032557|29152046;Agonist
compound 10a [PMID: 31283223];TLR7;f;;Human;31283223;Antagonist
compound 73 [WO2017106607A1];TLR7;f;;Human;;Antagonist
hydroxychloroquine;TLR7;f;;Human;24342772;Antagonist
3M-002;TLR8;f;;Human;22924757;Agonist
compound 12p [Larson et al., 2017];TLR8;f;;Human;29152046;Agonist
motolimod;TLR8;f;;Human;22128302;Agonist
resiquimod;TLR8;f;;Human;11812998|12032557|29152046;Agonist
selgantolimod;TLR8;f;;Human;32407112;Agonist
CU-CPT8m;TLR8;f;;Human;29155428;Inhibition
CU-CPT8m;TLR8;f;;Human;29155428;Inhibition
agatolimod;TLR9;f;;Human;16922592;Agonist
hydroxychloroquine;TLR9;f;;Human;24342772;Antagonist
BMS493;TLX;f;;Human;32763139;Agonist
tretinoin;TLX;f;;Human;32763139;Agonist
luminespib;TNF receptor associated protein 1;f;;Human;;Inhibition
lymphotoxin-α;toxicity and JNK inducer;t;Human;None;;None
phosphatidyl (3,5) inositol bisphosphate;TPC1;f;;Human;24776928;Activation
Cd2+;TPC1;f;;Human;24776928;Inhibition
verapamil;TPC1;f;;Human;24776928;Inhibition
phosphatidyl (3,5) inositol bisphosphate;TPC2;f;;Human;23063126;Activation
verapamil;TPC2;f;;Human;23063126;Inhibition
AGN192093;TP receptor;f;;Rat;8882612;Agonist
I-BOP;TP receptor;f;;Human;1830308;Agonist
STA2;TP receptor;f;;Human;8242228;Agonist
10,10-difluoro TXA2;TP receptor;f;;Human;2748606;Full agonist
AGN 191976;TP receptor;f;;Human;8882612;Full agonist
butaprost (free acid form);TP receptor;f;;Human;10634944;Full agonist
carbacyclin;TP receptor;f;;Human;10634944;Full agonist
carbocyclic thromboxane A2;TP receptor;f;;Human;1434130;Full agonist
cloprostenol;TP receptor;f;;Human;10634944;Full agonist
EP 171;TP receptor;f;;Human;2743082;Full agonist
fluprostenol;TP receptor;f;;Human;10634944;Full agonist
I-BOP;TP receptor;f;;Mouse;9313928;Full agonist
iloprost;TP receptor;f;;Human;10634944;Full agonist
MB-28767;TP receptor;f;;Human;10634944;Full agonist
PGE2;TP receptor;t;;Human;10634944;Full agonist
PGF2α;TP receptor;t;;Human;10634944;Full agonist
SQ 26655;TP receptor;f;;Rat;4067988;Full agonist
STA2;TP receptor;f;;Mouse;9313928;Full agonist
[125I]BOP;TP receptor;f;;Human;2530338;Full agonist
[3H]U46619;TP receptor;f;;Human;10634944;Full agonist
U46609;TP receptor;f;;Human;1434130;Full agonist
U46619;TP receptor;f;;Human;10634944;Full agonist
U46619;TP receptor;f;;Mouse;9313928;Full agonist
AH23848;TP receptor;f;;Human;10634944;Antagonist
daltroban;TP receptor;f;;Human;1434130;Antagonist
domitroban;TP receptor;f;;Human;1833018;Antagonist
domitroban;TP receptor;f;;Mouse;9313928;Antagonist
ICI 192605;TP receptor;f;;Human;8859002;Antagonist
ifetroban;TP receptor;f;;Human;8437108;Antagonist
I-SAP;TP receptor;f;;Human;1386885;Antagonist
KW-3635;TP receptor;f;;Human;1434130;Antagonist
ONO-3708;TP receptor;f;;Human;3008368;Antagonist
ONO-8711;TP receptor;f;;Human;10537280;Antagonist
PBT-3;TP receptor;f;;Human;14560042;Antagonist
PBT-3;TP receptor;f;;Human;14560042;Antagonist
ramatroban;TP receptor;f;;Human;1387312;Antagonist
S-5751;TP receptor;f;;Human;11454901;Antagonist
SQ-29548;TP receptor;f;;Human;16604093|10634944|2975605;Antagonist
SQ-29548;TP receptor;f;;Mouse;9313928;Antagonist
[125I]PTA-OH;TP receptor;f;;Human;3594077;Antagonist
[125I]SAP;TP receptor;f;;Human;1386885;Antagonist
[125I]SQ-29548;TP receptor;f;;Human;2968449;Antagonist
[3H]S-145;TP receptor;f;;Human;1825698;Antagonist
[3H]S-145;TP receptor;f;;Mouse;1375456;Antagonist
[3H]SQ-29548;TP receptor;f;;Human;16604093|10634944;Antagonist
[3H]SQ-29548;TP receptor;f;;Rat;7635958;Antagonist
terutroban;TP receptor;f;;Human;9871769;Antagonist
vapiprost;TP receptor;f;;Mouse;9313928;Antagonist
vapiprost;TP receptor;f;;Human;8242228|2527074;Antagonist
compound 5 [PMID: 23232060];TRAF2 and NCK interacting kinase;f;;Human;23232060;Inhibition
staurosporine;TRAF2 and NCK interacting kinase;f;;Human;23232060;Inhibition
TGFβ1;Transforming growth factor β receptor;t;Human;Human;;Agonist
TGFβ2;Transforming growth factor β receptor;t;Human;Human;;Agonist
TGFβ3;Transforming growth factor β receptor;t;Human;Human;;Agonist
H. polygyrus TGF-β mimic;transforming growth factor beta receptor 1;f;;Human;29170498;Agonist
BIX02189;transforming growth factor beta receptor 1;f;;Human;18834865;Inhibition
BMS-986260;transforming growth factor beta receptor 1;f;;Human;32071685;Inhibition
compound 13d [PMID: 23639540];transforming growth factor beta receptor 1;f;;Human;23639540;Inhibition
compound 13r [PMID: 23639540];transforming growth factor beta receptor 1;f;;Human;23639540;Inhibition
compound 15b [PMID: 16539403];transforming growth factor beta receptor 1;f;;Human;16539403;Inhibition
galunisertib;transforming growth factor beta receptor 1;f;;Human;29467918;Inhibition
galunisertib;transforming growth factor beta receptor 1;f;;Human;;Inhibition
LDN-214117;transforming growth factor beta receptor 1;f;;Human;25101911;Inhibition
LY2109761;transforming growth factor beta receptor 1;f;;Human;18413796;Inhibition
SB-431542;transforming growth factor beta receptor 1;f;;Human;11855979;Inhibition
SD-208;transforming growth factor beta receptor 1;f;;Human;17289388;Inhibition
TGF-beta RI inhibitor III;transforming growth factor beta receptor 1;f;;Human;21696866;Inhibition
TGF-beta RI kinase inhibitor;transforming growth factor beta receptor 1;f;;Human;19035792;Inhibition
vactosertib;transforming growth factor beta receptor 1;f;;Human;24786585;Inhibition
H. polygyrus TGF-β mimic;transforming growth factor beta receptor 2;f;;Human;29170498;Agonist
TGFβ3;transforming growth factor beta receptor 2;t;Human;Human;29170498;Agonist
compound 13a [PMID: 23639540];transforming growth factor beta receptor 2;f;;Human;23639540;Inhibition
compound 13d [PMID: 23639540];transforming growth factor beta receptor 2;f;;Human;23639540;Inhibition
compound 15b [PMID: 16539403];transforming growth factor beta receptor 2;f;;Human;16539403;Inhibition
galunisertib;transforming growth factor beta receptor 2;f;;Human;29467918;Inhibition
LY2109761;transforming growth factor beta receptor 2;f;;Human;18413796;Inhibition
ERW1041E;transglutaminase 2;f;;Human;29689097;Inhibition
JAK3 inhibitor IV;transglutaminase 2;f;;Human;18804034;Inhibition
emapunil;Translocator protein;f;;Rat;19217778;Agonist
PK 11195;Translocator protein;f;;Human;21741237;Binding
compound 5 [PMID: 21741839];transmembrane serine protease 11D;f;;Human;21741839;Inhibition
inhibitor 1 [Colombo et al., 2012];transmembrane serine protease 11D;f;;Human;24900505;Inhibition
camostat;transmembrane serine protease 2;f;;Human;27550352;Inhibition
compound 5 [PMID: 21741839];transmembrane serine protease 2;f;;Human;21741839;Inhibition
I-432;transmembrane serine protease 2;f;;Human;27277342;Inhibition
nafamostat;transmembrane serine protease 2;f;;Human;27550352;Inhibition
inhibitor 1 [Colombo et al., 2012];transmembrane serine protease 6;f;;Human;24900505;Inhibition
tafamidis;transthyretin;f;;Human;22645360;Binding
taltirelin;TRH1 receptor;f;;Human;23087672;Full agonist
TRH;TRH1 receptor;t;Human|Mouse|Rat;Rat;8592728;Full agonist
MeTRH;TRH1 receptor;f;;Human;5001013;Partial agonist
[3H]MeTRH;TRH1 receptor;f;;Rat;6264336;Partial agonist
chlordiazepoxide;TRH1 receptor;f;;Mouse;2175902;Antagonist
chlordiazepoxide;TRH1 receptor;f;;Rat;2566295;Antagonist
diazepam;TRH1 receptor;f;;Rat;2566295;Antagonist
midazolam;TRH1 receptor;f;;Rat;2566295;Antagonist
taltirelin;TRH2 receptor;f;;Mouse;23303050;Full agonist
TRH;TRH2 receptor;f;Human|Mouse|Rat;Rat;8592728;Full agonist
MeTRH;TRH2 receptor;f;;Mouse;23303050;Partial agonist
[3H]MeTRH;TRH2 receptor;f;;Rat;6264336;Partial agonist
compound 34 [PMID: 25974391];tripartite motif containing 24;f;;Human;25974391;Binding
dTRIM24;tripartite motif containing 24;f;;Human;29507391;Binding
example 8 [WO1999033801A1];tripeptidyl peptidase 2;f;;Human;;Inhibition
peptide 4 [PMID: 18294843];tripeptidyl peptidase 2;f;;Human;18294843;Inhibition
anatumomab mafenatox;trophoblast glycoprotein;f;;Human;11437414;Binding
naptumomab estafenatox;trophoblast glycoprotein;f;;Human;20463598;Binding
1,6-hexamethylene diisocyanate;TRPA1;f;;Human;19036859;Activation
1'-acetoxychavicol acetate;TRPA1;f;;Human;20699565;Activation
2-iodoacetamide;TRPA1;f;;Mouse;17237762;Activation
2-pentenal;TRPA1;f;;Unknown;20356305;Activation
4-hydroxynonenal;TRPA1;t;;Rat;17684094|17942735;Activation
4-oxo-nonenal;TRPA1;t;;Mouse;18322093;Activation
acetaldehyde;TRPA1;f;;Human;17970723;Activation
acetaldehyde;TRPA1;f;;Mouse;17970723;Activation
allyl isothiocyanate;TRPA1;f;;Rat;14712238;Activation
allyl isothiocyanate;TRPA1;f;;Mouse;15046718;Activation
apomorphine;TRPA1;f;;Human;23220749;Activation
artepillin C;TRPA1;f;;Human;23133611;Activation
ASP7663;TRPA1;f;;Mouse;24291101;Activation
ASP7663;TRPA1;f;;Rat;24291101;Activation
ASP7663;TRPA1;f;;Human;24291101;Activation
auranofin;TRPA1;f;;Human;23220116;Activation
benzoquinone;TRPA1;f;;Human;22109525;Activation
benzyl bromide;TRPA1;f;;Human;19036859;Activation
bromoacetone;TRPA1;f;;Human;19036859;Activation
Cd2+;TRPA1;f;;Human;19416844|23448290;Activation
Cd2+;TRPA1;f;;Mouse;19416844|23448290;Activation
chlorobenzylidene malononitrile;TRPA1;f;;Human;18501939;Activation
chloropicrin;TRPA1;f;;Human;19036859;Activation
crotylaldehyde;TRPA1;f;;Rat;18568077;Activation
Cu2+;TRPA1;f;;Human;19416844|23448290;Activation
Cu2+;TRPA1;f;;Mouse;19416844|23448290;Activation
dibenzoxazepine;TRPA1;f;;Human;18501939;Activation
dibutyl phthalate;TRPA1;f;;Human;19135264;Activation
docosahexaenoic acid;TRPA1;t;;Rat;22723860;Activation
flufenamic acid;TRPA1;f;;Rat;19888597;Activation
formalin;TRPA1;f;;Mouse;17686976|17942735;Activation
H2O2;TRPA1;t;;Mouse;18322093|18364033;Activation
isoflurane;TRPA1;f;;Rat;18574153;Activation
isovelleral;TRPA1;f;;Human;18550530;Activation
JT010;TRPA1;f;;Human;26630251;Activation
methylglyoxal;TRPA1;t;;Human;22701540|22740698|22133672;Activation
methyl isocyanate;TRPA1;f;;Human;19036859;Activation
methyl p-hydroxybenzoate;TRPA1;f;;Mouse;17351650;Activation
morphanthridine;TRPA1;f;;Human;18501939;Activation
MTSEA;TRPA1;f;;Mouse;17237762;Activation
N-acetyl-4-benzoquinoneimine;TRPA1;f;;Rat;20720158|22109525;Activation
NaHS;TRPA1;t;;Mouse;18031925;Activation
NH4Cl;TRPA1;f;;Mouse;19033673;Activation
nicotine;TRPA1;f;;Human;19749751;Activation
niflumic acid;TRPA1;f;;Rat;19888597;Activation
nitrooleic acid;TRPA1;f;;Human;19171673;Activation
NPPB;TRPA1;f;;Human;20226176;Activation
oleocanthal;TRPA1;f;;Human;21248124;Activation
omega-chloroacetophenone;TRPA1;f;;Human;18501939;Activation
O3;TRPA1;f;;Human;20008466;Activation
PF-4840154;TRPA1;f;;Human;21741838;Activation
polygodial;TRPA1;f;;Human;18550530;Activation
prostaglandin A2;TRPA1;t;;Mouse;18687886;Activation
salirasib;TRPA1;f;;Human;18171730;Activation
super cinnamaldehyde;TRPA1;f;;Mouse;17237762;Activation
thymol;TRPA1;f;;Human;18334983;Activation
Zn2+;TRPA1;f;;Mouse;19202543|19416844;Activation
acrolein;TRPA1;f;;Human;16564016;Agonist
allicin;TRPA1;f;;Mouse;15916949;Agonist
allicin;TRPA1;f;;Human;16103371;Agonist
cannabichromene;TRPA1;f;;Rat;20356305;Agonist
cannabidiolic acid;TRPA1;f;;Rat;20356305;Agonist
cinnamaldehyde;TRPA1;f;;Mouse;15046718;Agonist
Δ9-tetrahydrocannabinol;TRPA1;f;;Human;14712238;Agonist
eugenol;TRPA1;f;;Mouse;15046718;Agonist
gingerol;TRPA1;f;;Mouse;15046718;Agonist
icilin;TRPA1;f;;Mouse;12654248;Agonist
methyl salicylate;TRPA1;f;;Mouse;15046718;Agonist
URB597;TRPA1;f;;Human;17314320;Agonist
(-)-menthol;TRPA1;f;;Human;18815250|17855602;Partial agonist
AM-0902;TRPA1;f;;Human;26942860;Antagonist
Gd3+;TRPA1;f;;Mouse;15843607;Antagonist
amiloride;TRPA1;f;;Mouse;15843607;Inhibition
AP18;TRPA1;f;;Human;18086313;Inhibition
HC030031;TRPA1;f;;Human;17686976;Inhibition
ruthenium red;TRPA1;f;;Mouse;15843607;Inhibition
camphor;TRPA1;f;;Mouse;16829128;Antagonist
gentamicin;TRPA1;f;;Mouse;15843607;Antagonist
(-)-menthol;TRPA1;f;;Mouse;16829128;Antagonist
A-967079;TRPA1;f;;Human;21402443;Inhibition
AP18;TRPA1;f;;Human;18086313;Inhibition
AP18;TRPA1;f;;Mouse;18086313;Inhibition
HC030031;TRPA1;f;;Human;17686976;Inhibition
isopentenyl diphosphate;TRPA1;t;;Mouse;20880407;Inhibition
resolvin D1;TRPA1;t;;Mouse;22171045|20880407;Inhibition
resolvin D2;TRPA1;t;;Mouse;22171045;Inhibition
TCS 5861528;TRPA1;f;;Human;19512877;Inhibition
AM-0902;TRPA1;f;;Rat;26942860;Antagonist
2-APB;TRPC1;f;;Human;11301024;Antagonist
Gd3+;TRPC1;f;;Human;8663995;Antagonist
La3+;TRPC1;f;;Human;11301024;Antagonist
GsMTx-4;TRPC1;f;;Human;;None
SKF96365;TRPC1;f;;Human;;None
DOG;TRPC2;f;;Mouse;14642279;Agonist
OAG;TRPC2;f;;Mouse;14642279;Agonist
SAG;TRPC2;f;;Mouse;14642279;Agonist
Ca2+;TRPC2;t;;None;;None
2-APB;TRPC2;f;;Mouse;14642279;Antagonist
U73122;TRPC2;f;;Mouse;;Antagonist
pyrazolopyrimidine 4n;TRPC3;f;;Human;28395140;Activation
GSK1702934A;TRPC3;f;;Human;;Agonist
OAG;TRPC3;f;;Human;9930701;Agonist
2-APB;TRPC3;f;;Human;15933213;Antagonist
BTP2;TRPC3;f;;Human;15647288;Antagonist
Gd3+;TRPC3;f;;Human;10970899;Antagonist
GSK417651A;TRPC3;f;;Human;23886683;Antagonist
La3+;TRPC3;f;;Human;10970899;Antagonist
Pyr10;TRPC3;f;;Human;22862290;Antagonist
ACAA;TRPC3;f;;Human;;None
clemizole;TRPC3;f;;Human;25140002;None
GSK2833503A;TRPC3;f;;Human;24453217;None
KB-R7943;TRPC3;f;;Human;;None
Ni2+;TRPC3;f;;Human;;None
norgestimate;TRPC3;f;;Human;22530015;None
Pyr3;TRPC3;f;;Human;19289841;None
SAR7334;TRPC3;f;;Human;25847402;None
SH045;TRPC3;f;;Human;29522264;None
SKF96365;TRPC3;f;;Human;;None
tonantzitlolone;TRPC4;f;;Human;29859013;Activation
(-)-englerin A;TRPC4;f;;Human;25707820;Agonist
La3+;TRPC4;f;;Human;;None
HC-070;TRPC4;f;;Human;29385160;Antagonist
niflumic acid;TRPC4;f;;Mouse;12388058;Antagonist
M084;TRPC4;f;;Human;25816897;Inhibition
M084;TRPC4;f;;Human;30943030;Inhibition
ML204;TRPC4;f;;Mouse;21795696;Inhibition
Pico145;TRPC4;f;;Human;28325835;Inhibition
2-APB;TRPC4;f;;Human;;None
clemizole;TRPC4;f;;Human;25140002;None
La3+;TRPC4;f;;Human;;None
ML204;TRPC4;f;;Human;21795696;None
SKF96365;TRPC4;f;;Human;;None
AM237;TRPC5;f;;Human;31277085;Activation
BTD;TRPC5;f;;Human;28807145;Activation
BTD;TRPC5;f;;Human;28807145;Activation
Ca2+;TRPC5;f;;Mouse;19398778|19815560;Activation
methylprednisolone;TRPC5;f;;Human;28807145;Activation
riluzole;TRPC5;f;;Human;24117252;Activation
rosiglitazone;TRPC5;f;;Human;21406603;Activation
tonantzitlolone;TRPC5;f;;Human;29859013;Activation
(-)-englerin A;TRPC5;f;;Human;25707820;Agonist
Ca2+;TRPC5;t;;Human;;None
daidzein;TRPC5;f;;Human;;None
Gd3+;TRPC5;f;;Human;;None
genistein;TRPC5;f;;Human;20233211;None
La3+;TRPC5;f;;Human;;None
lysophosphatidylcholine;TRPC5;t;;Human;;None
Pb2+;TRPC5;f;;Human;;None
2-APB;TRPC5;f;;Human;15806115;Antagonist
HC-070;TRPC5;f;;Human;29385160;Antagonist
La3+;TRPC5;f;;Mouse;12456670;Antagonist
AC1903;TRPC5;f;;Human;29217578;Inhibition
AM12;TRPC5;f;;Human;26565375;Inhibition
bromoenol lactone;TRPC5;f;;Mouse;21795434;Inhibition
KB-R7943;TRPC5;f;;Human;17658472;Inhibition
M084;TRPC5;f;;Human;25816897;Inhibition
M084;TRPC5;f;;Human;30943030;Inhibition
Mg2+;TRPC5;f;;Rat;15689561;Inhibition
Pico145;TRPC5;f;;Human;28325835;Inhibition
progesterone;TRPC5;f;;Human;21108630;Inhibition
BTP2;TRPC5;f;;Human;;None
chlorpromazine;TRPC5;f;;Human;;None
clemizole;TRPC5;f;;Human;25140002;None
flufenamic acid;TRPC5;f;;Human;;None
galangin;TRPC5;f;;Human;26565375;None
GsMTx-4;TRPC5;f;;Human;;None
ML204;TRPC5;f;;Human;21795696;None
SKF96365;TRPC5;f;;Human;;None
pyrazolopyrimidine 4n;TRPC6;f;;Human;28395140;Activation
GSK1702934A;TRPC6;f;;Human;;Agonist
OAG;TRPC6;f;;Human;9930701;Agonist
SAG;TRPC6;f;;Human;9930701;Agonist
SLG;TRPC6;f;;Human;9930701;Agonist
20-HETE;TRPC6;t;;Human;;None
arachidonic acid;TRPC6;t;;Human;;None
flufenamate;TRPC6;f;;Human;;None
hyp 9;TRPC6;f;;Human;20008516;None
hyperforin;TRPC6;f;;Human;17666455;None
lysophosphatidylcholine;TRPC6;t;;Human;;None
amiloride;TRPC6;f;;Mouse;11179201;Antagonist
Cd2+;TRPC6;f;;Mouse;11179201;Antagonist
Gd3+;TRPC6;f;;Mouse;11179201;Antagonist
GSK417651A;TRPC6;f;;Human;23886683;Antagonist
La3+;TRPC6;f;;Mouse;11179201;Antagonist
SKF96365;TRPC6;f;;Mouse;11179201;Antagonist
larixyl acetate;TRPC6;f;;Human;26500253;Inhibition
2-APB;TRPC6;f;;Human;;None
ACAA;TRPC6;f;;Human;;None
clemizole;TRPC6;f;;Human;25140002;None
GSK2833503A;TRPC6;f;;Human;24453217;None
GsMTx-4;TRPC6;f;;Human;;None
H+;TRPC6;f;;Human;;None
KB-R7943;TRPC6;f;;Human;;None
La3+;TRPC6;f;;Human;;None
ML9;TRPC6;f;;Human;;None
norgestimate;TRPC6;f;;Human;22530015;None
SAR7334;TRPC6;f;;Human;25847402;None
SH045;TRPC6;f;;Human;29522264;None
pyrazolopyrimidine 4n;TRPC7;f;;Human;28395140;Activation
DOG;TRPC7;f;;Mouse;10488066;Agonist
OAG;TRPC7;f;;Mouse;10488066;Agonist
La3+;TRPC7;f;;Mouse;10488066;Antagonist
SKF96365;TRPC7;f;;Mouse;10488066;Antagonist
2-APB;TRPC7;f;;Human;;None
amiloride;TRPC7;f;;Human;;None
SAR7334;TRPC7;f;;Human;25847402;None
SH045;TRPC7;f;;Human;29522264;None
pregnenolone sulphate;TRPM1;t;;Human;21278253;None
Zn2+;TRPM1;t;;Human;;None
OAADPR;TRPM2;f;;Human;16565078;Activation
PIP2;TRPM2;t;;Human;22847436;Activation
ADP ribose;TRPM2;t;;Human;11385575;Agonist
cADPR;TRPM2;t;;Human;16601673|15808509|16585058;Agonist
H2O2;TRPM2;t;;Human;15302683|12562896|11960981|14512294|11804595;Agonist
NAADP;TRPM2;t;;Human;16585058;Agonist
NAD;TRPM2;t;;Human;16601673|11509734|11804595|12564954;Agonist
Ca2+;TRPM2;t;;Human;;None
GEA 3162;TRPM2;f;;Human;;None
arachidonic acid;TRPM2;t;;Human;11804595;Potentiation
2-APB;TRPM2;f;;Human;18204483;Antagonist
ACAA;TRPM2;f;;Human;16604090;Antagonist
clotrimazole;TRPM2;f;;Human;15549272;Antagonist
econazole;TRPM2;f;;Human;15549272;Antagonist
flufenamic acid;TRPM2;f;;Human;18204483|15275834;Antagonist
miconazole;TRPM2;f;;Human;18204483;Antagonist
tatM2NX;TRPM2;f;;Human;31772034;Antagonist
H+;TRPM2;t;;Human;;None
Zn2+;TRPM2;t;;Human;;None
CIM0216;TRPM3;f;;Human;28720517|25733887;Activation
dihydrosphingosine;TRPM3;t;;Human;15550678;Agonist
NN-dimethyl-D-erythrosphingosine;TRPM3;t;;Human;15550678;Agonist
sphingosine;TRPM3;t;;Human;15550678;Agonist
epipregnanolone sulphate;TRPM3;t;;Human;20735426;None
nifedipine;TRPM3;f;;Human;;None
pregnenolone sulphate;TRPM3;t;;Human;18978782;None
Gd3+;TRPM3;f;;Human;12672827|12672799;Antagonist
La3+;TRPM3;f;;Human;12672827|12672799;Antagonist
Mg2+;TRPM3;t;;Mouse;15824111;Antagonist
diclofenac;TRPM3;f;;Human;27433342;None
isosakuranetin;TRPM3;f;;Human;24006495;None
liquiritigenin;TRPM3;f;;Human;24006495;None
maprotiline;TRPM3;f;;Human;28106668;None
mefenamic acid;TRPM3;f;;Human;21198543;None
naringenin;TRPM3;f;;Human;23190005|24006495;None
Na+;TRPM3;t;;Human;;None
pioglitazone;TRPM3;f;;Human;21406603;None
primidone;TRPM3;f;;Human;28106668;None
rosiglitazone;TRPM3;f;;Human;21406603;None
troglitazone;TRPM3;f;;Human;;None
2-APB;TRPM3;f;;Human;15806115;Antagonist
BTP2;TRPM4;f;;Human;16407466;Agonist
Ca2+;TRPM4;t;;Human;15590641|16424899|16407466|15331675;Agonist
decavanadate;TRPM4;f;;Human;15331675;Agonist
PIP2;TRPM4;t;;Mouse;16186107;Agonist
PIP2;TRPM4;t;;Human;16424899;Agonist
ATP;TRPM4;t;;Human;14758478;Antagonist
ATP;TRPM4;t;;Mouse;15670874;Antagonist
spermine;TRPM4;f;;Mouse;15670874;Antagonist
spermine;TRPM4;f;;Human;14758478;Antagonist
9-phenanthrol;TRPM4;f;;Human;18297105;None
adenosine;TRPM4;f;;Human;;None
adenosine 5'-monophosphate;TRPM4;t;;Human;14758478;Antagonist
ADP;TRPM4;t;;Human;14758478;Antagonist
AMP-PNP;TRPM4;f;;Human;14758478;Antagonist
ATP;TRPM4;t;;Human;14758478;Antagonist
clotrimazole;TRPM4;f;;Human;;Antagonist
flufenamic acid;TRPM4;f;;Mouse;15670874;Antagonist
compound 5 [PMID: 29579323];TRPM4;f;;Human;29579323;None
compound 6 [PMID: 29579323];TRPM4;f;;Human;29579323;None
Ca2+;TRPM5;t;;Mouse;15670874|12842017|14657398;Agonist
flufenamic acid;TRPM5;f;;Human;;None
H+;TRPM5;f;;Human;;None
spermine;TRPM5;f;;Human;;None
2-APB;TRPM6;f;;Human;16636202;Agonist
Mg2+;TRPM6;t;;Human;;None
H+;TRPM6;t;;Human;;Potentiation
Mg2+;TRPM6;t;;Human;14576148;Antagonist
ruthenium red;TRPM6;f;;Human;14576148;Antagonist
Ca2+;TRPM6;t;;Human;;None
Mg2+;TRPM6;t;;Human;;None
ruthenium red;TRPM6;f;;Human;;None
2-APB;TRPM7;f;;Mouse;11385574;Activation
naltriben;TRPM7;f;;Human;24633576;Activation
PIP2;TRPM7;t;;Rat;11941371;Agonist
H+;TRPM7;t;;Human;;Potentiation
La3+;TRPM7;f;;Mouse;11161216;Antagonist
Mg2+;TRPM7;f;;Mouse;11385574;Antagonist
2-APB;TRPM7;f;;Mouse;16636202;Inhibition
carvacrol;TRPM7;f;;Mouse;19135721;Inhibition
fingolimod;TRPM7;f;;Mouse;23145923;Inhibition
nafamostat;TRPM7;f;;Human;21122141;Inhibition
NS8593;TRPM7;f;;Mouse;22242975;Inhibition
spermine;TRPM7;f;;Rat;12149283;Inhibition
sphingosine;TRPM7;f;;Mouse;23145923;Inhibition
waixenicin A;TRPM7;f;;Mouse;21926172;Inhibition
icilin;TRPM8;f;;Mouse;15190109|14757700;Agonist
CPS125;TRPM8;f;;Rat;20816009;Full agonist
frescolat ML;TRPM8;f;;Rat;14757700|20816009;Full agonist
icilin;TRPM8;f;;Rat;11882888|11893340|19492038;Full agonist
WS-12;TRPM8;f;;Rat;18930858|20816009;Full agonist
WS-5;TRPM8;f;;Rat;20816009;Full agonist
(-)-menthol;TRPM8;f;;Human;15306801;None
cooling agent 10;TRPM8;f;;Mouse;14757700;Partial agonist
eucalyptol;TRPM8;f;;Rat;11882888;Partial agonist
eucalyptol;TRPM8;f;;Mouse;14757700;Partial agonist
frescolat MGA;TRPM8;f;;Mouse;14757700;Partial agonist
frescolat ML;TRPM8;f;;Mouse;14757700;Partial agonist
geraniol;TRPM8;f;;Mouse;14757700;Partial agonist
hydroxycitronellal;TRPM8;f;;Mouse;14757700;Partial agonist
isopulegol;TRPM8;f;;Mouse;14757700;Partial agonist
linalool;TRPM8;f;;Mouse;14757700;Partial agonist
(-)-menthol;TRPM8;f;;Mouse;15190109|14757700;Partial agonist
(-)-menthol;TRPM8;f;;Rat;11882888;Partial agonist
(+)-menthol;TRPM8;f;;Mouse;14757700;Partial agonist
PMD38;TRPM8;f;;Mouse;14757700;Partial agonist
WS-23;TRPM8;f;;Mouse;14757700;Partial agonist
WS-3;TRPM8;f;;Mouse;14757700;Partial agonist
cannabigerol;TRPM8;f;;Rat;21902175;Antagonist
elismetrep;TRPM8;f;;Human;;Antagonist
KPR-5714;TRPM8;f;;Human;32102918;Antagonist
2-APB;TRPM8;f;;Mouse;15194687|21964764;Antagonist
BCTC;TRPM8;f;;Mouse;14757700;Antagonist
capsazepine;TRPM8;f;;Mouse;14757700;Antagonist
PF-05105679;TRPM8;f;;Human;25893043;Antagonist
thio-BCTC;TRPM8;f;;Mouse;14757700;Antagonist
PBMC;TRPM8;f;;Rat;21984952;Inhibition
thio-BCTC;TRPM8;f;;Rat;14757700|17135413;Inhibition
5-benzyloxytryptamine;TRPM8;f;;Human;;None
ACAA;TRPM8;f;;Human;;None
AMTB;TRPM8;f;;Human;18562636;None
anandamide;TRPM8;f;;Human;;None
cannabidiol;TRPM8;f;;Human;;None
clotrimazole;TRPM8;f;;Human;;None
Δ9-tetrahydrocannabinol;TRPM8;f;;Human;;None
La3+;TRPM8;f;;Human;;None
linoleic acid;TRPM8;f;;Human;;None
NADA;TRPM8;f;;Human;;None
M8-B;TRPM8;f;;Rat;22323721;Pore blocker
MK6-83;TRPML1;f;;Human;25119295;Activation
MK6-83;TRPML1;f;;Human;25119295;Activation
ML SA1;TRPML1;f;;Human;22415822;Activation
phosphatidyl (3,5) inositol bisphosphate;TRPML1;t;;Human;20802798;Activation
SF-22;TRPML1;f;;Human;25119295;Activation
SF-51;TRPML1;f;;Human;22415822;Activation
ML SA1;TRPML2;f;;Human;22415822;Activation
phosphatidyl (3,5) inositol bisphosphate;TRPML2;f;;Human;20802798;Activation
ML2-SA1;TRPML2;f;;Human;30479274;Agonist
MK6-83;TRPML3;f;;Human;;Activation
ML SA1;TRPML3;f;;Human;22415822;Activation
phosphatidyl (3,5) inositol bisphosphate;TRPML3;f;;Human;20802798;Activation
SF-11;TRPML3;f;;Human;20189104;Activation
SF-21;TRPML3;f;;Human;20189104;Activation
SN-1;TRPML3;f;;Human;20189104;Activation
SN-2;TRPML3;f;;Human;20189104;Activation
Gd3+;TRPML3;f;;Mouse;18162548;Antagonist
Ca2+;TRPP1;f;;Human;11854751;None
Cd2+;TRPP1;f;;Human;16396967;None
Ni2+;TRPP1;f;;Human;16396967;None
SKF96365;TRPP1;f;;Human;16396967;None
Ca2+;TRPP2;f;;Human;10517637;Agonist
Ca2+;TRPP2;f;;Human;10517637;Agonist
citric acid;TRPP2;f;;Human;16891422;Agonist
HCl;TRPP2;f;;Human;16891422;Agonist
malic acid;TRPP2;f;;Human;16891422;Agonist
amiloride;TRPP2;f;;Human;;None
benzamil;TRPP2;f;;Human;;None
ethylisopropylamiloride;TRPP2;f;;Human;;None
flufenamate;TRPP2;f;;Human;;None
flufenamic acid;TRPP2;f;;Human;10517637;None
Gd3+;TRPP2;f;;Human;10517637;None
La3+;TRPP2;f;;Human;10517637;None
phenamil;TRPP2;f;;Human;;None
anandamide;TRPV1;t;;Human;12761211;Activation
DkTx;TRPV1;f;;Rat;20510930;Activation
[3H]resiniferatoxin;TRPV1;f;;Human;;Activation
12S-HPETE;TRPV1;t;;Rat;10823958;Agonist
2-APB;TRPV1;f;;Mouse;15194687;Agonist
5S-HPETE;TRPV1;t;;Rat;10823958;Agonist
allicin;TRPV1;f;;Rat;15916949;Agonist
anandamide;TRPV1;t;;Human;10694225;Agonist
anandamide;TRPV1;t;;Rat;10440374;Agonist
arvanil;TRPV1;f;;Mouse;15489017;Agonist
capsaicin;TRPV1;f;;Mouse;15489017;Agonist
capsaicin;TRPV1;f;;Human;15306801;Agonist
capsaicin;TRPV1;f;;Rat;9349813;Agonist
LTB4;TRPV1;t;;Rat;10823958;Agonist
olvanil;TRPV1;f;;Mouse;15489017;Agonist
olvanil;TRPV1;f;;Rat;10864900;Agonist
olvanil;TRPV1;f;;Human;11301059;Agonist
piperine;TRPV1;f;;Human;15685214;Agonist
PPAHV;TRPV1;f;;Rat;11226139;Agonist
resiniferatoxin;TRPV1;f;;Mouse;15489017;Agonist
resiniferatoxin;TRPV1;f;;Rat;9349813;Agonist
resiniferatoxin;TRPV1;f;;Human;11301059;Agonist
vanillotoxin-1;TRPV1;f;;Rat;17093448;Agonist
vanillotoxin-2;TRPV1;f;;Rat;17093448;Agonist
vanillotoxin-3;TRPV1;f;;Rat;17093448;Agonist
5S-HETE;TRPV1;t;;Human;;None
camphor;TRPV1;f;;Human;;None
diphenylboronic anhydride;TRPV1;f;;Human;;None
H+;TRPV1;t;;Human;;None
phenylacetylrinvanil;TRPV1;f;;Human;15356216;None
asivatrep;TRPV1;f;;Rat;;Antagonist
BCTC;TRPV1;f;;Rat;12721338;Antagonist
BCTC;TRPV1;f;;Human;24055075;Antagonist
capsazepine;TRPV1;f;;Rat;11226139;Antagonist
capsazepine;TRPV1;f;;Human;11226139;Antagonist
JNJ17203212;TRPV1;f;;Human;15771431;Antagonist
JYL1421;TRPV1;f;;Rat;12237342;Antagonist
ruthenium red;TRPV1;f;;Human;11226139;Antagonist
ruthenium red;TRPV1;f;;Rat;11226139;Antagonist
SB452533;TRPV1;f;;Human;;Antagonist
SB705498;TRPV1;f;;Human;17392405;Antagonist
[125I]resiniferatoxin;TRPV1;f;;Rat;11125018;Antagonist
agatoxin 489;TRPV1;f;;Rat;16300403;Inhibition
AMG 9810;TRPV1;f;;Human;15615864;Inhibition
2-APB;TRPV1;f;;Human;;None
5'-iodoresiniferatoxin;TRPV1;f;;Human;;None
6-iodo-nordihydrocapsaicin;TRPV1;f;;Human;;None
A425619;TRPV1;f;;Human;15837819;None
A778317;TRPV1;f;;Human;17660385;None
allicin;TRPV1;f;;Human;;None
AMG517;TRPV1;f;;Human;20307063;None
AMG628;TRPV1;f;;Rat;17585751;None
NADA;TRPV1;f;;Human;;None
ruthenium red;TRPV1;f;;Human;;None
SB366791;TRPV1;f;;Human;14654105;None
[3H]A778317;TRPV1;f;;Human;17660385;None
AZD1386;TRPV1;f;;Human;;Inhibition
cannabidiol;TRPV2;f;;Rat;18550765;Activation
cannabidiol;TRPV2;f;;Human;18550765;Activation
cannabinol;TRPV2;f;;Rat;18550765;Activation
Δ9-tetrahydrocannabinol;TRPV2;f;;Rat;18550765;Activation
lysophosphatidylcholine;TRPV2;f;;Mouse;21147993|19321128;Activation
lysophosphatidylinositol;TRPV2;f;;Mouse;19321128;Activation
probenecid;TRPV2;f;;Rat;17850966;Activation
2-APB;TRPV2;f;;Mouse;15194687|17673572;Agonist
diphenylboronic anhydride;TRPV2;f;;Mouse;15722340|17673572;Agonist
insulin-like growth factor 1;TRPV2;f;Mouse;Mouse;10559903;Agonist
neuropeptide head activator;TRPV2;f;;Mouse;11707512;Agonist
2-APB;TRPV2;f;;Rat;17395593|18550765;None
ruthenium red;TRPV2;f;;Mouse;10201375;Antagonist
citral;TRPV2;f;;Rat;18461159;Inhibition
fampridine;TRPV2;f;;Mouse;17673572;Inhibition
tetraethylammonium;TRPV2;f;;Mouse;17673572;Inhibition
TRIM;TRPV2;f;;Mouse;17673572;Inhibition
amiloride;TRPV2;f;;Human;;None
La3+;TRPV2;f;;Human;;None
ruthenium red;TRPV2;f;;Human;;None
SKF96365;TRPV2;f;;Human;;None
6-tert-butyl-m-cresol;TRPV3;f;;Mouse;17420775;Activation
borneol;TRPV3;f;;Mouse;17420775;Activation
cannabidiol;TRPV3;f;;Rat;21726418;Activation
carveol;TRPV3;f;;Mouse;17420775;Activation
citral;TRPV3;f;;Mouse;18461159;Activation
dihydrocarveol;TRPV3;f;;Mouse;17420775;Activation
farnesyl diphosphate;TRPV3;f;;Mouse;20395302;Activation
incensole acetate;TRPV3;f;;Mouse;18492727;Activation
(-)-menthol;TRPV3;f;;Mouse;16829128;Activation
tetrahydrocannabivarin;TRPV3;f;;Rat;21726418;Activation
vanillin;TRPV3;f;;Mouse;16617338;Activation
cinnamaldehyde;TRPV3;f;;Mouse;16829128;Agonist
2-APB;TRPV3;f;;Mouse;15175387;Full agonist
camphor;TRPV3;f;;Mouse;15746429;Full agonist
carvacrol;TRPV3;f;;Mouse;16617338;Full agonist
diphenylboronic anhydride;TRPV3;f;;Mouse;15722340;Full agonist
eugenol;TRPV3;f;;Mouse;16617338;Full agonist
thymol;TRPV3;f;;Mouse;16617338;Full agonist
compound 74a [PMID: 27077528];TRPV3;f;;Human;27077528;Antagonist
diphenyltetrahydrofuran;TRPV3;f;;Mouse;15722340;Antagonist
aspirin-triggered resolvin D1;TRPV3;f;;Human;21718307;Inhibition
forsythoside B;TRPV3;f;;Human;30377214;Inhibition
isopentenyl diphosphate;TRPV3;f;;Human;21353389;Inhibition
osthole;TRPV3;f;;Human;30108138;Inhibition
ruthenium red;TRPV3;f;;Mouse;12016205;Inhibition
4α-PDH;TRPV4;f;;Mouse;19361196;Activation
arachidonic acid;TRPV4;f;;Mouse;12879072;Activation
GSK1016790A;TRPV4;f;;Rat;18499744;Activation
GSK1016790A;TRPV4;f;;Mouse;18499743;Activation
GSK1016790A;TRPV4;f;;Human;18499743;Activation
RN1747;TRPV4;f;;Mouse;19737537;Activation
RN1747;TRPV4;f;;Human;19737537;Activation
RN1747;TRPV4;f;;Rat;19737537;Activation
4α-PDD;TRPV4;f;;Human;12970074;Agonist
4α-PDD;TRPV4;f;;Mouse;11827975;Agonist
5,6-epoxyeicosatrienoic acid;TRPV4;t;;Mouse;12879072;Agonist
bisandrographolide;TRPV4;f;;Mouse;16899456;Agonist
citric acid;TRPV4;f;;Mouse;12692122;Agonist
phorbol 12-myristate 13-acetate;TRPV4;f;;Human;12970074;Agonist
phorbol 12-myristate 13-acetate;TRPV4;f;;Mouse;11827975;Agonist
RN-9893;TRPV4;f;;Human;26235950;Antagonist
RN-9893;TRPV4;f;;Mouse;26235950;Antagonist
ruthenium red;TRPV4;f;;Mouse;11827975;Antagonist
GSK2193874;TRPV4;f;;Human;23136043;Inhibition
GSK2193874;TRPV4;f;;Rat;23136043;Inhibition
GSK2193874;TRPV4;f;;Mouse;23136043;Inhibition
HC067047;TRPV4;f;;Human;20956320;Inhibition
HC067047;TRPV4;f;;Rat;20956320;Inhibition
HC067047;TRPV4;f;;Mouse;20956320;Inhibition
NSC151066;TRPV4;f;;Human;;Inhibition
NSC212069;TRPV4;f;;Human;;Inhibition
NSC600684;TRPV4;f;;Human;;Inhibition
RN1734;TRPV4;f;;Rat;19737537;Inhibition
RN1734;TRPV4;f;;Human;19737537;Inhibition
RN1734;TRPV4;f;;Mouse;19737537;Inhibition
ruthenium red;TRPV4;f;;Rat;12151520;Inhibition
Gd3+;TRPV4;f;;Human;;None
La3+;TRPV4;f;;Human;;None
Crotamiton;TRPV4;f;;None;28612138;Inhibition
ruthenium red;TRPV5;f;;Rabbit;11588099;Inhibition
econazole;TRPV5;f;;Human;;None
Mg2+;TRPV5;f;;Human;;None
miconazole;TRPV5;f;;Human;;None
ruthenium red;TRPV5;f;;Human;;None
2-APB;TRPV6;f;;Human;;Potentiation
ruthenium red;TRPV6;f;;Mouse;11744752;Antagonist
Cd2+;TRPV6;f;;Human;;None
La3+;TRPV6;f;;Human;;None
Mg2+;TRPV6;f;;Human;;None
gabexate;tryptase alpha/beta 1;f;;Human;11172730;Inhibition
nafamostat;tryptase alpha/beta 1;f;;Human;12939527;Inhibition
RWJ-56423;tryptase alpha/beta 1;f;;Human;12930148;Inhibition
WX-UK1;tryptase gamma 1;f;;Unknown;10560742;Inhibition
LM10;tryptophan 2,3-dioxygenase;f;;Human;22308364|21726069;Inhibition
LM10;tryptophan 2,3-dioxygenase;f;;Human;22308364;Inhibition
LM10;tryptophan 2,3-dioxygenase;f;;Mouse;22308364;Inhibition
navoximod;tryptophan 2,3-dioxygenase;f;;Human;26207924;Inhibition
compound 8b [PMID: 22408719];TSH receptor;f;;Human;22408719;Agonist
TSH;TSH receptor;t;Human;Human;;Agonist
[125I]TSH (human);TSH receptor;f;;Human;;Full agonist
AZ3146;TTK protein kinase;f;;Human;20624899;Inhibition
compound 20 [PMID: 30998356];TTK protein kinase;f;;Human;30998356;Inhibition
compound 27f [PMID: 25625617];TTK protein kinase;f;;Human;25625617;Inhibition
compound 34h [PMID: 27055065];TTK protein kinase;f;;Human;27055065;Inhibition
empesertib;TTK protein kinase;f;;Human;26832791;Inhibition
GNE-7915;TTK protein kinase;f;;Human;24354345;Inhibition
MPI-0479605;TTK protein kinase;f;;Human;21980130;Inhibition
MPS1-IN-1;TTK protein kinase;f;;Human;20383151;Inhibition
NMS-P715;TTK protein kinase;f;;Human;21723120;Inhibition
Ro3280;TTK protein kinase;f;;Human;22172702;Inhibition
combretastatin A4;tubulin beta 3 class III;f;;Human;23895532;Inhibition
cabazitaxel;tubulin beta class I;f;;Human;;Inhibition
colchicine;tubulin beta class I;f;;Human;16504507;Inhibition
docetaxel;tubulin beta class I;f;;Human;;Inhibition
eribulin;tubulin beta class I;f;;Human;21324687;Inhibition
ixabepilone;tubulin beta class I;f;;Human;;Inhibition
paclitaxel;tubulin beta class I;f;;Human;16377187;Inhibition
vinblastine;tubulin beta class I;f;;Human;;Inhibition
vincristine;tubulin beta class I;f;;Human;;Inhibition
sacituzumab govitecan;tumor associated calcium signal transducer 2;f;;Human;;Binding
lymphotoxin-α;tumor necrosis factor receptor 1;t;Human;Human;;None
tumour necrosis factor membrane form;tumor necrosis factor receptor 1;t;Human;Human;;None
tumour necrosis factor shed form;tumor necrosis factor receptor 1;t;Human;Human;;None
lymphotoxin-α;tumor necrosis factor receptor 2;t;Human;Human;;None
tumour necrosis factor membrane form;tumor necrosis factor receptor 2;t;Human;Human;;None
TWEAK;TWEAK receptor;t;Human;Human;;None
acalabrutinib;TXK tyrosine kinase;f;;Human;26641137;Inhibition
bosutinib;TXK tyrosine kinase;f;;Human;19039322;Inhibition
compound 23 [PMID: 17600705];TXK tyrosine kinase;f;;Human;17600705;Inhibition
compound 31 [PMID: 24915291];TXK tyrosine kinase;f;;Human;24915291;Inhibition
compound 38 [PMID: 24915291];TXK tyrosine kinase;f;;Human;24915291;Inhibition
compound 7 [PMID: 22464456];TXK tyrosine kinase;f;;Human;22464456;Inhibition
compound 9 [PMID: 26006010];TXK tyrosine kinase;f;;Human;26006010;Inhibition
ibrutinib;TXK tyrosine kinase;f;;Human;26641137;Inhibition
PRN694;TXK tyrosine kinase;f;;Human;25593320;Inhibition
BMS-777607;TYRO3 protein tyrosine kinase;f;;Human;19260711;Inhibition
compound 21 [PMID: 23312943];TYRO3 protein tyrosine kinase;f;;Human;23312943;Inhibition
LDC1267;TYRO3 protein tyrosine kinase;f;;Human;24553136;Inhibition
UNC4203;TYRO3 protein tyrosine kinase;f;;Human;30347155;Inhibition
growth arrest specific protein 6;TYRO3 protein tyrosine kinase;t;Human;Human;8939948;None
protein S;TYRO3 protein tyrosine kinase;t;Human;Human;7867073;None
compound 7 [PMID: 21334791];tyrosinase;f;;Unknown;21334791;Inhibition
BMS-986165;tyrosine kinase 2;f;;Human;31318208;Inhibition
BMS-986165;tyrosine kinase 2;f;;Human;31318208;Inhibition
AZD4205;tyrosine kinase 2;f;;Human;32297743;Inhibition
baricitinib;tyrosine kinase 2;f;;Human;24417533;Inhibition
BMS-911543;tyrosine kinase 2;f;;Human;22015772;Inhibition
brepocitinib;tyrosine kinase 2;f;;Human;30113844;Inhibition
cerdulatinib;tyrosine kinase 2;f;;Human;25253883;Inhibition
compound 29 [Moslin et al., 2017];tyrosine kinase 2;f;;Human;30108788;Inhibition
delgocitinib;tyrosine kinase 2;f;;Human;32511913;Inhibition
delgocitinib;tyrosine kinase 2;f;;Human;25387665;Inhibition
example 1 [WO2018112379A1];tyrosine kinase 2;f;;Human;;Inhibition
example 1 [WO2020051105A1];tyrosine kinase 2;f;;Human;;Inhibition
fedratinib;tyrosine kinase 2;f;;Human;21106455;Inhibition
filgotinib;tyrosine kinase 2;f;;Human;24417533;Inhibition
filgotinib;tyrosine kinase 2;f;;Human;24006460;Inhibition
ilginatinib;tyrosine kinase 2;f;;Human;22829185;Inhibition
izencitinib;tyrosine kinase 2;f;;Human;;Inhibition
JAK3 inhibitor 32;tyrosine kinase 2;f;;Human;30423248;Inhibition
JAK3 inhibitor 34;tyrosine kinase 2;f;;Human;30423248;Inhibition
JAK inhibitor 17b;tyrosine kinase 2;f;;Human;30460842;Inhibition
JAK inhibitor 20a;tyrosine kinase 2;f;;Human;30460842;Inhibition
JAK inhibitor I;tyrosine kinase 2;f;;Human;18077363;Inhibition
LASW1393;tyrosine kinase 2;f;;Human;31609613;Inhibition
oclacitinib;tyrosine kinase 2;f;;Human;;Inhibition
peficitinib;tyrosine kinase 2;f;;Human;28117214;Inhibition
PF-06263276;tyrosine kinase 2;f;;Human;27983835;Inhibition
PF-956980;tyrosine kinase 2;f;;Human;32352776;Inhibition
ruxolitinib;tyrosine kinase 2;f;;Human;23061660;Inhibition
ruxolitinib;tyrosine kinase 2;f;;Human;24417533;Inhibition
SAR-20347;tyrosine kinase 2;f;;Human;21193033;Inhibition
SAR-20347;tyrosine kinase 2;f;;Human;;Inhibition
solcitinib;tyrosine kinase 2;f;;Human;;Inhibition
TG02;tyrosine kinase 2;f;;Human;21860433;Inhibition
tofacitinib;tyrosine kinase 2;f;;Human;24417533;Inhibition
upadacitinib;tyrosine kinase 2;f;;Human;;Inhibition
xiliertinib;tyrosine kinase non receptor 1;f;;Human;28881608;Inhibition
XMD8-92;tyrosine kinase non receptor 1;f;;Human;20832753;Inhibition
bosutinib;tyrosine kinase non receptor 2;f;;Human;19039322;Inhibition
compound 30 [PMID: 17280833];tyrosine kinase non receptor 2;f;;Human;17280833;Inhibition
NIK inhibitor 12f;tyrosine kinase non receptor 2;f;;Human;32479083;Inhibition
compound R-16 [PMID: 21967808];tyrosine kinase with immunoglobulin like and EGF like domains 1;f;;Human;21967808;Inhibition
merestinib;tyrosine kinase with immunoglobulin like and EGF like domains 1;f;;Human;23275061;Inhibition
LDN-91946;ubiquitin C-terminal hydrolase L1;f;;Human;17449248;Inhibition
compound 6 [PMID: 17948018];ubiquitin C-terminal hydrolase L3;f;;Human;17948018;Inhibition
ML323;ubiquitin specific peptidase 1;f;;Human;25229643;Inhibition
IU1;ubiquitin specific peptidase 14;f;;Human;20829789;Inhibition
VLX1570;ubiquitin specific peptidase 14;f;;Human;27264969;Inhibition
vialinin A;ubiquitin specific peptidase 5;f;;Human;23791076;Inhibition
miglustat;UDP-glucose ceramide glucosyltransferase;f;;Human;;Inhibition
ritonavir;UDP glucuronosyltransferase family 1 member A1;f;;Human;21030469;Inhibition
squarunkin A;unc-119 lipid binding chaperone;f;;Human;28471079;Binding
compound R-16 [PMID: 21967808];unc-51 like autophagy activating kinase 1;f;;Human;21967808;Inhibition
compound 15 [PMID: 24900237];unc-51 like kinase 3;f;;Human;24900237;Inhibition
lesinurad;Urate anion exchanger 1;f;;Human;;Inhibition
sufinpyrazone;Urate anion exchanger 1;f;;Human;17325024;Inhibition
verinurad;Urate anion exchanger 1;f;;Human;;Inhibition
[3-iodo-Tyr6]U-II-(4-11) (human);UT receptor;f;;Human;12943190;Agonist
Urolinin;UT receptor;f;;Human;27791374;Agonist
AC-7954;UT receptor;f;;Human;12408704|15781415;Full agonist
[Bz-Phe6]U-II (human);UT receptor;f;;Human;12495432;Full agonist
FL104;UT receptor;f;;Human;17112638|19481466;Full agonist
[Pen5]U-(4-11) (human);UT receptor;f;;Human;12238917;Full agonist
[125I]U-II (human);UT receptor;f;;Human;10499587|11015293|17125276|1546952;Full agonist
[125I]U-II (human);UT receptor;f;;Mouse;11976263;Full agonist
[125I]U-II (human);UT receptor;f;;Rat;10499587;Full agonist
U-II-(4-11) (human);UT receptor;f;;Human;12238917;Full agonist
urotensin-II;UT receptor;f;Rat;Mouse;11976263|15852036;Full agonist
urotensin-II;UT receptor;t;Human;Human;11976263|12238917|15852036;Full agonist
urotensin-II;UT receptor;t;Mouse;Mouse;11976263|15852036;Full agonist
urotensin-II;UT receptor;f;Human;Rat;15852036;Full agonist
urotensin-II;UT receptor;f;Human;Mouse;11976263|15852036;Full agonist
urotensin-II;UT receptor;t;Rat;Rat;15852036;Full agonist
urotensin-II;UT receptor;f;Mouse;Rat;15852036;Full agonist
urotensin-II;UT receptor;f;Mouse;Human;15852036;Full agonist
urotensin-II;UT receptor;f;Rat;Human;15852036;Full agonist
urotensin II-related peptide;UT receptor;t;Human|Mouse|Rat;Human;11015293|18710417;Full agonist
urotensin II-related peptide;UT receptor;t;Human|Mouse|Rat;Human;14550283;Full agonist
BIM 23127;UT receptor;f;;Human;12770925;Antagonist
[Cha6]U-II-(4-11);UT receptor;f;;Rat;17125276;Antagonist
compound 1a [PMID: 18573659];UT receptor;f;;Human;18573659;Antagonist
JNJ-39319202;UT receptor;f;;Human;19731961;Antagonist
[Orn5]URP;UT receptor;f;;Rat;18082287;Antagonist
palosuran;UT receptor;f;;Human;15146030;Antagonist
SB-436811;UT receptor;f;;Rat;15936190;Antagonist
SB-611812;UT receptor;f;;Human;16171813;Antagonist
SB-706375;UT receptor;f;;Mouse;15852036;Antagonist
SB-706375;UT receptor;f;;Human;15852036;Antagonist
SB-706375;UT receptor;f;;Rat;15852036;Antagonist
SR101099;UT receptor;f;;Human;32332113;Antagonist
tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide;UT receptor;f;;Human;12535707;Antagonist
urantide;UT receptor;f;;Human;14645137;Antagonist
4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide;UT receptor;f;;Human;12535707;Inverse agonist
S6716;UT receptor;f;;Human;11960491;Inverse agonist
[125I]N-biotin-[Ahx0, Bpa3]U-II (human);UT receptor;f;;Human;22044114;None
example 25 [WO2018228934];vanin 1;f;;Human;;Inhibition
aminobenzovesamicol;Vesicular acetylcholine transporter;f;;Human;7702637;Inhibition
vesamicol;Vesicular acetylcholine transporter;f;;Human;7702637;Inhibition
[123I]iodobenzovesamicol;Vesicular acetylcholine transporter;f;;Human;;None
[3H]vesamicol;Vesicular acetylcholine transporter;f;;Human;8910293;None
vigabatrin;Vesicular inhibitory amino acid transporter;f;;Human;9349821;Inhibition
ketanserin;Vesicular monoamine transporter 1;f;;Human;8643547;Inhibition
reserpine;Vesicular monoamine transporter 1;f;;Human;8643547;Inhibition
tetrabenazine;Vesicular monoamine transporter 1;f;;Human;8643547;Inhibition
deutetrabenazine;Vesicular monoamine transporter 2;f;;Human;;Inhibition
ketanserin;Vesicular monoamine transporter 2;f;;Human;8643547;Inhibition
reserpine;Vesicular monoamine transporter 2;f;;Human;8643547;Inhibition
[11C]DTBZ;Vesicular monoamine transporter 2;f;;Human;;Inhibition
[125I]7-azido-8-iodoketanserine;Vesicular monoamine transporter 2;f;;Human;9325342;Inhibition
[125I]iodovinyl-TBZ;Vesicular monoamine transporter 2;f;;Human;7855735;Inhibition
[3H]TBZOH;Vesicular monoamine transporter 2;f;;Human;8910293;Inhibition
tetrabenazine;Vesicular monoamine transporter 2;f;;Human;8643547;Inhibition
valbenazine;Vesicular monoamine transporter 2;f;;Rat;;Inhibition
clodronic acid;Vesicular nucleotide transporter;f;;Human;28720702;Inhibition
1,25-dihydroxyvitamin D3;Vitamin D receptor;t;;Human;7976510|12089348;Agonist
2MD;Vitamin D receptor;f;;Human;9804706;Agonist
3-keto-lithocholic acid;Vitamin D receptor;t;;Human;12016314;Agonist
calcipotriol;Vitamin D receptor;f;;Human;7976510;Agonist
calcitriol-26,23-lactone;Vitamin D receptor;t;;Human;6572492;Agonist
doxercalciferol;Vitamin D receptor;f;;Human;;Agonist
eldecalcitol;Vitamin D receptor;f;;Rat;8396500;Agonist
elocalcitol;Vitamin D receptor;f;;Rat;11956143;Agonist
falecalcitriol;Vitamin D receptor;f;;Chicken;11003160;Agonist
gemini;Vitamin D receptor;f;;Unknown;15013848;Agonist
inecalcitol;Vitamin D receptor;f;;Human;10825140;Agonist
lexacalcitol;Vitamin D receptor;f;;Human;8573413;Agonist
LG190178;Vitamin D receptor;f;;Human;10322128;Agonist
lithocholic acid;Vitamin D receptor;t;;Human;12016314;Agonist
maxacalcitol;Vitamin D receptor;f;;Rat;8443002;Agonist
paricalcitol;Vitamin D receptor;f;;Human;;Agonist
seocalcitol;Vitamin D receptor;f;;Human;8573413|1472092;Agonist
tacalcitol;Vitamin D receptor;f;;Human;7976510;Agonist
TEI-9647;Vitamin D receptor;f;;Chicken;17125259;Antagonist
ZK159222;Vitamin D receptor;f;;Human;12901907|11094341;Antagonist
acenocoumarol;vitamin K epoxide reductase complex subunit 1;f;;Rat;17275317;Inhibition
alitretinoin;vitamin K epoxide reductase complex subunit 1;f;;Human;10327215|18374197;Inhibition
dicumarol;vitamin K epoxide reductase complex subunit 1;f;;Human;18610395;Inhibition
phenindione;vitamin K epoxide reductase complex subunit 1;f;;Human;12978288|13037763;Inhibition
phenprocoumon;vitamin K epoxide reductase complex subunit 1;f;;Human;13037763;Inhibition
warfarin;vitamin K epoxide reductase complex subunit 1;f;;Human;23618698;Inhibition
[Ala11,22,28]VIP;VPAC1 receptor;f;;Human;10801840;Agonist
[Ala11,22,28]VIP;VPAC1 receptor;f;;Human;10801840;Agonist
[Ala11,22,28]VIP;VPAC1 receptor;f;;Human;16930633;Agonist
[Ala11,22,28]VIP;VPAC1 receptor;f;;Human;16930633;Agonist
[Arg16]chicken secretin;VPAC1 receptor;f;;Rat;9437714;Agonist
[Arg16]chicken secretin;VPAC1 receptor;f;;Human;9437714;Agonist
BAY 55-9837;VPAC1 receptor;f;;Human;11978642;Agonist
BAY 55-9837;VPAC1 receptor;f;;Human;11978642;Agonist
GHRH;VPAC1 receptor;t;Human;Human;8791009;Agonist
helodermin;VPAC1 receptor;f;;Rat;9928018;Agonist
helodermin;VPAC1 receptor;f;;Human;8791009;Agonist
helodermin;VPAC1 receptor;f;;Human;9928018;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC1 receptor;f;;Rat;9437714;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC1 receptor;f;;Human;11931347;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC1 receptor;f;;Human;9437714;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC1 receptor;f;;Human;11931347;Agonist
N-stearyl-[Nle17]VIP;VPAC1 receptor;f;;Human;9726637;Agonist
N-stearyl-[Nle17]VIP;VPAC1 receptor;f;;Rat;9726637;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Rat;9928018;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;8791009;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;16930633;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;11931347;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;11931347;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;16930633;Agonist
PACAP-27;VPAC1 receptor;t;Human|Mouse|Rat|Sheep;Human;9928018;Agonist
PACAP-38;VPAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
PACAP-38;VPAC1 receptor;t;Human|Mouse|Rat;Human;8791009;Agonist
PACAP-38;VPAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
PG 99-465;VPAC1 receptor;f;;Human;16930633;Agonist
PG 99-465;VPAC1 receptor;f;;Human;16930633;Agonist
PHI;VPAC1 receptor;f;Pig;Human;9928018;Agonist
PHI;VPAC1 receptor;f;Pig;Rat;9928018;Agonist
PHM;VPAC1 receptor;t;Human;Human;8791009;Agonist
PHV;VPAC1 receptor;f;Rat;Human;9928018;Agonist
PHV;VPAC1 receptor;t;Rat;Rat;9928018;Agonist
Ro 25-1392;VPAC1 receptor;f;;Human;9152366;Agonist
Ro 25-1392;VPAC1 receptor;f;;Human;9152366;Agonist
secretin;VPAC1 receptor;f;Pig;Rat;9437714;Agonist
secretin;VPAC1 receptor;f;Pig;Human;9928018;Agonist
secretin;VPAC1 receptor;f;Pig;Rat;9928018;Agonist
secretin;VPAC1 receptor;f;Pig;Human;8791009;Agonist
secretin;VPAC1 receptor;f;Pig;Human;9437714;Agonist
[125I]PACAP-27;VPAC1 receptor;f;;Human;;Agonist
[125I]VIP (human, mouse, rat);VPAC1 receptor;f;;Human;10801840;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;10570056;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;10801840;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;9454823;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;8074647;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Rat;9726637;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;10570056;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;9726637;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;9928018;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;8074647;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;11931347;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;8791009;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;8074647;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;8390245;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;9152366;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Rat;9437714;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;8074647;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;10801840;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;9437714;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Rat;9928018;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;11931347;Agonist
VIP;VPAC1 receptor;t;Human|Mouse|Rat;Human;9152366;Agonist
PG 99-465;VPAC1 receptor;f;;Human;11068102;Partial agonist
Ro 25-1553;VPAC1 receptor;f;;Human;11931347;Partial agonist
Ro 25-1553;VPAC1 receptor;f;;Human;11931347;Partial agonist
Ro 25-1553;VPAC1 receptor;f;;Human;9145428;Partial agonist
Ro 25-1553;VPAC1 receptor;f;;Human;10570056;Partial agonist
Ro 25-1553;VPAC1 receptor;f;;Human;10570056;Partial agonist
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28);VPAC1 receptor;f;;Human;11931347;Antagonist
PG 97-269;VPAC1 receptor;f;;Rat;9437716;Antagonist
PG 97-269;VPAC1 receptor;f;;Human;16930633;Antagonist
PG 97-269;VPAC1 receptor;f;;Human;16930633;Antagonist
PG 97-269;VPAC1 receptor;f;;Human;9437716|10570056;Antagonist
PG 97-269;VPAC1 receptor;f;;Human;10570056;Antagonist
[Ala11,22,28]VIP;VPAC2 receptor;f;;Human;10801840;Agonist
[Ala11,22,28]VIP;VPAC2 receptor;f;;Human;10801840;Agonist
[Ala11,22,28]VIP;VPAC2 receptor;f;;Human;16930633;Agonist
[Ala11,22,28]VIP;VPAC2 receptor;f;;Human;16930633;Agonist
[Arg16]chicken secretin;VPAC2 receptor;f;;Human;9437714;Agonist
[Arg16]chicken secretin;VPAC2 receptor;f;;Rat;9437714;Agonist
BAY 55-9837;VPAC2 receptor;f;;Human;11978642;Agonist
BAY 55-9837;VPAC2 receptor;f;;Human;11978642;Agonist
helodermin;VPAC2 receptor;f;;Rat;9928018;Agonist
helodermin;VPAC2 receptor;f;;Human;9928018;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC2 receptor;f;;Human;9437714;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC2 receptor;f;;Human;11931347;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC2 receptor;f;;Human;11931347;Agonist
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2;VPAC2 receptor;f;;Rat;9437714;Agonist
N-stearyl-[Nle17]VIP;VPAC2 receptor;f;;Rat;9726637;Agonist
N-stearyl-[Nle17]VIP;VPAC2 receptor;f;;Human;9726637;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Human;9928018;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Human;11978642;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Human;16930633;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Human;11931347;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Rat;9928018;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Human;11931347;Agonist
PACAP-27;VPAC2 receptor;t;Human|Mouse|Rat|Sheep;Human;16930633;Agonist
PACAP-38;VPAC2 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
PACAP-38;VPAC2 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
PHI;VPAC2 receptor;f;Pig;Rat;9928018;Agonist
PHI;VPAC2 receptor;f;Pig;Human;9928018;Agonist
PHV;VPAC2 receptor;t;Rat;Rat;9928018;Agonist
PHV;VPAC2 receptor;f;Rat;Human;9928018;Agonist
Ro 25-1392;VPAC2 receptor;f;;Human;9152366;Agonist
Ro 25-1392;VPAC2 receptor;f;;Human;9152366;Agonist
Ro 25-1553;VPAC2 receptor;f;;Human;10570056;Agonist
Ro 25-1553;VPAC2 receptor;f;;Human;11931347|10570056|9145428;Agonist
Ro 25-1553;VPAC2 receptor;f;;Human;11931347;Agonist
secretin;VPAC2 receptor;f;Pig;Rat;9928018;Agonist
secretin;VPAC2 receptor;f;Pig;Human;9437714;Agonist
secretin;VPAC2 receptor;f;Pig;Rat;9437714;Agonist
secretin;VPAC2 receptor;f;Pig;Human;9928018;Agonist
[125I]BAY 55-9837;VPAC2 receptor;f;;Human;11978642;Agonist
[125I]PACAP-27;VPAC2 receptor;f;;Human;;Agonist
[125I]VIP (human, mouse, rat);VPAC2 receptor;f;;Human;10801840;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;9928018;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;10570056;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;10801840;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;10570056;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;9454823;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;11931347;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;11931347;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;9437714;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;9152366;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;9152366;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;10801840;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Rat;9437714;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Rat;9928018;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;16930633;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Rat;9726637;Agonist
VIP;VPAC2 receptor;t;Human|Mouse|Rat;Human;9726637;Agonist
maxadilan;VPAC2 receptor;f;;Human;;Full agonist
PG 99-465;VPAC2 receptor;f;;Human;16930633;Partial agonist
PG 99-465;VPAC2 receptor;f;;Human;16930633;Partial agonist
PG 99-465;VPAC2 receptor;f;;Human;16930633;Partial agonist
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28);VPAC2 receptor;f;;Human;11931347;Antagonist
PG 97-269;VPAC2 receptor;f;;Rat;9437716;Antagonist
PG 97-269;VPAC2 receptor;f;;Human;10570056;Antagonist
PG 97-269;VPAC2 receptor;f;;Human;9437716;Antagonist
PG 99-465;VPAC2 receptor;f;;Human;11068102;Antagonist
GTPγS;VRAC;f;;Human;;None
1,9-dideoxyforskolin;VRAC;f;;Human;;None
9-anthroic acid;VRAC;f;;Human;;None
arachidonic acid;VRAC;t;;Human;;None
carbenoxolone;VRAC;f;;Human;;None
clomiphene;VRAC;f;;Human;;None
DCPIB;VRAC;f;;Human;;None
diBA-(5)-C4;VRAC;f;;Human;;None
DIDS;VRAC;f;;Human;;None
gossypol;VRAC;f;;Human;;None
IAA-94;VRAC;f;;Human;;None
mefloquine;VRAC;f;;Human;;None
Mg2+;VRAC;t;;Human;;None
mibefradil;VRAC;f;;Human;;None
nafoxidine;VRAC;f;;Human;;None
nordihydroguiaretic acid;VRAC;f;;Human;;None
NPPB;VRAC;f;;Human;;None
NS3728;VRAC;f;;Human;;None
quinidine;VRAC;f;;Human;;None
quinine;VRAC;f;;Human;;None
tamoxifen;VRAC;f;;Human;;None
LIT-001;V1A receptor;f;;Human;30199637;Antagonist
arginine vasotocin;V1A receptor;f;;Rat;7774575;Full agonist
arginine vasotocin;V1A receptor;f;;Human;9322919;Full agonist
dAVP;V1A receptor;f;;Human;12446593|15084136;Full agonist
DAVP;V1A receptor;f;;Rat;7774575;Full agonist
d[Cha4]AVP;V1A receptor;f;;Human;12446593;Full agonist
d[Cha4,Dab8]VP;V1A receptor;f;;Rat;17300166;Full agonist
d[Cha4]LVP;V1A receptor;f;;Rat;17300166;Full agonist
desmopressin;V1A receptor;f;;Human;9884074|9334232|10780976|9322919|15084136|9264324;Full agonist
desmopressin;V1A receptor;f;;Rat;7774575;Full agonist
d[Leu4]AVP;V1A receptor;f;;Human;15084136;Full agonist
d[Leu4,Dap8]VP;V1A receptor;f;;Rat;17300166;Full agonist
d[Leu4]LVP;V1A receptor;f;;Rat;17300166;Full agonist
d[D-Phe2]AVP;V1A receptor;f;;Human;12446593;Full agonist
dVDAVP;V1A receptor;f;;Human;9322919|12446593;Full agonist
F180;V1A receptor;f;;Human;10866830|11934825;Full agonist
LVP;V1A receptor;f;Pig;Human;9322919;Full agonist
OPC-51803;V1A receptor;f;;Human;10780976;Full agonist
oxytocin;V1A receptor;t;Human|Mouse|Rat;Rat;7774575;Full agonist
oxytocin;V1A receptor;t;Human|Mouse|Rat;Human;8106369|9884074|9334232|9322919|9459574|9264324|10519430|12660315;Full agonist
[Phe3]OT;V1A receptor;f;;Rat;7774575;Full agonist
[3H]AVP (human, mouse, rat);V1A receptor;f;;Human;8106369|9884074|9459574|7774575|11337500;Full agonist
[3H]OT (human, mouse, rat);V1A receptor;f;;Human;9334232;Full agonist
[Thr4,Gly7]OT;V1A receptor;f;;Human;9884074|9334232;Full agonist
[Val4]AVP;V1A receptor;f;;Human;12446593;Full agonist
vasopressin;V1A receptor;t;Human|Mouse|Rat;Human;8106369|9884074|9334232|10780976|9322919|12446593|9459574|15084136|9264324|10866830|9864265|10519430;Full agonist
vasopressin;V1A receptor;t;Human|Mouse|Rat;Rat;7774575;Full agonist
3-N3-Phpa-LVA;V1A receptor;f;;Human;9334232;Antagonist
atosiban;V1A receptor;f;;Human;10519430|12660315|14722330|15880385;Antagonist
balovaptan;V1A receptor;f;;Human;31951127;Antagonist
conivaptan;V1A receptor;f;;Human;9884074|9459574;Antagonist
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP;V1A receptor;f;;Human;8106369|9322919;Antagonist
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP;V1A receptor;f;;Human;9322919;Antagonist
d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP;V1A receptor;f;;Human;10866830;Antagonist
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP;V1A receptor;f;;Human;9884074;Antagonist
d(CH2)5[Tyr(Me)2,Arg8]VP;V1A receptor;f;;Human;;Antagonist
d(CH2)5[Tyr(Me)2]AVP;V1A receptor;f;;Human;9884074|9334232|9322919|9459574|9264324|10866830;Antagonist
d(CH2)5[Tyr(Me)2,Thr4]OVT;V1A receptor;f;;Human;9322919;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT;V1A receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT;V1A receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT;V1A receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT;V1A receptor;f;;Human;9322919|15880385;Antagonist
d[Pen1,Tyr(Me)2]AVP;V1A receptor;f;;Human;9884074;Antagonist
d[D-Pal2]AVP;V1A receptor;f;;Human;9322919|12446593|1649739;Antagonist
L023103;V1A receptor;f;;Human;16302826;Antagonist
LS-192629;V1A receptor;f;;Human;12660315;Antagonist
mozavaptan;V1A receptor;f;;Rat;9864265;Antagonist
mozavaptan;V1A receptor;f;;Human;9884074|9322919|9864265;Antagonist
nelivaptan;V1A receptor;f;;Human;11861823;Antagonist
OH-LVA;V1A receptor;f;;Human;9322919;Antagonist
OPC-21268;V1A receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP;V1A receptor;f;;Human;8106369|9322919;Antagonist
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP;V1A receptor;f;;Human;8106369|9322919;Antagonist
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP;V1A receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP;V1A receptor;f;;Human;9322919;Antagonist
relcovaptan;V1A receptor;f;;Human;8106369|9884074|10866830|10519430|16158071;Antagonist
Ro5028442;V1A receptor;f;;Human;25654260;Antagonist
RWJ-351647;V1A receptor;f;;Human;16620295;Antagonist
satavaptan;V1A receptor;f;;Human;9884074|11429400;Antagonist
SSR126768A;V1A receptor;f;;Human;14722330;Antagonist
[125I]3-N3-Phpa-LVA;V1A receptor;f;;Human;9334232;Antagonist
[125I]OH-LVA;V1A receptor;f;;Human;10866830|7774575;Antagonist
[3H]d(CH2)5[Tyr(Me)2]AVP;V1A receptor;f;;Human;;Antagonist
[3H]relcovaptan;V1A receptor;f;;Human;8123034;Antagonist
[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP;V1A receptor;f;;Human;9322919;Antagonist
tolvaptan;V1A receptor;f;;Rat;9864265;Antagonist
tolvaptan;V1A receptor;f;;Human;9864265;Antagonist
YM 218;V1A receptor;f;;Human;15661579;Antagonist
YM 471;V1A receptor;f;;Human;11429400;Antagonist
arginine vasotocin;V1B receptor;f;;Human;9322919;Full agonist
dAVP;V1B receptor;f;;Human;9884074|12446593|15084136;Full agonist
d[Cha4]AVP;V1B receptor;f;;Human;12446593|16158071;Full agonist
d[Cha4,Dab8]VP;V1B receptor;f;;Rat;17300166;Full agonist
d[Cha4]LVP;V1B receptor;f;;Rat;17300166;Full agonist
desmopressin;V1B receptor;f;;Human;10780976|9322919|15084136|9264324;Full agonist
d[Leu4]AVP;V1B receptor;f;;Human;15084136;Full agonist
d[Leu4,Dap8]VP;V1B receptor;f;;Rat;17300166;Full agonist
d[Leu4]LVP;V1B receptor;f;;Human;17300166;Full agonist
d[D-Pal2]AVP;V1B receptor;f;;Human;9322919|12446593|1649739;Full agonist
d[D-Phe2]AVP;V1B receptor;f;;Human;12446593;Full agonist
dVDAVP;V1B receptor;f;;Human;9322919|12446593;Full agonist
LVP;V1B receptor;f;Pig;Human;9322919;Full agonist
oxytocin;V1B receptor;t;Human|Mouse|Rat;Human;9884074|9322919|9459574|9264324|16158071;Full agonist
[3H]AVP (human, mouse, rat);V1B receptor;f;;Human;9884074|9322919|12446593|9459574|9264324;Full agonist
[3H]d[Cha4]AVP;V1B receptor;f;;Human;12446593;Full agonist
[3H]OT (human, mouse, rat);V1B receptor;f;;Human;9322919;Full agonist
[Val4]AVP;V1B receptor;f;;Human;12446593;Full agonist
vasopressin;V1B receptor;t;Human|Mouse|Rat;Human;9884074|10780976|9322919|12446593|9459574|15084136|9264324|9864265|10519430|16158071;Full agonist
vasopressin;V1B receptor;t;Human|Mouse|Rat;Rat;9264324;Full agonist
desmopressin;V1B receptor;f;;Rat;9264324;Partial agonist
atosiban;V1B receptor;f;;Human;12660315|14722330;Antagonist
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP;V1B receptor;f;;Human;9322919;Antagonist
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP;V1B receptor;f;;Human;9322919;Antagonist
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP;V1B receptor;f;;Human;9884074;Antagonist
d(CH2)5[Tyr(Me)2]AVP;V1B receptor;f;;Human;9884074|9322919|9459574|9264324;Antagonist
d(CH2)5[Tyr(Me)2,Thr4]OVT;V1B receptor;f;;Human;9322919;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT;V1B receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT;V1B receptor;f;;Human;9322919;Antagonist
d[Pen1,Tyr(Me)2]AVP;V1B receptor;f;;Human;9884074;Antagonist
mozavaptan;V1B receptor;f;;Human;9322919;Antagonist
nelivaptan;V1B receptor;f;;Human;11861823|16158071;Antagonist
OH-LVA;V1B receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP;V1B receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP;V1B receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP;V1B receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP;V1B receptor;f;;Human;9322919;Antagonist
relcovaptan;V1B receptor;f;;Human;9884074|9322919|11429400|16158071;Antagonist
satavaptan;V1B receptor;f;;Human;11429400;Antagonist
[3H]nelivaptan;V1B receptor;f;;Human;;Antagonist
[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP;V1B receptor;f;;Human;9322919;Antagonist
YM 218;V1B receptor;f;;Human;15661579;Antagonist
YM 471;V1B receptor;f;;Human;11429400;Antagonist
d[D-Pal2]AVP;V2 receptor;f;;Human;9322919|12446593|1649739;Agonist
LIT-001;V2 receptor;f;;Human;30199637;Agonist
arginine vasotocin;V2 receptor;f;;Human;9322919|7774575;Full agonist
dAVP;V2 receptor;f;;Human;12446593|15084136;Full agonist
DAVP;V2 receptor;f;;Human;7774575|9792651;Full agonist
DAVP;V2 receptor;f;;Rat;9792651;Full agonist
d[Cha4]AVP;V2 receptor;f;;Human;12446593;Full agonist
d[Cha4,Dab8]VP;V2 receptor;f;;Rat;17300166;Full agonist
d[Cha4]LVP;V2 receptor;f;;Rat;17300166;Full agonist
desmopressin;V2 receptor;f;;Human;9884074|10780976|9322919|15084136|9264324|7774575|11012895|9792651;Full agonist
desmopressin;V2 receptor;f;;Rat;9792651;Full agonist
d[Leu4]AVP;V2 receptor;f;;Human;15084136;Full agonist
d[Leu4,Dap8]VP;V2 receptor;f;;Rat;17300166;Full agonist
d[Leu4]LVP;V2 receptor;f;;Rat;17300166;Full agonist
d[D-Phe2]AVP;V2 receptor;f;;Human;12446593;Full agonist
d[Val4,DArg8]VP;V2 receptor;f;;Human;;Full agonist
dVDAVP;V2 receptor;f;;Human;9322919|12446593;Full agonist
LVP;V2 receptor;f;Pig;Human;9322919|11012895;Full agonist
OPC-51803;V2 receptor;f;;Human;10780976;Full agonist
oxytocin;V2 receptor;t;Human|Mouse|Rat;Human;9884074|9322919|9459574|9264324|7774575|12660315;Full agonist
[Phe3]OT;V2 receptor;f;;Human;7774575;Full agonist
[3H]AVP (human, mouse, rat);V2 receptor;f;;Human;9884074|10780976|9459574|9864265|9792651;Full agonist
[3H]AVP (human, mouse, rat);V2 receptor;f;;Rat;9792651;Full agonist
[3H]dDAVP;V2 receptor;f;;Human;2964362;Full agonist
[3H]OT (human, mouse, rat);V2 receptor;f;;Human;;Full agonist
[Val4]AVP;V2 receptor;f;;Human;12446593;Full agonist
vasopressin;V2 receptor;t;Human|Mouse|Rat;Human;9884074|10780976|9322919|12446593|9459574|15084136|9264324|9864265|10519430|7774575|11012895;Full agonist
VNA932;V2 receptor;f;;Human;16297621;Full agonist
atosiban;V2 receptor;f;;Human;12660315|14722330;Antagonist
balovaptan;V2 receptor;f;;Human;31951127;Antagonist
conivaptan;V2 receptor;f;;Human;20471258;Antagonist
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP;V2 receptor;f;;Human;9322919;Antagonist
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP;V2 receptor;f;;Human;9322919|11012895;Antagonist
d(CH2)5[D-Ile2,Ile4]AVP;V2 receptor;f;;Human;11012895|9792651;Antagonist
d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP;V2 receptor;f;;Human;9792651;Antagonist
d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP;V2 receptor;f;;Rat;9792651;Antagonist
d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP;V2 receptor;f;;Human;9792651;Antagonist
d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP;V2 receptor;f;;Rat;9792651;Antagonist
d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP;V2 receptor;f;;Human;10866830;Antagonist
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP;V2 receptor;f;;Human;9884074|11012895;Antagonist
d(CH2)5[Tyr(Me)2]AVP;V2 receptor;f;;Human;9884074|9322919|9459574|9264324|10866830|11012895;Antagonist
d(CH2)5[Tyr(Me)2,Thr4]OVT;V2 receptor;f;;Human;9322919;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT;V2 receptor;f;;Human;11337500;Antagonist
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT;V2 receptor;f;;Human;9322919|11012895;Antagonist
d[Pen1,Tyr(Me)2]AVP;V2 receptor;f;;Human;9884074|11012895;Antagonist
nelivaptan;V2 receptor;f;;Human;11861823;Antagonist
OH-LVA;V2 receptor;f;;Human;9322919;Antagonist
OPC-21268;V2 receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP;V2 receptor;f;;Human;9322919|11012895;Antagonist
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP;V2 receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP;V2 receptor;f;;Human;9322919;Antagonist
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP;V2 receptor;f;;Human;9322919;Antagonist
relcovaptan;V2 receptor;f;;Human;9884074|9322919|10866830|11429400|11012895;Antagonist
Ro5028442;V2 receptor;f;;Human;25654260;Antagonist
RWJ-351647;V2 receptor;f;;Human;16620295;Antagonist
satavaptan;V2 receptor;f;;Human;9884074|10519430|11012895|9792651|8981918;Antagonist
satavaptan;V2 receptor;f;;Rat;9792651;Antagonist
SKF-105494;V2 receptor;f;;Human;11012895;Antagonist
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP;V2 receptor;f;;Rat;9792651;Antagonist
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP;V2 receptor;f;;Rat;9792651;Antagonist
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP;V2 receptor;f;;Human;9792651;Antagonist
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP;V2 receptor;f;;Rat;9792651;Antagonist
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP;V2 receptor;f;;Rat;9792651;Antagonist
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP;V2 receptor;f;;Human;9792651;Antagonist
[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP;V2 receptor;f;;Human;9322919;Antagonist
tolvaptan;V2 receptor;f;;Human;9864265;Antagonist
tolvaptan;V2 receptor;f;;Rat;9864265;Antagonist
YM 218;V2 receptor;f;;Human;15661579;Antagonist
YM 471;V2 receptor;f;;Human;11429400;Antagonist
lixivaptan;V2 receptor;f;;Human;11012895|9651149;Inverse agonist
mozavaptan;V2 receptor;f;;Human;9884074|9322919|9864265|11012895|9792651;Inverse agonist
mozavaptan;V2 receptor;f;;Rat;9864265|9792651;Inverse agonist
[3H]SR 121463A;V2 receptor;f;;Human;9792651|8981918;Inverse agonist
[3H]desGly-NH2[D-Ile2,Ile4]VP;V2 receptor;f;;Human;;None
enoxacin;V-type ATPase V1 motor B2 subunit;f;;Human;19630402;Inhibition
OICR-9429;WD repeat domain 5;f;;Human;;Antagonist
adavosertib;WEE1 G2 checkpoint kinase;f;;Human;;Inhibition
PD166285;WEE1 G2 checkpoint kinase;f;;Human;11719452;Inhibition
PP1;WNK lysine deficient protein kinase 1;f;;Human;19739668;Inhibition
compound 25 [PMID: 17935989];WNK lysine deficient protein kinase 2;f;;Human;17935989;Inhibition
compound 2c [PMID: 24900538];WNK lysine deficient protein kinase 3;f;;Human;24900538;Inhibition
allopurinol;xanthine dehydrogenase;f;;Human;8691450;Inhibition
allopurinol;xanthine dehydrogenase;f;;Human;8691450;Inhibition
febuxostat;xanthine dehydrogenase;f;;Human;24508129;Inhibition
febuxostat;xanthine dehydrogenase;f;;Bovine;23122864;Inhibition
febuxostat;xanthine dehydrogenase;f;;Bovine;12421831;Inhibition
topiroxostat;xanthine dehydrogenase;f;;None;;Inhibition
XCL1;XCR1;t;Human;Human;25497737;Agonist
XCL2;XCR1;t;Human;Human;25497737;Agonist
[125I]XCL1 (human);XCR1;f;;Human;9632725;Full agonist
AZD5582;X-linked inhibitor of apoptosis;f;;Human;24320998;Antagonist
birinapant;X-linked inhibitor of apoptosis;f;;Human;23225169;Antagonist
GDC-0152;X-linked inhibitor of apoptosis;f;;Human;22413863;Antagonist
SM-337;X-linked inhibitor of apoptosis;f;;Human;19049347;Antagonist
xevinapant;X-linked inhibitor of apoptosis;f;;Human;21443232;Antagonist
BV-6;X-linked inhibitor of apoptosis;f;;Human;18022362;Inhibition
LCL161;X-linked inhibitor of apoptosis;f;;Human;24083782;Inhibition
SM-122;X-linked inhibitor of apoptosis;f;;Human;19049347;Inhibition
apstatin;X-prolyl aminopeptidase 1;f;;Human;10395480;Inhibition
apstatin;X-prolyl aminopeptidase 2;f;;Human;10395480;Inhibition
apstatin;X-prolyl aminopeptidase 2;f;;Human;10395480;Inhibition
compound 6 [PMID: 10395480];X-prolyl aminopeptidase 2;f;;Human;10395480;Inhibition
eCF506;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;27115835;Inhibition
ibrutinib;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;26641137;Inhibition
rebastinib;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;23787099;Inhibition
saracatinib;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;17064066;Inhibition
spebrutinib;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;;Inhibition
SU6656;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;18077363;Inhibition
xiliertinib;YES proto-oncogene 1, Src family tyrosine kinase;f;;Human;28881608;Inhibition
[Leu31,Pro34]NPY;Y1 receptor;f;;Human;8590988;Agonist
neuropeptide Y;Y1 receptor;t;Human|Mouse|Rat;Human;;Agonist
peptide YY;Y1 receptor;t;Human;Human;;Agonist
[Ala31,Aib32]NPY (pig);Y1 receptor;f;;Human;12069595;Full agonist
[Leu31,Pro34]NPY;Y1 receptor;f;;Rat;9145427;Full agonist
[Leu31,Pro34]NPY;Y1 receptor;f;;Rat;1316999;Full agonist
[Leu31,Pro34]NPY (pig);Y1 receptor;f;;Rat;10694200;Full agonist
[Leu31,Pro34]PYY (human);Y1 receptor;f;;Human;;Full agonist
[Leu31,Pro34]PYY (human);Y1 receptor;f;;Rat;9145427;Full agonist
[Leu31,Pro34]PYY (pig);Y1 receptor;f;;Rat;10694200;Full agonist
neuropeptide Y;Y1 receptor;t;Human|Mouse|Rat;Rat;9145427;Full agonist
neuropeptide Y;Y1 receptor;t;Human|Mouse|Rat;Rat;1316999;Full agonist
NPY;Y1 receptor;f;Pig;Human;16097949;Full agonist
NPY;Y1 receptor;f;Pig;Rat;9145427;Full agonist
NPY-(13-36) (pig);Y1 receptor;f;;Rat;9145427;Full agonist
NPY-(2-36);Y1 receptor;f;;Rat;9145427;Full agonist
NPY-(2-36) (pig);Y1 receptor;f;;Rat;10694200;Full agonist
NPY-(3-36) (pig);Y1 receptor;f;;Rat;9145427;Full agonist
pancreatic polypeptide;Y1 receptor;t;Rat;Rat;9145427;Full agonist
pancreatic polypeptide;Y1 receptor;f;Bovine;Rat;9145427;Full agonist
pancreatic polypeptide;Y1 receptor;f;Human;Rat;9145427;Full agonist
peptide YY;Y1 receptor;t;Mouse|Pig|Rat;Rat;9145427;Full agonist
peptide YY;Y1 receptor;f;Human;Rat;1316999|10694200;Full agonist
[Pro34]NPY;Y1 receptor;f;;Human;;Full agonist
[Pro34]PYY (human);Y1 receptor;f;;Human;;Full agonist
PYY-(13-36) (mouse, rat, pig);Y1 receptor;f;;Rat;9145427;Full agonist
PYY-(3-36);Y1 receptor;f;Human;Rat;9145427;Full agonist
[125I][Leu31,Pro34]NPY;Y1 receptor;f;;Human;;Full agonist
[125I]NPY (human, mouse, rat);Y1 receptor;f;;Rat;1316999;Full agonist
[125I]PYY (pig);Y1 receptor;f;;Human;1317848;Full agonist
[125I]PYY (pig);Y1 receptor;f;;Human;16097949;Full agonist
[3H]NPY (human, mouse, rat);Y1 receptor;f;;Mouse;7623780;Full agonist
BIBO3304;Y1 receptor;f;;Rat;10694200;Antagonist
BIBO3304;Y1 receptor;f;;Human;9806339;Antagonist
BIBP3226;Y1 receptor;f;;Rat;9145427|8886416|7562541;Antagonist
BIBP3226;Y1 receptor;f;;Human;7562541|7562543;Antagonist
GR231118;Y1 receptor;f;;Rat;9145427;Antagonist
GR231118;Y1 receptor;f;;Rat;10694200;Antagonist
SR120819A;Y1 receptor;f;;Human;16097949;Antagonist
[125I]GR231118;Y1 receptor;f;;Rat;10694200;Antagonist
[3H]BIBP3226;Y1 receptor;f;;Human;;Antagonist
neuropeptide Y;Y2 receptor;t;Human|Mouse|Rat;Human;;Agonist
peptide YY;Y2 receptor;t;Human;Human;;Agonist
[Ala31,Aib32]NPY (pig);Y2 receptor;f;;Human;12069595;Full agonist
C2-NPY (pig);Y2 receptor;f;;Human;7592910;Full agonist
[D-Trp32]NPY;Y2 receptor;f;;Rat;11408607;Full agonist
[D-Trp32]NPY;Y2 receptor;f;;Human;8632753;Full agonist
N-α-Ac-PYY-(22-36) (rat);Y2 receptor;f;;Rat;11408607;Full agonist
N-α-Ac-PYY-(25-36) (rat);Y2 receptor;f;;Rat;11408607;Full agonist
[Leu31,Pro34]NPY;Y2 receptor;f;;Human;7592910;Full agonist
[Leu31,Pro34]NPY (pig);Y2 receptor;f;;Human;8632753;Full agonist
[Leu31,Pro34]PYY (human);Y2 receptor;f;;Human;8632753;Full agonist
neuropeptide Y;Y2 receptor;t;Human|Mouse|Rat;Human;8632753|7592910;Full agonist
neuropeptide Y;Y2 receptor;t;Human|Mouse|Rat;Rat;11408607;Full agonist
neuropeptide Y-(3-36);Y2 receptor;t;Human|Mouse|Rat;Human;;Full agonist
NPY;Y2 receptor;f;Pig;Human;8632753|7592910;Full agonist
NPY-(13-36) (human);Y2 receptor;f;;Rat;11408607;Full agonist
NPY-(13-36) (pig);Y2 receptor;f;;Human;8632753|7592910;Full agonist
NPY-(16-36) (pig);Y2 receptor;f;;Human;7592910;Full agonist
NPY-(20-36) (pig);Y2 receptor;f;;Human;7592910;Full agonist
NPY-(22-36) (pig);Y2 receptor;f;;Human;7592910;Full agonist
NPY-(2-36);Y2 receptor;f;;Human;7592910;Full agonist
NPY-(2-36) (pig);Y2 receptor;f;;Human;8632753|7592910;Full agonist
NPY-(26-36) (pig);Y2 receptor;f;;Human;7592910;Full agonist
NPY-(3-36) (pig);Y2 receptor;f;;Human;8632753;Full agonist
NPY-(3-36) (pig);Y2 receptor;f;;Rat;11408607;Full agonist
peptide YY;Y2 receptor;f;Mouse|Pig|Rat;Rat;11408607;Full agonist
peptide YY;Y2 receptor;t;Human;Human;8632753|7592910;Full agonist
peptide YY;Y2 receptor;f;Mouse|Pig|Rat;Human;7592910;Full agonist
[Pro34]PYY (human);Y2 receptor;f;;Human;8632753;Full agonist
PYY-(13-36) (mouse, rat, pig);Y2 receptor;f;;Human;8632753|7592910;Full agonist
PYY-(3-36);Y2 receptor;t;Human;Human;8632753|7592910;Full agonist
PYY-(3-36) (pig);Y2 receptor;f;;Rat;11408607;Full agonist
[125I]NPY (human, mouse, rat);Y2 receptor;f;;Human;7559383;Full agonist
[125I]PYY;Y2 receptor;f;;Human;7559383;Full agonist
[125I]PYY-(3-36) (human);Y2 receptor;f;;Human;;Full agonist
BIIE0246;Y2 receptor;f;;Rat;11408607;Antagonist
BIIE0246;Y2 receptor;f;;Human;10611450;Antagonist
JNJ-5207787;Y2 receptor;f;;Human;14617685;Antagonist
[Ala31,Aib32]NPY (pig);Y4 receptor;f;;Human;12069595;Full agonist
GR231118;Y4 receptor;f;;Mouse;16807358;Full agonist
GR231118;Y4 receptor;f;;Human;16807358;Full agonist
GR231118;Y4 receptor;f;;Rat;10694200;Full agonist
[Ile31,Gln34]PP (human);Y4 receptor;f;;Rat;9210181;Full agonist
[Leu31,Pro34]NPY;Y4 receptor;f;;Rat;9145427|8643536|9210181;Full agonist
[Leu31,Pro34]NPY;Y4 receptor;f;;Human;7493937;Full agonist
[Leu31,Pro34]NPY;Y4 receptor;f;;Mouse;8641440;Full agonist
[Leu31,Pro34]NPY;Y4 receptor;f;;Rat;9210181;Full agonist
[Leu31,Pro34]NPY (pig);Y4 receptor;f;;Rat;10694200;Full agonist
[Leu31,Pro34]PYY (human);Y4 receptor;f;;Rat;9145427;Full agonist
[Leu31,Pro34]PYY (pig);Y4 receptor;f;;Rat;10694200;Full agonist
neuropeptide Y;Y4 receptor;t;Human|Mouse|Rat;Rat;9210181;Full agonist
neuropeptide Y;Y4 receptor;t;Human|Mouse|Rat;Rat;9145427|9210181;Full agonist
neuropeptide Y;Y4 receptor;t;Human|Mouse|Rat;Human;7493937;Full agonist
NPY;Y4 receptor;f;Pig;Rat;9145427;Full agonist
NPY-(13-36) (pig);Y4 receptor;f;;Rat;9145427|9210181;Full agonist
NPY-(13-36) (pig);Y4 receptor;f;;Human;7493937;Full agonist
NPY-(2-36);Y4 receptor;f;;Rat;9145427;Full agonist
NPY-(2-36);Y4 receptor;f;;Mouse;8641440;Full agonist
NPY-(2-36) (pig);Y4 receptor;f;;Human;7493937;Full agonist
NPY-(3-36) (pig);Y4 receptor;f;;Rat;9145427;Full agonist
pancreatic polypeptide;Y4 receptor;t;Human;Human;8643460|7493937|16807358|7592911;Full agonist
pancreatic polypeptide;Y4 receptor;f;Bovine;Rat;9145427|9210181;Full agonist
pancreatic polypeptide;Y4 receptor;f;Human;Mouse;16807358;Full agonist
pancreatic polypeptide;Y4 receptor;f;Human;Rat;9145427|9210181;Full agonist
pancreatic polypeptide;Y4 receptor;t;Rat;Rat;9145427|8643536|9210181;Full agonist
pancreatic polypeptide;Y4 receptor;f;Rat;Human;16807358;Full agonist
pancreatic polypeptide;Y4 receptor;f;Bovine;Human;8643460;Full agonist
pancreatic polypeptide;Y4 receptor;f;Rat;Mouse;16807358;Full agonist
peptide YY;Y4 receptor;t;Mouse|Pig|Rat;Mouse;8641440;Full agonist
peptide YY;Y4 receptor;f;Human;Rat;9210181;Full agonist
peptide YY;Y4 receptor;t;Mouse|Pig|Rat;Rat;9145427|9210181;Full agonist
peptide YY;Y4 receptor;t;Human;Human;7493937;Full agonist
peptide YY;Y4 receptor;f;Mouse|Pig|Rat;Rat;9210181;Full agonist
PP-(13-36) (human);Y4 receptor;f;;Rat;9210181;Full agonist
PP-(20-36) (human);Y4 receptor;f;;Rat;9210181;Full agonist
PP-(2-36) (human);Y4 receptor;f;;Rat;9210181;Full agonist
[Pro34]PYY (human);Y4 receptor;f;;Human;16807358;Full agonist
[Pro34]PYY (human);Y4 receptor;f;;Mouse;16807358;Full agonist
[Pro34]PYY (human);Y4 receptor;f;;Rat;9210181;Full agonist
PYY-(13-36) (mouse, rat, pig);Y4 receptor;f;;Rat;9210181;Full agonist
PYY-(13-36) (mouse, rat, pig);Y4 receptor;f;;Rat;9145427;Full agonist
PYY-(3-36);Y4 receptor;f;Human;Rat;9145427;Full agonist
PYY-(3-36);Y4 receptor;t;Mouse|Rat;Rat;9210181;Full agonist
[125I]GR231118;Y4 receptor;f;;Rat;10694200;Full agonist
[125I]PP (human);Y4 receptor;f;;Human;;Full agonist
[125I]PYY (pig);Y4 receptor;f;;Human;7493937;Full agonist
niclosamide;Y4 receptor;f;;Human;27294784;Positive
GR231118;Y4 receptor;f;;Rat;9145427;Antagonist
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP;Y5 receptor;f;;Rat;15337369;Agonist
[Ala31,Aib32]NPY;Y5 receptor;f;;Rat;12890716;Full agonist
[Ala31,Aib32]NPY (pig);Y5 receptor;f;;Rat;12069595;Full agonist
[Ala31,Aib32]NPY (pig);Y5 receptor;f;;Human;12069595;Full agonist
[D-Trp32]NPY;Y5 receptor;f;;Rat;8824284;Full agonist
[D-Trp32]NPY;Y5 receptor;f;;Human;8824284;Full agonist
GR231118;Y5 receptor;f;;Rat;12890716;Full agonist
[Leu31,Pro34]NPY (pig);Y5 receptor;f;;Rat;8824284|12890716;Full agonist
[Leu31,Pro34]NPY (pig);Y5 receptor;f;;Human;8824284;Full agonist
[Leu31,Pro34]PYY (human);Y5 receptor;f;;Human;8824284;Full agonist
[Leu31,Pro34]PYY (human);Y5 receptor;f;;Rat;8824284;Full agonist
neuropeptide Y;Y5 receptor;t;Human|Mouse|Rat;Human;8824284;Full agonist
neuropeptide Y;Y5 receptor;t;Human|Mouse|Rat;Rat;8824284;Full agonist
NPY-(13-36) (pig);Y5 receptor;f;;Rat;8824284;Full agonist
NPY-(13-36) (pig);Y5 receptor;f;;Human;8824284;Full agonist
NPY-(18-36) (human, pig);Y5 receptor;f;;Rat;8824284;Full agonist
NPY-(18-36) (human, pig);Y5 receptor;f;;Human;8824284;Full agonist
NPY-(2-36);Y5 receptor;f;;Rat;8824284;Full agonist
NPY-(2-36);Y5 receptor;f;;Human;8824284;Full agonist
NPY-(3-36) (pig);Y5 receptor;f;;Human;8824284;Full agonist
NPY-(3-36) (pig);Y5 receptor;f;;Rat;8824284;Full agonist
pancreatic polypeptide;Y5 receptor;t;Rat;Rat;8824284;Full agonist
pancreatic polypeptide;Y5 receptor;f;Human;Rat;8824284|12890716;Full agonist
pancreatic polypeptide;Y5 receptor;f;Rat;Human;8824284;Full agonist
pancreatic polypeptide;Y5 receptor;t;Human;Human;8824284;Full agonist
peptide YY;Y5 receptor;t;Mouse|Pig|Rat;Rat;8824284;Full agonist
peptide YY;Y5 receptor;f;Mouse|Pig|Rat;Human;8824284;Full agonist
[PP1-17,Ala31,Aib32]NPY (human);Y5 receptor;f;;Human;12890716;Full agonist
PYY-(13-36) (mouse, rat, pig);Y5 receptor;f;;Rat;8824284;Full agonist
PYY-(13-36) (mouse, rat, pig);Y5 receptor;f;;Human;8824284;Full agonist
PYY-(3-36);Y5 receptor;f;Mouse|Rat;Human;8824284;Full agonist
PYY-(3-36);Y5 receptor;t;Mouse|Rat;Rat;8824284;Full agonist
[125I][PP1-17,Ala31,Aib32]NPY (human);Y5 receptor;f;;Rat;12890716;Full agonist
CGP 71683A;Y5 receptor;f;;Rat;12890716;Antagonist
FMS586;Y5 receptor;f;;Human;16436501;Antagonist
JCF 109;Y5 receptor;f;;Rat;12890716;Antagonist
L-152,804;Y5 receptor;f;;Rat;10872822;Antagonist
L-152,804;Y5 receptor;f;;Human;10872822;Antagonist
Cu2+;ZAC ;t;;Human;26872532;Agonist
H+;ZAC ;t;;Human;26872532;Agonist
Zn2+;ZAC ;t;;Human;12381728|26872532;Agonist
Ca2+;ZAC ;f;;Human;26872532;Antagonist
tubocurarine;ZAC ;f;;Human;12381728;Antagonist
compound 15b [PMID: 16539403];ZAK sterile alpha motif and leucine zipper containing kinase AZK;f;;Human;16539403;Inhibition
ZAK inhibitor 6p;ZAK sterile alpha motif and leucine zipper containing kinase AZK;f;;Human;31244114;Inhibition
ZAK inhibitor 6p;ZAK sterile alpha motif and leucine zipper containing kinase AZK;f;;Human;31244114;Inhibition
aloisine;zeta chain of T cell receptor associated protein kinase 70;f;;Human;22289061;Inhibition
mivavotinib;zeta chain of T cell receptor associated protein kinase 70;f;;Human;27839918;Inhibition
Syk inhibitor II;zeta chain of T cell receptor associated protein kinase 70;f;;Human;15990316;Inhibition
NSC157058;Zika virus genome polyprotein;f;;Zika virus;28461069;Inhibition
